Rank	NCT Number	Title	Acronym	Status	Study Results	Conditions	Interventions	Outcome Measures	Sponsor/Collaborators	Gender	Age	Phases	Enrollment	Funded Bys	Study Type	Study Designs	Other IDs	Start Date	Primary Completion Date	Completion Date	First Posted	Results First Posted	Last Update Posted	Locations	Study Documents	URL
1	NCT05003960	Safety of Cultured Allogeneic Adult Umbilical Cord Derived Mesenchymal Stem Cell Intravenous Infusion for Autism		Recruiting	No Results Available	Autism	Biological: AlloRx	Safety (adverse events)|Efficacy: Autism Treatment Evaluation Checklist (ATEC)	The Foundation for Orthopaedics and Regenerative Medicine	All	Child, Adult, Older Adult	Phase 1	15	Other	Interventional	Allocation: N/A|Intervention Model: Single Group Assignment|Masking: None (Open Label)|Primary Purpose: Treatment	SC-8-ATG-8-02	January 23, 2022	September 2025	September 2025	August 13, 2021		October 27, 2022	Medical Surgical Associates Center, St. John's, Antigua and Barbuda		https://ClinicalTrials.gov/show/NCT05003960
2	NCT03982290	Psychophysiological Effects of Lactobacillus Plantarum PS128 in Preschool Children With Autism Spectrum Disorder		Unknown status	No Results Available	Autism	Other: Probiotic, Lactobacillus plantarum PS128|Other: Placebo, microcrystalline cellulose	Changes from baseline of anxiety subscale in Children's Behavior Checklist (CBCL)/Achenbach System of Empirically Based Assessment (ASEBA) at week 8 and week 16|Changes from hyperactivity subscale of Attention-Deficit/Hyperactivity Disorder Test (ADHDT) at week 8 and week 16|Gastrointestinal symptoms recorded by using GI Severity Index (6-GSI) at week 8 and week 16|Change of total scores at week 8 and week 16 from baseline of Changes of Childhood Asperger Syndrome Test (CAST)|Change of total scores at week 8 and week 16 from baseline of Penn Interactive Peer Play Scale, (PIPPS)|Change of total scores at week 8 and week 16 from baseline of Social Interaction Assessment Scale|Comparison of Microbiota composition between week 8 and baseline	Mackay Memorial Hospital	All	30 Months to 7 Years   (Child)	Not Applicable	250	Other	Interventional	Allocation: Randomized|Intervention Model: Crossover Assignment|Masking: Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)|Primary Purpose: Treatment	17MMHIS193e	October 1, 2018	December 2019	December 2020	June 11, 2019		June 11, 2019	Department of Pediatric Neurology, MacKay Children's Hospital, Taipei, Taiwan		https://ClinicalTrials.gov/show/NCT03982290
3	NCT01098383	Treatment With Acetyl-Choline Esterase Inhibitors in Children With Autism Spectrum Disorders		Unknown status	No Results Available	Autism	Drug: Acetyl-Choline Esterase Inhibitors and Choline supplements|Drug: Indistinguishable placebo tablets, matching both donepezil and choline	Core autistic symptoms (ATEC)|Side effects and adverse events questionnaire|Linguistic performance (CELF-4)|Adaptive functioning (Vineland-II)|Comorbid behaviors (CSI-4 questionnaire)|Executive functions (BRIEF questionnaire)	Sheba Medical Center|The Israeli Society of Clinical Pediatrics (HIPAK)	All	10 Years to 18 Years   (Child, Adult)	Phase 4	84	Other	Interventional	Allocation: Randomized|Intervention Model: Crossover Assignment|Masking: Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)|Primary Purpose: Treatment	SHEBA-09-7151-LG-CTIL	March 2010	December 2017	December 2017	April 2, 2010		October 14, 2016	Sheba Medical Center, Tel Hashomer, Ramat Gan, Israel		https://ClinicalTrials.gov/show/NCT01098383
4	NCT01836562	A Clinical Trial to Study the Safety and Efficacy of Bone Marrow Derived Autologous Cells for the Treatment of Autism	BMCA	Unknown status	No Results Available	Autism	Biological: STEM CELL THERAPY	Improvement in childhood autism rating scale|Improvement in perfusion of brain with PET scan report	Chaitanya Hospital, Pune	All	3 Years to 70 Years   (Child, Adult, Older Adult)	Phase 1|Phase 2	100	Other	Interventional	Allocation: N/A|Intervention Model: Single Group Assignment|Masking: None (Open Label)|Primary Purpose: Treatment	00105	September 2014	June 2016	June 2016	April 22, 2013		September 17, 2014	Chaitanya Hospital, Pune, Maharashtra, India		https://ClinicalTrials.gov/show/NCT01836562
5	NCT03723876	Basic Body Awareness Therapy for Persons With Autism		Completed	No Results Available	Autism	Behavioral: Body awareness therapy	Change of experienced health problem from Numeric rating scale|Change of results of Body Awareness Scale Movement Quality and Experiences, BAS MQ-E	Lund University|Vastra Gotaland Region	All	15 Years to 30 Years   (Child, Adult)	Not Applicable	57	Other	Interventional	Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Treatment	Ingrid Bertilsson	May 1, 2018	June 15, 2022	June 15, 2022	October 30, 2018		July 1, 2022	Vuxenhabiliteringen, Vaxjo, Kronoberg, Sweden|Habiliteringen Vastra Gotalandsregionen, Skovde, Vastra Gotaland, Sweden		https://ClinicalTrials.gov/show/NCT03723876
6	NCT03786744	Allogenic Cord Blood Transfusion in Patients With Autism		Completed	Has Results	Autism Spectrum Disorder|Autism	Biological: ASD CB-MNC injection.|Other: Standard therapy.	A Number of Participants With Non-serious and Serious Adverse Events 24 Hrs Post-transfusion|Autism Treatment Evaluation Checklist (ATEC).|Cytokine Analysis.|Immune Status as Determined by Percentage of Peripheral Blood Cells|Immune Status as Determined by Absolute Cell Count of Peripheral Blood Cells	State-Financed Health Facility "Samara Regional Medical Center Dinasty"	All	3 Years to 15 Years   (Child)	Phase 1|Phase 2	20	Other	Interventional	Allocation: Non-Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Treatment	12112018	October 12, 2018	October 12, 2019	December 12, 2019	December 26, 2018	November 19, 2020	November 19, 2020	Medical Centre Dinasty, Samara, Russian Federation	"Study Protocol and Statistical Analysis Plan", https://ClinicalTrials.gov/ProvidedDocs/44/NCT03786744/Prot_SAP_000.pdf	https://ClinicalTrials.gov/show/NCT03786744
7	NCT02807766	Brain Plasticity of Autism in Response to Early Behavioral Intervention: A Multimodal MRI Study		Unknown status	No Results Available	Autism	Behavioral: Behavior modification|Behavioral: Behavior modification and sensory integration training|Behavioral: Behavior modification and applied behavioral analysis|Behavioral: Behavior modification and TEACCH	Brain structural and functional change under behavioral intervention at 6 months in children with autism|Prediction model of intervention effect based on multimodal multivariate pattern analysis methods	University of Electronic Science and Technology of China	All	2 Years to 8 Years   (Child)	Not Applicable	150	Other	Interventional	Allocation: Randomized|Intervention Model: Factorial Assignment|Masking: Triple (Participant, Care Provider, Investigator)|Primary Purpose: Basic Science	UESTC-chenhuafulab-001	May 2016	December 2022	December 2022	June 21, 2016		January 18, 2020	Department of Children's and Adolescent Health, Public Health College of Harbin Medical University, Harbin, Heilongjiang, China|Center for Information in BioMedicine, Key laboratory for NeuroInformation of Ministry of Education, School of Life Science and Technology, University of Electronic Science and Technology of China, Chengdu, Sichuan, China		https://ClinicalTrials.gov/show/NCT02807766
8	NCT03368001	Investigating Social Competence in Youth With Autism		Active, not recruiting	No Results Available	Autism Spectrum Disorder	Behavioral: SENSE Theatre|Behavioral: Tackling Teenage Together	NEPSY Memory for Faces Delayed|Incidental Face Memory (IFM) Event-Related Potential (ERP) task|Social Responsiveness Scale (SRS)|Adaptive Behavior Scales for Children (ABAS)|Contextual Assessment of Social Skills (CASS)|Child Behavior Checklist (CBCL)	Vanderbilt University Medical Center	All	8 Years to 16 Years   (Child)	Not Applicable	405	Other	Interventional	Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Single (Outcomes Assessor)|Primary Purpose: Treatment	171153	November 22, 2017	August 15, 2022	January 2023	December 11, 2017		August 29, 2022	University of Alabama, Tuscaloosa, Alabama, United States|Stony Brook University, Stony Brook, New York, United States|Vanderbilt University Medical Center, Nashville, Tennessee, United States	"Informed Consent Form", https://ClinicalTrials.gov/ProvidedDocs/01/NCT03368001/ICF_000.pdf	https://ClinicalTrials.gov/show/NCT03368001
9	NCT04533607	Modular Approach for Autism Programs in Schools	MAAPS	Recruiting	No Results Available	Autism Spectrum Disorder	Behavioral: MAAPS	Change in score for Developmental Disability-Clinical Global Assessment Scale (DD-CGAS)|Change in rating for Teacher Nominated Target Problems (TNTP)|Change in score for Social Skills Improvement System (SSIS)|Change in score for Children's Communication Checklist, Second Edition (CCC-2)|Change in score for Children's Yale-Brown Obsessive-Compulsive Scales-ASD (CYBOCS-ASD)|Change in engaged time measured by Academic Engaged Time (AET)|Change in score for Adaptive Behavior Assessment System, Third Edition (ABAS-3)|Usage Rating Profile-Intervention, Revised (URP-IR)	May Institute|University of South Florida|University of Rochester	All	5 Years to 12 Years   (Child)	Not Applicable	120	Other	Interventional	Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Single (Outcomes Assessor)|Primary Purpose: Treatment	R324A200154	November 4, 2020	June 2024	June 2024	August 31, 2020		February 24, 2021	University of South Florida, Tampa, Florida, United States|May Institute, Randolph, Massachusetts, United States|University of Rochester, Rochester, New York, United States		https://ClinicalTrials.gov/show/NCT04533607
10	NCT03467464	The Efficacy of EMDR in Youngsters With Autism	EYE-catcher	Unknown status	No Results Available	Autism Spectrum Disorder	Other: Eye Movement Desensitization and Reprocessing (EMDR)	Change in autism symptoms|Change in disease severity|Change in experienced stress|Change in general well-being|Change in working memory capacity	Karakter Kinder- en Jeugdpsychiatrie|Fonds Psychische Gezondheid	All	12 Years to 21 Years   (Child, Adult)	Not Applicable	20	Other	Interventional	Allocation: N/A|Intervention Model: Single Group Assignment|Masking: None (Open Label)|Primary Purpose: Treatment	NL6002609116	December 1, 2017	December 2018	December 2018	March 16, 2018		March 16, 2018	Karakter kinder- en jeugdpsychiatrie, Nijmegen, Gelderland, Netherlands		https://ClinicalTrials.gov/show/NCT03467464
11	NCT05406076	the Efficacy of Oral Motor Therapy in Children With Autism		Not yet recruiting	No Results Available	Autism	Behavioral: oral motor therapy|Behavioral: ABA	Changes in the Verbal Behavior Milestones Assessment and Placement Program (VB-MAPP) scores|Changes in Assessment of Basic Language and Learning Skills-Revised (ABLLS-R) scores|Change in the Autism Behavior Scale (ABC) scores|Change in Childhood Autism Rating Scale (CARS) scores|Change in China Rehabilitation Research Center version of the Sign-Significance（S-S，CRRC version） scores	The First Affiliated Hospital of Anhui Medical University|Hefei Kanghua Rehabilitation Hospital|Hefei Jingu Rehabilitation Hospital	All	2 Years to 5 Years   (Child)	Not Applicable	80	Other	Interventional	Allocation: Randomized|Intervention Model: Crossover Assignment|Masking: None (Open Label)|Primary Purpose: Treatment	WDX-05	December 1, 2022	June 1, 2023	August 1, 2023	June 6, 2022		October 27, 2022			https://ClinicalTrials.gov/show/NCT05406076
12	NCT05192993	Effect of Oculomotor Exercise on Writing Capabilities on Autism		Enrolling by invitation	No Results Available	Autism	Other: visual motor integration group|Other: Handwriting intervention programs|Other: visual motor integration program and Handwriting intervention programs	gaze stability|eye head coordination	Misr University for Science and Technology	All	5 Years to 8 Years   (Child)	Not Applicable	40	Other	Interventional	Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Single (Participant)|Primary Purpose: Treatment	P.T.REC/012/003283	January 1, 2022	March 2022	March 2022	January 14, 2022		January 14, 2022	Misr university for science and technology, Cairo, Egypt		https://ClinicalTrials.gov/show/NCT05192993
13	NCT04861740	Autism Access Link for Early Referral and Treatment	Autism ALERT	Active, not recruiting	No Results Available	Autism Spectrum Disorder	Other: Autism ALERT|Other: Screening Intervention	Change in satisfaction with Care Coordination in general and for autism in particular|Change in Parent stress|Change in Parenting stress|Change in Family Empowerment|Change in Family Centered and Coordinated Care|Family Satisfaction with Program|% referred to program who complete an ASD educational evaluation within 6 months|Time from EI/ECSE referral to ASD treatment in EI/ECSE, among children with ASD|Family self-reported ASD knowledge|Change in provider self-efficacy about autism management|Change in provider autism paperwork burden|Time from EI/ECSE referral to evaluation among children with ASD|Age of EI/ECSE educational determination, among children with ASD|% with ASD determination receiving ASD services 6 months after enrollment|monthly service hours among children with ASD 6 months after enrollment|age of ASD medical diagnosis among children on Medicaid|% with ASD medical diagnosis receiving ASD therapy 6 months after enrollment, among children on Medicaid	Oregon Health and Science University|Boston Medical Center|Providence Health & Services	All	12 Months to 54 Months   (Child)	Not Applicable	148	Other	Interventional	Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Health Services Research	00001	March 18, 2021	December 31, 2022	December 31, 2022	April 27, 2021		September 21, 2022	Ohsu Cdrc, Portland, Oregon, United States		https://ClinicalTrials.gov/show/NCT04861740
14	NCT04766177	Role of Bumetanide in Treatment of Autism		Recruiting	No Results Available	Autism	Drug: Bumetanide|Drug: Placebo	Number of patients with improved CARS score	Sherief Abd-Elsalam|Tanta University	All	3 Years to 12 Years   (Child)	Phase 3	80	Other	Interventional	Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)|Primary Purpose: Treatment	autism	January 1, 2021	December 1, 2030	December 1, 2030	February 23, 2021		February 23, 2021	Sherief Abd-Elsalam, Tanta, Egypt		https://ClinicalTrials.gov/show/NCT04766177
15	NCT04246398	FMT in Children With Autism and Gastrointestinal Symptoms		Unknown status	No Results Available	Children With Autism	Other: FMT|Other: FMT - placebo	Incidence of Treatment-Emergent Adverse Events [Safety and Tolerability]|Incidence of Treatment-Emergent Adverse Events [Safety and Tolerability])|Significant change in GI symptoms [efficiency]|Change in food selection [efficiency]|Improving ASD symptoms [efficiency]|Diversity and variability of the gut microbiome	Assaf Harofeh MC|Assaf-Harofeh Medical Center	All	7 Years to 20 Years   (Child, Adult)	Not Applicable	50	Other	Interventional	Allocation: Randomized|Intervention Model: Crossover Assignment|Masking: Single (Participant)|Primary Purpose: Treatment	0052-19-ASF	February 2020	December 2022	December 2022	January 29, 2020		February 5, 2020	Assaf-HarofehMC, Zerifin, Israel		https://ClinicalTrials.gov/show/NCT04246398
16	NCT02842671	Autism Spectrum Ambassador Program	ASAP	Completed	No Results Available	Autism Spectrum Disorder	Other: Assigned Ambassador	Patient Satisfaction Survey (questionnaire)|Medical Student Satisfaction Survey (questionnaire)|Medical Student Career Interest (questionnaire)|Medical Student Comfort Level (questionnaire)	Milton S. Hershey Medical Center	All	30 Months to 17 Years   (Child)	Not Applicable	23	Other	Interventional	Allocation: Non-Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Supportive Care	00004103	December 1, 2016	November 25, 2019	November 25, 2019	July 25, 2016		June 18, 2021	Penn State Hershey Children's Hospital, Hershey, Pennsylvania, United States		https://ClinicalTrials.gov/show/NCT02842671
17	NCT04666493	Adapting Anxiety Intervention for Youth With Autism for Rapid Response to COVID-19		Unknown status	No Results Available	Autism Spectrum Disorder	Other: Cognitive behavior therapy (CBT), specifically using the Facing Your Fears (FYF) curriculum	Screen for Child Anxiety Related Emotional Disorders (SCARED), Parent version|Screen for Child Anxiety Related Emotional Disorders (SCARED), Child version	Evdokia Anagnostou|Anagnostou, Evdokia, M.D.	All	8 Years to 13 Years   (Child)	Not Applicable	100	Other	Interventional	Allocation: N/A|Intervention Model: Single Group Assignment|Masking: None (Open Label)|Primary Purpose: Treatment	0240	December 4, 2020	November 30, 2021	November 30, 2021	December 14, 2020		December 14, 2020	Holland Bloorview Kids Rehabilitation Hospital, Toronto, Ontario, Canada		https://ClinicalTrials.gov/show/NCT04666493
18	NCT05580432	The Effect of Parenting With Positive Behavior Interventions on Community Inclusion for Military Connected and Dependent Children With Autism and Their Parents		Recruiting	No Results Available	Autism	Behavioral: Parenting with Positive Behavior Interventions	Change in frequency of child with ASD's challenging behavior|Change in severity of child with ASD's challenging behavior|Change in frequency of participation by child with ASD|Change in involvement during participation by child with ASD|Change in parent desire for change in participation by child with ASD|Change in environmental support for participation by child with ASD|Change in community participation by parents|Change in parental stress|Change in child's behavior|Change in child's response to behavior|Parental acceptability the treatment	Virginia Commonwealth University	All	5 Years to 11 Years   (Child)	Not Applicable	40	Other	Interventional	Allocation: Randomized|Intervention Model: Single Group Assignment|Masking: None (Open Label)|Primary Purpose: Supportive Care	HM20025356	February 2023	July 2024	July 2024	October 14, 2022		December 6, 2022	Virginia Commonwealth University, Richmond, Virginia, United States		https://ClinicalTrials.gov/show/NCT05580432
19	NCT02111551	Phase I Nicotinic Agonist Treatment Trial for Autism		Terminated	No Results Available	Autism	Drug: DMXB-A 150 mg|Other: placebo|Drug: DMXB-A 75 mg	Difference between drug and placebo on theTotal Scale Score on the repeatable Battery for the Assessment of neuropsychological Status at 2 hours after administration|Difference between drug and placebo on the CPT at 30 minutes after administration|Difference between the P50 auditory evoked potential test/conditioning ratio 1 hour after administration|Difference between placebo and drug on the Social Responsiveness scale 2 hours after administration	University of Colorado, Denver	All	18 Years to 50 Years   (Adult)	Phase 1	2	Other	Interventional	Allocation: Randomized|Intervention Model: Crossover Assignment|Masking: Triple (Participant, Investigator, Outcomes Assessor)|Primary Purpose: Treatment	14-0614	June 2015	May 2016	May 2016	April 11, 2014		June 16, 2016	University of Colorado Denver, Aurora, Colorado, United States		https://ClinicalTrials.gov/show/NCT02111551
20	NCT04209452	Improving Working Memory of Children With Autism		Terminated	No Results Available	Autism	Behavioral: Rehearsal strategy|Behavioral: Reinforcement|Behavioral: Rehearsal strategy and reinforcement	Change in percent recall|Change in percent strategy used.	Arizona State University|Shanghai Xuhui Clover Children Healthy Garden|Jingdezhen Kindkids Autism Rehabilitation and Training Center|Sunshine Special Education Center	All	4 Years to 8 Years   (Child)	Not Applicable	15	Other	Interventional	Allocation: Randomized|Intervention Model: Factorial Assignment|Masking: None (Open Label)|Primary Purpose: Treatment	STUDY00010960	January 15, 2020	November 10, 2020	November 10, 2020	December 24, 2019		November 12, 2020	Jingdezhen Kindkids Autism Rehabilitation and Training Center, Jingdezhen, Jiangxi, China|Sunshine Special Education Center, Taizhou, Zhejiang, China|Shanghai Xuhui Clover Children Healthy Garden, Shanghai, China		https://ClinicalTrials.gov/show/NCT04209452
21	NCT03569176	Examining the Efficacy of a Mobile Therapy for Children With Autism Spectrum Disorder		Completed	No Results Available	Autism Spectrum Disorder	Device: Autism Glass	Change in socialization subscale scores of the Vineland Adaptive Behavior Scales, 2nd Edition (VABS-II) from baseline to week 6.|Change in Parent Rated Social Responsiveness Scale 2 (SRS-2) from baseline to week 6|Change in NEPSY-II, Affect Recognition subscale scores from baseline to week 6|Change in Emotion Guessing Game (EGG) scores from baseline to week 6|Change in ASD symptoms as measured by Brief Observation of Social Communication Change (BOSCC) from baseline to week 6|Change in adaptive social and personal skills as measured by Vineland Adaptive Behavior Scales, 2nd edition (VABS-II) Full Scale from baseline to week 6.|Change in child's emotional, behavioral, and social problems from Baseline (week 0) to Week 6 as measured by Child Behavior Checklist (CBCL).	Dennis Paul Wall|Stanford University	All	6 Years to 12 Years   (Child)	Not Applicable	74	Other	Interventional	Allocation: Randomized|Intervention Model: Crossover Assignment|Masking: Double (Investigator, Outcomes Assessor)|Primary Purpose: Treatment	IRB-34059	November 1, 2016	April 11, 2018	April 15, 2018	June 26, 2018		July 17, 2018			https://ClinicalTrials.gov/show/NCT03569176
22	NCT02627508	Pilot Trial of Pregnenolone in Autism		Recruiting	No Results Available	Autism Spectrum Disorder|Autism	Drug: Pregnenolone|Drug: Placebo	Change from baseline in parent rated Aberrant Behavior Checklist Irritability (ABC-I) score during treatment|Change from baseline in parent rated Aberrant Behavior Checklist (ABC) scores during treatment|Change from baseline in parent rated Sensory Profile Questionnaire (SPQ) scores during treatment|Change from baseline in Vineland Adaptive Behavior Scales Second Edition (VABS-II)|Change from baseline in Clinical Global Impression (CGI) scores during treatment|Change from baseline in levels of pregnenolone and its related neurosteroids in peripheral blood|Change from baseline on the Autism Diagnostic Observation Schedule (ADOS)|Change from baseline in laboratory based eye-gaze measures|Change from baseline in laboratory based electroencephalography (EEG) measures|Change from baseline in laboratory clinical lab values including complete metabolic panel, complete blood count with differential, cholesterol panel and routine urinalysis.|Change from baseline in parent rated Social Responsiveness Scale (SRS) scores during treatment|Change from baseline on the Dosage Record Treatment Emergent Symptom Scale (DOTES) scores during treatment	Stanford University|Simons Foundation	All	14 Years to 25 Years   (Child, Adult)	Phase 2	40	Other	Interventional	Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)|Primary Purpose: Treatment	IRB-34762	January 29, 2016	April 2023	April 2023	December 11, 2015		February 16, 2022	Stanford University School of Medicine, Stanford, California, United States		https://ClinicalTrials.gov/show/NCT02627508
23	NCT05140356	Therapeutic Intervention Effects of rTMS on Children With Autism Spectrum Disorder		Recruiting	No Results Available	Autism	Device: Applied high amplitude repeated transcranial magnetic stimulation|Device: Applied low amplitude repeated transcranial magnetic stimulation	The gray matter volume of children with autism at baseline and after repeated transcranial magnetic stimulation intervention as assessed by magnetic resonance imaging.|The functional connectivity of whole brain of whole brain in children with autism with repeated transcranial magnetic stimulation intervention as assessed by functional magnetic resonance imaging.	University of Electronic Science and Technology of China	All	2 Years to 8 Years   (Child)	Not Applicable	60	Other	Interventional	Allocation: Randomized|Intervention Model: Crossover Assignment|Masking: Double (Participant, Investigator)|Primary Purpose: Basic Science	UESTC-chenhuafulab-003	May 1, 2019	December 2024	December 2024	December 1, 2021		December 1, 2021	School of Life Science and Technology, University of Electronic Science and Technology, Chengdu, Sichuan, China		https://ClinicalTrials.gov/show/NCT05140356
24	NCT03887754	Therapeutic Issues for Autism		Completed	No Results Available	Autism Spectrum Disorder	Drug: Risperidone|Device: hyperbaric oxygen therapy|Drug: Non specific Multivitamin	Childhood Autism Rating Scale version 2 (CARS2)measured after one year and after two years to compare the effect of hyperbaric oxygen therapy, Risperidone, both of them and the placebo effect	Minia University	All	5 Years to 7 Years   (Child)	Phase 2	80	Other	Interventional	Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Single (Outcomes Assessor)|Primary Purpose: Treatment	Autism Spectrum Disorder	January 2016	January 2018	December 2018	March 25, 2019		March 25, 2019			https://ClinicalTrials.gov/show/NCT03887754
25	NCT05551728	Autism Caregiver Coaching in Africa	ACACIA	Not yet recruiting	No Results Available	Autism or Autistic Traits	Behavioral: ESDM-informed caregiver coaching	Change from Baseline VABS-3 Communication Domain Standard Score at 6 months|Change from Baseline Griffiths III Language and Communication Developmental Quotient at 6 months|Change from Baseline JERI composite score at 3 months	Duke University|University of Cape Town	All	18 Months to 60 Months   (Child)	Not Applicable	320	Other	Interventional	Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Single (Outcomes Assessor)|Primary Purpose: Treatment	Pro00111048	January 2023	March 2027	September 2027	September 23, 2022		September 23, 2022	University of Cape Town, Cape Town, West Cape, South Africa		https://ClinicalTrials.gov/show/NCT05551728
26	NCT05582655	Leveraging Autism Intervention for Families Using Telehealth (LIFT)	LIFT	Not yet recruiting	No Results Available	Autism Spectrum Disorder	Behavioral: ONLINE|Behavioral: COACH	Change in Acceptability: Caregiver Diary|Change in Adoption: Caregiver Involvement Scale|Change in Fidelity: JASPER Coaching Fidelity|Change in Caregivers' JASPER Strategy Use: JASPER Implementation Fidelity|Change in Children's Time in Child Initiated Joint Engagement (Caregiver Child Interaction)	University of Oregon	All	up to 72 Months   (Child)	Not Applicable	80	Other	Interventional	Allocation: Randomized|Intervention Model: Sequential Assignment|Masking: Single (Outcomes Assessor)|Primary Purpose: Treatment	R324B200017	November 1, 2022	December 31, 2024	December 31, 2024	October 17, 2022		November 3, 2022			https://ClinicalTrials.gov/show/NCT05582655
27	NCT00252603	Galantamine Versus Placebo in Childhood Autism		Completed	No Results Available	Autism|Childhood Autism	Drug: Galantamine	Autism Diagnostic Observation Schedule-Generic (ADOS-G)- Change from Baseline to Final Visit|Clinical Global Impression Improvement (CGI)- Change from Baseline to Final Visit|Aberrant Behavior Checklist (ABC) (hyperactivity/irritability sections)- Change from Baseline to Final Visit|Vineland Adaptive Behavior Scale- Change from Baseline to Final Visit|MacArthur Communicative Development Inventory (MCDI)- Change from Baseline to Final Visit|Conners' Parent Rating Scale-Revised: Long form (CPRS-R:L)- Change from Baseline to Final Visit	University of Medicine and Dentistry of New Jersey|National Alliance for Autism Research|Rutgers, The State University of New Jersey	All	5 Years to 17 Years   (Child)	Phase 3	20	Other	Interventional	Allocation: Randomized|Intervention Model: Single Group Assignment|Masking: Double|Primary Purpose: Treatment	4682	April 2004		April 2007	November 11, 2005		January 29, 2007	UMDNJ Robert Wood Johnson Medical School - Dept of Psychiatry, Piscataway, New Jersey, United States		https://ClinicalTrials.gov/show/NCT00252603
28	NCT00166621	Early Pharmacotherapy Aimed at Neuroplasticity in Autism : Safety and Efficacy		Completed	No Results Available	Autism	Drug: Buspirone	Safety will be measured by obtaining clinical laboratory tests, vital signs and evaluating probably or definitely related adverse events.|Population pharmacokinetics will be conducted to measure plasma concentrations in relation to the drug responses to buspirone.|The primary efficacy outcome will be the overall severity score from the Clinical Global Impressions assessment obtained from two raters, (parent and examiner)|Comparisons of allele, and genotype frequencies between responders and non-responders will be done for each polymorphism using Fisher's exact test to best predict response to buspirone.	Chugani, Diane C.	All	2 Years to 6 Years   (Child)	Phase 1|Phase 2	20	Other	Interventional	Allocation: Randomized|Intervention Model: Crossover Assignment|Masking: Double|Primary Purpose: Treatment	PPRU 10659s	March 2004		August 2005	September 14, 2005		July 20, 2011	PET Center/Children's Hospital of Michigan, Detroit, Michigan, United States		https://ClinicalTrials.gov/show/NCT00166621
29	NCT04679974	Melodic-based Communication Therapy for Promoting Spoken Language Development in Individuals With Nonverbal Autism	MBCT	Completed	No Results Available	Nonverbal and Low Verbal Autism	Behavioral: Melodic-based Communication Therapy	Number of spoken words|Frequency of repetitive and stereotypical behaviors	Loma Linda University	All	3 Years to 10 Years   (Child)	Not Applicable	10	Other	Interventional	Allocation: N/A|Intervention Model: Single Group Assignment|Masking: None (Open Label)|Primary Purpose: Treatment	5170235	June 17, 2018	August 16, 2018	August 30, 2018	December 22, 2020		December 22, 2020	Loma Linda University, Loma Linda, California, United States		https://ClinicalTrials.gov/show/NCT04679974
30	NCT02086110	Effect of Milk Oligosaccharides and Bifidobacteria on the Intestinal Microflora of Children With Autism		Completed	Has Results	Autism	Dietary Supplement: Synbiotic|Dietary Supplement: Prebiotic	Stool Microbiota Composition Change During Prebiotic Only Treatment|Stool Microbiota Composition Change During Synbiotic Treatment|Serum Immune Profile Change During Prebiotic Only Treatment	University of California, Davis	All	2 Years to 11 Years   (Child)	Not Applicable	11	Other	Interventional	Allocation: Randomized|Intervention Model: Crossover Assignment|Masking: Triple (Participant, Care Provider, Investigator)|Primary Purpose: Basic Science	450072	June 6, 2014	November 16, 2015	November 16, 2015	March 13, 2014	August 1, 2019	August 1, 2019	UC Davis MIND Institute, Sacramento, California, United States		https://ClinicalTrials.gov/show/NCT02086110
31	NCT02591459	Android Mobile Devices to Assist Routine Anticipation for Autistic Children		Unknown status	No Results Available	Autism	Other: Using the app to assist routine anticipation	Increase in verbal communication	University of Mogi das Cruzes	All	3 Years to 9 Years   (Child)	Not Applicable	10	Other	Interventional	Allocation: N/A|Intervention Model: Single Group Assignment|Masking: None (Open Label)	49354415.0.0000.5497	October 2015	October 2015	December 2015	October 29, 2015		October 29, 2015	Centro de inclusão e Apoio ao Autista de Guarulhos (CIAAG), Guarulhos, Sao Paulo, Brazil		https://ClinicalTrials.gov/show/NCT02591459
32	NCT04501588	Parent Telehealth Intervention for Children With Autism		Completed	No Results Available	Autism Spectrum Disorder|Autism	Behavioral: Responsive training with no video feedback|Behavioral: Responsive training with video feedback	Parent Use of Language Support Strategies (Mother-child interaction)|MacArthur-Bates Communicative Development Inventory (MCDI) (Child)	Northwestern University	All	18 Months to 48 Months   (Child)	Phase 2	47	Other	Interventional	Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Single (Outcomes Assessor)|Primary Purpose: Treatment	STU00201708	March 6, 2020	September 2, 2021	November 24, 2021	August 6, 2020		January 10, 2022	Northwestern University, Evanston, Illinois, United States	"Informed Consent Form", https://ClinicalTrials.gov/ProvidedDocs/88/NCT04501588/ICF_000.pdf	https://ClinicalTrials.gov/show/NCT04501588
33	NCT01676389	Osteopathic Manual Medicine Treatment in Autism	OMMA	Completed	No Results Available	Autism Spectrum Disorders	Other: Sham OMM|Other: Osteopathic Manual Medicine (Body Therapy)	Autism Behavior Checklist (ABC)|Salivary IgA and Salivary Cortisol|WeeFIM measurement of child's functional abilities	New York Institute of Technology	All	3 Years to 11 Years   (Child)	Not Applicable	3	Other	Interventional	Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Double (Participant, Outcomes Assessor)|Primary Purpose: Treatment	BHS-760	January 2013	October 2014	May 2015	August 30, 2012		January 21, 2016	Family Care Center - New York Institute of Technology College of Osteopathic Medicine, Central Islip, New York, United States|Academic Health Care Center at Old Westbury, Old Westbury, New York, United States		https://ClinicalTrials.gov/show/NCT01676389
34	NCT05581069	Improving Outcomes in Autism: Community Implementation of Stepped Transition in Education Program		Recruiting	No Results Available	Autism Spectrum Disorder	Behavioral: STEPS	Adult Functioning Scale|Rehabilitation Success	University of Alabama, Tuscaloosa	All	16 Years to 25 Years   (Child, Adult)	Not Applicable	25	Other	Interventional	Allocation: N/A|Intervention Model: Single Group Assignment|Masking: None (Open Label)|Primary Purpose: Treatment	A22-0209	May 15, 2022	December 2023	February 2024	October 14, 2022		October 14, 2022	Center for Youth Development and Intervention, Tuscaloosa, Alabama, United States		https://ClinicalTrials.gov/show/NCT05581069
35	NCT02236650	Primary Care Stepping Stones Triple P for Children With Autism		Completed	No Results Available	Autism	Behavioral: Primary Care Stepping Stones Triple P (PC-SS Triple P)|Other: Treatment as Usual	Change from Baseline in Eyberg Child Behavior Inventory Score at 4 weeks|Change from Baseline in Connor-Davidson Resilience Scale Score at 4 weeks|Change from Baseline in Parent Stress Index - Short Form Score at 4 weeks|Change from Baseline in Family Assessment Device score at 4 weeks|Change from Baseline in Aberrant Behavior Checklist Score at 4 weeks|Change from Baseline in The Parenting Scale Score at 4 weeks|Change from Baseline in the Parenting Sense of Competence Scale Score at 4 weeks	St. Louis University	All	18 Years and older   (Adult, Older Adult)	Not Applicable	26	Other	Interventional	Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Treatment	SLUBM_24272	July 2014	December 2015	December 2015	September 10, 2014		December 17, 2015	Saint Louis University, Knights of Columbus Developmental Center, St. Louis, Missouri, United States		https://ClinicalTrials.gov/show/NCT02236650
36	NCT03164746	Treatment by Therapeutic Body Wraps in Children and Adolescents Suffering From Autism With Severe Injurious Behavior.	PACKING	Completed	No Results Available	Autism Spectrum Disorder	Other: Dry sheet Therapeutic body wraps|Other: WET sheet Therapeutic body wraps	Aberrant Behavior Checklist (ABC) irritability score|ABC hyperactivity score|ABC lethargy score|ABC inappropriate speech score|ABC stereotypic behavior score|ABC Total score|Child Autism Rating Scale (CARS)|Clinical Global Impression-Improvement (CGI-I)|Clinical Global Impression-Severity (CGI-S)	University Hospital, Lille|Ministry of Health, France	All	5 Years to 18 Years   (Child, Adult)	Not Applicable	48	Other	Interventional	Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Double (Investigator, Outcomes Assessor)|Primary Purpose: Supportive Care	2007/0715|2007-A01376-47|DGS 2008-0070	December 2007	December 2014	December 2014	May 24, 2017		May 24, 2017	Centre de Santé Mentale Angevin, Angers, France|Centre Hospitalier d'Arras, Arras, France|Centre Hospitalier Robert Ballanger, Aulnay-sous-Bois, France|Centre Hospitalier Montfavet, Avignon, France|Institut Départemental Albert Calmette, Camiers, France|Centre Hospitalier de Douai, Douai, France|Etablissement Public de Santé Roger Prévot, Gennevilliers, France|Centre Hospitalier de Lens, Lens, France|Hôpital Fontan, CHRU, Lille, France|Institut Médico-éducatif, Montigny-en-Ostrevent, France|Etablissement de Santé Maison Blanche, Paris, France|Groupe Hospitalier Pitier-Salpêtrière, Paris, France|Etablissement Public de Santé Mentale Val de Lys-Artois, Saint-Venant, France		https://ClinicalTrials.gov/show/NCT03164746
37	NCT04936048	Music for Autism (M4A)	M4A	Recruiting	No Results Available	Autism Spectrum Disorder|Autism	Behavioral: Music Therapy|Behavioral: Play therapy	Children's Communication Checklist-2|Brain connectivity of frontotemporal regions|Child and Adolescent Scale of Participation|Beach Center Family Quality of Life Scale|Peabody Picture Vocabulary Test- 4th edition|Social Responsiveness Scale|Vineland Adaptive Behavior Scales|Hair cortisol concentration|Grey and white matter volume (Structural brain changes)	NORCE Norwegian Research Centre AS|University of Bergen|University of Vienna	All	6 Years to 12 Years   (Child)	Not Applicable	80	Other	Interventional	Allocation: Randomized|Intervention Model: Crossover Assignment|Masking: Single (Outcomes Assessor)|Primary Purpose: Treatment	M4A	August 1, 2021	June 30, 2023	June 30, 2023	June 23, 2021		August 25, 2021	University of Vienna, Vienna, Austria|NORCE Norwegian Research Centre, Bergen, Norway		https://ClinicalTrials.gov/show/NCT04936048
38	NCT04078061	Comparative Effectiveness of EIBI and Adaptive ABA for Children With Autism	ISOLDE	Active, not recruiting	No Results Available	Autism Spectrum Disorder	Behavioral: MABA|Behavioral: EIBI	Change in Vineland Adaptive Behavior Scale (VABS-3)|Change in ASD symptoms using the Ohio Autism Clinical Impressions Scale (OACIS)	University of Rochester|The Cleveland Clinic|May Institute|Nationwide Children's Hospital|Vanderbilt University Medical Center|University of Michigan|University of Virginia	All	18 Months to 5 Years   (Child)	Not Applicable	60	Other	Interventional	Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Single (Outcomes Assessor)|Primary Purpose: Treatment	W81XWH-18-1-0790	August 22, 2019	September 2023	September 2023	September 4, 2019		November 9, 2022	May Institute, Jacksonville, North Carolina, United States|Cleveland Clinic, Cleveland, Ohio, United States|Nationwide Children's Hospital, Columbus, Ohio, United States|Vanderbilt University Medical Center, Nashville, Tennessee, United States|May Institute, Richmond, Virginia, United States		https://ClinicalTrials.gov/show/NCT04078061
39	NCT02536365	Sensory Integration Therapy in Autism: Mechanisms and Effectiveness		Recruiting	No Results Available	Autism	Behavioral: Sensory Integration Therapy|Behavioral: Applied Behavioral Analysis	The Pediatric Evaluation of Disability Inventory-Computer Adaptive Test (PEDI-CAT) Daily Living|The Assessment of Motor and Process Skills (AMPS)|Repetitive Behavior Scale-Revised (RBS-R)	Albert Einstein College of Medicine|Thomas Jefferson University|Queens College, The City University of New York|Children's Specialized Hospital	All	6 Years to 114 Months   (Child)	Not Applicable	135	Other	Interventional	Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Triple (Participant, Care Provider, Outcomes Assessor)|Primary Purpose: Treatment	2014-3795	September 2015	December 2023	December 2023	August 31, 2015		August 5, 2022	Children's Specialized Hospital, New Brunswick, New Jersey, United States		https://ClinicalTrials.gov/show/NCT02536365
40	NCT05363982	Evaluation of Transcranial Photobiomodulation in Autism Spectrum Disorder		Recruiting	No Results Available	Autism Spectrum Disorder	Device: Transcranial Photobiomodulation (tPBM)|Device: Placebo/ Sham	ASD symptoms as measured by change through study completion, on the Clinical Global Impression of Improvement of Autism Spectrum Disorder (CGI-ASD-I)|ASD symptoms as measured by change through study completion on the Social Responsiveness Scale-2nd Edition (SRS-2)|Treatment-related changes in social cognition functions|Treatment-related changes in associated executive functions|Treatment-related changes in associated psychopathology (Attention Deficit Hyperactivity Disorder, ADHD)|Treatment-related changes in associated psychopathology (depression)|Treatment-related changes in associated psychopathology (anxiety)|Treatment-related changes in associated psychopathology|Treatment-related changes in quality of life|The monitoring of treatment-emergent adverse events	Massachusetts General Hospital	All	18 Years to 59 Years   (Adult)	Not Applicable	54	Other	Interventional	Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Double (Participant, Investigator)|Primary Purpose: Treatment	2021- P- 002646	February 11, 2022	February 11, 2023	February 11, 2024	May 6, 2022		May 6, 2022	Massachusetts General Hospital, Boston, Massachusetts, United States		https://ClinicalTrials.gov/show/NCT05363982
41	NCT04739982	Evaluating Efficacy of GuessWhat Mobile App Therapy for Children With Autism		Recruiting	No Results Available	Autism|Autism Spectrum Disorder	Device: GuessWhat Mobile App	Change in parent reported socialization based on the Vineland Adaptive Behavior Scales 3rd Edition (VABS-3) Parent/Caregiver Socialization Subscale, from baseline to week 4|GuessWhat App Usage Data|Parent reported feedback|Change in Parental Stress Scale - from baseline to week 4|Change in Emotion Recognition from baseline to week 4	Stanford University	All	3 Years to 12 Years   (Child)	Not Applicable	600	Other	Interventional	Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Treatment	60181	July 7, 2021	December 31, 2023	January 31, 2024	February 5, 2021		December 14, 2022	Stanford University, Stanford, California, United States	"Informed Consent Form", https://ClinicalTrials.gov/ProvidedDocs/82/NCT04739982/ICF_000.pdf	https://ClinicalTrials.gov/show/NCT04739982
42	NCT00406159	Effects of Hyperbaric Oxygen Therapy on Children With Autism		Completed	No Results Available	Autism	Device: Hyperbaric Oxygen Therapy	Standardized Measures|In addition to the direct measures of behavior described above, standardized intelligence and adaptive assessments will be conducted prior to the initiation of HBOT. These will include:|ADI/ADOS|WPPSI-III (2-6 years) /WASI (6+ years)|Vineland Adaptive Behavior Scale (VABS)|Subjective Questionnaires|Aberrant Behavior Checklist|Clinical Global Impression|ATEC|Selected sections of the APEQ|BRIEF|Parenting Stress Index|Repetitive Behavior Scale|A side effect questionnaire|Thoughtful House Caregiver diary	Thoughtful House	All	2 Years to 10 Years   (Child)	Phase 1	30	Other	Interventional	Allocation: Randomized|Intervention Model: Single Group Assignment|Masking: None (Open Label)|Primary Purpose: Treatment	06.10.0004	November 2006		September 2007	December 4, 2006		August 7, 2009	Medical Center at Thoughtful House, Austin, Texas, United States		https://ClinicalTrials.gov/show/NCT00406159
43	NCT03634761	Early Intervention and Autism: Transformation From Research to Practice Through a Competency Based Model	AUT-TID	Completed	No Results Available	Autism Spectrum Disorder	Behavioral: Competency based model|Behavioral: Comprehensive program	Change in overall program quality measured by the Autism Program Environment Rating Scale (APERS-P-SE)|Ethics, Values and Allegiance (EVA)|Evidence Based Practices (EBP)|Autism Knowledge Questionnaire (AKQ)|Self-Efficacy and Stress Questionnaire (SESQ)|Goal Attainment Scale (GAS)|Clinical Global Impression-autism (CGI-AUT)|Children's Engagement Questionnaire (CEQ)|Vineland Adaptive Behavior Scales - Second Edition (Vineland-II) - Teacher ratings	Stockholm University|Karolinska Institutet	All	2 Years to 5 Years   (Child)	Not Applicable	17	Other	Interventional	Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Other	VR 2015-01212	May 15, 2017	May 30, 2019	May 30, 2019	August 16, 2018		September 20, 2019	BanyanCenter, Stockholm, Sweden|Autismcenter för Små Barn, Stockholm, Sweden		https://ClinicalTrials.gov/show/NCT03634761
44	NCT02508922	Trial of Vitamin D3 Supplementation in Paediatric Autism		Completed	No Results Available	Autism	Dietary Supplement: Vitamin D3|Dietary Supplement: Placebo	Change from baseline in stereotypic behaviour from the aberrant behaviour checklist|Change from baseline in serum 25-hydroxyvitamin D levels|Change from baseline in serum calcium levels, corrected for albumin|Change from baseline in aberrant behaviour checklist|Change from baseline in cytokines|Change from baseline in autoimmune markers|Change from baseline in behaviour Assessment System for Children - Second Edition|Change from baseline in repetitive behavior Scale - Revised|Change from baseline in Social Responsiveness Scale|Change from baseline in Developmental Disabilities-Children's Global Assessment Scale|Change from baseline in Vitamin D and Sun Questionnaire	University of Dublin, Trinity College|The National Children's Hospital, Tallaght	All	3 Years to 12 Years   (Child)	Not Applicable	42	Other	Interventional	Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)|Primary Purpose: Supportive Care	NCHVitDASD	September 2015	June 2016	July 2016	July 27, 2015		October 25, 2016	Linn Dara and BeechPark, Dublin, Ireland|National Children's Hopsital, Dublin, Ireland|Trinity College Dublin, Dublin, Ireland		https://ClinicalTrials.gov/show/NCT02508922
45	NCT02712281	Autism MEAL Plan: Parent Training to Manage Eating Aversions & Limited Variety		Completed	No Results Available	Autism Spectrum Disorder	Behavioral: Autism MEAL Plan|Behavioral: Parent Education	Change in Clinical Global Impression - Improvement scale (CGI-I) score|Change in Parenting Stress Index- Short Form (PSI) score|Parent Satisfaction Rating|Change in Brief Autism Mealtime Behavior Inventory (BAMBI) scores|Change in Food Preference Inventory (FPI) scores|Change in nutritional intake|Change in Aberrant Behavior Checklist (ABC) scores|Change in rapid acceptance during 10 minute meal observation|Change in rapid swallowing during 10-minute meal observation|Change in disruptions during 10-minute meal observation|Change in crying during 10-minute meal observation|Change in volume of food consumed during 10-minute meal observation|Weight|Height|Body Mass Index	Emory University|Children's Healthcare of Atlanta	All	3 Years to 8 Years   (Child)	Not Applicable	38	Other	Interventional	Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Single (Outcomes Assessor)|Primary Purpose: Treatment	IRB00085811	July 2016	March 2018	April 2018	March 18, 2016		December 19, 2018	Marcus Autism Center, Atlanta, Georgia, United States		https://ClinicalTrials.gov/show/NCT02712281
46	NCT03300128	Incredible Years Program for Parents of Children With Autism	IY-ASD	Terminated	No Results Available	Autism Spectrum Disorder	Behavioral: Incredible Years - ASD|Other: Circle of Parents	Change in child behavior|Change in parent stress|Change in coping mechanisms|Change in parenting practices|Change in depression, anxiety, and stress|Satisfaction survey|Weekly IY-ASD evaluation	University of Maryland, Baltimore	All	18 Years and older   (Adult, Older Adult)	Not Applicable	27	Other	Interventional	Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Treatment	HP-00074617	June 1, 2017	May 31, 2018	December 10, 2018	October 3, 2017		January 2, 2020	Onslow County Partnership for Children, Jacksonville, North Carolina, United States		https://ClinicalTrials.gov/show/NCT03300128
47	NCT02654743	Open Label of Clinical Trial of Sulforaphane in Children With Autism		Completed	No Results Available	Autism	Dietary Supplement: Sulforaphane	Urinary metabolites|Behavior Measures	University of California, San Francisco	All	5 Years to 22 Years   (Child, Adult)	Phase 3	21	Other	Interventional	Allocation: N/A|Intervention Model: Single Group Assignment|Masking: None (Open Label)|Primary Purpose: Treatment	SF15-17002	January 2016	May 2016	September 2016	January 13, 2016		March 6, 2019			https://ClinicalTrials.gov/show/NCT02654743
48	NCT04031755	A Proof-of-Concept Study of Minocycline in Autism		Completed	No Results Available	Autism Spectrum Disorder|Autism	Drug: Minocycline|Drug: Placebos	Subject weight will be compared pre- and post-treatment in the drug versus placebo conditions|Aberrant Behavior will be evaluated pre- and post-treatment in the drug versus placebo conditions|Incidence of liver toxicity will be evaluated in the pre- and post-treatment setting in the drug versus placebo conditions	Children's Hospital Medical Center, Cincinnati	All	12 Years to 22 Years   (Child, Adult)	Phase 1	53	Other	Interventional	Allocation: Randomized|Intervention Model: Crossover Assignment|Masking: Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)|Primary Purpose: Treatment	CIN001 - Minocycline in ASD	April 19, 2019	October 30, 2020	October 30, 2020	July 24, 2019		December 8, 2020	Thompson Center for Autism & Neurodevelopmental Disorders - University of Missouri, Columbia, Missouri, United States|Cincinnati Children's Hospital Medical Center, Cincinnati, Ohio, United States|Center for Autism and Developmental Disorders - University of Pittsburgh Medical Center, Pittsburgh, Pennsylvania, United States		https://ClinicalTrials.gov/show/NCT04031755
49	NCT00490802	Intranasal Oxytocin in the Treatment of Autism		Completed	Has Results	Autism	Drug: Oxytocin|Drug: Placebo	Clinical Global Impressions Scale - Improvement - Social|Repetitive Behavior Scale - Revised|Diagnostic Analysis of Nonverbal Accuracy, Paralanguage Test|Yale-Brown Obsessive-Compulsive Scale|Social Responsiveness Scale	Evdokia Anagnostou|Icahn School of Medicine at Mount Sinai|Anagnostou, Evdokia, M.D.	All	18 Years to 60 Years   (Adult)	Phase 2	19	Other	Interventional	Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)|Primary Purpose: Treatment	06-0230 0001 02 PS	June 2006	September 2011	April 2012	June 25, 2007	November 5, 2014	October 23, 2015	Mount Sinai School of Medicine, New York, New York, United States		https://ClinicalTrials.gov/show/NCT00490802
50	NCT01780883	Melatonin Dose-effect Relation in Childhood Autism	MELADOSE	Completed	No Results Available	Childhood Autism	Drug: melatonin|Drug: Placebo	Severity of autistic disorder|Severity of autistic impairments|Sleep problems|Excretion of the urinary metabolite of melatonin	Rennes University Hospital|Centre Hospitalier Guillaume Régnier, RENNES	Male	6 Years to 8 Years   (Child)	Phase 2	34	Other	Interventional	Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)|Primary Purpose: Treatment	ANSM A91245-56	February 2013	July 2013	September 2013	January 31, 2013		September 5, 2013	Service de Psychiatrie de l'Enfant et de l'Adolescent - Hôpital de la Pitié-Salpêtrière, Paris, France|Centre Hospitalier Spécialisé Henri Laborit, Poitiers, France|Service de Psychothérapie de l'Enfant et de l'Adolescent - Hôpital Robert Debré, Reims, France|Pôle de Psychiatrie de l'Enfant et de l'Adolescent - Centre Hospitalier Guillaume Régnier, Rennes, France		https://ClinicalTrials.gov/show/NCT01780883
51	NCT03677089	Extension for Community Healthcare Outcomes Autism Replication Evaluation	ECHO Autism	Completed	Has Results	Autism Spectrum Disorder	Behavioral: 12 ECHO Autism telehealth clinics	Longitudinal Pattern of ASD Screening in PCP Charts|Longitudinal Pattern of Reported Co-occurring Medical Conditions Correctly Treated in PCP Charts|Longitudinal Pattern of Scores on Provider ASD Knowledge Assessment|Longitudinal Pattern of Scores on Provider ASD Self-Efficacy Assessment|Longitudinal Pattern of the Number of Perceived Barriers to Care|Participant Satisfaction With ECHO Autism Program|PCP ECHO Program Attendance|Number of Co-morbidities in Children With ASD	Massachusetts General Hospital|University of Toronto|Children's Hospital of Philadelphia|University of Pittsburgh|University of Rochester|Children's Hospital Medical Center, Cincinnati|University of Arkansas|Nationwide Children's Hospital|Vanderbilt University Medical Center|University of California, Irvine|University of Missouri-Columbia	All	Child, Adult, Older Adult	Not Applicable	148	Other	Interventional	Allocation: N/A|Intervention Model: Single Group Assignment|Masking: None (Open Label)|Primary Purpose: Health Services Research	2016P000415|UA3MC11054	September 1, 2016	November 27, 2018	November 27, 2018	September 19, 2018	April 30, 2020	April 30, 2020		"Study Protocol", https://ClinicalTrials.gov/ProvidedDocs/89/NCT03677089/Prot_000.pdf|"Statistical Analysis Plan: Original", https://ClinicalTrials.gov/ProvidedDocs/89/NCT03677089/SAP_001.pdf|"Statistical Analysis Plan: Amendment 1", https://ClinicalTrials.gov/ProvidedDocs/89/NCT03677089/SAP_002.pdf|"Statistical Analysis Plan: Amendment 2", https://ClinicalTrials.gov/ProvidedDocs/89/NCT03677089/SAP_003.pdf	https://ClinicalTrials.gov/show/NCT03677089
52	NCT00211796	Divalproex Sodium ER in Adult Autism		Completed	No Results Available	Autism	Drug: Divalproex Sodium ER	the Clinical Global Improvement and Severity scales (CGI-I and CGI-S)|Overt Aggression Scale-Modified (OAS M)|Affective Lability Scale (ALS).|Global Assessment of Functioning Scale (GAF)|Aggression Questionnaire (AQ)|the Hamilton Depression (Ham-D) Scale|Yale Brown Obsessive Compulsion Scale (YBOCS)|Compulsion sub-scale|Aberrant Behavior Checklist (ABC)|Barratt Impulsiveness Scale|Version11 (BIS-11).	Montefiore Medical Center	All	18 Years to 65 Years   (Adult, Older Adult)	Phase 4	10	Other	Interventional	Allocation: Non-Randomized|Intervention Model: Single Group Assignment|Masking: None (Open Label)|Primary Purpose: Treatment	GCO#04-1106	April 2005	April 2007	April 2007	September 21, 2005		May 31, 2018	Mount Sinai School of Medicine, New York, New York, United States		https://ClinicalTrials.gov/show/NCT00211796
53	NCT04696133	Sensory Integration Versus Fine Motor Intervention in Children With Autism		Completed	No Results Available	Autism Spectrum Disorder	Other: fine motor skills|Other: sensory integration	Gilliam autism rating scale|Bruininks-Oseretsky Test Of Motor Proficiency|Pediartic Quality of life Inventory Scale	Cairo University	All	8 Years to 12 Years   (Child)	Not Applicable	40	Other	Interventional	Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Triple (Participant, Care Provider, Outcomes Assessor)|Primary Purpose: Treatment	Autism spectrum	March 15, 2020	May 15, 2022	May 15, 2022	January 6, 2021		May 23, 2022	faculty of physical therapy, Cairo university, Giza, Egypt		https://ClinicalTrials.gov/show/NCT04696133
54	NCT02059577	Nutritional and Dietary Treatment Study for Children/Adults With Autism		Completed	No Results Available	Autism	Dietary Supplement: Nutritional and Dietary Interventions	Childhood Autism Rating Scale|Reynolds Intellectual Assessment Scales|Vineland Adaptive Behavior Scale	Arizona State University|Autism Research Instittute	All	30 Months to 60 Years   (Child, Adult)	Phase 2	120	Other	Interventional	Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Single (Outcomes Assessor)|Primary Purpose: Treatment	NutritionDietAutism	November 2011	April 2013	April 2013	February 11, 2014		February 11, 2014	Arizona State University, Tempe, Arizona, United States		https://ClinicalTrials.gov/show/NCT02059577
55	NCT04623398	Effect of Lithium in Patients With Autism Spectrum Disorder and Phelan-McDermid Syndrome (SHANK3 Haploinsufficiency)	Lisphem	Recruiting	No Results Available	Autism Spectrum Disorder	Drug: Lithium Carbonate|Drug: Placebo	Score social responsiveness scale|score of autism diagnosis observation scale|Score of attention deficit hyperactivity disorder|score of child's sleep disorder rating scale|Score of Dunn Sensory Profile|Score of Aberrant Behavior checklist scale|score of global functioning|Score of Vineland Adaptive Behavior Composite|Score of surrounding constraints|score of Columbia Suicide Severity Rating Scale	Assistance Publique - Hôpitaux de Paris	All	7 Years to 18 Years   (Child, Adult)	Phase 3	22	Other	Interventional	Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Double (Participant, Investigator)|Primary Purpose: Treatment	P160914	February 21, 2022	February 2024	February 2024	November 10, 2020		September 19, 2022	Hôpital Robert Debré, Paris, France		https://ClinicalTrials.gov/show/NCT04623398
56	NCT00873834	Fluoxetine Essay in Children With Autism	FAIR	Withdrawn	No Results Available	Autism	Drug: fluoxetine|Drug: placebo	Subscores of Autism Diagnostic Interview (ADI-R)at each visit of the protocol (LECOUTER et RUTTER, 1989)|Sides effect scale (FSEC)|Aberrant Behavior Checklist (Aman et al., 1985)|Clinical Global Impressions (CGI) severity and improvement (NIMH.1985)	Assistance Publique - Hôpitaux de Paris	All	5 Years to 12 Years   (Child)	Phase 2	0	Other	Interventional	Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)|Primary Purpose: Treatment	P030901|AOM 98082	September 2009	November 2010	November 2011	April 2, 2009		January 10, 2012			https://ClinicalTrials.gov/show/NCT00873834
57	NCT04295746	Improving Daily Living Skills in People With Autism Spectrum Disorder Through a Personalised Serious Game		Unknown status	No Results Available	Autism Spectrum Disorder	Other: Serious Game ShopAut	change from baseline in a specific evaluation form based on the International Classification of Functioning, Disability and Health: children and youth version (ICF-CY) at 11 weeks|change from baseline in Vineland Adaptive Behavior Scale II (VABS-II) at 6 months|Vineland Adaptive Behavior Scale II (VABS-II) at 12 months|a specific evaluation form based on the International Classification of Functioning, Disability and Health: children and youth version (ICF-CY) at 12 months	Federico II University	All	8 Years to 16 Years   (Child)	Not Applicable	10	Other	Interventional	Allocation: N/A|Intervention Model: Single Group Assignment|Masking: None (Open Label)|Primary Purpose: Treatment	9820	March 1, 2019	November 30, 2019	September 30, 2021	March 4, 2020		July 23, 2020	University of Naples Federico II - Centro Medico Riabilitativo Pompei, Naples, Italy		https://ClinicalTrials.gov/show/NCT04295746
58	NCT00208559	Ziprasidone in Children With Autism: A Pilot Study		Completed	No Results Available	Autism	Drug: Ziprasidone	Clinical Global Impressions|Children's Psychiatric Rating Scale	Drexel University College of Medicine|Drexel University	All	12 Years to 18 Years   (Child, Adult)	Phase 2	15	Other	Interventional	Allocation: Non-Randomized|Intervention Model: Single Group Assignment|Masking: None (Open Label)|Primary Purpose: Treatment	00936	February 2002	June 2005	August 2006	September 21, 2005		June 17, 2010	Drexel University College of Medicine at Friends Hospital, Philadelphia, Pennsylvania, United States		https://ClinicalTrials.gov/show/NCT00208559
59	NCT04660669	Early Intervention in Remote Autism (IPAAD)	IPAAD	Not yet recruiting	No Results Available	Early Intervention in Remote Autism	Other: ESDM intervention|Other: MOOC	The gain in developmental quotient measured using the Mullen Scales of Early Learning (MSEL)|Assessment of child autism symptoms and change in autism symptoms using ADOS-2|Assessment of child behavioral adaptation using The Vineland Adaptive Behavior Scales second version (VABS-2)|Assessment of sensory reactivity using The Dunn's Sensory Profile for toddlers|Assessment of the parent burden and quality of life using the CareQuol-7D	University Hospital, Brest	All	15 Months to 36 Months   (Child)	Not Applicable	90	Other	Interventional	Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Other	IPAAD (29BRC19.0279)	December 2020	December 2021	December 2024	December 9, 2020		December 9, 2020	CH Réné-Dubos, Cergy-Pontoise, France|CHU Le Havre, Le Havre, France|CH Limoges, Limoges, France|CHU Nantes, Nantes, France		https://ClinicalTrials.gov/show/NCT04660669
60	NCT01740869	Autologous Bone Marrow Stem Cells for Children With Autism Spectrum Disorders	Autism	Unknown status	No Results Available	Autism|Autism Spectrum	Other: Stem cells	IDEA Improvement|CARS improvement	Hospital Universitario Dr. Jose E. Gonzalez	All	5 Years to 15 Years   (Child)	Phase 1|Phase 2	30	Other	Interventional	Allocation: Non-Randomized|Intervention Model: Crossover Assignment|Masking: None (Open Label)|Primary Purpose: Treatment	HE12-021|Autism uanl	November 2012	November 2016	December 2016	December 4, 2012		June 4, 2015	Hematology Service, Hospital Universitario Dr. Jose E. Gonzalez, Monterrey, Nuevo Leon, Mexico		https://ClinicalTrials.gov/show/NCT01740869
61	NCT01770548	Neurophysiological Molecular and Developmental Analysis of the Glutamate Synapse in Autism	NMDA-Autism	Completed	No Results Available	Autism	Genetic: analysis of the glutamate synapse in autism|Genetic: DNA collection|Other: Auditory evoked potentials	screening of about 50 genes encoding proteins of the NMDA receptor complex, chosen according to their chromosomal localisation located in hotspots depicted by genome-wide screens in large population of autistic patients	University Hospital, Tours	All	2 Years and older   (Child, Adult, Older Adult)	Not Applicable	497	Other	Interventional	Allocation: Non-Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)	AORT08-FBB/NMDA-Autism|2008-A01162-53	January 2009	January 2011	June 2014	January 17, 2013		January 16, 2017	CHRU - Centre de Ressources Autisme (CRA), Brest, France|CHS du ROUVRAY, Rouen, France|Chru - Cic, Tours, France|CHRU - Pédopsychiatrie, Tours, France		https://ClinicalTrials.gov/show/NCT01770548
62	NCT04517799	Trial of Cannabidiol to Treat Severe Behavior Problems in Children With Autism		Active, not recruiting	No Results Available	Autism|Autism Spectrum Disorder	Drug: Epidiolex|Drug: placebo oral solution	Total Score on Repetitive Behavior Scale-Revised (RBS-R)|Total Score on Child Behavior Checklist (CBCL)|Autism Diagnostic Observation Scale- 2 (ADOS-2)|Total Score on Aberrant Behavior Checklist (ABC)|Total Score on Self Harm Inventory|Total Score on Social Responsiveness Scale|Total Score on Peabody Picture Vocabulary test (PPVT-4)|Total Score on Expressive One Word Picture Vocabulary test, Fourth Edition (EOWPVT-4)|Total Score on Children's Sleep Habits Questionnaire (CSHQ)	University of California, San Diego|Wholistic Research and Education Foundation	Male	7 Years to 14 Years   (Child)	Phase 2|Phase 3	42	Other	Interventional	Allocation: Randomized|Intervention Model: Crossover Assignment|Masking: Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)|Primary Purpose: Treatment	181455	June 1, 2020	December 31, 2022	March 31, 2023	August 18, 2020		March 18, 2022	University of California, San Diego, La Jolla, California, United States		https://ClinicalTrials.gov/show/NCT04517799
63	NCT01727466	Treatment for Children With Autism and Anxiety		Completed	No Results Available	Autism	Behavioral: Facing Your Fears	Change in Clinical Global Impression Scale - Improvement and Severity (CGIS-S; CGIS-I)|Anxiety Disorders Interview Survey for Children-Parent Version (ADIS-P)	University of Colorado, Denver|Autism Speaks	All	8 Years to 14 Years   (Child)	Not Applicable	50	Other	Interventional	Allocation: N/A|Intervention Model: Single Group Assignment|Masking: Single (Outcomes Assessor)|Primary Purpose: Treatment	03-0245	August 2006	September 2009	December 2009	November 16, 2012		November 16, 2012			https://ClinicalTrials.gov/show/NCT01727466
64	NCT02090829	Intranasal Oxytocin and Learning in Autism		Withdrawn	No Results Available	Autism Spectrum Disorders	Drug: Syntocinon (synthetic oxytocin)|Other: Placebo	Change from Baseline to Post-testing on the The Part/Whole Identity Test|Change from Baseline to Post-testing on the Reading the Mind in the Eyes Task|Change from Baseline to Post-testing on measures of social attention, reward/motivation, perception and cognition	University of Minnesota|Children's Hospital of Philadelphia	Male	12 Years to 17 Years   (Child)	Phase 2	0	Other	Interventional	Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Triple (Participant, Care Provider, Investigator)|Primary Purpose: Treatment	1402M48250	March 2014	March 2018	March 2018	March 18, 2014		November 1, 2019	Center for Neurobehavioral Development, Minneapolis, Minnesota, United States		https://ClinicalTrials.gov/show/NCT02090829
65	NCT01630811	Nuedexta for the Treatment of Adults With Autism	Nuedexta	Completed	Has Results	Autism	Drug: Nuedexta|Other: Placebo	Change in Maladaptive Behaviors|Primary Safety Endpoints|Change in Aggressive Behavior	Sutter Health	All	18 Years to 60 Years   (Adult)	Phase 2	13	Other	Interventional	Allocation: Randomized|Intervention Model: Crossover Assignment|Masking: Triple (Participant, Care Provider, Investigator)|Primary Purpose: Treatment	CHKI-Nued0911	January 24, 2012	December 15, 2015	December 15, 2015	June 28, 2012	December 8, 2017	December 8, 2017	Sutter Pediatric Neurology, Sacramento, California, United States		https://ClinicalTrials.gov/show/NCT01630811
66	NCT04288986	The Impact of Group Based Activity Programmes on Children Who Have Autism and Their Families in Staffordshire		Unknown status	No Results Available	Autism Spectrum Disorder	Behavioral: Keep Achieving	Social Skills Improvement System Rating Scales - Parent (SSIS; Gresham & Elliott (2007).|Social Skills Improvement System Rating Scales - Child (SSIS; Gresham & Elliott (2007).|Social Connectedness Scale Revised (SCS-R; Lee, Draper & Lee 2001)|Self Image Profile (SIP; Butler)|The Short Warwick-Edinburgh Mental Wellbeing Scales (SWEMWBS; Stewart-Brown et al., 2009)|Goal Based Outcomes (GBOs)	Midlands Psychology CIC	All	5 Years to 100 Years   (Child, Adult, Older Adult)	Not Applicable	80	Other	Interventional	Allocation: N/A|Intervention Model: Single Group Assignment|Masking: None (Open Label)|Primary Purpose: Supportive Care	MP/KA-3	March 15, 2020	January 1, 2021	January 1, 2021	February 28, 2020		February 28, 2020	The Hates, Stafford, Staffs, United Kingdom		https://ClinicalTrials.gov/show/NCT04288986
67	NCT01474993	Sulforaphane-rich Broccoli Sprout Extract for Autism		Completed	Has Results	Autism	Drug: Sulforaphane-rich Broccoli Sprout Extract|Drug: Placebo	Change From Screening/Baseline in Social Responsiveness Scale (SRS) at 4 Weeks, 10 Weeks, 18 Weeks and 22 Weeks|Change From Screening/Baseline in Aberrant Behavior Checklist (ABC) at 4 Weeks, 10 Weeks, 18 Weeks and 22 Weeks|Ohio Autism Clinical Global Impression Scale - Severity (OACIS-S) Scale at 4 Weeks, 10 Weeks, 18 Weeks and 22 Weeks|Ohio Autism Clinical Impressions Scale - Improvement (OACIS-I) (or CGI-I Scores) Scores at 4 Weeks, 10 Weeks, 18 Weeks and 22 Weeks|Liver Function Tests [Serum Glutamic Oxaloacetic Transaminase (SGOT) and Serum Glutamic Pyruvic Transaminase (SGPT)] at 4 Weeks, 18 Weeks and 22 Weeks|Renal Function Tests (Serum Creatinine) at 4 Weeks, 18 Weeks and 22 Weeks|Thyroid Stimulating Hormone (TSH) at 4 Weeks, 18 Weeks and 22 Weeks|Red Blood Cell (RBC) Count at 4 Weeks, 18 Weeks and 22 Weeks|White Blood Cell (WBC) Count at 4 Weeks, 18 Weeks and 22 Weeks|Platelet Count at 4 Weeks, 18 Weeks and 22 Weeks|Change From Screening and Baseline in Urinary Isoprostane F2α-VI Levels at 24 Hours After First Dose, at 4 Weeks, 10 Weeks, 18 Weeks and 22 Weeks|Change From the Screening Visit in Heat Shock Protein Gene Expression (Relative Maximum Gene Expression) at 24 Hours After First Dose, 18 Weeks and 22 Weeks	Andrew Zimmerman|Johns Hopkins University|University of Massachusetts, Worcester	Male	13 Years to 30 Years   (Child, Adult)	Phase 2	44	Other	Interventional	Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)|Primary Purpose: Treatment	2011P002221	December 2011	November 2013	November 2013	November 18, 2011	November 24, 2014	September 12, 2018	Lurie Center for Autism, MassGeneral Hospital for Children, Lexington, Massachusetts, United States		https://ClinicalTrials.gov/show/NCT01474993
68	NCT04766970	Telehealth Autism Assessment for Adults		Recruiting	No Results Available	Autism Spectrum Disorder	Behavioral: ADOS-2 Module 4|Behavioral: Adapted Telehealth ADOS-2 Module 4	Concurrent validity	Vanderbilt University Medical Center	All	18 Years to 60 Years   (Adult)	Not Applicable	100	Other	Interventional	Allocation: Non-Randomized|Intervention Model: Sequential Assignment|Masking: None (Open Label)|Primary Purpose: Diagnostic	202427	October 1, 2022	December 31, 2025	December 31, 2025	February 23, 2021		October 26, 2022	Vanderbilt University Medical Center, Nashville, Tennessee, United States		https://ClinicalTrials.gov/show/NCT04766970
69	NCT05341505	Outcomes of Emotion Regulation Therapy in Young Autistic Adults		Recruiting	No Results Available	Autism	Behavioral: Emotion Regulation Intervention	Adult Self Report (ASR)|Adult Behavior Checklist (ABC-L)	Michal Assaf|Hartford Hospital	All	18 Years to 40 Years   (Adult)	Not Applicable	5	Other	Interventional	Allocation: N/A|Intervention Model: Single Group Assignment|Masking: None (Open Label)|Primary Purpose: Treatment	R-HHC-2017-0161	July 15, 2022	January 30, 2023	January 30, 2023	April 22, 2022		October 14, 2022	Institute of Living, Hartford Hospital, Hartford, Connecticut, United States		https://ClinicalTrials.gov/show/NCT05341505
70	NCT05277194	Reducing Challenging Behaviors in Children With Autism Through Digital Health		Not yet recruiting	No Results Available	Autism Spectrum Disorder	Behavioral: KeepCalm app	System Usability Scale (SUS)|Acceptability of Intervention Measure (AIM)|Feasibility of Intervention Measure (FIM)|Intervention Appropriateness Measure (IAM)|Qualitative interview|School Situations Questionnaire (SSQ)|Institute for Basic Research Modified Overt Aggression Scale (IBR-MOAS)|Emotion Dysregulation Inventory (EDI)	University of Pennsylvania|Alevio LLC	All	3 Years to 12 Years   (Child)	Not Applicable	20	Other	Interventional	Allocation: Randomized|Intervention Model: Sequential Assignment|Masking: None (Open Label)|Primary Purpose: Treatment	829690	February 2023	June 2024	June 2024	March 14, 2022		December 8, 2022			https://ClinicalTrials.gov/show/NCT05277194
71	NCT00655174	Fluvoxamine and Sertraline in Childhood Autism - Does SSRI Therapy Improve Behaviour and/or Mood?		Completed	No Results Available	Autism	Drug: fluvoxamine|Drug: sertraline|Drug: Placebo	The severity of the autistic child's behaviour or condition (assessed by parents)|Weight and vital signs|Blood count and liver function studies	The Hospital for Sick Children	All	3 Years to 10 Years   (Child)	Phase 3	108	Other	Interventional	Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Triple (Participant, Care Provider, Investigator)|Primary Purpose: Treatment	0019990290	June 1999	September 2006	January 2007	April 9, 2008		April 9, 2008	The Hospital for Sick Children, Toronto, Ontario, Canada		https://ClinicalTrials.gov/show/NCT00655174
72	NCT01638819	Autologous Cord Blood Stem Cells for Autism		Completed	Has Results	Autism	Biological: Autologous Cord Blood Stem Cells|Biological: Placebo	Change in Language (Total Standard Score, Range 40 - 160)|Change in Behavior/Learning (Standard Score, Range 40 - 160 for Each Subtest)|Change in Knowledge and Fluid Reasoning (Scaled Score, Range 1-19 for Each Subtest)	Sutter Health	All	2 Years to 7 Years   (Child)	Phase 2	30	Other	Interventional	Allocation: Randomized|Intervention Model: Crossover Assignment|Masking: Triple (Participant, Care Provider, Investigator)|Primary Purpose: Treatment	CB2011Chez	August 2012	December 2015	December 2016	July 12, 2012	August 20, 2018	August 20, 2018	Sutter Pediatric Neurology, Sacramento, California, United States		https://ClinicalTrials.gov/show/NCT01638819
73	NCT00208533	Aripiprazole in Children With Autism: A Pilot Study		Completed	No Results Available	Autism	Drug: Aripiprazole	Clinical Global Impressions	Drexel University College of Medicine|Drexel University	All	12 Years to 18 Years   (Child, Adult)	Phase 2	11	Other	Interventional	Allocation: N/A|Intervention Model: Single Group Assignment|Masking: None (Open Label)|Primary Purpose: Treatment	02841	February 2004	November 16, 2011	November 16, 2011	September 21, 2005		July 30, 2018	Drexel University College of Medicine at Friends Hospital, Philadelphia, Pennsylvania, United States		https://ClinicalTrials.gov/show/NCT00208533
74	NCT01624194	Intranasal Oxytocin Treatment for Social Deficits in Children With Autism		Completed	Has Results	Autism	Drug: Oxytocin nasal spray|Drug: Placebo	Change From Baseline in Parent Rated Social Responsiveness Scale (SRS) Scores During Treatment.|Number of Participants With Side Effects Assessed Using Parent Rated Dosage Record Treatment Emergent Symptom Scale (DOTES) Scores During Treatment|Change From Baseline in Height.|Clinical Global Impression-Improvement (CGI-I) Score at Week 4|Parent Rated Aberrant Behavior Checklist (ABC) Irritability Scores at Baseline and Week 4|Change From Baseline in Parent Rated Spence Children's Anxiety Scale (SCAS) During Treatment.|Change From Baseline in Vineland Adaptive Behavior Scales, Second Edition - Social and Communication Subscales During Treatment.|Change From Baseline in Laboratory Based Facial Emotion Recognition Abilities During Treatment.|Change From Baseline in Laboratory Based Eye-gaze to Social Cues During Treatment.|Change From Baseline in Reading the Mind in the Eyes Test, Child Version (RMET-child) Scores During Treatment.|Change From Baseline in Laboratory Based Social Mimicry Abilities During Treatment.|Change From Baseline in Developmental NEuroPSYchological Assessment (NEPSY-II) Affect Recognition Scores During Treatment.|Change From Baseline in Plasma Oxytocin Levels During Treatment.|Change From Baseline in Parent Rated Repetitive Behavior Scale- Revised (RBS-R) Scores During Treatment.|Change From Baseline in Weight|Change From Baseline in Heart Rate|Change From Baseline in Blood Pressure	Stanford University	All	6 Years to 12 Years   (Child)	Phase 2	54	Other	Interventional	Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)|Primary Purpose: Treatment	SU-12132011-8827	June 2012	May 2016	May 2016	June 20, 2012	June 6, 2018	July 15, 2019	Stanford University School of Medicine, Stanford, California, United States		https://ClinicalTrials.gov/show/NCT01624194
75	NCT00378157	Joint Attention Intervention and Young Children With Autism		Completed	No Results Available	Autism	Behavioral: Joint attention intervention	childrens score on measures of joint attention|score on measures of joint engagement -child and mother|childrens score on measures of language|parents and service providers perception of the intervention	Ullevaal University Hospital|Centre for Child and Adolescent Mental Health|Oslo University Hospital	All	24 Months to 60 Months   (Child)	Phase 1|Phase 2	61	Other	Interventional	Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Treatment	UUS 29560105	September 2006	December 2009	January 2010	September 19, 2006		February 23, 2011	Ullevaal University Hospital, Oslo, Norway		https://ClinicalTrials.gov/show/NCT00378157
76	NCT04939974	Probiotic in Autism		Not yet recruiting	No Results Available	Autism Spectrum Disorder	Dietary Supplement: probiotic	change in childhood autism rating scale at 24 weeks as compared to baseline	All India Institute of Medical Sciences, New Delhi	All	2 Years to 18 Years   (Child, Adult)	Not Applicable	100	Other	Interventional	Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)|Primary Purpose: Treatment	probiotic autism	August 1, 2021	August 1, 2022	August 1, 2022	June 25, 2021		June 25, 2021			https://ClinicalTrials.gov/show/NCT04939974
77	NCT05153551	Pediatric Early Autism Recognition System: PEARS	PEARS	Completed	No Results Available	Autism Spectrum Disorder	Other: Play-based assessment (RITA-T)	Proportion of PEARS PCP visits in which PCPs report overall feasibility in regard to workflow, delivery, and administration of the RITA-T|Percentage of parents that felt that the RITA-T visit was comfortable and useful|Change on the Parent Activation Measure for Children with Developmental Disabilities (PAM-DD)|Qualitative data from parents semi-structured interviews|The number of days between enrollment and completed RITA-T assessment|The percentage of participants that experienced scheduling and/or transportation barriers	University of Michigan|Blue Cross Blue Shield of Michigan Foundation	All	18 Months and older   (Child, Adult, Older Adult)	Not Applicable	60	Other	Interventional	Allocation: N/A|Intervention Model: Single Group Assignment|Masking: None (Open Label)|Primary Purpose: Health Services Research	HUM00203538	January 27, 2022	October 18, 2022	October 18, 2022	December 10, 2021		October 20, 2022	Michigan Medicine Briarwood Center for Women, Children, and Young Adults., Ann Arbor, Michigan, United States|Michigan Medicine Brighton Health Center, Brighton, Michigan, United States|Michigan Medicine Northville Health Center, Northville, Michigan, United States		https://ClinicalTrials.gov/show/NCT05153551
78	NCT05604326	Evaluating the Efficacy of Pathways Parent-Mediated Early Autism Intervention on Social Attention and Language		Recruiting	No Results Available	Autism Spectrum Disorder	Behavioral: Pathways Intervention|Behavioral: Parent Education Intervention (PEI)	Changes in child social orienting|Changes in child Joint attention|Change in child social communication|Change in child language|change in intentional communication|Changes in parenting stress|changes in child adaptive functioning|changes in cognitive skills|Changes in motor skills|changes in parent responsivity	The University of Texas at Dallas	All	12 Months to 42 Months   (Child)	Not Applicable	150	Other	Interventional	Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Double (Investigator, Outcomes Assessor)|Primary Purpose: Treatment	THECB AGP 27509	October 27, 2022	February 1, 2025	February 1, 2025	November 3, 2022		November 17, 2022	The University of Texas/Callier Center for Communication Disorders, Dallas, Texas, United States		https://ClinicalTrials.gov/show/NCT05604326
79	NCT01225198	Vitamin/Mineral Supplement for Children and Adults With Autism		Completed	No Results Available	Autism	Dietary Supplement: Multi-Vitamin/Mineral Supplement|Other: Liquid Placebo	Oxidative Stress|Parent Global Impressions - Revised	Arizona State University|Autism Research Institute|Legacy Foundation	All	3 Years to 60 Years   (Child, Adult)	Phase 2	143	Other	Interventional	Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)|Primary Purpose: Treatment	AutismVitaminStudy2008	May 2008	February 2009	February 2009	October 20, 2010		October 20, 2010	Arizona State University, Tempe, Arizona, United States		https://ClinicalTrials.gov/show/NCT01225198
80	NCT03015272	Testing a Novel Speech Intervention in Minimally Verbal Children With Autism Spectrum Disorder (ASD)		Completed	No Results Available	Autism	Behavioral: Auditory-Motor Mapping Training|Behavioral: Speech-Repetition Therapy	Change in approximately correct Consonant-Vowel Syllables between Best-Baseline and Post-25-session assessment|Change in approximately correct Consonant-Vowel Syllables between Best-Baseline and Post-4-week follow-up assessment	Beth Israel Deaconess Medical Center|Boston University	All	66 Months to 120 Months   (Child)	Phase 2|Phase 3	14	Other	Interventional	Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Single (Outcomes Assessor)|Primary Purpose: Treatment	2012P000344	November 2014	September 2019	December 2019	January 10, 2017		May 19, 2020	Beth Israel Deaconess Medical Center, Boston, Massachusetts, United States|Boston University, Autism Center of Excellence, Boston, Massachusetts, United States		https://ClinicalTrials.gov/show/NCT03015272
81	NCT01625299	Pilot Study of Diet and Behavior in Children With Autism		Completed	No Results Available	Autism	Dietary Supplement: Gluten and dry milk|Dietary Supplement: Placebo	Intestinal Permeability|Psychometric testing|Gastrointestinal symptoms	The University of Texas Health Science Center, Houston	All	3 Years to 12 Years   (Child)	Not Applicable	12	Other	Interventional	Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Double (Participant, Outcomes Assessor)|Primary Purpose: Supportive Care	HSC-MS-07-0223	October 2008	March 2011	March 2011	June 21, 2012		June 21, 2012	The University of Texas Health Science Center At Houston, Houston, Texas, United States		https://ClinicalTrials.gov/show/NCT01625299
82	NCT04551313	Effectiveness of Social Skills Training Group for Children With Autism Spectrum Disorder		Recruiting	No Results Available	Autism Spectrum Disorder	Behavioral: social skill group	GAS (Goal attainment scale)|Vineland Adaptive Behavior Scale	National Taiwan University Hospital	All	5 Years to 6 Years   (Child)	Not Applicable	104	Other	Interventional	Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Health Services Research	202006158RINA	October 19, 2020	October 2023	October 2023	September 16, 2020		October 20, 2021	National Taiwan University Hospital, Taipei, Taiwan|NTUH, Taipei, Taiwan		https://ClinicalTrials.gov/show/NCT04551313
83	NCT05499910	Neuro Strengths-Based Approach to Autism	NSBAA	Not yet recruiting	No Results Available	Autism Spectrum Disorder	Behavioral: NSBAA	Measurable change in the participant's satisfaction with their ability to write neuro-strength-based goals|Measurable change in participants' knowledge of the clinical reasoning for the goals they write|Measurable change in the completeness of the goals:	Baio Enterprises|Baio Institute	All	18 Years to 65 Years   (Adult, Older Adult)	Not Applicable	20	Other	Interventional	Allocation: N/A|Intervention Model: Single Group Assignment|Masking: None (Open Label)|Primary Purpose: Treatment	STUDY00015835	August 15, 2022	November 2022	December 2022	August 12, 2022		August 12, 2022			https://ClinicalTrials.gov/show/NCT05499910
84	NCT04484077	hCT-MSC Infusion in Adults With Autism Spectrum Disorder	AIMs	Recruiting	No Results Available	Autism Spectrum Disorder|Autism	Biological: hCT-MSC	Incidence of infusion reactions|Incidence of product-related infections|Evidence of formation of anti-HLA antibodies|Incidence of graft vs. host disease|Incidence of unexpected adverse events, by severity and relation to study|The Vineland Adaptive Behavior Scale Interview, 3rd Edition, Comprehensive interview form|Social Responsiveness Scale, Second Edition (SRS-2)|Social Withdrawal Subscale of the Aberrant Behavior Checklist, Community Edition (ABC-C)|Pediatric Quality of Life Inventory General Core Scales|Pediatric Quality of Life Inventory Family Impact Measure|Pediatric Quality of Life Inventory General Core Scales - Adult Version	Joanne Kurtzberg, MD|The Marcus Foundation|Duke University	All	18 Years to 34 Years   (Adult)	Phase 1	12	Other	Interventional	Allocation: N/A|Intervention Model: Single Group Assignment|Masking: None (Open Label)|Primary Purpose: Treatment	PRO00104691	January 24, 2022	March 2023	June 2023	July 23, 2020		September 6, 2022	Duke University Medical Center, Durham, North Carolina, United States		https://ClinicalTrials.gov/show/NCT04484077
85	NCT04472780	Hyperbaric Oxygen Treatment in Autism Spectrum Disorders		Recruiting	No Results Available	Child Autism	Device: Hyperbaric oxygen Therapy HBOT	clinical severity assesement|dosage of Inetreleukine 6|dosage of TNFα|Oxidatif stress profil|dosage of Glutathione peroxidase	General Administration of Military Health, Tunisia|Military Hospital of Tunis	All	4 Years to 14 Years   (Child)	Not Applicable	80	Other	Interventional	Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Single (Outcomes Assessor)|Primary Purpose: Treatment	Autism spectrum disorder	June 1, 2019	October 1, 2021	October 1, 2021	July 15, 2020		September 22, 2021	HBOT Department Military Hospital, Tunis, Montfleury, Tunisia		https://ClinicalTrials.gov/show/NCT04472780
86	NCT03005431	Parents of Newly Diagnosed Preschool Children With Autism Spectrum Disorder:		Unknown status	No Results Available	Autism	Behavioral: Parent training and support	Change in the Parent's Knowledge of ASD and Early Home Intervention Questionnaire.|Change in the Early Intervention Techniques Parent Rating Scale.|Change in Parent/Child Joint Engagement|Change in Expressive Communication Measure|Change in the Parenting Stress Index-Short Form|Change in the Family Support Scale	University of Manitoba	All	up to 59 Months   (Child)	Not Applicable	60	Other	Interventional	Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Single (Outcomes Assessor)|Primary Purpose: Treatment	HS20295 (H2016:427)	January 2017	April 2018	April 2018	December 29, 2016		October 3, 2017			https://ClinicalTrials.gov/show/NCT03005431
87	NCT05551260	Assessing Moral Cognitive Skills in Adults With Autism Spectrum Disorders	CoMorA	Not yet recruiting	No Results Available	Autism Spectrum Disorder	Other: Neuropsychological assessments (tests allowing to measures attentional, executive and emotional performances) and experimental protocol assessing moral cognition	Evaluation of moral cognition|Reasoning and general intellectual level|Attentional and executive measures|Social cognitive measures|Alexithymia	Hôpital le Vinatier	All	18 Years to 40 Years   (Adult)	Not Applicable	60	Other	Interventional	Allocation: Non-Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Prevention	2022-A01040-43	January 1, 2023	April 1, 2025	April 1, 2025	September 22, 2022		November 25, 2022			https://ClinicalTrials.gov/show/NCT05551260
88	NCT04654117	Examining the Active Ingredients of Consultation to Improve Implementation of a Parent-mediated Intervention for Children With Autism in the Community Mental Health System		Active, not recruiting	No Results Available	Autism Spectrum Disorder	Other: Consultee-centered administrative consultation	Treatment adherence|Parent-mediated intervention competence|Case penetration|Ratings of feasibility, acceptability, and appropriateness of each consultation phase|Ratings of feasibility, acceptability, and appropriateness of Project ImPACT|Child social communication skills	Michigan State University	All	18 Years and older   (Adult, Older Adult)	Not Applicable	43	Other	Interventional	Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Single (Outcomes Assessor)|Primary Purpose: Health Services Research	R40MC27705	October 1, 2021	October 14, 2022	March 2023	December 4, 2020		November 8, 2022	Michigan State University, East Lansing, Michigan, United States	"Informed Consent Form", https://ClinicalTrials.gov/ProvidedDocs/17/NCT04654117/ICF_000.pdf	https://ClinicalTrials.gov/show/NCT04654117
89	NCT00819364	Early Intervention Program for Children With Autism (BCRI Model)		Unknown status	No Results Available	Autism|Autism Spectrum Disorder	Behavioral: BCRI intervention program|Behavioral: Standard community care	Psychoeducational Profile-3rd Edition(PEP-3)|SRS(social response scale) scores and/or C-WYCSI scores at 2-year follow-up. SRS(social response scale) scores and/or C-WYSC scores at 5-year follow-up.	Sun Yat-sen University	All	up to 30 Months   (Child)	Not Applicable	200	Other	Interventional	Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Single (Outcomes Assessor)|Primary Purpose: Treatment	2007024	August 2009	August 2013	August 2016	January 9, 2009		August 11, 2009			https://ClinicalTrials.gov/show/NCT00819364
90	NCT01040221	Trichuris Suis Ova in Autism Spectrum Disorders	TSO	Completed	No Results Available	Autism	Drug: Trichuris Suis Ova	Yale-Brown Obsessive Compulsive Scale (YBOCS): to measure repetitive behaviors|Aberrant Behavior Checklist (ABC): to measure aggression and irritability|Clinical Global Impression - Improvement (CGI-I): to measure global functioning|Repetitive Behavior Scale-Revised.	Montefiore Medical Center|Simons Foundation	All	18 Years to 35 Years   (Adult)	Phase 1	10	Other	Interventional	Allocation: Randomized|Intervention Model: Crossover Assignment|Masking: Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)|Primary Purpose: Treatment	11-11-384	November 2012	June 2014	July 2014	December 29, 2009		April 3, 2018	Montefiore Medical Center, Albert Einstein College of Medicine, Bronx, New York, United States		https://ClinicalTrials.gov/show/NCT01040221
91	NCT01260961	Developing Treatment, Treatment Validation and Treatment Scope in the Setting of an Autism Clinical Trial		Active, not recruiting	No Results Available	Autism	Dietary Supplement: Placebo|Dietary Supplement: Docosahexanoic Acid	Amelioration of phenotypic features of autism|oxidative stress biomarkers	Rutgers, The State University of New Jersey	All	5 Years to 17 Years   (Child)	Not Applicable	132	Other	Interventional	Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)|Primary Purpose: Treatment	0220080189	November 2010	July 2015	July 1, 2023	December 15, 2010		October 26, 2022	Rutgers, Piscataway, New Jersey, United States		https://ClinicalTrials.gov/show/NCT01260961
92	NCT03866668	A Study of Esomeprazole in Children With Autism		Suspended	No Results Available	Autism|Autism Spectrum Disorder	Drug: Esomeprazole	Change from Baseline on the Social Responsiveness Scale, 2nd Edition (SRS-2)|Change from Baseline on the Aberrant Behavior Checklist, 2nd Edition (ABC-2)	Stanford University|SPARK (Stanford University)	All	2 Years to 6 Years   (Child)	Phase 2	25	Other	Interventional	Allocation: N/A|Intervention Model: Single Group Assignment|Masking: None (Open Label)|Primary Purpose: Treatment	IRB-44589	May 29, 2019	December 2024	December 2024	March 7, 2019		February 16, 2022	Stanford University School of Medicine, Stanford, California, United States		https://ClinicalTrials.gov/show/NCT03866668
93	NCT02586935	Tideglusib vs. Placebo in the Treatment of Adolescents With Autism Spectrum Disorders	TIDE	Completed	No Results Available	Autism Spectrum Disorders	Drug: Tideglusib|Other: Placebo	Effect of tideglusib vs. placebo on measures of social engagement/withdrawal|Efficacy of tideglusib vs. placebo on measures of repetitive behaviours|Efficacy of tideglusib vs. placebo on measures of social function|Safety and tolerability of tideglusib in adolescents with ASD|Pharmacokinetic (PK) parameters in this age group	Evdokia Anagnostou|Holland Bloorview Kids Rehabilitation Hospital|McMaster University|University of Western Ontario, Canada|Unity Health Toronto|University of Toronto|Anagnostou, Evdokia, M.D.	All	12 Years to 17 Years   (Child)	Phase 2	83	Other	Interventional	Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)|Primary Purpose: Treatment	TIDE-06-2015	February 10, 2016	February 25, 2018	February 25, 2018	October 27, 2015		May 31, 2018	McMaster University, Offord Centre for Child Studies, Hamilton, Ontario, Canada|University of Western Ontario, Lawson Health Research Institute, London, Ontario, Canada|Holland Bloorview Kids Rehabilitation Hospital, Toronto, Ontario, Canada		https://ClinicalTrials.gov/show/NCT02586935
94	NCT01912378	Triadic Interactions of Families With Autism and Oxytocin	TAO	Withdrawn	No Results Available	Autism Disorder	Drug: Oxytocin|Drug: Placebo nasal spray	Parental social behavior|Child and Parent Physiological Synchrony|Child social behavior	University of California, San Francisco	All	7 Years to 60 Years   (Child, Adult)	Phase 1	0	Other	Interventional	Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Triple (Participant, Investigator, Outcomes Assessor)|Primary Purpose: Basic Science	TAO	August 2013	May 2015	May 2015	July 31, 2013		January 16, 2019	University of California, San Francisco, San Francisco, California, United States		https://ClinicalTrials.gov/show/NCT01912378
95	NCT02579109	Multisensorial Information's Treatment in Autism Spectrum Disorder		Completed	No Results Available	Autism	Other: memory test	rate of reminder after 30 minutes between the group autistic and the group witness( %)|Difference of the scores of reminders words (%)	Centre Hospitalier Universitaire de Nice	All	7 Years to 13 Years   (Child)	Not Applicable	38	Other	Interventional	Allocation: Non-Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Basic Science	13AOI09	February 2014	February 2014	August 2014	October 19, 2015		October 19, 2015			https://ClinicalTrials.gov/show/NCT02579109
96	NCT04859998	Effects of Animal-assisted Therapy on the Physical Function and Communication of Adults With Autism		Enrolling by invitation	No Results Available	Autism Spectrum Disorder|Autism	Behavioral: dog-assisted therapy	Changes in walking performance (10m)|Changes in walking performance (6m)|Changes in balance and risk of falling|Changes in communication without dog|Changes in communication with dog|Changes in the ability to climb and descend stairs|Changes in step length (6m)|Changes in step length (10m)|Changes in cadence (6m)|Changes in cadence (10m)|Changes in duration of phases in the gait cycle (6m)|Changes in duration of phases in the gait cycle (10m)	Daniel Collado-Mateo|Asociación de Padres de Personas Con Autismo (APNA)|Asociación Nuevo Horizonte|Federación Autismo Madrid|Universidad Rey Juan Carlos	All	40 Years and older   (Adult, Older Adult)	Not Applicable	24	Other	Interventional	Allocation: Non-Randomized|Intervention Model: Parallel Assignment|Masking: Single (Investigator)|Primary Purpose: Supportive Care	AATinAutism	April 26, 2021	July 15, 2021	July 15, 2021	April 26, 2021		April 26, 2021	King Juan Carlos University, Móstoles, Madrid, Spain		https://ClinicalTrials.gov/show/NCT04859998
97	NCT05644366	Postural Control Instability in Children With Mild Autism		Completed	No Results Available	Autism Spectrum Disorder	Other: Postural Control Balance Assessment	Postural Stability	Texas Woman's University	All	7 Years to 12 Years   (Child)	Not Applicable	10	Other	Interventional	Allocation: N/A|Intervention Model: Single Group Assignment|Masking: None (Open Label)|Primary Purpose: Screening	A2540214	August 14, 2014	August 14, 2015	September 14, 2015	December 9, 2022		December 9, 2022			https://ClinicalTrials.gov/show/NCT05644366
98	NCT02272192	Intervention Effects of Intensity and Delivery Style for Toddlers With Autism	TADPOLE	Completed	No Results Available	Autism Spectrum Disorder	Behavioral: Early Start Denver Model (ESDM)|Behavioral: Early Intensive Behavioral Intervention (EIBI)	Expressive Communication Composite Score|Autism Severity Composite Score|Receptive Language Composite Score|Nonverbal Development Composite Score	University of California, Davis|University of Washington|Vanderbilt University|University of California, Los Angeles	All	15 Months to 30 Months   (Child)	Not Applicable	87	Other	Interventional	Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Single (Outcomes Assessor)|Primary Purpose: Treatment	406188	March 2013	July 1, 2019	July 1, 2019	October 22, 2014		January 6, 2020	UC Davis MIND Institute, Sacramento, California, United States|Vanderbilt University, Nashville, Tennessee, United States|University of Washington Autism Center, Seattle, Washington, United States		https://ClinicalTrials.gov/show/NCT02272192
99	NCT00786799	Omega-3 Fatty Acids for Autism Treatment		Completed	Has Results	Autism	Dietary Supplement: Omega-3 Fatty Acids	Group-specific and Comparison of Change in Aberrant Behavior Checklist-Hyperactivity Subscale Score (Active Omega-3 Group Only, Placebo Group Only and Comparison Between Groups)|Change in Percentage of Serum Omega-3 Fatty Acids|Change in Serum TNFα (Cytokine) Level	University of California, San Francisco|Autism Speaks	All	3 Years to 8 Years   (Child)	Phase 2	27	Other	Interventional	Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)|Primary Purpose: Treatment	200816175-1	August 2008	September 2009	September 2009	November 6, 2008	August 31, 2012	August 31, 2012	UC San Francisco, San Francisco, California, United States		https://ClinicalTrials.gov/show/NCT00786799
100	NCT00467753	Oxcarbazepine Versus Placebo in Childhood Autism		Completed	Has Results	Autism	Drug: Oxcarbazepine|Other: Placebo/sugar pill	Vineland Adaptive Behavior Scales|Aberrant Behavior Checklist|Autism Diagnostic Observation Schedule|Clinical Global Impression Improvement (CGI-AD)	University of Medicine and Dentistry of New Jersey|National Alliance for Research on Schizophrenia and Depression|Rutgers, The State University of New Jersey	All	5 Years to 17 Years   (Child)	Not Applicable	5	Other	Interventional	Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)|Primary Purpose: Treatment	0220055339	April 2006	December 2011	December 2011	May 1, 2007	December 16, 2013	January 13, 2021	Child and Adolescent Psychiatry at the University Behavioral Healthcare Building, UMDNJ-RWJMS, Piscataway, New Jersey, United States		https://ClinicalTrials.gov/show/NCT00467753
101	NCT05359757	Naturalistic Teaching Strategies in Children With Autism		Completed	No Results Available	Autism Spectrum Disorder	Other: Effect of Naturalistic Teaching Strategies in Children with autism spectrum disorder|Other: PECS Therapy only	Portage Early Education Program for Naturalistic Teaching Strategies for children with autism spectrum disorder.|Picture Exchange Communication System (PECS), an AAC system designed to minimize difficulties with communication skills experienced by individuals with Autism Spectrum Disorder	Riphah International University	All	3 Years to 8 Years   (Child)	Not Applicable	19	Other	Interventional	Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Single (Outcomes Assessor)|Primary Purpose: Treatment	REC/Lhr/21/0627 Maha Nasir	November 25, 2021	March 1, 2022	April 10, 2022	May 4, 2022		May 4, 2022	Riphah International University, Lahore, Punjab, Pakistan		https://ClinicalTrials.gov/show/NCT05359757
102	NCT04186364	Autism Spectrum Ambassador Program (ASAP) in the ED		Withdrawn	No Results Available	Autism Spectrum Disorder	Behavioral: Assigned Ambassador	Patient Satisfaction Survey (Questionnaire)|Medical Student Satisfaction Survey (Questionnaire)|Medical Student Career Interest (Questionnaire)|Medical Student Comfort Level (Questionnaire)	Milton S. Hershey Medical Center	All	30 Months to 17 Years   (Child)	Not Applicable	0	Other	Interventional	Allocation: Non-Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Supportive Care	00002020	April 1, 2021	April 8, 2021	April 8, 2021	December 4, 2019		April 13, 2021	Penn State Hershey Medical Center, Hershey, Pennsylvania, United States		https://ClinicalTrials.gov/show/NCT04186364
103	NCT03693313	The Effect of CrossFit Kids on Social Skills in Children With Autism Spectrum Disorder (CrossFit KAMP)	CrossFit KAMP	Completed	No Results Available	Autism Spectrum Disorder	Behavioral: CrossFit Kids exercise program	Improvement in social skills in children with ASD|Improvement in behavioral symptoms in children with ASD|Improvement in repetitive behaviors in children with ASD	University of California, Davis	All	8 Years to 11 Years   (Child)	Not Applicable	19	Other	Interventional	Allocation: Randomized|Intervention Model: Crossover Assignment|Masking: None (Open Label)|Primary Purpose: Treatment	1235533	September 4, 2018	August 30, 2019	September 30, 2019	October 2, 2018		October 31, 2019	UC Davis MIND Institute, Sacramento, California, United States		https://ClinicalTrials.gov/show/NCT03693313
104	NCT02094651	Treatment of Children With Autism Spectrum Disorders and Epileptiform EEG With Divalproex Sodium		Withdrawn	No Results Available	Autism	Drug: divalproex sodium|Other: Placebo	effect of drug vs placebo on reduction in epileptiform EEG discharges in children with ASD|behavior changes in drug vs placebo.	Boston Children's Hospital|University of Louisville	All	4 Years to 10 Years   (Child)	Phase 2	0	Other	Interventional	Allocation: Randomized|Intervention Model: Crossover Assignment|Masking: Triple (Participant, Care Provider, Investigator)|Primary Purpose: Treatment	P00005744	April 2014	October 2016	October 2016	March 24, 2014		October 21, 2016	University of Louisville, Louisville, Kentucky, United States|Boston Childrens Hospital, Boston, Massachusetts, United States		https://ClinicalTrials.gov/show/NCT02094651
105	NCT04576559	Effect of Modified Dental Visual Aids on Behavior Management During Dental Treatment in Children With Autism Spectrum Disorder		Completed	No Results Available	Child Autism	Other: Modified dental visual aids|Other: Regular dental visual aids	Plaque Index Scoring|Anxiety Scale for Children with Autism Spectrum Disorder (ASC-ASD)|The Observational Scale of Behavioral Distress (OSBD)	King Abdulaziz University	All	6 Years to 10 Years   (Child)	Not Applicable	64	Other	Interventional	Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Triple (Care Provider, Investigator, Outcomes Assessor)|Primary Purpose: Other	KingAbdulazizUni	September 1, 2019	July 1, 2021	August 30, 2021	October 6, 2020		August 17, 2022	King Abdulaziz University, Jeddah, Select A State Or Province, Saudi Arabia		https://ClinicalTrials.gov/show/NCT04576559
106	NCT04845776	Vitamin/Mineral Supplement for Children With Autism		Recruiting	No Results Available	Autism Spectrum Disorder	Dietary Supplement: ANRC Essentials Plus	Parent Global Impressions of Autism	Arizona State University|Southwest College of Naturopathic Medicine	All	3 Years to 17 Years   (Child)	Not Applicable	25	Other	Interventional	Allocation: N/A|Intervention Model: Single Group Assignment|Masking: None (Open Label)|Primary Purpose: Treatment	STUDY00013694	May 4, 2021	December 20, 2022	April 20, 2023	April 15, 2021		May 20, 2022	Arizona State University, Tempe, Arizona, United States		https://ClinicalTrials.gov/show/NCT04845776
107	NCT04744428	Trial of Autism Parent Navigator Program	APN	Recruiting	No Results Available	Autism Spectrum Disorder	Behavioral: Autism Parent Navigators|Behavioral: Peer mentoring	Weekly Count of Service Navigation Behaviors|Parenting Scale (Arnold)|CES-Depression|Coparenting Relationship Scale (Feinberg, Brown, & Kan, 2012)|Family Empowerment Scale - FES|PDD-BI	Penn State University|University of South Carolina|Family Connections	All	2 Years and older   (Child, Adult, Older Adult)	Not Applicable	360	Other	Interventional	Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Double (Participant, Outcomes Assessor)|Primary Purpose: Supportive Care	APN-RT01	March 25, 2021	July 1, 2024	July 1, 2025	February 9, 2021		July 7, 2022	Family Connections, Columbia, South Carolina, United States		https://ClinicalTrials.gov/show/NCT04744428
108	NCT04165655	Keep Achieving:The Impact of Group Based Activity Programmes on Children Who Have Autism and Their Families		Unknown status	No Results Available	Autism Spectrum Disorder	Behavioral: Keep Achieving (KA)	Change in Social Skills Improvement System Rating Scales - Parent (Social Skills Improvement System; Gresham & Elliott (2007).|Change in Social Skills Improvement System Rating Scales - Child (Social Skills Improvement System; Gresham & Elliott (2007).|Social Connectedness Scale Revised (SCS-R; Lee, Draper & Lee 2001)|Self Image Profile (SIP; Butler)|The Short Warwick-Edinburgh Mental Wellbeing Scales (SWEMWBS; Stewart-Brown et al., 2009)|Goal Based Outcomes (GBOs)	Midlands Psychology CIC	All	8 Years to 80 Years   (Child, Adult, Older Adult)	Not Applicable	80	Other	Interventional	Allocation: Non-Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Supportive Care	MP/KA-1	February 1, 2020	April 2020	May 2020	November 18, 2019		March 2, 2020	The Hayes, Stafford, Staffordshire, United Kingdom		https://ClinicalTrials.gov/show/NCT04165655
109	NCT02560415	Gaming Open Library for Intervention in Autism at Home (GOLIAH /MICHELANGELO)	MICHELANGELO	Completed	No Results Available	Autism Spectrum Disorder	Device: Experimental|Behavioral: Comparator	change from baseline in Autism Diagnostic Observation Schedule (ADOS) at 6 months|change from baseline in Vineland II at 6 months|change from baseline in Child Behavior Check List at 6 months|change from baseline in Wechsler Intelligence scale at 6 months|change from baseline in Social Communication Questionnaire at 6 months|change from baseline in Parental Stress Index at 6 months	Assistance Publique - Hôpitaux de Paris|European Commission	All	5 Years to 8 Years   (Child)	Not Applicable	24	Other	Interventional	Allocation: Non-Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Treatment	IDRCB2014-A-00170-47 - P120914|EU: FP7-ICT-2011-7 (n°288241)	September 2014	June 2015	June 2015	September 25, 2015		September 25, 2015			https://ClinicalTrials.gov/show/NCT02560415
110	NCT04107064	Achieving Steady Work Among Adults With Autism Through Specialized Employment Program		Recruiting	No Results Available	Autism Spectrum Disorder|Autism	Behavioral: NaW|Behavioral: NaW-DS	Job Retention Rates|Duration of Sustained Employment|Costs of Employee Turnover|Rates of Job Offers|World Health Organization Quality of Life Assessment [WHOQOL-100]|Maslach's Burnout Measure|Meyer and Allen's Affective Commitment Measure|Eisenberger's Perceived Organizational Support|Morgensen and Humphrey's Job Characteristics (WDQ)|Judge's Global Job Satisfaction|MOAQ Subscale: Intent to Turnover|Work Motivation and Engagement (UWES)|ANZ Financial Well-being Scale	Lawrence Fung|3R Behavioral Solutions|Rangam Consultants|Stanford University	All	18 Years to 55 Years   (Adult)	Not Applicable	80	Other	Interventional	Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Single (Participant)|Primary Purpose: Treatment	50268	September 30, 2019	March 2024	December 2025	September 27, 2019		September 21, 2021	Stanford University School of Medicine, Palo Alto, California, United States		https://ClinicalTrials.gov/show/NCT04107064
111	NCT05553262	A Protocol to Streamline Dental Care in Autistic Children	DentAutism	Completed	No Results Available	Autism Spectrum Disorder	Behavioral: Behavioral support	Collaboration|Acceptance	University of Padova|ULSS 6 Euganea|Nastrificio Victor S.p.A.	All	4 Years to 13 Years   (Child)	Not Applicable	170	Other	Interventional	Allocation: Non-Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Treatment	AUTISM	January 1, 2019	December 31, 2021	December 31, 2021	September 23, 2022		September 27, 2022	Piove di Sacco Hospital, Piove Di Sacco, PD, Italy		https://ClinicalTrials.gov/show/NCT05553262
112	NCT04832152	Telehealth Intervention for Autism Spectrum Disorder		Not yet recruiting	No Results Available	Autism Spectrum Disorder	Other: OT4ASD	Daily Living Skills Change Score - Pediatric Evaluation of Disabilities Inventory|Pervasive Developmental Disorders Behavioral Inventory T Score Autism Behaviors|Goal Attainment Scale T Score|Sensory Processing Measure	Thomas Jefferson University|Montefiore Medical Center	All	4 Years to 12 Years   (Child)	Not Applicable	10	Other	Interventional	Allocation: N/A|Intervention Model: Single Group Assignment|Masking: None (Open Label)|Primary Purpose: Other	412579-19406	June 15, 2022	September 30, 2022	October 14, 2022	April 5, 2021		April 22, 2022			https://ClinicalTrials.gov/show/NCT04832152
113	NCT02235467	Multisite Study: Parental Training Using Video Modelling to Develop Social Skills in Children With Autism		Completed	No Results Available	Autism Spectrum Disorders	Behavioral: ABA parent training	Acquisition from baseline of new behaviors at 8 weeks|Acquisition from baseline of new behaviors at 16 weeks|Acquisition from baseline of new behaviors at 21 weeks|Change from baseline in Eye-tracking at 21 weeks|Change from baseline in Vineland Scale at 21 weeks|Change from baseline in SON-R 2½-7 at 21 weeks|Change from baseline in Zaritt Burden Interview at 21 weeks|Change from baseline in OERA at 21 weeks	Federal University of São Paulo|Mackenzie Presbiterian University, São Paulo, Brazil|University of Sao Paulo	All	3 Years to 7 Years   (Child)	Phase 4	67	Other	Interventional	Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Single (Outcomes Assessor)|Primary Purpose: Treatment	U1111-1157-8984|2012/51584-0	February 2014	December 2014	December 2014	September 10, 2014		April 2, 2015	Federal University of São Paulo Department of Psychiatry, São Paulo, Brazil		https://ClinicalTrials.gov/show/NCT02235467
114	NCT03215394	Evaluation of Social ABCs With Attention Training Intervention for Toddlers With Suspected Autism		Completed	No Results Available	Autism Spectrum Disorder	Behavioral: Attention Training Program|Behavioral: Social ABCs|Other: Treatment As Usual|Behavioral: Sham Attention Training	Improved Attentional Flexibility|Improved Attentional Control|Increased Social Orienting to Parent|Increased Child Smiling|Increased Child Responsivity to Parent Prompt|Parent Fidelity of Implementation|Receptive Language|Expressive Language|Joint Attention	Holland Bloorview Kids Rehabilitation Hospital|IWK Health Centre|Dalhousie University|University of Alberta|University of East London|University of London	All	12 Months to 30 Months   (Child)	Not Applicable	150	Other	Interventional	Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Treatment	16-666	April 1, 2017	August 30, 2020	August 30, 2020	July 12, 2017		January 27, 2021	University of Alberta - Autism Research Centre, Edmonton, Alberta, Canada|IWK Health Centre / Dalhousie University, Halifax, Nova Scotia, Canada|Holland Bloorview Kids Rehabilitation Hospital, Toronto, Ontario, Canada|University of East London, London, United Kingdom		https://ClinicalTrials.gov/show/NCT03215394
115	NCT03771560	Folinic Acid in Autism		Completed	Has Results	Autism Spectrum Disorder	Drug: folinic acid	Aberrant Behavior Checklist (ABC) - Parent Reported Change|Aberrant Behavior Checklist (ABC) - Teacher Reported Change|Social Responsiveness Scale (SRS) - Parent Reported Change|Social Responsiveness Scale (SRS) - Teacher Reported Change|Pediatric Quality of Life (PedsQL) - Parent Reported Change	University of California, San Francisco	All	5 Years to 25 Years   (Child, Adult)	Phase 2|Phase 3	18	Other	Interventional	Allocation: N/A|Intervention Model: Single Group Assignment|Masking: None (Open Label)|Primary Purpose: Treatment	Folinic acid	February 15, 2018	June 30, 2018	June 30, 2018	December 11, 2018	December 3, 2019	December 3, 2019	University of California, San Francisco, San Francisco, California, United States	"Study Protocol and Statistical Analysis Plan", https://ClinicalTrials.gov/ProvidedDocs/60/NCT03771560/Prot_SAP_000.pdf	https://ClinicalTrials.gov/show/NCT03771560
116	NCT04710810	UCB Stem Cells for Autism Spectrum Disorders		Completed	No Results Available	Autism Spectrum Disorder	Other: umbilical cord blood mononuclear stem cells	Incidence of Treatment Emergent Adverse Events|Changes in severity of autistic symptoms from baseline at 3d and 6th month (measured by Checklist for Autism Spectrum Disorders (CASD)|Changes in severity of autistic symptoms from baseline at 3d and 6th month (measured by Autism Treatment Evaluation Checklist (ATEC)|"Digit Span" subscale of Wechsler Intelligence Scale for Children (WISC)|"Picture completion" subscale of Wechsler Intelligence Scale for Children (WISC)|"Block design" subscale of Wechsler Intelligence Scale for Children (WISC)|"Coding" subscale of Wechsler Intelligence Scale for Children (WISC)	St. Petersburg Bekhterev Research Psychoneurological Institute	All	3 Years to 11 Years   (Child)	Phase 1	30	Other	Interventional	Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Treatment	SCA1512	November 4, 2019	January 31, 2021	July 31, 2021	January 15, 2021		August 4, 2021	St.-Petersburg Bekhterev Reserach Psychoneurological Institute, Saint Petersburg, Санкт-Петербург, Russian Federation		https://ClinicalTrials.gov/show/NCT04710810
117	NCT03778827	A Center Based Study of Pivotal Response Treatment for Preschoolers With Autism	PRT-C	Recruiting	No Results Available	Autism Spectrum Disorder|Autism	Behavioral: Intensive Center-Based Pivotal Response Treatment (PRT-C)	Mean Change from baseline on the Social Responsiveness Scale-2 Total Score at 12 Weeks|Mean change from baseline on the Brief Observation of Communication Change (BOSCC) total score at 12 Weeks|Mean change from baseline on the frequency if the child's functional utterances on the structured lab observation at 12 Weeks|Mean change from baseline on the Vineland Adaptive Behavior Scales 3rd Edition Socialization subscale at 12 Weeks|Mean change from baseline on the MacArthur-Bates Communication Development Inventory at 12 Weeks	Stanford University|John & Marcia Goldman Foundation	All	2 Years to 3 Years   (Child)	Not Applicable	44	Other	Interventional	Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Double (Investigator, Outcomes Assessor)|Primary Purpose: Treatment	IRB-49033	May 8, 2019	May 2023	May 2023	December 19, 2018		February 16, 2022	Stanford University School of Medicine, Stanford, California, United States		https://ClinicalTrials.gov/show/NCT03778827
118	NCT05098392	Sibling-Mediated Intervention on Literacy and Reciprocity for Children With Autism		Recruiting	No Results Available	Autism Spectrum Disorder	Behavioral: Sibling-mediated intervention	Change in oral reading accuracy|Change in social engagement|Change in sibling relationship|Change in sibling self-efficacy.|Change in reciprocal conversation|Change in oral retell|Social validity	Arizona State University	All	5 Years to 11 Years   (Child)	Not Applicable	40	Other	Interventional	Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Single (Outcomes Assessor)|Primary Purpose: Treatment	STUDY00014411	November 2, 2021	November 1, 2022	November 1, 2022	October 28, 2021		November 9, 2021	Children's Autism Center, Round Rock, Texas, United States|Best Love Child Development Center, Kunming, Yunnan, China|Clover Children Rehabilitation Kindergarten, Shanghai, China		https://ClinicalTrials.gov/show/NCT05098392
119	NCT03575429	Autism Adaptive Community-based Treatment to Improve Outcomes Using Navigators (ACTION) Network		Completed	No Results Available	Autism Spectrum Disorder	Behavioral: Engagement Intervention|Behavioral: Engagement + Coaching Intervention	Parent contingent responsiveness change over time|Observation of DSM-5 features of autism spectrum disorder change over time|Child social communication change over time|Autism Diagnostic Observation Schedule (ADOS)|Mullen Scales of Early Learning (MSEL)|Vineland Adaptive Behavior Scales (VABS-3)	Florida State University|Boston Medical Center|University of Miami|University of Massachusetts, Boston|Kaiser Permanente|Children's Hospital of Philadelphia|Boston University	All	12 Months to 24 Months   (Child)	Not Applicable	81	Other	Interventional	Allocation: Randomized|Intervention Model: Sequential Assignment|Masking: Double (Investigator, Outcomes Assessor)|Primary Purpose: Health Services Research	R01HD093055	August 1, 2019	November 18, 2022	November 18, 2022	July 2, 2018		November 29, 2022	University of Miami, Coral Gables, Florida, United States|Florida State University Autism Institute, Tallahassee, Florida, United States|Boston Medical Center Corporation, Boston, Massachusetts, United States		https://ClinicalTrials.gov/show/NCT03575429
120	NCT04089579	hCT-MSC in Children With Autism Spectrum Disorder	IMPACT	Active, not recruiting	No Results Available	Autism|Autism Spectrum Disorder	Biological: Cord Tissue Mesenchymal Stromal Cells|Other: Placebo Infusion	Change on the Socialization and Communication Subscale Standard Scores on the Vineland Behavior Scales|Change in VABS-3 Socialization Standard Score|Change in VABS-3 Communication Standard Score|Change in CGI-Severity score|CGI-Intervention score|Change in the Pediatric Quality of Life Scale	Joanne Kurtzberg, MD|The Marcus Foundation|Duke University	All	4 Years to 11 Years   (Child)	Phase 2	164	Other	Interventional	Allocation: Randomized|Intervention Model: Crossover Assignment|Masking: Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)|Primary Purpose: Treatment	Pro00102894	October 12, 2020	April 1, 2023	October 1, 2023	September 13, 2019		October 28, 2022	Duke University Medical Center, Durham, North Carolina, United States		https://ClinicalTrials.gov/show/NCT04089579
121	NCT05288868	The Effect of Simulation-based Training on Confidence and Competence in Obtaining Vitals in a Child With Autism		Recruiting	No Results Available	Autism Spectrum Disorder	Other: Educational Intervention: online didactic lecture and educational simulation activity	Mean change from baseline in confidence scores on the employee questionnaire at weeks 10 and 16|Mean change from baseline in competency scores on the employee questionnaire at weeks 10 and 16|Mean change from baseline in knowledge scores on the employee questionnaire at weeks 10 and 16|Mean change from baseline in caregiver satisfaction score on the caregiver survey between weeks 6-10 and 12-16|Mean change in the number of times vital signs obtained between weeks 0-4, weeks 6-10, and weeks 12-16	Weill Medical College of Cornell University	All	Child, Adult, Older Adult	Not Applicable	50	Other	Interventional	Allocation: Non-Randomized|Intervention Model: Single Group Assignment|Masking: None (Open Label)|Primary Purpose: Other	21-05023509	June 7, 2022	December 30, 2022	May 31, 2023	March 21, 2022		December 6, 2022	Weill Cornell Medicine, New York, New York, United States		https://ClinicalTrials.gov/show/NCT05288868
122	NCT03994757	Effects of Routines-Based Early Intervention in Children With Autism Spectrum Disorder		Unknown status	No Results Available	Autism Spectrum Disorder	Behavioral: MRBI|Behavioral: Control	Goal Attainment Scale(GAS)|Comprehensive Developmental Inventory for Infants and Toddlers(CDIIT)|Childhood Asperger Syndrome Test(CAST)|The Children Autism Rating Scale Second Edition(CARS-2)|Clancy Behavior Scale|Social Responsiveness Scale(SRS)|Theory of Mind Inventory-2(ToMI-2)|The Berry-Buktenica Developmental Test of Visual-Motor Integration(VMI)|Preschool Language Impaired Scale(PLS)/ Language Impaired Scale(LS)|Peabody Picture Vocabulary Test-Revised(PPVT-R)|Assessment of preschool children's participation(APCP) / Children Assessment of Participation and Enjoyment andPreferences for Activity of Children(CAPE)|Functional Independence Measure for Children(WeeFIM)|TNO-AZL Preschool children Quality of Life(TAPQOL)/TNO-AZL Quality of Life Questionnaire(TACQOL)|Sensory Profile(SP)|Parenting Stress Index(PSI)|Swanson, Nolan, and Pelham Questionnaire(SNAP)	Chang Gung Memorial Hospital	All	3 Years to 9 Years   (Child)	Not Applicable	40	Other	Interventional	Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Double (Participant, Outcomes Assessor)|Primary Purpose: Treatment	201602004A3	August 1, 2017	September 2019	September 2019	June 21, 2019		August 1, 2019	Chang Gung Memorial Hospital, Taoyuan, Taiwan		https://ClinicalTrials.gov/show/NCT03994757
123	NCT04321915	Intestinal Dysbiosis and BBB Integrity in Autism	LEDA	Recruiting	No Results Available	Autism Spectrum Disorder	Other: Analysis of intestinal microbiota in autism spectrum desorder|Other: Analysis of neuroinflammation markers in autism spectrum desorder	Intestinal microbiota assessment|Measuring the severity of ASD|Evaluation of the level of social interaction|Behavioural disorders|Quality of life of children with ASD|Developmental trajectory of children with ASD|IQ (Intellectual Quotient)|Assessment of stools aspect|Repetitive and stereotypical behaviours|Intensity of GI disorders|Measurement of neuroinflammation|Intestinal permeability|Intestinal inflammation|TH1/TH2 immune response|Metabolome analysis	University Hospital, Montpellier|Inserm1047, CHU Nîmes|LBPC, Inserm 1183, IRMB CHU Montpellier|UMR 5203, InsermU1191, IGF, Montpellier	All	6 Years to 16 Years   (Child)	Not Applicable	60	Other	Interventional	Allocation: N/A|Intervention Model: Single Group Assignment|Masking: None (Open Label)|Primary Purpose: Basic Science	RECHMPL18_0197	April 26, 2021	October 26, 2024	February 26, 2025	March 25, 2020		April 22, 2022	Centre de Ressources Autisme, Montpellier, France		https://ClinicalTrials.gov/show/NCT04321915
124	NCT00584480	Pilot Study of the Effect of Hyperbaric Oxygen Treatment on Behavioral and Biomarker Measures in Children With Autism	HBOT	Completed	Has Results	Autism	Other: Hyperbaric Oxygen Treatment (HBOT)	Number of Participants With the Given Clinical Global Impression Scale - Improvement (CGI-I) Score	University of California, San Francisco|University of California, Davis	All	3 Years to 8 Years   (Child)	Phase 3	10	Other	Interventional	Allocation: N/A|Intervention Model: Single Group Assignment|Masking: None (Open Label)|Primary Purpose: Treatment	200715202-1	October 2007	September 2009	September 2009	January 2, 2008	April 13, 2012	August 7, 2012			https://ClinicalTrials.gov/show/NCT00584480
125	NCT02878499	Do Sleep and Circadian Rhythm Disturbances Impact the Cognitive and Behavioural Development of Children With Autism?		Recruiting	No Results Available	Autism Spectrum Disorder	Other: polysomnography	Change in sleep latency at 1 year follow-up and 2 year follow-up compared to baseline|Change in sleep fragmentation index at 1 year follow-up and 2 year follow-up compared to baseline|Change in nocturnal melatonin secretion at 1 year follow-up and 2 year follow-up compared to baseline|Change in amplitude of the day-night melatonin secretion at 1 year follow-up and 2 year follow-up compared to baseline|Change in non-verbal index (INV, derived from the Kaufmann-Assessment Battery fir Children II (K-ABC II)) at 1 year follow-up and 2 year follow-up compared to baseline|Change in verbal intelligence quotient (IQ) at 1 year follow-up and 2 year follow-up compared to baseline|Change in Raven performance IQ at 1 year follow-up and 2 year follow-up compared to baseline|Change in Autism Diagnostic Observation Schedule (ADOS), module 1-3: part 'D' et 'E' (repetitive and abnormal behaviour) at 1 year follow-up and 2 year follow-up compared to baseline|Change in aberrant Behaviour Checklist (ABCL) global score at 1 year follow-up and 2 year follow-up compared to baseline|presence of an intrinsic sleep disorders (e.g. obstructive or central sleep apnea syndrome, restless legs syndrome and periodic limb movements during sleep…)|Total sleep time (TST)|Time and percentage of TST spent in different sleep stages (slow wave sleep, rapid eye movement (REM) sleep)|Sleep spindle density in light slow wave sleep|Density of rapid eye movements in REM sleep|Spectral analysis of the sleep electro-encephalogram (EEG)|24h urinary 6-sulfatoxymelatonin levels (ng/ml)|Inter-daily stability (IS) and intra-daily variability (IV) of circadian rhythms (actigraphy derived)|Circadian phase of body temperature|Level of ferritin in plasma	University Hospital, Strasbourg, France	All	3 Years to 8 Years   (Child)	Not Applicable	105	Other	Interventional	Allocation: N/A|Intervention Model: Single Group Assignment|Masking: None (Open Label)|Primary Purpose: Other	5060	December 19, 2012	December 2022	February 2023	August 25, 2016		June 30, 2022	CHRU de Lille - Hôpital Roger Salengro, Lille, France|CHU de Lyon - CHS Le Vinatier, Lyon, France|CHU Gui de Chaulhiac, Montpellier, France|Hôpitaux Universitaires de Strasbourg, Strasbourg, France|CHU de TOURS - Hôpital Bretonneau, Tours, France		https://ClinicalTrials.gov/show/NCT02878499
126	NCT03131635	Effectiveness of a Developmental Reciprocity Treatment Program in Autism	DRTP	Terminated	No Results Available	Autism Spectrum Disorder|Autism	Behavioral: Developmental Reciprocity Treatment Program (DRT-P)	Change from Baseline on the Social Responsiveness Scale (SRS) at 6, 12, and 24 weeks|Change from Baseline on the Brief Observation of Social Communication Change (BOSCC) at 24 weeks|Change from Baseline on the Vineland Adaptive Behavior Scales, Second Edition (VABS-II) at 12, and 24 weeks|Change from Baseline on the Stanford Social Dimensions Scale (SSDS) Questionnaire.	Stanford University	All	2 Years to 5 Years   (Child)	Not Applicable	54	Other	Interventional	Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Treatment	IRB 40026	July 26, 2017	July 16, 2020	July 16, 2020	April 27, 2017		September 15, 2022	Stanford University, Stanford, California, United States		https://ClinicalTrials.gov/show/NCT03131635
127	NCT05473104	PEERS® for Italy, a Study on Social Skills Intervention for Adolescents With Autism Spectrum Disorder (ASD).		Completed	No Results Available	Autism Spectrum Disorder	Behavioral: Program for the Education and Enrichment of Relational Skills	Social Responsiveness Scale (SRS) (Costantino & Gruber, 2005), changes after 14 weeks and 3 months.|Quality of Socialization Questionnaire-Revised (QSQ-R) (Laugeson & Frankel, 2010; Laugeson et al., 2012), changes after 14 weeks and 3 months.|Test of Adolescent Social Skills Knowledge (TASSK) (Laugeson & Frankel 2010), changes after 14 weeks and 3 months.|Child Behavior Checklist (CBCL) (Achenbach & Rescorla, 2001), changes after 14 weeks and 3 months.|Multidimensional Anxiety Scale for Children-Second Edition (MASC-2) (March, 2013), changes after 14 weeks and 3 months.|Children's Depression Inventory, Second Edition (CDI-2) (Kovacs, 2010), changes after 14 weeks and 3 months.|Behavior Rating Inventory of Executive Function, Second Edition (BRIEF-2) (Gioia et al., 2015), changes after 14 weeks and 3 months.	Istituto Superiore di Sanità|University of Roma La Sapienza	All	12 Years to 18 Years   (Child, Adult)	Phase 2	37	Other	Interventional	Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Double (Care Provider, Outcomes Assessor)|Primary Purpose: Treatment	871	January 14, 2021	April 14, 2021	November 14, 2021	July 25, 2022		July 25, 2022	Istituto Superiore di Sanità, Roma, Rome, Italy		https://ClinicalTrials.gov/show/NCT05473104
128	NCT04574206	Testing a Novel Parenting Intervention for Children With Autism	PAREint	Unknown status	No Results Available	Autism Spectrum Disorder	Behavioral: Elaborative Reminiscence (ER)|Behavioral: Present Tense Talk (PTT)	Trial recruitment feasibility|Feasibility of training procedures|Training enactment|Implementation fidelity (actual dosage)|Implementation fidelity (frequency of intervention delivery)|Intervention acceptability|Memory test|Memory elaborations|Mental state understanding|Self-concept	City, University of London	All	7 Years to 11 Years   (Child)	Not Applicable	50	Other	Interventional	Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Single (Participant)|Primary Purpose: Supportive Care	GRY190053860	December 1, 2020	August 2022	October 2022	October 5, 2020		January 28, 2021	City University of London, London, Greater London, United Kingdom		https://ClinicalTrials.gov/show/NCT04574206
129	NCT00935701	Acupressure and Acupuncture as an Intervention With Children With Autism II		Completed	Has Results	Autism Spectrum Disorder	Device: Acupressure and Acupuncture	Proportions of Children Completing Acupressure and Acupuncture Treatment.|Change in Conners' Rating Scales|Change in Children's Sleep Habits Questionnaire|Change in Parenting Stress Index	Johns Hopkins University|Autism Speaks	All	3 Years to 10 Years   (Child)	Not Applicable	10	Other	Interventional	Allocation: N/A|Intervention Model: Single Group Assignment|Masking: None (Open Label)|Primary Purpose: Treatment	NA_00026158|2949	July 2009	February 2011	February 2011	July 9, 2009	September 26, 2014	April 18, 2017	Kennedy Krieger Institute, Baltimore, Maryland, United States		https://ClinicalTrials.gov/show/NCT00935701
130	NCT04628715	Biofeedback Intervention in Adolescents With Autism Spectrum Disorder		Recruiting	No Results Available	Autism Spectrum Disorder	Device: RSA biofeedback	Change in Root Mean Square of Successive Differences between normal heart beats (RMSSD) as a measure of cardiac vagal modulation.|Change in Logarithm of High-Frequency Heart Rate Variability (LnHF-HRV) as a measure of cardiac vagal modulation.|Change in Heart rate|Change in Breathing frequency|Change in Skin conductance|Change in Fingertip temperature|Change in Cortisol level|Autism Spectrum Quotient - Adolescent Version (AQ)|Change on Social Responsiveness Scale - 2nd edition (SRS-2)|Change on Repetitive Behavior Scale - Revised (RBS-R)|Change on Strengths and Difficulties Questionnaire - parent report (SDQ-PR)|Change on Strengths and Difficulties Questionnaire - adolescent self-report (SDQ-SR)|Change on Perceived Stress Scale - Adolescent version (PSS)|Change on Depression Anxiety and Stress Scale-21 items version|Change on Physical Activity Vital Sign|Change on Visual Analogue Scale (VAS) for sensory hyper-responsivity|Change on Visual Analogue Scale for perceived stress	Universitaire Ziekenhuizen KU Leuven	All	13 Years to 18 Years   (Child, Adult)	Not Applicable	128	Other	Interventional	Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Single (Participant)|Primary Purpose: Treatment	s64219	November 26, 2020	December 2022	August 2023	November 13, 2020		May 19, 2022	KU Leuven, Leuven, Vlaams Brabant, Belgium		https://ClinicalTrials.gov/show/NCT04628715
131	NCT02007447	Oxytocin in Adolescents With Autism Spectrum Disorders	OXYASD	Terminated	No Results Available	Autism Spectrum Disorder	Drug: OCYTOCINA - SPRAY NASAL	SOCIAL SKILLS|REPETITIVE BEHAVIOR	University of Sao Paulo General Hospital	Male	12 Years to 18 Years   (Child, Adult)	Phase 2|Phase 3	30	Other	Interventional	Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)|Primary Purpose: Treatment	CAAE 10922213.7.0000.0068	June 2015	August 2015	May 4, 2018	December 10, 2013		October 28, 2019	Institute os Psychiatry, Clinical Hospital at São Paulo, São Paulo, Brazil		https://ClinicalTrials.gov/show/NCT02007447
132	NCT03427138	Training Early Social Language in Autism	TESLA	Active, not recruiting	No Results Available	Autism Spectrum Disorder	Behavioral: Jasper|Behavioral: Parent Education	Change in EEG Frequency Data- Resting State|Change in EEG Frequency Data- Grasping Objects|Change in EEG Frequency Data- Observing actions|Change in joint attention measured with the Early Social and Communication scales (ESCS)|Change in play level measured with the Structured Play Assessment (SPA)|Change in imitation measured with the Elicited Imitation Battery (adapted from Rogers et al., 2003)|Change in language measured with the Elicitation of Language Sample Assessment-Toddler version (ELSA-T)|Change in parent-child interactions|Change in predictive gaze measured with eye-tracking	Boston University Charles River Campus|University of Maryland, College Park|University of Chicago|Centre National de la Recherche Scientifique, France|University of California, Los Angeles|Boston Medical Center	All	18 Months to 59 Months   (Child)	Not Applicable	100	Other	Interventional	Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Single (Outcomes Assessor)|Primary Purpose: Treatment	4190E	July 1, 2016	August 31, 2021	August 31, 2021	February 9, 2018		February 5, 2021	Boston University, Boston, Massachusetts, United States		https://ClinicalTrials.gov/show/NCT03427138
133	NCT04482088	Piloting an Enhanced Protocol of Occupational Therapy in an Equine Environment for Youth With Autism		Completed	No Results Available	Autism Spectrum Disorder	Behavioral: Occupational Therapy in an Equine Environment|Behavioral: Occupational Therapy in a Clinic (OTC)	Change in Goal Performance using Goal Attainment Scaling|Change in Aberrant Behavior Checklist- Community|Change in Social Responsiveness Scale, Second Edition|Change in Pediatric Disability Inventory Computer Adaptive Test for Autism Spectrum Disorders|Change in World Health Organization Quality of Life- BREF|Change in Emotional Dysregulation Inventory	Colorado State University|Hearts and Horses Therapeutic Riding Center	All	6 Years to 13 Years   (Child)	Not Applicable	20	Other	Interventional	Allocation: N/A|Intervention Model: Single Group Assignment|Masking: None (Open Label)|Primary Purpose: Treatment	20-10140H	January 20, 2020	November 9, 2021	November 9, 2021	July 22, 2020		August 22, 2022	Temple Grandin Equine Center Colorado State University, Fort Collins, Colorado, United States		https://ClinicalTrials.gov/show/NCT04482088
134	NCT04773548	Feasibility and Safety of a Virtual-Reality Based Job Interview Training Tool in Teenagers With High-Functioning Autism		Completed	No Results Available	Autism Spectrum Disorder	Other: VR-JIT	Change in mock job interview	Kessler Foundation	All	13 Years to 18 Years   (Child, Adult)	Not Applicable	12	Other	Interventional	Allocation: N/A|Intervention Model: Single Group Assignment|Masking: None (Open Label)|Primary Purpose: Treatment	R-1036-18	October 24, 2018	October 24, 2020	October 24, 2020	February 26, 2021		February 26, 2021	Kessler Foundation, East Hanover, New Jersey, United States		https://ClinicalTrials.gov/show/NCT04773548
135	NCT02897687	Facebook for Social Skills Training in Autism: Project Rex Connect	FBREX	Completed	No Results Available	Autism Spectrum Disorder	Behavioral: Facebook Group|Behavioral: Book Club Group	Improvements in social skills as assessed by Social Responsiveness Scale.|Improvements in social skills as assessed by Social Skills Improvement System.|Improvements in social skills as assessed by the Project Rex Parent Survey.|Participant satisfaction as assessed by the Project Rex Connect Participant Survey.	Medical University of South Carolina	All	12 Years to 20 Years   (Child, Adult)	Not Applicable	12	Other	Interventional	Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Treatment	Pro00021530	April 2013	June 2014	August 2016	September 13, 2016		May 9, 2018	Medical University of South Carolina, Charleston, South Carolina, United States		https://ClinicalTrials.gov/show/NCT02897687
136	NCT01425918	Social Cognitive Development in Young Children With Autism		Completed	No Results Available	Autism Spectrum Disorder	Behavioral: Social Enhancement Intervention|Behavioral: Parent Education	Change in Baseline Eye Tracking Tasks|Change in Baseline Communication and Symbolic Behavior Scale Developmental Profile|Change in Baseline Spontaneous Imitation Task|Change in Baseline Autism Diagnostic Observation Schedule|Change in Baseline Mullen Scales of Early Learning|Change in Baseline Action/intention understanding taks	Hugo W. Moser Research Institute at Kennedy Krieger, Inc.|Autism Speaks	All	24 Months to 42 Months   (Child)	Not Applicable	61	Other	Interventional	Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Single (Outcomes Assessor)|Primary Purpose: Treatment	NA_00050400	January 2012	April 2015	April 2015	August 30, 2011		March 10, 2021	Kennedy Krieger Institute, Baltimore, Maryland, United States		https://ClinicalTrials.gov/show/NCT01425918
137	NCT04017793	Mindfulness-Associated Brain Changes in Adults With Autism		Active, not recruiting	No Results Available	Autism Spectrum Disorder	Behavioral: Mindfulness Based Stress Reduction|Behavioral: Relaxation Group	Beck Depression Inventory - II|Beck Depression Inventory - 2|State-Trait Anxiety Inventory|World Health Organization Quality of Life	Arizona State University|Southwest Autism Research and Resource Center (SARRC)|Banner Alzheimer's Institute	All	18 Years and older   (Adult, Older Adult)	Not Applicable	108	Other	Interventional	Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Triple (Participant, Investigator, Outcomes Assessor)|Primary Purpose: Treatment	IRB # STUDY00007227	May 6, 2019	December 31, 2021	December 31, 2022	July 12, 2019		November 22, 2022	Arizona State University, Tempe, Arizona, United States		https://ClinicalTrials.gov/show/NCT04017793
138	NCT04259671	Exploring the Efficacy and Usability of the My Autism Passport (MAP).		Unknown status	No Results Available	Autism Spectrum Disorder	Device: My Autism Passport (MAP) Application	Number of services contacted at 6 months|Number of services contacted at 12 months|Number of services contacted at 18 months|Parental Stress Scale at 6 months|Parental Stress Scale at 12 months|Parental Stress Scale at 18 months|Parent Empowerment and Efficacy Measure at 6 months|Parent Empowerment and Efficacy Measure at 12 months|Parent Empowerment and Efficacy Measure at 18 months	Unity Health Toronto|Autism Speaks	All	1 Month to 6 Years   (Child)	Not Applicable	100	Other	Interventional	Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Double (Investigator, Outcomes Assessor)|Primary Purpose: Other	REB 18-168	March 1, 2020	November 1, 2021	February 1, 2022	February 6, 2020		March 23, 2020	Unity Health Toronto, St.Michael's Hospital, Toronto, Ontario, Canada		https://ClinicalTrials.gov/show/NCT04259671
139	NCT04024111	Social Groups for Australian Children on the Autism Spectrum		Recruiting	No Results Available	Autism Spectrum Disorder	Behavioral: KONTAKT(c)|Other: Art group	Change in the Goal Attainment Scale (GAS)|Change in the Emotion Regulation Checklist (ERC)|Change in the Negative Incidents and Effects of Psychological Treatment (NEQ)|Change in the Child Health Utility 9D (CHU9D)|Change in Treatment Inventory of Costs in Patients (TIC-P)|Treatment Satisfaction Scale|Change in the Social responsiveness scale - Second Edition (SRS-2)|International classification of functioning (ICF) - Autism coreset|Junior Temperament and characteristic Inventory (JTCI)|Motivation to participate|Change in the LERID friendship questionnaire|Change in the Social Interaction anxiety scale (SIAS)|Change in Social Skills Assessment Questionnaire (SSAQ)	Curtin University|Autism Association of Western Australia|Stan Perron charitable trust|Karolinska Institutet	All	8 Years to 12 Years   (Child)	Not Applicable	90	Other	Interventional	Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Triple (Participant, Care Provider, Outcomes Assessor)|Primary Purpose: Treatment	HRE2017-0245-34	December 1, 2019	May 1, 2022	May 1, 2022	July 18, 2019		August 3, 2021	Curtin University, Bentley, Western Australia, Australia		https://ClinicalTrials.gov/show/NCT04024111
140	NCT03392870	Evaluation of a Clinical Transitional Program in Autism	TAVA	Unknown status	No Results Available	Autism Spectrum Disorder (ASD)	Other: Integrative interventional programme|Other: As usual	Change in Quality of life.|Change in: Asperger Symptoms.|Change in: Depressive symptoms|Change in: Anxiety Symptoms.|Change in: Obsessive-compulsive symptoms.|Change in: ASD symptoms evaluated by parents/caregiver.|Change in: ASD symptoms.|Change in: Social phobia symptoms.|Change in: Evaluation of support needs.|Change in: Caregiver's burden associated with the disorder.|Change in: Evaluation of the level of autonomy, self-regulation, self-empowerment, self-knowledge.	Corporacion Parc Tauli	All	18 Years to 21 Years   (Adult)	Not Applicable	102	Other	Interventional	Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Single (Outcomes Assessor)|Primary Purpose: Treatment	CSPT04_TAVA	March 1, 2017	March 2019	April 2019	January 8, 2018		January 8, 2018	Corporacio Sanitaria Parc Tauli, Sabadell, Barcelona, Spain		https://ClinicalTrials.gov/show/NCT03392870
141	NCT03827941	Auricular Transcutaneous Electrical Nerve Stimulation Treatment of Autism		Not yet recruiting	No Results Available	Autism Spectrum Disorder	Other: 1 Hz Auricular transcutaneous electrical nerve stimulation|Other: 20 Hz Auricular transcutaneous electrical nerve stimulation	Change in Autism Treatment Evaluation Checklist (ATEC)|Change in Aberrant Behavior Checklist (ABC)|Change in Clinical Global Impression-Improvement (CGI-I)|Change in PROMIS Sleep Disturbance Short Form|Change in Penn State Worry Questionnaire|Change in Sleep Quality Assessment (PSQI)|PROMIS-29|EEG (optional)|Salivary oxytocin quantification (optional)|Quantification of species-level L. reuteri abundance in human stool samples (optional)|Autonomic measurements via wristband photoplethysmograph (PPG) sensor (optional)|ECG (optional)|Pulse oximetry measurements (optional)	Massachusetts General Hospital	All	18 Years to 60 Years   (Adult)	Not Applicable	40	Other	Interventional	Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Double (Participant, Outcomes Assessor)|Primary Purpose: Treatment	2017P000894	October 1, 2022	January 28, 2024	January 28, 2024	February 4, 2019		September 9, 2022			https://ClinicalTrials.gov/show/NCT03827941
142	NCT01996800	Study of Chiropractic and Neuromuscular Reeducation as a Treatment for Autism Symptoms		Terminated	No Results Available	Autism	Procedure: Spinal Manipulative Therapy (SMT)|Procedure: SMT and Neuromuscular Reeducation	Assessing change using the Autism Treatment Evaluation Checklist	Southern California University of Health Sciences	All	5 Years to 15 Years   (Child)	Phase 1	8	Other	Interventional	Allocation: Randomized|Intervention Model: Factorial Assignment|Masking: None (Open Label)|Primary Purpose: Treatment	SCU-AUT-01	August 2013	August 2014	August 2014	November 27, 2013		October 4, 2016	Southern California University of Health Sciences, Whittier, California, United States		https://ClinicalTrials.gov/show/NCT01996800
143	NCT03376373	Neurotherapy to Promote Emotion Recognition in Autism		Completed	No Results Available	Autism Spectrum Disorder	Behavioral: neurofeedback	facial emotion recognition (RMET)	Virginia Polytechnic Institute and State University	Male	16 Years to 29 Years   (Child, Adult)	Not Applicable	28	Other	Interventional	Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Single (Outcomes Assessor)|Primary Purpose: Treatment	MH100268	September 1, 2016	December 31, 2019	December 31, 2019	December 18, 2017		September 16, 2020	Child Study Center, Blacksburg, Virginia, United States		https://ClinicalTrials.gov/show/NCT03376373
144	NCT00811083	Dimercaptosuccinic Acid (DMSA) Treatment of Children With Autism and Heavy Metal Toxicity		Completed	No Results Available	Autism	Drug: DMSA - dimercaptosuccinic acid	Determine the effect of DMSA therapy on the symptoms of autism|Determine the safety of DMSA therapy by pre/post assessment of complete blood count, standard chem panel including liver/kidney function, and excretion of essential minerals|Determine if the initial severity of autism correlates with the excretion of toxic metals	Southwest College of Naturopathic Medicine	All	3 Years to 8 Years   (Child)	Phase 1|Phase 2	80	Other	Interventional	Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Triple (Participant, Care Provider, Investigator)|Primary Purpose: Treatment	DMSA	May 2005	April 2007	April 2007	December 18, 2008		December 18, 2008	Southwest College of Naturopathic Medicine, Tempe, Arizona, United States		https://ClinicalTrials.gov/show/NCT00811083
145	NCT01881737	A Study of Pregnenolone in the Treatment of Individuals With Autism		Completed	Has Results	Autistic Disorder	Drug: Pregnenolone	Number of Participants With Adverse Events According to Dosage Record and Treatment Emergent Symptom (DOTES) as Assessed at All Follow-up Visits (2, 4, 6, 8, 10, 12, and 16 Weeks)|Social Responsiveness Scale (SRS) Total Score|Sensory Profile Questionnaire Total Score|Vineland Adaptive Behavior Scale|Repetitive Behavior Scale|Pregnenolone Level in Peripheral Blood as Measured at Baseline and After 12 Weeks	Stanford University	All	18 Years to 45 Years   (Adult)	Phase 2	15	Other	Interventional	Allocation: N/A|Intervention Model: Single Group Assignment|Masking: None (Open Label)|Primary Purpose: Treatment	SU-08092011-8246	July 2011	September 2013	September 2013	June 20, 2013	March 29, 2017	March 29, 2017	Stanford University School of Medicine, Stanford, California, United States		https://ClinicalTrials.gov/show/NCT01881737
146	NCT03117530	Measuring Brain Inflammation in Autism		Suspended	No Results Available	Autism Spectrum Disorder	Drug: Minocycline	Evaluate differences in CNS microglial activation in adults with ASD versus healthy volunteers via in vivo CNS binding of [11C]-DAA1106|Evaluate the effect of 12-weeks of minocycline exposure on CNS microglial activation in adults with ASD by measuring change in [11C]-DAA1106 binding pre- and post- treatment|Effect of minocycline exposure on cognition across seven cognitive domains before and after low dose intervention and regular dose intervention as measured by MCCB (MATRICS Consensus Cognitive Battery) subdomain scores|Effect of minocycline exposure on self-rated anxiety and emotion regulation as measured by ADAMS (Anxiety and Depression Mood Scale)|Effect of minocycline exposure on peripheral inflammatory cytokine profiles as measured by DNA and RNA expression in blood samples	University of California, Los Angeles	Male	18 Years to 35 Years   (Adult)	Phase 1	30	Other	Interventional	Allocation: N/A|Intervention Model: Single Group Assignment|Masking: None (Open Label)|Primary Purpose: Treatment	16-001784	April 11, 2017	December 2022	December 2022	April 18, 2017		August 10, 2020	UCLA, Los Angeles, California, United States		https://ClinicalTrials.gov/show/NCT03117530
147	NCT03513419	The AMOR Method: Resilience Training for Parents of Children With Autism		Completed	No Results Available	Autism Spectrum Disorder	Behavioral: The AMOR Method	Change in Connor-Davidson Resilience Scale (CDRISC) from Baseline to week 8|Change in Acceptance and Action Questionnaire-II (AAQ-II) from Baseline to week 8|Change in Mindful Attention Awareness Scale (MAAS) from Baseline to week 8|Change in Life Orientation Test Revised (LOT-R) from Baseline to week 8	Stanford University	All	Child, Adult, Older Adult	Not Applicable	36	Other	Interventional	Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Single (Outcomes Assessor)|Primary Purpose: Treatment	45774	May 25, 2018	February 29, 2020	February 29, 2020	May 1, 2018		May 7, 2021	Stanford University, Stanford, California, United States		https://ClinicalTrials.gov/show/NCT03513419
148	NCT01372449	A Multi-site Double-blind Placebo-controlled Trial of Memantine Versus Placebo in Children With Autism (MEM)		Completed	No Results Available	Autism Spectrum Disorder	Drug: Memantine|Drug: Placebo	Developmental Neuropsychological Assessment (NEPSY) Apraxia and Repetition of Nonsense Words Subtests|Expressive Vocabulary Test (EVT)|Vineland Adaptive Behavior Scale - Revised|Safety Monitoring Uniform Research Form	Evdokia Anagnostou|Icahn School of Medicine at Mount Sinai|Rush University Medical Center|Nationwide Children's Hospital|Anagnostou, Evdokia, M.D.	All	6 Years to 12 Years   (Child)	Phase 2	23	Other	Interventional	Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Double (Participant, Investigator)|Primary Purpose: Treatment	111576	December 2011	October 2015	October 2015	June 14, 2011		March 20, 2017	Rush University Medical Center, Chicago, Illinois, United States|Mount Sinai School of Medicine, New York, New York, United States		https://ClinicalTrials.gov/show/NCT01372449
149	NCT01918787	rTMS for Adults With Autistic Spectrum Disorder		Unknown status	No Results Available	Autism	Device: repetitive TMS	continuous performance test|Yale-Brown Obsessive Compulsive Scale	Chang Gung Memorial Hospital	All	18 Years to 40 Years   (Adult)	Phase 1|Phase 2	30	Other	Interventional	Allocation: N/A|Intervention Model: Single Group Assignment|Masking: None (Open Label)|Primary Purpose: Treatment	100-2985C|NSC 100-2314-B-182A-075	April 2012	April 2015	April 2015	August 8, 2013		August 8, 2013	Chang Gung Memorial Hospital, Taoyuan, Taiwan		https://ClinicalTrials.gov/show/NCT01918787
150	NCT00263796	An fMRI Study of the Effect of Intravenous Oxytocin vs. Placebo on Response Inhibition and Face Processing in Autism		Completed	No Results Available	Autism	Drug: Oxytocin|Drug: Placebo	Change in BOLD with oxytocin infusion	Anagnostou, Evdokia, M.D.	All	18 Years to 50 Years   (Adult)	Phase 1	16	Other	Interventional	Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Double (Participant, Investigator)|Primary Purpose: Treatment	GCO # 04-0749 (2)	March 2006	October 2010	September 2012	December 9, 2005		April 30, 2014	Mount Sinai School of Medicine, New York, New York, United States		https://ClinicalTrials.gov/show/NCT00263796
151	NCT01248728	Omega-3 Fatty Acids For Treatment Of Young Children With Autism (OMG)		Completed	Has Results	Autism Spectrum Disorder	Dietary Supplement: Omega-3 Fatty Acids|Dietary Supplement: Placebo	Change From Baseline in the Pervasive Developmental Disorder-Behavioral Inventory (PDDBI) - Autism Composite Score|Change From Baseline in the Behaviour Assessment System for Children (BASC-2) - Externalizing Problems Composite|Number of Participants Classified as Responders by the Clinical Global Impression - Improvement (CGI-I)|Change From Baseline in the Vineland Adaptive Behavioral Scales (VABS) - Adaptive Functioning Composite|Change From Baseline in the Preschool Language Scale (PLS-4) - Total Language	Evdokia Anagnostou|Holland Bloorview Kids Rehabilitation Hospital|The Hospital for Sick Children|Anagnostou, Evdokia, M.D.	All	2 Years to 5 Years   (Child)	Phase 2	38	Other	Interventional	Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)|Primary Purpose: Treatment	09-018	November 2010	December 2013	June 2014	November 25, 2010	May 18, 2016	May 18, 2016	Holland Bloorview Kids Rehabilitation Hospital, Toronto, Ontario, Canada		https://ClinicalTrials.gov/show/NCT01248728
152	NCT02940899	Syracuse University Fit Families Program: Autism	SUFFP	Completed	No Results Available	Autism Spectrum Disorders	Other: Intervention: Syracuse University Fir Families Program (SUFFP)	Physical Activity|Motor skills of Parents and Children|Adaptive behavior|Reported Behavior Problems|Sensory Processing|Quality of Life of Parents of Children with Autism Spectrum Disorders|Physical Activity Experiences|Cardiovascular Health	Syracuse University|Texas Woman's University	All	5 Years to 11 Years   (Child)	Not Applicable	36	Other	Interventional	Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Supportive Care	28491	January 2015	November 30, 2018	December 30, 2018	October 21, 2016		April 4, 2019	Syracuse University, Syracuse, New York, United States		https://ClinicalTrials.gov/show/NCT02940899
153	NCT02977962	Treatment of Anxiety in Late Adolescents With Autism	TALAA	Unknown status	No Results Available	Autism Spectrum Disorder	Behavioral: Cognitive-Behavior Therapy|Other: Treatment as Usual	Change from Baseline in anxiety severity on the Hamilton Anxiety Scale after 16 weeks of treatment.|Change from Baseline in anxiety severity on the Clinical Global Impressions Scale after 16 weeks of treatment.	University of South Florida|Johns Hopkins All Children's Hospital	All	16 Years to 21 Years   (Child, Adult)	Not Applicable	44	Other	Interventional	Allocation: Randomized|Intervention Model: Factorial Assignment|Masking: Single (Outcomes Assessor)|Primary Purpose: Treatment	USF-ACH 001	January 2017	April 2021	August 2021	November 30, 2016		April 24, 2020	Rothman Center for Neuropsychiatry, University of South Florida, Saint Petersburg, Florida, United States		https://ClinicalTrials.gov/show/NCT02977962
154	NCT01881750	Pivotal Response Group Treatment for Parents of Young Children With Autism	PRTG	Completed	Has Results	Autistic Disorder	Behavioral: Pivotal Response Training (PRT)|Behavioral: Parent Education Group (PEG)	Change From Baseline in Communication During Structured Lab Observation (SLO) at 12 Weeks|Parenting Stress Index Total Score|Family Empowerment Scale Total Score|Behavior Rating Inventory of Executive Function- Preschool Global Executive Composite Score|Repetitive Behavior Scale- Revised Total Score|Sensory Profile Questionnaire Sensory Seeking Raw Score|Pediatric Quality of Life Scale Scaled Total Mean Score	Stanford University|Autism Speaks	All	2 Years to 6 Years   (Child)	Not Applicable	53	Other	Interventional	Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Treatment	SU-11022010-7151	July 2010	June 2012	July 2012	June 20, 2013	August 16, 2019	August 16, 2019	Stanford University School of Medicine, Stanford, California, United States		https://ClinicalTrials.gov/show/NCT01881750
155	NCT02708901	Gut to Brain Interaction in Autism. Role of Probiotics on Clinical, Biochemical and Neurophysiological Parameters		Completed	No Results Available	Autism Spectrum Disorder	Dietary Supplement: Vivomixx®|Dietary Supplement: Placebo	Changes in severity level of ASD symptomatology|Changes in GI symptomatology|Changes in Electroencephalogram (EEG) power|Changes in EEG coherence|Changes in EEG asymmetry|Changes in levels of serum Lipopolysaccharide|Changes in levels of serum Leptin|Changes in levels of serum Resistin|Changes in levels of serum Tumor Necrosis Factor - alfa|Changes in levels of serum Interleukin-6 (IL-6)|Changes in levels of serum Plasminogen Activator Inhibitor-1 (PAI-1)|Changes in levels of fecal calprotectin|Changes in global ASD symptomatology assessed by Childhood Autism Rating Scale|Changes in ASD symptomatology: repetitive behaviors|Changes in ASD symptomatology: sensory profiles|Changes in global ASD symptomatology assessed by Social Communication Questionnaire|Changes in Developmental Quotient|Changes in Adaptive Functioning|Changes in Behavioral Profiles|Changes in Parental Stress	IRCCS Fondazione Stella Maris|Ministry of Health, Italy|Istituto di Fisiologia Clinica CNR	All	18 Months to 72 Months   (Child)	Not Applicable	85	Other	Interventional	Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)|Primary Purpose: Treatment	GR-2011-02348280	November 2015	August 2018	September 2018	March 15, 2016		February 18, 2019	IRCCS Stella Maris Foundation, Calambrone, Pisa, Italy		https://ClinicalTrials.gov/show/NCT02708901
156	NCT05475132	Exergaming on Hand Dexterity In Autistic Children		Recruiting	No Results Available	Autism Spectrum Disorder	Other: Exergaming|Other: Conventional Dexterity Exercises	Minnesota Manual Dexterity Test (MMDT)|Box and Block Tests (BBT)	Riphah International University	All	5 Years to 12 Years   (Child)	Not Applicable	20	Other	Interventional	Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Double (Care Provider, Outcomes Assessor)|Primary Purpose: Treatment	REC/22/0204 Maham Shabbir	June 15, 2022	August 1, 2022	September 1, 2022	July 26, 2022		July 26, 2022	CARD(Clinic for autism and related disorders), Lahore, Punjab, Pakistan|Lahore Autism Centre, Lahore, Punjab, Pakistan		https://ClinicalTrials.gov/show/NCT05475132
157	NCT02928068	Telehealth Coaching for Families of Children With Autism		Completed	No Results Available	Autism Spectrum Disorders	Behavioral: Occupational Performance Coaching (OPC)	Parent Sense of Competence Scale|Canadian Occupational Performance Measure	University of Kansas Medical Center	All	12 Months to 84 Months   (Child)	Not Applicable	18	Other	Interventional	Allocation: N/A|Intervention Model: Single Group Assignment|Masking: None (Open Label)|Primary Purpose: Supportive Care	STUDY00002264	April 2015	June 2017	June 2017	October 7, 2016		November 17, 2017	Occupational Therapy Education, Kansas City, Kansas, United States		https://ClinicalTrials.gov/show/NCT02928068
158	NCT04452045	SweetDreams Sleep Study for Children With Autism		Completed	No Results Available	Autism Spectrum Disorder|Insomnia	Device: SweetDreams	Change in Children's Sleep Habits Questionnaire (CSHQ)|Change in Pittsburgh Sleep Quality Index (PSQI)	University of California, San Francisco	All	12 Months to 60 Months   (Child)	Not Applicable	20	Other	Interventional	Allocation: Randomized|Intervention Model: Crossover Assignment|Masking: Single (Outcomes Assessor)|Primary Purpose: Treatment	UL1TR001872	September 1, 2020	December 30, 2021	December 31, 2021	June 30, 2020		December 19, 2022	University of California, San Francisco, San Francisco, California, United States		https://ClinicalTrials.gov/show/NCT04452045
159	NCT03573128	Development and Pilot Testing of the Students With Autism Accessing General Education (SAAGE) Model	SAAGE	Completed	No Results Available	Autism Spectrum Disorder	Behavioral: Students with Autism Accessing General Education|Other: Enhanced Services As Usual	Mean change in student function as measured by the Developmental Disability-Clinical Global Assessment Scale|Mean change in social communication and interaction as rated by child's teacher using the 30 item Social Skills Subscale of the Social Skills Improvement System|Mean change in restricted and repetitive behavior as measured by the Children's Yale-Brown Obsessive-Compulsive Scales - PDD|Change in teacher-nominated target behaviors|Change in on-task behavior during instruction|School-related adaptive functioning|Social skills and behavior regulation|Class placement	University of Rochester|May Institute|University of South Florida	All	Child, Adult, Older Adult	Not Applicable	72	Other	Interventional	Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Single (Outcomes Assessor)|Primary Purpose: Treatment	R324A150032	August 1, 2017	August 28, 2018	August 28, 2018	June 29, 2018		November 16, 2018	University of Rochester Medical Center, Rochester, New York, United States		https://ClinicalTrials.gov/show/NCT03573128
160	NCT03493347	A Mixed Methods Investigation of Equine-assisted Occupational Therapy for Children With Autism		Completed	No Results Available	Autism Spectrum Disorder	Behavioral: Equine-assisted Occupational Therapy	Change in Visual Analog Scale (VAS) ratings of individualized occupational performance goals|Change in Irritability|Change in Hyperactivity|Change in Social Functioning|Change in Canadian Occupational Performance Measure	Colorado State University	All	5 Years to 14 Years   (Child)	Not Applicable	8	Other	Interventional	Allocation: N/A|Intervention Model: Single Group Assignment|Masking: None (Open Label)|Primary Purpose: Treatment	17-7112H	July 24, 2017	December 18, 2017	December 31, 2018	April 10, 2018		April 12, 2019	Hearts and Horses Therapeutic Riding Center, Loveland, Colorado, United States		https://ClinicalTrials.gov/show/NCT03493347
161	NCT02940574	Neural and Behavioral Effects of Oxytocin in Autism Spectrum Disorders		Completed	Has Results	Autism Spectrum Disorders	Drug: Syntocinon (Oxytocin)|Other: Placebo (Physiological water (solution of sodium chloride (NaCl) in water))	Change From Baseline in Brain Activity During Task (Task-based fMRI) After a Single Dose of Nasal Spray|Change From Baseline in Brain Activity During Task (Task-based fMRI) After 4 Weeks of Nasal Spray|Change From Baseline in Brain Activity During Task (Task-based fMRI) After 8 Weeks, Including 4 Weeks Without Nasal Spray|Change From Baseline in Brain Activity During Task (Task-based fMRI) After 52 Weeks, Including 48 Weeks Without Nasal Spray|Change From Baseline in Brain Connectivity During Rest (Resting-state fMRI) After a Single Dose of Nasal Spray|Change From Baseline in Brain Connectivity During Rest (Resting-state fMRI) After 4 Weeks of Nasal Spray|Change From Baseline in Brain Connectivity During Rest (Resting-state fMRI) After 8 Weeks, Including 4 Weeks Without Nasal Spray|Change From Baseline in Brain Connectivity During Rest (Resting-state fMRI) After 52 Weeks, Including 48 Weeks Without Nasal Spray|Change From Baseline in Performance on the Emotion Recognition Task (Accuracy/Reaction Time) After a Single Dose of Nasal Spray|Change From Baseline in Performance on the Emotion Recognition Task (Accuracy/ Reaction Time) After 4 Weeks of Nasal Spray|Change From Baseline in Performance on the Emotion Recognition Task (Accuracy/ Reaction Time) After 8 Weeks (Including 4 Weeks Without Nasal Spray)|Change From Baseline in Performance on the Emotion Recognition Task (Accuracy/ Reaction Time) After 52 Weeks (Including 48 Weeks Without Nasal Spray)|Change From Baseline in Informant-based/ Self-report Scores on Questionnaires Assessing Attachment, Social Functioning, Quality of Life and Mood After 4 Weeks of Nasal Spray|Change From Baseline in Informant-based/ Self-report Scores on Questionnaires Assessing Attachment, Social Functioning, Quality of Life and Mood After 8 Weeks, Including 4 Weeks Without Nasal Spray|Change From Baseline in Informant-based/ Self-report Scores on Questionnaires Assessing Attachment, Social Functioning, Quality of Life and Mood After 52 Weeks, Including 48 Weeks Without Nasal Spray|Change From Baseline in Scores on Questionnaire Assessing Mood After a Single Dose of Nasal Spray	KU Leuven|The Branco Weiss Fellowship|Research Foundation Flanders	Male	18 Years to 40 Years   (Adult)	Phase 4	40	Other	Interventional	Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)|Primary Purpose: Treatment	S56327|2014-000586-45	April 2015	December 2016	December 2019	October 21, 2016	February 13, 2020	February 10, 2021			https://ClinicalTrials.gov/show/NCT02940574
162	NCT02277756	Pain in Adults With Autism Spectrum Disorder	DOUPA	Terminated	No Results Available	Autism|Pain	Device: thermode	Pain as assessed by Computerized Visual analog scale|salivary cortisol|Behavioral response to thermal stimulation assessed by an inspired EDM-DI behavior scale|heart rate variability	University Hospital, Brest	All	18 Years and older   (Adult, Older Adult)	Not Applicable	39	Other	Interventional	Allocation: Non-Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Diagnostic	DOUPA (RB 14.035)	May 29, 2015	April 5, 2017	April 5, 2017	October 29, 2014		October 12, 2017	CHRU Brest, Brest, France		https://ClinicalTrials.gov/show/NCT02277756
163	NCT03361787	A Multi-dimensional Program for Parents of Adolescents With High-functioning Autism		Completed	No Results Available	Autism Spectrum Disorder	Behavioral: "Parentship"- a multi dimensional intervention program to improve parental resilience	Canadian Occupational Performance Measure (COPM)|Autism: Parenting Questionnaire (APQ)|Clinical Assessment of Therapeutic Responses (CATR)	Hadassah Medical Organization|Hebrew University of Jerusalem	All	13 Years to 18 Years   (Child, Adult)	Not Applicable	10	Other	Interventional	Allocation: N/A|Intervention Model: Single Group Assignment|Masking: None (Open Label)|Primary Purpose: Treatment	0269-17-HMO-CTIL	January 15, 2018	August 15, 2019	September 24, 2019	December 5, 2017		February 12, 2021	Hadassah medical organization, Jerusalem Israel, Jerusalem, Israel		https://ClinicalTrials.gov/show/NCT03361787
164	NCT03570372	Internet-based Treatment for Adults With Autism Spectrum Disorder	MILAS	Completed	No Results Available	Autism Spectrum Disorder	Behavioral: Internet-based treatment for adults with autism spectrum|Behavioral: Psychoeducation about autism spectum disorder	Change in life quality|Change in depressive and anxiety symptoms|Change in knowledge of ASD|Subjective experience of ICBT|Content of communication	Örebro County Council|Örebro University, Sweden	All	16 Years to 55 Years   (Child, Adult)	Not Applicable	84	Other	Interventional	Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Treatment	17RS4920	August 1, 2018	May 30, 2020	May 30, 2020	June 27, 2018		September 19, 2022	Region Örebro County, Örebro, Örebro County, Sweden		https://ClinicalTrials.gov/show/NCT03570372
165	NCT02773303	Neurofeedback Therapy for Children Diagnosed With Autism		Completed	No Results Available	Autism Spectrum Disorder	Device: Mente Autism™|Device: Sham	Changes in qEEG|Changes in Stability Score|Changes in Questions about Behavioural Function (QABF) test|The Behavior Rating Inventory of Executive Function (BRIEF)|Changes in Social Responsiveness Scale (Second Edition) SRS-2|Changes in Autism Behaviour Checklist (ABC)	Carrick Institute for Graduate Studies	All	2 Years to 18 Years   (Child, Adult)	Not Applicable	83	Other	Interventional	Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Double (Participant, Care Provider)|Primary Purpose: Treatment	CI-IRB-20160321001	May 2016	December 13, 2017	December 13, 2017	May 16, 2016		July 24, 2018	Plasticity Brain Centers, Orlando, Florida, United States		https://ClinicalTrials.gov/show/NCT02773303
166	NCT04607616	Interactive Guidance Therapy With Video Feed-back of Parent and Child With Autism Spectrum Disorder	GIETSA	Recruiting	No Results Available	Autism Spectrum Disorders	Behavioral: Baseline sessions TAU|Behavioral: Interactive guidance therapy|Diagnostic Test: Developmental and diagnostic assessments|Behavioral: Developmental assessment -Parental scales|Behavioral: Qualitative analysis	Percentage of time spent in a joint attention situation|Parent-child interactive features/ joint attention|Parent-child interactive features / DCMA scale|Parent-child interactive features / Parental synchrony|Parent-child interactive features / Communication|Parent-child interactive features / Initiation of communication|Child development / MSEL|Child development / CDI|Child development / IFDC|Autistic Symptoms / CARS|Autistic Symptoms ECAR|Autistic Symptoms ADOS-2|Autistic Symptoms ADIR|Adaptive behavior of the child|Change process|Content analysis of guidance session by parent	Assistance Publique - Hôpitaux de Paris|Ville Evrard Hospital	All	18 Months to 3 Years   (Child)	Not Applicable	24	Other	Interventional	Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Supportive Care	APHP180671|2019-A02707-50	March 26, 2021	February 2024	August 2024	October 29, 2020		July 13, 2022	Hôpital Necker Enfants Malades, Paris, France		https://ClinicalTrials.gov/show/NCT04607616
167	NCT03294668	KONTAKT Australia a Social Skills Group Training for Adolescents on the Autism Spectrum		Completed	No Results Available	Autism Spectrum Disorder	Behavioral: KONTAKT Australia|Other: Super Chef	Change in the Goal Attainment Scale (GAS)|Change in the Emotion Regulation and Social Skills Questionnaire (ERSSQ)|Mind Reading Battery|Change in the Circumplex Scale of Interpersonal Efficacy (CSIE)|Change in the Paediatric Quality of life Inventory- 4th edition (PedQL-4.0)|Change in the Perth Loneliness Scale (PALs)|Change in the Negative Incidents and Effects of Psychological Treatment (NEQ)|Change in the Child Health Utility 9D (CHU9D)|Change in Emotions via Experience Sampling (ESM)|Change in Social Interaction Anxiety Scale (SIAS)|Change in Treatment Inventory of Costs in Patients (TIC-P)|Change in social functioning|Treatment Satisfaction Scale|Change in the Social responsiveness scale - Second Edition (SRS-2)	Curtin University|Autism Association of Western Australia|Karolinska Institutet	All	12 Years to 17 Years   (Child)	Not Applicable	90	Other	Interventional	Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Double (Investigator, Outcomes Assessor)|Primary Purpose: Treatment	HRE2017-0245	February 1, 2017	October 6, 2019	October 25, 2020	September 27, 2017		July 28, 2022	Curtin University, Bentley, Western Australia, Australia		https://ClinicalTrials.gov/show/NCT03294668
168	NCT02627131	Autologous Bone Marrow Stem Cell Therapy for Autism		Completed	No Results Available	Autistic Disorder	Biological: Autologous Bone Marrow Mononuclear Cells	Change in Total Score of Childhood Autism Rating Scale (CARS)|Number of adverse events	Vinmec Healthcare System	All	3 Years to 16 Years   (Child)	Phase 2	24	Other	Interventional	Allocation: N/A|Intervention Model: Single Group Assignment|Masking: None (Open Label)|Primary Purpose: Treatment	TBG 003	April 2014	December 2015	December 2015	December 10, 2015		December 10, 2015	Vinmec International Hospital, Hanoi, Vietnam		https://ClinicalTrials.gov/show/NCT02627131
169	NCT01614275	Using Web-based Technology to Expand and Enhance Applied Behavioral Analysis Programs for Children With Autism in Military Families		Unknown status	No Results Available	Autism Spectrum Disorders	Behavioral: Technology-Enhanced Parent Training|Behavioral: Technology-Enhanced Tutor Training|Behavioral: Technology-enhanced Early Intensive Behavioral Intervention|Behavioral: No-Intervention	Intelligent Quotient: Differential Abilities Scales, Second Edition|Parent Training: Behavioral Implementation Skills for Play Activities|Tutor Training: Behavioral Implementation of Work Activities	University of Nebraska|State University of New York - Upstate Medical University	All	18 Months to 48 Months   (Child)	Not Applicable	66	Other	Interventional	Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Single (Investigator)|Primary Purpose: Treatment	059-11|W81XWH-11-1-0444	May 30, 2012	July 1, 2017	July 1, 2018	June 7, 2012		February 7, 2018	University of Nebraska Medical Center, Omaha, Nebraska, United States		https://ClinicalTrials.gov/show/NCT01614275
170	NCT05157477	Targeting the Sensory Disturbance in Autism Spectrum Disorder		Recruiting	No Results Available	Autistic Spectrum Disorder	Behavioral: CBT-based VR exporsure program	The change of heart rate	National Taiwan University Hospital	All	20 Years to 45 Years   (Adult)	Not Applicable	90	Other	Interventional	Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Single (Participant)|Primary Purpose: Treatment	201712172RINC	June 17, 2020	May 31, 2022	August 31, 2022	December 15, 2021		December 15, 2021	National Taiwan University Hospital, Taipei, Taiwan		https://ClinicalTrials.gov/show/NCT05157477
171	NCT02374541	Screening and Linkage to Services for Autism	SaLSA	Completed	No Results Available	Autism Spectrum Disorders	Behavioral: Patient Navigation	Completion of developmental evaluation / eligibility determination|Individualized Family Service Plan (IFSP) development|Age at Individualized Family Service Plan (IFSP) development|Time to Individualized Family Service Plan (IFSP) development|Initiation of indicated early intervention (EI) services|Age at initiation of indicated early intervention services|Time to initiation of indicated early intervention services|Referral for developmental evaluation / eligibility determination|Time to referral for and implementation of developmental evaluation / eligibility determination|Age at referral for and implementation of developmental evaluation / eligibility determination	University of Colorado, Denver|Denver Health and Hospital Authority|Rocky Mountain Human Services|El Grupo Vida	All	16 Months to 32 Months   (Child)	Not Applicable	305	Other	Interventional	Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Double (Investigator, Outcomes Assessor)|Primary Purpose: Health Services Research	14-1728|R40MC27702	February 16, 2015	May 31, 2018	November 21, 2018	March 2, 2015		April 6, 2020	Colorado School of Public Health, University of Colorado Denver, Aurora, Colorado, United States|University of Colorado, Aurora, Colorado, United States|Denver Health and Hospital Authority, Denver, Colorado, United States		https://ClinicalTrials.gov/show/NCT02374541
172	NCT04294290	Open Label Phase I hCT-MSC in Toddlers With Autism Spectrum Disorder	TACT	Active, not recruiting	No Results Available	Autism Spectrum Disorder	Biological: hCT-MSC infusion	Safety of hCT-MSC infusion as measured by incidence of infusion reactions|Safety of hCT-MSC infusion as measured by severity of infusion reactions|Safety of hCT-MSC infusion as measured by incidence of product-related infections|Safety of hCT-MSC infusion as measured by severity of product-related infections|Safety of hCT-MSC infusion as measured by evidence of alloimmunization via anit-HLA antibodies|Safety of hCT-MSC infusion as measured by incidence of graft vs. host disease|Safety of hCT-MSC infusion as measured by severity of graft vs. host disease|Safety of hCT-MSC infusion as measured by incidence of unexpected adverse events|Safety of hCT-MSC infusion as measured by severity of unexpected adverse events|Change in PDD Behavior Inventory Autism Composite Score (PDDBI)|Change in mean of the Socialization Subscale and Communication Subscale standard scores on the Vineland Adaptive Behavior Scales (VABS-3)|Change in Clinical Global Impression Scale (CGI)|Change in Communicative Development Inventories (CDI-2)|Change in attention abilities as assess via eye-tracking|Change in brain activity as measured by EEG	Duke University|The Marcus Foundation	All	18 Months to 48 Months   (Child)	Phase 1	12	Other	Interventional	Allocation: N/A|Intervention Model: Single Group Assignment|Masking: None (Open Label)|Primary Purpose: Treatment	Pro00104460	February 24, 2021	December 1, 2022	December 1, 2022	March 4, 2020		November 15, 2022	Duke University Medical Center, Durham, North Carolina, United States		https://ClinicalTrials.gov/show/NCT04294290
173	NCT01780090	Handheld Technology for Speech Development in Students With Autism		Completed	No Results Available	Autism Spectrum Disorders	Other: iPad software	Learning of software|Usability of software|Student engagement in treatment|Software effectiveness	Yale University|Handhold Adaptive	All	4 Years to 19 Years   (Child, Adult)	Not Applicable	40	Other	Interventional	Allocation: N/A|Intervention Model: Single Group Assignment|Masking: None (Open Label)|Primary Purpose: Treatment	1208010627|ED-IES-12-R-0007	September 2012	December 2012	January 2013	January 30, 2013		January 30, 2013	Yale Child Study Center, New Haven, Connecticut, United States		https://ClinicalTrials.gov/show/NCT01780090
174	NCT01417026	Intranasal Oxytocin and Learning in Autism		Completed	Has Results	Autism Spectrum Disorders	Drug: Intranasal Oxytocin (Trade name: Syntocinon)	Change From Baseline to Post-testing (After Max. 12 Days) on the Part/Whole Identity Test (LFI Skills Battery)|Change From Baseline to Post-testing (After Max. 12 Days) on the Reading the Mind in the Eyes Test (Child Version)|Changes From Baseline to Post-testing (After Max. 12 Days) on the "Happy Faces" Measure of Social Attention	Robert Schultz|Children's Hospital of Philadelphia	Male	12 Years to 17 Years   (Child)	Phase 2	36	Other	Interventional	Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)|Primary Purpose: Treatment	11-008241	September 2011	April 2015	April 2015	August 16, 2011	March 30, 2017	March 30, 2017	The Children's Hospital of Philadelphia, Philadelphia, Pennsylvania, United States		https://ClinicalTrials.gov/show/NCT01417026
175	NCT03538431	Improving Driving in Young People With Autism Spectrum Disorders		Completed	Has Results	Autism Spectrum Disorder	Drug: Buspirone	Driving Performance - Measured by Mean Off-Road Glance Duration|Heart Rate	Massachusetts General Hospital|Massachusetts Institute of Technology	All	18 Years to 24 Years   (Adult)	Phase 4	26	Other	Interventional	Allocation: Randomized|Intervention Model: Crossover Assignment|Masking: None (Open Label)|Primary Purpose: Other	2018-P-000900	October 31, 2018	December 16, 2019	December 16, 2019	May 29, 2018	March 18, 2021	March 18, 2021	Massachusetts General Hospital, Boston, Massachusetts, United States	"Study Protocol and Statistical Analysis Plan", https://ClinicalTrials.gov/ProvidedDocs/31/NCT03538431/Prot_SAP_001.pdf	https://ClinicalTrials.gov/show/NCT03538431
176	NCT00503191	NeuroModulation Technique Treatment of Autism	NMT	Completed	No Results Available	Autism|Neurodevelopmental Disorder	Behavioral: NeuroModulation Technique	Primary efficacy outcome measures include mean change from start of treatment to end of treatment on the PDDBI Autism Composite Index, the ABC-C Total Score, and the ATEC Total Score.|Secondary outcome measures include mean change from start of treatment to end of treatment on the remaining subscales of the PDDBI, the ABC-C, and the ATEC.	NeuroModulation Technique Research Institute	All	5 Years to 10 Years   (Child)	Phase 1	18	Other	Interventional	Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Treatment	NMTRI001-01	July 2007	February 2009	February 2009	July 18, 2007		January 22, 2014	Robert H. Weiner, Ph.D., Dallas, Texas, United States		https://ClinicalTrials.gov/show/NCT00503191
177	NCT02751957	Pilot Study to Improve Access to Early Intervention for Autism in Africa		Completed	No Results Available	Autism Spectrum Disorder	Behavioral: Early Start Denver Model	The Griffiths Scales of Mental Development: Change in developmental quotient and language subdomain developmental quotient|The Vineland Adaptive Behavior Scales: Changes in communication and socialization standard scores	Duke University|University of Cape Town	All	18 Months to 72 Months   (Child)	Not Applicable	26	Other	Interventional	Allocation: N/A|Intervention Model: Single Group Assignment|Masking: None (Open Label)|Primary Purpose: Treatment	Pro00064533	July 1, 2016	July 2020	July 2020	April 26, 2016		August 25, 2020	University of Cape Town, Cape Town, Western Cape Province, South Africa		https://ClinicalTrials.gov/show/NCT02751957
178	NCT02508259	University of California, San Diego (UCSD) Suramin Autism Treatment-1 (SAT1) Trial	SAT1	Completed	Has Results	Autism Spectrum Disorders	Drug: Suramin|Drug: Saline	Autism Diagnostic Observation Schedule, 2nd Edition (ADOS2)|Expressive Language|Aberrant Behavior Checklist (ABC)|Autism Treatment Evaluation Checklist (ATEC)|The Clinical Global Impression - Improvement Scale (CGI-I)|Repetitive Behavior Questionnaire	University of California, San Diego	Male	4 Years to 17 Years   (Child)	Phase 1|Phase 2	10	Other	Interventional	Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)|Primary Purpose: Treatment	15-0134	May 2015	March 2016	April 2016	July 24, 2015	July 16, 2019	July 16, 2019	University of California, San Diego School of Medicine, La Jolla, California, United States		https://ClinicalTrials.gov/show/NCT02508259
179	NCT01974973	Stem Cell Therapy in Autism Spectrum Disorders		Withdrawn	No Results Available	Autism Spectrum Disorders	Procedure: Autologous bone marrow mononuclear cell transplantation	Improvement in the scales for Autism spectrum disorders|Positron Emission Tomography- computed tomography to study change in brain metabolism	Neurogen Brain and Spine Institute	All	6 Months to 40 Years   (Child, Adult)	Phase 1	0	Other	Interventional	Allocation: N/A|Intervention Model: Single Group Assignment|Masking: None (Open Label)|Primary Purpose: Treatment	NGBSI-02	August 2009	January 2016	May 2016	November 3, 2013		October 25, 2018	Neurogen brain and spine institute, Mumbai, Maharashtra, India		https://ClinicalTrials.gov/show/NCT01974973
180	NCT02472860	Feasibility and Effectiveness of Computerized Cognitive Training in Adolescents With Autism Spectrum Disorder	MGHTCT	Completed	No Results Available	Autism Spectrum Disorder	Behavioral: Targeted Cognitive Training (TCT)|Other: Youth Appropriate Online Games	Cambridge Neuropsychological Test Automated Battery (CANTAB)	Massachusetts General Hospital|Deborah Munroe Noonan Memorial Research Fund	All	13 Years to 17 Years   (Child)	Not Applicable	29	Other	Interventional	Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)|Primary Purpose: Treatment	2015P000610	June 2015	August 2, 2017	August 2, 2017	June 16, 2015		March 27, 2018			https://ClinicalTrials.gov/show/NCT02472860
181	NCT03232775	Use of a Visual Pedagogy and Structure With Children With Autism for Routine Physical Exams		Completed	No Results Available	Autism Spectrum Disorder	Other: Treatment: Physical Exam with Visual Pedagogy and Structure|Other: Control: Physical Exam without Visual Pedagogy and Structure	Change from baseline on the Aberrant Behavior Checklist-Community measure ( irritability and stereotypy subscales)|Number of study exam items completed during study exams|Change from baseline in Cooperation likert-scale rating form	University of Colorado, Denver|Children's Hospital Colorado	All	4 Years to 10 Years   (Child)	Not Applicable	18	Other	Interventional	Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Single (Care Provider)|Primary Purpose: Supportive Care	07-0362	September 2007	August 2011	August 2011	July 28, 2017		July 28, 2017			https://ClinicalTrials.gov/show/NCT03232775
182	NCT02811627	Predicting Treatment Response to Memantine in Autism Using Magnetic Resonance Spectroscopy		Completed	No Results Available	Autism Spectrum Disorder	Drug: Memantine|Device: Magnetic Resonance Imaging	Clinical Global Impressions - Improvement|Social Responsiveness Scale (SRS)|General Social Outcomes Measure (GSOM)|Aberrant Behavior Checklist (ABC)|Test of Language Competence	University of Missouri-Columbia	All	16 Years and older   (Child, Adult, Older Adult)	Early Phase 1	10	Other	Interventional	Allocation: N/A|Intervention Model: Single Group Assignment|Masking: None (Open Label)|Primary Purpose: Other	2004983HS	June 2016	April 2021	April 2021	June 23, 2016		April 14, 2021	University of Missouri, Columbia, Missouri, United States	"Study Protocol and Statistical Analysis Plan", https://ClinicalTrials.gov/ProvidedDocs/27/NCT02811627/Prot_SAP_000.pdf	https://ClinicalTrials.gov/show/NCT02811627
183	NCT03791385	Effectiveness of Picture Exchange Communication System on Gingival Health of Children With Autism Spectrum Disorders		Completed	No Results Available	Autism Spectrum Disorder	Behavioral: Picture Exchange Communication System (PECS)	Gingival index score|Plaque index score|Parents' rating of PECS difficulty|PECS usefulness	Jordan University of Science and Technology	All	4 Years to 18 Years   (Child, Adult)	Not Applicable	37	Other	Interventional	Allocation: N/A|Intervention Model: Single Group Assignment|Masking: None (Open Label)|Primary Purpose: Supportive Care	20110011	April 2011	October 2011	October 2011	January 2, 2019		January 2, 2019	Jordan University of Science and Technology, Irbid, Jordan		https://ClinicalTrials.gov/show/NCT03791385
184	NCT02595697	Communication Intervention for Toddlers With Autism	J-EMT	Completed	No Results Available	Autism Spectrum Disorder	Behavioral: J-EMT for Toddlers with Autism	Number of spontaneous social communication attempts made as assessed by a 20 minute lanugage sample.	Vanderbilt University|Northwestern University	All	24 Months to 36 Months   (Child)	Not Applicable	120	Other	Interventional	Allocation: Randomized|Intervention Model: Single Group Assignment|Masking: Single (Outcomes Assessor)|Primary Purpose: Treatment	R324A150094	July 2015	December 2019	June 2020	November 3, 2015		October 6, 2020	Northwestern University, Evanston, Illinois, United States|Vanderbilt University, Nashville, Tennessee, United States		https://ClinicalTrials.gov/show/NCT02595697
185	NCT03724552	Photobiomodulation in Autism Spectrum Disorder (ASD)		Active, not recruiting	No Results Available	Autism|Autism Spectrum Disorder	Device: Transcranial LED Therapy	Reduction in ASD Symptoms (SRS)|Reduction in ASD Symptoms (CGI)	Massachusetts General Hospital	All	18 Years to 59 Years   (Adult)	Not Applicable	30	Other	Interventional	Allocation: N/A|Intervention Model: Single Group Assignment|Masking: None (Open Label)|Primary Purpose: Treatment	2016P002826	April 13, 2017	August 2023	August 2023	October 30, 2018		September 30, 2022	Massachusetts General Hospital, Boston, Massachusetts, United States		https://ClinicalTrials.gov/show/NCT03724552
186	NCT02714101	Equine-assisted Occupational Therapy for Children With Autism Spectrum Disorder		Completed	No Results Available	Autism Spectrum Disorder	Other: Equine assisted occupational therapy	Rater coding of engagement|Rater coding of enjoyment	University of Alberta	All	3 Years to 8 Years   (Child)	Not Applicable	8	Other	Interventional	Allocation: N/A|Intervention Model: Single Group Assignment|Masking: None (Open Label)|Primary Purpose: Treatment	Pro00031008	June 2012	December 2012	September 2013	March 21, 2016		March 21, 2016			https://ClinicalTrials.gov/show/NCT02714101
187	NCT03640156	Modulating Socially Adaptive Mirror System Functioning in Autism by Oxytocin		Completed	No Results Available	Autism Spectrum Disorder	Drug: Oxytocin|Other: Placebo	Change from baseline in socially adaptive mirroring as measured by TMS|Change from baseline in mirroring of others' actions as measured by TMS|Change from baseline in corticospinal excitability as measured by TMS|Change from baseline in total fixation duration towards the eye region of the model.	KU Leuven	Male	18 Years to 35 Years   (Adult)	Phase 3	25	Other	Interventional	Allocation: Randomized|Intervention Model: Crossover Assignment|Masking: Triple (Participant, Investigator, Outcomes Assessor)|Primary Purpose: Basic Science	S56327c	July 26, 2018	December 19, 2019	December 19, 2019	August 21, 2018		February 5, 2020	Katholieke Universiteit Leuven, Leuven, Belgium		https://ClinicalTrials.gov/show/NCT03640156
188	NCT02675933	Satisfaction Rates Among Parents of Children With Autism in the ED	ASD	Terminated	No Results Available	Autism Spectrum Disorder	Behavioral: Questionnaire	Satisfaction Scores|Length of Stay|Admission rate|Number of PIV attempts|Sedating medications needed for procedures	Seton Healthcare Family	All	2 Years to 18 Years   (Child, Adult)	Not Applicable	116	Other	Interventional	Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Supportive Care	CR-15-162	February 2016	January 6, 2017	January 6, 2017	February 5, 2016		August 2, 2018	Dell Children's Medical Center of Central Texas, Austin, Texas, United States		https://ClinicalTrials.gov/show/NCT02675933
189	NCT02493426	Single Dose Intranasal Oxytocin and Cognitive Effects in Autism		Completed	No Results Available	Autism Spectrum Disorders	Drug: Intranasal Oxytocin|Drug: Placebo	Social Cognition Tasks|Cognitive Rigidity Tasks|Brain Body Physiology measures	University of Minnesota	All	5 Years to 40 Years   (Child, Adult)	Phase 2	30	Other	Interventional	Allocation: Randomized|Intervention Model: Crossover Assignment|Masking: Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)|Primary Purpose: Other	PSYCH-2016-21943	May 2014	March 31, 2021	March 31, 2021	July 9, 2015		December 29, 2021	Center for Neurobehavioral Development, Minneapolis, Minnesota, United States		https://ClinicalTrials.gov/show/NCT02493426
190	NCT03235596	Effects of Cathodal tDCS on Executive Functions in Autism	TRANSFEX	Unknown status	No Results Available	Autism Spectrum Disorder	Device: tDCS	Cognitive dysexecutive functions|Score changes in the tDCS adapted version of the Udvalg pour Kliniske Undersøgelser (UKU) Side Effect Rating Scale|Behavioral dysexecutive functions|Trail Making Test A and B|Stroop Test|Verbal Fluency Test	Centre Hospitalier du Rouvray	All	20 Years to 50 Years   (Adult)	Not Applicable	22	Other	Interventional	Allocation: N/A|Intervention Model: Single Group Assignment|Masking: None (Open Label)|Primary Purpose: Treatment	2016-A00805-46	December 2016	August 2017	August 2017	August 1, 2017		August 1, 2017	Centre Hospitalier du Rouvray, Sotteville-lès-Rouen, France		https://ClinicalTrials.gov/show/NCT03235596
191	NCT05123066	Effect of Aquatic Training on Motor Function in Children With Autism Spectrum Disorder		Recruiting	No Results Available	Autism Spectrum Disorder	Other: Aquatic Exercises|Other: Land Exercises	Autism Index|Motor Development|Pediatric Quality of life Inventory Scale	Cairo University	All	3 Years to 5 Years   (Child)	Not Applicable	40	Other	Interventional	Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Triple (Participant, Care Provider, Outcomes Assessor)|Primary Purpose: Treatment	AQUATIC TRAINING	December 1, 2021	March 31, 2023	March 31, 2023	November 17, 2021		December 20, 2022	Eman S Albadry, Giza, Egypt		https://ClinicalTrials.gov/show/NCT05123066
192	NCT05221515	The Effectiveness of an Attention-based Intervention for School Aged Autistic Children With Anger Regulating Problems		Completed	No Results Available	Autism Spectrum Disorder	Behavioral: Anger can go!|Behavioral: Parent psycho-education	Aggressive behavior problems: Arguing, Temper tantrums, Destroying things and Physical violence|Aggressive behavior problems: aggression as reported by parent|Aggressive behavior problems: aggression as reported by teacher|Anger coping strategies|Quality of life of the child|Social impairment due to autism symptoms|Parental stress|Parental well-being	VU University of Amsterdam	All	8 Years to 13 Years   (Child)	Not Applicable	51	Other	Interventional	Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Treatment	BOBpaper2021	January 1, 2011	October 30, 2018	October 30, 2018	February 3, 2022		February 3, 2022	De Bascule, Amsterdam, Noord-Holland, Netherlands|Wei43, Amsterdam, Netherlands		https://ClinicalTrials.gov/show/NCT05221515
193	NCT04468620	A Peer-mediated Vocational Social Skills Program for Young Adults With Autism		Completed	No Results Available	Autism Spectrum Disorder High-Functioning	Behavioral: Assistive Soft Skills & Employment Training (ASSET)	Baseline Social Functioning|Change in Social Functioning|Baseline General Self-efficacy|Change in General Self-efficacy|Baseline Perceived Empathic Self-efficacy|Change in Perceived Empathic Self-efficacy|Baseline Perceived Social Self-efficacy|Change in Perceived Social Self-efficacy|Baseline Depression|Change in Depression|Baseline Anxiety|Changes in Anxiety	Florida Gulf Coast University	All	18 Years to 29 Years   (Adult)	Not Applicable	15	Other	Interventional	Allocation: N/A|Intervention Model: Single Group Assignment|Masking: None (Open Label)|Primary Purpose: Treatment	2018-11	September 16, 2019	April 15, 2020	June 30, 2020	July 13, 2020		February 3, 2021	Florida Gulf Coast University, Fort Myers, Florida, United States		https://ClinicalTrials.gov/show/NCT04468620
194	NCT01970345	A Pilot Treatment Study of Insulin-Like Growth Factor-1 (IGF-1) in Autism Spectrum Disorder		Recruiting	No Results Available	Autism Spectrum Disorder	Drug: IGF-1|Drug: Placebo/saline	Aberrant Behavior Checklist - Social Withdrawal Subscale|Social|Language|Repetitive Behavior|Overall Functional Outcomes|Caregiver Strain	Icahn School of Medicine at Mount Sinai|Autism Science Foundation	All	5 Years to 12 Years   (Child)	Phase 2	10	Other	Interventional	Allocation: Randomized|Intervention Model: Crossover Assignment|Masking: Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)|Primary Purpose: Treatment	GCO 13-1206	May 2014	July 2024	July 2024	October 28, 2013		July 5, 2022	Icahn School of Medicine at Mount Sinai, New York, New York, United States		https://ClinicalTrials.gov/show/NCT01970345
195	NCT02477904	Ketogenic Diet Therapy for Autism Spectrum Disorder		Completed	No Results Available	Autism Spectrum Disorder	Other: Ketogenic Diet	Change from baseline in core symptoms of ASD|Change from baseline in the number of medications used for ASD management|Change from baseline in the dosage of medications used for ASD management|Change from baseline in the number of lab tests ordered for ASD management|Change from baseline in the number of emergency room or hospital visits for ASD management|Change from baseline in subject/family satisfaction with the ketogenic diet|Change from baseline in biochemical profiles due to the ketogenic diet	Shriners Hospitals for Children|University of Hawaii	All	2 Years to 21 Years   (Child, Adult)	Not Applicable	119	Other	Interventional	Allocation: Non-Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Treatment	HON1403	March 2015	April 28, 2017	April 28, 2017	June 23, 2015		September 20, 2019	Shriners Hospitals for Children - Honolulu, Honolulu, Hawaii, United States		https://ClinicalTrials.gov/show/NCT02477904
196	NCT03434366	Intranasal Ketamine With Dexmedetomidine for the Treatment of Children With Autism Spectrum Disorder		Suspended	No Results Available	Autism Spectrum Disorder	Drug: ketamine and dexmedetomidine|Drug: ketamine|Drug: Saline	Autism Diagnostic Interview Revised (ADI-R)|Autism Diagnostic Observation Schedule (ADOS)|autism behavior checklist (ABC)|magnetic resonance spectroscopy(MRS)|Childhood Autism Rating Scale (CARS)	Guangzhou Women and Children's Medical Center	All	2 Years to 15 Years   (Child)	Phase 2	50	Other	Interventional	Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)|Primary Purpose: Treatment	intranasal ketamine	January 20, 2018	December 30, 2023	December 30, 2023	February 15, 2018		April 12, 2022	Guangzhou Women and Children Medical Center, Guangzhou, Guangdong, China		https://ClinicalTrials.gov/show/NCT03434366
197	NCT04630847	Familial Fecal Microbiota Transplant for the Treatment of Subjects With Autism Spectrum Disorders		Not yet recruiting	No Results Available	Autism|Autism Spectrum Disorder	Biological: Fecal Microbiota Transplant	Adverse Events|Serious Adverse Events|ATEC|CARS-2|QoLA|SRS-II|Shannon Diversity Index	ProgenaBiome|Ventura Clinical Trials	All	2 Years and older   (Child, Adult, Older Adult)	Phase 1	30	Other	Interventional	Allocation: N/A|Intervention Model: Single Group Assignment|Masking: None (Open Label)|Primary Purpose: Treatment	VCT-1	May 2022	June 2025	December 2025	November 16, 2020		February 25, 2022	ProgenaBiome, Ventura, California, United States		https://ClinicalTrials.gov/show/NCT04630847
198	NCT02360332	A Collaborative Public/Private Employment Training and Placement Model ASD Transition Age Youth With Autism Spectrum Disorder (ASD)	ProjSEARCH1	Completed	No Results Available	Autism Spectrum Disorder	Behavioral: Project SEARCH plus ASD Supports	Change in Employment Status across 3 points in time (Employed or not employed)|Change in Hours worked weekly across 3 points in time|Change in Hourly wage earned across 3 points in time|Change in Intensity of work support required across 3 points in time	Virginia Commonwealth University|Henrico County Public Schools|Virginia Department of Aging and Rehabilitative Services|Chesterfield County Public Schools	All	18 Years to 21 Years   (Adult)	Not Applicable	54	Other	Interventional	Allocation: Randomized|Intervention Model: Single Group Assignment|Masking: None (Open Label)|Primary Purpose: Treatment	NIDDRDRRP09-13	October 2009	September 2013	January 2015	February 10, 2015		February 10, 2015			https://ClinicalTrials.gov/show/NCT02360332
199	NCT02291172	Comprehensive Communication Intervention for Minimally Verbal Children With Autism		Completed	No Results Available	Autism Spectrum Disorder	Behavioral: Intervention JEP	Spontaneous communicative utterances	Vanderbilt University	All	36 Months to 54 Months   (Child)	Not Applicable	74	Other	Interventional	Allocation: Randomized|Intervention Model: Single Group Assignment|Masking: Single (Outcomes Assessor)|Primary Purpose: Treatment	141453	September 2014	December 2017	March 2018	November 14, 2014		July 12, 2018	Metro Nashville Schools, Nashville, Tennessee, United States		https://ClinicalTrials.gov/show/NCT02291172
200	NCT04652388	Impact of Nutritional Counselling in Children With Autism		Unknown status	No Results Available	Autism Spectrum Disorder	Behavioral: Nutritional counseling	Adherence to Mediterranean Diet|Change in food selectivity|Change in eating habits	Federico II University	All	24 Months to 48 Months   (Child)	Not Applicable	20	Other	Interventional	Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Other	353/20	September 1, 2020	September 1, 2020	September 1, 2022	December 3, 2020		December 3, 2020	University of Naples Federico II, Naples, Italy		https://ClinicalTrials.gov/show/NCT04652388
201	NCT04992169	Clinicianless Training in Autism Treatment: An Adaptive Online Parent Education Program		Recruiting	No Results Available	Autism Spectrum Disorder|Parents	Behavioral: Smartphone-App Parent Training in Pivotal Response Treatment	Change from Baseline in Parent Fidelity of Implementation of Pivotal Response Treatment (PRT) during Behaviorally Coded Parent-Child Intervention Videos at 8 weeks, 16 weeks|Change from Baseline in Frequency of Child Vocalizations/Word Use during Behaviorally Coded Parent-Child Intervention Videos at 8 weeks, 16 weeks.|Change from Baseline in Percentage of Child Positive Affect during Behaviorally Coded Parent-Child Intervention Videos at 8 weeks, 16 weeks.|Change from Baseline in MacArthur-Bates Communicative Development Inventory (CDI), Level I Short Form (Total Score) at 16 weeks|Change from Baseline in Vineland Adaptive Behavior Scales, Third Edition (Standard Score on Communication Domain) at 16 weeks|Change from Baseline in Vineland Adaptive Behavior Scales, Third Edition (Standard Score on Socialization Domain) at 16 weeks|Change from Baseline in Social Responsiveness Scale, Second Edition (SRS-2; Total T-Score) at 16 weeks	University of California, Santa Barbara	All	12 Months to 54 Months   (Child)	Not Applicable	48	Other	Interventional	Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Triple (Participant, Investigator, Outcomes Assessor)|Primary Purpose: Treatment	24-21-0034	August 23, 2021	March 30, 2023	June 30, 2023	August 5, 2021		October 25, 2022	University of California, Santa Barbara, Santa Barbara, California, United States	"Study Protocol", https://ClinicalTrials.gov/ProvidedDocs/69/NCT04992169/Prot_000.pdf|"Statistical Analysis Plan", https://ClinicalTrials.gov/ProvidedDocs/69/NCT04992169/SAP_001.pdf|"Informed Consent Form", https://ClinicalTrials.gov/ProvidedDocs/69/NCT04992169/ICF_002.pdf	https://ClinicalTrials.gov/show/NCT04992169
202	NCT05013528	Balance Auditory Vision Training (Bal-A-Vis-X) and Aerobic Training in Children With Autism Spectrum Disorder	Bal-A-Vis-X	Completed	No Results Available	Autism Spectrum Disorder	Other: Bal-A-Vis-X training|Other: Aerobic Training Group	Bruininks- Oseretsky Test of Motor Proficiency-2 (BOT-2)|Childhood Executive Functioning Inventory|Color Trail Test	Riphah International University	All	4 Years to 12 Years   (Child)	Not Applicable	36	Other	Interventional	Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Double (Participant, Outcomes Assessor)|Primary Purpose: Treatment	REC/00826 Mahnoor Zia	November 11, 2021	January 30, 2022	January 30, 2022	August 19, 2021		April 18, 2022	Child Dream Center, Faisalabad, Punjab, Pakistan		https://ClinicalTrials.gov/show/NCT05013528
203	NCT05524753	Active Ingredients & Efficacy of Aquatic Therapy for Autistic Children		Active, not recruiting	No Results Available	Autism Spectrum Disorder	Behavioral: AquOTic	Change in swim skills|Questionnaire to track change in parent perception and satisfaction with progress on individualized family-centered goals|Parent Perspective	Ohio State University|American Occupational Therapy Foundation	All	5 Years to 9 Years   (Child)	Not Applicable	36	Other	Interventional	Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Single (Outcomes Assessor)|Primary Purpose: Treatment	2019H0204 Phase 2	August 4, 2022	July 2023	December 2023	September 1, 2022		October 6, 2022	The Ohio State University, Columbus, Ohio, United States		https://ClinicalTrials.gov/show/NCT05524753
204	NCT04658043	Early Socioemotional Intervention for Children With Autism Spectrum Disorder in Hong Kong and Mainland China		Unknown status	No Results Available	Autism Spectrum Disorder	Other: Intervention on socioemotional functioning	Change in Autism Diagnostic Observation Schedule, Second Edition (ADOS-2)|Change in the Autism Spectrum Quotient (AQ)|Change in Dyadic Parent-Child Interaction Coding System (DPICS system)|Change in Parenting Stress Index, Fourth Edition Short Form (PSI-4-SF)|Change in Self-Efficacy in Nurturing Role Questionnaire|Change in Classroom Observation Scale (COS)|Change in Social Responsiveness Scale, Second Edition (SRS-2)	The University of Hong Kong|Shenzhen University|Guangdong Province, Department of Science and Technology	All	3 Years to 6 Years   (Child)	Not Applicable	1000	Other	Interventional	Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)|Primary Purpose: Treatment	EA1811014	September 22, 2019	August 31, 2022	August 31, 2022	December 8, 2020		December 8, 2020	Shenzhen University, Shenzhen, China|University of Hong Kong, Hong Kong, Hong Kong	"Informed Consent Form", https://ClinicalTrials.gov/ProvidedDocs/43/NCT04658043/ICF_000.pdf	https://ClinicalTrials.gov/show/NCT04658043
205	NCT04274127	Early Screening of Autism Spectrum Disorder in General and Pediatric Practices	KitCAT	Recruiting	No Results Available	Autism Spectrum Disorder	Diagnostic Test: early detection kit composed of 2 questionnaires (M-CHAT-R + CSBS-ITC)	number of children with a confirmed ASD diagnosis	Hôpital le Vinatier	All	16 Months to 24 Months   (Child)	Not Applicable	1700	Other	Interventional	Allocation: N/A|Intervention Model: Single Group Assignment|Masking: None (Open Label)|Primary Purpose: Diagnostic	2015-A00823-46	April 9, 2018	January 2024	January 2024	February 18, 2020		August 12, 2022	Centre Hospitalier Le Vinatier, Bron, Rhône, France		https://ClinicalTrials.gov/show/NCT04274127
206	NCT05450536	Self-Advocacy Training for Autistic College Students at a Public University	ACS	Active, not recruiting	No Results Available	Autism Spectrum Disorder	Other: Video Model and Role Play	Advocacy Skills|Social Validity Application of the Intervention Package	University of Texas at Austin	All	18 Years to 22 Years   (Adult)	Not Applicable	6	Other	Interventional	Allocation: N/A|Intervention Model: Single Group Assignment|Masking: None (Open Label)|Primary Purpose: Other	Self-Advocacy ASD	October 1, 2022	November 30, 2022	April 2023	July 8, 2022		December 7, 2022	University of Texas Austin, Austin, Texas, United States		https://ClinicalTrials.gov/show/NCT05450536
207	NCT04498078	Creatine Supplementation in Autism Spectrum Disorder	CREATOR	Active, not recruiting	No Results Available	Autism Spectrum Disorder	Dietary Supplement: Creatine	Brain creatine change|Brain N-acetylaspartate change|Autism Treatment Evaluation Checklist (ATEC) score	University of Novi Sad, Faculty of Sport and Physical Education	All	10 Years and older   (Child, Adult, Older Adult)	Not Applicable	20	Other	Interventional	Allocation: N/A|Intervention Model: Single Group Assignment|Masking: None (Open Label)|Primary Purpose: Supportive Care	ABL-21-AUCR	January 15, 2022	January 15, 2023	February 14, 2023	August 4, 2020		November 1, 2022	FSPE Applied Bioenergetics Lab, Novi Sad, Vojvodina, Serbia		https://ClinicalTrials.gov/show/NCT04498078
208	NCT05045339	Ball Exercises and Stereotypic Behavior in Autism Spectrum Disorder		Completed	No Results Available	Autism Spectrum Disorder	Procedure: Ball Exercises	Stereotypic Behaviors	University of Faisalabad	All	4 Years to 16 Years   (Child)	Not Applicable	30	Other	Interventional	Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Single (Outcomes Assessor)|Primary Purpose: Supportive Care	TUF/DR/DPT/157	February 6, 2018	April 20, 2018	May 28, 2018	September 16, 2021		October 6, 2021	The University of Faisalabad, Faisalābad, Punjab, Pakistan		https://ClinicalTrials.gov/show/NCT05045339
209	NCT05491720	Electrical Brain Stimulation and Pharmacological Treatments in Autism Spectrum Disorder		Active, not recruiting	No Results Available	Autism Spectrum Disorder	Drug: RisperiDONE 1 MG/ML|Device: transcranial direct current stimulation|Drug: Placebo|Device: sham transcranial direct current stimulation	Gilliam Autism Rating Scale (GADS)|verbal fluency task|Theory of mind	The National Brain Mapping Laboratory (NBML)|Ardabil University of Medical Sciences|Leibniz Research Centre for Working Environment and Human Factors|University of Tehran	All	7 Years to 16 Years   (Child)	Phase 1	45	Other	Interventional	Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Triple (Participant, Investigator, Outcomes Assessor)|Primary Purpose: Treatment	IR.ARUMS.REC.1395.20	August 15, 2020	March 15, 2022	August 3, 2022	August 8, 2022		August 8, 2022	The National Brain Mapping Laboratory (NBML), Tehran, Iran, Islamic Republic of		https://ClinicalTrials.gov/show/NCT05491720
210	NCT05063656	Biomarker-Driven Pharmacological Treatment of Adolescents With Autism Spectrum Disorder With Gabapentin		Recruiting	No Results Available	Autism Spectrum Disorder	Drug: Gabapentin	Right Anterior Insula GABA level	David Cochran|Eagles Autism Foundation|University of Massachusetts, Worcester	All	13 Years to 17 Years   (Child)	Phase 4	40	Other	Interventional	Allocation: N/A|Intervention Model: Single Group Assignment|Masking: None (Open Label)|Primary Purpose: Treatment	Gabapentin ASD Trial	February 4, 2022	February 2024	March 2024	October 1, 2021		April 12, 2022	University of Massachusetts Medical School, Worcester, Massachusetts, United States		https://ClinicalTrials.gov/show/NCT05063656
211	NCT05192109	Study 2: Learning New Words From Overhearing in Children With Autism Spectrum Disorder (ASD)		Active, not recruiting	No Results Available	Autism Spectrum Disorder	Behavioral: Overheard Speech|Behavioral: Addressed Speech	Proportion of time during which children's eye gaze is directed toward the target object	New York University|Emerson College	All	18 Months to 71 Months   (Child)	Not Applicable	295	Other	Interventional	Allocation: Non-Randomized|Intervention Model: Parallel Assignment|Masking: Single (Investigator)|Primary Purpose: Basic Science	280522	December 1, 2020	February 1, 2025	February 1, 2025	January 14, 2022		November 28, 2022	Emerson College, Boston, Massachusetts, United States|New York University, New York, New York, United States	"Informed Consent Form", https://ClinicalTrials.gov/ProvidedDocs/09/NCT05192109/ICF_000.pdf	https://ClinicalTrials.gov/show/NCT05192109
212	NCT05196230	A Virtual Dental Office Experience for Children With Autism Spectrum Disorder		Enrolling by invitation	No Results Available	Autism Spectrum Disorder	Device: Control Condition (Social Story)|Device: Experimental Condition (360° Video)	Dental visit "completeness"|Pre-visit anxiety	Holland Bloorview Kids Rehabilitation Hospital	All	4 Years to 12 Years   (Child)	Not Applicable	130	Other	Interventional	Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Single (Care Provider)|Primary Purpose: Other	eREB#209	June 30, 2021	June 2022	August 2022	January 19, 2022		January 19, 2022	Holland Bloorview Kids Rehabilitation Hospital, Toronto, Ontario, Canada		https://ClinicalTrials.gov/show/NCT05196230
213	NCT05578261	Explore the Impacts of One Session Theta Burst Stimulation Over Cerebellum in Adults With Autism Spectrum Disorder		Not yet recruiting	No Results Available	Autism Spectrum Disorder	Device: intermittent theta burst stimulation	Adverse effects report form (Headache)|Adverse effects report form (Dizziness)|Adverse effects report form (Tinnitus)|Adverse effects report form (Seizure)|Adverse effects report form (Other)|MRI T1|functional MRI (resting-state/biological motion task) - BOLD signal	Chang Gung Memorial Hospital	All	18 Years and older   (Adult, Older Adult)	Not Applicable	10	Other	Interventional	Allocation: N/A|Intervention Model: Single Group Assignment|Masking: None (Open Label)|Primary Purpose: Treatment	202200409A0	October 2022	June 2023	July 2023	October 13, 2022		October 13, 2022	Chang Gung Memorial Hospital, Taoyuan, Taiwan		https://ClinicalTrials.gov/show/NCT05578261
214	NCT05159102	Fit Families Program for Families of Children With Autism Spectrum Disorder		Completed	No Results Available	Autism Spectrum Disorder	Other: 12-week FMS Intervention|Behavioral: Physical Activities & Activity Booklets (via FitFamilies app)	Change in Gross Motor Development as Measured by TGMD-3|Change in qualitative perceptions of the participants as measured via semi-structured interview.|Change in Social Communication Questionnaire (SCQ)|Change in Parenting Stress Index (PSI)- Short form|Change in Sensory Profile (Dunn 1999)|Change in the Behavioral Assessment System for Children (BASC-III) (Reynolds & Kamphaus, 2015)|Change in Adaptive Behavior Assessment System (ABAS-3)|Change in Physical Activity Questionnaire	University of Wisconsin, Madison	All	4 Years to 11 Years   (Child)	Not Applicable	25	Other	Interventional	Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Other	2019-1256 New Cohort|A176000|EDUC/KINESIOLOGY/KINESIO	August 6, 2021	January 8, 2022	January 8, 2022	December 15, 2021		January 27, 2022	University of Wisconsin, Madison, Wisconsin, United States		https://ClinicalTrials.gov/show/NCT05159102
215	NCT03369431	Efficacy of Vivomixx on Behaviour and Gut Function in Autism Spectrum Disorder	VIVO-ASD	Completed	Has Results	Autism Spectrum Disorder	Dietary Supplement: Vivomixx|Dietary Supplement: Placebo	A Change in the Autism Treatment Evaluation Checklist (ATEC) Total Score Compared to Baseline.|The Change in the Frequency of Gastrointestinal Symptoms Compared to Baseline, as Measured by the Gastrointestinal History (GIH) Questionnaire.|A Change in the Aberrant Behaviour Checklist (ABC) Section Scores Compared to Baseline.|The Change in the Autism Parenting Stress Index (APSI) Score Compared to Baseline.	University College, London	All	3 Years to 16 Years   (Child)	Not Applicable	69	Other	Interventional	Allocation: Randomized|Intervention Model: Crossover Assignment|Masking: Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)|Primary Purpose: Treatment	17/0148	February 1, 2018	October 2, 2020	January 29, 2021	December 12, 2017	February 14, 2022	March 8, 2022	University College Hospital, London, United Kingdom	"Study Protocol", https://ClinicalTrials.gov/ProvidedDocs/31/NCT03369431/Prot_000.pdf|"Statistical Analysis Plan", https://ClinicalTrials.gov/ProvidedDocs/31/NCT03369431/SAP_001.pdf	https://ClinicalTrials.gov/show/NCT03369431
216	NCT04442061	Autism Spectrum Disorders: Double Blind Randomized Placebo-control Active Pilot Study of Transcranial Magnetic Stimulation Applied to the Superior Temporal Sulcus	STIMAUT	Recruiting	No Results Available	Autism Spectrum Disorders	Device: Transcranial magnetic stimulation|Device: MRI|Device: Neuronavigation|Device: Eye-tracking|Genetic: Salivary samples|Other: Clinical scales	Changes gaze pattern to the eyes|Autistic Behavior Checklist (ABC) scale at v1|Autistic Behavior Checklist (ABC) scale at v2|Autistic Behavior Checklist (ABC) scale at v3|Autistic Behavior Checklist (ABC) scale at v4|"Evaluation des comportements Autistiques révisée" (ECA-R) scale at v1|"Evaluation des comportements Autistiques révisée"(ECA-R) scale at v2|"Evaluation des comportements Autistiques révisée" (ECA-R) scale at v3|"Evaluation des comportements Autistiques révisée" (ECA-R) scale at v4|Clinical Global Impression (CGI) scale at v1|Clinical Global Impression (CGI) scale at v2|Clinical Global Impression (CGI) scale at v3|Clinical Global Impression (CGI) scale at v4|Changes in rest brain fonctionning at v1|Changes in rest brain fonctioning at v2|Changes in rest brain fonctioning at v4|Putative changes on brain functional connectivity at rest at V1|Putative changes on brain functional connectivity at rest at V2|Putative changes on brain functional connectivity at V4|Anatomical connectivity abnormalities|BDNF/COMT polymorphisms	Assistance Publique - Hôpitaux de Paris|Fondation de France|Fondation Malakoff Médéric	Male	18 Years to 25 Years   (Adult)	Phase 2	20	Other	Interventional	Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Double (Participant, Investigator)|Primary Purpose: Treatment	APHP191009	February 2, 2022	May 2024	October 2024	June 22, 2020		September 9, 2022	Hôpital Necker Enfants Malades - Service de radiologie pédiatrique, Paris, France		https://ClinicalTrials.gov/show/NCT04442061
217	NCT05096676	Understanding Oxytocin's Neural and Behavioral Effects in Adolescents Diagnosed With Autism		Completed	No Results Available	Autism Spectrum Disorder|Oxytocin	Drug: Oxytocin: Including placebo	The change in social-related neural components (time-locked neural activity) with and without oxytocin|The change in oscillatory activity - power magnitude of Delta, Theta, Alpha, Beta and Gamma neural bands with and without oxytocin|The change in behavioral measurments - reaction times and accurecy rates, with and without oxytocin	Prof. Ilanit gordon|Bar-Ilan University, Israel	Male	12 Years to 18 Years   (Child, Adult)	Not Applicable	58	Other	Interventional	Allocation: Randomized|Intervention Model: Crossover Assignment|Masking: Triple (Participant, Care Provider, Investigator)|Primary Purpose: Basic Science	16082021IG	August 1, 2016	October 1, 2019	October 1, 2019	October 27, 2021		October 27, 2021		"Statistical Analysis Plan", https://ClinicalTrials.gov/ProvidedDocs/76/NCT05096676/SAP_000.pdf	https://ClinicalTrials.gov/show/NCT05096676
218	NCT03625999	A Novel Intervention for Training Auditory Attention in Adolescents With Autism Spectrum Disorder		Withdrawn	No Results Available	Autism Spectrum Disorder|Autism	Behavioral: video game training exercise	Child Behavioral Assessment: ADOS|Child Behavioral Assessment: Leiter-3|Child Behavioral Assessment: PPVT-5|Child Behavioral Assessment: EVT-3|Parent Questionnaire: SCQ|Parent Questionnaire: VABS-3|Parent Questionnaire: RBS-R|Parent Questionnaire: SSP|Parent Questionnaire: CASI-5|Post-test EEG	Boston University Charles River Campus|Carnegie Mellon University	All	13 Years to 20 Years   (Child, Adult)	Not Applicable	0	Other	Interventional	Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Single (Outcomes Assessor)|Primary Purpose: Basic Science	4875E	August 1, 2021	September 30, 2021	September 30, 2021	August 10, 2018		April 9, 2021	Center for Autism Research Excellence, Boston, Massachusetts, United States		https://ClinicalTrials.gov/show/NCT03625999
219	NCT05341011	Establishment of Social Skills Training Group in Adolescents With Autism Spectrum Disorder and Effectiveness Analysis		Active, not recruiting	No Results Available	Autism Spectrum Disorder High-Functioning	Behavioral: PEERS® Social Skills Training	Test of Adolescents Social Skills Knowledge (TASSK)|Quality of Play Questionnaire (QPQ)|Chinese version of the School Bullying Experience Questionnaire (C-SBEQ)|Swanson, Nolan, and Pelham, version IV (SNAP-IV)|Social Adjustment Inventory for Children and Adolescents (SAICA)|Empathy Quotient (EQ)|Friendship Questionnaire (FQ)|Friendship Quality Scale (FQS)|Assessing Emotions Scale (AES)|Youth Self Report (YSR)|Child Behavior Checklist (CBCL)|World Health Organization Quality of Life (WHOQoL-BREF)|Parenting Stress Index - Short Form (PSI-SF)|Parental Bonding Instrument (PBI)|Communicative Behavior Observatory Scale (CBOS) Behavior Observatory Scale (CBOS)|Social Responsiveness Scale (SRS)|Autism Spectrum Quotient (AQ)|Autism Diagnostic Observation Schedule (ADOS)|Autism Diagnostic Interview-Revised (ADI-R)	National Taiwan University Hospital	All	12 Years to 18 Years   (Child, Adult)	Not Applicable	42	Other	Interventional	Allocation: Randomized|Intervention Model: Crossover Assignment|Masking: Single (Outcomes Assessor)|Primary Purpose: Health Services Research	201906022RIND	August 2, 2019	August 17, 2021	May 30, 2023	April 22, 2022		December 5, 2022	National Taiwan University Hospital, Taipei, Taiwan		https://ClinicalTrials.gov/show/NCT05341011
220	NCT03195244	Aquatic Therapy and Autism Spectrum Disorders	AT&ASD	Completed	No Results Available	Autism Spectrum Disorder	Other: Aquatic Physical Therapy	Change in PedsQL Score	Sloan W. Rush, MD|Panhandle Eye Group, LLP	All	3 Years to 17 Years   (Child)	Not Applicable	50	Other	Interventional	Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Double (Participant, Outcomes Assessor)|Primary Purpose: Treatment	AT&ASD	June 12, 2017	April 12, 2022	April 12, 2022	June 22, 2017		April 21, 2022	Turn Center, Amarillo, Texas, United States		https://ClinicalTrials.gov/show/NCT03195244
221	NCT04655326	Probiotic Therapy for Children and Adults With Autism Spectrum Disorder		Recruiting	No Results Available	Autism Spectrum Disorder	Biological: Flore	Parent Global Impressions of Autism|Social Responsiveness Scale|Gastrointestinal Symptom Rating Scale	Arizona State University|Sun Genomics	All	30 Months to 75 Years   (Child, Adult, Older Adult)	Early Phase 1	1000	Other	Interventional	Allocation: N/A|Intervention Model: Single Group Assignment|Masking: None (Open Label)|Primary Purpose: Treatment	STUDY00012299	October 15, 2020	October 15, 2022	March 15, 2023	December 7, 2020		December 30, 2021	Arizona State University, Tempe, Arizona, United States		https://ClinicalTrials.gov/show/NCT04655326
222	NCT04772898	Effectiveness of a 6-week Hippotherapy Program in Children With Autism Spectrum Disorder		Active, not recruiting	No Results Available	Autism Spectrum Disorder	Behavioral: Hippotherapy	Social Responsiveness Scale (SRS)|Postural control, center of pressure measures (range, root mean square, sway path, sample entropy)|Coherence and Cross Sample Entropy between the movement sensors and heart rate sensors of the horse and rider|Correlation between horse temperament and therapeutic outcomes|Aberrant Behavior Checklist	Creighton University	All	5 Years to 10 Years   (Child)	Not Applicable	30	Other	Interventional	Allocation: N/A|Intervention Model: Single Group Assignment|Masking: None (Open Label)|Primary Purpose: Basic Science	5R03HD101115-02	September 7, 2021	July 2022	July 2022	February 26, 2021		July 18, 2022	Hearthland Equine Therapeutic Riding Academy, Gretna, Nebraska, United States		https://ClinicalTrials.gov/show/NCT04772898
223	NCT04440852	Randomized, Controlled Trial of an Intervention for Preschool Children With Autism: TEACCH		Completed	No Results Available	Autism Spectrum Disorder	Behavioral: TEACCH	Chinese Version of Psycho-educational Profile-3rd edition (CPEP-3)	Wuhan Mental Health Centre|Wuhan University	All	36 Months to 90 Months   (Child)	Not Applicable	60	Other	Interventional	Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Triple (Participant, Care Provider, Investigator)|Primary Purpose: Treatment	KY2016(53)	January 1, 2018	December 31, 2019	March 30, 2020	June 22, 2020		June 22, 2020	Wuhan Mental Health Centre, Wuhan, Hubei, China		https://ClinicalTrials.gov/show/NCT04440852
224	NCT04987749	The Therapeutic Effects of Intermittent Theta Burst Stimulation in Autism Spectrum Disorder		Recruiting	No Results Available	Autism Spectrum Disorder	Device: intermittent theta burst stimulation	Changes of total scores of Social Responsiveness Scale|Changes of total scores of Repetitive Behavior Scale-Revised|Changes of total scores of Emotional Dysregulation Inventory|Changes of total scores of Adaptive Behavior Assessment System|Changes in accuracy of Frith-Happe animation|Changes in accuracy of Eyes task|Changes in accuracy of Wisconsin Card Sorting Test|Changes of total scores of Behavior Rating Inventory of Executive Function|Raven's Progressive Matrices|Autism Diagnostic Observation Schedule - Generic|MRI T1|functional MRI (resting-state/biological motion task) - BOLD signal|Diffusion Tensor Imaging (DTI) - FA|Electroencephalography	Chang Gung Memorial Hospital	All	8 Years to 30 Years   (Child, Adult)	Not Applicable	60	Other	Interventional	Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Double (Participant, Care Provider)|Primary Purpose: Treatment	201900713A0	November 5, 2019	August 2023	November 2023	August 3, 2021		July 8, 2022	Chang Gung Memorial Hospital, Taoyuan, Taiwan		https://ClinicalTrials.gov/show/NCT04987749
225	NCT01836965	Replication of the The Multi-Media Social Skills Project for Adolescents With Autism Spectrum Disorders		Completed	No Results Available	Autism Spectrum Disorders	Behavioral: Social Skills Intervention	Change from Baseline Social Responsiveness Scale Score after Intervention|Video recording of Social Interaction|Change from Baseline Strengths and Difficulties Questionnaire (SDQ) after Intervention|Change from Baseline Loneliness Scale after Intervention|Change from Baseline Multidimensional Anxiety Scale for Children after Intervention|Change from Baseline Strengths and Difficulties Questionnaire (parent form)after Intervention|Change from Baseline Strengths and Difficulties Questionnaire at 3 month Follow Up|Change from Baseline Loneliness Scale at 3-month Follow Up|Change from Baseline Multidimensional Anxiety Scale for Children at 3 month Follow Up|Change from Baseline Strengths and Difficulties Questionnaire (parent form)at 3 Month Follow Up	Milton S. Hershey Medical Center	All	13 Years to 17 Years   (Child)	Not Applicable	155	Other	Interventional	Allocation: N/A|Intervention Model: Single Group Assignment|Masking: None (Open Label)|Primary Purpose: Treatment	42565EP	March 2013	April 9, 2018	April 9, 2018	April 22, 2013		March 13, 2019	Penn State Hershey Psychiatry Clinic, Hershey, Pennsylvania, United States		https://ClinicalTrials.gov/show/NCT01836965
226	NCT01648868	Transcranial Magnetic Stimulation (rTMS) and Autism.	TMSAUTISME	Completed	No Results Available	Autism Spectrum Disorder	Device: Transcranial Magnetic Stimulation (rTMS)	Fixation time in eyes, mouth and face areas|Eye-tracking or voice human perception correlation|Fractional anisotropy covariation|Fractional anisotropy comparison	Assistance Publique - Hôpitaux de Paris	All	18 Years to 30 Years   (Adult)	Not Applicable	97	Other	Interventional	Allocation: Non-Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Treatment	P 081232|2009-A01025-52	April 6, 2011	September 27, 2017	May 13, 2019	July 24, 2012		March 23, 2021	Hôpital Necker-Enfants Malades, Paris, France		https://ClinicalTrials.gov/show/NCT01648868
227	NCT04987541	The Therapeutic Effect of TBS Stimulation on Emotion Regulation in Autism Spectrum Disorder		Recruiting	No Results Available	Autism Spectrum Disorder	Device: intermittent theta burst stimulation	Changes of total scores of Emotional Dysregulation Inventory|Changes of total scores of Aberrant Behavior Checklist|Changes of total scores of Child Behavior Checklist|Changes of total scores of Social Responsiveness Scale|Changes of total scores of Repetitive Behavior Scale-Revised|Changes of total scores of Adaptive Behavior Assessment System|Changes in accuracy of Frith-Happe animation|Changes in accuracy of Eyes task|Changes in accuracy of Wisconsin Card Sorting Test|Changes of total scores of Behavior Rating Inventory of Executive Function|Raven's Progressive Matrices|MRI T1|functional MRI (resting-state/biological motion task) - BOLD signal|Diffusion Tensor Imaging (DTI) - FA|Electroencephalography	Chang Gung Memorial Hospital	All	8 Years to 30 Years   (Child, Adult)	Not Applicable	60	Other	Interventional	Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Double (Participant, Investigator)|Primary Purpose: Treatment	202002498A0	September 6, 2022	September 2025	December 2025	August 3, 2021		October 13, 2022	Chang Gung Memorial Hospital, Taoyuan, Taiwan		https://ClinicalTrials.gov/show/NCT04987541
228	NCT02212275	Cortical Metrics in Intervention Trials With Autism Spectrum Disorders		Withdrawn	No Results Available	Autism Spectrum Disorders	Drug: Dextromethophan	The difference in the Cortical Metric before and after acute exposure to dextromethorphan (DXM)|Change in the cortical metric|The Cortical Metric|Aberrant Behavior Checklist (ABC) Total Score|Pervasive Developmental Disorders Behavior Inventory - Screening Version Score (PDDBI-SV) Social Deficit Score|Social Responsiveness Scale, Version 2 Total Score (SRS)	Duke University|North Carolina Translational and Clinical Sciences Institute	Male	8 Years to 12 Years   (Child)	Phase 2|Phase 3	0	Other	Interventional	Allocation: Non-Randomized|Intervention Model: Single Group Assignment|Masking: None (Open Label)	Pro00065239|14-1141	August 2015	July 2016	July 2016	August 8, 2014		August 25, 2016	University of North Carolina, Chapel Hill, Chapel Hill, North Carolina, United States|Duke Center for Autism and Brain Development, Durham, North Carolina, United States		https://ClinicalTrials.gov/show/NCT02212275
229	NCT02791789	SEMATIC Pilot Study in Children With Autism Spectrum Disorder Using an Innovative Edutainment Software	sematic	Completed	No Results Available	Autism Spectrum Disorder	Other: Autism Spectrum Disorder	measure learning words and phrases while using SEMATIC in children with ASD and non-readers without functional language|Evaluate the impact of learning words and phrases on the acquisition of the lexicon (speech and language test ELO)|Evaluate the duration of the game necessary to learning|Assess the number of sessions necessary to learning|Assess the technical performance and usability of the game platform|Evaluate the satisfaction of organizing the SEMATIC survey of parents and educators	Fondation Lenval	All	6 Years to 12 Years   (Child)	Not Applicable	17	Other	Interventional	Allocation: N/A|Intervention Model: Single Group Assignment|Masking: None (Open Label)	14-HPNCL-10	October 2013	February 2015	February 2015	June 7, 2016		June 7, 2016	Fondation LENVAL - Hôpitaux Pédiatriques de Nice CHU-LENVAL, Nice, France		https://ClinicalTrials.gov/show/NCT02791789
230	NCT04993144	The Therapeutic Effects of Continuous Theta Burst Stimulation in Autism Spectrum Disorder		Recruiting	No Results Available	Autism Spectrum Disorder	Device: continuous theta burst stimulation	Changes of total scores of Social Responsiveness Scale|Changes of total scores of Repetitive Behavior Scale-Revised|Changes of total scores of Emotional Dysregulation Inventory|Changes of total scores of Adaptive Behavior Assessment System|Changes of total scores of Vineland Adaptive Behavior Scales|Changes in accuracy of Frith-Happe animation|Changes in accuracy of Eyes task|Changes in accuracy of Wisconsin Card Sorting Test|Changes of total scores of Behavior Rating Inventory of Executive Function|Raven's Progressive Matrices|Autism Diagnostic Observation Schedule - Generic|MRI T1|functional MRI (resting-state/biological motion task) - BOLD signal|Diffusion Tensor Imaging (DTI) - FA	Chang Gung Memorial Hospital	All	8 Years to 30 Years   (Child, Adult)	Not Applicable	90	Other	Interventional	Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Double (Participant, Care Provider)|Primary Purpose: Treatment	201802246A0	December 10, 2019	September 2022	September 2022	August 6, 2021		July 8, 2022	Chang Gung Memorial Hospital, Taoyuan, Taiwan		https://ClinicalTrials.gov/show/NCT04993144
231	NCT02363673	The Effect of Individualised Homoeopathic Treatment of Autism Spectrum Disorder in Children		Completed	No Results Available	Autism Spectrum Disorder	Other: Individualised homoeopathic remedy in aqua distilla	Childhood Autism Rating Scale|Autism Treatment Evaluation Checklist|Case notes	University of Johannesburg	All	3 Years to 6 Years   (Child)	Phase 2	10	Other	Interventional	Allocation: N/A|Intervention Model: Single Group Assignment|Masking: None (Open Label)|Primary Purpose: Treatment	CGoodwin201006636|REC-01-128-2014	February 2015	July 2015	July 2015	February 16, 2015		May 19, 2016	University of Johannesburg Doornfontein Campus, Johannesburg, Gauteng, South Africa		https://ClinicalTrials.gov/show/NCT02363673
232	NCT04737707	Dialectical Behavior Therapy for Adults With Autism Spectrum Disorders	Autisemo	Recruiting	No Results Available	Autism Spectrum Disorders	Other: Dialectical Behavior Therapy (DBT)	Difficulties in Emotion Regulation Scale (DERS)	University Hospital, Strasbourg, France	All	18 Years and older   (Adult, Older Adult)	Not Applicable	48	Other	Interventional	Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Treatment	8108	April 16, 2021	September 1, 2024	September 1, 2024	February 4, 2021		August 19, 2022	Service de psychiatrie, Strasbourg, France		https://ClinicalTrials.gov/show/NCT04737707
233	NCT01333072	Biomarkers in Autism of Aripiprazole and Risperidone Treatment (BAART)	BAART	Completed	Has Results	Autistic Disorder	Drug: Aripiprazole|Drug: Risperidone	Changes in the Irritability Subscale of the Larger ABC (Abberent Behavior Checklist) That Occur From Baseline to 10 Weeks	Medical University of South Carolina	All	6 Years to 17 Years   (Child)	Phase 4	80	Other	Interventional	Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)|Primary Purpose: Supportive Care	R01HD062550-01A1	July 2011	August 2015	August 2015	April 11, 2011	September 26, 2018	September 26, 2018	Medical University of South Carolina, Charleston, South Carolina, United States		https://ClinicalTrials.gov/show/NCT01333072
234	NCT04980963	Cognitive Support Technology for Postsecondary Students With Autism Spectrum Disorder		Recruiting	No Results Available	Autism Spectrum Disorder	Behavioral: Cognitive Support Technology (CST)	Grade Point Average (GPA)|Current academic standing|Post-Secondary Enrollment Status|Satisfaction with current living status and transportation access|Satisfaction with Social Support|Current Employment Status|% of Participants Receiving Disability Benefits|Depression Symptoms|Overall Health Status|Perceived Stress|Acceptance of Disability|Quality of Life (QoL)	Kent State University|Virginia Commonwealth University	All	Child, Adult, Older Adult	Not Applicable	90	Other	Interventional	Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Single (Participant)|Primary Purpose: Supportive Care	20-069	March 1, 2020	June 30, 2024	June 30, 2024	July 28, 2021		July 28, 2021	Kent State University, Kent, Ohio, United States		https://ClinicalTrials.gov/show/NCT04980963
235	NCT05578209	Therapeutic Impacts of Theta Burst Stimulation Over Bilateral Posterior Superior Temporal Sulcus in Autism Spectrum Disorder		Not yet recruiting	No Results Available	Autism Spectrum Disorder	Device: intermittent theta burst stimulation	Changes of total scores of Social Responsiveness Scale|Changes of total scores of Repetitive Behavior Scale-Revised|Changes of total scores of Aberrant Behavior Checklist|Changes of total scores of Emotional Dysregulation Inventory|Changes of total scores of Child Behavior Checklist|Changes of total scores of Adaptive Behavior Assessment System|Changes in accuracy of Frith-Happe animation|Changes in accuracy of Eyes task|Changes in accuracy of Wisconsin Card Sorting Test|Changes of total scores of Behavior Rating Inventory of Executive Function|Raven's Progressive Matrices|MRI T1|functional MRI (resting-state/biological motion task) - BOLD signal|Diffusion Tensor Imaging (DTI) - FA|Electroencephalography	Chang Gung Memorial Hospital	All	8 Years to 30 Years   (Child, Adult)	Not Applicable	60	Other	Interventional	Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Double (Participant, Investigator)|Primary Purpose: Treatment	202102232A0	October 2022	July 2025	August 2025	October 13, 2022		October 13, 2022	Chang Gung Memorial Hospital, Taoyuan, Taiwan		https://ClinicalTrials.gov/show/NCT05578209
236	NCT05651126	Psilocybin in Adults With and Without Autism Spectrum Disorder	PSILAUT	Recruiting	No Results Available	Autism Spectrum Disorder	Drug: Psilocybin 5 mg|Drug: Psilocybin 2 mg|Drug: Placebo	Brain activation and connectivity response to serotonergic stimulation as assessed by functional magnetic resonance imaging.|Brain electrophysiological activity task-free electroencephalography (EEG)|Brain electrophysiological activity electroencephalography (EEG) during visual stimulation|Brain electrophysiological activity electroencephalography (EEG) during auditory stimulation|Brain excitation and inhibition response to serotonergic stimulation as assessed by magnetic resonance spectroscopy.	King's College London|University of Cambridge	All	18 Years to 60 Years   (Adult)	Not Applicable	70	Other	Interventional	Allocation: Randomized|Intervention Model: Crossover Assignment|Masking: Double (Participant, Investigator)|Primary Purpose: Basic Science	IRAS: 292281; REC: 21/LO/0795	December 2022	December 2024	December 2024	December 14, 2022		December 14, 2022	King's College London, London, United Kingdom		https://ClinicalTrials.gov/show/NCT05651126
237	NCT01493609	A Clinical Trial of a New Computer Based Intervention for Children With Autism.	Click-East	Completed	No Results Available	Autism Spectrum Disorder	Behavioral: Click-East app	Autism Diagnostic Observation Schedule - Change (ADOS-C)	University of Edinburgh|NHS Lothian|Newcastle University	All	15 Months to 6 Years   (Child)	Early Phase 1	54	Other	Interventional	Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Single (Outcomes Assessor)|Primary Purpose: Treatment	2010/C/PMLD/03|NCF/36343	February 2012	June 2013	June 2013	December 16, 2011		November 25, 2013	University of Edinburgh, Edinburgh, Midlothian, United Kingdom|Clinical Research Facility, Royal Hospital for Sick Children, Edinburgh, Midlothian, United Kingdom		https://ClinicalTrials.gov/show/NCT01493609
238	NCT03267095	Use Music Therapy In Autism Spectrum Disorder		Unknown status	No Results Available	Autism Spectrum Disorder	Behavioral: music therapy sessions .	The Arabic Language test	Assiut University	All	3 Years to 7 Years   (Child)	Not Applicable	60	Other	Interventional	Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Treatment	MTH ASD	October 1, 2019	October 1, 2020	November 1, 2021	August 30, 2017		July 23, 2019			https://ClinicalTrials.gov/show/NCT03267095
239	NCT04802434	Strengthening Skills Behavioral Intervention for Adults With Autism Spectrum Disorder		Active, not recruiting	No Results Available	Autism Spectrum Disorder	Behavioral: Strengthening Skills Program|Behavioral: PEERS Social Skills Program	Mean Change from Baseline in Adaptive Functioning on the Adaptive Behavior Assessment System, Third Edition (ABAS-3)|Mean Change from Baseline in Self-reported Quality of Life on the World Health Organization's Brief Quality of Life assessment (WHOQOL-BREF)|Mean Change from Baseline in Prospective Memory on the Royal Prince Alfred Prospective Memory Test	Southwest Autism Research & Resource Center|Arizona State University|Mayo Clinic	All	21 Years to 70 Years   (Adult, Older Adult)	Not Applicable	42	Other	Interventional	Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Treatment	00011585|W81XWH-20-1-0171	April 1, 2021	April 2023	April 2023	March 17, 2021		October 5, 2022	Arizona State University, Tempe, Arizona, United States		https://ClinicalTrials.gov/show/NCT04802434
240	NCT03912896	Taekwondo for Children With Autism Spectrum Disorder		Completed	No Results Available	Autism Spectrum Disorder	Behavioral: Taekwondo	Subject response to taekwondo	Loma Linda University	All	7 Years to 11 Years   (Child)	Not Applicable	6	Other	Interventional	Allocation: N/A|Intervention Model: Single Group Assignment|Masking: None (Open Label)|Primary Purpose: Health Services Research	5180418	June 11, 2019	November 20, 2019	February 10, 2020	April 11, 2019		March 6, 2020	Loma LInda University Health, Loma Linda, California, United States		https://ClinicalTrials.gov/show/NCT03912896
241	NCT04838912	Testing a CBT Program for Anxiety in Teenagers With Autism: A Feasibility Study		Recruiting	No Results Available	Anxiety|Autism	Behavioral: Cool Kids (Chilled) Anxiety program adapted to children and youths with anxiety disorders (ASA)	The Experience of Service Questionnaire|Anxiety Disorders Interview Schedule for DSM-IV: Parent & Child interview schedule (ADIS C/P)|Spence Children's Anxiety Scale (SCAS)|Children's Anxiety Life Inference Scale (CALIS)|Children's Automatic Thoughts Scale (CATS)	University of Aarhus	All	14 Years to 18 Years   (Child, Adult)	Not Applicable	15	Other	Interventional	Allocation: N/A|Intervention Model: Single Group Assignment|Masking: None (Open Label)|Primary Purpose: Treatment	1-16-02-37-21	June 1, 2021	May 2022	May 2022	April 9, 2021		October 13, 2021	Auhus University Hospital, Psychiatry, Aarhus N, Denmark	"Study Protocol", https://ClinicalTrials.gov/ProvidedDocs/12/NCT04838912/Prot_001.pdf	https://ClinicalTrials.gov/show/NCT04838912
242	NCT04293783	Randomized Double-blind Clinical Trial With L.Reuteri Supplementation in Children With Autism Spectrum Disorder		Unknown status	No Results Available	Autism Spectrum Disorder	Dietary Supplement: L.Reuteri|Dietary Supplement: Placebo	Changes in severity level of ASD symptomatology|Changes in Microbiome Profile|Changes in GI symptoms|Changes in ASD symptomatology: problematic behaviors|Changes in ASD symptomatology: repetitive behaviors|Changes in Adaptive Functioning|Changes in global ASD symptomatology|Changes in Behavioral Profiles|Changes in Parental Stress|Changes in Metabolomic Profile|Changes in Inflammatory Profile	University of Rome Tor Vergata|University of Bari	All	18 Months to 8 Years   (Child)	Not Applicable	80	Other	Interventional	Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Triple (Participant, Care Provider, Investigator)|Primary Purpose: Treatment	Reg. Sperim. 244/19	February 1, 2020	October 30, 2020	August 30, 2021	March 3, 2020		March 3, 2020	University of Bari, Bari, BA, Italy|University of Rome Tor Vergata, Rome, RM, Italy		https://ClinicalTrials.gov/show/NCT04293783
243	NCT03310775	The Effect of Korean Version of PEERS Social Skills Training for Young Adults (PEERS-YA-K) With Autism Spectrum Disorder		Completed	Has Results	Autism Spectrum Disorder|Autism	Behavioral: Parent-assisted social skills training program for young adult with ASD	Change From Baseline in Autism Diagnostic Observation Schedule(ADOS) at 4 Month|Change From Baseline in Test of Young Adult Social Skills Knowledge(TYASSK) at 4 Month|Change From Baseline in Korean Version of the Social Skills Rating System (K-SSRS) at 4 Month|Change From Baseline in Social Responsiveness Scale-2 (SRS-2) at 4 Month|Korean Version of the Vineland Adaptive Behavior Scale, Second Edition|Change From Baseline in Beck Depression Inventory (BDI) at 4month	Seoul National University Hospital	All	18 Years to 35 Years   (Adult)	Not Applicable	47	Other	Interventional	Allocation: Randomized|Intervention Model: Sequential Assignment|Masking: Double (Participant, Care Provider)|Primary Purpose: Treatment	B-1611-371-303	November 9, 2016	October 30, 2018	October 30, 2018	October 16, 2017	September 9, 2020	September 9, 2020		"Study Protocol and Statistical Analysis Plan", https://ClinicalTrials.gov/ProvidedDocs/75/NCT03310775/Prot_SAP_000.pdf	https://ClinicalTrials.gov/show/NCT03310775
244	NCT00725556	The Development of Autistic Children Based on Mothers´Response in Autism Behavior Checklist		Completed	No Results Available	Autism|Asperger Syndrome	Other: Speech Therapy	To evaluate the process of development of autistic children, in a direct and indirect intervention context from mother´s response in Autism Behavior Checklist.	Federal University of São Paulo	All	3 Years to 12 Years   (Child)	Phase 1|Phase 2	11	Other	Interventional	Allocation: Non-Randomized|Intervention Model: Parallel Assignment|Masking: Double (Investigator, Outcomes Assessor)|Primary Purpose: Treatment	Ana Carina Tamanaha	March 2006	March 2007	December 2007	July 30, 2008		August 1, 2008	Ana Carina Tamanaha, São Paulo, Brazil		https://ClinicalTrials.gov/show/NCT00725556
245	NCT02550912	A Study Evaluating the Effect of Vitamin D on Clinical Outcome in Autistic Children		Completed	No Results Available	Autism	Drug: Vitamin D3|Other: Placebo	Effect of vitamin D on changes in behavioral measures (Childhood autism rating scale)|Effect of vitamin D on changes in behavioral measures (autism treatment evaluation checklist)|Effect of vitamin D on calcium level|Effect of vitamin D on phosphorous level|Effect of vitamin D on alkaline phosphatase level|Effect of vitamin D on parathyroid hormone level|Effect of vitamin D on liver function test (alanine transaminase and aspartate transaminase)|Effect of vitamin D on kidney function test (Blood urea nitrogen and serum creatinine)	Ain Shams University	All	2 Years to 15 Years   (Child)	Phase 2	42	Other	Interventional	Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)|Primary Purpose: Treatment	PhD(NO.18)	August 2015	February 2016	March 2016	September 16, 2015		July 12, 2016	Faculty of Pharmacy AinShams University, Cairo, Egypt		https://ClinicalTrials.gov/show/NCT02550912
246	NCT04220086	Pediatric Massage for Children With Autism Spectrum Disorder		Recruiting	No Results Available	Autism Spectrum Disorder	Procedure: Pediatric massage therapy|Procedure: Usual care|Other: No intervention	Changes in the Autism Behavior Checklist (ABC)|Changes in the Childhood Autism Rating Scale (CARS)|Changes in the Social Responsiveness Scale - Second Edition (SRS-2)|Changes in the Children's Sleep Habits Questionnaire (CSHQ)|Changes in the Eysenck Personality Questionnaire (EPQ) - adult version|Changes in electroencephalography (EEG)|Changes in functional near-infrared spectroscopy (fNIRS) of the brain|Number of participants with non-serious and serious adverse events (AEs)|Number of participants with abnormal laboratory values in blood routine examination.|Changes in the Autism Treatment Evaluation Checklist (ATEC).	The University of Hong Kong|Shenzhen Children's Hospital	All	3 Years to 10 Years   (Child)	Not Applicable	87	Other	Interventional	Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Single (Outcomes Assessor)|Primary Purpose: Treatment	TNASD1	May 30, 2021	June 30, 2022	December 31, 2022	January 7, 2020		September 29, 2021	Shenzhen Children's Hospital, Shenzhen, Guangdong, China|Department of Chinese Medicine, The University of Hong Kong-Shenzhen Hospital, Shenzhen, Guangdong, China		https://ClinicalTrials.gov/show/NCT04220086
247	NCT03678129	GABA Pathways in Autism Spectrum Disorder (ASD)		Active, not recruiting	No Results Available	Autism Spectrum Disorder	Drug: AZD7325_10|Drug: AZD7325_20|Drug: Placebo	Neurochemical response to GABAergic stimulation.|Functional connectivity measures using resting state functional magnetic resonance imaging.|Brain oscillations under sensory stimulation	King's College London	All	18 Years to 60 Years   (Adult)	Not Applicable	28	Other	Interventional	Allocation: Randomized|Intervention Model: Crossover Assignment|Masking: Double (Participant, Investigator)|Primary Purpose: Basic Science	REC 18/WM/0208	December 7, 2018	February 15, 2023	August 26, 2023	September 19, 2018		April 15, 2022	King's College London, London, United Kingdom		https://ClinicalTrials.gov/show/NCT03678129
248	NCT04612647	Fit Families Program: Fundamental Motor Skill Intervention in Children With Autism Spectrum Disorders and Their Parents		Completed	No Results Available	Autism Spectrum Disorder	Other: 12-week FMS Intervention|Behavioral: Physical Activities & Activity Booklets	Change in Gross Motor Development as Measured by TGMD-3|Number of Participants Whose Perceptions Qualitatively Improve as measured via semi-structured interview|Fidelity of Intervention reported as Number of Parents who Implements the Intervention as Intended|Change in Social Communication Questionnaire (SCQ)	University of Wisconsin, Madison	All	4 Years to 11 Years   (Child)	Not Applicable	41	Other	Interventional	Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Other	2019-1256|A176000|EDUC/KINESIOLOGY/KINESIO	January 2, 2020	May 24, 2020	May 24, 2020	November 3, 2020		November 3, 2020	University of Wisconsin, Madison, Wisconsin, United States		https://ClinicalTrials.gov/show/NCT04612647
249	NCT03864289	Parent Skills Training for Families of Children With Autism Spectrum Disorder		Completed	No Results Available	Autism Spectrum Disorder	Behavioral: Parent skills training	Change from baseline average score of the Interaction Fidelity Rating System at 8 weeks|Change from baseline correct answer rate of the Questionnaire on Awareness and Knowledge of Interventions about Autism at 8 weeks	Children's Hospital of Fudan University	All	18 Months to 54 Months   (Child)	Not Applicable	200	Other	Interventional	Allocation: N/A|Intervention Model: Single Group Assignment|Masking: None (Open Label)|Primary Purpose: Treatment	FDEK-PST-2019	March 15, 2019	December 14, 2021	March 14, 2022	March 6, 2019		March 31, 2022	Children's hospital of Fudan University, Shanghai, Shanghai, China		https://ClinicalTrials.gov/show/NCT03864289
250	NCT01788072	INtranasal OXyTocin for the Treatment of Autism Spectrum Disorders	INOXT	Completed	No Results Available	Autism Spectrum Disorder	Drug: Intranasal Oxytocin|Drug: Placebo	Efficacy of intranasal oxytocin vs. placebo on social function in adults with ASD|Efficacy of intranasal oxytocin vs. placebo on a continuous measure of social cognition in adults with ASD|Efficacy of intranasal oxytocin vs. placebo on a continuous measure of social function in adults with ASD|Efficacy of intranasal oxytocin vs. placebo on a continuous measure of social responsiveness in adults with ASD|Safety and tolerability of intranasal oxytocin in adults with ASD|Efficacy of intranasal oxytocin vs. placebo on quality of life|Efficacy of intranasal oxytocin vs. placebo on anxiety	Evdokia Anagnostou|Holland Bloorview Kids Rehabilitation Hospital|McMaster University|Unity Health Toronto|Anagnostou, Evdokia, M.D.	All	18 Years to 45 Years   (Adult)	Phase 2	70	Other	Interventional	Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)|Primary Purpose: Treatment	INOXT-10-2013	June 2014	August 2017	October 2017	February 11, 2013		January 25, 2018	St. Joseph's Healthcare Hamilton, Hamilton, Ontario, Canada|Holland Bloorview Kids Rehabilitation Hospital, Toronto, Ontario, Canada		https://ClinicalTrials.gov/show/NCT01788072
251	NCT03466671	A Trial of TTA-121 on Autism Spectrum Disorder		Unknown status	No Results Available	Autism Spectrum Disorder	Drug: TTA-121	Efficacy on autism spectrum social core symptom assessed by social reciprocity score on the Autism Diagnostic Observation Schedule module 4|Efficacy on autism spectrum core symptom assessed by communication score on the Autism Diagnostic Observation Schedule module 4|Efficacy on autism spectrum core symptom assessed by repetitive and restricted behavior score on the Autism Diagnostic Observation Schedule module 4|Efficacy on autism spectrum core symptom assessed by revised algorithm score of social affect on the Autism Diagnostic Observation Schedule module 4|Efficacy on autism spectrum core symptom assessed by revised algorithm of repetitive and restricted behavior score on the Autism Diagnostic Observation Schedule module 4|Efficacy assessed by Clinical Global Impression-Improvement|Efficacy assessed by Clinical Global Impression-Severity|Efficacy assessed by Global Assessment of Functioning|Efficacy assessed by gaze fixation time on social region|Efficacy assessed by quantitative analysis of facial expression	Hamamatsu University|Japan Agency for Medical Research and Development	Male	18 Years to 54 Years   (Adult)	Phase 2	144	Other	Interventional	Allocation: Randomized|Intervention Model: Crossover Assignment|Masking: Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)|Primary Purpose: Treatment	UMIN000031412	February 27, 2018	March 16, 2020	March 30, 2020	March 15, 2018		December 20, 2019	Hamamatsu University School of Medicine, Hamamatsu, Shizuoka, Japan		https://ClinicalTrials.gov/show/NCT03466671
252	NCT04054349	The Effect of the Low Fodmap Diet in Children With Autism Spectrum Disorders		Completed	No Results Available	Autism Spectrum Disorder	Other: Low FODMAP diet	Pediatric Quality of Life Inventory (PedsQL) Gastrointestinal Module-Parent Report|Assessment of stool consistency|Assessment of stool frequency|Assessment of behavioral problems|Energy and Nutrient Intake	Ohio State University	All	6 Years to 17 Years   (Child)	Not Applicable	15	Other	Interventional	Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Treatment	2018H0543	January 3, 2019	July 30, 2019	July 30, 2019	August 13, 2019		August 13, 2019	The Ohio State University Nisonger Center, Columbus, Ohio, United States		https://ClinicalTrials.gov/show/NCT04054349
253	NCT04097457	Group Based Parent Training for Children With Autism and Disruptive Behaviors		Unknown status	No Results Available	Autism Spectrum Disorder	Behavioral: "Parent training for disruptive behaviors" manual (Bearss, Johnson, Handen, Butter, Lecavalier, Smith & Scahill, 2018)	The aberrant behavior checklist: a behavior rating scale for the assessment of treatment effects (Aman, M. G., Singh, N. N., Stewart, A. W., & Field, C. J.,1985)|Home Situations Questionnaire (HSQ) (Barkley & Murphy, 1998)|Social Responsiveness Scale (SRS) (Constantino & Gruber, 2005)|Adaptive Behavior Assessment System (ABAS-II)|Parenting Stress Index Short Version (PSI-SR) (Abidin, 1990)	Hebrew University of Jerusalem	All	4 Years to 8 Years   (Child)	Not Applicable	100	Other	Interventional	Allocation: Non-Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Treatment	GroupPT ASD	October 2, 2017	September 2, 2020	January 2, 2021	September 20, 2019		September 20, 2019	The Hebrew university, Jerusalem, Israel		https://ClinicalTrials.gov/show/NCT04097457
254	NCT03865719	Weight Management Intervention for Youth and Young Adults With Autism Spectrum Disorder	ACORN-ASD	Completed	No Results Available	Autism Spectrum Disorder	Behavioral: Healthy Habits for Life	Change in Body Mass Index (BMI) z-score|Inflammation as indicated by change in circulating high sensitivity C-reactive protein (hs-CRP)|Implementation effectiveness|Change in Waist circumference|Change in Blood pressure|Change in Lipid Panel Lab Values|Change in Glucose Serum|Change in Insulin|Change in HOMA-IR|Change in aberrant behaviors|Change in emotional dysregulation|Change in parenting stress|Change in weight loss behaviors|Change in physical activity habits	University of Pittsburgh|Massachusetts General Hospital	All	8 Years to 26 Years   (Child, Adult)	Not Applicable	10	Other	Interventional	Allocation: N/A|Intervention Model: Single Group Assignment|Masking: None (Open Label)|Primary Purpose: Treatment	STUDY18120156	August 7, 2019	March 15, 2021	December 1, 2021	March 7, 2019		April 6, 2022	Autism Treatment Network Site at Merck Child and Adolescent Outpatient Clinic, Pittsburgh, Pennsylvania, United States		https://ClinicalTrials.gov/show/NCT03865719
255	NCT04427150	Affective Prosody Recognition and Auditory Intervention for Children With Autism Spectrum Disorders (ASD)		Completed	No Results Available	Autism Spectrum Disorder	Behavioral: Auditory Training|Behavioral: Non-auditory training	Change in Accuracy of Affective Prosody Recognition|Change in Ability in Discriminating Pitch Differences|Change in Accuracy in Processing Rapid Presentation of Two Tones	Hong Kong Baptist University|The Hong Kong Polytechnic University|Education University of Hong Kong	All	8 Years to 14 Years   (Child)	Not Applicable	120	Other	Interventional	Allocation: Non-Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Treatment	HKBU 12604418	September 25, 2020	December 31, 2021	December 31, 2021	June 11, 2020		March 31, 2022	Centre of Learning Science, Kowloon Tong, Hong Kong		https://ClinicalTrials.gov/show/NCT04427150
256	NCT04520685	CASCADE: CAnnabidiol Study in Children With Autism Spectrum DisordEr	CASCADE	Recruiting	No Results Available	Autism Spectrum Disorder	Drug: Oral cannabidiol 100mg/mL|Drug: Placebo	Aberrant Behavior Checklist- 2nd Edition (ABC-2): Irritability subscale raw score|Aberrant Behavior Checklist- 2nd Edition (ABC-2): Lethargy/Social Withdrawal subscale|Aberrant Behavior Checklist- 2nd Edition (ABC-2): Stereotypic Behavior subscale|Aberrant Behavior Checklist- 2nd Edition (ABC-2): Inappropriate Speech subscale|Aberrant Behavior Checklist- 2nd Edition (ABC-2): Hyperactivity/Noncompliance subscale|Anxiety, Depression, and Mood Scale (ADAMS): Total Score|Anxiety, Depression, and Mood Scale (ADAMS): General Anxiety subscale|Anxiety, Depression, and Mood Scale (ADAMS): Social Avoidance subscale|Social Responsiveness Scale - 2nd Edition (SRS-2): total T-score|Ohio Autism Clinical Impressions Scale - Severity (OACIS-S) scale|Ohio Autism Clinical Impressions Scale - Improvement (OACIS-I) scale|Autism Screening Instrument for Educational Planning - 3rd Edition (ASIEP - 3): Interaction Assessment Autism Interaction Score|Repetitive Behavior Scale - Revised (RBS-R)|Brief Rating Inventory of Executive Functioning - 2nd edition (BRIEF-2): Global Executive Functioning Score|Brief Rating Inventory of Executive Functioning - 2nd edition (BRIEF-2): ADHD score|Brief Rating Inventory of Executive Functioning - 2nd edition (BRIEF-2): Index scores|Sleep Clinical Global Impressions - Severity Scale (Sleep CGI-S)|Sleep Clinical Global Impressions - Improvement Scale (Sleep CGI-I)|Autism Family Experience Questionnaire (AFEQ)|NIH Toolbox Scales: Satisfaction with Social Roles and Activities - Short Form 4a|NIH Toolbox Scales: Life Satisfaction - Short Form 8b|NIH Toolbox Scales: Positive Affect - Short Form 4a|Pediatric Quality of Life Inventory (PedsQL) - Core Scale|Pediatric Quality of Life Inventory (PedsQL) - Cognitive Functioning Scale	University of Colorado, Denver	All	5 Years to 17 Years   (Child)	Phase 2	70	Other	Interventional	Allocation: Randomized|Intervention Model: Crossover Assignment|Masking: Triple (Participant, Care Provider, Investigator)|Primary Purpose: Treatment	19-2168	December 15, 2021	June 1, 2023	June 1, 2023	August 20, 2020		January 11, 2022	Children's Hospital Colorado, Aurora, Colorado, United States		https://ClinicalTrials.gov/show/NCT04520685
257	NCT04722783	Effect of ESDM and PCIT-A in Autism Spectrum Disorder	TAFF	Recruiting	No Results Available	Autism Spectrum Disorder	Behavioral: Parent-Child-Interaction Therapy adapted for children with autism spectrum disorder (PCIT-A)|Behavioral: Early Start Denver Model (ESDM) intervention|Behavioral: 1-hour ESDM|Behavioral: Early special needs education (ESNE)	Disruptive behavior change (for PCIT-A analysis)|Autism symptoms change (for ESDM analysis)|Disruptive behavior long-term change (for PCIT-A analysis)|Autism symptoms change (for PCIT-A analysis)|Developmental level change (for PCIT-A analysis)|Non-verbal Intelligence change (for PCIT-A analysis)|Adaptive behavior change (for PCIT-A analysis)|Social-emotional competence change (for PCIT-A analysis)|Parenting stress change (for PCIT-A analysis)|Autism symptoms long-term change (for ESDM analysis)|Disruptive behavior change (for ESDM analysis)|Developmental level change (for ESDM analysis)|Non-verbal intelligence change (for ESDM analysis)|Adaptive behavior change (for ESDM analysis)|Social-emotional competence change (for ESDM analysis)|Parenting stress change (for ESDM analysis)	Bruno Rhiner|West Virginia University|University of Arkansas|Psychiatrische Dienste Thurgau	All	24 Months to 59 Months   (Child)	Not Applicable	28	Other	Interventional	Allocation: Randomized|Intervention Model: Factorial Assignment|Masking: Single (Outcomes Assessor)|Primary Purpose: Treatment	Protocol_PDT_010_TAFF|2020-02787 (EKOS 20/223)	January 14, 2021	October 31, 2022	October 31, 2023	January 25, 2021		September 28, 2022	Psychiatric Services of Thurgovia, Münsterlingen, Thurgau, Switzerland		https://ClinicalTrials.gov/show/NCT04722783
258	NCT03853265	The Effect Of Virtual Reality Glasses On The Behavior Of Children With Autism Spectrum Disorder		Completed	No Results Available	Autism Spectrum Disorder	Behavioral: Simulated dental office visit	Change in heart rate|Change in 5-point Venham Anxiety Scores|Change in 5-point Venham Uncooperative Behavior Scores	Virginia Commonwealth University	All	5 Years to 25 Years   (Child, Adult)	Not Applicable	5	Other	Interventional	Allocation: Randomized|Intervention Model: Sequential Assignment|Masking: Single (Outcomes Assessor)|Primary Purpose: Prevention	HM20015131	October 23, 2019	February 17, 2020	February 17, 2020	February 25, 2019		November 9, 2020	Virginia Commonwealth University, Richmond, Virginia, United States		https://ClinicalTrials.gov/show/NCT03853265
259	NCT03725644	Parent Training Program for Preschool Children With Autism Spectrum Disorders		Completed	No Results Available	Autism Spectrum Disorder	Behavioral: parent-training program|Behavioral: traditional program	Change Scores of Functional Emotional Assessment Scale|Change Scores of Chinese Version of Psychoeducational Profile - Third Edition|Change Scores of Vineland Adaptive Behavior Scales	National Cheng Kung University	All	36 Months to 71 Months   (Child)	Not Applicable	40	Other	Interventional	Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Single (Outcomes Assessor)|Primary Purpose: Treatment	B-BR-103-065	January 29, 2015	September 30, 2017	September 30, 2017	October 31, 2018		October 31, 2018			https://ClinicalTrials.gov/show/NCT03725644
260	NCT04242355	Transcranial Magnetic Stimulation on Neural and Behavioral Facets of Social Cognition in Autism Spectrum Disorder	TMSinASD	Active, not recruiting	No Results Available	Autism Spectrum Disorder	Behavioral: Transcranial Magnetic Stimulation (TMS)	right lateralized N170 latency to upright faces|proportion of visual attention to the eye region of the face|The Benton Face Recognition Task	Yale University	All	18 Years to 40 Years   (Adult)	Not Applicable	100	Other	Interventional	Allocation: Randomized|Intervention Model: Crossover Assignment|Masking: None (Open Label)|Primary Purpose: Treatment	2000021846	July 1, 2019	July 2024	July 2025	January 27, 2020		May 19, 2022	Yale University, New Haven, Connecticut, United States		https://ClinicalTrials.gov/show/NCT04242355
261	NCT00614198	ScanBrit Dietary Intervention in Autism	ScanBrit	Completed	Has Results	Autism|Autism Spectrum Disorder (ASD)	Other: Gluten- and casein-free diet	Change in Diet Groups Scores on One of Several Measures Used Against Pre-defined Statistical Thresholds as Evidence of Improvement.|Changes to Appearance of Multiple Compounds in Urine Samples	Center for Autisme, Denmark|Norway: Bo Nils og Seim Family Settlement|The Robert Luff Foundation, United Kingdom|Eric Birger Christensen Fond, Denmark|Norsk Proteinintolerance, Norway	All	4 Years to 11 Years   (Child)	Phase 2	72	Other	Interventional	Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Single (Investigator)|Primary Purpose: Treatment	KA 0503g	April 2006	October 2008	October 2008	February 13, 2008	October 1, 2010	October 1, 2010			https://ClinicalTrials.gov/show/NCT00614198
262	NCT03254992	Real and Virtual Environments in Autism Spectrum Disorder		Completed	No Results Available	Autism Spectrum Disorder	Device: ASD - Abstract task|Device: ASD - Tangible task|Device: TD - Abstract task|Device: TD - Tangible task	Change in performance, measured by coincident timing task	University of Sao Paulo	All	7 Years to 15 Years   (Child)	Not Applicable	100	Other	Interventional	Allocation: Randomized|Intervention Model: Crossover Assignment|Masking: None (Open Label)|Primary Purpose: Supportive Care	55498016.1.0000.5390	November 2, 2016	October 20, 2017	November 20, 2017	August 21, 2017		November 27, 2017	Escola de Artes,Ciencias e Humanidades da Universidade d Sao Paulo, Sao Paulo, Brazil		https://ClinicalTrials.gov/show/NCT03254992
263	NCT01039792	Trial of Methyl B12 on Behavioral and Metabolic Measures in Children With Autism	B12	Completed	Has Results	Autistic Disorder	Drug: Methyl B12|Dietary Supplement: Placebo	Clinical Global Impression-Improvement (CGI-I)	University of California, San Francisco|University of California, Davis|Arkansas Children's Hospital Research Institute	All	3 Years to 7 Years   (Child)	Phase 2|Phase 3	57	Other	Interventional	Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Triple (Participant, Care Provider, Investigator)|Primary Purpose: Treatment	Autism Speaks 3031	January 2010	October 2013	November 2013	December 25, 2009	February 24, 2017	February 24, 2017	UCSF, San Francisco, California, United States		https://ClinicalTrials.gov/show/NCT01039792
264	NCT00996931	Efficacy and Safety of Lenalidomide for Treatment of Autistic Spectrum Disorders		Completed	Has Results	Autism	Drug: lenalidomide	Change in TNF-alpha Levels|Change in Childhood Autism Rating Scale (CARS)Value From Baseline to 6 Weeks	Sutter Medical Foundation	Male	6 Years to 16 Years   (Child)	Phase 2	6	Other	Interventional	Allocation: N/A|Intervention Model: Single Group Assignment|Masking: None (Open Label)|Primary Purpose: Treatment	RV-ASD-CHEZ-0329	February 2009	December 2009	December 2009	October 16, 2009	May 29, 2013	May 29, 2013			https://ClinicalTrials.gov/show/NCT00996931
265	NCT03835117	Effect of a Wide Spectrum Nutritional Supplement on Mitochondrial Function in Children With Autism Spectrum Disorder		Active, not recruiting	No Results Available	Autism Spectrum Disorder	Drug: Wide-spectrum nutritional supplement|Other: Placebo	Change in mitochondrial activity in study patients|Change in the Childhood Autism Rating Scale (CARS) score|Change in the Clinical Global Impression scale (CGI) score|Change in the Children's Yale-Brown Obsessive Compulsive Scale modified for Autism Spectrum Disorder (CYBOCS-ASD) score|Change in the Aberrant Behavior Checklist (ABC) scores|Change in the Parent-rated Anxiety Scale for ASD (PRAS-ASD) score|Change in the Caregiver Strain Questionnaire (CGSQ) score|Change in the Vineland III Caregiver score|Evaluate intervention safety|Evaluate intervention effect on cellular regulatory pathways known to be implicated in ASD|Examine the change in attention to social stimuli|Examine the change in cognitive ability	Rossignol Medical Center|Southwest Autism Research & Resource Center	All	2 Years to 17 Years   (Child)	Phase 2	50	Other	Interventional	Allocation: Randomized|Intervention Model: Crossover Assignment|Masking: Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)|Primary Purpose: Treatment	MITO	February 1, 2020	December 2023	December 2023	February 8, 2019		September 28, 2022	Southwestern Research & Resource Center, Phoenix, Arizona, United States		https://ClinicalTrials.gov/show/NCT03835117
266	NCT03537950	Shifting Brain Excitation-Inhibition Balance in Autism Spectrum Disorder		Unknown status	No Results Available	Autism Spectrum Disorder	Drug: PLC|Drug: CBD|Drug: CBDV	Brain biochemistry response to pharmacological stimulation|Measurement of low frequency brain activity using resting state fMRI|Measurement of brain functional connectivity using resting state fMRI	King's College London	Male	18 Years to 50 Years   (Adult)	Not Applicable	38	Other	Interventional	Allocation: Randomized|Intervention Model: Crossover Assignment|Masking: Double (Participant, Investigator)|Primary Purpose: Basic Science	HR15-162744	August 22, 2016	February 16, 2017	April 27, 2019	May 25, 2018		May 25, 2018	King's College London, London, United Kingdom		https://ClinicalTrials.gov/show/NCT03537950
267	NCT03621189	The Impacts of Theta-burst Stimulation on Children and Adolescents With Autism Spectrum Disorder		Completed	Has Results	Autism Spectrum Disorder	Device: intermittent theta burst stimulation	Changes of Total Scores of Social Responsiveness Scale|Changes of Total Scores of Repetitive Behavior Scale-Revised|Changes in Accuracy of Frith-Happe Animation|Changes in Accuracy of Eyes Task|Functional MRI (Biological Motion Task)|Resting State fMRI|Diffusion Tensor Imaging	Chang Gung Memorial Hospital	All	7 Years to 18 Years   (Child, Adult)	Not Applicable	80	Other	Interventional	Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Double (Participant, Care Provider)|Primary Purpose: Treatment	201509413A0	November 2, 2016	April 17, 2019	April 17, 2019	August 8, 2018	August 27, 2021	August 27, 2021	Chang Gung Memorial Hospital, Taoyuan, Taiwan	"Study Protocol and Statistical Analysis Plan", https://ClinicalTrials.gov/ProvidedDocs/89/NCT03621189/Prot_SAP_000.pdf	https://ClinicalTrials.gov/show/NCT03621189
268	NCT03177525	Parent Training to Enhance Social Success for Children With Autism Spectrum Disorder		Completed	No Results Available	Autism Spectrum Disorder	Behavioral: Social SUCCESS|Behavioral: Wait List	Change in Visual Analog Scale Rating from Baseline to Week 12|Change in frequency of child initiations|Change in parent fidelity of implementation|Social Responsiveness Scale, Second Edition|Social Skills Improvement System	Stanford University	All	4 Years to 6 Years   (Child)	Not Applicable	22	Other	Interventional	Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Single (Outcomes Assessor)|Primary Purpose: Treatment	41867	August 9, 2017	November 12, 2021	November 23, 2021	June 6, 2017		December 10, 2021	Stanford University, Stanford, California, United States		https://ClinicalTrials.gov/show/NCT03177525
269	NCT04298164	Evaluating the Effectiveness of an Acceptance and Commitment Therapy-based Group Intervention for Parents of Children With a Diagnosis of Autism Spectrum Disorder		Completed	No Results Available	Autism Spectrum Disorder	Behavioral: START programme|Behavioral: Treatment as Usual	Change in psychological flexibility|Parenting stress|Mental wellbeing|Parent relationship	University College Dublin	All	18 Years and older   (Adult, Older Adult)	Not Applicable	56	Other	Interventional	Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Single (Outcomes Assessor)|Primary Purpose: Treatment	START1	November 25, 2019	March 30, 2021	March 30, 2021	March 6, 2020		May 3, 2021	HSE Donegal, Donegal, Ireland|HSE Longford/Westmeath, Longford, Ireland		https://ClinicalTrials.gov/show/NCT04298164
270	NCT03020277	Use of a Smartphone© Application to Study Autism Spectrum Disorders (ASD)	SMARTAUTISM	Unknown status	No Results Available	Autism Spectrum Disorders	Other: Ecological Momentary Assessment with Smartphone© Application	Filling rate of the application|child behavior with pairs|child sleep disorders|child eating disorders|child general behavior|Visual Analogic scale quotation about parental self esteem|Visual Analogic scale quotation about parental anxiety|Visual Analogic scale quotation about parental sleep|Visual Analogic scale quotation about parental mood|Visual Analogic scale quotation about parental stress|Visual Analogic scale quotation about parental pain|Visual Analogic scale quotation about parental professional life|Visual Analogic scale quotation about parental personal life|Visual Analogic scale quotation about parental social life|Visual Analogic scale quotation about parental support and resources|the duration of use|the time of use|rate of complete filling	Nantes University Hospital|Institut de Recherche en Santé Publique, France	All	3 Years to 16 Years   (Child)	Not Applicable	100	Other	Interventional	Allocation: N/A|Intervention Model: Single Group Assignment|Masking: None (Open Label)	RC16_0185	January 2017	January 2018	January 2018	January 13, 2017		January 13, 2017	Nantes CHU, France, Nantes, France|Angers CHU, Angers, France		https://ClinicalTrials.gov/show/NCT03020277
271	NCT03594552	Modulation of the Brain Excitatory/Inhibitory (E/I) Balance in Autism Spectrum Disorder (ASD)		Completed	No Results Available	Autism Spectrum Disorder	Drug: Arbaclofen_15|Drug: Arbaclofen_30|Drug: Placebo	Neurochemical response to GABAergic stimulation.|Functional connectivity measures using resting state functional magnetic resonance imaging.|Brain oscillations under sensory stimulation	King's College London	All	18 Years to 60 Years   (Adult)	Not Applicable	87	Other	Interventional	Allocation: Randomized|Intervention Model: Crossover Assignment|Masking: Double (Participant, Investigator)|Primary Purpose: Basic Science	HR16-17 4081	February 1, 2018	March 12, 2020	March 12, 2020	July 20, 2018		November 22, 2022	King's College London, London, United Kingdom		https://ClinicalTrials.gov/show/NCT03594552
272	NCT02280746	Gluten for Autism Spectrum Disorders		Unknown status	No Results Available	Autism Spectrum Disorders	Other: Gluten challenge	The extent of autistic symptoms based on the Autism Diagnostic Observation Schedule - 2 (ADOS-2)|The severity of symptoms based on a Social Communication Questionnaire (SCQ)|Presentation of gastrointestinal (GI) functional disorders (evaluation based on a parent-report form - Rome III diagnostic questionnaire|The extent of adaptive level of functioning on Vineland Adaptive Behavior Scale (VABS)|The extent of functioning on Autism Spectrum Rating Scale (ASRS)|Anthropometry|Intelligence test Leiter International Performance Scale	Medical University of Warsaw|Nutricia Foundation	All	3 Years to 6 Years   (Child)	Not Applicable	70	Other	Interventional	Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Treatment	RG 8/2013	September 2014	December 2015	December 2015	October 31, 2014		October 31, 2014	Medical University of Warsaw, Warsaw, Poland		https://ClinicalTrials.gov/show/NCT02280746
273	NCT01366885	Vitamin D to Prevent Autism in Newborn Siblings		Completed	Has Results	Autistic Disorder	Drug: Vitamin D3	Number of Children Who Developed Autism|Number of Mothers Who Developed Side Effects From Vitamin D	Oregon Health and Science University	Female	20 Years to 44 Years   (Adult)	Phase 2	20	Other	Interventional	Allocation: N/A|Intervention Model: Single Group Assignment|Masking: None (Open Label)|Primary Purpose: Prevention	OHSU-AS-11-1-11	February 2008	February 2016	February 2016	June 6, 2011	June 14, 2016	June 14, 2016	Evergreen Center, Oregon City, Oregon, United States		https://ClinicalTrials.gov/show/NCT01366885
274	NCT05391113	REward SYSTem in Autism Spectrum Disorder and Addictive Disorder	RESYSTAA	Not yet recruiting	No Results Available	Autism Spectrum Disorder	Diagnostic Test: MRI	Blood Oxygene Level Dependent (BOLD) MRI signal|Tolerance to an MRI examination for FAD with overweight or obesity|Regulation of sensory, an fMRI measurement of the BOLD physiological signal for sensory responses (sensory block) in terms of brain activation in patients	University Hospital, Tours|INSERM UMR-1253, Tours, France	All	18 Years and older   (Adult, Older Adult)	Not Applicable	54	Other	Interventional	Allocation: Non-Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Diagnostic	DR220016-RESYSTAA|2022-A01098-35|22-87	November 9, 2022	November 9, 2025	January 9, 2026	May 25, 2022		October 31, 2022	Center-Val de Loire Region Autism Resource Center, Tours, France|University Addictology Service, Liaison Team and Addictology Care, Tours, France|University Hospital, Medical Imaging Service, Tours, France		https://ClinicalTrials.gov/show/NCT05391113
275	NCT03003221	Improving Dental Care and Oral Health in Children With Autism Spectrum Disorder		Completed	No Results Available	Autism Spectrum Disorder	Behavioral: AIR-P Dental Toolkit|Behavioral: Parent Training	Frequency of tooth brushing at home|Child oral health according to standardized measures from visual exam|Child behavior during tooth brushing at home according to questionnaire|Observed child anxiety and behavior at the dental office visit as indexed by observer ratings on the Venham Anxiety and Behavior Scales (aggregate composite)|Dentist-reported child behavioral compliance during dental office visit as indexed by questionnaire|Completion of dental visit procedures according to questionnaire	University of California, Irvine|Massachusetts General Hospital|Nationwide Children's Hospital|California State University, Fullerton|Healthy Smiles for Kids of Orange County	All	3 Years to 13 Years   (Child)	Not Applicable	119	Other	Interventional	Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Single (Outcomes Assessor)|Primary Purpose: Treatment	2016-3043	December 2016	June 2019	June 2019	December 26, 2016		April 14, 2021	University of California Irvine, Irvine, California, United States|Nationwide Children's Hospital, Columbus, Ohio, United States		https://ClinicalTrials.gov/show/NCT03003221
276	NCT03195465	The Effect of High Antioxidant Cacao on Behaviors in Children With Autism Spectrum Disorder		Terminated	Has Results	Autism Spectrum Disorder	Dietary Supplement: Dark Chocolate	Aberrant Behavior Checklist 2nd Edition	Loma Linda University	All	4 Years to 18 Years   (Child, Adult)	Not Applicable	16	Other	Interventional	Allocation: N/A|Intervention Model: Single Group Assignment|Masking: None (Open Label)|Primary Purpose: Supportive Care	5170206	November 14, 2017	April 1, 2018	April 1, 2018	June 22, 2017	May 13, 2021	June 2, 2021	Loma Linda University Health, Loma Linda, California, United States	"Study Protocol and Statistical Analysis Plan", https://ClinicalTrials.gov/ProvidedDocs/65/NCT03195465/Prot_SAP_000.pdf	https://ClinicalTrials.gov/show/NCT03195465
277	NCT05271955	e-GOLIAH in Autistic Spectrum Disorders	e-GOLIAH-ECO	Not yet recruiting	No Results Available	Autism Spectrum Disorder	Device: "e-GOLIAH"|Behavioral: Usual care	Comparison of Incremental Cost-Utility Ratio (ICUR) at 12 months between the 2 groups|Comparison of Incremental Cost-utility ratio (ICUR) at 6 months between the 2 groups|Comparison of Incremental cost-effectiveness ratio (ICER) between the 2 groups|Comparison of the out of pocket payment for the consumption of treatments linked to the TSA between the 2 groups|Budget impact analysis (BIA) of e-GOLIAH in the management of children diagnosed with TSA for health insurance|Comparison of Quality of life between the 2 groups|Comparison of Adaptive symptoms between the 2 groups|Comparison of Autistic symptoms between the 2 groups|Comparison of Social interactions between the 2 groups|Comparison of Parental Stress between the 2 groups|The child's acceptability to the e-GOLIAH game at home	Assistance Publique - Hôpitaux de Paris|University Hospital, Montpellier	All	3 Years to 6 Years   (Child)	Not Applicable	150	Other	Interventional	Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Other	APHP200052|2020-A03389-30	June 15, 2022	December 15, 2024	December 15, 2024	March 9, 2022		April 25, 2022	Fondation Lenval - Hôpitaux Pédiatriques de Nice- CHU Lenval, Nice, Alpes Maritimes, France|Centre Hospitalier Universitaire de Strasbourg, Strasbourg, Bas-Rhin, France|Centre Hospitalier Universitaire de Toulouse, Toulouse, Haut-Garonne, France|Centre Hospitalier Universitaire de Montpellier, Montpellier, Hérault, France|Assistance Publique - Hôpitaux de Paris, Site de la Pitié-Salpêtrière, Paris, Ile De France, France|Centre Hospitalier Sainte-Anne / GHU Paris Psychiatrie et Neurosciences, Paris, Ile De France, France|Assistance Publique - Hôpitaux de Paris, Site de Necker, Paris, Ile De France, France|Centre Hospitalier de Versailles - André Mignot, Versailles, Ile De France, France|Centre Hospitalier Universitaire de Tours, Tours, Indre-et-Loire, France|Centre Hospitalier Universitaire de Nancy, Nancy, Meurthe-et-Moselle, France|Centre Hospitalier d'Amiens, Amiens, Somme, France|Centre Hospitalier Universitaire de Paris - Centre Hospitalier d'Henri Laborit, Poitiers, Vienne, France		https://ClinicalTrials.gov/show/NCT05271955
278	NCT03254264	Impact of Early Interventions on Neurocognitive Profile of Children With Autism Spectrum Disorder	IDEAEYE	Terminated	No Results Available	Autism Spectrum Disorder	Behavioral: Early Start Denver Model|Behavioral: 'as-usual' intervention	The primary outcome will be the time spent on biological motion in the task of visual preference stimuli.|Average proximity from pattern eyes norm in complex social scene task|Difference of saccadic latencies between overlap and gap condition|Time spent on unpredictable stimuli	Hôpital le Vinatier	All	15 Months to 36 Months   (Child)	Not Applicable	1	Other	Interventional	Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Single (Outcomes Assessor)|Primary Purpose: Treatment	2015-A00696-43	May 29, 2017	March 25, 2022	March 25, 2022	August 18, 2017		April 6, 2022	Hopital Vinatier, Bron, France		https://ClinicalTrials.gov/show/NCT03254264
279	NCT03156153	A Study of Bumetanide for the Treatment of Autism Spectrum Disorders		Completed	No Results Available	Autism Spectrum Disorder	Drug: Bumetanide|Drug: Placebo	Childhood Autism Rating Scale(CARS)|Clinical Global Impressions Scale (CGI)|Social Responsiveness Scale (SRS)|Autism Diagnostic Observation Schedule (ADOS)|Short Sensory Profile Report|Symbolic Play Test|Chinese Communicative Development Inventory	Xinhua Hospital, Shanghai Jiao Tong University School of Medicine|Shanghai Jiao Tong University School of Medicine	All	3 Years to 6 Years   (Child)	Phase 2	120	Other	Interventional	Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)|Primary Purpose: Treatment	XH-16-048	May 24, 2017	July 8, 2019	July 10, 2019	May 17, 2017		March 1, 2021	Xinhua Hospital, Shanghai, Shanghai, China		https://ClinicalTrials.gov/show/NCT03156153
280	NCT02445625	BCI (Brain Computer Interface) Intervention in Autism	BCIAUT	Completed	Has Results	Autism Spectrum Disorder	Device: BCI to train joint attention in ASD	JAAT_NoFace|JAAT_Face|ATEC - Autism Treatment Evaluation Checklist|VABS - Vineland Adaptive Behaviour Scale	University of Coimbra	All	16 Years to 30 Years   (Child, Adult)	Not Applicable	15	Other	Interventional	Allocation: N/A|Intervention Model: Single Group Assignment|Masking: None (Open Label)|Primary Purpose: Treatment	IBILI-VB-2015-01	February 2016	November 2017	September 2018	May 15, 2015	February 18, 2019	February 18, 2019		"Statistical Analysis Plan", https://ClinicalTrials.gov/ProvidedDocs/25/NCT02445625/SAP_000.pdf|"Study Protocol", https://ClinicalTrials.gov/ProvidedDocs/25/NCT02445625/Prot_001.pdf	https://ClinicalTrials.gov/show/NCT02445625
281	NCT03055533	Headsprout Reading Program in Children With Autism Spectrum Disorder and Reading Delay		Completed	No Results Available	Autism Spectrum Disorder	Behavioral: Headsprout reading program	Change in Kaufman Test of Educational Achievement score (KTEA-3)|Change in the Dynamic Indicators of Basic Early Literacy Skills (DIBELS) assessment score	University of Nebraska	All	7 Years to 18 Years   (Child, Adult)	Not Applicable	16	Other	Interventional	Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Supportive Care	278-18	October 1, 2018	March 3, 2022	June 24, 2022	February 16, 2017		June 28, 2022	University of Nebraska Medical Center, Omaha, Nebraska, United States		https://ClinicalTrials.gov/show/NCT03055533
282	NCT02358317	Motor Learning and Brain Changes in Autism		Completed	No Results Available	Autistic Disorder	Behavioral: Video Game Motor Training|Behavioral: Sedentary Video Game Training	Balance Time|Postural Stability|White matter microstructure of the Corticospinal tract|Adaptive Daily Living Skills|Social Responsiveness	University of Wisconsin, Madison|Brain & Behavior Research Foundation	All	13 Years to 17 Years   (Child)	Not Applicable	62	Other	Interventional	Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Supportive Care	2014-1499	March 2015	May 2019	May 24, 2019	February 6, 2015		June 11, 2019	Waisman Center, University of Wisconsin-Madison, Madison, Wisconsin, United States		https://ClinicalTrials.gov/show/NCT02358317
283	NCT02493699	Martial Arts Therapy in Autism Spectrum Disorders		Completed	No Results Available	Autism Spectrum Disorders	Other: physical exercise- based intervention (Karate techniques training)	Raw score of communication subscale of Gilliam Autism Rating Scale-Second Edition (GARS-2) as the measure of communication deficit	University of Isfahan	All	5 Years to 16 Years   (Child)	Not Applicable	30	Other	Interventional	Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Treatment	14/02/2011	May 2011	August 2011	September 2011	July 9, 2015		July 9, 2015			https://ClinicalTrials.gov/show/NCT02493699
284	NCT02382172	Social Cognition and Interaction Training for Autism	SCIT-A	Completed	No Results Available	Autism|Social Behavior	Behavioral: Social Cognition and Interaction Training for Autism (SCIT-A)|Other: Treatment as Usual (TAU)	Change in visual attention from baseline as measured by the Tobii Eye Tracking Paradigm|Change in patient social skills as measured by the Social Responsiveness Scale (SRS)|Change in patient social cognition as measured by the Hinting Task|Change in patient social cognition as measured by the Penn Emotion Recognition Task-40 (ER40)	University of North Carolina, Chapel Hill|North Carolina Translational and Clinical Sciences Institute|Carolina Institute for Developmental Disabilities	All	10 Years to 69 Years   (Child, Adult, Older Adult)	Not Applicable	44	Other	Interventional	Allocation: Non-Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Other	14-2804	January 2015	January 2017	January 2017	March 6, 2015		April 25, 2017	Carolina Institute for Developmental Disabilities, Carrboro, North Carolina, United States		https://ClinicalTrials.gov/show/NCT02382172
285	NCT02551380	Folinic Acid in Children With Autism Spectrum Disorders	EFFET	Unknown status	No Results Available	Autism Spectrum Disorder	Drug: FOLINORAL|Other: Placebo	Evaluation of severity of autistic symptoms with standardized scale ADOS (Autism Diagnosis Observation Scale)|Evaluation of the reduction of autistic symptom perceived by parents with a heteroevaluation scale : SRS (social responsiveness scale)|evaluate the constancy of auto antibodies anti-FRα	Central Hospital, Nancy, France	All	3 Years to 10 Years   (Child)	Phase 2	40	Other	Interventional	Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Single (Participant)|Primary Purpose: Treatment	2015-000955-25	October 2015	January 2018	January 2018	September 16, 2015		April 7, 2017	CHU Nancy-Hopital Brabois Enfants, Vandoeuvre les Nancy, France		https://ClinicalTrials.gov/show/NCT02551380
286	NCT02488226	Gaze Modification Strategies for Toddlers With Autism Spectrum Disorder	ASD	Completed	No Results Available	Autism Spectrum Disorder	Other: Gaze-contingent eye-tracking technology	Gaze behavior during eye tracking tasks measured by standard eye-tracking analysis protocols|Behavior during real-world interactions measured by coding of video recordings	Yale University	All	18 Months to 60 Months   (Child)	Not Applicable	81	Other	Interventional	Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)|Primary Purpose: Other	1306012246	June 2015	October 2016	December 2016	July 2, 2015		March 6, 2020	Yale Child Study Center, New Haven, Connecticut, United States		https://ClinicalTrials.gov/show/NCT02488226
287	NCT02733120	Metabolic Processes in Adults and Adolescents With Autism Spectrum Disorder	ASD	Unknown status	No Results Available	Autism Spectrum Disorder	Other: stable isotope infusion	Tryptophan turnover|leucine turnover|Whole body myofibrillar protein breakdown rate (reflecting muscle protein breakdown)|glutathione turnover|hydroxyproline breakdown (reflecting collagen breakdown)|glutamate turnover|taurine turnover|urea production|Group differences in state of mood as measured by the Hospital Anxiety and Depression Scale (HADS),|Group differences in learning and memory as measured by Auditory Verbal Learning Test (AVLT)|Group differences in learning and memory as measured by Controlled Oral Word Association Test (COWAT),|Group differences in learning and memory as measured by Digit Span|Group differences in overall cognitive abilities as measured by Montreal Cognitive Assessment (MoCA)|Group differences in attention and executive functions as measured by Trail Making Test (TMT),|Group differences in attention and executive functions as measured by Stroop Color-Word Test (SCWT),|Adolescent/Adult Sensory Profile|Group differences in attention and executive functions as measured by Brief-A|Group differences in attention and executive functions as measured by PASAT	Texas A&M University	All	16 Years and older   (Child, Adult, Older Adult)	Not Applicable	40	Other	Interventional	Allocation: Non-Randomized|Intervention Model: Single Group Assignment|Masking: None (Open Label)|Primary Purpose: Supportive Care	2015-0542	October 2015	September 2020	September 2020	April 11, 2016		January 16, 2019	Texas A&M University-CTRAL, College Station, Texas, United States		https://ClinicalTrials.gov/show/NCT02733120
288	NCT00789932	Cognitive Behavioral Therapy for Core Autism Symptoms in School-Aged Children: A Randomized, Controlled Trial	BIACA-2	Completed	No Results Available	Autism Spectrum Disorder	Behavioral: cognitive behavioral therapy|Behavioral: Usual community care	ADIS-C/P (Anxiety Disorder Interview Schedule for Children and Parents)|Behavioral observations of social responsiveness	University of California, Los Angeles|Organization for Autism Research	All	7 Years to 11 Years   (Child)	Phase 1|Phase 2	20	Other	Interventional	Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Single (Outcomes Assessor)|Primary Purpose: Treatment	OAR-UCLA-2009	September 2008	December 2011	December 2011	November 13, 2008		February 5, 2013	UCLA, Los Angeles, California, United States		https://ClinicalTrials.gov/show/NCT00789932
289	NCT05067361	Effectiveness of Aerobic Exercises on the Autistic Children		Completed	No Results Available	Autism Spectrum Disorder	Procedure: Aerobic Exercise|Procedure: Ball Exercises	Repetitive behavior scale revised (RBS-R)|Jebsen Hand Function Test (JHFT)	University of Faisalabad	All	6 Years to 20 Years   (Child, Adult)	Not Applicable	38	Other	Interventional	Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Single (Participant)|Primary Purpose: Supportive Care	TUF/DR/MSPP/173	March 3, 2020	August 8, 2020	October 26, 2020	October 5, 2021		October 5, 2021	University of Faisalabad, Faisalābad, Punjab, Pakistan		https://ClinicalTrials.gov/show/NCT05067361
290	NCT02747056	Study of the Personal Identity in Adults With Autism Spectrum Disorder Without Intellectual Deficiency	TSASDI	Completed	No Results Available	Autism Spectrum Disorders	Other: clinical, psychological and neuropsychological assessment|Other: Autobiographical memories Assessment|Other: Autobiographical memories assessment characteristics	The number of details in the memory (A)/The specificity of the memory (B)|Study A and B: Autistic symptoms questionnaire 1|Study A and B: Autistic symptoms questionnaire 2|Study A and B: Autistic symptoms questionnaire 3|Study A and B:Executives functions, test 1|Study Aand B:Executives functions test 2|Study A and B:Executives functions test 3|Study A and B: The self concept, questionnaire 1|Study A and B: The self concept, questionnaire 2|Study A and B: The self concept, questionnaire 3|Study A: the number of remember/ know/ guess responses, the perspective in recollection and the subjective temporal distance in the memory|Study B:The importance for the self of the memory test1|Study B:The importance for the self of the memory test 2|Study B:The importance for the self of the memory test 3|Study B:The importance for the self of the memory test 4	University Hospital, Strasbourg, France	All	18 Years to 65 Years   (Adult, Older Adult)	Not Applicable	102	Other	Interventional	Allocation: Non-Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Basic Science	6282	June 2016	August 2019	August 2019	April 21, 2016		August 21, 2019	Hôpitaux universitaires de Strasbourg, Strasbourg, France		https://ClinicalTrials.gov/show/NCT02747056
291	NCT01308749	A Study of Oxytocin in Children and Adolescents With Autistic Disorder	Oxytocin	Completed	Has Results	Autism	Drug: Oxytocin|Drug: Placebo	Number of Participants Who Could Tolerate Twice Daily Oxytocin|Change in Mean Plasma Oxytocin Level During Period 1 - Double Blind Phase|Change in Mean Weight|Change in Mean Total Social Social Responsiveness Scale (SRS) T-score|Change in Mean Autism Diagnostic Observation Schedule (ADOS) Total Score|Change in Mean Aberrant Behavior Checklist (ABC)-Social Withdrawal Subscale Score Over Both Periods|Change in Mean Pervasive Developmental Disorder Behavior Inventory - Screening Version (PDDBI-SV) Total Score Over Both Periods|Change in Mean Systolic Blood Pressure During Period 1|Mean Change in Prolactin Levels Over Period 1|Mean Change in Temperature During Period 1	University of North Carolina, Chapel Hill|Autism Speaks	All	3 Years to 17 Years   (Child)	Phase 2	25	Other	Interventional	Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)|Primary Purpose: Treatment	11-0493	March 2011	April 2013	April 2013	March 4, 2011	July 17, 2017	July 17, 2017	University of North Carolina Chapel Hill, Chapel Hill, North Carolina, United States		https://ClinicalTrials.gov/show/NCT01308749
292	NCT02608333	Efficiency of Early Intervention for Autism Spectrum Disorder	IDEA	Completed	No Results Available	Autism Spectrum Disorder	Behavioral: ESDM-12|Behavioral: control group	Developmental quotient at the Mullen Scale of Early Learning|Severity of autism symptoms is measured with ADOS 2|Adaptive behavior score is measured by the composite score of Vineland adaptative behavior scale 2|Productive language level assessed with a standardized French productive language developmental scale|Costs associated with interventions|Developement of communication and symbolic behavior|Parent child naturalistic interaction during play|Sensorial profil|Change at the Brief Observation of Social Communication Change (BOSCC)	Hôpital le Vinatier|University Hospital, Strasbourg, France|Versailles Hospital|Centre hospitalier Saint Jean de Dieu - ARHM|Hospices Civils de Lyon	All	15 Months to 36 Months   (Child)	Not Applicable	180	Other	Interventional	Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Single (Outcomes Assessor)|Primary Purpose: Treatment	2015-A00124-45	September 9, 2015	June 30, 2021	June 30, 2021	November 18, 2015		July 9, 2021	Hopital Vinatier, Bron, Aura, France		https://ClinicalTrials.gov/show/NCT02608333
293	NCT02487082	Pilot Study of Sleep Therapy and Biomarkers in Children With Autism Spectrum Disorders		Terminated	No Results Available	Autism Spectrum Disorder	Drug: Melatonin and Donepezil|Other: Placebo	Lethargy/Social Withdrawal|Stereotypic Behavior|Sleep quality|Clinician Global improvement|Parent Global improvement	Stony Brook University	All	4 Years to 17 Years   (Child)	Phase 2	12	Other	Interventional	Allocation: Randomized|Intervention Model: Crossover Assignment|Masking: Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)|Primary Purpose: Treatment	65708	June 2015	December 31, 2020	January 29, 2021	July 1, 2015		April 28, 2021	Stony Brook University, Stony Brook, New York, United States		https://ClinicalTrials.gov/show/NCT02487082
294	NCT02439671	Transition Support Program for Young Adults With Autism Spectrum Disorders		Completed	No Results Available	Autism Spectrum Disorder	Behavioral: McGill Transition Support Program	Change in Social problem-solving task (Channon & Crawford, 2010)|Change in Arc's Self-Determination Scale (SDS; Wehmeyer & Kelchner, 1995)|Change in Quality of Life Questionnaire (Shalock & Keith, 1993)|Curriculum-specific workbook questions|Participant Program Evaluation Survey (Flanagan & Nadig, 2012)|Parent Program Evaluation Survey (Flanagan & Nadig, 2012)|Questionnaire on vocational, educational and living situation outcomes|Communication task (Nadig, Vivanti, & Ozonoff, 2009)	McGill University	All	18 Years to 30 Years   (Adult)	Not Applicable	34	Other	Interventional	Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Single (Outcomes Assessor)|Primary Purpose: Treatment	Max Bell / McGill x-209094	May 2012	July 2015	July 2016	May 12, 2015		May 9, 2017	McGill University, Montreal, Quebec, Canada		https://ClinicalTrials.gov/show/NCT02439671
295	NCT03805828	Effectiveness of Educational Program on Parenting Stress and Coping Mechanism Among Parents of Children With Autism Spectrum Disorder in Amman, Jordan		Unknown status	No Results Available	Autism Spectrum Disorder	Other: Educational program on parenting stress and coping mechanism	parenting stress|coping mechanism	Universiti Putra Malaysia	All	20 Years and older   (Adult, Older Adult)	Not Applicable	200	Other	Interventional	Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Single (Participant)|Primary Purpose: Treatment	University Putra Malaysia	March 1, 2019	August 1, 2019	August 1, 2019	January 16, 2019		January 16, 2019	Centers for the treatment of Autistic Disorder, Amman, Jordan|Ministry of Social Development, Amman, Jordan		https://ClinicalTrials.gov/show/NCT03805828
296	NCT05171244	Use of Immersive Virtual Reality to Train the Multisensory Processing Capacities of Children Aged 8 to 16 Years-old With an Autism Spectrum Disorder: Single-center Randomized Pilot Study in Parallel Groups - SEVIRE. (Sensory Virtual Reality)	SEVIRE	Recruiting	No Results Available	Autism Spectrum Disorder	Behavioral: virtual reality training|Behavioral: usual care	Vineland Adaptive Behavior Scales II (VABS II) score|Measures of autistic behaviour by Autism Behavior Rating Scale (ECA2)|Measures of autistic behaviour by Autism Behavior Rating Scale for Parents (ECA2P)|Measures of autistic behaviour by Dunn sensory profile|Measures of autistic behaviour by Vineland Adaptive Behavior Scales II (VABS II)|Cognitive rigidity measure|Cognitive rigidity measure by rating scale of repeated en restricted behaviours (EC2R)	University Hospital, Tours	All	8 Years to 16 Years   (Child)	Not Applicable	50	Other	Interventional	Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Other	DR200078	March 3, 2022	July 2024	November 2024	December 28, 2021		May 25, 2022	Le Centre universitaire de pédopsychiatrie, Tours, France|Pedopsychiatry, University Hospital, Tours, Tours, France		https://ClinicalTrials.gov/show/NCT05171244
297	NCT02360449	Social Motivation Intervention for Children With Autism Spectrum Disorder: Improving Peer Initiation		Completed	No Results Available	Autism Spectrum Disorder	Behavioral: Social Initiation Motivation Intervention	Initiation Frequency (observational rating of the frequency of child initiations to peers measured from video recording during free play sessions)	Stanford University	All	4 Years to 6 Years   (Child)	Not Applicable	44	Other	Interventional	Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Single (Outcomes Assessor)|Primary Purpose: Treatment	31420	January 2015	July 19, 2017	November 5, 2020	February 10, 2015		January 8, 2021	Stanford University, Stanford, California, United States		https://ClinicalTrials.gov/show/NCT02360449
298	NCT02496819	Metacognitive Self-regulated Learning and Sensory Integrative Approaches for Children With Autism Spectrum Disorders		Completed	No Results Available	Autism Spectrum Disorder	Other: Meta-cognitive self-regulated learning intervention|Other: Sensory integration intervention|Other: Activity-based intervention	Adaptive behaviour on the Vineland Adaptive Behaviour Scales - change from baseline after the intervention|Adaptive behaviour on the Vineland Adaptive Behaviour Scales - change from baseline at one month after the intervention completed|Executive function behaviours on the Behaviour Rating Inventory of Executive Function - change from baseline after the intervention|Executive function behaviours on the Behaviour Rating Inventory of Executive Function - change from baseline at one month after the intervention completed|School-related task performance on the School Function Assessment - change from baseline after the intervention|School-related task performance on the School Function Assessment - change from baseline at one month after the intervention completed|Social skills on the Walker Mc-Connell scale - change from baseline after the intervention|Social skills on the Walker Mc-Connell scale - change from baseline at one month after the intervention completed|Sensory processing difficulties on the Sensory Processing Measures - change from baseline after the intervention|Sensory processing difficulties on the Sensory Processing Measures - change from baseline at one month after the intervention completed|Sensory processing patterns and effects on functional performance on the Sensory Profile - change from baseline after the intervention|Sensory processing patterns and effects on functional performance on the Sensory Profile - change from baseline at one month after the intervention completed	University of Western Sydney|National University of Malaysia	All	6 Years to 12 Years   (Child)	Not Applicable	60	Other	Interventional	Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Triple (Participant, Care Provider, Outcomes Assessor)|Primary Purpose: Treatment	SR-Autism	June 2015	December 2016	March 2017	July 14, 2015		November 6, 2017	National University of Malaysia, Bangi, Selango, Malaysia		https://ClinicalTrials.gov/show/NCT02496819
299	NCT03708614	A Study Looking at How Well Children With Autism Spectrum Disorder on Medications Like Having More Protein		Unknown status	No Results Available	Autism Spectrum Disorder	Other: Controlled energy diet with elevated protein intake	Caloric and protein intake|Pre- (at time of study enrolment) and post-intervention anthropometric measurements|Post-intervention interview with participants and family|Study feasibility (designs, methods, processes)	Holland Bloorview Kids Rehabilitation Hospital	All	6 Years to 17 Years   (Child)	Not Applicable	10	Other	Interventional	Allocation: N/A|Intervention Model: Single Group Assignment|Masking: None (Open Label)|Primary Purpose: Supportive Care	REB 18-781	December 7, 2018	April 2020	June 2020	October 17, 2018		August 26, 2019	Holland Bloorview Kids Rehabilitation Hospital, Toronto, Ontario, Canada		https://ClinicalTrials.gov/show/NCT03708614
300	NCT02311751	rTMS for Executive Function Deficits in Autism Spectrum Disorder		Completed	No Results Available	Autism Spectrum Disorder	Device: Repetitive Transcranial Magnetic Stimulation	Change in accuracy on the Cambridge Neuropsychological Test Automated Battery (CANTAB) Spatial Working Memory Task|Change in scores on Behaviour Rating Inventory of Executive Functioning (A) (BRIEF) (A)	Centre for Addiction and Mental Health|Academic Health Science Centres	All	16 Years to 35 Years   (Child, Adult)	Not Applicable	40	Other	Interventional	Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Triple (Participant, Investigator, Outcomes Assessor)|Primary Purpose: Treatment	119/2013	October 2014	May 4, 2018	May 4, 2018	December 8, 2014		March 6, 2019	Centre for Addictions and Mental Health, Toronto, Ontario, Canada		https://ClinicalTrials.gov/show/NCT02311751
301	NCT05236803	Better Understand Motor Deficits Associated With Autism Spectrum Disorders: Development of an Assessment Protocol	MOTRICITE TSA	Recruiting	No Results Available	Autism Spectrum Disorder	Behavioral: Testing of general motor skills, fine motor skills and occulomotricity|Behavioral: Questionnaires	Measurement performance of fine motor skills (graphics, pointing task)|Measurement performance of general motor skills with biomechanical analysis|Measurement of oculomotricity with eye-tracking system (visual orientation and control)|Motor performance : success, error rate (%)|Motor performance : task duration (ms), reaction time (ms) and latency (ms)|IQ as assessed using WISC IV|Score of socio-communicative skills as assessed using Social Responsiveness Scale|ADHD as assessed using Conners-3|Developmental Coordination Disorder as assessed using Developmental Coordination Disorder Questionnaire|ASD Clinical Assessment as assessed using Childhood Autism Rating Scale	Centre Hospitalier Charles Perrens, Bordeaux	All	6 Years to 11 Years   (Child)	Not Applicable	110	Other	Interventional	Allocation: N/A|Intervention Model: Single Group Assignment|Masking: None (Open Label)|Primary Purpose: Other	2021-A02426-35	February 7, 2022	January 31, 2024	March 31, 2024	February 11, 2022		April 6, 2022	Centre Hospitalier Charles Perrens, Bordeaux, France|Centre Hospitalier La Rochelle Re Aunis, La Rochelle, France|CHU de LIMOGES, Limoges, France|Centre Hospitalier Henri Laborit, Poitiers, France		https://ClinicalTrials.gov/show/NCT05236803
302	NCT02428452	Social ABCs for Toddlers With Signs of Autism Spectrum Disorder: Trial of a Parent-Mediated Intervention		Completed	No Results Available	Autism Spectrum Disorder	Behavioral: Social ABCs parent-mediated intervention program	Change from Baseline in Child Vocal Responsivity at 12 and 24 weeks|Change from Baseline in Child Vocal Initiations at 12 and 24 weeks|Change from Baseline in Parent-Child Shared Smiling at 12 and 24 weeks|Change from Baseline in Parent Fidelity of Implementation at 12 and 24 weeks	Jessica Brian|IWK Health Centre|Holland Bloorview Kids Rehabilitation Hospital	All	12 Months to 30 Months   (Child)	Not Applicable	63	Other	Interventional	Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Treatment	11-192|1005465	May 2011	March 2015	March 2015	April 28, 2015		July 13, 2017	IWK Health Centre, Halifax, Nova Scotia, Canada|Holland Bloorview Kids Rehabilitation Hospital, Toronto, Ontario, Canada		https://ClinicalTrials.gov/show/NCT02428452
303	NCT02879110	A 12-weeks Study to Evaluate Sulforaphane in Treatment of Autism Spectrum Disorder		Completed	No Results Available	Autism Spectrum Disorder	Dietary Supplement: Sulforaphane|Other: Placebo	The change of social impairments of children with autism spectrum disorder|The change of rigid interests and behaviors of children with autism spectrum disorder|The change of clinical symptoms of children with autism spectrum|The change of other behavioral problems of children with autism spectrum|The change of adaptive behaviors of children with autism spectrum|The change of clinical general impression of children with autism spectrum|The change of heart rate as measured by stopwatch|The change of weight as measured by weighing-machine|The change of height as measured by Height measurement tools|The change of blood routine test as tested by clinical laboratory|The change of fasting blood-glucose as tested by clinical laboratory|The change of blood lipid as tested by clinical laboratory|The change of liver function as tested by clinical laboratory|The change of kidney function as tested by clinical laboratory|The change of thyroid function as tested by clinical laboratory|The change of HBV test as tested by clinical laboratory|The change of helicobacter pylori test as tested by clinical laboratory|The change of urine routine test as tested by clinical laboratory|Number of participants with treatment-related adverse events as assessed by Systematic Assessment for Treatment Emergent Effects	Central South University|Davis family funding|University of California|University of Illinois at Chicago	All	3 Years to 15 Years   (Child)	Not Applicable	110	Other	Interventional	Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)|Primary Purpose: Treatment	ASD201512	August 2016	July 2019	July 2019	August 25, 2016		July 30, 2019	Guangzhou Huiai Hospital, Guangzhou, Guangdong, China|The second Xiangya hospital of central south university, Changsha, Hunan, China		https://ClinicalTrials.gov/show/NCT02879110
304	NCT01695200	Omega-3 Fatty Acids in Autism Spectrum Disorders		Completed	No Results Available	Autism Spectrum Disorders	Dietary Supplement: Omega-3 fatty acids	Change from baseline in parent rated Social Responsiveness Scale (SRS) scores during treatment|Change from baseline in parent rated Child Behavior Checklist (CBCL) scores during treatment|Change from baseline in teacher rated Teacher Report (TRF) scores during treatment|Change from baseline in teacher rated Social Responsiveness Scale (SRS) scores during treatment|Change from baseline in clinician rated Clinical Global Impression (Severity and Improvements) scores during treatment|Change from baseline in clinician rated Global Assessment of Functioning (GAF) scores during treatment|Children's Yale-Brown Obsessive Compulsive Scale modified for Pervasive Developmental Disorders (CYBOCS-PDD)	National Healthcare Group, Singapore	All	5 Years to 18 Years   (Child, Adult)	Phase 4	60	Other	Interventional	Allocation: N/A|Intervention Model: Single Group Assignment|Masking: None (Open Label)|Primary Purpose: Treatment	DSRB: 2011/00028	September 2011	January 2013	January 2013	September 27, 2012		May 1, 2013	Institute of Mental Health, Singapore, Singapore		https://ClinicalTrials.gov/show/NCT01695200
305	NCT02160691	Examining the Efficacy of the Anxiety Meter for Recognition and Management of Anxiety Signs in Autism Spectrum Disorder		Completed	No Results Available	Autism Spectrum Disorder	Device: Anxiety Meter	Proportion of responders|Change in heart rate|Change in self-reported anxiety level	Holland Bloorview Kids Rehabilitation Hospital	All	8 Years to 18 Years   (Child, Adult)	Not Applicable	41	Other	Interventional	Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Treatment	ANXMT_RCT1	October 2015	August 2020	November 2021	June 11, 2014		January 19, 2022	Holland Bloorview Kids Rehabilitation Hospital, Toronto, Ontario, Canada		https://ClinicalTrials.gov/show/NCT02160691
306	NCT05013164	Role of Folinic Acid in Improving the Adaptive Skills and Language Impairment in Children With Autism Spectrum Disorder		Completed	No Results Available	Autism Spectrum Disorder	Drug: Folinic Acid	To determine the role of folinic acid in improving the speech and adaptive skills among children with autism spectrum disorders|To dertermine improvement of stereotype movements and hyperactivity in children with autism spectrum disorders	Nishtar Medical University	All	3 Years to 14 Years   (Child)	Phase 2	44	Other	Interventional	Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Treatment	ICHMultan	October 1, 2020	March 30, 2021	March 30, 2021	August 19, 2021		August 24, 2021	Children's Hospital and Institute of Child Health, Multan, Punjab, Pakistan		https://ClinicalTrials.gov/show/NCT05013164
307	NCT02081027	Pilot Study of Riluzole for Drug-Refractory Irritability in Autism Spectrum Disorders		Completed	No Results Available	Autism Spectrum Disorders	Drug: Riluzole|Other: placebo	Clinical Global Impression-Improvement|Aberrant Behavior Checklist- Irritability	Children's Hospital Medical Center, Cincinnati	All	12 Years to 25 Years   (Child, Adult)	Early Phase 1	8	Other	Interventional	Allocation: Randomized|Intervention Model: Crossover Assignment|Masking: Triple (Participant, Care Provider, Investigator)|Primary Purpose: Basic Science	CIN001- Riluzole in Autism	September 19, 2013	April 2015	May 2015	March 7, 2014		January 14, 2021	Cincinnati Children's Hospital Medical Center, Cincinnati, Ohio, United States		https://ClinicalTrials.gov/show/NCT02081027
308	NCT03177590	Recording Facial and Vocal Emotional Productions in Children With Autism as Part of the JEMImE Project		Completed	No Results Available	Autism|Pervasive Developmental Disorder	Other: Recordings of facial and vocal emotional productions	Record facial and vocal emotional productions of children of an imitation situation|Record facial and vocal emotional productions of children in a situation of mime on written request|Record facial and vocal emotional productions of children in a situation of mime on presentation of an image	Fondation Lenval	All	6 Years to 12 Years   (Child)	Not Applicable	35	Other	Interventional	Allocation: N/A|Intervention Model: Single Group Assignment|Masking: None (Open Label)|Primary Purpose: Other	15-HPNCL-02	May 10, 2016	July 10, 2017	July 10, 2017	June 6, 2017		July 31, 2018	Fondation Lenval Hôpitaux Pédiatriques de Nice CHU-LENVAL, Nice, France|Hôpital de La Salpétrière - APHP, Paris, France		https://ClinicalTrials.gov/show/NCT03177590
309	NCT00572741	Treating Oxidative Stress and the Metabolic Pathology of Autism		Completed	No Results Available	Autistic Disorder	Dietary Supplement: B12|Dietary Supplement: Placebo|Dietary Supplement: folate|Dietary Supplement: B complex|Dietary Supplement: vitamin C|Dietary Supplement: cod liver oil|Dietary Supplement: Mineral complex|Dietary Supplement: carnitine	Behavioral test scores|Plasma metabolic profile	Arkansas Children's Hospital Research Institute	All	3 Years to 7 Years   (Child)	Not Applicable	39	Other	Interventional	Allocation: Randomized|Intervention Model: Crossover Assignment|Masking: Triple (Participant, Care Provider, Investigator)|Primary Purpose: Treatment	59538	June 2008	April 2016	April 2016	December 13, 2007		May 5, 2016	Arkansas Children's Hospital Research Institute, Little Rock, Arkansas, United States		https://ClinicalTrials.gov/show/NCT00572741
310	NCT00468130	Efficacy of Aripiprazole Versus Placebo in the Reduction of Aggressive and Aberrant Behavior in Autistic Children	Abilify	Completed	Has Results	Autism	Drug: Aripiprazole|Drug: Placebos	Clinical Global Impression Improvement (CGI-AD)|Aberrant Behavior Checklist	University of Medicine and Dentistry of New Jersey|Rutgers, The State University of New Jersey	All	5 Years to 17 Years   (Child)	Not Applicable	13	Other	Interventional	Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)|Primary Purpose: Treatment	0220055441	May 2006	November 2009	November 2009	May 2, 2007	January 14, 2022	January 14, 2022	Department of Child and Adolescent Psychiatry, University Behavioral Health Care Building, Piscataway, New Jersey, United States		https://ClinicalTrials.gov/show/NCT00468130
311	NCT01612897	Study of the Effectiveness of a Computer Decision Support System to Improve Physicians' Screening for Autism	CAAC	Completed	No Results Available	Healthy Children Undergoing Routine Care|Children With Autism	Other: Computer based care reminders	Structure autism screening instrument administered|Are appropriate diagnostic studies conducted among children who screen positive for autism.	Indiana University	All	17 Months to 4 Years   (Child)	Not Applicable	368	Other	Interventional	Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Single (Outcomes Assessor)|Primary Purpose: Screening	R01HS018453	September 2009	July 2014	July 2014	June 6, 2012		March 24, 2015	Wishard (Eskenazi) Healthcare clinics, Indianapolis, Indiana, United States		https://ClinicalTrials.gov/show/NCT01612897
312	NCT01966679	Targeting GABA-A for the Treatment of Social Disability in Young Adults With Autism Spectrum Disorders: A Phase II Proof of Mechanism Trial	FAST-AS	Completed	No Results Available	Autism Spectrum Disorder	Drug: AZD7325|Drug: Placebo	EEG	University of California, Los Angeles	All	18 Years to 35 Years   (Adult)	Phase 2	40	Other	Interventional	Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)|Primary Purpose: Treatment	HHS-NIH-DA-12-241	October 2013	July 2015	July 2015	October 21, 2013		October 22, 2015	UCLA, Los Angeles, California, United States|Emory University, Atlanta, Georgia, United States|Seattle Children's Research Institute, Seattle, Washington, United States		https://ClinicalTrials.gov/show/NCT01966679
313	NCT00263367	Effect of Hyperbaric Therapy on Markers of Oxidative Stress in Children With Autism		Completed	No Results Available	Autism|Oxidative Stress	Other: Hyperbaric Oxygen	glutathione	The International Child Development Resource Center	All	5 Years to 12 Years   (Child)	Not Applicable	10	Other	Interventional	Allocation: Non-Randomized|Intervention Model: Single Group Assignment|Masking: None (Open Label)|Primary Purpose: Treatment	ICDRC-22.2005	October 2005	January 2006	February 2006	December 8, 2005		June 22, 2011	ICDRC, Melbourne, Florida, United States		https://ClinicalTrials.gov/show/NCT00263367
314	NCT01914939	A Randomized, Controlled Trial of Intranasal Oxytocin as an Adjunct to Behavioral Therapy for Autism Spectrum Disorder		Completed	No Results Available	Autism Spectrum Disorders	Drug: Oxytocin|Behavioral: Social Skills focused CBT|Behavioral: Stress management/relaxation training|Drug: placebo drug	Changes in the Autism Diagnostic Observation Schedule (ADOS)|Clinical Global Impression Scale (CGI)|Social Responsiveness Scale (SRS)|Reading the Mind in the Eyes Test (RMET)|Social Ball Tossing Task	Massachusetts General Hospital|Massachusetts Institute of Technology	Male	18 Years to 40 Years   (Adult)	Phase 2	92	Other	Interventional	Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)|Primary Purpose: Treatment	W81XWH-12-1-0543|Clinical Trial Award	April 2014	November 2017	November 2017	August 2, 2013		January 27, 2020	Massachusetts General Hospital, Boston, Massachusetts, United States|Massachusetts Institute of Technology Martinos Imaging Center, Cambridge, Massachusetts, United States		https://ClinicalTrials.gov/show/NCT01914939
315	NCT01501058	Parent-supported Social Skills Training for Teens With Autism Spectrum Disorders (PEERS-K)		Unknown status	No Results Available	Autism Spectrum Disorders	Behavioral: parent-assisted social skills training program for adolescents with autism spectrum disorder|Behavioral: Delayed intervention	Change from baseline in Test of Adolescent Social Skills Knowledge(TASSK) at 3month|Change from baseline in Social Skills Rating Scale (SSRS) at 3 month|Change from baseline in Friendship Qualities Scale (FQS) at 3month	Seoul National University Hospital	All	11 Years to 18 Years   (Child, Adult)	Not Applicable	40	Other	Interventional	Allocation: Randomized|Intervention Model: Crossover Assignment|Masking: None (Open Label)|Primary Purpose: Treatment	PEERSK2011	December 2011	June 2012	September 2013	December 29, 2011		May 29, 2013	Seoul National University Bundang Hospital, Seongnam, Korea, Republic of		https://ClinicalTrials.gov/show/NCT01501058
316	NCT05458466	The Effect of Pilates on Muscle Strength, Balance Performance, Gross Motor Skills, Social Skills in Children With ASD		Completed	No Results Available	Autism	Other: Pilates training	Muscle Strength|Balance|Gross Motor Skills|Social Skills	Aydin Adnan Menderes University	All	7 Years to 12 Years   (Child)	Not Applicable	21	Other	Interventional	Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Single (Participant)|Primary Purpose: Treatment	Alinazan	March 11, 2021	September 13, 2021	September 13, 2021	July 14, 2022		July 14, 2022	Aydin Efeler Autism Sports Center, Aydin, Turkey		https://ClinicalTrials.gov/show/NCT05458466
317	NCT03183674	Oxytocin in Spectrum Autism Disorders	OxytocinASD	Completed	No Results Available	Autistic Disorder	Drug: Oxytocin|Other: placebo	Eye tracking|Nepsy	University of Sao Paulo General Hospital	All	3 Years to 16 Years   (Child)	Phase 1	80	Other	Interventional	Allocation: Randomized|Intervention Model: Crossover Assignment|Masking: Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)|Primary Purpose: Other	10922213.7.0000.0068-2	July 15, 2016	July 20, 2017	May 15, 2018	June 12, 2017		October 28, 2019	Instituto de Psiquiatria, São Paulo, Brazil		https://ClinicalTrials.gov/show/NCT03183674
318	NCT04523805	Adapted Judo for Children With Autistic Spectrum Disorders	AUTJUDO	Unknown status	No Results Available	Autism Spectrum Disorder	Behavioral: Adapted judo programme	Change from Pre-intervention in psycho-social and behavioural scores|Change from Pre-intervention in motor skills scores|Change from Baseline in psycho-social and behavioural scores|Change from Baseline in motor skills scores	University Ramon Llull|Myriam Guerra|Cristina Curto Luque	All	8 Years to 15 Years   (Child)	Not Applicable	20	Other	Interventional	Allocation: N/A|Intervention Model: Single Group Assignment|Masking: None (Open Label)|Primary Purpose: Supportive Care	01-autjudo	July 1, 2019	July 1, 2020	July 1, 2021	August 24, 2020		August 24, 2020	Jose Morales, Barcelona, Spain		https://ClinicalTrials.gov/show/NCT04523805
319	NCT04261595	Dates as a Functional Food for Autism		Completed	No Results Available	Autistic Spectrum Disorder	Other: Dates fruit as functional Food|Behavioral: behavioral modification and stimulation|Other: nutritional Guidance	Dates' ability to change the oxidative stress of ASD|change on the pathogenic microbiota of the autistic children as detected by traditional stool analysis through DNA extraction (quantitative PCR) of the fecal samples|change on the useful microbiota of the autistic children ( probiotics)|Dates' effect on the change of the behavioral rating assessed by an Observation Checklist using the "Bailey Scales of Infant and Toddler Development|Dates' effect on the change of the mental development assessed by an Observation Checklist using the "Bailey Scales of Infant and Toddler Development"|Dates' effect on the change of the Psychomotor abilities assessed by the observational checklist using the "Bailey Scales of Infant and Toddler Development|Dates' effect on the changes of the level of the autism as assessed by the 5th edition of the DSM-V|Dates' effect on the changes of the severity of the autism as assessed by Childhood Autism Rating Scale (CARS) measure|Dates' effect on the change on the dietary intake using the Food frequency questionnaire, 24-hour dietary recall, Dietary record	National Research Centre, Egypt	All	3 Years to 12 Years   (Child)	Not Applicable	120	Other	Interventional	Allocation: Non-Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Supportive Care	12060158	December 15, 2019	January 15, 2022	April 15, 2022	February 10, 2020		June 3, 2022	National Research Centre, Giza, Al Jizah, Egypt		https://ClinicalTrials.gov/show/NCT04261595
320	NCT01337687	Intranasal Oxytocin for the Treatment of Autism Spectrum Disorders	INOT	Completed	Has Results	Autism Spectrum Disorders	Drug: Intranasal Oxytocin|Drug: Placebo	Number of Participants With Improvement on the Clinical Global Impression-Improvement (CGI-I) Scale|Change in Obsessive- Compulsive Behavior Based on Yale Brown Obsessive Compulsive Scale (YBOCS)|Change in Repetitive Behavior Based Repetitive Behavior Scale - Revised (RBS-R)|Change in Facial Emotion Recognition Based on Diagnostic Analysis of Nonverbal Accuracy - 2 (DANVA-2)	Montefiore Medical Center|National Alliance for Research on Schizophrenia and Depression	All	18 Years to 55 Years   (Adult)	Not Applicable	19	Other	Interventional	Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)|Primary Purpose: Treatment	09-10-303	October 2009	December 2013	December 2013	April 19, 2011	February 27, 2020	February 27, 2020	Montefiore Medical Center, Albert Einstein College of Medicine, Bronx, New York, United States		https://ClinicalTrials.gov/show/NCT01337687
321	NCT01972074	Behavioral and Neural Response to Memantine in Adolescents With Autism Spectrum Disorder		Completed	Has Results	Autism Spectrum Disorder	Drug: Memantine|Other: Placebo	Treatment Responder	Massachusetts General Hospital|Mclean Hospital	All	8 Years to 17 Years   (Child)	Phase 3	84	Other	Interventional	Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)|Primary Purpose: Treatment	2013-P-001826	February 17, 2015	May 7, 2018	May 7, 2018	October 30, 2013	September 11, 2019	September 11, 2019	Massachusetts General Hospital, Boston, Massachusetts, United States	"Study Protocol and Statistical Analysis Plan", https://ClinicalTrials.gov/ProvidedDocs/74/NCT01972074/Prot_SAP_000.pdf	https://ClinicalTrials.gov/show/NCT01972074
322	NCT03459625	Mindfulness for Parents of Children With Autism Spectrum Disorder Autism Spectrum Disorder	ASD	Recruiting	No Results Available	Autism Spectrum Disorder	Behavioral: Mindfulness-Based Stress Reduction (MSBR)|Behavioral: Psychoeducational Support Group (PE)	Child externalizing behavior problems as evidenced by reductions in the Externalizing scores on a standardized parent-report questionnaire.|Child externalizing behavior problems as evidenced by reductions in the Externalizing score on a standardized parent-report questionnaire.|Parenting Stress	Loma Linda University|California State University, Fullerton	All	3 Years to 5 Years   (Child)	Not Applicable	138	Other	Interventional	Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Single (Outcomes Assessor)|Primary Purpose: Treatment	5110264	July 21, 2018	May 2023	May 2023	March 9, 2018		April 25, 2022	Loma Linda University, Loma Linda, California, United States		https://ClinicalTrials.gov/show/NCT03459625
323	NCT04099381	Safety and Efficacy of the Transfusion of UCB in Patients With an ASD Depending on the Degree of HLA Compatibility.	ASD-HLA2019	Unknown status	No Results Available	Autism Spectrum Disorder|Autism	Biological: ASD CB-MNC infusion low level HLA compatibility.|Biological: ASD CB-MNC infusion high level HLA compatibility.|Other: Standard therapy.	Number of participants with non-serious and serious adverse events.|The Childhood Autism Rating Scale (CARS2).|Autism Treatment Evaluation Checklist (ATEC).|Evaluation of the survival of donor cells in the host body without immune responses|The correlation of the concentration of T-regulatory cells (CD4/CD25/FoxP3) in the sample of umbilical cord blood and the treatment effectiveness degree|The correlation of the concentration of T-regulatory cells (CD4/CD25/FoxP3) in the patient depending on the severity of the disease.|The correlation of the concentration of CD34+ cells in the cord blood sample and the treatment effectiveness degree	State-Financed Health Facility "Samara Regional Medical Center Dinasty"|INBIO, LLC	All	3 Years to 14 Years   (Child)	Phase 1|Phase 2	150	Other	Interventional	Allocation: Non-Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Treatment	ASD-HLA2019	August 10, 2019	December 26, 2021	May 26, 2022	September 23, 2019		March 2, 2020	Medical Centre Dinasty, Samara, Russian Federation		https://ClinicalTrials.gov/show/NCT04099381
324	NCT05502484	Development of Self-regulation by Dialectial Behavioural Therapy in Adults With Autism	DASHBOARD	Enrolling by invitation	No Results Available	Autism Spectrum Disorder|Regulation, Self	Behavioral: Integrative Dialectical Behavioural Therapy (DBT)	Maladaptive coping: using harmful behaviours|Non Suicidal Self Injury (NSSI)|Suicidal ideation|Interoceptive body-awareness|Emotion-dysregulation|Cognitive emotion-regulation|Behavioural emotion-regulation|Sensory sensitivity|Well-being	Radboud University Medical Center|Dimence mental health institute	All	18 Years and older   (Adult, Older Adult)	Not Applicable	30	Other	Interventional	Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Treatment	DASHBOARD	January 1, 2021	July 2025	July 2025	August 16, 2022		August 16, 2022	Dimence mental health institute, Deventer, Gelderland, Netherlands		https://ClinicalTrials.gov/show/NCT05502484
325	NCT01322984	Cognitive and Emotional Processing of Social Stimuli in Children and Youth With Autism Spectrum Disorder		Unknown status	No Results Available	Autism Spectrum Disorder	Behavioral: Pictures|Behavioral: Startle eliciting noise	The eyeblink of the Startle reflex is measured.	University of Tromso|The Royal Norwegian Ministry of Health	All	7 Years to 18 Years   (Child, Adult)	Not Applicable	60	Other	Interventional	Allocation: Non-Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Basic Science	2010/238	March 2011	January 2013		March 25, 2011		October 25, 2012	Department of Psychology, University of Tromso, Tromso, Troms, Norway		https://ClinicalTrials.gov/show/NCT01322984
326	NCT05212493	The Effects of Medical Cannabis in Children With Autistic Spectrum Disorder		Active, not recruiting	No Results Available	Autism Spectrum Disorder	Drug: Cannabis oil	Cannabinoids levels change|Changes in attention span|Changes in cognitive level|Comparison of efficacy between two different cannabis oil products|Changes in adaptive behavior|Changes in violent behavior|Side effects|Therapeutic failure|Changes in sleep problems|Changes in eating problems|Changes in hormonal profile|Changes in biochemical parameters	Assaf-Harofeh Medical Center|Seach Sarid Ltd|Canndoc Ltd	All	5 Years to 25 Years   (Child, Adult)	Phase 3	128	Other	Interventional	Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Treatment	0281-17-ASF|20175083	November 14, 2019	December 31, 2021	December 2022	January 28, 2022		February 23, 2022	Assaf Harofeh Medical Center, Zerifin, Israel	"Study Protocol", https://ClinicalTrials.gov/ProvidedDocs/93/NCT05212493/Prot_000.pdf	https://ClinicalTrials.gov/show/NCT05212493
327	NCT00335790	A Controlled Trial of the Clinical Effects of Hyperbaric Therapy in Autistic Children		Completed	No Results Available	Autism	Procedure: Hyperbaric Therapy	Blinded Therapist Autism Diagnostic Observation Schedule (ADOS)|Blinded Therapist Aberrant Behavior Checklist (ABC-C)|Blinded Physician Clinical Global Impression Severity Score (CGI)|Parental Autism Treatment Evaluation Checklist (ATEC)	International Hyperbarics Association	All	2 Years to 7 Years   (Child)	Not Applicable	60	Other	Interventional	Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Double|Primary Purpose: Treatment	HBA-2	June 2006		March 2007	June 12, 2006		April 10, 2007	Center for Autism Research and Education, Phoenix, Arizona, United States|International Child Development Resource Center, Melbourne, Florida, United States|Blue Ridge Spectrum Center, Charlottesville, Virginia, United States|Advocates for Children, Lynchburg, Virginia, United States		https://ClinicalTrials.gov/show/NCT00335790
328	NCT04276571	EMPATIA@Lecco- Balance Rehabilitation of Autistic Children With Virtual rEality	BRAVE	Recruiting	No Results Available	Autism Spectrum Disorder	Device: exergames with GRAIL virtual immersive reality environment	experimental balance assessment|Movement Assessment Battery for Children 2 (MABC2) (Henderson et al., 2007).|Developmental Coordination Disorder Questionnaire (DCDQ) (Wilson et al., 2007).|assessment of balance in response to perturbation applied by accelerating the dual-belt treadmill the dominant side at toe-off|assessment of overground balance using GSENSOR (BTS Bioengineering), a medical device for motion analysis|evaluation of gait features using the GRAIL (Motekforce Link)	IRCCS Eugenio Medea	All	7 Years to 14 Years   (Child)	Not Applicable	20	Other	Interventional	Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Treatment	GIP-679	October 18, 2019	December 31, 2022	December 31, 2022	February 19, 2020		March 31, 2022	Scientific Institute IRCCS E. Medea, Bosisio Parini, Lecco, Italy		https://ClinicalTrials.gov/show/NCT04276571
329	NCT05256095	Thinking in Speech for Children With Autism		Completed	No Results Available	Autism Spectrum Disorder|Speech	Behavioral: Thinking in Speech	Change from Baseline in Emotion Dysregulation Inventory scores to Post-Intervention|Number of Thinking in Speech therapy sessions attended among all participants|Change from Baseline in Patient-Reported Outcomes Measurement Information System - Anger Measure to Post-Intervention|Change from Baseline in Patient-Reported Outcomes Measurement Information System - Anxiety Short Form to Post-Intervention	University of Pittsburgh	All	7 Years to 11 Years   (Child)	Not Applicable	22	Other	Interventional	Allocation: Randomized|Intervention Model: Sequential Assignment|Masking: None (Open Label)|Primary Purpose: Treatment	STUDY20060157	May 12, 2021	August 10, 2022	August 10, 2022	February 25, 2022		October 7, 2022	University of Pittsburgh, Pittsburgh, Pennsylvania, United States		https://ClinicalTrials.gov/show/NCT05256095
330	NCT00936182	Study of Fluconazole in Children With Autism Spectrum Disorder		Unknown status	No Results Available	Autism Spectrum Disorder	Drug: Fluconazole	PDD Behavior Inventory	The Center for Autism and Related Disorders|The International Child Development Resource Center|Thoughtful House	All	3 Years to 10 Years   (Child)	Not Applicable	50	Other	Interventional	Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)|Primary Purpose: Treatment	C0901	July 2009	July 2010	July 2011	July 9, 2009		July 9, 2009	Center for Autism and Related Disorders, Tarzana, California, United States|International Child Development Resource Center, Melbourne, Florida, United States|Thoughtful House, Austin, Texas, United States		https://ClinicalTrials.gov/show/NCT00936182
331	NCT00404846	Effects of Hyperbaric Oxygenation Therapy on Adaptive, Aberrant and Stereotyped Behaviors in Children With Autism		Unknown status	No Results Available	Autism	Procedure: Hyperbaric Oxygenation Therapy	Direct Behavioral Observations|The Vineland Adaptive Behavior Scales: Expanded Edition (VABS)|Peabody Picture Vocabulary Test (PPVT)|Test of Visual-Perceptual Skills (TVPS)|The Beery-Buktenica Developmental Test of Visual-Motor Integration (VMI)|Autism Diagnostic Observation Schedule (ADOS)|The Behavior Rating Inventory of Executive Functioning (BRIEF)|Aberrant Behavior Checklist|Clinical Global Impression Scale	The Center for Autism and Related Disorders|The International Child Development Resource Center	All	2 Years to 14 Years   (Child)	Not Applicable	40	Other	Interventional	Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Double|Primary Purpose: Treatment	906001	November 2006	September 2007	December 2007	November 29, 2006		May 5, 2009	Center for Autism and Related Disorders, Tarzana, California, United States		https://ClinicalTrials.gov/show/NCT00404846
332	NCT03008889	A Feasibility Study of N-acetylcysteine for Self-injurious Behavior in Children With Autism Spectrum Disorder	NAC	Completed	Has Results	Autism Spectrum Disorder	Drug: N-acetylcysteine|Drug: Placebo	Percentage of Participants Randomized|Attrition Rate|Study Medication Compliance|Successful Collection of Outcome Measures|Parent Satisfaction Rating|Positive Predictive Value of Screening Method of Classifying Self-injurious Behavior (SIB) by Type.|Aberrant Behavior Checklist Irritability Subscale Score at Baseline and 9 Weeks Post-intervention|Number of Self-Injurious Behavior Events|Change in Clinical Global Impression (CGI-I) Scale at 9 Weeks Post-intervention|Change in Biomarkers and Possible Mechanisms of Action of NAC in Children With ASD.	Emory University	All	5 Years to 12 Years   (Child)	Phase 2	8	Other	Interventional	Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)|Primary Purpose: Treatment	IRB00088115	July 5, 2018	September 12, 2019	September 12, 2019	January 4, 2017	December 16, 2020	January 26, 2021	Marcus Autism Center, Atlanta, Georgia, United States	"Study Protocol and Statistical Analysis Plan", https://ClinicalTrials.gov/ProvidedDocs/89/NCT03008889/Prot_SAP_000.pdf	https://ClinicalTrials.gov/show/NCT03008889
333	NCT01333865	A Study of Memantine Hydrochloride (Namenda®) for Cognitive and Behavioral Impairment in Adults With Autism Spectrum Disorders		Completed	Has Results	Autism Spectrum Disorders	Drug: Memantine	Number of Participants With Reduction in ASD Symptom Severity as Defined by the Social Responsiveness Scale (SRS)|Number of Participants With Reduction in ASD Symptom Severity as Defined by the NIMH Clinical Global Impression for Pervasive Developmental Disorders (CGI-PDD) Improvement Score	Massachusetts General Hospital	All	18 Years to 50 Years   (Adult)	Phase 4	25	Other	Interventional	Allocation: N/A|Intervention Model: Single Group Assignment|Masking: None (Open Label)|Primary Purpose: Treatment	2010-P-000016	January 2010	July 2014	July 2014	April 12, 2011	October 6, 2014	March 24, 2016	Massachusetts General Hospital, Boston, Massachusetts, United States		https://ClinicalTrials.gov/show/NCT01333865
334	NCT04270708	Intranasal Dexmedetomidine vs Oral Triclofos Sodium for EEG in Children With Autism		Unknown status	No Results Available	Autistic Disorder	Drug: Dexmedetomidine|Drug: Triclofos 100 MG/ML	Maximal Sedation Depth|Technician satisfaction from sedation|Neurologist satisfaction from EEG motion artifact|Compliance with IN vs Oral Delivery|Resistance to drug administration (1-10 scale)|Achieving sedation following single dose|Achieving sedation following rescue dose|Sedation onset, duration and recovery periods|Adverse Events	Rabin Medical Center	All	3 Years to 19 Years   (Child, Adult)	Phase 4	200	Other	Interventional	Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Double (Care Provider, Outcomes Assessor)|Primary Purpose: Supportive Care	0090-20-RMC	March 1, 2020	March 1, 2022	August 1, 2022	February 17, 2020		February 17, 2020			https://ClinicalTrials.gov/show/NCT04270708
335	NCT05614206	Biomarkers Trajectories of Early Intervention in Siblings of Children With Autism Spectrum Disorder		Recruiting	No Results Available	Autism Spectrum Disorder|Early Intervention	Behavioral: Behavioral intervention based on Applied Behavior Analysis principles	Change of electroencephalographic theta power (theta frequency band)|Change of looking behavior (time of fixations to Area of Interests) and pupillometry parameters (pupil diameter)|Change of standardized scores of clinical measures	IRCCS Eugenio Medea	All	18 Months to 24 Months   (Child)	Not Applicable	80	Other	Interventional	Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Prevention	897	September 26, 2022	September 26, 2023	September 26, 2024	November 14, 2022		November 14, 2022	Associazione La Nostra Famiglia - IRCCS Eugenio Medea, Bosisio Parini, Lecco, Italy		https://ClinicalTrials.gov/show/NCT05614206
336	NCT05568056	Efficacy of Reading Intervention on the Brain Connectivity in Autism	BrainREAD	Recruiting	No Results Available	Autism Spectrum Disorder|Autism|Reading Problem	Behavioral: Visualizing and Verbalizing for Language comprehension and Thinking	Functional and anatomical changes in the brain|Change in reading comprehension|Relationship between neurobiological and behavioral changes	University of Alabama, Tuscaloosa|University of Alabama at Birmingham	All	7 Years to 13 Years   (Child)	Early Phase 1	200	Other	Interventional	Allocation: Randomized|Intervention Model: Factorial Assignment|Masking: None (Open Label)|Primary Purpose: Treatment	19-03-2120	January 10, 2019	August 31, 2023	August 31, 2023	October 5, 2022		October 5, 2022	University of Alabama, Tuscaloosa, Alabama, United States		https://ClinicalTrials.gov/show/NCT05568056
337	NCT03234608	Health System Integration of Tools to Improve Primary Care for Autistic Adults		Completed	Has Results	Autism Spectrum Disorder	Behavioral: AASPIRE Healthcare Toolkit	Change in Barriers to Healthcare|Change in Patient-Provider Communication|Change in Healthcare Self-Efficacy|Change in Visit Preparedness|Change in Receipt of Healthcare Accommodations	Portland State University|Oregon Health and Science University|Kaiser Permanente	All	18 Years and older   (Adult, Older Adult)	Not Applicable	244	Other	Interventional	Allocation: Non-Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Health Services Research	1R34MH111536-01	August 24, 2017	March 15, 2019	December 15, 2019	July 31, 2017	October 21, 2021	November 3, 2021	Kaiser Permanente Northern California, Oakland, California, United States|Legacy Health System, Portland, Oregon, United States|Oregon Health and Science University, Portland, Oregon, United States	"Study Protocol and Statistical Analysis Plan", https://ClinicalTrials.gov/ProvidedDocs/08/NCT03234608/Prot_SAP_000.pdf|"Informed Consent Form", https://ClinicalTrials.gov/ProvidedDocs/08/NCT03234608/ICF_001.pdf	https://ClinicalTrials.gov/show/NCT03234608
338	NCT00382382	Diffusion Tensor Imaging in Autism		Withdrawn	No Results Available	Autistic Disorder	Other: diffusion tensor imaging (DTI)	RBS-R scores, including both total and subset scores	University of Florida	Male	8 Years to 12 Years   (Child)	Not Applicable	0	Other	Interventional	Allocation: Non-Randomized|Intervention Model: Single Group Assignment|Masking: None (Open Label)|Primary Purpose: Health Services Research	1R03HD051656	July 2008	July 2009	July 2009	September 29, 2006		March 13, 2015	McKnight Brain Institute of the University of Florida, Gainesville, Florida, United States		https://ClinicalTrials.gov/show/NCT00382382
339	NCT01813318	Study of Acamprosate in Autism		Completed	No Results Available	Autistic Disorder	Drug: Acamprosate|Drug: Placebo	Change from baseline to week 10 on the Social WIthdrawal subscale of ABC|Change Clinical Global Impression- Improvement|Change in ABC subscales: Irritability, Stereotypy, Hyperactivity, and Inappropriate Speech from baseline to week 10	Children's Hospital Medical Center, Cincinnati|Autism Speaks	All	5 Years to 17 Years   (Child)	Phase 1	36	Other	Interventional	Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)|Primary Purpose: Basic Science	CIN001-Acamprosate in Autism	July 2, 2013	September 7, 2017	September 7, 2017	March 18, 2013		February 3, 2021	Cincinnati Children's Hospital Medical Center, Cincinnati, Ohio, United States		https://ClinicalTrials.gov/show/NCT01813318
340	NCT02947880	Evaluation of the Efficiency of Treatment by BUMETANIDE on Autistic Children With a Known Ethiology	BUMAUTEP	Withdrawn	No Results Available	Autistic Disorder	Drug: Bumetanide|Drug: Placebo	Change (evolution) between day 0 and day 99 of the result of the scale CARS (Childhood Autism Rating Scale).|CARS (Childhood Autism Rating Scale) between D0 and D99 and between D99 and D190 which will be describe by etiology	University Hospital, Limoges	All	5 Years to 17 Years   (Child)	Phase 2	0	Other	Interventional	Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Triple (Participant, Care Provider, Investigator)|Primary Purpose: Treatment	I14039	December 2016	December 2019	June 2020	October 28, 2016		June 2, 2021			https://ClinicalTrials.gov/show/NCT02947880
341	NCT04899544	Trial of Center-Based vs. In-Home Pivotal Response Treatment (PRT) in Autism	PRT-HvC	Recruiting	No Results Available	Autism|Autism Spectrum Disorder|ASD	Behavioral: Center-Based Pivotal Response Treatment (PRT) Intervention (PRT-C)|Behavioral: Home-Based Pivotal Response Treatment (PRT Intervention (PRT-H)	Change in Number of Child Utterances during the Parent-Child portion of the Structured Lab Observation (SLO).|Change on MacArthur-Bates Communication Development Inventory (CDI) Scores|Change From Baseline in Parent Rated Vineland Adaptive Behavior Scale- 3 (VABS-3) Scores|Change From Baseline in Parent Rated Social Responsiveness Scale, 2nd Edition (SRS-2) Score|Change From Baseline in Parent Rated Stanford Social Dimension Scale (SSDS) Scores|Change on the Brief Observation of Social Communication Change (BOSCC) direct child observation assessment.|Change on the Clinical Global Impressions (CGI) Scale.	Stanford University|Anonymous Donor	All	2 Years to 5 Years   (Child)	Not Applicable	120	Other	Interventional	Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Single (Outcomes Assessor)|Primary Purpose: Treatment	IRB-61427	October 18, 2022	September 15, 2026	September 15, 2026	May 24, 2021		December 14, 2022	Stanford University School of Medicine, Stanford, California, United States		https://ClinicalTrials.gov/show/NCT04899544
342	NCT04909658	The Effect of Acceptance and Commitment Therapy	ASDMatrix	Completed	No Results Available	Autism, Infantile	Behavioral: ACT Matrix|Behavioral: PT Protocol	Acceptance and Action Questionnaire (AAQ-II)|Home Situation Questionnaire (HSQ-ASD)|Valued Living Questionnaire (VLQ)|Mindful Attention Awareness Scale (MAAS)|Parental Stress Index/Short Form (PSI/SF)	S.Anna Rehabilitation Institute|Istituto per la Ricerca e l'Innovazione Biomedica	All	3 Years to 13 Years   (Child)	Not Applicable	66	Other	Interventional	Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Double (Investigator, Outcomes Assessor)|Primary Purpose: Supportive Care	CNR-AMMCEN 54444/2018	January 7, 2018	December 30, 2019	December 30, 2020	June 2, 2021		June 2, 2021	Institute for Biomedical Research and Innovation (IRIB), Messina, Italy		https://ClinicalTrials.gov/show/NCT04909658
343	NCT01258465	Research in Autism: Parent Intervention		Completed	No Results Available	Autistic Disorder	Behavioral: Pivotal Response Training|Behavioral: Picture Exchange Communication System	Mullen Scales of Early Learning|Vineland Adaptive Behavior Scales	University of California, San Diego	All	24 Months to 47 Months   (Child)	Not Applicable	39	Other	Interventional	Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Treatment	MH39434	January 2005	December 2009	December 2009	December 13, 2010		December 13, 2010	University of California, San Diego Psychology Department, La Jolla, California, United States|University of California, Santa Barbara, School of Education, Department of Clinical, Counseling, and School Psychology, Santa Barbara, California, United States		https://ClinicalTrials.gov/show/NCT01258465
344	NCT02275455	Design Of WELL Being Monitoring Systems, Application in Autism	Do Well B	Unknown status	No Results Available	Autistic Disorder	Behavioral: real life situations	Heart Rate Variability from holter electrocardiogram|Heart Rate Variability from the heart rate transmitter belt	University Hospital, Clermont-Ferrand	All	12 Years to 25 Years   (Child, Adult)	Not Applicable	60	Other	Interventional	Allocation: Non-Randomized|Intervention Model: Parallel Assignment|Masking: Double (Investigator, Outcomes Assessor)|Primary Purpose: Prevention	CHU-0213|2014-A00611-46	October 2014	December 2016	December 2018	October 27, 2014		July 26, 2016	University Hospital of Clermont-Ferrand (CHU), France, Clermont-Ferrand, France		https://ClinicalTrials.gov/show/NCT02275455
345	NCT02004236	Transcranial Random Noise Stimulation (tRNS) Over Fronto-temporal Cortex Improves Verbal Fluency and Empathy in Autism Children	tRNS25112013	Completed	Has Results	Autism|ASD	Device: tRNS Fronto-temporal cortex|Device: tRNS over fusiform temporal cortex|Device: tRNS with sham	Verbal Fluency|Sociability|Ratio Theta/Beta Before tRNS|Theta Amplitude in T5 Before tRNS|Ratio Theta/Beta After tRNS|Theta Amplitude in T5 After tRNS|Reaction Time in ECPT Before tRNS|Omission Errors Before tRNS|Commission Errors Before tRNS|P3b Wave Amplitude Before tRNS|Reaction Time After tRNS|Ommision Errors After tRNS|Commission Errors After tRNS|P3b Wave Amplitude After tRNS	Spanish Foundation for Neurometrics Development	All	5 Years to 12 Years   (Child)	Not Applicable	225	Other	Interventional	Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Double (Participant, Outcomes Assessor)|Primary Purpose: Treatment	Autism and tRNS	January 2014	August 2014	September 2014	December 9, 2013	October 16, 2014	May 4, 2021	General Elche Hospital, Elche, Alicante, Spain		https://ClinicalTrials.gov/show/NCT02004236
346	NCT05509309	Promoting Inclusive Educational Environments for Children With Autism and Other Social-communication Challenges: Preschool Class and Primary School		Not yet recruiting	No Results Available	Autism Spectrum Disorder|Social Communication Challenges	Behavioral: APERS-based model	Change from baseline in autism program quality assessed with the Autism Program Environment Rating Scale - Preschool and primary school (APERS-Fk/L-SE)|Change from baseline in how children feel about their school assessed with How I Feel About My School (HIFAMS)|Change from baseline in parents ratings on their children's body functions, activities and participation and contextual factors assessed with the International Classification of Functioning, Disability and Health (ICF) Core Sets for Autism|Change from baseline in children's self-regulation and academic behavior assessed with children's self-regulation and academic behavior questionnaire|Change from baseline in teachers' global impression of the child in the classroom|Change in teachers' stress assessed with the Teachers' Stress Scale|Change in teachers' perceived self-efficacy for supporting students with autism using the Autism Self-Efficacy Scale for Teachers|Change in teachers' work satisfaction assessed with the Teacher Work Satisfaction Questionnaire	Stockholm University|Karolinska Institutet	All	6 Years to 9 Years   (Child)	Not Applicable	48	Other	Interventional	Allocation: Non-Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Other	VR 2020-03267	August 15, 2022	July 1, 2024	July 1, 2024	August 22, 2022		August 22, 2022			https://ClinicalTrials.gov/show/NCT05509309
347	NCT02465086	Reasoning Skills in Theory of Mind and Linguistic Tests in the Autistic Population		Unknown status	No Results Available	Autism Spectrum Disorder	Other: Training of linguistic recursion	Performance on second-order false-belief tasks	Roskilde University	All	7 Years to 15 Years   (Child)	Not Applicable	60	Other	Interventional	Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Supportive Care	Protocol-01/2015	September 2015	May 2017	May 2017	June 8, 2015		April 6, 2016	School Ellebaekskolen, Koege, Denmark		https://ClinicalTrials.gov/show/NCT02465086
348	NCT04725383	Amitriptyline for Repetitive Behaviors in Autism Spectrum Disorders		Not yet recruiting	No Results Available	Autism Spectrum Disorder|Repetitive Compulsive Behavior	Drug: amitriptyline	Clinical Global Impressions scale-Improvement of Much Improved (2) or Very Much Improved (1)|Child Yale Brown Obsessive Compulsive Scale- Pervasive Developmental Disorders (CYBOCS-PDD)|Repetitive Behavior Scale-revised	University of Missouri, Kansas City	All	6 Years to 17 Years   (Child)	Phase 3	30	Other	Interventional	Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)|Primary Purpose: Treatment	2015984|17-055	June 1, 2021	June 1, 2024	December 20, 2024	January 26, 2021		May 11, 2021			https://ClinicalTrials.gov/show/NCT04725383
349	NCT01248130	Omega-3 Fatty Acids Monotherapy in Children and Adolescents With Autism Spectrum Disorders		Terminated	Has Results	Autism Spectrum Disorder (ASD)	Drug: Omega-3 Fatty Acid	Change in Social Responsiveness Scale (SRS) Total Raw Score|Change in NIMH Clinical Global Impression Scale for Pervasive Developmental Disorders (CGI-PDD) Improvement Scores	Massachusetts General Hospital	All	6 Years to 17 Years   (Child)	Phase 2	7	Other	Interventional	Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Triple (Participant, Care Provider, Investigator)|Primary Purpose: Treatment	2009-P-001593	November 2009	April 2013	April 2013	November 25, 2010	September 22, 2014	November 6, 2017	Massachusetts General Hospital, Boston, Massachusetts, United States		https://ClinicalTrials.gov/show/NCT01248130
350	NCT00004486	Randomized Study of Fluoxetine in Children and Adolescents With Autism		Completed	No Results Available	Autism	Drug: fluoxetine		Icahn School of Medicine at Mount Sinai|FDA Office of Orphan Products Development	All	5 Years to 17 Years   (Child)	Not Applicable	45	Other	Interventional	Allocation: Randomized|Intervention Model: Crossover Assignment|Masking: Double|Primary Purpose: Treatment	199/14266|MTS-FDR001520|MTS-GCO-96-713	September 1998		December 2002	October 19, 1999		March 25, 2015	Albert Einstein College of Medicine, Bronx, New York, United States|New York University Medical Center, New York, New York, United States|Mount Sinai School of Medicine, New York, New York, United States		https://ClinicalTrials.gov/show/NCT00004486
351	NCT05099705	Testing a Family Service Navigator Program for Low-resourced Families of Young Children With Autism Spectrum Disorder		Recruiting	No Results Available	Autism Spectrum Disorder|Mental Health Services	Behavioral: Access to a Family Service Navigator and Treatment Support System	Change in Knowledge at 9 months|Change in Skills at 9 months|Change in Advocacy at 9 months|Change in Empowerment at 9 months|Change in Parenting self-efficacy at 9 months|Change in Service Delivery Outcomes|Change in Adaptive and maladaptive behavior at 9 months|Change in Social responsiveness at 9 months	University of Illinois at Urbana-Champaign	All	18 Years and older   (Adult, Older Adult)	Not Applicable	55	Other	Interventional	Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Health Services Research	University of Illinois	July 1, 2022	December 30, 2023	December 30, 2023	October 29, 2021		October 31, 2022	University of Illinois at Urbana-Champaign, Champaign, Illinois, United States		https://ClinicalTrials.gov/show/NCT05099705
352	NCT03489811	The Effect of Aroma on Anxiety Among Children With Autism.		Withdrawn	No Results Available	Anxiety|Autism Spectrum Disorder	Other: Test Essential Oil Blend|Other: Active Essential Oil Blend|Other: Control Blend	39-Question Spence Children's Anxiety Scale (SCAS)	Franklin Health Research	All	6 Years to 11 Years   (Child)	Not Applicable	0	Other	Interventional	Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Double (Participant, Outcomes Assessor)|Primary Purpose: Prevention	17-2100	July 24, 2019	August 31, 2021	August 31, 2021	April 6, 2018		November 5, 2021	Franklin Institute of Wellness, Franklin, Tennessee, United States		https://ClinicalTrials.gov/show/NCT03489811
353	NCT02469870	ASD Parent Trainer: Online Coaching for Parents of Children With Autism	APT	Completed	Has Results	Autism Disorder	Behavioral: Autism Parent Trainer (APT)|Behavioral: Teaching Routines (Control)	Child Behavior Measured by Strengths and Difficulties Questionnaire (Goodman, 1997)|Family Quality of Life as Measured by Family Quality of Life Survey (Summers et al., 2005)|Parenting Scale (Arnold, O'Leary, Wolff, & Aker, 1993)|Scales of Independent Behavior-Revised (SIB-R; Bruininks, Woodcock, Weatherman, & Hill, 1996)|Knowledge About Applied Behavior Analysis and Acceptance Commitment Training Measured by Questionnaire|Consumer Satisfaction Questionnaire	IRIS Media Inc	All	18 Years and older   (Adult, Older Adult)	Not Applicable	156	Other	Interventional	Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Supportive Care	2R44MH102845-02	August 2016	October 2017	October 30, 2017	June 12, 2015	February 5, 2020	February 5, 2020	IRIS Educational Media, Eugene, Oregon, United States	"Study Protocol and Statistical Analysis Plan", https://ClinicalTrials.gov/ProvidedDocs/70/NCT02469870/Prot_SAP_000.pdf	https://ClinicalTrials.gov/show/NCT02469870
354	NCT03785327	Improving Social Interaction for Adolescents With Autism During the Transition to Adulthood		Enrolling by invitation	No Results Available	Autism Spectrum Disorder|Typical Development	Device: tDCS|Behavioral: Autism Training	Objective Social Interaction Quality|Subjective Social Interaction Quality|Social Cognition	The University of Texas at Dallas	Male	18 Years to 21 Years   (Adult)	Not Applicable	154	Other	Interventional	Allocation: Randomized|Intervention Model: Crossover Assignment|Masking: Single (Participant)|Primary Purpose: Basic Science	1806799	January 18, 2019	July 2022	July 2022	December 24, 2018		September 30, 2021	The University of Texas at Dallas, Richardson, Texas, United States		https://ClinicalTrials.gov/show/NCT03785327
355	NCT02077985	Sensory Adapted Dental Environment to Enhance Oral Care for Children With ASD	SADE	Completed	No Results Available	Autism	Behavioral: Sensory Adapted Dental Environment	Electrodermal activity (EDA)|Children's Dental Behavioral Rating Scale (CDBRS)|Number of hands used to restrain child|Frankl Scale|The Anxiety and Cooperation Scale (A & C Scale)|Time	University of Southern California|Children's Hospital Los Angeles	All	6 Years to 12 Years   (Child)	Not Applicable	45	Other	Interventional	Allocation: Randomized|Intervention Model: Crossover Assignment|Masking: None (Open Label)|Primary Purpose: Treatment	5R34DE022263-02	October 2012	June 2013	June 2013	March 4, 2014		March 4, 2014			https://ClinicalTrials.gov/show/NCT02077985
356	NCT05311982	Transcranial Direct Current Stimulation in Autistic Spectrum Disorder	TDCSinASD	Completed	No Results Available	Autistic Disorders Spectrum	Device: DLPFC-R (F4) TDCS|Device: DLPFC-L (F3) and DLPFC-R (F4) TDCS|Device: sham-tDCS	to compare the effectiveness of Neuromodulation techniques - transcranial direct current stimulation (tDCS) - in the treatment of people with Autism Spectrum Disorder|Check the effects of tDCS modulations on cognitive responses through Autism Treatment Evaluation Checklist	Federal University of Paraíba	All	5 Years to 18 Years   (Child, Adult)	Not Applicable	12	Other	Interventional	Allocation: Randomized|Intervention Model: Crossover Assignment|Masking: Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)|Primary Purpose: Treatment	Tdcs Autism ufpb	March 1, 2021	July 30, 2021	September 30, 2021	April 5, 2022		April 5, 2022	Federal University of Paraíba,Department of Psychology, João Pessoa,, Paraiba, Brazil|Suellen Marinho Andrade, João Pessoa, Paraíba, Brazil		https://ClinicalTrials.gov/show/NCT05311982
357	NCT03108976	Build-up of Action Representation in Autism Spectrum Disorders	ASD-BARN	Completed	No Results Available	Healthy|Autism Spectrum Disorder	Other: Behavioral assessments|Other: Magnetoencephalography (MEG)|Other: Magnetic Resonance Imaging (MRI)	Changes of cerebral oscillations in three frequency bands (alpha, beta, gamma) during sensori-motor learning.|Correlation between oscillatory measures and learning performance.	Hospices Civils de Lyon	All	7 Years to 12 Years   (Child)	Not Applicable	54	Other	Interventional	Allocation: Non-Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Basic Science	69HCL16_0677	April 10, 2015	December 31, 2018	December 31, 2018	April 11, 2017		August 26, 2022	CH le Vinatier, Bron, France		https://ClinicalTrials.gov/show/NCT03108976
358	NCT03924973	3 Year Follow up Study of the IDEA Population	IDEA2SCOLA	Recruiting	No Results Available	Autism	Behavioral: ESDM followed by treatment as usual	ADOS (Autism Diagnostic Observation Schedule )|Wechsler (Wechsler Intelligence Scale for Children)|VABS (Vineland Adaptive Behavior Scales)|PPVT ( Peabody Picture Vocabulary Test )|Parental self-assentiment	Hôpital le Vinatier	All	39 Months to 60 Months   (Child)	Not Applicable	174	Other	Interventional	Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Single (Outcomes Assessor)|Primary Purpose: Treatment	2017-A02446-47	April 17, 2019	December 31, 2022	December 31, 2025	April 23, 2019		August 12, 2022	Hopital Vinatier, Bron, France		https://ClinicalTrials.gov/show/NCT03924973
359	NCT01183221	The Effects of Oxytocin on Complex Social Cognition in Autism Spectrum Disorders		Completed	Has Results	Autism|ASD	Drug: Syntocinon|Drug: Placebo	Empathic Accuracy Performance|Fmri BOLD Response During Empathic Accuracy Task	Alexander Kolevzon|Icahn School of Medicine at Mount Sinai	All	18 Years to 45 Years   (Adult)	Phase 2	30	Other	Interventional	Allocation: Randomized|Intervention Model: Crossover Assignment|Masking: Double (Participant, Investigator)|Primary Purpose: Basic Science	GCO 09-0857	June 18, 2010	April 25, 2014	April 25, 2014	August 17, 2010	April 15, 2021	April 15, 2021	Mount Sinai School of Medicine - Seaver Autism Center for Research and Treatment, New York, New York, United States		https://ClinicalTrials.gov/show/NCT01183221
360	NCT02914951	Cognitive-Behavioral Therapy for Irritability in Children With Autism Spectrum Disorder and Intellectual Disability		Active, not recruiting	No Results Available	Autism|Intellectual Disability	Behavioral: Cognitive-Behavioral Therapy|Other: Functional magnetic resonance imaging (fMRI)	Modified Overt Aggression Scale (MOAS)|Aberrant Behavior Checklist - Irritability Scale (ABC-I)|Home Situations Questionnaire (HSQ)	Yale University	All	8 Years to 16 Years   (Child)	Not Applicable	6	Other	Interventional	Allocation: N/A|Intervention Model: Single Group Assignment|Masking: None (Open Label)|Primary Purpose: Treatment	0102012121-D	October 2016	December 2022	December 2022	September 26, 2016		February 7, 2022	Yale Child Study Center, New Haven, Connecticut, United States		https://ClinicalTrials.gov/show/NCT02914951
361	NCT00247156	An Autism Study Using Nambudripad's Food Allergy Elimination Treatments		Completed	No Results Available	Autism|Food Allergies	Procedure: Acupressure treatments and NAET treatments	Improvement in speech and communication|Elimination or reduction of commonly seen autistic traits	Nambudripad's Allergy Research Foundation	All	3 Years to 10 Years   (Child)	Phase 1|Phase 2	60	Other	Interventional	Allocation: Non-Randomized|Intervention Model: Single Group Assignment|Masking: None (Open Label)|Primary Purpose: Treatment	narfoundationautismstudy|narffoundation 101	November 2004		November 2005	November 1, 2005		June 26, 2008	PNIB Research Center, Buena Park, California, United States		https://ClinicalTrials.gov/show/NCT00247156
362	NCT04244721	Effectiveness of a Parent-mediated Intervention With PACT on Children With ASD	iPACT	Recruiting	No Results Available	Autism Spectrum Disorder	Other: Preschool Autism Communication Therapy (PACT)|Other: Treatment As Usual (TAU)	Autism symptoms|Social Interactions of the child|Parent-child synchrony and initiative in communication|Number of words produced by the child|Adaptative behavior|Autism Family Experience|Characteristics of the parents	Hôpital le Vinatier	All	18 Months to 36 Months   (Child)	Not Applicable	238	Other	Interventional	Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Single (Participant)|Primary Purpose: Treatment	2018-A02516-49	June 30, 2020	June 2023	February 2024	January 28, 2020		July 9, 2021	Hopital Vinatier, Bron, France		https://ClinicalTrials.gov/show/NCT04244721
363	NCT01395953	Double-blind Trial of Buspirone for the Treatment of Anxiety in Youth With Autism Spectrum Disorders		Withdrawn	No Results Available	Autism Spectrum Disorder (ASD)	Drug: Buspirone|Drug: Placebo	Reduction in Pediatric Anxiety Rating Scale (PARS) Score|Clinical Global Impression-Anxiety (CGI-Anxiety) Improvement Score	Massachusetts General Hospital	All	6 Years to 17 Years   (Child)	Phase 2	0	Other	Interventional	Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Double (Participant, Investigator)|Primary Purpose: Treatment	2011-P-000703	November 2011	July 2013	July 2013	July 18, 2011		July 9, 2021	Massachusetts General Hospital, Boston, Massachusetts, United States		https://ClinicalTrials.gov/show/NCT01395953
364	NCT02504554	Beneficial Bacteria Treatment for Autism	BBT	Completed	Has Results	Gastrointestinal Problems|Autism Spectrum Disorders	Drug: oral Vancomycin|Drug: MoviPrep|Drug: Prilosec|Biological: human fecal material; processed, frozen administered orally|Biological: human fecal material; processed, frozen; administered orally and rectally	Gastrointestinal Symptom Responsiveness Scale (GSRS)|Parent Global Impressions-Revised (PGI-R)|Blood Safety Markers (Assessment of Blood Chemistry Panel and Complete Blood Count)|Childhood Autism Rating Scale (CARS)|Social Responsiveness Scale (SRS)|Short Sensory Profile|Vineland Adaptive Behavior Scale (VABS)|Daily Stool Record (DSR)	Arizona State University|Northern Arizona University|University of Arizona|University of Minnesota	All	7 Years to 17 Years   (Child)	Phase 1|Phase 2	18	Other	Interventional	Allocation: Non-Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Treatment	STUDY00001053	July 2014	April 2016	April 2016	July 22, 2015	December 18, 2019	December 18, 2019			https://ClinicalTrials.gov/show/NCT02504554
365	NCT01400269	An Evaluation of a Developmentally-Based Parent Training Program for Children With Autism		Completed	No Results Available	Autistic Disorder	Behavioral: Pacific Autism Center for Education (PACE ) developmentally based parent delivered intervention	Social Responsiveness Scale|Repetitive Behavior Scale|Family Empowerment Scale|Caregiver Strain questionnaire|Pediatric Quality of Life Inventory|Sensory Profile Questionnaire	Stanford University	All	18 Months to 6 Years   (Child)	Not Applicable	48	Other	Interventional	Allocation: N/A|Intervention Model: Single Group Assignment|Masking: None (Open Label)|Primary Purpose: Treatment	SU-11022010-7169	September 2010	January 2014	January 2014	July 22, 2011		February 16, 2022	Stanford University School of Medicine, Stanford, California, United States		https://ClinicalTrials.gov/show/NCT01400269
366	NCT00273650	Efficacy Study of Subcutaneous Methyl-B12 in Children With Autism		Completed	No Results Available	Autistic Disorder	Drug: methylcobalamin|Other: saline placebo	Primary measure is the Clinical Global Impression Scale -Improvement supplemented by videos taken at all visits and rated blindly to measure executive function, speech, and language, and socio-economic development.|Secondary measures:NEPSY, ABC, PPVT, SB:V, PDRF, MCDI, PIA-CV, and CARS.	University of California, San Francisco	All	3 Years to 8 Years   (Child)	Phase 2|Phase 3	30	Other	Interventional	Allocation: Randomized|Intervention Model: Crossover Assignment|Masking: Triple (Participant, Care Provider, Investigator)|Primary Purpose: Treatment	MB12-AUT	July 2005	June 2009	August 2009	January 9, 2006		October 9, 2019	UC Davis MIND Institute, Sacramento, California, United States		https://ClinicalTrials.gov/show/NCT00273650
367	NCT02862340	Study of the Involvement of 15q11 - q13 Chromosome Region and CYFIP1 Gene in Autism. Attempt a Genotype-phenotype Correlation		Completed	No Results Available	Autistic Disorder	Genetic: Genetic test	presence or absence of abnormality in 15q11q13 gene|phenotype	Centre Hospitalier Universitaire de Nice	All	4 Years to 18 Years   (Child, Adult)	Not Applicable	60	Other	Interventional	Allocation: N/A|Intervention Model: Single Group Assignment|Masking: None (Open Label)|Primary Purpose: Diagnostic	07-PP-01	January 2008	January 2008	February 2012	August 11, 2016		August 11, 2016	CHU de Nice, Nice, France		https://ClinicalTrials.gov/show/NCT02862340
368	NCT05419895	Early Diagnostic Response Model (EDRM)		Recruiting	No Results Available	Autism Spectrum Disorder|Autism	Behavioral: Early Diagnostic Response Model (EDRM)	Number of participants referred to the Early Diagnostic Response Model (EDRM)|Number of participants consented in the Early Diagnostic Response Model (EDRM) study|Response rate in the Early Diagnostic Response Model (EDRM) study|Number of participants that completed the Early Diagnostic Response Model (EDRM) study|Time from referral to completion of the program|Number of high-risk referral assessments that completed entirely via streamlined telehealth protocol|Number of participants with additional information collected to make a final DSM-5 conclusion|Parent satisfaction of EDRM assessment survey|BCW provider(s) Service Coordinator satisfaction with EDRM assessment survey|Parent satisfaction with access to treatment survey|BCW provider(s) Early Intervention Coordinator satisfaction with EDRM pilot survey	Emory University|Georgia Department of Public Health	All	16 Months to 36 Months   (Child)	Not Applicable	100	Other	Interventional	Allocation: N/A|Intervention Model: Single Group Assignment|Masking: None (Open Label)|Primary Purpose: Diagnostic	STUDY00003763	June 16, 2022	July 2023	July 2023	June 15, 2022		June 21, 2022	Emory Autism Center, Atlanta, Georgia, United States		https://ClinicalTrials.gov/show/NCT05419895
369	NCT00541346	A Pilot Study of Daytrana TM in Children With Autism Co-Morbid for Attention Deficit Hyperactivity Disorder (ADHD) Symptoms		Completed	Has Results	Autism|Attention Deficit Hyperactivity Disorder	Drug: Methylphenidate Transdermal System	Change in Attention Deficit Hyperactivity Disorder Rating Scale - IV (ADHD-RS-IV) Total Score From Baseline to 8-week Follow-up Visit|Change in Aberrant Behavior Checklist (ABC) Hyperactivity Scores From Baseline to 8-week Follow-up Visit|Change in Aberrant Behavior Checklist (ABC) Irritability Scores From Baseline to 8-week Follow-up Visit|Change in Aberrant Behavior Checklist (ABC) Lethargy Scores From Baseline to 8-week Follow-up Visit|Change in Aberrant Behavior Checklist (ABC) Stereotypy Scores From Baseline to 8-week Follow-up Visit|Change in Aberrant Behavior Checklist (ABC) Inappropriate Speech Scores From Baseline to 8-week Follow-up Visit|Change in Lifetime Participation Scale (LPS) Total Scores From Baseline to 8-week Follow-up Visit|Change in Family III General Scale Summed Score From Baseline to 8-week Follow-up Visit|Change in Pediatric Evaluation Disability Inventory (PEDI) Caregiver Assistance: Self-Care From Baseline to 8-week Follow-up Visit|Change in Pediatric Evaluation Disability Inventory (PEDI) Social Function From Baseline to 8-week Follow-up Visit|Change in Attention Deficit Hyperactivity Disorder Rating Scale IV: Teacher Assessment Total Scores From Baseline to 8-week Follow-up Visit	University of Oklahoma|Mark L. Wolraich, M.D.	All	6 Years to 11 Years   (Child)	Phase 3	16	Other	Interventional	Allocation: Non-Randomized|Intervention Model: Single Group Assignment|Masking: None (Open Label)|Primary Purpose: Treatment	SPD485-420-Lock	September 2007	May 2009	February 2010	October 10, 2007	February 6, 2014	February 6, 2014	OU Child Study Center, Oklahoma City, Oklahoma, United States		https://ClinicalTrials.gov/show/NCT00541346
370	NCT02003820	Using Video Modeled Social Stories to Improve Oral Hygiene in Children With Autism Spectrum Disorder		Completed	No Results Available	Autism Spectrum Disorder|Dental Caries	Behavioral: video modeled social story	Measure of video intervention use|Plaque index|Caregiver survey	Yale University	All	5 Years to 14 Years   (Child)	Not Applicable	19	Other	Interventional	Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Double (Investigator, Outcomes Assessor)|Primary Purpose: Prevention	Pedidentalautism	July 2014	June 2015	July 2015	December 6, 2013		August 8, 2016	Yale New Haven Hospital Pediatric Dental Center, New Haven, Connecticut, United States|Yale Pediatric Dental Center Suite 403, New Haven, Connecticut, United States		https://ClinicalTrials.gov/show/NCT02003820
371	NCT03438994	Early Assessment of Autism Through Smart Tablet Gameplay		Unknown status	No Results Available	Autism Spectrum Disorder|Other Neurodevelopmental Disorder	Diagnostic Test: Play.Care	Diagnostic accuracy of Play.Care to detect ASD|Ability of Play.Care to distinguish ASD from OND	University of Strathclyde|Harimata|University of Glasgow|University of Aberdeen|Göteborg University	All	30 Months to 5 Years   (Child)	Not Applicable	760	Other	Interventional	Allocation: Non-Randomized|Intervention Model: Parallel Assignment|Masking: Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)|Primary Purpose: Diagnostic	UEC17/49	January 10, 2018	July 30, 2019	November 30, 2019	February 20, 2018		September 23, 2019	Gillberg Neuropsychiatry Centre, Gothenburg, Sweden|University of Strathclyde, Glasgow, United Kingdom		https://ClinicalTrials.gov/show/NCT03438994
372	NCT04948814	Application of Fecal Microbiota Transplantation in Children With ASD		Recruiting	No Results Available	Autism Spectrum Disorder	Biological: Fecal microbiota transplantation|Drug: Vancomycin	Change in Autism Diagnostic Observation Scale (ADOS) in ASD children|Changes in the Autism Behavior Checklist (ABC) in ASD children|Changes in the Childhood Autism Rating Scale (CARS) in ASD children|Change in Social Responsiveness Scale (SRS) in ASD children|Change in Autism Treatment Evaluation Checklist (ATEC) in ASD children|Change in gastrointestinal symptoms among children with ASD|Evaluate the difference of the gut microbe composition between children with ASD and healthy children by sequencing faecal metagenome.	Tongji Hospital	All	3 Years to 18 Years   (Child, Adult)	Phase 1	100	Other	Interventional	Allocation: Non-Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Treatment	F616|2018B030335001	July 1, 2021	September 1, 2023	September 1, 2023	July 2, 2021		July 2, 2021	Tongji Hospital, Wuhan, Hubei, China|Tongji Hospital, Wuhan, Hubei, China		https://ClinicalTrials.gov/show/NCT04948814
373	NCT00676195	An Open-Label Study of N-Acetyl Cysteine in Children With Autism		Completed	Has Results	Autistic Disorder	Drug: N-Acetyl Cysteine	Number of Participants With Adverse Events Reported on the Dosage Record and Treatment Emergent Symptom Scale (DOTES)|Social Responsiveness Scale (SRS)|Sensory Profile Questionnaire (SPQ)|Irritability Subscale of the Aberrant Behavior Checklist (ABC)|Glutathione Metabolism Intermediates in Peripheral Blood Measured by High-performance Liquid Chromatography	Stanford University	All	3 Years to 12 Years   (Child)	Phase 2	24	Other	Interventional	Allocation: N/A|Intervention Model: Single Group Assignment|Masking: None (Open Label)|Primary Purpose: Treatment	SU-05062008-1139	June 2008	June 2010	June 2010	May 12, 2008	March 29, 2017	March 29, 2017	Stanford University School of Medicine, Stanford, California, United States		https://ClinicalTrials.gov/show/NCT00676195
374	NCT04245306	Pilot Evaluation of a New Computerized Test for Pragmatic Inferences in Children With ASD	TIPI	Recruiting	No Results Available	Autism Spectrum Disorder	Other: computerized test for pragmatic inferences	Discrimination power of the measure assessed by the dissociation of the developmental trajectories of children with ASD compared to TD children in the composite score of the TIPi.|Sensitivity of the TIPi composite score (measuring pragmatic inferencing) to typical development in the targeted age range: 8 to 12 years oldin the targeted age range: 8 to 12 years old|The TIPi composite score provides additional information compared to other cognitive assessments typically provided in the global assessment of children with ASD|Discrimination power of the measure assessed by the dissociation of the developmental trajectories of children with ASD compared to children with DLD in the composite score of the TIPi.	Hôpital le Vinatier	All	8 Years to 12 Years   (Child)	Not Applicable	200	Other	Interventional	Allocation: Non-Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Diagnostic	2019-A01721-56	February 7, 2020	February 7, 2020	February 7, 2023	January 28, 2020		March 24, 2022	Ch Le Vinatier, Bron, France		https://ClinicalTrials.gov/show/NCT04245306
375	NCT05588570	Coaching Children With Anxiety and Autism Through Telehealth	CAT	Recruiting	No Results Available	Autism|Autism Spectrum Disorder|Anxiety	Behavioral: CAT	Change in Child Anxiety Symptoms as assessed by PRAS-ASD|Change in Parent Accommodation as assessed by FAS-A|Child Heart Rate|Parent Heart Rate|Child Respiratory Sinus Arrhythmia as assessed by Actiheart software|Parent Respiratory Sinus Arrhythmia as assessed by Actiheart software|Parent Anxiety Symptoms as assessed by GAD-7|Change in Parenting Stress as assessed by Parenting Stress Index-Short Form (PSI-SF)|Caregiver Satisfaction with treatment as assessed by Therapy Attitude Inventory (TAI)	Medical University of South Carolina	All	48 Months to 107 Months   (Child)	Not Applicable	20	Other	Interventional	Allocation: N/A|Intervention Model: Single Group Assignment|Masking: None (Open Label)|Primary Purpose: Treatment	00121415	September 23, 2022	June 2023	June 2023	October 20, 2022		October 20, 2022	Medical University of South Carolina, Charleston, South Carolina, United States		https://ClinicalTrials.gov/show/NCT05588570
376	NCT05018169	Behavioral Activation for Treatment of Depression in Adolescents With Autism	BA-A	Not yet recruiting	No Results Available	Depression|Autism	Behavioral: BA-A	Children's Depression Inventory, Second Edition, Parent Report|Children's Depression Inventory, Second Edition, Self Report|Children's Depression Rating Scale, Revised|Spence Children's Anxiety Scale, Self Report|Spence Children's Anxiety Scale, Parent Report|Social Skills Improvement System, Parent Report	University of Virginia	All	12 Years to 17 Years   (Child)	Not Applicable	23	Other	Interventional	Allocation: N/A|Intervention Model: Single Group Assignment|Masking: None (Open Label)|Primary Purpose: Treatment	HSR200385	August 2021	August 2022	August 2022	August 24, 2021		August 24, 2021			https://ClinicalTrials.gov/show/NCT05018169
377	NCT05105126	Non-invasive Brain Stimulation in Children With Autism		Not yet recruiting	No Results Available	Autism Spectrum Disorder|Executive Dysfunction|Child Autism	Device: Transcranial Direct Current Stimulation (tDCS)|Device: Sham tDCS	Change in the Behavior Rating Inventory of Executive Function (BRIEF)|Change in Electrodncephalogram (EEG)|Change in the Pervasive Developmental Disorder Behavior Inventory (PDDBI)|Change in discrete trial training (DTT) data from applied behavior analysis (ABA) therapy	Rutgers, The State University of New Jersey|New York State Institute for Basic Research|Boston Children's Hospital	All	5 Years to 12 Years   (Child)	Not Applicable	24	Other	Interventional	Allocation: Randomized|Intervention Model: Crossover Assignment|Masking: Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)|Primary Purpose: Treatment	Pro2020000931	November 2021	December 2023	December 2023	November 3, 2021		November 3, 2021	Department of Pediatrics, Division of Pediatric Neurology, Robert Wood Johnson Medical School, New Brunswick, New Jersey, United States		https://ClinicalTrials.gov/show/NCT05105126
378	NCT02414451	Trial of Propranolol in Adults and Adolescents With ASD and Predictors of Response		Withdrawn	No Results Available	Autism	Drug: Propranolol|Drug: Placebo	Change in General Social Outcome Measure (GSOM)|Change in Social Responsiveness Scale (SRS)|Change in Anagrams task|Change in Verbal fluency for categories task|Change in Spence Children's Anxiety Scale (SCAS)|Vertical attention task|Change in Clinical Global Impression of Change (CGIC) scale|Change in Autism Impact Measure (AIM)|Change in Vineland Adaptive Behavior Scales-II (VABS)|Change in Aberrant Behavior Checklist (ABC)|Change in Clinical Global Impression of Severity (CGIS) scale	University of Missouri-Columbia	All	15 Years to 30 Years   (Child, Adult)	Not Applicable	0	Other	Interventional	Allocation: Randomized|Intervention Model: Crossover Assignment|Masking: Triple (Participant, Care Provider, Investigator)|Primary Purpose: Treatment	200089	September 2016	September 2016	September 2016	April 10, 2015		October 4, 2016			https://ClinicalTrials.gov/show/NCT02414451
379	NCT00627705	A Study of N-Acetyl Cysteine in Children With Autism		Completed	Has Results	Autistic Disorder	Drug: N-Acetyl Cysteine|Other: Placebo - sugar pill	Total Number of Subjects With Reported Side Effects as Assessed by Dosage Record and Treatment Emergent Symptom Scale (DOTES)|The Clinical Global Rating Scale (CGRS) Improvement Subscale Score|Glutathione (GSH) Levels in Peripheral Blood, Measured by State-of-the-art High-performance Liquid Chromatography (HPLC)|Irritability Subscale of the Aberrant Behavior Checklist (ABC)|The Aberrant Behavior Checklist Total Score (ABC)|Social Responsiveness Scale (SRS)|Sensory Profile Questionnaire (SPQ)|Glutathione (GSH) Metabolism Intermediates in Peripheral Blood	Stanford University	All	3 Years to 12 Years   (Child)	Phase 2	43	Other	Interventional	Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)|Primary Purpose: Treatment	SU-02012008-995|10142	February 2008	September 2010	September 2010	March 3, 2008	May 18, 2017	May 18, 2017	Stanford University School of Medicine, Stanford, California, United States		https://ClinicalTrials.gov/show/NCT00627705
380	NCT00692315	Treating Oxidative Stress in Children With Autism		Completed	No Results Available	Autistic Disorder	Drug: Methylcobalamin (methylB12)	Glutathione redox status (GSH/GSSG)|Vineland Adaptive Behavior Scales	Arkansas Children's Hospital Research Institute	All	3 Years to 7 Years   (Child)	Not Applicable	40	Other	Interventional	Allocation: Non-Randomized|Intervention Model: Single Group Assignment|Masking: None (Open Label)|Primary Purpose: Treatment	28839	September 2006	June 2007	December 2007	June 6, 2008		April 15, 2016	Arkansas Children's Hospital Research Institute, Little Rock, Arkansas, United States		https://ClinicalTrials.gov/show/NCT00692315
381	NCT02279680	Associative Memory in Adults With an Autism Spectrum Disorder	MEM-T2A	Unknown status	No Results Available	Autistic Disorder	Device: Electroencephalography|Behavioral: Neuropsychological assesments	The associative memory index|theta and gamma oscillations during the associative memory task	University Hospital, Caen	All	18 Years to 30 Years   (Adult)	Not Applicable	40	Other	Interventional	Allocation: Non-Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Health Services Research	2013-AO1800-45	June 2014	December 2015	December 2016	October 31, 2014		October 31, 2014	UMR1077 Inserm/EPHE/UCBN, Caen, France		https://ClinicalTrials.gov/show/NCT02279680
382	NCT02225808	Neural Mechanisms of CBT for Anxiety in Autism (Open Pilot Study)		Completed	No Results Available	Autism|Autism Spectrum Disorder|Anxiety	Behavioral: CBT for anxiety in autism	functional magnetic resonance imaging (fMRI)|Multidimensional anxiety scale for children (MASC)|Pediatric Anxiety Rating Scale (PARS)	Yale University	All	8 Years to 14 Years   (Child)	Not Applicable	10	Other	Interventional	Allocation: N/A|Intervention Model: Single Group Assignment|Masking: None (Open Label)|Primary Purpose: Treatment	1211011144	August 2014	December 2016	December 2016	August 26, 2014		January 14, 2020	Yale School of Medicine, Child Study Center, New Haven, Connecticut, United States		https://ClinicalTrials.gov/show/NCT02225808
383	NCT01977248	Sensorimotor Affect Relationship-based Therapy (SMART) for Children With Autism Spectrum Disorders Ages 2-12	SMART	Completed	No Results Available	Autism Spectrum Disorder|Autistic Disorder	Behavioral: Sensorimotor Affect Relationship-based Therapy (SMART)	Pervasive Developmental Disorder Behavior Inventory (PDDBI)	Nationwide Children's Hospital	All	2 Years to 12 Years   (Child)	Not Applicable	37	Other	Interventional	Allocation: N/A|Intervention Model: Single Group Assignment|Masking: None (Open Label)|Primary Purpose: Treatment	IRB13-00460	October 2013	December 2014	December 2014	November 6, 2013		February 4, 2015	Nationwide Children's Hospital Hilliard Close to Home, Hilliard, Ohio, United States		https://ClinicalTrials.gov/show/NCT01977248
384	NCT00954213	A Study of a Developmental,Individual-Difference,Relationship-Bases/Floortime Intervention for Children With Autistic	DIR	Completed	No Results Available	Autism Spectrum Disorders	Behavioral: DIR/Floortime parent intervention	The Functional Emotional Assessment Scale (FEAS) Ratings (the child part)|The Childhood Autism Rating Scale (CARS) Clinical rating of the children (6 point scale related to Greenspan's six Functional Development Level -FDL) Satisfaction of the effectiveness of the intervention of their child (Six-point Likert scale)	Mahidol University	All	2 Years to 6 Years   (Child)	Not Applicable	40	Other	Interventional	Allocation: N/A|Intervention Model: Single Group Assignment|Masking: None (Open Label)|Primary Purpose: Treatment	206/2551(EC1)	May 2008	March 2010	June 2010	August 7, 2009		July 26, 2010	Kingkaew Pajareya, Bangkoknoi, Bangkok, Thailand		https://ClinicalTrials.gov/show/NCT00954213
385	NCT01535508	Open Label Clinical Trial of Vitamin D in Children With Autism		Completed	No Results Available	Autism|Vitamin D Deficiency	Drug: Liquid Vitamin D	Clinical Global Impression Scale - Improvement (CGI-I)	University of California, San Francisco	All	3 Years to 8 Years   (Child)	Phase 2|Phase 3	10	Other	Interventional	Allocation: N/A|Intervention Model: Single Group Assignment|Masking: None (Open Label)|Primary Purpose: Treatment	VitD11-06899	February 2012	September 2015	December 2015	February 17, 2012		October 9, 2019	University of California, San Francisco, San Francisco, California, United States		https://ClinicalTrials.gov/show/NCT01535508
386	NCT05235919	Treatment to Promote Self-regulation in Children With Autism Spectrum Disorder		Recruiting	No Results Available	Autism Spectrum Disorder|Self-Regulation, Emotion	Device: repetitive transcranial magnetic stimulation (rTMS)|Other: Sham stimulation	Recruitment|Attrition|Adherence|Blinding success|Clinical Measure of Self-regulation: Emotion Dysregulation Index Reactivity and Dysphoria|Clinical Measure of Self-Regulation: The Response To Stress Questionnaire - Family Stress|Clinical Measure of Self-regulation: Aberrant Behaviour Checklist - Irritability Subscale|Clinical Measure of Self-regulation: Emotional Regulation Checklist|Overall Clinical Change|Inhibitory control|Functional brain changes (magnetic resonance imaging)|Structural brain changes (magnetic resonance imaging)	Holland Bloorview Kids Rehabilitation Hospital|Centre for Addiction and Mental Health|University of Toronto	All	9 Years to 18 Years   (Child, Adult)	Phase 2	50	Other	Interventional	Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Triple (Participant, Investigator, Outcomes Assessor)|Primary Purpose: Treatment	ASDSR01	September 22, 2022	February 2025	February 2025	February 11, 2022		October 31, 2022	Bloorivew Research Institute, Toronto, Ontario, Canada		https://ClinicalTrials.gov/show/NCT05235919
387	NCT02300597	Internet-based Support for Young People With ADHD and Autism - a Controlled Study		Completed	No Results Available	ADHD|Autism Spectrum Disorders	Other: Internet based support and coaching	QoL|Self esteem|Sense of coherence|Anxiety and depressive symptoms|Depressive symptoms	Göteborg University|Södra Älvsborg Hospital|Habilitation Services in Skaraborg, Skövde	All	15 Years to 30 Years   (Child, Adult)	Not Applicable	45	Other	Interventional	Allocation: Non-Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Treatment	IBSC-2	September 2010	June 2015	June 2015	November 25, 2014		May 21, 2019	Department of Psychiatry and Neurochemistry, Institute of Neurosceince and Physiology, Gothenburg, Sweden		https://ClinicalTrials.gov/show/NCT02300597
388	NCT04980677	A Smart Toy for Motor Function and Early Assessment of Children With Possible Autism	Tangiball	Recruiting	No Results Available	Autism Spectrum Disorder|Neurodevelopmental Disorders	Device: Tangiball	Accelerometer outputs|User Experience Questionnaire|"Hands-On" assessment tool	Sussex Community NHS Foundation Trust|National Institute for Health Research, United Kingdom|Brighton & Sussex Medical School|Nottingham Trent University|University of Cambridge|Council for Disabled Children|Autistica	All	2 Years to 5 Years   (Child)	Not Applicable	20	Other	Interventional	Allocation: N/A|Intervention Model: Single Group Assignment|Masking: None (Open Label)|Primary Purpose: Device Feasibility	SCFT v1.0_Tangiball_29/04/2021	February 1, 2021	November 30, 2022	December 31, 2022	July 28, 2021		May 19, 2022	Sussex Community NHS Foundation Trust, Brighton, United Kingdom		https://ClinicalTrials.gov/show/NCT04980677
389	NCT03982888	Deep Brain Stimulation in Children With Autism		Recruiting	No Results Available	Autism Spectrum Disorder|Self-Injurious Behavior	Procedure: Deep Brain Stimulation|Device: DBS	Changes in repetitive behaviour|Changes in self-injurious behaviour|Changes in abberant behaviour|Changes in obsessive-compulsive thoughts|Changes in quality of life|Changes in physical brain abnormalities|Changes in metabolic brain abnormalities|Changes in activity|Type of adverse events reported in caregiver logs|Changes in number of complications pre and post intervention will be compared.	The Hospital for Sick Children	All	7 Years to 18 Years   (Child, Adult)	Not Applicable	6	Other	Interventional	Allocation: N/A|Intervention Model: Single Group Assignment|Masking: None (Open Label)|Primary Purpose: Treatment	REB1000060282	August 14, 2019	August 14, 2023	August 14, 2024	June 12, 2019		October 25, 2022	The Hospital for Sick Children, Toronto, Ontario, Canada		https://ClinicalTrials.gov/show/NCT03982888
390	NCT04450641	Piloting a Mobile Game for Behavioral Therapy		Completed	No Results Available	Autism Spectrum Disorder|Autism	Other: GuessWhat Mobile Application	Change in parent reported social responsiveness from week 0 to week 4|Change in parent reported socialization subscale scores of the Vineland Adaptive Behavior Scales,2nd Edition (VABS-II) from baseline to week 4|GuessWhat App Usage Data|Parent reported feedback|Change in parent reported communication subscale scores of the Vineland Adaptive Behavior Scales,2nd Edition (VABS-II) from baseline to week 4	Stanford University	All	3 Years to 12 Years   (Child)	Not Applicable	186	Other	Interventional	Allocation: Non-Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Other	39562	October 1, 2019	December 1, 2020	December 31, 2020	June 29, 2020		February 3, 2021	Stanford University, Stanford, California, United States		https://ClinicalTrials.gov/show/NCT04450641
391	NCT00027404	Study of Fluoxetine in Adults With Autistic Disorder		Completed	No Results Available	Autistic Disorder	Drug: Fluoxetine		Icahn School of Medicine at Mount Sinai|FDA Office of Orphan Products Development	All	18 Years to 65 Years   (Adult, Older Adult)	Not Applicable	48	Other	Interventional	Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Double|Primary Purpose: Treatment	FD-R-2026-01|FD-R-002026-01	September 2001		August 2005	December 7, 2001		March 25, 2015	Mount Sinai School of Medicine, New York, New York, United States		https://ClinicalTrials.gov/show/NCT00027404
392	NCT04319640	Cognitive Behaviour Therapy for Sleep Problems in Children With Autism Spectrum Disorder		Unknown status	No Results Available	Autism Spectrum Disorder|Cognitive Behaviour Therapy	Behavioral: Cognitive behaviour therapy for insomnia|Behavioral: psychoeducation for ASD	congnitive-neural outcomes|ADOS-2|Sleep diaries by using Actigraphy	Shanghai Jiao Tong University School of Medicine	All	24 Months to 59 Months   (Child)	Not Applicable	160	Other	Interventional	Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Single (Participant)|Primary Purpose: Treatment	SCMCIRB-K2018040	March 1, 2019	September 1, 2020	December 31, 2020	March 24, 2020		March 24, 2020	shanghai children's medicial center affiliated shanghai jiaotong University School of Medicine, Shanghai, Shanghai, China		https://ClinicalTrials.gov/show/NCT04319640
393	NCT04675580	Telehealth Language Intervention for Children With Autism Ages 2-4 Years		Completed	No Results Available	Autism Spectrum Disorder	Behavioral: Toy Talk	Change in number of unique combinations of subjects and verbs - caregiver|Change in number of unique combinations of subjects and verbs - child|Change in caregiver mean length of utterance|Change in child mean length of utterance|Change in Brief Observation of Social Communication Change (BOSCC) scores|Change in scores on the Observation of Spontaneous Expressive Language (OSEL) - baseline|Change in scores on the Vineland-3	Weill Medical College of Cornell University	All	2 Years to 4 Years   (Child)	Not Applicable	14	Other	Interventional	Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Double (Participant, Outcomes Assessor)|Primary Purpose: Treatment	21-03023432|19-07020518	December 23, 2020	July 15, 2022	July 15, 2022	December 19, 2020		August 2, 2022	Center for Autism and the Developing Brain/New York-Presbyterian Hospital, White Plains, New York, United States		https://ClinicalTrials.gov/show/NCT04675580
394	NCT02903030	Probiotics for Quality of Life in Autism Spectrum Disorders		Completed	Has Results	Autism Spectrum Disorders|Anxiety	Drug: Maltose (placebo)|Drug: Visbiome Extra Strength	Change in Gastrointestinal (GI) Module of the Pediatric Quality of Life Inventory (PedsQL) at From Baseline at Week 8|Change in Target Symptom Rating From Baseline at Week 8|Change in Parent Anxiety Checklist--ASD From Baseline at Week 8|Change in The Aberrant Behavior Checklist (ABC) From Baseline at Week 8|Change in Social Responsiveness Scale (SRS) From Baseline at Week 8|Children's Sleep Habits Questionnaire (CSHQ) at Week 8|Change in The Parenting Stress Index Short Form (PSI)	Ohio State University|Autism Treatment Network|Autism Speaks	All	3 Years to 12 Years   (Child)	Early Phase 1	13	Other	Interventional	Allocation: Randomized|Intervention Model: Crossover Assignment|Masking: Triple (Participant, Care Provider, Investigator)|Primary Purpose: Treatment	2016H0174	August 2016	December 1, 2017	December 1, 2017	September 16, 2016	February 5, 2020	February 5, 2020	Ohio State University Wexner Medical Center, Columbus, Ohio, United States	"Study Protocol and Statistical Analysis Plan", https://ClinicalTrials.gov/ProvidedDocs/30/NCT02903030/Prot_SAP_000.pdf	https://ClinicalTrials.gov/show/NCT02903030
395	NCT03323931	The Efficacy of Robot-enhanced Therapy for Children With Autism Spectrum Disorders	DREAM-RCT	Completed	No Results Available	Autistic Disorders Spectrum	Behavioral: (2) robot--enhanced intervention|Behavioral: (1) discrete trial training / cognitive-behavior therapy	Changes in Imitation skills ratings|Changes in Joint-attention skills ratings|Changes in Turn-taking skills ratings|Changes in Engagement in the task ratings|Changes in Verbal utterances ratings|Changes in Performance in sharing information task|Changes in Performance in sorting in categories task|Performance in continuing repetitive patterns task	Babes-Bolyai University|University of Skövde|Vrije Universiteit Brussel|University of Plymouth|University of Portsmouth|De Montfort University|SoftBank Robotics	All	3 Years to 6 Years   (Child)	Not Applicable	70	Other	Interventional	Allocation: Randomized|Intervention Model: Factorial Assignment|Masking: Single (Investigator)|Primary Purpose: Treatment	30664/10.02.2017	March 1, 2017	December 31, 2018	December 31, 2018	October 27, 2017		May 14, 2019	Babes-Bolyai University Psychological Clinic, Cluj-Napoca, Romania		https://ClinicalTrials.gov/show/NCT03323931
396	NCT03279471	Specifying and Treating Anxiety in Autism Research	STAAR	Recruiting	No Results Available	Autism Spectrum Disorder|Anxiety	Drug: Sertraline|Behavioral: CBT/BIACA|Drug: Placebo	Change in Pediatric Anxiety Rating Scale	University of California, Davis	All	8 Years to 14 Years   (Child)	Phase 2	132	Other	Interventional	Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Triple (Participant, Care Provider, Outcomes Assessor)|Primary Purpose: Treatment	1097281	October 1, 2017	December 15, 2022	June 14, 2023	September 12, 2017		February 7, 2022	UC Davis MIND Institute, Sacramento, California, United States		https://ClinicalTrials.gov/show/NCT03279471
397	NCT03099239	hCT-MSCs for Children With Autism Spectrum Disorder (ASD)	hCT-MSCs	Completed	No Results Available	Autism|Autism Spectrum Disorder|ASD	Biological: hCT-MSC infusion	Incidence of Infusion reactions|Incidence of Infections	Joanne Kurtzberg, MD|The Marcus Foundation|Duke University	All	2 Years to 11 Years   (Child)	Phase 1	12	Other	Interventional	Allocation: Non-Randomized|Intervention Model: Sequential Assignment|Masking: None (Open Label)|Primary Purpose: Treatment	Pro00079421	June 6, 2017	June 10, 2019	June 10, 2019	April 4, 2017		December 3, 2019	Duke University Medical Center, Durham, North Carolina, United States		https://ClinicalTrials.gov/show/NCT03099239
398	NCT02813564	Cognitive Training in Children With ASD		Unknown status	No Results Available	Autism Spectrum Disorder	Behavioral: Cognitive Assessment & Video-game INtervention Solutions (CAVINS)	The Dimensional Change Card Sorting task (DCCS): Measuring change in mental flexibility|The Go/NoGo task: Measuring change in inhibitory control|The preschool version of the Behavior Rating Inventory of Executive Function (BRIEF-P): Measuring change in everyday executive functions|Flanker Test: Measuring change in selective attention|Aberrant Behaviour Checklist (ABC): Measuring change in behaviour|Tower of Hanoi: Measuring change in planning ability|The Stroop-like day-night: Measuring change in inhibitory control|Sequential Order (SO): Measuring change in reasoning ability|The Peabody Picture Vocabulary Test (PPVT): Measuring change in communication abilities	McMaster University	All	3 Years to 7 Years   (Child)	Not Applicable	50	Other	Interventional	Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Single (Participant)|Primary Purpose: Treatment	0323	March 2, 2018	March 1, 2019	March 1, 2020	June 27, 2016		August 21, 2018	McMaster University, Hamilton, Ontario, Canada		https://ClinicalTrials.gov/show/NCT02813564
399	NCT04049981	Investigation of Mechanisms of Action in Superpower Glass		Suspended	No Results Available	Autism Spectrum Disorder|Autism	Device: Superpower Glass	Change in socialization subscale scores of the Vineland Adaptive Behavior Scales,3rd Edition (VABS-III) from baseline to week 4.|Change in Parent Rated Social Responsiveness Scale 2 (SRS-2) from baseline to week 4|Changes in Parent Self Agency Measure scores from Baseline to Week 4|Change in ASD symptoms as measured by Brief Observation of Social Communication Change (BOSCC) from baseline to week 4	Stanford University	All	4 Years to 8 Years   (Child)	Phase 1|Phase 2	80	Other	Interventional	Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Single (Outcomes Assessor)|Primary Purpose: Treatment	34059|PHIND Dream Team Award|SPARK Pilot Program	September 4, 2019	December 1, 2023	March 1, 2024	August 8, 2019		December 14, 2022	Stanford University, Stanford, California, United States		https://ClinicalTrials.gov/show/NCT04049981
400	NCT05017779	A Hybrid Effectiveness-implementation Trial of a School Based Executive Function Treatment for Transition Age Youth With Autism		Enrolling by invitation	No Results Available	Executive Dysfunction|Autism Spectrum Disorder|Adolescent Behavior	Behavioral: Unstuck & On Target: High School|Other: Treatment as Usual	Classroom Behavior|Adaptive Behavior (at follow-up)|Adaptive Behavior (end of intervention)	Children's National Research Institute	All	14 Years to 22 Years   (Child, Adult)	Not Applicable	224	Other	Interventional	Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Single (Outcomes Assessor)|Primary Purpose: Treatment	R01MH124772	September 7, 2021	October 30, 2024	November 30, 2024	August 24, 2021		November 3, 2021	Center for Autism Spectrum Disorders, Children's National Hospital, Rockville, Maryland, United States		https://ClinicalTrials.gov/show/NCT05017779
401	NCT01661855	A Pilot Study of Riluzole Versus Placebo in the Treatment of Children and Adolescents With ASD	RILISE	Completed	No Results Available	Autism Spectrum Disorders	Drug: Riluzole|Drug: Placebo	Efficacy of riluzole vs. placebo on measures of social function|Efficacy of riluzole vs. placebo on measures of repetitive behaviors|Safety and tolerability of riluzole in children and adolescents with ASD	Evdokia Anagnostou|Holland Bloorview Kids Rehabilitation Hospital|McMaster University|The Hospital for Sick Children|University of Western Ontario, Canada|Unity Health Toronto|University of Toronto|Anagnostou, Evdokia, M.D.	All	6 Years to 17 Years   (Child)	Phase 2	58	Other	Interventional	Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)|Primary Purpose: Treatment	RILISE-07-2013	September 2013	September 2015	October 2015	August 10, 2012		March 20, 2017	Offord Centre for Child Studies, Hamilton, Ontario, Canada|Lawson Health Research Institute, London, Ontario, Canada|Holland Bloorview Kids Rehabilitation Hospital, Toronto, Ontario, Canada		https://ClinicalTrials.gov/show/NCT01661855
402	NCT03592654	Pilot Study: A Telehealth Intervention for Caregivers of Infants With Early Signs of Autism Spectrum Disorder		Completed	No Results Available	Autism Spectrum Disorder|Developmental Delay	Behavioral: infant telehelp	Child Behaviors Targeted by Intervention|Autism Observation Scale for Infants|Ages and Stages Questionnaires, 3rd Edition|Individual Growth and Development Indices|Vineland Adaptive Behavior Scales, 2nd edition|Parent Satisfaction Rating|Working Alliance Scale for Interventions with Children|Caregiver Fidelity of Treatment Implementation	University of California, Davis	All	5 Months to 12 Months   (Child)	Not Applicable	12	Other	Interventional	Allocation: N/A|Intervention Model: Sequential Assignment|Masking: None (Open Label)|Primary Purpose: Treatment	1249018	July 1, 2018	September 18, 2019	October 1, 2019	July 19, 2018		September 4, 2020	MIND institute, Sacramento, California, United States		https://ClinicalTrials.gov/show/NCT03592654
403	NCT02278328	MEG Study of Acute STX209 Effects in ASD		Completed	Has Results	Autism Disorder	Drug: STX209 (15mg)|Drug: placebo|Drug: STX209 (30mg)	M50 Latency (Left Hemisphere)|M50 Latency (Right Hemisphere)|Steady State Inter Trial Coherence (Left Hemisphere)|Steady State Inter Trial Coherence (Right Hemisphere)|GABA (Left Hemisphere)	Timothy Roberts|Simons Foundation|Clinical Research Associates, LLC|Children's Hospital of Philadelphia	Male	14 Years to 17 Years   (Child)	Early Phase 1	25	Other	Interventional	Allocation: Randomized|Intervention Model: Crossover Assignment|Masking: None (Open Label)|Primary Purpose: Basic Science	14-010857	February 2016	July 30, 2018	September 27, 2019	October 30, 2014	October 21, 2019	October 21, 2019	Children's Hospital of Phladelphia, Philadelphia, Pennsylvania, United States	"Study Protocol and Statistical Analysis Plan", https://ClinicalTrials.gov/ProvidedDocs/28/NCT02278328/Prot_SAP_000.pdf	https://ClinicalTrials.gov/show/NCT02278328
404	NCT03883139	PRISM Intervention Study		Recruiting	No Results Available	Autism Spectrum Disorder	Behavioral: JASPER|Behavioral: DTT (Discrete Trial Training)	Change of spontaneous utterances (SCU) from the Language Sample throughout the study.|Change in Joint Engagement on the Adult-Child Interaction (ACX) over the course of the study.|Change in receptive language using the Preschool Language Scales-5 (PLS-5) throughout the study.|Presence of word combinations in the Language Sample over the course of the study.	University of California, Los Angeles	All	36 Months to 59 Months   (Child)	Not Applicable	140	Other	Interventional	Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Single (Outcomes Assessor)|Primary Purpose: Treatment	19-000193	March 1, 2021	March 31, 2025	March 31, 2026	March 20, 2019		August 15, 2022	UCLA, Los Angeles, California, United States|University of Rochester, Rochester, New York, United States|University of Oregon, Eugene, Oregon, United States		https://ClinicalTrials.gov/show/NCT03883139
405	NCT02995564	The Multi-Media Social Skills Project for Adults		Completed	No Results Available	Autism Spectrum Disorders	Behavioral: social skills therapy	Social Responsiveness Scale - Adult|Video recording of Social Interaction|Achenbach Adult Behavior Checklist|Social and Emotional Loneliness Scale for Adults (SELSA)|Social Skills Inventory (SSI)|Social Phobia Inventory (SPIN)|Empathy Quotient|Achenbach Adult Behavior Checklist - Self Report|Social Fluency Assessment	Milton S. Hershey Medical Center|Pennsylvania Bureau of Autism Services	All	18 Years to 35 Years   (Adult)	Not Applicable	199	Other	Interventional	Allocation: N/A|Intervention Model: Single Group Assignment|Masking: None (Open Label)|Primary Purpose: Treatment	41078EP	July 2013	April 9, 2018	April 9, 2018	December 16, 2016		March 13, 2019	The Pennsylvania Psychiatric Institute Northeast Drive Clinic, Hershey, Pennsylvania, United States		https://ClinicalTrials.gov/show/NCT02995564
406	NCT03721913	Participation-based Intervention on Community Participation and Parent Empowerment for Children With ASD	PBI-ASD	Completed	No Results Available	Autism Spectrum Disorder	Other: participation-based intervention	Change in the Canadian Occupational Performance Measure (COPM) performance and satisfaction scores|Change in the Goal Attainment Scaling (GAS) scores|Parent Empowerment and Efficacy Measure (PEEM)|Family Quality of Life (FaQoL)|Chinese version of Family-Professional Partnership Scale (FPPS-P-C)	Chang Gung University|Chang Gung Memorial Hospital	All	6 Years to 10 Years   (Child)	Not Applicable	24	Other	Interventional	Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Single (Outcomes Assessor)|Primary Purpose: Treatment	201800429A3	October 23, 2018	December 30, 2020	December 30, 2020	October 26, 2018		August 26, 2022	Chang Gung University, Taoyuan, Taiwan		https://ClinicalTrials.gov/show/NCT03721913
407	NCT05531669	Effect of PLAY Project Intervention Program on Children With ASD		Recruiting	No Results Available	Autism Spectrum Disorder	Behavioral: PLAY Project|Behavioral: Parental Education	Changes in Diagnostic and Statistical Manual of Mental Disorders fifth edition (DSM-Ⅴ) in ASD children|Changes in Autism Diagnostic Observation Schedule-Second Edition (ADOS-2) in ASD children|Changes in Child Autism Rating Scale (CARS) in ASD children|Changes in Social Communication Questionnaire (SCQ) in ASD children|Changes in Gesell Developmental Schedules (GDS) in ASD children|Changes in Pivotal Behavior Rating Scale (PBRS) in ASD children|Changes in Maternal Behavior Rating Scale (MBRS) in the interaction between ASD children and their parents|Raven's Standard Progressive Matrices (SPM)|Hamilton Depression Scale (HAMD)|Changes in Parenting Stress Index-Short Form (PSI-SF) in parents of ASD children	Tongji Hospital|Tongji Hospital affiliated to Tongji Medical College of Huazhong University of Science & Technology|Fuzhou Children's Hospital of Fujian Medical University|Third Affiliated Hospital of Zhengzhou University|Shenzhen Hospital of Southern Medical University|Children's Hospital of Zhejiang University School of Medicine	All	18 Months to 6 Years   (Child)	Not Applicable	200	Other	Interventional	Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Double (Participant, Outcomes Assessor)|Primary Purpose: Treatment	TJPLAY	August 1, 2022	December 31, 2023	December 31, 2023	September 8, 2022		September 27, 2022	Fuzhou Children's Hospital of Fujian Medical University, Fuzhou, Fujian, China|Shenzhen Hospital of Southern Medical University, Shenzhen, Guangdong, China|The Third Affiliated Hospital of Zhengzhou University, Zhengzhou, Henan, China|Tongji Hospital affiliated to Tongji Medical College of Huazhong University of Science & Technology, Wuhan, Hubei, China|Children's Hospital of Zhejiang University School of Medicine, Hangzhou, Zhejiang, China		https://ClinicalTrials.gov/show/NCT05531669
408	NCT02719951	Glutaminergic Transmission in Autism : Molecular Imaging Exploration	TANGAU	Completed	No Results Available	Autism|Fragile-X Syndrome (FXS)|Healthy Volunteers	Drug: [18F]FPEB PET imaging|Other: Biological samples|Other: MRI	cerebral glutaminergic activity assessed by binding potential of [18F]FPEB|distribution volume of [18F]FPEB	University Hospital, Tours	Male	18 Years to 45 Years   (Adult)	Phase 1	27	Other	Interventional	Allocation: Non-Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Diagnostic	PRIA 14 FBB / TANGAU	April 2016	November 15, 2018	May 2019	March 25, 2016		June 11, 2019	CHU Tours, Tours, France		https://ClinicalTrials.gov/show/NCT02719951
409	NCT00352352	Use of Acupuncture In Children With Autistic Spectrum Disorder		Completed	No Results Available	Autism|Autistic Disorder	Procedure: Tongue Acupuncture (Procedure)	Ritvo-Freeman Real Life Scale (RFRLS) was conducted on both groups before (Week 0) and after (Week 8) acupuncture.|Functional Independence Measure for children (WeeFIM) consists of 18 questions concerning on the Functional Independence Measure for children, which was conducted on both groups before (Week 0) and after (Week 8) acupuncture.|Parental Stress Index (PSI) consists of child domain, parent domain and a total domain, which was conducted on both groups before (Week 0) and after (Week 8) acupuncture.|Clinical Global Impression Scale (CGIS) is a measure in a Likert scale of 0 - 7, which was conducted on both groups before (Week 0) and after (Week 8) acupuncture.	The University of Hong Kong	All	3 Years to 15 Years   (Child)	Phase 3	30	Other	Interventional	Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Single|Primary Purpose: Treatment	3469296479554546				July 14, 2006		July 14, 2006	Duchess of Kent of Children Hospital, Hong Kong, Hong Kong		https://ClinicalTrials.gov/show/NCT00352352
410	NCT03337035	Probiotics and Oxytocin Nasal Spray on Social Behaviors of Autism Spectrum Disorder (ASD) Children		Completed	No Results Available	Autism Spectrum Disorder	Drug: intranasal oxytocin|Dietary Supplement: oral probiotics|Dietary Supplement: oral placebo	Social Responsiveness Scale (SRS) Edition 2|Aberrant Behavior Checklist (ABC) Edition 2|Neuroinflammation and Oxytocin levels|structural MRI|Functional MRI (resting state)|Functional MRI (task based)|Autonomic indices 1|Autonomic indices 2|Autonomic indices 3|Autonomic indices 4|Autonomic indices 5|Microbiome|Eye tracking and Behavioral task (joint attention)|Eye tracking and behavioral task (emotion response)|Eye tracking and behavioral task (eye behavior)	Massachusetts General Hospital	All	3 Years to 25 Years   (Child, Adult)	Phase 1	35	Other	Interventional	Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Triple (Participant, Care Provider, Investigator)|Primary Purpose: Treatment	2017P001667	December 1, 2018	October 2, 2019	October 2, 2019	November 8, 2017		March 4, 2020	Massachusetts General Hospital, Charlestown, Massachusetts, United States		https://ClinicalTrials.gov/show/NCT03337035
411	NCT05131347	Effects of Motor Skill Occupational Therapy Intervention ON ASD (Motion ASD)		Recruiting	No Results Available	Autism Spectrum Disorder	Behavioral: motor intervention|Behavioral: cognitive intervention	Bruininks-Oseretsky Test of Motor Proficiency-Second Edition (BOT-2) Brief Form|Vineland Adaptive Behavior Scales-Third Edition	National Cheng Kung University	All	4 Years to 5 Years   (Child)	Not Applicable	30	Other	Interventional	Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Single (Outcomes Assessor)|Primary Purpose: Treatment	A-BR-109-011	May 6, 2022	December 31, 2022	December 31, 2023	November 23, 2021		December 20, 2022	National Cheng Kung University, Tainan, Taiwan		https://ClinicalTrials.gov/show/NCT05131347
412	NCT00346736	Use of Acupuncture In Children With Autistic Spectrum Disorder		Completed	No Results Available	Autistic Disorder|Autism	Procedure: Acupuncture (Procedure)	Aberrant Behavioral Checklist (ABC) will be completed by parents and teachers at Week 0, once during Week 6 to Week 7, and once during Week 14 to Week 15.|Ritvo-Freeman Real LIfe Scale (RFRLS) will be completed by parents and teachers at Week 0, once during Week 6 to Week 7, and once during Week 14 to Week 15.|Functional Independence Measure for Children (WeeFIM) will be conducted by trained Research Assistant at Week 0, once during Week 6 to Week 7, and once during Week 14 to Week 15.|Pediatric Evaluation Disability Inventory (PEDI) will be completed by parents and teachers at Week 0, once during Week 6 to Week 7, and once during Week 14 to Week 15.|Leiter International Performance Scale-Revised will be conducted on patient by trained Research Assistant at Week 0, once during Week 6 to Week 7, and once during Week 14 to Week 15.|Reynell Language Developmental Scale will be conducted on patient by trained Research Assistant at Week 0, once during Week 6 to Week 7, and once during Week 14 to Week 15.|Symbolic Play Test will be conducted on patient by trained Research Assistant at Week 0, once during Week 6 to Week 7, and once during Week 14 to Week 15.|Clinical Global Impression Scale (CGIS) will be self administered by parent and by trained Research Assistant at Week 0, once during Week 6 to Week 7, and once during Week 14 to Week 15.	The University of Hong Kong	All	3 Years to 18 Years   (Child, Adult)	Phase 3	80	Other	Interventional	Allocation: Randomized|Intervention Model: Crossover Assignment|Masking: Double|Primary Purpose: Treatment	UW 04-096 T/418	May 2005	June 2006	March 2007	June 30, 2006		September 3, 2008	TWGHs Tung Wah Hospital, Hong Kong, Hong Kong		https://ClinicalTrials.gov/show/NCT00346736
413	NCT00325572	Evaluation and Treatment of Copper/Zinc Imbalance in Children With Autism		Terminated	Has Results	Autism|Pervasive Developmental Disorder	Drug: oral zinc and vitamin C supplements|Other: oral Placebo	Copper/Zinc Ratio of Children With Autism Compared to Typically Developing Children Phase 2: Change in Copper/Zinc Ratio With Supplementation of Zinc and Vitamin C	Milton S. Hershey Medical Center|Thrasher Research Fund	All	3 Years to 8 Years   (Child)	Phase 1	89	Other	Interventional	Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)|Primary Purpose: Treatment	23275	November 2006	December 2010	December 2011	May 15, 2006	July 17, 2019	July 17, 2019	Penn State Children's Hospital, Hershey, Pennsylvania, United States		https://ClinicalTrials.gov/show/NCT00325572
414	NCT03196713	Early Intervention, Supervision, Quality and Outcome in ASD		Completed	No Results Available	Autism Spectrum Disorder	Behavioral: Early Intensive Behavioral Intervention	York Measure of Quality of Behavioural Intensive Intervention (YMQI)|Vineland Adaptive Behavior Scales (VABS)|Social Responsiveness Scale (SRS)	Karolinska Institutet	All	2 Years to 6 Years   (Child)	Not Applicable	34	Other	Interventional	Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Single (Outcomes Assessor)|Primary Purpose: Health Services Research	EIBI Quality	April 1, 2013	August 31, 2017	October 27, 2017	June 23, 2017		August 15, 2018	KIND, CAP Research Center, Stockholm, Sweden		https://ClinicalTrials.gov/show/NCT03196713
415	NCT02812368	Clonidine for Sleep Disturbances in Children With Autism Spectrum Disorder		Withdrawn	No Results Available	Autism Spectrum Disorder	Drug: Clonidine|Drug: Placebo (for clonidine)	Change in Children's Sleep Habits Questionnaire (CSHQ) Total Score	Ohio State University|Autism Treatment Network|Autism Intervention Research Network on Physical Health	All	6 Years to 14 Years   (Child)	Phase 2	0	Other	Interventional	Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)|Primary Purpose: Treatment	2016H0181	August 2016	January 2017	January 2017	June 24, 2016		February 2, 2017	Ohio State University Nisonger Center, Columbus, Ohio, United States		https://ClinicalTrials.gov/show/NCT02812368
416	NCT03020927	Therapist and Parent Delivered Reciprocal Imitation Training for Young Children With Autism Spectrum Disorder	ParentRIT	Suspended	No Results Available	Autism Spectrum Disorder	Behavioral: Reciprocal Imitation Training (Therapist-Delivered)|Behavioral: Reciprocal Imitation Training (Therapist + Parent Delivered)	Unstructured Imitation Assessment (UIA)|Percentage of parent acts imitated during Parent-Child Play Interaction|Parenting Stress Index, 4th Edition|Motor Imitation Scales|Early Social Communication Scales|Proportion of time spent jointly engaged during Parent-Child Play Interaction	Ohio State University	All	24 Months to 60 Months   (Child)	Not Applicable	30	Other	Interventional	Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Treatment	2015B0475	April 2016	December 2023	December 2023	January 13, 2017		November 22, 2022	The Ohio State University, Columbus, Ohio, United States		https://ClinicalTrials.gov/show/NCT03020927
417	NCT05092321	Aquatic Therapy for ASD		Recruiting	No Results Available	Autism Spectrum Disorder	Behavioral: Aquatic Occupational Therapy	Change in swim skills|Change in individualized goals|Change in parent comfort|Parent perspective	Ohio State University|Franklin County Board of Developmental Disabilities	All	3 Years to 12 Years   (Child)	Not Applicable	48	Other	Interventional	Allocation: N/A|Intervention Model: Single Group Assignment|Masking: None (Open Label)|Primary Purpose: Treatment	2019J0204	September 14, 2021	August 31, 2023	December 31, 2023	October 25, 2021		October 6, 2022	The Ohio State University, Columbus, Ohio, United States		https://ClinicalTrials.gov/show/NCT05092321
418	NCT01340092	Use of a Family Navigator in Families With Children Newly Diagnosed With Autism Spectrum Disorder		Completed	No Results Available	Autistic Disorder	Other: Family Navigator	Hours of Services|Receipt of adequate services|Time to Receipt of Services|Family Psychological Functioning	Boston Medical Center	All	15 Years to 64 Years   (Child, Adult)	Not Applicable	192	Other	Interventional	Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Single (Outcomes Assessor)|Primary Purpose: Supportive Care	29964|HRSA R40MC19928-01-00	April 2011	May 2014	May 2014	April 22, 2011		April 25, 2016	Boston Medical Center, Boston, Massachusetts, United States		https://ClinicalTrials.gov/show/NCT01340092
419	NCT00355329	Randomized Control Trial of Using Tongue Acupuncture in Autistic Spectrum Disorder Using PET Scan for Clinical Correlation		Completed	No Results Available	Autism|Autistic Disorder	Procedure: Tongue Acupuncture (Procedure)	Autism Treatment Evaluation Checklist (ATEC) consisting of 4 subscales before (Week 0) and after (Week 8) acupuncture|Reynell Language Developmental Scale (RLDS) before (Week 0) and after (Week 8) acupuncture|Symbolic Play Test (SPT) before (Week 0) and after (Week 8) acupuncture|Functional Independence Measure for children (WeeFIM) with 3 domains before (Week 0) and after (Week 8) acupuncture|Clinical Global Impression Scale (CGIS) before (Week 0) and after (Week 8) acupuncture|18F-fluorodeoxyglucose Positron Emission Tomography (PET) before (Week 0) and after (Week 8) acupuncture	The University of Hong Kong	All	3 Years to 16 Years   (Child)	Phase 3	30	Other	Interventional	Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Double|Primary Purpose: Treatment	PET-001				July 21, 2006		October 20, 2006	Duchess of Kent of Children Hospital, Hong Kong, Hong Kong		https://ClinicalTrials.gov/show/NCT00355329
420	NCT01078714	Efficiency of Bumetanide in Autistic Children	BUMEA	Completed	No Results Available	Autistics Children	Drug: bumetanide	Child Autism Rating Scale score|Clinical global impressions score|Repetitive end restricted behavior score|GRAM score	University Hospital, Brest	All	3 Years to 10 Years   (Child)	Phase 3	60	Other	Interventional	Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Double (Participant, Investigator)|Primary Purpose: Treatment	RB09-017	March 2010	June 2011	June 2011	March 2, 2010		December 21, 2011	Lemonnier, Brest, France|Chevreuil, Rennes, France|DUPIN, Vannes, France		https://ClinicalTrials.gov/show/NCT01078714
421	NCT04955093	Heart Rate Variability Biofeedback in Young People With Autism		Completed	No Results Available	Autistic Disorders Spectrum	Device: Biofeedback	Reduction in Anxiety Scale using Beck Youth Inventory|Any change in Heart rate variability (ideally key metrics increased)	University of Ulster|South Eastern Health and Social Care Trust	All	13 Years to 24 Years   (Child, Adult)	Not Applicable	20	Other	Interventional	Allocation: Randomized|Intervention Model: Sequential Assignment|Masking: None (Open Label)|Primary Purpose: Treatment	IRAS139122|15/NI/0255	May 30, 2016	August 9, 2017	August 9, 2017	July 8, 2021		July 8, 2021	South Eastern Health Trust, Belfast, Northern Ireland, United Kingdom		https://ClinicalTrials.gov/show/NCT04955093
422	NCT05268744	Micronutrient Supplementation in Children With ASD		Active, not recruiting	No Results Available	Autism Spectrum Disorder	Drug: Micronutrient	Correlation between change in the Autism Behavior Inventory, Short Form (ABI-S) and change in metabolites.|Correlation between change in the Social Responsiveness Scale (SRS) and change in metabolites.	University of California, San Francisco	All	5 Years to 22 Years   (Child, Adult)	Phase 2	20	Other	Interventional	Allocation: N/A|Intervention Model: Single Group Assignment|Masking: None (Open Label)|Primary Purpose: Treatment	22-35971	November 14, 2022	January 12, 2023	January 30, 2023	March 7, 2022		December 2, 2022	University of California, San Francisco, San Francisco, California, United States		https://ClinicalTrials.gov/show/NCT05268744
423	NCT05218577	The Effect of High Selenium Functional Food and Selenium Supplement		Completed	No Results Available	Autism Spectrum Disorder	Other: high selenium functional food|Dietary Supplement: selenium supplement|Other: Placebo	The change of Developmental level|The change of GPx level|The change of IL-1 betha level|The change of IL-6 level|The change of TNF-Alpha level	Neny Triana|Karya Husada Sshool Health Science	All	2 Months to 6 Years   (Child)	Not Applicable	65	Other	Interventional	Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Double (Participant, Investigator)|Primary Purpose: Treatment	Neny Triana	January 1, 2021	December 24, 2021	December 24, 2021	February 1, 2022		February 1, 2022	Neny Triana, Kediri, Jawa Timur, Indonesia		https://ClinicalTrials.gov/show/NCT05218577
424	NCT05472870	Efficacy and Mechanism of rTMS in Children With ASD: an Open-label Clinical Trial(Ⅱ)		Enrolling by invitation	No Results Available	Autism Spectrum Disorder	Device: repetitive Transcranial Magnetic Stimulation	Change in Social Response Scale (SRS)|Childhood Autism Rating Scale (CARS)|Behavior Rating Inventory of Executive Function(BRIEF)|Conners Scale|Repetitive Stereotyped Behavior - Revised (RBS-R)|Peabody Picture Vocabulary Test（PPVT）|Chinese Communicative Development Inventory (CCDI)|Clinical Efficacy Rating Scale (CGI)	Xinhua Hospital, Shanghai Jiao Tong University School of Medicine|Shanghai Mental Health Center	All	4 Years to 16 Years   (Child)	Not Applicable	30	Other	Interventional	Allocation: N/A|Intervention Model: Single Group Assignment|Masking: None (Open Label)|Primary Purpose: Treatment	XHEC-C-2022-008-4	July 12, 2022	September 2023	December 2023	July 25, 2022		July 27, 2022	Fei Li, Shanghai, Shanghai, China		https://ClinicalTrials.gov/show/NCT05472870
425	NCT00352248	Randomized Controlled Trial of Acupuncture Versus Sham Acupuncture in Autistic Spectrum Disorder		Completed	No Results Available	Autistic Disorder|Autism	Procedure: Tongue Acupuncture (Procedure)	Griffiths Mental Developmental Scale (GMDS) was conducted before (at Week 0) and after (at Week 9) acupuncture.|Ritvo-Freeman Real Life Scale (RFRLS) was conducted before (at Week 0) and after (at Week 9) acupuncture.|Reynell Language Developmental Scale (RLDS) was conducted before (at Week 0) and after (at Week 9) acupuncture.|Symbolic Play Test (SPT) was conducted before (at Week 0) and after (at Week 9) acupuncture.|Functional Independence Measure for children (WeeFIM) was conducted before (at Week 0) and after (at Week 9) acupuncture.	The University of Hong Kong	All	3 Years to 11 Years   (Child)	Phase 3	50	Other	Interventional	Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Single|Primary Purpose: Treatment	9608944339555027				July 14, 2006		July 14, 2006	Duchess of Kent of Children Hospital, Hong Kong, Hong Kong		https://ClinicalTrials.gov/show/NCT00352248
426	NCT05238298	Efficacy and Mechanism of rTMS in Children With ASD: an Open-label Clinical Trial		Completed	No Results Available	Autism Spectrum Disorder	Device: repetitive Transcranial Magnetic Stimulation	Social Response Scale (SRS)|Repetitive Stereotyped Behavior - Revised (RBS-R)|ADHD Rating Scale|Behavior Rating Inventory of Executive Function(BRIEF)|Childhood Autism Rating Scale (CARS)|Clinical Efficacy Rating Scale (CGI)	Xinhua Hospital, Shanghai Jiao Tong University School of Medicine|Shanghai Mental Health Center	All	6 Years to 10 Years   (Child)	Not Applicable	20	Other	Interventional	Allocation: N/A|Intervention Model: Single Group Assignment|Masking: None (Open Label)|Primary Purpose: Treatment	XHEC-C-2022-008	January 28, 2022	March 29, 2022	April 1, 2022	February 14, 2022		May 5, 2022	ShanghaiXinhua, Shanghai, Shanghai, China		https://ClinicalTrials.gov/show/NCT05238298
427	NCT05066906	Videogame-based Tool for Job Search and Executive Function Improvement in Adults With ASD		Withdrawn	No Results Available	Autism Spectrum Disorder	Device: Use of Identifor assessment tool and Companion app|Other: Referral to employment agencies	Rate of securing internship, part-time, or full-time positions|Level of satisfaction|Behavior Rating Inventory of Executive Function for Adults (BRIEF-A)	Stanford University	All	18 Years to 55 Years   (Adult)	Not Applicable	0	Other	Interventional	Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Device Feasibility	IRB-52313	May 2021	June 2021	July 2021	October 4, 2021		October 4, 2021			https://ClinicalTrials.gov/show/NCT05066906
428	NCT04942522	Application of Probiotic PS128 in Children With ASD		Enrolling by invitation	No Results Available	Autism Spectrum Disorder	Biological: probiotics PS128|Drug: placebo (Microcrystalline cellulose )	change in Autism Diagnostic Observation Scale (ADOS)|change in Social Responsiveness Scale (SRS)|Change in Social Communication Questionnaire (SCQ)|Change in the Autism Behavior Checklist (ABC)|Change in the Childhood Autism Rating Scale (CARS)|Change in Gesell developmental scale|Change in frequency of child behavioral problems|Change in frequency of ASD symptoms|change in gastrointestinal symptoms among children with ASD|Cytokine Analysis|Evaluate changes of type, number and structural composition of gut microorganisms in children with ASD.	Yan Hao|Tongji Hospital	All	2 Years to 5 Years   (Child)	Phase 1	80	Other	Interventional	Allocation: Randomized|Intervention Model: Crossover Assignment|Masking: Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)|Primary Purpose: Treatment	S313	June 6, 2021	June 6, 2023	October 6, 2023	June 28, 2021		August 31, 2022	Tongji Hospital, Wuhan, Hubei, China		https://ClinicalTrials.gov/show/NCT04942522
429	NCT05307536	Autologous BMMNCs Combined With Educational Intervention for ASD		Recruiting	No Results Available	Autism Spectrum Disorder	Combination Product: Autologous BMMNCs transplantation and educational intervention|Combination Product: Educational intervention	Change of severity of ASD after intervention through the Diagnostic and Statistical Manual of Mental Disorders|Change of severity of ASD after intervention through the Childhood Autism Rating Scale|Changes in social interaction; adaptive behaviour; daily living skills through Vineland Adaptive Behaviour Scale|Changes in social interaction; adaptive behaviour; daily living skills through Clinical Global Impression Improvement|Changes in health-related quality of life using Pediatric Quality of Life Inventory (PedsQL)	Vinmec Research Institute of Stem Cell and Gene Technology	All	3 Years to 7 Years   (Child)	Phase 2	54	Other	Interventional	Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Treatment	ISC.19.50	December 26, 2021	June 30, 2023	June 30, 2023	April 1, 2022		August 29, 2022	Vinmec Research Institute of Stem Cell and Gene Technology, Hanoi, Vietnam		https://ClinicalTrials.gov/show/NCT05307536
430	NCT04729127	A Trial of Project ImPACT in Early Intervention		Completed	No Results Available	Autism Spectrum Disorder	Behavioral: Project ImPACT	Vineland Adaptive Behavior Scales 3rd Edition|Brief Observation of Social Communication Change (BOSCC)|Early Intervention Parenting Self-Efficacy Scale (EIPSES)|Parenting Interactions with Children: Checklist of Observations Linked to Outcomes (PICCOLO)|Project ImPACT Intervention Fidelity Checklist|Project ImPACT Coaching Fidelity Checklist	University of Pennsylvania|Michigan State University	All	up to 30 Months   (Child)	Not Applicable	120	Other	Interventional	Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Treatment	842506	June 11, 2020	August 15, 2022	August 31, 2022	January 28, 2021		September 14, 2022	Center for Mental Health, Philadelphia, Pennsylvania, United States		https://ClinicalTrials.gov/show/NCT04729127
431	NCT02139514	Virtual Reality Social Cognition Training for Adults With Autism Spectrum Disorders		Completed	No Results Available	Autism Spectrum Disorders	Behavioral: Virtual Reality Social Cognition Training	functional magnetic resonance imaging (MRI)	Yale University|University of Texas	Male	18 Years to 40 Years   (Adult)	Not Applicable	10	Other	Interventional	Allocation: Non-Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Treatment	1211011083	January 2013	June 2016	June 2016	May 15, 2014		October 26, 2016	Yale University, New Haven, Connecticut, United States		https://ClinicalTrials.gov/show/NCT02139514
432	NCT04467073	Stepped-care Telehealth for Young Children With ASD		Completed	No Results Available	Autism Spectrum Disorder	Behavioral: Online RIT	Change from Baseline RIT Parent Fidelity Form (RIT-PFF) Score at 15 weeks|Change from Baseline Unstructured Imitation Assessment (UIA) Score at 15 weeks|Change from Baseline Early Intervention Parenting Self-Efficacy Scale (EIPSES) Score at 15 weeks|Change from Baseline Social Communication Checklist (SCC) Score at 15 weeks|Change from Baseline Beach Center Family Quality of Life Scale (FQOL) Score at 15 weeks	Rush University Medical Center	All	16 Months to 60 Months   (Child)	Not Applicable	20	Other	Interventional	Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Treatment	15100203	January 10, 2016	August 30, 2017	August 30, 2017	July 10, 2020		July 10, 2020	Rush University Medical Center, Chicago, Illinois, United States		https://ClinicalTrials.gov/show/NCT04467073
433	NCT03432065	A Pilot Study of Buspirone for the Treatment of Anxiety in Youth With Autism Spectrum Disorders		Not yet recruiting	No Results Available	Autism Spectrum Disorder|Anxiety	Drug: Buspirone	Reduction in Child and Adolescent Symptom Inventory-5-Anxiety (CASI-Anx) Score	Massachusetts General Hospital	All	6 Years to 17 Years   (Child)	Phase 2	15	Other	Interventional	Allocation: N/A|Intervention Model: Single Group Assignment|Masking: None (Open Label)|Primary Purpose: Treatment	2017-P-002731	December 2022	August 2023	August 2023	February 13, 2018		January 12, 2022	Massachusetts General Hospital, Boston, Massachusetts, United States		https://ClinicalTrials.gov/show/NCT03432065
434	NCT04147988	Characterizing ASD Adult Population Asking for a Diagnosis	ASSORT	Completed	No Results Available	Autism Spectrum Disorder	Other: screening and diagnostic assessment DONALD T unit list	Autism Diagnostic Observation Schedule (ADOS-2)|Adult Asperger's Assessment (AAA)|Vineland Adaptative Behavior Scale (VABS-2)|Hospital Anxiety and Depression Scale (HADS)|Liebowitz Social Anxiety Scale (LSAS)|Yale-Brown Scale(Y-BOCS)	Hôpital le Vinatier	All	18 Years to 65 Years   (Adult, Older Adult)	Not Applicable	42	Other	Interventional	Allocation: N/A|Intervention Model: Single Group Assignment|Masking: None (Open Label)|Primary Purpose: Diagnostic	2019-A01130-57	September 27, 2019	July 31, 2021	September 30, 2021	November 1, 2019		January 27, 2022	Centre hospitalier Le Vinatier, Bron, Aura, France		https://ClinicalTrials.gov/show/NCT04147988
435	NCT03859336	High-Frequency Transdermal Neuromodulation to Decrease Anxiety and Improve Sleep in ASD		Completed	No Results Available	Autism Spectrum Disorder	Device: Transdermal Neuromodulation Stimulation	Change in physiological response measure of heart rate variability in the time-domain as measured by the standard deviation of the normal-to-normal heart beat (SDNN)|Change in physiological response measure of heart rate variability in the frequency-domain as measured by the power of the low frequency (LF) band|Change in physiological response measure of heart rate variability in the frequency-domain as measured by the power of the high frequency (HF) band|Change in physiological response measure of galvanic skin response (GSR)|Change in the Screen for Child Anxiety Related Disorders (SCARED) score|Change in the Parent Reported Anxiety Scale (PRAS) score|Change in amylase and cortisol levels|Change in the Children's Sleep Habits Questionnaire (CSHQ) score	Phoenix Children's Hospital	All	10 Years to 25 Years   (Child, Adult)	Not Applicable	10	Other	Interventional	Allocation: N/A|Intervention Model: Single Group Assignment|Masking: None (Open Label)|Primary Purpose: Treatment	TENS_ASD	May 21, 2019	July 19, 2021	October 6, 2021	March 1, 2019		December 20, 2021	Phoenix Children's Hospital, Phoenix, Arizona, United States		https://ClinicalTrials.gov/show/NCT03859336
436	NCT04060030	Treatment of Social and Language Deficits With Leucovorin for Young Children With Autism		Active, not recruiting	No Results Available	Autism Spectrum Disorder|Language Disorders	Drug: Levoleucovorin Calcium|Other: Placebo	Evaluate the change in social communication symptoms|Evaluate the safety and tolerability of L-leucovorin calcium in young children with ASD|Evaluate the safety of L-leucovorin calcium in young children with ASD|Examine the change in measures of Expressive and Receptive Language|Evaluate the change in effects of autism symptoms on family members|Evaluate the change in stereotypical autism symptoms|Evaluate change in overall autism severity|Evaluate the change in overall cognitive ability|Evaluate the change in adaptive functioning|Evaluate the overall change in core ASD symptoms of social communication	Rossignol Medical Center|Autism Speaks|State University of New York - Downstate Medical Center|Southwest Autism Research & Resource Center	All	30 Months to 60 Months   (Child)	Phase 2	80	Other	Interventional	Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)|Primary Purpose: Treatment	AS Leucovorin	October 8, 2020	December 2023	December 2023	August 16, 2019		September 28, 2022	Southwestern Research & Resource Center, Phoenix, Arizona, United States|State University of New York, Downstate, Brooklyn, New York, United States		https://ClinicalTrials.gov/show/NCT04060030
437	NCT03963479	Vitamin B6 and Magnesium- A Clinical Trial on ASD Patients		Unknown status	No Results Available	Autism Spectrum Disorder	Combination Product: Magnesium and Vitamin B6	Autism Spectrum Disorder	Bangabandhu Sheikh Mujib Medical University, Dhaka, Bangladesh	All	2 Years to 12 Years   (Child)	Phase 2	50	Other	Interventional	Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Triple (Participant, Care Provider, Outcomes Assessor)|Primary Purpose: Supportive Care	BSMMU/2018/14607	January 1, 2019	July 31, 2019	July 31, 2019	May 24, 2019		July 31, 2019	Farhana Khan, Dhaka, Bangladesh		https://ClinicalTrials.gov/show/NCT03963479
438	NCT05208411	Prodromal ImPACT Intervention for Children at Elevated Likelihood of ASD	SAPIENS	Recruiting	No Results Available	Autism Spectrum Disorder	Behavioral: Project ImPACT: Improving Parents As Communication Teachers	Bigger change from baseline in the parent-child interaction in the intervention group compared to the no-intervention group.|Bigger change from post-test in the intervention group in the parent-child interaction compared to the no-intervention group.|Bigger change from baseline in Social Engagement in the intervention group compared to the no-intervention group.|Bigger change from baseline in the score of imitation in the intervention group compared to the no-intervention group.|Bigger change from baseline in the score of intentional communication in the intervention group compared to the no-intervention group|Bigger change from baseline in attention disengagement in the intervention group compared to the no-intervention group|Bigger change from baseline in the intervention group compared to the no-intervention group in electrophysiological spectral power and connectivity (theta and alpha band) in response to social versus non-social videos, measured with EEG.|Bigger change from post-test in the intervention group in the score of Social Engagement compared to the no-intervention group.|Bigger change from post-test in the score of a semi-structured social imitation task compared to the no-intervention group.|Bigger change from post-test in the score of intentional communication in the intervention group compared to the no-intervention group|Bigger change from post-test in the intervention group in electrophysiological spectral power and connectivity (theta and alpha band) in response to social versus non-social videos, measured with EEG.|Bigger change from post-test in attention disengagement in the intervention group compared to the no-intervention group, measured with Eye-tracking|Difference between intervention and no-intervention group in the severity score of the Autism Diagnostic Observational Scale - 2 (ADOS-2).|Bigger change from baseline in the in the intervention group in the score of the Bayley Scales of Infant and Toddler Development - Third Edition - NL compared to the no-intervention group.|Bigger change from baseline in the intervention group score of the Nijmeegse Ouderlijke Stress Index compared to the no-intervention group.|Bigger change from baseline in the intervention group score of the Vineland screener questionnaire (0-6 years) compared to the no-intervention group.|Difference between intervention and no-intervention group in language.	University Ghent	All	9 Months to 18 Months   (Child)	Not Applicable	80	Other	Interventional	Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Double (Investigator, Outcomes Assessor)|Primary Purpose: Prevention	814302	March 28, 2022	September 2023	September 2023	January 26, 2022		November 8, 2022	Ghent University, Ghent, Oost-Vlaanderen, Belgium		https://ClinicalTrials.gov/show/NCT05208411
439	NCT01847521	Effects of the Anti-inflammatory Flavonoid Luteolin on Behavior in Children With Autism Spectrum Disorders		Completed	No Results Available	Autism Spectrum Disorders	Dietary Supplement: Luteolin, Quercetin and Rutin combined in a capsule	Change in Age-Equivalent scores of the Vineland Adaptive Behavior Scales domains from baseline at 26 weeks|Change in Aberrant Behavior Checklist subscales from baseline at 18th week and at 26th week|Change in Autism Treatment Evaluation Checklist from baseline at 18th week and at 26th week|Clinical Global Impression-Improvement score at 18th week and at 26th week	Attikon Hospital	All	4 Years to 10 Years   (Child)	Phase 2	50	Other	Interventional	Allocation: N/A|Intervention Model: Single Group Assignment|Masking: None (Open Label)|Primary Purpose: Treatment	NeuroproteckOpenLabel	December 2011	February 2013	March 2013	May 7, 2013		May 7, 2013	Attikon Hospital, Chaidari, Athens, Greece		https://ClinicalTrials.gov/show/NCT01847521
440	NCT03972254	Feasibility of Using Telepractice to Provide Modified Interaction Guidance.		Completed	No Results Available	Autism Spectrum Disorder	Behavioral: Modified Interaction Guidance	Parenting Interactions with Children Checklist of Observations Linked to Outcomes (PICCOLO)|Goal Attainment Scale (GAS)	University of Manitoba	All	10 Months to 35 Years   (Child, Adult)	Not Applicable	8	Other	Interventional	Allocation: N/A|Intervention Model: Single Group Assignment|Masking: None (Open Label)|Primary Purpose: Treatment	H2019:105	November 1, 2020	March 1, 2021	December 1, 2021	June 3, 2019		January 12, 2022	College of Rehabilitation Sciences, Winnipeg, Manitoba, Canada		https://ClinicalTrials.gov/show/NCT03972254
441	NCT02755051	Targeting Sleep in Kids With Autism Spectrum Disorder		Completed	No Results Available	Autism Spectrum Disorder|Chronic Insomnia	Behavioral: Cognitive Behavioral Therapy	Change from Baseline Subjective Sleep at 12 weeks|Change from Baseline Objective Sleep at 12 weeks|Change from Baseline Subjective Sleep at 18 weeks|Change from Baseline Objective Sleep at 18 weeks|Child Behavior at Baseline|Child Behavior at Post-treatment|Child Behavior at Follow-up|Change in subjective Parent Sleep from Baseline at 12 weeks|Change in subjective Parent Sleep from Baseline at 18 weeks|Change in objective Parent Sleep from Baseline at 12 weeks|Change in objective Parent Sleep from Baseline at 18 weeks	University of Missouri-Columbia	All	6 Years to 12 Years   (Child)	Not Applicable	30	Other	Interventional	Allocation: N/A|Intervention Model: Single Group Assignment|Masking: None (Open Label)|Primary Purpose: Treatment	2004675	July 2016	March 2018	March 2018	April 28, 2016		July 20, 2018	Department of Health Psychology, University of Missouri-Columbia, Columbia, Missouri, United States		https://ClinicalTrials.gov/show/NCT02755051
442	NCT04145076	Brain Response to Serotonergic Medications in ASD		Recruiting	No Results Available	Autism Spectrum Disorder	Drug: Placebo|Drug: Citalopram|Drug: Tianeptine	Brain excitation and inhibition response to pharmacological stimulation as assessed by magnetic resonance spectroscopy|Brain activation response to pharmacological stimulation as assessed by functional magnetic resonance imaging|Brain connectivity response to pharmacological stimulation as assessed by resting-state functional magnetic resonance imaging	King's College London	Male	18 Years to 60 Years   (Adult)	Not Applicable	100	Other	Interventional	Allocation: Randomized|Intervention Model: Crossover Assignment|Masking: Double (Participant, Investigator)|Primary Purpose: Basic Science	14/LO/0663	December 15, 2014	February 2023	May 31, 2023	October 30, 2019		April 15, 2022	King's College London, London, United Kingdom		https://ClinicalTrials.gov/show/NCT04145076
443	NCT03980366	Use of Electroconvulsive Therapy to Treat Self-Injurious Behavior in Adults With Autism Spectrum Disorders		Terminated	No Results Available	Autism Spectrum Disorder|Self-Injurious Behavior	Device: Electroconvulsive Therapy (ECT)	Changes in Self-Injury Trauma Scale (SIT) across time|Changes in Daily Diary Card across time|Changes in Repetitive Behavior Scale-Revised (RBS-R) across time|Changes in Aberrant Behavior Checklist (ABC) across time|Changes in ASD Diagnostic Checklist (ADC) across time	Eastern Virginia Medical School|Sentara Norfolk General Hospital	All	18 Years to 89 Years   (Adult, Older Adult)	Not Applicable	1	Other	Interventional	Allocation: N/A|Intervention Model: Single Group Assignment|Masking: None (Open Label)|Primary Purpose: Treatment	ECT4ASD	March 15, 2019	September 9, 2020	September 9, 2020	June 10, 2019		June 24, 2021	Eastern Virginia Medical School, Norfolk, Virginia, United States	"Study Protocol", https://ClinicalTrials.gov/ProvidedDocs/66/NCT03980366/Prot_000.pdf|"Informed Consent Form", https://ClinicalTrials.gov/ProvidedDocs/66/NCT03980366/ICF_001.pdf	https://ClinicalTrials.gov/show/NCT03980366
444	NCT02010086	Schema, Emotion and Behavior-Based Therapy for School Children	SEBASTIEN JR	Completed	No Results Available	Autism Spectrum Disorder	Behavioral: Individual Cognitive Behavioral Therapy|Behavioral: Standard Community Treatment	Playground Observation of Peer Engagement scale	University of California, Los Angeles	All	6 Years to 10 Years   (Child)	Not Applicable	44	Other	Interventional	Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Single (Outcomes Assessor)|Primary Purpose: Treatment	12000556|Autism Speaks 7552	December 2011	November 2015	June 2016	December 12, 2013		September 7, 2018	Jeffrey Wood, Los Angeles, California, United States		https://ClinicalTrials.gov/show/NCT02010086
445	NCT03812068	Parent-mediated Developmental Behavioral Intervention	PDBI	Unknown status	No Results Available	Autism Spectrum Disorder	Behavioral: Long-distance developmental behavioral intervention|Behavioral: Developmental behavioral intervention	The Autism Diagnostic Observation Schedule|Child Behavior Checklist Ages 1.5-5|Pediatric Evaluation of Disability Inventory|Mullen Scale of Early Learning|Movement Assessment Battery for Children|3D Gait Assessment Foot-worn Inertial Sensor|Peabody Developmental Motor Scales, Second Edition|Parenting Stress Index|Parenting Sense of Competence Scale	National Taiwan University Hospital	All	30 Months and older   (Child, Adult, Older Adult)	Not Applicable	120	Other	Interventional	Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Single (Outcomes Assessor)|Primary Purpose: Treatment	201809001RINC	September 30, 2018	August 31, 2021	August 31, 2021	January 22, 2019		January 22, 2019	School and Graduate Institute of Physical Therapy, National Taiwan University, Taipei, Taiwan		https://ClinicalTrials.gov/show/NCT03812068
446	NCT03362840	Integrating the ESDM in ASD Preschools in Israel	ESDM-ISR	Unknown status	No Results Available	Autism Spectrum Disorder	Behavioral: Early Start Denver Model|Behavioral: Eclectic preschool intervention	Change from baseline Mullen Scales of Early Learning (MSEL)|Change from baseline Vineland Adaptive Behavior Scales, Second Edition (VABS-II)|Change from baseline Parent Sense of Competence Scale (PSOC)|Change from baseline Parenting Stress Index - Short Form (PSI\SF)|Change from baseline parent-child interaction paradigm|Change from baseline child-staff member interaction paradigm	Bar-Ilan University, Israel|Association for Children at Risk	All	3 Years to 6 Years   (Child)	Not Applicable	59	Other	Interventional	Allocation: Non-Randomized|Intervention Model: Factorial Assignment|Masking: Single (Outcomes Assessor)|Primary Purpose: Treatment	BarIlanU	November 1, 2016	September 30, 2017	September 30, 2018	December 5, 2017		December 5, 2017	Bar Ilan University, Ramat Gan, Israel		https://ClinicalTrials.gov/show/NCT03362840
447	NCT04926090	Developing Mental Health Supports for Autistic Students		Completed	No Results Available	Autism Spectrum Disorder|Depression, Anxiety	Behavioral: Emotional Support Plan - Clinician Guided (ESP-C)|Behavioral: Emotional Support Plan - Self Guided (ESP-S)	Change in distress on Patient Health Questionnaire (PHQ-9)|Change in distress on Ecological Momentary Assessment (EMA) reports|Change in anxiety symptoms on the Generalized Anxiety Disorder Questionnaire (GAD-7)|Change in Adult Self Report|Change in Adult Behavior Checklist|Change in Emotion Dysregulation Inventory|Change Young Adult Coping Orientation for Problem Experience (YA-COPE)	Rutgers, The State University of New Jersey|Organization for Autism Research	All	17 Years and older   (Child, Adult, Older Adult)	Not Applicable	19	Other	Interventional	Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Prevention	Pro2021000076	July 26, 2021	July 27, 2022	July 27, 2022	June 14, 2021		August 10, 2022	Rutgers University, Piscataway, New Jersey, United States		https://ClinicalTrials.gov/show/NCT04926090
448	NCT03372421	The Use of Social Stories to Reduce Negative Affect and Improve Satisfaction in Adults Attending an ASD Assessment		Completed	No Results Available	Autism Spectrum Disorder	Other: Social Story|Other: Standard Information	Positive and Negative Affect Schedule|Assessment Satisfaction|Predictability	University of Sheffield	All	18 Years and older   (Adult, Older Adult)	Not Applicable	51	Other	Interventional	Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Single (Participant)|Primary Purpose: Supportive Care	rjenkinson001	May 26, 2018	April 30, 2019	April 30, 2019	December 13, 2017		August 30, 2019	Sheffield Adult Autism and Neurodevelopmental Service, Sheffield, South Yorkshire, United Kingdom		https://ClinicalTrials.gov/show/NCT03372421
449	NCT04301141	Using Virtual Reality to Treat Social Anxiety in Autistic Adolescents		Unknown status	No Results Available	Autism Spectrum Disorder|Social Anxiety	Other: Virtual Reality Assisted Cognitive Behavioural Therapy	VR session completion rate.|Rate of participant identification.|Recruitment rate.|Rate of participant retention.|Therapy attendance.|Frequency and number of sessions.|Adverse effects.|Experience and opinions on the intervention.|Data completion rates.|Homework compliance.|Change in progress with attaining therapy goals.|Change in anxiety (including social anxiety) and depression levels.|Change in Global Outcome Ratings of Severity of Illness.	King's College London|South London and Maudsley NHS Foundation Trust|National Institute for Health Research, United Kingdom|Guy's and St Thomas' NHS Foundation Trust	All	13 Years to 18 Years   (Child, Adult)	Not Applicable	5	Other	Interventional	Allocation: N/A|Intervention Model: Single Group Assignment|Masking: None (Open Label)|Primary Purpose: Treatment	0c Valmaggia	January 2021	September 2021	September 2021	March 10, 2020		September 9, 2020	St Thomas Hospital, Guy's and St Thomas' NHS Foundation Trust, London, United Kingdom|King's College London, London, United Kingdom|Maudsley Hospital, South London and Maudsley NHS Foundation Trust, London, United Kingdom		https://ClinicalTrials.gov/show/NCT04301141
450	NCT04312152	Q10 Ubiquinol in Autism Spectrum Disorder and in Phelan-McDermid Syndrome.	Q10ASD	Enrolling by invitation	No Results Available	Autism Spectrum Disorder|Phelan-McDermid Syndrome	Dietary Supplement: Q10 Ubiquinol|Dietary Supplement: Vitamin E|Dietary Supplement: Multi-Vitamin B complex	Change in Vineland Adaptive Behavior Scales scores|Change in Childhood Autism Rating Scale score|Change in Clinical Global Impression of Improvement scale scores between experimental and active comparator arms.|Change in Visual Analog Scales scores|Children's Global Assessment Scale|Social Responsiveness Scale|Repetitive Behaviors Scale - Revised|Aberrant Behavior Checklist|Short Sensory Profile|Conners' Parent Rating Scale-Revised|Child Behavior Checklist|Intellectual Quotient|The Quality of Life in Autism Questionnaire|The World Health Organization's Quality of Life Questionnaire|Measurement of protein carbonylation level as a marker of oxidative stress in leukocytes.|Measurement of the activity of mitochondrial respiratory chain complexes.|Measurement of expression levels of mitochondrial respiratory chain complexes.	Antonio Persico|Associazione Italiana Sindrome di Phelan-McDermid (AISPHEM)|University of Bari|University of Messina	All	2 Years to 40 Years   (Child, Adult)	Not Applicable	200	Other	Interventional	Allocation: Randomized|Intervention Model: Crossover Assignment|Masking: Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)|Primary Purpose: Treatment	Q10_study_ASD	March 9, 2019	December 31, 2022	August 31, 2023	March 18, 2020		March 18, 2020	Interdipartimental Program "Autismo 0-90" at "G. Martino" Universitary Hospital, Messina, ME, Italy		https://ClinicalTrials.gov/show/NCT04312152
451	NCT04339153	Feasibility Study on Parents Skill Training Program for Reducing Parental Distress and Disruptive Behavior of Their Children With Autism Spectrum Disorder (ASD)		Unknown status	No Results Available	Autism Spectrum Disorder|Disruptive Behaviours	Behavioral: Parent Training for Disruptive Behaviours	Aberrant Behavior Checklist-Community (ABC-C; Aman & Singh, 1994)|Parenting Stress Index, Fourth Edition Short Form (PSI-4; Abidin, 1995)|Symptom Checklist-90 (SCL-90, Derogatis, Rickels, Rock, 1976)|Vineland Adaptive Behavior Scales (Vineland-II; Sparrow, Cicchetti, & Balla, 2005)|Home Situations Questionnaire Disorder (HSQ; Chowdhury et al, 2016)|Clinical Global Impressions - Improvement Scale (CGI; Guy 1976)	Foundation University Islamabad	All	3 Years to 10 Years   (Child)	Not Applicable	60	Other	Interventional	Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Single (Outcomes Assessor)|Primary Purpose: Treatment	FUI/CTR/2020/2	April 2, 2020	September 2, 2021	September 2, 2021	April 9, 2020		April 9, 2020			https://ClinicalTrials.gov/show/NCT04339153
452	NCT03818490	Aromatherapy for Anxiety Among Children With Autism Spectrum Disorder		Completed	No Results Available	Anxiety|Autism Spectrum Disorder	Other: Bergamot Aromatherapy	Change from baseline State Trait Anxiety Inventory for Children|Change from baseline in Blood Pressure|Change from baseline in Heart Rate	Franklin Health Research	All	6 Years to 11 Years   (Child)	Not Applicable	28	Other	Interventional	Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Single (Participant)|Primary Purpose: Treatment	17-1200	June 24, 2016	March 9, 2018	March 30, 2018	January 28, 2019		January 28, 2019	Franklin Institute of Wellness, Franklin, Tennessee, United States		https://ClinicalTrials.gov/show/NCT03818490
453	NCT03682978	Arbaclofen in Children and Adolescents With ASD	AIMS2-CT1	Recruiting	No Results Available	Autism Spectrum Disorder	Drug: Arbaclofen|Drug: Placebo	Effect of Arbaclofen vs. placebo on social function|Effect of Arbaclofen vs. placebo on measures of global function|Effect of Arbaclofen vs. placebo on other adaptive domains|Effect of Arbaclofen on measures of social abilities and responsiveness|Effect of Arbaclofen on measures of social abilities and responsiveness through BOSCC|Effect of Arbaclofen on measures of social abilities and responsiveness through SRS-2-P|Effect of Arbaclofen on measures of social abilities and responsiveness through SRS-2-T|Effect of Arbaclofen on measures of problem behaviours|Effect of Arbaclofen on other measures of core symptoms|Safety and tolerability of Arbaclofen in children and adolescents with ASD as assessed with the SMURF|Safety and tolerability of Arbaclofen in children and adolescents with ASD as assessed with the ESS-CHAD|Safety and tolerability of Arbaclofen in children and adolescents with ASD as assessed with the C-SSRS|Safety and tolerability of Arbaclofen in children and adolescents with ASD as assessed with a pulse rate measurement|Safety and tolerability of Arbaclofen in children and adolescents with ASD as assessed with a body temperature measurement|Safety and tolerability of Arbaclofen in children and adolescents with ASD as assessed with a blood pressure measurement|Safety and tolerability of Arbaclofen in children and adolescents with ASD as assessed by measuring weight|Safety and tolerability of Arbaclofen in children and adolescents with ASD as assessed by measuring height|Safety and tolerability of Arbaclofen in children and adolescents with ASD as assessed with the Tanner scale|Safety and tolerability of Arbaclofen in children and adolescents with ASD as assessed with blood tests|To explore the use and feasibility of digital biomarkers	Celso Arango, MD, PhD|UMC Utrecht	All	5 Years to 17 Years   (Child)	Phase 2	130	Other	Interventional	Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)|Primary Purpose: Treatment	AIMS2-CT-01|2018-000942-21	September 19, 2019	December 31, 2022	December 31, 2022	September 25, 2018		August 11, 2022	Robert Debré Hospital, Paris, France|Hospital Clínic de Barcelona, Barcelona, Spain|Servicio de Psiquiatría del Niño y del Adolescente, Hospital General Universitario Gregorio Marañón, SERMAS, Madrid, Spain|University of Salamanca & Complejo asistencial de Zamora, Salamanca, Spain|University of Glasgow, Glasgow, United Kingdom|King's College London, London, United Kingdom|University of Newcastle upon Tyne, Newcastle, United Kingdom		https://ClinicalTrials.gov/show/NCT03682978
454	NCT01205282	Dose Finding Study of Pioglitazone in Children With Autism Spectrum Disorders (ASD) (PIO)		Completed	No Results Available	Autism Spectrum Disorders	Drug: Pioglitazone|Drug: Placebo	Safety of pioglitazone in children with ASD ages 5-12 years|Efficacy of outcome measure to be used in a follow-up multisite randomized control trial of pioglitazone in children with ASD|Maximum tolerated dose to be used in the follow-up multisite randomized controlled trial|Efficacy of pioglitazone on markers of inflammation (cytokine levels) and oxidative stress (superoxide dismutase, malonyl aldehydes)|Relationship between different doses and response to treatment	Evdokia Anagnostou|Holland Bloorview Kids Rehabilitation Hospital|Anagnostou, Evdokia, M.D.	All	5 Years to 12 Years   (Child)	Phase 2	28	Other	Interventional	Allocation: Non-Randomized|Intervention Model: Single Group Assignment|Masking: Single (Participant)|Primary Purpose: Treatment	10-002	April 2013	September 2015	September 2015	September 20, 2010		March 20, 2017	Holland Bloorview Kids Rehabilitation Hospital, Toronto, Ontario, Canada		https://ClinicalTrials.gov/show/NCT01205282
455	NCT05271357	Transcranial Magnetic Stimulation for Depression in Autism Spectrum Conditions	RESTORE	Recruiting	No Results Available	Autism Spectrum Disorder|Major Depressive Disorder	Procedure: Bilateral TMS|Procedure: Unilateral TMS	Change-from-baseline at 4 weeks in mean Hamilton Depression Rating Scale (HDRS-17) score.|Change-from-baseline at 4 weeks in mean and Beck Depression Inventory (BDI-II) scores.|Change-from-baseline at 4 weeks in physiological markers via the use of high-resolution electroencephalography (EEG).|Change-from-baseline at 4 weeks in handgrip strength or relative handgrip strength.	Children's Hospital Medical Center, Cincinnati	All	12 Years to 26 Years   (Child, Adult)	Not Applicable	24	Other	Interventional	Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Treatment	2021-0594	November 24, 2021	February 24, 2023	February 24, 2023	March 9, 2022		April 11, 2022	Cincinnati Children's Hospital Medical Center, Cincinnati, Ohio, United States	"Study Protocol and Statistical Analysis Plan", https://ClinicalTrials.gov/ProvidedDocs/57/NCT05271357/Prot_SAP_001.pdf	https://ClinicalTrials.gov/show/NCT05271357
456	NCT03255837	tDCS on Working Memory (WM) in Adults With ASD		Completed	No Results Available	Autism Spectrum Disorder	Device: Transcranial direct current stimulation (tDCS)	Working memory accuracy score compared to typically developed controls scores.|Difference in working memory accuracy score between adults with ASD and healthy controls	NHS Greater Glasgow and Clyde|University of Glasgow	Male	18 Years to 35 Years   (Adult)	Not Applicable	50	Other	Interventional	Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Single (Participant)|Primary Purpose: Supportive Care	GN17MH365	February 26, 2018	December 21, 2018	December 21, 2018	August 21, 2017		January 25, 2019	University of Glasgow, Glasgow, United Kingdom		https://ClinicalTrials.gov/show/NCT03255837
457	NCT02747459	Sensory Supported Swimming for Children With ASD	SSS	Enrolling by invitation	No Results Available	Autism Spectrum Disorders	Behavioral: Sensory Supported Swimming	Skill Acquisition Form|Instructor Survey|Parent Survey|Program Records	University of Kansas Medical Center	All	4 Years to 18 Years   (Child, Adult)	Not Applicable	500	Other	Interventional	Allocation: N/A|Intervention Model: Single Group Assignment|Masking: None (Open Label)|Primary Purpose: Supportive Care	13124	March 2012	September 2022	September 2022	April 21, 2016		October 4, 2021	University of Kansas Medical Center, Kansas City, Kansas, United States		https://ClinicalTrials.gov/show/NCT02747459
458	NCT04416360	Autism Spectrum Disorder or Attention Deficit Hyperactivity Disorder in Covid-19 Outbreak	CLIECO	Unknown status	No Results Available	Autism Spectrum Disorder|Attention-deficit Hyperactivity Disorder	Other: Interview by psychologists	Interview of the parents : contextual data|Interview of the children/adolescents/ parents : Experience of the confinement in general|Interview of the referring caregiver : data relating to disease and management of care	University Hospital, Toulouse|Institut National de la Santé Et de la Recherche Médicale, France	All	6 Years to 17 Years   (Child)	Not Applicable	40	Other	Interventional	Allocation: N/A|Intervention Model: Single Group Assignment|Masking: None (Open Label)|Primary Purpose: Other	RC31/20/0151	May 5, 2020	July 2020	January 2021	June 4, 2020		June 4, 2020	University hospital of Toulouse, Toulouse, Occitanie, France|Centre Hospitalier de Versailles, Le Chesnay, France|Centre Hospitalier Esquirol, Limoges, France|Hôpital Robert-Debré (AP-HP), Paris, France|Maison de Solenn (Hôpital Cochin AP-HP), Paris, France		https://ClinicalTrials.gov/show/NCT04416360
459	NCT02555241	Emergence of Generative Language		Completed	No Results Available	Autism Spectrum Disorder	Behavioral: Mand Training|Behavioral: Matrix|Behavioral: Stimulus Equivalence Training	Change in Mean Length of Utterances (MLU) during manding|Acquisition of noun-verb and color-shape combinations during tacting|Emergence of intraverbal responses|Change in Macarthur Bates-Communicative Development Inventory (CDI) Score|Observe overall improvements in pragmatic language within social/play interactions with parents/caregivers, as measured on the Direct Observation of Spoken Language (DOSL).	Emory University	All	4 Years to 6 Years   (Child)	Not Applicable	9	Other	Interventional	Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Treatment	IRB00080641	September 2015	November 2016	November 2016	September 21, 2015		December 5, 2016			https://ClinicalTrials.gov/show/NCT02555241
460	NCT03757585	Natural Treatments for the Management of Emotional Dysregulation in Youth With Non-verbal Learning Disability (NVLD) and/or Autism Spectrum Disorders (ASD)		Recruiting	No Results Available	Non-verbal Learning Disorder|Autism Spectrum Disorder|Autism	Drug: Open-label Treatment with Omega-3 Fatty Acids + Inositol|Drug: Open-label Treatment with N-acetylcysteine	Mean Change in the Parent-Young Mania Rating Scale (P-YMRS) Score|Mean Change in the Parent-completed Children's Depression Inventory (CDI)|Mean Change in the NIMH Clinical Global Improvement scale (CGI)	Massachusetts General Hospital|Demarest Lloyd Jr. Foundation	All	5 Years to 17 Years   (Child)	Phase 4	60	Other	Interventional	Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Treatment	2018P002261	May 20, 2019	December 2023	December 2023	November 29, 2018		November 3, 2022	Massachusetts General Hospital, Boston, Massachusetts, United States		https://ClinicalTrials.gov/show/NCT03757585
461	NCT03123146	Cognitive Behavioural Therapy for Children With Autism Spectrum Disorder and Obsessive Compulsive Behaviour		Completed	No Results Available	Autism Spectrum Disorder|Obsessive-Compulsive Behavior	Behavioral: Functional Behavior-Based Cognitive Behavioral Therapy	Change in Repetitive Behavior Scale (RBS_SCR)|Change in Children's Yale-Brown Obsessive-Compulsive Scale (CY-BOCS)|Change in Repetitive Behavior Scale 100 (RBS_100)|Change in The child Obsessive-Compulsive Impact Scale-Revised (COIS-R)|Parent OCB Rating Scale.	Tricia Vause|Ontario Mental Health Foundation|Ontario Ministry of Health and Long Term Care|Brock University	All	7 Years to 13 Years   (Child)	Not Applicable	37	Other	Interventional	Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Single (Outcomes Assessor)|Primary Purpose: Treatment	09-066-VAUSE	June 1, 2010	February 1, 2014	February 1, 2014	April 21, 2017		April 21, 2017	Brock University, St Catharines, Ontario, Canada		https://ClinicalTrials.gov/show/NCT03123146
462	NCT02464527	Stimulus-Stimulus Pairing Study		Completed	No Results Available	Autism Spectrum Disorder	Behavioral: Stimulus-stimulus pairing|Other: Vocal recorder	Feasibility of intervention assessed by a change in frequency of target vocalizations and/or approximations during sessions|Change in frequency of target vocalizations and/or approximations at home|Change in parent-reported vocalizations|Feasibility of intervention assessed by reliability of delivery by therapists|Acceptability of stimulus-stimulus pairing (SSP) by parents|Feasibility of intervention assessed by compliance of the vocal recorder|Feasibility of the vocal recorder assessed by the utility of vocal recorder	Emory University	All	24 Months to 47 Months   (Child)	Not Applicable	16	Other	Interventional	Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Treatment	IRB00073588	June 2014	May 2015	May 2015	June 8, 2015		July 15, 2016	Marcus Autism Center, Atlanta, Georgia, United States		https://ClinicalTrials.gov/show/NCT02464527
463	NCT01179841	Intervention for Toddlers at Risk for Autism Spectrum Disorders (ASD)		Completed	No Results Available	Autism Spectrum Disorder	Behavioral: Playgroup|Behavioral: Parent Training	Developmental Level|Communication|Presence and Severity of Autism	Hugo W. Moser Research Institute at Kennedy Krieger, Inc.|Autism Speaks	All	11 Months to 21 Months   (Child)	Not Applicable	49	Other	Interventional	Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Treatment	NA_00006553	January 2008	December 2011	December 2011	August 11, 2010		March 10, 2021	Kennedy Krieger Institute, Baltimore, Maryland, United States		https://ClinicalTrials.gov/show/NCT01179841
464	NCT02483910	Direct Instruction Language for Learning in Autism Spectrum Disorder	DILLASD	Completed	No Results Available	Autism Spectrum Disorder|Moderate Language Delay	Behavioral: Direct Instruction-Language for Learning (DI-LL) via telehealth (e.g., Zoom or WebEx)|Behavioral: Standard of care delivered via telehealth (e.g., Zoom or WebEx)	Change in the Clinical Evaluation of Language Fundamentals-4 (CELF-4) Score|Change in Clinical Evaluation of Language Fundamentals-Preschool 2 (CELF-P) Score|Improvement item of the Clinical Global Impression scale (CGI-I)	Emory University	All	4 Years to 7 Years   (Child)	Not Applicable	137	Other	Interventional	Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Single (Outcomes Assessor)|Primary Purpose: Treatment	IRB00081144|AR140208	October 2015	November 24, 2020	November 24, 2020	June 29, 2015		January 6, 2021	Marcus Autism Center - Children's Healthcare of Atlanta, Atlanta, Georgia, United States	"Informed Consent Form", https://ClinicalTrials.gov/ProvidedDocs/10/NCT02483910/ICF_000.pdf	https://ClinicalTrials.gov/show/NCT02483910
465	NCT02348125	Does Clinical Treatment of Mitochondrial Dysfunction Impact Autism Spectrum Disorder (ASD)?	MitoASD	Unknown status	No Results Available	Autism Spectrum Disorders|Mitochondrial Diseases	Drug: Mitochondrial Cocktail	Change in features of Autistic behavior phenotype assessed using the Social Responsiveness Scale (SRS)|Change in Executive Function assessed using the Behavior Rating Inventory of Executive Function (BRIEF)|Changes in mitochondrial enzyme specific activities biochemically evaluated using buccal swab analysis|Change in buccal oxidative stress markers and mitochondrial DNA (mtDNA) damage	Drexel University	All	3 Years to 12 Years   (Child)	Phase 1	50	Other	Interventional	Allocation: N/A|Intervention Model: Single Group Assignment|Masking: None (Open Label)|Primary Purpose: Treatment	DrexelMitoApp	March 2016	June 2017	June 2017	January 28, 2015		April 14, 2017	St. Christopher's Hospital for Children, Philadelphia, Pennsylvania, United States		https://ClinicalTrials.gov/show/NCT02348125
466	NCT02797379	The Development of a Psychoeducational Tool to Manage Anxiety in People With Autism Spectrum Disorders	MANAGE	Completed	No Results Available	Autism Spectrum Disorders|Anxiety	Other: Psychoeducation	Knowledge about anxiety in ASD|Anxiety symptoms|Acceptability, usefulness and appropriateness of the guide	King's College London|South London and Maudsley NHS Foundation Trust|Guy's and St Thomas' NHS Foundation Trust	All	8 Years to 25 Years   (Child, Adult)	Not Applicable	35	Other	Interventional	Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Treatment	200774	September 1, 2016	August 31, 2017	August 31, 2017	June 13, 2016		September 13, 2019	South London and the Maudsley, London, United Kingdom|Guy's and St Thomas' NHS trust, London, United Kingdom		https://ClinicalTrials.gov/show/NCT02797379
467	NCT04587557	Storytelling With or Without Social Contextual Information in Children With Autistic Spectrum Disorder and Typical Development		Completed	No Results Available	Autism Spectrum Disorder|Healthy	Behavioral: Storytelling with social contextual information|Behavioral: Storytelling without social contextual information|Other: Children with ASD|Other: Children with TD	Eye gaze on the eye tracker|Trail Making Test	The Hong Kong Polytechnic University	All	6 Years to 12 Years   (Child)	Not Applicable	52	Other	Interventional	Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Single (Participant)|Primary Purpose: Treatment	HSEARS20160427001	June 2016	December 2018	December 2018	October 14, 2020		October 14, 2020	The Hong Kong Polytechnic University, Department of Rehabilitation Sciences, Hong Kong, Hong Kong		https://ClinicalTrials.gov/show/NCT04587557
468	NCT05408793	Effects of Transcranial Pulse Stimulation on ASD		Recruiting	No Results Available	Autism Spectrum Disorder|High-functioning Autism	Device: Transcranial Pulse Stimulation	Autism severity|Autistic traits|Social deficits|Asperger's Syndrome|Theory of Mind and Social Cognition|Executive Function|Working memory|Clinical Global Impression|Neuroimaging	The Hong Kong Polytechnic University	All	12 Years to 17 Years   (Child)	Not Applicable	36	Other	Interventional	Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Double (Participant, Investigator)|Primary Purpose: Treatment	HongKongPU_HSEARS20220228005	March 1, 2022	August 31, 2024	August 31, 2024	June 7, 2022		June 7, 2022	School of Nursing HongKongPolyU, HongKong, Hong Kong		https://ClinicalTrials.gov/show/NCT05408793
469	NCT01882153	Evaluating Parent Delivered Interventions for Children With Autism		Completed	No Results Available	Autistic Disorder|Developmental Disabilities	Behavioral: Pivotal Response Training (PRT)|Behavioral: PACE Therapy|Behavioral: PACE and PRT Hybrid	Change in CGI-S (Clinical Global Impression - Severity)|Change in SRS (Social Responsiveness Scale)|Change in CDI (Communicative Development Survey) Score|Change in social and communication behaviors as assessed by standardized laboratory observations|Change in VABS (Vineland Adaptive Behavior Scale) Score|Change in social and communication behaviors as assessed from home videos|Change in PSI (Parenting Stress Index) Score|Change in FES (Family Empowerment Scale) Score|Change in frequency and duration of investigation therapy|Change in demographics data	Stanford University	All	18 Months to 17 Years   (Child)	Not Applicable	104	Other	Interventional	Allocation: Non-Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Treatment	SU-11232011-8727	February 2010	February 18, 2022	February 18, 2022	June 20, 2013		September 15, 2022	Stanford University School of Medicine, Stanford, California, United States		https://ClinicalTrials.gov/show/NCT01882153
470	NCT04638452	Evaluation of Behavioural Psycho & Physiological Responses in People With ASD During a Blood Test in Routine Care Practice	AUTICOPP	Recruiting	No Results Available	Autism Spectrum Disorder	Behavioral: Video & movements recording|Behavioral: Questionnaires	Facial expression during blood sample|Body movement during blood sample|Evaluation of emotion felt by participants during blood sample	Centre Hospitalier Charles Perrens, Bordeaux	All	6 Years to 65 Years   (Child, Adult, Older Adult)	Not Applicable	150	Other	Interventional	Allocation: N/A|Intervention Model: Single Group Assignment|Masking: None (Open Label)|Primary Purpose: Other	2020-A00693-36	February 8, 2021	November 30, 2023	February 28, 2024	November 20, 2020		August 18, 2021	Centre Hospitalier Charles PERRENS, Bordeaux, France		https://ClinicalTrials.gov/show/NCT04638452
471	NCT04972136	rTMS for Depression in Young Adults With Autism	rTMS-MDD	Recruiting	No Results Available	Autism Spectrum Disorder|Major Depressive Disorder	Device: Active Bilateral Theta Burst Stimulation|Device: Sham Bilateral Theta Burst Stimulation	Change in scores on the 17-item Hamilton Rating Scale for Depression (HRSD-17)|Change in scores on the Beck Scale for Suicide Ideation (BSI)	Centre for Addiction and Mental Health	All	16 Years to 29 Years   (Child, Adult)	Not Applicable	80	Other	Interventional	Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)|Primary Purpose: Treatment	141/2019	January 14, 2021	January 14, 2024	January 14, 2024	July 22, 2021		July 22, 2021	Centre for Addiction and Mental Health, Toronto, Ontario, Canada		https://ClinicalTrials.gov/show/NCT04972136
472	NCT00277407	Treatment of Autistic Children Using NAET Procedures		Completed	No Results Available	Autism|Food Allergies	Procedure: NAET with acupressure and/or chiropractic procedures	Improvement in verbal and norverbal communication|Reduction of commonly seen autistic traits	Nambudripad's Allergy Research Foundation|Anonymous	All	3 Years to 10 Years   (Child)	Not Applicable	48	Other	Interventional	Allocation: Non-Randomized|Intervention Model: Single Group Assignment|Masking: None (Open Label)|Primary Purpose: Treatment	MulticlinicalAutism Study|NARFoundationAutismStudy2006	June 2006		May 2007	January 16, 2006		May 7, 2007	NAET Pain Clinic, Buena Park, California, United States		https://ClinicalTrials.gov/show/NCT00277407
473	NCT04779632	Fish Oil Affects Cognition and ADHD Symptoms in Adults With Autism Spectrum Disorder		Completed	No Results Available	Autism Spectrum Disorder|Attention Deficit Hyperactivity Disorder	Dietary Supplement: Experimental: Fish Oil|Dietary Supplement: Comparator: Safflower Oil	Change in short-term spatial working memory|Change in attention|Cognitive flexibility and inhibition|ADHD symptoms|Executive function|ASD symptoms	University of Copenhagen	All	18 Years to 45 Years   (Adult)	Not Applicable	26	Other	Interventional	Allocation: Randomized|Intervention Model: Crossover Assignment|Masking: Triple (Participant, Investigator, Outcomes Assessor)|Primary Purpose: Basic Science	D227	December 10, 2019	February 13, 2020	February 13, 2020	March 3, 2021		March 3, 2021	University of Copenhagen - Department of Nutrition & Exercise, Copenhagen, Frederiksberg, Denmark		https://ClinicalTrials.gov/show/NCT04779632
474	NCT01734941	TSO in Pediatric Autistic Spectrum Disorders	TSO	Terminated	No Results Available	Autistic Spectrum Disorders	Drug: TSO|Drug: Placebo	Aberrant Behavior Checklist (ABC) subscale scores|Secondary assessments of efficacy will be assessed via: The change from baseline in the CY-BOCS, CGI-I, SRS, SCQ.	Hadassah Medical Organization	All	6 Years to 17 Years   (Child)	Phase 2	9	Other	Interventional	Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Triple (Participant, Care Provider, Investigator)|Primary Purpose: Treatment	0522-12-HMO	April 2014	May 2015	May 2015	November 28, 2012		February 2, 2016	The Neuro-Cognitive Center, Pediatric Division, Hadassah-Hebrew University Medical Center, Jerusalem, Mount Scopus, Israel		https://ClinicalTrials.gov/show/NCT01734941
475	NCT01929642	Rapalogues for Autism Phenotype in TSC: A Feasibility Study	RAPT	Completed	Has Results	Tuberous Sclerosis Complex|Self-injury|Autism	Drug: Sirolimus|Drug: Everolimus	Number of Participants With Compliance to the Treatment Protocol.|Caregiver Burden|Feasibility Measurements of Parental Stress|Total Number of Aggressions or Self-injuries|Cognitive Function as Assessed by the Capute Scale|Repetitive Behavior|Self-Injury Trauma Scale--SIT Scale|Frequency of Seizures Assessed by Total Number of Seizures	Hugo W. Moser Research Institute at Kennedy Krieger, Inc.	All	2 Years to 30 Years   (Child, Adult)	Phase 2	3	Other	Interventional	Allocation: N/A|Intervention Model: Single Group Assignment|Masking: None (Open Label)|Primary Purpose: Treatment	AM00037881	July 2013	July 2016	August 2016	August 28, 2013	March 29, 2021	March 29, 2021	Kennedy Krieger Institute, Baltimore, Maryland, United States		https://ClinicalTrials.gov/show/NCT01929642
476	NCT00808782	The Use of rTMS to Improve Theory of Mind Among Adults With Autism and Asperger's Disorder		Completed	No Results Available	Autistic Disorder|Asperger's Disorder	Device: Deep rTMS|Device: Sham rTMS	Theory of Mind Neurobehavioural Battery|Autism Spectrum Quotient	Bayside Health	All	18 Years to 65 Years   (Adult, Older Adult)	Not Applicable	30	Other	Interventional	Allocation: Randomized|Intervention Model: Crossover Assignment|Masking: Double (Participant, Investigator)|Primary Purpose: Treatment	277/07	December 2008	October 2012	October 2012	December 16, 2008		February 7, 2013	Alfred Psychiatry Research Centre, Melbourne, Victoria, Australia		https://ClinicalTrials.gov/show/NCT00808782
477	NCT01694667	Omega-3 Fatty Acids for Hyperactivity Treatment in Autism Spectrum Disorder		Completed	Has Results	Autism Spectrum Disorders|Hyperactivity	Drug: Omega-3 Fatty Acids|Other: Placebo	Change in Aberrant Behavior Checklist - Hyperactivity Subscale (ABC-H) Score|Change in Aberrant Behavior Checklist - Lethargy Subscale Score|Change in Aberrant Behavior Checklist - Stereotypy Subscale Score|Aberrant Behavior Checklist - Irritability Subscale Score|Aberrant Behavior Checklist - Inappropriate Speech Subscale Score|Change in Social Responsiveness Scale (SRS) Score|Change in Clinical Global Impression - Improvement (CGI-I) Score	Hugo W. Moser Research Institute at Kennedy Krieger, Inc.|University of California, San Francisco	All	5 Years to 8 Years   (Child)	Phase 2	57	Other	Interventional	Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)|Primary Purpose: Treatment	NA_00068694	September 2012	December 2012	May 2013	September 27, 2012	June 16, 2014	August 31, 2020	This study is open to continental USA, Multiple Locations, Maryland, United States		https://ClinicalTrials.gov/show/NCT01694667
478	NCT01558180	Telephone Care Management to Address Sleep Problems in Young Children With Autism		Completed	No Results Available	Autism Spectrum Disorders|Insomnia	Behavioral: Telephone Care Management|Behavioral: Usual Care	Children's Sleep Habits Questionnaire|Actigraphy (Activity Monitoring)	Nationwide Children's Hospital|The Ingram Foundation is funding this work.	All	3 Years to 6 Years   (Child)	Phase 2	60	Other	Interventional	Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Single (Outcomes Assessor)|Primary Purpose: Treatment	IRB11-00719	April 2012	December 2013	December 2013	March 20, 2012		February 3, 2015	Nationwide Children's Hospital, Columbus, Ohio, United States		https://ClinicalTrials.gov/show/NCT01558180
479	NCT05213286	The Development of a Screening Questionnaire to Discriminate Autism Spectrum Disorder and Schizotypal Disorder, and Validation of the Danish Version of RAADS-R	ZA-RAA	Recruiting	No Results Available	Autism Spectrum Disorder|Schizotypal Disorder	Diagnostic Test: Application of ZAQ and RAADS-R-DK	ZAQ|RAADS-R-DK|AQ|WHO-DAS 2.0|WHO-5	Glostrup University Hospital, Copenhagen	All	18 Years to 65 Years   (Adult, Older Adult)	Not Applicable	600	Other	Interventional	Allocation: N/A|Intervention Model: Single Group Assignment|Masking: None (Open Label)|Primary Purpose: Diagnostic	ZA-RAA	February 1, 2022	August 31, 2023	August 31, 2023	January 28, 2022		March 16, 2022	Glostrup University Hospital, Copenhagen, Denmark		https://ClinicalTrials.gov/show/NCT05213286
480	NCT04569058	Transcranial Photobiomodulation Therapy for the Treatment of Autistic Traits in Children and Adolescents With ADHD		Recruiting	No Results Available	Autism|Attention Deficit Hyperactivity Disorder	Device: Transcranial Photobiomodulation	Efficacy-Attention Deficit Hyperactivity Disorder (Attention Deficit Hyperactivity Disorder Symptom Checklist)|Efficacy-Autism Spectrum Disorder (Social Responsiveness Scale-2)|Safety (The Transcranial Photobiomodulation Self-Report Questionnaire)|Number of Participants that Report Adverse Events (Clinician-Rated Treatment Emergent Adverse Events Log)	Massachusetts General Hospital	All	9 Years to 17 Years   (Child)	Not Applicable	60	Other	Interventional	Allocation: N/A|Intervention Model: Single Group Assignment|Masking: None (Open Label)|Primary Purpose: Treatment	2020-P-002352	January 14, 2021	October 2023	October 2023	September 29, 2020		December 1, 2022	Massachusetts General Hospital, Boston, Massachusetts, United States		https://ClinicalTrials.gov/show/NCT04569058
481	NCT02008396	Phase 2 Pilot Safety Study of MDMA-assisted Therapy for Social Anxiety in Autistic Adults		Completed	Has Results	Social Anxiety in Autistic Adults	Drug: Placebo|Drug: 75 mg to 125 mg MDMA|Behavioral: Psychotherapy	Liebowitz Social Anxiety Scale (LSAS) Total Score at Baseline|Liebowitz Social Anxiety Scale (LSAS) Total Score 1-Month Post Experimental Session 2|Change in Leibowitz Social Anxiety Scale (LSAS) Total Score From Baseline to 1-Month Post Experimental Session 2	Multidisciplinary Association for Psychedelic Studies|Lundquist Institute for Biomedical Innovation at Harbor-UCLA Medical Center	All	21 Years and older   (Adult, Older Adult)	Phase 2	12	Other	Interventional	Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Triple (Participant, Investigator, Outcomes Assessor)|Primary Purpose: Treatment	MAA-1	February 2014	August 2017	August 2017	December 11, 2013	October 14, 2020	July 6, 2022	Los Angeles Biomedical Research Institute, Torrance, California, United States	"Study Protocol", https://ClinicalTrials.gov/ProvidedDocs/96/NCT02008396/Prot_002.pdf|"Statistical Analysis Plan", https://ClinicalTrials.gov/ProvidedDocs/96/NCT02008396/SAP_001.pdf|"Informed Consent Form", https://ClinicalTrials.gov/ProvidedDocs/96/NCT02008396/ICF_003.pdf	https://ClinicalTrials.gov/show/NCT02008396
482	NCT01850355	An Open-Label Trial of Buspirone for the Treatment of Anxiety in Youth With Autism Spectrum Disorders		Active, not recruiting	No Results Available	Autism Spectrum Disorders|Anxiety	Drug: Buspirone	Reduction in Pediatric Anxiety Rating Scale (PARS) score|Clinical Global Impression-Anxiety (CGI-Anxiety) Improvement Score	Massachusetts General Hospital	All	6 Years to 17 Years   (Child)	Not Applicable	9	Other	Interventional	Allocation: N/A|Intervention Model: Single Group Assignment|Masking: None (Open Label)|Primary Purpose: Treatment	2013-P-000661	July 2013	December 2022	December 2022	May 9, 2013		March 31, 2022	Massachusetts General Hospital, Boston, Massachusetts, United States		https://ClinicalTrials.gov/show/NCT01850355
483	NCT01154894	Dietary Fatty Acids Improve Social Impairment in Autism Spectrum Disorders	Fatty acid	Completed	No Results Available	Autism Spectrum Disorders	Other: Aravita including arachidonic acid and docosaheaenoic acid	Aberrant Behavior Checklist-community (ABC)|Social Responsiveness Scale (SRS)	Ashiya University	All	6 Years to 29 Years   (Child, Adult)	Not Applicable	13	Other	Interventional	Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Double (Participant, Investigator)|Primary Purpose: Treatment	KunioYui	February 2009	February 2009	December 2009	July 1, 2010		June 23, 2011			https://ClinicalTrials.gov/show/NCT01154894
484	NCT01825798	Treatment of Overweight Induced by Antipsychotic Medication in Young People With Autism Spectrum Disorders (ASD)	MET	Completed	Has Results	Overweight|Autism Spectrum Disorder	Drug: Metformin|Drug: Placebo	Change in Body Mass Index Z-score|Changes in Additional Body Composition Parameters (Absolute Change in Weight)|Changes in Additional Body Composition Parameters (Relative Change in Weight)|Changes in Additional Body Composition Parameters (Absolute BMI)|Changes in Additional Body Composition Parameters (Abdominal Circumference)|Changes in Additional Body Composition Parameters (Hip Circumference)|Changes in Fasting Metabolic Parameters (Total Cholesterol)|Changes in Fasting Metabolic Parameters (LDL)|Changes in Fasting Metabolic Parameters (HDL)|Changes in Fasting Metabolic Parameters (Triglycerides)|Changes in Fasting Metabolic Parameters (Glucose)|Changes in Fasting Metabolic Parameters (Insulin)	Evdokia Anagnostou|Massachusetts General Hospital|Vanderbilt University|University of Pittsburgh|Nationwide Children's Hospital|Ohio State University|Anagnostou, Evdokia, M.D.	All	6 Years to 17 Years   (Child)	Phase 3	60	Other	Interventional	Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)|Primary Purpose: Treatment	MET-10-2012	April 2013	June 2015	October 2015	April 8, 2013	February 22, 2018	February 22, 2018	Ohio State University/Nationwide Children's Hospital, Columbus, Ohio, United States|University of Pittsburgh Medical Center, Pittsburgh, Pennsylvania, United States|Vanderbilt University, Nashville, Tennessee, United States|Holland Bloorview Kids Rehabilitation Hospital, Toronto, Ontario, Canada		https://ClinicalTrials.gov/show/NCT01825798
485	NCT03071120	Parent-Mediated Intervention for Families With Children With Autism and Feeding Challenges		Active, not recruiting	No Results Available	Parent-Child Relations|Meals|Autism Spectrum Disorder	Behavioral: Parent-Mediated Intervention	Change in Brief Autism Mealtime Behavior Inventory (BAMBIC)|Change in Sensory Experiences Questionnaire (SEQ 3.0)|Change in Behavioral Pediatric Feeding Assessment Scale (BPFAS)|Change in Goal Attainment Scaling (GAS).|Beck Depression Inventory-II (BDI)|Parenting Stress Index-Short Form (PSI-SF)|Change in the Caregiver Involvement Scale Score	University of Wisconsin, Madison	All	2 Years to 7 Years   (Child)	Not Applicable	38	Other	Interventional	Allocation: N/A|Intervention Model: Single Group Assignment|Masking: None (Open Label)|Primary Purpose: Treatment	2016-1428|A176000|EDUC\KINESIOLOGY\KINESIO	February 3, 2017	February 2023	February 2023	March 6, 2017		August 5, 2022	Waisman Center, Madison, Wisconsin, United States		https://ClinicalTrials.gov/show/NCT03071120
486	NCT02795611	Family Centered Occupational Therapy on Play Skills and Participation of Children With ASD		Completed	No Results Available	Autism Spectrum Disorder	Behavioral: Family-centered occupational therapy|Behavioral: regular occupational therapy|Other: intervention done outside our hospital	Goal Attainment Scale (GAS)|Revised Knox Preschool Play Scale (RKPPS)|Vineland Adaptive Behavior Scale-Chinese version (VABS-C)|Parenting Stress Index Short Form (PSI/SF)|Family Outcomes Survey (FOS)|Family Empowerment Scale (FES)|Home Observation for Measurement of the Environment (HOME)	National Taiwan University Hospital	All	2 Years to 6 Years   (Child)	Not Applicable	23	Other	Interventional	Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Triple (Participant, Care Provider, Outcomes Assessor)|Primary Purpose: Treatment	201509008RINC	May 2016	December 2017	December 2017	June 10, 2016		December 28, 2017	National Taiwan University Hospital, Taipei, Zhongzheng, Taiwan		https://ClinicalTrials.gov/show/NCT02795611
487	NCT01978210	Development of a Manualized Wireless Moisture Pager Intervention for Teaching Toileting in Children With Autism		Completed	No Results Available	Autism|Enuresis|Incontinence	Device: Wireless Moisture Pager (WMP)	Total number of participants successfully recruited|Percentage of participants retained across the life of the study|Treatment Fidelity (Interventionists)|Fidelity of Parent Implementation|Rate of toileting accidents|Participants' Daily Rate of Toilet Use for Urination|Parent Satisfaction with Toilet Training Intervention	University of Rochester|Autism Treatment Network	All	3 Years to 6 Years   (Child)	Not Applicable	31	Other	Interventional	Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Treatment	Moisture Pager Intervention	September 2013	June 2015	June 2015	November 7, 2013		February 24, 2017	University of Rochester Medical Center, Rochester, New York, United States|Nationwide Children's Hospital, Columbus, Ohio, United States|Whitney Loring, Nashville, Tennessee, United States		https://ClinicalTrials.gov/show/NCT01978210
488	NCT02568631	Improving Social Cognition for Adults With ASD by the Serious Game JeStiMulE Versus Controls		Completed	No Results Available	Autistic Disorder	Other: serious game JeStiMulE|Other: control video game	Change of Emotion recognition|Change of Social cognition|Change of impact on quality of life|Impact on the verbal fluency of emotional words (number of words emitted perminute)|Feedback from JeStiMulE players	Fondation Lenval	All	18 Years to 40 Years   (Adult)	Not Applicable	30	Other	Interventional	Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Single (Outcomes Assessor)|Primary Purpose: Other	15-HPNCL-01	September 22, 2015	September 20, 2016	September 20, 2017	October 6, 2015		July 31, 2018	Fondation Lenval, Nice, France|Hôpital Pasteur - CHU de Nice, Nice, France|Hôpital psychiatrique de Sainte marie, Nice, France		https://ClinicalTrials.gov/show/NCT02568631
489	NCT02874690	Eye Tracking as a Predictor of Methylphenidate Response in Autism With ADHD	SAT	Completed	No Results Available	Autism Spectrum Disorder|Attention Deficit Hyperactivity Disorder	Drug: Methylphenidate|Drug: Placebo	Change in Eye-Tracking: Microsaccades and pupil size using Tobii eye tracker|Change in Short Interval IntraCortical Inhibition (SICI) using Transcranial Magnetic Stimulation (TMS)|Change in Resting State Electroencephalogram (EEG)	Children's Hospital Medical Center, Cincinnati	All	8 Years to 21 Years   (Child, Adult)	Early Phase 1	40	Other	Interventional	Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)|Primary Purpose: Basic Science	2015-4401	February 19, 2016	August 3, 2017	August 3, 2017	August 22, 2016		January 15, 2021	Cincinnati Children's Hospital Medical Center, Cincinnati, Ohio, United States	"Study Protocol and Statistical Analysis Plan", https://ClinicalTrials.gov/ProvidedDocs/90/NCT02874690/Prot_SAP_000.pdf	https://ClinicalTrials.gov/show/NCT02874690
490	NCT01816178	Using a Voice Output Communication Aid to Facilitate Language Development in Young Children With ASD		Completed	No Results Available	Autistic Disorder	Behavioral: communication training	Improved Communication|Review of text output from the VOCA	University of South Alabama	All	2 Years to 5 Years   (Child)	Not Applicable	5	Other	Interventional	Allocation: N/A|Intervention Model: Single Group Assignment|Masking: None (Open Label)|Primary Purpose: Treatment	ASUIRB-1	February 2004	August 2005	August 2005	March 22, 2013		March 22, 2013	Arkansas State University, State University, Arkansas, United States		https://ClinicalTrials.gov/show/NCT01816178
491	NCT01655173	Cognitive Behavioural Therapy (CBT) and Recreational Activity for Autism Spectrum Disorders (ASD)		Completed	No Results Available	Asperger Syndrome|Autistic Disorder|Atypical Autism	Behavioral: Cognitive behaviour therapy|Behavioral: Recreational activity intervention	The Quality of Life Inventory (QOLI, Frisch et al. 1992)|Sense of Coherence (SoC, Antonovsky 1993)|The ten-item Rosenberg Self Esteem Scale (RSES, Rosenberg 1962)|The patient versions of the Clinical Global Impression scale - Severity (patient CGI-S)|Clinical Global Impression scale - Improvement (patient CGI-I)|Autism Quotient (AQ, Baron-Cohen et al. 2001)|Adult ADHD Self-Report Scale (ASRS, Kessler et al. 2005)|Beck Depression Inventory (BDI, Beck et al. 1996)|Symptom Checklist 90 (SCL-90, Derogatis & Cleary 1977)	Karolinska Institutet|Ministry of Health and Social Affairs, Sweden	All	18 Years and older   (Adult, Older Adult)	Not Applicable	68	Other	Interventional	Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Treatment	Dnr 52-6104	August 2005	September 2011	September 2011	August 1, 2012		October 22, 2020	Northern Stockholm psychiatry, St. Göran hospital, Stockholm, Sweden		https://ClinicalTrials.gov/show/NCT01655173
492	NCT05009095	The Listening Program® With Bone Conduction Headphones Changes Hypersensitivity to Sound and Behavioral Responses		Recruiting	No Results Available	Autism Spectrum Disorder	Device: The Listening Program® with bone conduction headphones	Change from Baseline Adaptive Behavior Assessment System, Third Edition (ABAS-3) Score at 41 Weeks (Immediately Post-Treatment)|Pediatric Evaluation of Disability Inventory Computer Adaptive Test with ASD Scales (PEDI-CAT (ASD))	Children's Health	All	5 Years to 10 Years   (Child)	Not Applicable	8	Other	Interventional	Allocation: N/A|Intervention Model: Single Group Assignment|Masking: None (Open Label)|Primary Purpose: Treatment	STU-2019-1698	June 13, 2022	May 1, 2023	May 1, 2023	August 17, 2021		August 5, 2022	Childrens's Health Specialty Center Richardson, Richardson, Texas, United States		https://ClinicalTrials.gov/show/NCT05009095
493	NCT03115671	Efficacy Study of Vayarin in Children With Autism and Comorbid Attention Deficit Hyperactivity Disorder (ADHD)		Completed	No Results Available	Autism Spectrum Disorder|Attention Deficit Hyperactivity Disorder	Dietary Supplement: Vayarin	Conners 3rd Edition - Parent|Social Responsiveness Scale (SRS)|Aberrant Behaviour Checklist (ABC)|Physical examination and safety evaluation (PAERS)	Institute of Mental Health, Singapore	All	6 Years to 12 Years   (Child)	Not Applicable	24	Other	Interventional	Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Single (Outcomes Assessor)|Primary Purpose: Treatment	DSRB A/16/01120|CTC 1600529	November 30, 2016	December 31, 2018	December 31, 2018	April 14, 2017		August 14, 2019	Child Guidance Clinic, Singapore, Singapore		https://ClinicalTrials.gov/show/NCT03115671
494	NCT05280613	The Family Check-Up in Autism Services		Recruiting	No Results Available	Autism Spectrum Disorder|Behavior Problem|Emotional Problem	Behavioral: Family Check-Up|Behavioral: Treatment as Usual	Change in Aberrant Behavior Checklist (ABC) - irritability subscale|Change in Home Situation Questionnaire -ASD (HSQ-ASD)|Change in Center for Epidemiological Studies Depression Scale - Revised (CESD-R)|Change in Generalized Anxiety Disorder-7 (GAD-7)|Change in Parenting Daily Hassles|Change in Parenting Young Children (PARYC)|Change in Parental Monitoring Scale|Change in Parent Empowerment and Efficacy Measure (PEEM)|Change in Brief Coping Orientation to Problems Experienced (Brief COPE)|Clinical Global Impressions - Improvement (CGI-I)	McMaster University|Hamilton Health Sciences Corporation	All	6 Years to 17 Years   (Child)	Not Applicable	80	Other	Interventional	Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Double (Investigator, Outcomes Assessor)|Primary Purpose: Treatment	FAIR Study	October 2022	July 2023	December 2023	March 15, 2022		October 14, 2022	McMaster University, Hamilton, Ontario, Canada		https://ClinicalTrials.gov/show/NCT05280613
495	NCT05511220	Pivotal Response Intervention Minimal Responders Study	PRIMeR	Recruiting	No Results Available	Autism Spectrum Disorder With Impaired Functional Language	Behavioral: PRIMeR|Behavioral: PRT	Social initiations|Communication	IWK Health Centre|Canadian Institutes of Health Research (CIHR)	All	3 Years to 5 Years   (Child)	Not Applicable	40	Other	Interventional	Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Single (Outcomes Assessor)|Primary Purpose: Treatment	1027196	July 12, 2022	October 2024	March 30, 2025	August 22, 2022		August 22, 2022	IWK Health Centre, Halifax, Nova Scotia, Canada		https://ClinicalTrials.gov/show/NCT05511220
496	NCT02384486	Efficacy of Training Programme to Reduce Stress		Completed	No Results Available	Autism Spectrum Disorder (ASD)	Behavioral: Training to Reduce Stress in Mothers of Children with (ASD)|Other: Nothing (treatment as usual)	Parent Stress Index Short From (PSI-SF)	University of Nottingham	Female	18 Years and older   (Adult, Older Adult)	Not Applicable	67	Other	Interventional	Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Single (Investigator)	OVS12022015 SA SoM PAPsych PhD	April 2015	December 2015	December 2015	March 10, 2015		May 17, 2016	Voluntary sector ASD organization no.1, Jeddah, Saudi Arabia		https://ClinicalTrials.gov/show/NCT02384486
497	NCT02918864	Oxytocin and Social Cognitive Skills Groups	ION-ASD	Completed	No Results Available	Autism Spectrum Disorder	Drug: Oxytocin|Behavioral: Social Cognitive Skills Training|Behavioral: Facilitated Play Therapy	Change from Baseline in Social Behavior Composite|Change from Baseline in Social Cognition Composite|Change from Baseline in Global Functioning|Change from Baseline in Social Functioning|Change from Baseline in Quality of Life	Rush University Medical Center|University of Illinois at Chicago|University of Chicago|Northwestern University|Eotvos Lorand University	All	8 Years to 11 Years   (Child)	Phase 2	83	Other	Interventional	Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Single (Outcomes Assessor)|Primary Purpose: Treatment	14062403	June 15, 2016	September 2021	September 2021	September 29, 2016		November 4, 2022	Rush University Medical Center, Chicago, Illinois, United States		https://ClinicalTrials.gov/show/NCT02918864
498	NCT02552147	Nicotinic Cholinergic Modulation as a Novel Treatment Strategy for Aggression Associated With Autism		Completed	Has Results	Autism Spectrum Disorder|Aggression|Irritability	Drug: Transdermal nicotine|Other: Transdermal placebo	Change From Baseline in Aberrant Behavior Checklist Irritability Subscale (ABC-I)|Change in Social Responsiveness Scale-Adults (SRS-A)|Change in Qualitative Description of Irritability and Aggression Symptoms|Change in Frustration and Irritability Ratings During Frustration-induction Go-NoGo Task|Change in State/Trait Anxiety Inventory (STAI) Score|Nightly Sleep Quality	Yale University|Autism Speaks	All	18 Years to 60 Years   (Adult)	Phase 1	8	Other	Interventional	Allocation: Randomized|Intervention Model: Crossover Assignment|Masking: Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)|Primary Purpose: Treatment	1502015384	September 2015	November 17, 2017	November 17, 2017	September 16, 2015	March 14, 2019	May 6, 2022	Yale University, New Haven, Connecticut, United States	"Study Protocol and Statistical Analysis Plan", https://ClinicalTrials.gov/ProvidedDocs/47/NCT02552147/Prot_SAP_002.pdf|"Informed Consent Form", https://ClinicalTrials.gov/ProvidedDocs/47/NCT02552147/ICF_001.pdf	https://ClinicalTrials.gov/show/NCT02552147
499	NCT02677051	Sulforaphane in a New Jersey (NJ) Population of Individuals With Autism		Active, not recruiting	No Results Available	Autism|Autistic Disorder|Autism Spectrum Disorder|Autistic Behavior	Drug: Sulforaphane|Drug: Placebo	Change in Aberrant Behavior Checklist (ABC) scores.|Change in Social Responsiveness Scale (SRS) scores.|Clinical Global Impression Severity Scale (CGI-S).|Clinical Global Impression Improvement Scale (CGI-I) to measure change from baseline CGI-S scores.|Liver Function Tests as a screen for entry into the study and a monitor of potential change/adverse events due to treatment.|Renal Function Tests as a screen for entry into the study and a monitor of potential change/adverse events due to treatment.|Thyroid Stimulating Hormone (TSH) as a screen for entry into the study and a monitor of potential change/adverse events due to treatment.	Rutgers, The State University of New Jersey|Rowan University	Male	13 Years to 30 Years   (Child, Adult)	Phase 2	48	Other	Interventional	Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)|Primary Purpose: Treatment	Pro20120001884|CAUT15APL013	February 2016	December 2022	July 2023	February 9, 2016		November 16, 2022	Rutgers University - Staged Research Building, Piscataway, New Jersey, United States	"Informed Consent Form", https://ClinicalTrials.gov/ProvidedDocs/51/NCT02677051/ICF_000.pdf	https://ClinicalTrials.gov/show/NCT02677051
500	NCT05503459	Exercise and Cognition in Children With ASD		Completed	No Results Available	Cognitive Impairment|Child Autism	Other: Bicycle learning|Other: Stationary cycling	Change of cognitive flexibility|Change of inhibition|Perceived social support|Enjoyment|Stress level|Physical self-efficacy|Perceived physical fitness	Education University of Hong Kong|San Francisco State University|University of California, Riverside	All	8 Years to 12 Years   (Child)	Not Applicable	82	Other	Interventional	Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Single (Outcomes Assessor)|Primary Purpose: Supportive Care	EduUHK	March 1, 2021	May 28, 2022	June 3, 2022	August 16, 2022		August 23, 2022	EdUHK, Hong Kong, China, Hong Kong		https://ClinicalTrials.gov/show/NCT05503459
501	NCT00670891	A Clinical Trial of the Clinical Effects of Hyperbaric Oxygen Therapy in Thai Autistic Children	VPH	Completed	No Results Available	Autistic Disorder	Procedure: oxygen (Hyperbaric Oxygen Therapy)	Developmental and Skill training assessment, Rajanukul Hospital 5th edition	Vachira Phuket Hospital	All	5 Years to 9 Years   (Child)	Phase 1	7	Other	Interventional	Allocation: Non-Randomized|Intervention Model: Single Group Assignment|Masking: None (Open Label)|Primary Purpose: Treatment	VP 000001	July 2007	April 2008	April 2008	May 2, 2008		May 29, 2008	Vachira Phuket Hospital, Phuket, Thailand		https://ClinicalTrials.gov/show/NCT00670891
502	NCT05254769	Neurofeedback Intervention in Children With Autism Spectrum Disorder (ASD)		Recruiting	No Results Available	Neurofeedback|Autistic Disorder|Autism Spectrum Disorder|Neurodevelopmental Disorders	Device: Neurofeedback Equipment (Cygnet) by BEE Medic GmbH Technologies, Baden-Wurttemberg, Germany.	Childhood Autism Rating Scale (CARS)|IQ (Intelligence Quotient) scoring (Colored Progressive Matrices (CPM)|Reward sensitivity testing|Changes in Flanker Inhibitory Control and Attention Score|Changes in Dimensional Change Card Sort Score; Cognitive Flexibility|Changes in List Sorting Working Memory Score|Changes in Pattern Comparison Processing Speed Score	Shaheed Zulfiqar Ali Bhutto Medical University|Khyber Medical University Peshawar	All	7 Years to 17 Years   (Child)	Not Applicable	35	Other	Interventional	Allocation: N/A|Intervention Model: Single Group Assignment|Masking: None (Open Label)|Primary Purpose: Treatment	NFB	November 15, 2021	March 2022	May 2022	February 24, 2022		March 8, 2022	Federal Medical and Dental College, Shaheed Zulfiqar Ali Bhutto Medical University, Islamabad, Pakistan		https://ClinicalTrials.gov/show/NCT05254769
503	NCT01256060	Intranasal Oxytocin for the Treatment of Children and Adolescents With ASD (OXY)		Completed	Has Results	Autism Spectrum Disorder	Drug: Intranasal Oxytocin	Maximum Tolerated Dose (MTD)|Number of Participants With Serious Adverse Events|Baseline Levels of Oxytocin in Relation to Either Safety or Treatment Response|Blood Levels of Oxytocin During the Trial in Relation to Safety or Treatment Response	Evdokia Anagnostou|Holland Bloorview Kids Rehabilitation Hospital|The Hospital for Sick Children|University of Illinois at Chicago|Anagnostou, Evdokia, M.D.	All	10 Years to 17 Years   (Child)	Phase 2	15	Other	Interventional	Allocation: N/A|Intervention Model: Single Group Assignment|Masking: None (Open Label)|Primary Purpose: Treatment	10-001	November 2010	March 2013	March 2013	December 8, 2010	April 15, 2015	August 12, 2016	Holland Bloorview Kids Rehabilitation Hospital, Toronto, Ontario, Canada		https://ClinicalTrials.gov/show/NCT01256060
504	NCT03408886	Microbiota Transfer Therapy for Adults With Autism Spectrum Disorder (ASD) Who Have Gastrointestinal Disorders	MTT-ASD	Active, not recruiting	No Results Available	Autism Spectrum Disorder|Gastrointestinal Disorder	Drug: Vancomycin|Drug: MoviPrep|Biological: Full Spectrum Microbiota	Change in Childhood Autism Rating Scale (CARS) from baseline to 10 weeks|Change in Daily Stool Log (DSL) from baseline to 10 weeks|Change in Social Responsiveness Scale - 2 from baseline to 10 weeks of treatment|Change in Aberrant Behavior Checklist from baseline to 10 weeks	Arizona State University	All	18 Years to 60 Years   (Adult)	Phase 2	55	Other	Interventional	Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)|Primary Purpose: Treatment	MTT-Adults-1|Wi1XWH-16-1-0492	January 4, 2018	October 4, 2022	September 1, 2023	January 24, 2018		December 30, 2021	Arizona State University, Tempe, Arizona, United States		https://ClinicalTrials.gov/show/NCT03408886
505	NCT02826148	Validation of the French Adaptation of the RAADS-R Scale : Scale of Asperger Syndrome Diagnosis	RAADS-R	Completed	No Results Available	Autism Spectrum Disorder	Other: RAADS-R scale	score at the RAADS-R scale	University Hospital, Montpellier|Fondation Orange	All	18 Years to 75 Years   (Adult, Older Adult)	Not Applicable	324	Other	Interventional	Allocation: N/A|Intervention Model: Single Group Assignment|Masking: None (Open Label)|Primary Purpose: Diagnostic	8747	December 2011	December 2015	December 2015	July 7, 2016		July 7, 2016			https://ClinicalTrials.gov/show/NCT02826148
506	NCT04243382	Treatment of Children With Autistic Spectrum Disorder With Autologous Umbilical Cord Blood, a Pilot Study		Recruiting	No Results Available	Autistic Spectrum Disorder	Biological: Autologous umbilical cord blood|Biological: Placebo	Improvement of social communication skills|Functional assessment	Sheba Medical Center	All	18 Months to 12 Years   (Child)	Phase 2	60	Other	Interventional	Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)|Primary Purpose: Treatment	SHEBA-18-5105-OBY-CTIL	February 27, 2020	December 2024	December 2024	January 28, 2020		January 20, 2021	Chaim Seba Medical Center, Ramat Gan, Israel		https://ClinicalTrials.gov/show/NCT04243382
507	NCT05554198	Evaluating a Web Delivered Behavioral Parent Training Intervention for Rural Parents of Children With Autism Spectrum Disorder		Not yet recruiting	No Results Available	Autism Spectrum Disorder|Parenting|Parenting Intervention	Behavioral: Attend Behavior Parent Training	Intervention acceptability Interview|Intervention feasibility|Acceptability of Intervention (AIM),Intervention Appropriateness Measure (IAM), Feasibility of Intervention (FIM)|Aberrant Behavior Checklist (ABC)|Home Situations Questionnaire-Autism Spectrum Disorder (HSQ-ASD)|Patient-Reported Outcome Measurement Information System (PROMIS) Depression - Short Form 6a|Parenting Stress Index-Short Form (PSI-SF)	Ohio State University	All	2 Years to 11 Years   (Child)	Not Applicable	40	Other	Interventional	Allocation: N/A|Intervention Model: Single Group Assignment|Masking: None (Open Label)|Primary Purpose: Treatment	2021B0434|GR128585	December 2022	December 2024	December 2025	September 26, 2022		September 26, 2022			https://ClinicalTrials.gov/show/NCT05554198
508	NCT05599711	Transitioning Together Boston		Recruiting	No Results Available	Autism or Autistic Traits|Family Relations	Behavioral: Transitioning Together (TT) / Juntos en la Transicion (JET)|Behavioral: Usual autism transition care	Change in quality of life of autistic youth|Change in transition-related goal attainment|Change in youth problem behaviors|Change in family empowerment|Change in coping|Change in social support|Change in perceived burden|Change in parental well-being|Change in family climate|Change in transition readiness	Boston Medical Center|Deborah Munroe Noonan Memorial Research Fund	All	14 Years to 21 Years   (Child, Adult)	Not Applicable	256	Other	Interventional	Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Treatment	H-43047	January 2023	September 2024	September 2024	October 31, 2022		December 19, 2022	Boston Medical Center, Boston, Massachusetts, United States		https://ClinicalTrials.gov/show/NCT05599711
509	NCT01984944	Characterisation of Circadian Rhythm in Autistic Spectrum Disorder		Completed	No Results Available	Autistic Disorder	Other: Autistic functional exploration|Other: Control functional exploration	Urinary sulfatoxymelatonin secretion|Core body temperature rhythm|Circadian rhythms assessed with actometer	Assistance Publique - Hôpitaux de Paris|Henri Mondor University Hospital|Albert Chenevier Hospital (Department of Psychiatry)|Hopital Universitaire Robert-Debre|Pasteur Institute (Cognitive Function and Human Genetic)|Fondation FondaMental	All	6 Years and older   (Child, Adult, Older Adult)	Not Applicable	42	Other	Interventional	Allocation: Non-Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Basic Science	P081103|2009-011842-24	October 2009	August 2013	August 2013	November 15, 2013		November 7, 2014	Henri Mondor Hospital, Creteil, France		https://ClinicalTrials.gov/show/NCT01984944
510	NCT05200351	Equine-assisted Therapy for Therapy-resistant Adolescents With Autism Spectrum Disorders, a Replicated AB-design		Recruiting	No Results Available	Emotion Regulation|Autism Spectrum Disorder|Adolescent - Emotional Problem	Behavioral: Equine assisted Therapy (EAT)	Change from baseline on the Emotion dysregulation Index (EDI) after start of the intervention|Change from baseline of Quality of life as scored on the KIDSCREEN after 15 weeks and 1 year|Change from baseline of severity of autism spectrum symptoms as measured on the Social Responsiveness Scale (SRS-2) after 15 weeks and 1 year|Change from baseline on the Goal Attainment Scale (GAS) after the intervention after 15 weeks|Change from baseline of self-esteem as measured on the The Rosenberg Self-Esteem Scale (RSES) after 15 weeks and 1 year|Change from baseline of Global functioning as measured on the Child Behavior Checklist (CBCL) after 15 weeks and 1 year|Change from baseline of Goal attainment as measured on the Outcome Rating Scale (ORS) after 15 weeks|Change from baseline of family functioning as measured on the VGFO on T3|Change from baseline of Global functioning as measured on the Teachers Report Form (TRF) after 15 weeks and 1 year|Change from baseline of Global functioning as measured on the Youth Self Report (YSR) after 15 weeks and 1 year|Change from baseline of adherence as measured on the SRS after 15 weeks	Karakter Kinder- en Jeugdpsychiatrie|ZonMw: The Netherlands Organisation for Health Research and Development	All	11 Years to 18 Years   (Child, Adult)	Not Applicable	35	Other	Interventional	Allocation: N/A|Intervention Model: Single Group Assignment|Masking: None (Open Label)|Primary Purpose: Treatment	185-20 Pegasus|636310020	February 14, 2022	December 2024	December 2024	January 20, 2022		February 17, 2022	Karakter, Ede, Gelderland, Netherlands|Horses & Co, Heerjansdam, Netherlands|De Gagelhoeve, Mill, Netherlands	"Study Protocol and Statistical Analysis Plan", https://ClinicalTrials.gov/ProvidedDocs/51/NCT05200351/Prot_SAP_000.pdf	https://ClinicalTrials.gov/show/NCT05200351
511	NCT04879303	Robotic Intervention Framework for Children With Autism Spectrum Disorder to Enhance Social Engagement and Participation		Recruiting	No Results Available	Autism Spectrum Disorder|Social Engagement|Robotic Intervention	Behavioral: Robot-assisted social skill intervention|Behavioral: Human-only instruction programme on social skill training	The Autism Diagnostic Observation Schedule|Social Responsiveness Scale|The Canadian Occupational Performance Measure|Short sensory profile	Education University of Hong Kong	All	5 Years to 11 Years   (Child)	Not Applicable	60	Other	Interventional	Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Treatment	R1230	May 3, 2021	October 2021	June 30, 2022	May 10, 2021		August 18, 2021	The Education University of Hong Kong, Hong Kong, Hong Kong		https://ClinicalTrials.gov/show/NCT04879303
512	NCT02491645	Comparison of Effectiveness of Home Based Sensory Interventions Along With Standard Therapy Versus Standard Therapy Alone in Autistic Children With Sensory Processing Abnormalities		Completed	No Results Available	Autistic Children With Sensory Processing Abnormalities	Other: Sensory interventions	1. Comparison of change in total score on 10 item Likert scale (as rated by parents)|1. Comparison of change in health related quality of life using PedsQL ( Pediatric quality of life inventory) questionnaire|2. Comparison of change in overall functional outcome using CGAS (Children's global assessment scale) questionnaire	Postgraduate Institute of Medical Education and Research	All	3 Years to 12 Years   (Child)	Not Applicable	40	Other	Interventional	Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Supportive Care	PGIMER-HS	February 2015	June 2017	December 2017	July 8, 2015		August 1, 2018	Dr Hansashree P, Chandigarh, India		https://ClinicalTrials.gov/show/NCT02491645
513	NCT01983189	Transcranial Magnetic Stimulation for Evaluation and Treatment of Repetetive Behaviors in Autism		Terminated	No Results Available	Autism|Asperger Disorder|Other Developmental Pervasive Disorder	Procedure: transcranial magnetic stimulation	clinical improvement based on repetitive behavior scale.|clinical improvement based on the social responsiveness scale.	New York State Psychiatric Institute	All	18 Years to 55 Years   (Adult)	Phase 2	10	Other	Interventional	Allocation: N/A|Intervention Model: Single Group Assignment|Masking: Double (Participant, Outcomes Assessor)|Primary Purpose: Treatment	5594	November 2008	November 2010	November 2010	November 13, 2013		March 24, 2017	New York State Psychiatric Institute, 1051 Riverside Drive, New York, New York, United States		https://ClinicalTrials.gov/show/NCT01983189
514	NCT03889821	Mindfulness Training and Parent-coaching Interventions for Autism Spectrum Disorder		Completed	No Results Available	Autism Spectrum Disorder|Parents|Stress	Behavioral: Parent-implemented Early Start Denver Model|Behavioral: Mindfulness Based Stress Reduction	Change in parental stress|Change in parental depression|Change in parental anxiety|Change in parental mindfulness|Change in parent relationship quality|Change in parental life satisfaction|Change in parental sleep quality|Change in child autism symptom severity|Change in child cognitive functioning|Change in child adaptive behavior|Change in child problem behaviors|Change in child communication behaviors	Vanderbilt University Medical Center	All	12 Months and older   (Child, Adult, Older Adult)	Not Applicable	63	Other	Interventional	Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Treatment	MBSR and P-ESDM|R40MC30769	March 11, 2015	March 23, 2018	March 23, 2018	March 26, 2019		March 26, 2019	Vanderbilt University Medical Center, Nashville, Tennessee, United States		https://ClinicalTrials.gov/show/NCT03889821
515	NCT04358484	Implementation of Incredible Years for Autism and Language Delay Program in Spain	FS	Active, not recruiting	No Results Available	Autism Spectrum Disorder|Language Delay|Prematurity	Behavioral: Incredible Years - ASD and Language Delay®	Autism Program Parent Final Satisfaction Questionnaire|Register sheet of attendance|Autism Program Parent Weekly Evaluation.|Incredible Years® Parent Strategies Questionnaire for Children with Autism (2-5 years)|Parental Stress Index (PSI-SF) by Abidin.|Beck Depression Inventory (BDI)|Autism Specify Five Minutes Speech Sample - ASFMSS|Alabama Parenting Questionnaire Preschool revision (APQ-Pr).	Fundació Sant Joan de Déu	All	24 Months to 71 Months   (Child)	Not Applicable	72	Other	Interventional	Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Treatment	PIC-220-19	January 2, 2020	May 2021	May 2021	April 24, 2020		February 8, 2021	Fundació Sant Joan de Déu, Esplugues de Llobregat, Spain		https://ClinicalTrials.gov/show/NCT04358484
516	NCT05029375	Parental Insightfulness and the Acquisition of Social Skills in Children With ASD.	ASD	Recruiting	No Results Available	Autism Spectrum Disorder	Behavioral: PEERS® for Preschoolers	Behavioral peer interaction measurement|Insightfulness Assessment|Social Responsiveness Scale-second edition (Constantino & Gruber, 2012)|The Social Skills Improvement System (SSIS; Gresham & Elliott, 2008)|Quality of Play Questionnaire (QPQ; Frankel & Mintz, 2011).|The Parental Reflective Functioning Questionnaire (PRFQ; Luyten, Mayes, Nijssens & Fonagy, 2017).	Bar-Ilan University, Israel|Israel Science Foundation	All	4 Years to 8 Years   (Child)	Not Applicable	80	Other	Interventional	Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Triple (Participant, Care Provider, Outcomes Assessor)|Primary Purpose: Treatment	205698	August 2021	August 2023	October 2023	August 31, 2021		August 31, 2021	Bar-Ilan University, Ramat-Gan, Israel		https://ClinicalTrials.gov/show/NCT05029375
517	NCT02847182	Cord Blood Infusion for Children With Autism Spectrum Disorder	Duke ACT	Completed	Has Results	Autism Spectrum Disorder|ASD|Autism|PDD	Biological: Cord Blood Infusion|Biological: Placebo	Change in Social Communication as Measured by the Vineland Adaptive Behavior Scales, Third Edition (VABS-3)|Change in Vineland Socialization Domain Raw Score|Change in Vineland Socialization Domain Age Equivalent|Change in Pervasive Developmental Disorder Behavior Inventory (PDD-BI) Composite Standard Score (Parent Questionnaire)|Change in Clinical Global Impressions - Severity of Illness (CGI-S) Score, Clinician Assessment|Clinical Global Impressions - Global Improvement (CGI-I) Score, Clinician Assessment|Change in Expressive One-Word Picture Vocabulary Test (Clinician Assessment)|Change in Vineland Adaptive Behavior Scales II (VABS-II) Communication Subscale Standard Score|Change in Vineland Adaptive Behavior Scales II (VABS-II) Daily Living Subscale Standard Score|Change in Vineland Adaptive Behavior Scales II (VABS-II) Composite Score|Change in Pervasive Developmental Disorder Behavior Inventory (PDD-BI) Repetitive, Ritualistic and Pragmatic Problems T-Score|Change in PDD-BI Approach/Withdrawal Problems T-Score|Change in PDD-BI Sensory/Perceptual Approach Behaviors T-Score|Change in PDD-BI Ritualisms/Resistance to Change T-Score|Change in PDD-BI Social Pragmatic Problems T-Score|Change in PDD-BI Semantic/Pragmatic Problems T-Score|Change in PDD-BI Arousal Regulation Problems T-Score|Change in PDD-BI Specific Fears T-Score|Change in PDD-BI Aggressiveness T-Score|Change in PDD-BI Expressive Social Communication Abilities T-Score|Change in PDD-BI Receptive/Expressive Social Communication Ability T-Score|Change in PDD-BI Social Approach Behaviors T-Score|Change in PDD-BI Expressive Language T-Score|Change in PDD-BI Learning, Memory, and Receptive Language T-Score|Number of Participants With Infusion Reactions|Severity of Infusion Reactions|Number of Participants With Product-related Infections|Severity of Product-related Infections|Evidence of Alloimmunization Via Anti-HLA (Human Leukocyte Antigen) and Anti-RBC (Red Blood Cell) Antibodies and Nonspecific Markers of Systemic Inflammation (ESR, CRP)|Incidence of Graft vs. Host Disease|Severity of Graft vs. Host Disease|Incidence of Unexpected Adverse Events, by Relation to Study Product|Severity of Unexpected Adverse Events, by Relation to Study Product	Joanne Kurtzberg, MD|Duke University	All	2 Years to 7 Years   (Child)	Phase 2	180	Other	Interventional	Allocation: Randomized|Intervention Model: Crossover Assignment|Masking: Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)|Primary Purpose: Treatment	Pro00070514	September 2016	August 19, 2018	May 2019	July 28, 2016	December 26, 2019	June 9, 2020	Duke University Medical Center, Durham, North Carolina, United States	"Study Protocol and Statistical Analysis Plan", https://ClinicalTrials.gov/ProvidedDocs/82/NCT02847182/Prot_SAP_000.pdf	https://ClinicalTrials.gov/show/NCT02847182
518	NCT02265094	Associative Memory in Autism Spectrum Disorder	MEM-TA	Unknown status	No Results Available	Autistic Disorder	Other: Electroencephalography|Behavioral: Neuropsychological assessment	Index of discrimination obtained with the task of associative memory	University Hospital, Caen|Institut National de la Santé Et de la Recherche Médicale, France|Amiens University Hospital	All	10 Years to 18 Years   (Child, Adult)	Not Applicable	80	Other	Interventional	Allocation: Non-Randomized|Intervention Model: Factorial Assignment|Masking: None (Open Label)|Primary Purpose: Basic Science	2014- A00481-46	December 22, 2015	December 2018	December 2019	October 15, 2014		February 20, 2018	Caen University Hospital, Caen, France		https://ClinicalTrials.gov/show/NCT02265094
519	NCT04376151	Guided ACT and for Adults With ASD		Recruiting	No Results Available	Autism Spectrum Disorder (ASD)	Other: Acceptance and Commiment Therapy (ACT) bibliotherapy 'Get Out of Your Mind and Into Your Life'	Comprehensive Assessment of Acceptance and Commitment Therapy Process (CompACT) repeated measure of change|Comprehensive Assessment of Acceptance and Commitment Therapy Process (CompACT short form) repeated measure of change|The Depression, Anxiety and Stress Scale (DASS-21) repeated measure of change|Personal Questionnaire (PQ) repeated measure of change|World Health Organisation Quality of Life Questionnaire (WHO-QoL- BRIEF) repeated measure of change	University of Lincoln|Nottinghamshire Healthcare NHS Trust	All	18 Years and older   (Adult, Older Adult)	Not Applicable	8	Other	Interventional	Allocation: N/A|Intervention Model: Single Group Assignment|Masking: None (Open Label)|Primary Purpose: Health Services Research	245597	September 1, 2020	January 20, 2022	August 20, 2022	May 6, 2020		May 5, 2021	Nottingham City Autisum Service, Nottingham, Nottinghamshire, United Kingdom	"Study Protocol and Statistical Analysis Plan", https://ClinicalTrials.gov/ProvidedDocs/51/NCT04376151/Prot_SAP_000.pdf	https://ClinicalTrials.gov/show/NCT04376151
520	NCT03947086	Neurostimulation for Cognitive Rehabilitation in Autistic Spectrum Disorders		Unknown status	No Results Available	Autistic Disorders Spectrum	Device: Transcranial Direct Current Stimulation (TDCS)- Active|Device: Transcranial Direct Current Stimulation (TDCS)- Sham|Behavioral: Cognitive Training	Facial emotion recognition|Theory of mind- Verbal task|Theory of mind- Contextual task|Memory for Digit Span|Trail Making Test A e B|Seven Errors Test	Federal University of Paraíba	Male	8 Years to 12 Years   (Child)	Not Applicable	16	Other	Interventional	Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Double (Participant, Investigator)|Primary Purpose: Treatment	U1111-1221-6178	April 30, 2018	September 30, 2018	May 30, 2019	May 13, 2019		May 15, 2019	Gabriela Medeiros, João Pessoa, Paraíba, Brazil		https://ClinicalTrials.gov/show/NCT03947086
521	NCT05302544	Impact of Mixed Reality Training on Motor Skills in Children With Autistic Spectrum Disorder	RAMAu	Not yet recruiting	No Results Available	Autistic Spectrum Disorder	Other: Mixed Reality training|Other: motor activities	change of walking speed	Université de Reims Champagne-Ardenne	All	8 Years to 12 Years   (Child)	Not Applicable	44	Other	Interventional	Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Treatment	2022_RIPH_001_RAMAu	May 15, 2022	May 15, 2023	May 30, 2023	March 31, 2022		April 27, 2022			https://ClinicalTrials.gov/show/NCT05302544
522	NCT03814083	Transcranial Direct Current Stimulation in Autism Spectrum Disorder		Completed	No Results Available	Transcranial Direct Current Stimulation|Autistic Disorders Spectrum|Electroencephalography	Device: Active-tDCS|Device: Sham-tDCS|Other: Wait-list	Change in behavioral measures - Early Adolescent Temperament Questionnaire - Revised - Effortful control subscale (EATQ-R-EC)|Change in behavioral measures - Autism Quotient (AQ)|Change in behavioral measures - Social Responsiveness Scales (SRS)|Change in CANTAB® cognitive test - Stop Signal Task (SST)|Change in CANTAB® cognitive test - Reaction Time (RTI)|Change in CANTAB® cognitive test - One Touch Stockings of Cambridge (OTS)|Change in CANTAB® cognitive test - Multitasking Test (MTT)|Change in CANTAB® cognitive test - Emotion Recognition Task (ERT)|Change in n-back task|Change in the Attention Network Task (ANT)|Change in Electroencephalography (EEG) coherence measure|Change in functional near-infrared spectroscopy (fNIRS) recording	The Hong Kong Polytechnic University|Chinese University of Hong Kong	All	14 Years to 21 Years   (Child, Adult)	Not Applicable	105	Other	Interventional	Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Triple (Participant, Care Provider, Outcomes Assessor)|Primary Purpose: Treatment	HSEARS20171230001	July 23, 2019	February 28, 2022	August 31, 2022	January 23, 2019		November 15, 2022	The Hong Kong Polytechnic University, Hung Hom, Kowloon, Hong Kong		https://ClinicalTrials.gov/show/NCT03814083
523	NCT03348982	Examining the Association Between Physical Activity and Sleep Quality in Children With Autism Spectrum Disorder		Unknown status	No Results Available	Physical Activity|Sleep Apnea|Autism Spectrum Disorder	Behavioral: Jogging program	Sleep onset latency|Sleep efficiency|Wake after sleep onset|Sleep duration|Parental-assessed sleep quality|Melatonin	The Hong Kong Polytechnic University	All	9 Years to 12 Years   (Child)	Not Applicable	32	Other	Interventional	Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Treatment	28602517	January 2018	June 2019	June 2019	November 21, 2017		December 6, 2017			https://ClinicalTrials.gov/show/NCT03348982
524	NCT01031511	Effect of Cognitive Behavioural Therapy (CBT) for Children With Autistic Spectrum Disorders		Unknown status	No Results Available	Autism Spectrum Disorder|Anxiety	Behavioral: Cognitive Behavioural Therapy|Other: Social Recreational	Anxiety level of child|Parent Stress Level	National Healthcare Group, Singapore|Nanyang Technological University|Autism Resource Centre, Singapore	All	9 Years to 16 Years   (Child)	Early Phase 1	73	Other	Interventional	Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Single (Outcomes Assessor)|Primary Purpose: Treatment	DSRB Ref Code: A/05/091|NMRC/1002/2005|130/2005	June 2005	January 2010	February 2011	December 14, 2009		December 14, 2009	Institute of Mental Health, Singapore, Singapore, Singapore		https://ClinicalTrials.gov/show/NCT01031511
525	NCT03887676	Arbaclofen vs. Placebo in the Treatment of Children and Adolescents With ASD (ARBA)	ARBA	Active, not recruiting	No Results Available	Autism Spectrum Disorder	Drug: Arbaclofen|Other: Placebo	Vineland Adaptive Behavior Scales, Third Edition (Vineland-3) - Social Domain|Clinical Global Impressions - Impression Scale - Improvement (CGI-I)|Aberrant Behavior Checklist (ABC) - Social Withdrawal Subscale|Vineland Adaptive Behavior Scales, Third Edition (Vineland-3) - Communication Domain|Safety Monitoring Uniform Report Form (SMURF)|Clinical Global Impressions - Impression Scale - Global (CGI-I-Global)|Epworth Sleepiness Scale for Children and Adolescents (ESS-CHAD)|Suicidality assessment using the Columbia-Suicide Severity Rating Scale (C-SSRS)	Evdokia Anagnostou|Holland Bloorview Kids Rehabilitation Hospital|McMaster University|University of Western Ontario, Canada|Queen's University|Unity Health Toronto|University of Toronto|Anagnostou, Evdokia, M.D.	All	5 Years to 17 Years   (Child)	Phase 2	90	Other	Interventional	Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)|Primary Purpose: Treatment	ARB-05-2018	March 18, 2019	August 31, 2022	August 31, 2022	March 25, 2019		June 22, 2022	McMaster University, Offord Centre for Child Studies, Hamilton, Ontario, Canada|Queen's Universtiy, Kingston, Ontario, Canada|University of Western Ontario, Lawson Health Research Institute, London, Ontario, Canada|Holland Bloorview Kids Rehabilitation Hospital, Toronto, Ontario, Canada		https://ClinicalTrials.gov/show/NCT03887676
526	NCT01805128	Exploration of the Social Cognition in Adolescents With a Dissociative Disorder or Autism Spectrum		Completed	No Results Available	Schizophrenia|Autistic Disorder	Other: Facial recognition of emotions|Other: understanding metaphors|Other: Attribution of intentionality to others in social situations depending on the type of situation	Compare cognitive profiles in clinical adolescents with a schizophrenic disorder, autistic or healthy in the three areas of social cognition|Compare the cognitive profiles within the clinical group of schizophrenic|Cognitive profiles compare clinical results between the different types of schizophrenia and autism patients.	Centre Hospitalier Universitaire de Nice|Centre Hospitalier d'Antibes Juans les Pins|Centre Hospitalier de Cannes	All	12 Years to 18 Years   (Child, Adult)	Not Applicable	60	Other	Interventional	Allocation: Non-Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)	12-AOI-04	January 2013	April 2013	May 2013	March 6, 2013		May 29, 2013	Centre Hospitalier d'Antibes Juans les Pins, Antibes, France|Centre hospitalier de Cannes, Cannes, France|CHU de Nice, Nice, France		https://ClinicalTrials.gov/show/NCT01805128
527	NCT00773812	Placebo-Controlled Pilot Trial of Mecamylamine for Treatment of Autism Spectrum Disorders		Completed	No Results Available	Autistic Disorder|Pervasive Developmental Disorder	Drug: mecamylamine|Drug: placebo	The primary measure will be a global composite derived by calculating the z scores on each measure other than CGI from published norms (or from the baseline descriptives, then averaging the z scores of the various outcome measures for each individual.|OSU Autism Rating Scale-DSM-IV|Repetitive Behavior Questionnaire|Aberrant Behavior Checklist|Ohio Autism Clinical Impressions Scale|Social Responsiveness Scale|Expressive Vocabulary test-Second Edition|Adverse Experience checklist and AE log|Cognitive Battery	Ohio State University|Autism Speaks	All	4 Years to 12 Years   (Child)	Phase 1	20	Other	Interventional	Allocation: Randomized|Intervention Model: Factorial Assignment|Masking: Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)|Primary Purpose: Treatment	2007H0096	July 2007	November 2012	November 2012	October 16, 2008		January 13, 2017	Nisonger Center, Columbus, Ohio, United States		https://ClinicalTrials.gov/show/NCT00773812
528	NCT04460677	ASD (Autism Spectrum Disorder) Telehealth for Distress Related to COVID-19		Completed	No Results Available	Psychological Distress|Stress, Psychological|Autism Spectrum Disorder	Behavioral: Emotional Support Plan|Behavioral: Daily Monitoring	Decreased distress on Patient Health Questionnaire (PHQ-9)|Decreased distress on EMA reports|Decreased anxiety symptoms on the Generalized Anxiety Disorder Questionnaire (GAD-7)|Adult Self Report (ASR)	Rutgers, The State University of New Jersey	All	18 Years and older   (Adult, Older Adult)	Not Applicable	26	Other	Interventional	Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Prevention	Pro2020001593	August 12, 2020	February 9, 2022	February 9, 2022	July 7, 2020		August 10, 2022	Rutgers University, Piscataway, New Jersey, United States		https://ClinicalTrials.gov/show/NCT04460677
529	NCT05149144	Comutti - A Research Project Dedicated to Finding Smart Ways of Using Technology for a Better Tomorrow for Everyone, Everywhere.	COMUTTI	Recruiting	No Results Available	Autism Spectrum Disorder	Diagnostic Test: Clinical evaluation of participants by means of Autism Diagnostic Observation Schedule|Behavioral: audio signal dataset creation and validation; machine learning analysis, empirical evaluations	Frequency of audio signal samples and their associated labels|Participant-specific harmonic features derived by the audio signal samples|Accuracy of machine learning prediction	IRCCS Eugenio Medea|Politecnico di Milano|Massachusetts Institute of Technology	All	2 Years to 10 Years   (Child)	Not Applicable	25	Other	Interventional	Allocation: N/A|Intervention Model: Single Group Assignment|Masking: None (Open Label)|Primary Purpose: Basic Science	868	July 27, 2021	December 31, 2022	December 31, 2022	December 8, 2021		December 30, 2021	Scientific Institute, IRCCS Eugenio Medea, Bosisio Parini, Lecco, Italy		https://ClinicalTrials.gov/show/NCT05149144
530	NCT05151601	Combined Human Milk Oligosaccharides (HMOs) and Probiotics Intervention for Children With Autism		Recruiting	No Results Available	Autism Spectrum Disorder|Neurodevelopmental Disorders|Anxiety	Dietary Supplement: Experimental|Other: Placebo	Behaviour change|Behaviour Change|Change in GI Symptom Severity|Change in the Gut Microbiome|Change in Anxiety Levels|Change in Quality of Life|Change in Stool Consistency|Change in stool short chain fatty acids levels|Change in urinary serotonin concentration|Change in salivary cortisol levels	The University of Queensland	All	5 Years to 12 Years   (Child)	Not Applicable	60	Other	Interventional	Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Treatment	2020-11-30-Auts	May 17, 2022	December 31, 2022	December 31, 2022	December 9, 2021		July 21, 2022	University of Queensland, Child Health Research Centre, Brisbane, Queensland, Australia		https://ClinicalTrials.gov/show/NCT05151601
531	NCT04788537	Services to Enhance Social Functioning in Adults With Autism Spectrum Disorders		Recruiting	No Results Available	Autism|Autism Spectrum Disorder|Autistic Disorder|Asperger Syndrome|Pervasive Developmental Disorder	Behavioral: Training to Understand and Navigate Emotions and Interactions (TUNE In)	reduction in Social Responsiveness Scale, Second Edition (SRS-2) - Adult (relative/other report)	University of Pennsylvania	All	18 Years and older   (Adult, Older Adult)	Not Applicable	52	Other	Interventional	Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Single (Outcomes Assessor)|Primary Purpose: Treatment	820694	February 16, 2021	December 22, 2022	December 22, 2022	March 9, 2021		November 8, 2022	Perelman School of Medicine, Philadelphia, Pennsylvania, United States		https://ClinicalTrials.gov/show/NCT04788537
532	NCT05373537	Treatment to Improve Sleep in Caregivers With Insomnia and a Child With Autism		Recruiting	No Results Available	Autism Spectrum Disorder|Insomnia Chronic|Caregiver Burden	Behavioral: Cognitive behavioral therapy for Insomnia	Caregiver Acceptability Opinion Survey|Feasibility of pilot study|Change in reported sleep on sleep diaries|Change in Caregiver behaviors|Change in Child Daytime behaviors|Change in total sleep time average measured by an actigraphy watch for caregiver|Change in sleep latency as measured by actigraphy watch for caregiver|Change in wake after sleep onset as measured by by actigraphy watch for caregiver|Change in total sleep time as measured by actigraphy watch for child|Change in sleep latency as measured by actigraphy watch for child|Change in wake after sleep onset as measured by actigraphy for child|Change in Maternal Self-efficacy	University of Pennsylvania|Children's Hospital of Philadelphia	All	3 Years to 100 Years   (Child, Adult, Older Adult)	Not Applicable	80	Other	Interventional	Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Treatment	850797	September 26, 2022	March 15, 2024	July 15, 2024	May 13, 2022		September 22, 2022	University of Pennsylvania, Philadelphia, Pennsylvania, United States|University of Pennsylvania, Philadelphia, Pennsylvania, United States		https://ClinicalTrials.gov/show/NCT05373537
533	NCT04418492	An Intervention Targeting Daily Adaptive Skills Through Executive Function Training for Adults With ASD		Completed	No Results Available	Autism Spectrum Disorder|High-functioning Autism|Autism	Behavioral: Skills for Adaptive Functioning through Executive training (SAFE; tentative title)	The change in the Korean version of Barkley Deficits in Executive Functioning Scale (K-BDEFS)|The change in the Korean version of Vineland Adaptive Behavior Scale-II (K-Vineland-II)|The change in the Community Integration Skills Assessment-2 (CISA-2)|The change in the Cognitive Flexibility Inventory (CFI)	Seoul National University Hospital	All	18 Years to 35 Years   (Adult)	Not Applicable	7	Other	Interventional	Allocation: N/A|Intervention Model: Single Group Assignment|Masking: None (Open Label)|Primary Purpose: Treatment	B-1904/537-302	December 11, 2019	March 11, 2020	March 11, 2020	June 5, 2020		June 9, 2020	Seoul National University Bundang Hospital, Seongnam, Gyeonggi-do, Korea, Republic of		https://ClinicalTrials.gov/show/NCT04418492
534	NCT04994613	Use of an Adaptive Sensory Environment in Autism Spectrum Disorder (ASD) Patients in the Perioperative Environment		Active, not recruiting	No Results Available	Autism Spectrum Disorder|Anesthesia|Procedural Anxiety|Sensory Processing Disorder	Other: Sensory adaptive environment	Examine the preoperative anxiety scores of ASD patients in an adaptive sensory environment.|2. Determine the relationship of severity of sensory integration in ASD patients and their preoperative anxiety scores.|3. Explore family satisfaction with tailored care of their ASD child in the peri-operative environment.	Dayton Children's Hospital|Robert C. Cohn Memorial Research Grant	All	3 Years to 12 Years   (Child)	Not Applicable	60	Other	Interventional	Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)|Primary Purpose: Supportive Care	21-037	September 20, 2021	May 12, 2022	July 1, 2022	August 6, 2021		May 13, 2022	Dayton Children's Hospital, Dayton, Ohio, United States		https://ClinicalTrials.gov/show/NCT04994613
535	NCT04007224	Umbilical Cord Blood vs Personalized Treatments for Improving Autistic Disorder		Recruiting	No Results Available	Autistic Spectrum Disorder	Drug: Intranasal oxytocin|Biological: Autologous umbilical cord blood	Improvement in behaviour, interaction with family and peers|Improvement in behavior and social interaction|Improvement in overall functioning of the child	Fundatia Bio-Forum|Spitalul Angiomedica	All	3 Years to 7 Years   (Child)	Phase 1	20	Other	Interventional	Allocation: Non-Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Treatment	CORDUS	January 17, 2019	October 28, 2022	November 10, 2022	July 5, 2019		August 2, 2022	Spitalul Angiomedica, Bucharest, Bucuresti, Romania|Medicover Hospital, Bucharest, Romania	"Study Protocol, Statistical Analysis Plan, and Informed Consent Form", https://ClinicalTrials.gov/ProvidedDocs/24/NCT04007224/Prot_SAP_ICF_002.pdf	https://ClinicalTrials.gov/show/NCT04007224
536	NCT02828332	Developmental Trajectories in ASD Until Adulthood: A 15 Years Follow-up Study	EpiTED	Completed	No Results Available	Autism Spectrum Disorders	Other: Vineland II (VABS -II)|Other: Quality of life	Vineland II (VABS -II)|Quality of life|comorbidities	University Hospital, Montpellier	All	18 Years to 65 Years   (Adult, Older Adult)	Not Applicable	106	Other	Interventional	Allocation: N/A|Intervention Model: Single Group Assignment|Masking: None (Open Label)	8878	October 2012	September 2015	September 2015	July 11, 2016		July 11, 2016			https://ClinicalTrials.gov/show/NCT02828332
537	NCT01031823	Adolescent Social Skills Training Program	ASST	Completed	No Results Available	Asperger's Disorder|High-functioning Autism	Behavioral: Multi-Media Social Skills Training Program	Social Fluency|Loneliness Scale (Asher & Wheeler, 1985)|Social Responsiveness Scale (SRS; Constantino, 2002)|Strengths and Difficulties Questionnaire (SDQ; Goodman, 1997)	Milton S. Hershey Medical Center	All	13 Years to 17 Years   (Child)	Not Applicable	50	Other	Interventional	Allocation: N/A|Intervention Model: Single Group Assignment|Masking: None (Open Label)|Primary Purpose: Treatment	32300	November 2009	October 2012	July 10, 2013	December 15, 2009		June 6, 2019	Penn State College of Medicine, Penn State Milton S. Hershey Medical Center, Hershey, Pennsylvania, United States		https://ClinicalTrials.gov/show/NCT01031823
538	NCT04909710	Feasibility of Mobile Game System for Potential Treatment of Developmental Delays		Not yet recruiting	No Results Available	Autism Spectrum Disorder|Autism	Other: Mobile Game System for Potential Treatment of Developmental Delays	Preliminary change in parent/caregiver reported socialization on the Vineland Adaptive Behavior Scales,2nd Edition (VABS-2) from baseline to week 12|Mobile Application Usage|Change in parent/caregiver reported social responsiveness from week 0 to week 12|Change in mobile autism risk assessment score from week 0 to week 12|Video Based Feature Analysis|Change in Parent/Caregiver Confidence and Resources from baseline to week 12|Change in Parent Stress Index - Short Form (PSI-SF) from baseline to week 12|Engagement in gameplay across the 12 week period|Change in Emotion Recognition from baseline to week 12|Changes in parent/caregiver reported eye contact and joint attention from week 0 to week 12|Change in NIH-Emotion Toolbox from baseline to Week 12	Stanford University	All	2 Years to 8 Years   (Child)	Not Applicable	300	Other	Interventional	Allocation: Non-Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Other	IRB 39562	November 1, 2023	November 1, 2024	January 31, 2025	June 2, 2021		December 14, 2022	Stanford University, Stanford, California, United States		https://ClinicalTrials.gov/show/NCT04909710
539	NCT02680015	Understanding the Effects of Intervention on the Brain in Autism		Recruiting	No Results Available	Autism Spectrum Disorder|Asperger Disorder|PDD-NOS|Autism	Behavioral: PEERS	Social Responsiveness Scale (SRS: Constantino, 2005)|Test of Adolescent Social SKills (TASSK: Laugeson & Frankel, 2010)	Marquette University	All	4 Years to 28 Years   (Child, Adult)	Not Applicable	400	Other	Interventional	Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Triple (Participant, Care Provider, Investigator)|Primary Purpose: Treatment	HR 2020	August 2010	December 2025	December 2025	February 11, 2016		December 10, 2018	Marquette University, Milwaukee, Wisconsin, United States		https://ClinicalTrials.gov/show/NCT02680015
540	NCT04313283	Translating Peer-to-Peer Support Into a Clinical Setting		Completed	No Results Available	Development Delay|Neurodevelopmental Disorders|Autism	Behavioral: Parents Taking Action	Changes in parenting stress|Changes in depression|Changes in family functioning|Fidelity|Changes in child behavior	University of Maryland, Baltimore	All	18 Years and older   (Adult, Older Adult)	Not Applicable	36	Other	Interventional	Allocation: N/A|Intervention Model: Single Group Assignment|Masking: None (Open Label)|Primary Purpose: Treatment	HP-00090447	September 16, 2020	October 31, 2021	October 31, 2021	March 18, 2020		December 20, 2021	University of Maryland, Baltimore, Maryland, United States		https://ClinicalTrials.gov/show/NCT04313283
541	NCT03536351	Building Social Skills With Interdisciplinary Process Drama in ASD		Completed	No Results Available	Autistic Disorder	Behavioral: Interdisciplinary process drama	Social Skills Improvement Scale|Theory of Mind Battery & Inventory|recruitment|retention|Structured Play Assessment|Brain activity during ToM tasks|Parental perceptions of social skills|Changes in social skills during program|modifications needed to program	University of Utah	All	3 Years to 4 Years   (Child)	Not Applicable	15	Other	Interventional	Allocation: N/A|Intervention Model: Single Group Assignment|Masking: None (Open Label)|Primary Purpose: Treatment	IRB_0091961	July 1, 2018	January 15, 2019	January 15, 2019	May 24, 2018		August 19, 2020	University of Utah, Salt Lake City, Utah, United States		https://ClinicalTrials.gov/show/NCT03536351
542	NCT00518804	Functional Behavioural Skill Training for Young Children With Severe Autism		Unknown status	No Results Available	Autistic Disorder	Behavioral: Functional Behavioural Skills Group and Parent Training	Parenting Sense of Competence|Child Behavioural Skills Assessment|Child Intellectual Functioning|Child Language Functioning|Child Adaptive Behaviour|Child Maladaptive Behaviour|Caregiver Strain|Parent Behaviour Skills Assessment	Hamilton Health Sciences Corporation|McMaster University	All	3 Years to 10 Years   (Child)	Not Applicable	32	Other	Interventional	Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Double (Investigator, Outcomes Assessor)|Primary Purpose: Treatment	Reitzel 2007	August 2007		August 2009	August 21, 2007		December 5, 2008	McMaster University, 1280 Main Street West, Hamilton, Ontario, Canada		https://ClinicalTrials.gov/show/NCT00518804
543	NCT03665363	Evaluating the Efficacy and Effectiveness of SCOPE - RCT	SCOPERCT	Completed	No Results Available	Autism Spectrum Disorder|Transition	Other: SCOPE|Other: Self-study	Change in scores on the ASD Knowledge Quiz|Hospital Anxiety and Depression Scale|Acceptance and Action Questionnaire (AAQ-II)|Brunnsviken Brief Quality of Life Inventory (BBQ)	Karolinska Institutet|Stiftelsen Promobilia|Stiftelsen Sunnerdahls Handikappfond|Stiftelsen Sven Jerrings fond|L.J. Boëthius stiftelse|Stiftelsen Frimurarna Barnhuset|Stockholm County Council ALF/PPG	All	16 Years to 25 Years   (Child, Adult)	Not Applicable	144	Other	Interventional	Allocation: Randomized|Intervention Model: Crossover Assignment|Masking: None (Open Label)|Primary Purpose: Supportive Care	SCOPERCT	September 1, 2016	August 31, 2021	December 9, 2021	September 11, 2018		December 13, 2021	Habilitering & Hälsa, Stockholm, Stockholm County, Sweden		https://ClinicalTrials.gov/show/NCT03665363
544	NCT05635760	Parent-implemented Social Communication Treatment in Preschool Children With Autism Spectrum Disorder		Recruiting	No Results Available	Autism|Social Communication|Speech Therapy|Parenting|Autism Spectrum Disorder	Behavioral: Group-based Parent-implemented Social Communication Training|Behavioral: Self-learning-based Parent-implemented Social Communication Training	Change from Baseline Social Affect at 12 months|Change from Baseline Number of Parent-child Turn-taking at 6 months and 12 months|Change from Baseline Mean Length of Utterance at 6 months and 12 months|Change from Baseline Number of Nouns and Verbs at 6 months and 12 months|Change from Baseline Prosody in terms of loudness variation at 6 months and 12 months|Change from Baseline Prosody in terms of fundamental frequency at 6 months and 12 months	Chinese University of Hong Kong	All	24 Months to 60 Months   (Child)	Not Applicable	112	Other	Interventional	Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Single (Outcomes Assessor)|Primary Purpose: Treatment	CRFASD-SZ-22	October 1, 2022	June 30, 2025	June 30, 2026	December 2, 2022		December 2, 2022	Shenzhen Research Institute, The Chinese University of Hong Kong, Shenzhen, Guangdong, China|The Chinese University of Hong Kong, Hong Kong, Shatin, Hong Kong		https://ClinicalTrials.gov/show/NCT05635760
545	NCT03992118	Project LEaH: Learning to Eat at Home		Completed	No Results Available	Autism Spectrum Disorder|Feeding Behavior	Behavioral: Parent coaching	Parent Treatment Adherence Scale|Parent Satisfaction Scale|Treatment Fidelity Scale|Change in number of foods eaten from baseline to week 12 (or end of intervention whichever comes first)|Change from baseline in performance scores on the COPM scale at 12 weeks	Holland Bloorview Kids Rehabilitation Hospital	All	2 Years to 5 Years   (Child)	Not Applicable	15	Other	Interventional	Allocation: N/A|Intervention Model: Single Group Assignment|Masking: None (Open Label)|Primary Purpose: Treatment	18-786	August 7, 2018	April 23, 2020	July 23, 2020	June 20, 2019		November 20, 2020	Holland Bloorview Kids Rehabilitation Hospital, Toronto, Ontario, Canada		https://ClinicalTrials.gov/show/NCT03992118
546	NCT05455411	Parent-implemented Social Communication Treatment in Preschool Children With Autism Spectrum Disorder		Recruiting	No Results Available	Autism Spectrum Disorder|Autism|Social Communication|Speech Therapy|Parenting	Behavioral: Group-based Parent-implemented Training|Behavioral: Individual-based Parent-implemented Training	Change from Baseline Social Affect at 12 months|Change from Baseline Number of Parent-child Turn-taking at 6 months and 12 months|Change from Baseline Mean Length of Utterance at 6 months and 12 months|Change from Baseline Number of Nouns and Verbs at 6 months and 12 months|Change from Baseline Prosody in terms of loudness variation at 6 months and 12 months|Change from Baseline Prosody in terms of fundamental frequency at 6 months and 12 months	Chinese University of Hong Kong	All	18 Months to 60 Months   (Child)	Not Applicable	112	Other	Interventional	Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Single (Outcomes Assessor)|Primary Purpose: Treatment	CRFASD-22	July 1, 2022	June 30, 2025	June 30, 2026	July 13, 2022		July 13, 2022	The Chinese University of Hong Kong, Shatin, Hong Kong|Castle Peak Hospital, Tuen Mun, Hong Kong		https://ClinicalTrials.gov/show/NCT05455411
547	NCT03900923	Cannabidiol for ASD Open Trial		Recruiting	No Results Available	ASD|Autism Spectrum Disorder	Drug: 98% pure CBD	Clinical Global Impression Scale -Improvement (CGI-I)|Repetitive Behavior Scale-Revised (RBS-R)|Social Responsiveness Scale, 2nd Edition (SRS-2), School-Age Form|Aberrant Behavior Checklist (ABC) - Irritability and Social Withdrawal Subscales|Anxiety, Depression and Mood Scale (ADAMS)|Screen for Child Anxiety Related Disorders (SCARED), Parent Version|Sleep Disturbance Scale for Children (SDSC)|Vineland Adaptive Behavior Scales, Third Edition (Vineland-3) Parent/Caregiver Form|Clinical Global Impression-Severity (CGI-S):|Autism Family Experience Questionnaire (AFEQ)|Anxiety Scale for Children - Autism Spectrum Disorder - Parent Versions (ASC-ASD-P)|Anxiety Scale for Children - Autism Spectrum Disorder (ASC-ASD-C) - Child Versions|OSU Autism Clinical Global Impressions: Severity|OSU Autism Clinical Global Impressions: Improvement|Behavioral Inflexibility Scale (BIS)|Home Situations Questionnaire - Modified for ASD (HSQ-ASD)|16. Strengths and Weaknesses of Attention-Deficit/Hyperactivity Disorder Symptoms and Normal Behavior (SWAN)	NYU Langone Health	All	7 Years to 17 Years   (Child)	Phase 2	30	Other	Interventional	Allocation: N/A|Intervention Model: Single Group Assignment|Masking: None (Open Label)|Primary Purpose: Treatment	18-00250	March 12, 2019	August 31, 2023	August 31, 2023	April 3, 2019		August 2, 2022	NYU Langone Health, New York, New York, United States		https://ClinicalTrials.gov/show/NCT03900923
548	NCT01917864	iPad Application to Treat Prosodic Deficits in Students With Communication Disorders		Completed	No Results Available	Autism|Communication Disorders	Behavioral: iPad Application	Effectiveness of software|Usability of software|Student engagement in treatment|Improvement in peer acceptance	Yale University|Handhold Adaptive	All	4 Years to 18 Years   (Child, Adult)	Not Applicable	200	Other	Interventional	Allocation: N/A|Intervention Model: Single Group Assignment|Masking: None (Open Label)|Primary Purpose: Treatment	1306012259|ED-IES-13-R-0005	July 2013	May 2016	May 2016	August 7, 2013		June 14, 2016	Yale Child Study Center, New Haven, Connecticut, United States		https://ClinicalTrials.gov/show/NCT01917864
549	NCT04768816	Clinical Effect and Safety of Autologous Umbilical Cord Blood Transfusion in the Treatment of Autism Spectrum Disorder		Recruiting	No Results Available	Safety Issues;Effect of Drugs	Drug: 0.9% Sodium Chloride|Biological: Autologous Umbilical Cord Blood	ABC|CARS	Guangdong Women and Children Hospital	All	2 Years and older   (Child, Adult, Older Adult)	Phase 1	25	Other	Interventional	Allocation: Non-Randomized|Intervention Model: Parallel Assignment|Masking: Single (Outcomes Assessor)|Primary Purpose: Treatment	GuangdongWCHASD	July 1, 2019	December 31, 2022	December 31, 2024	February 24, 2021		February 24, 2021	Guangdong Women and Children's Hospital and Health Institute, Guangzhou, Guangdong, China		https://ClinicalTrials.gov/show/NCT04768816
550	NCT04903353	Pragmatic Trial Comparing Weight Gain in Children With Autism Taking Risperidone Versus Aripiprazole		Recruiting	No Results Available	Weight Gain|Autism Spectrum Disorder|Medication Side Effect	Drug: Comparison of Risperidone and Aripiprazole	weight gain	Vanderbilt University Medical Center	All	up to 17 Years   (Child)	Phase 4	350	Other	Interventional	Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Other	210757	February 1, 2022	July 1, 2024	July 1, 2025	May 26, 2021		March 14, 2022	Division of Developmental Medicine, Nashville, Tennessee, United States		https://ClinicalTrials.gov/show/NCT04903353
551	NCT05125003	Family-Implemented Treatment on the Behavioral Inflexibility of Children With Autism	FITBI	Recruiting	No Results Available	Autism Spectrum Disorder|Repetitive Compulsive Behavior	Behavioral: FITBI|Behavioral: Parental Education	Behavioral Inflexibility Scale - Clinical Interview|Aberrant Behavior Checklist-Community (ABC-C)|Direct Observation of Repetitive Behaviors in Autism (DORBA)|Behavioral Inflexibility Scale (BIS)	University of Kansas	All	3 Years to 9 Years   (Child)	Not Applicable	100	Other	Interventional	Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Single (Outcomes Assessor)|Primary Purpose: Treatment	R01HD105036	April 1, 2022	December 31, 2025	March 31, 2026	November 18, 2021		November 8, 2022	Juniper Gardens Children's Project, Kansas City, Kansas, United States		https://ClinicalTrials.gov/show/NCT05125003
552	NCT05398250	A Comparison of Two Brief Suicide Prevention Interventions Tailored for Youth on the Autism Spectrum		Recruiting	No Results Available	Suicidal Ideation|Suicidal and Self-injurious Behavior|Suicide|Autism Spectrum Disorder	Behavioral: Safety Planning Intervention tailored for Autistic Individuals|Behavioral: Safety Planning Intervention Tailored for Autistic Individuals Plus Structured Follow-Up Contacts	Change in suicidal ideation and behavior|Change in mental health treatment utilization|Change in quality of life|Change in well-being|Change in skills to manage suicidal ideation|Change in access to lethal means|Change in safety plan use|Change in acute care services for suicidality|Intervention acceptability|Intervention feasibility	University of North Carolina, Chapel Hill|Patient-Centered Outcomes Research Institute|University of Pennsylvania|Nationwide Children's Hospital|Hugo W. Moser Research Institute at Kennedy Krieger, Inc.|Children's Hospital of Philadelphia	All	15 Years to 99 Years   (Child, Adult, Older Adult)	Not Applicable	1665	Other	Interventional	Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Single (Outcomes Assessor)|Primary Purpose: Treatment	21-2110	August 23, 2022	September 2026	September 2026	May 31, 2022		October 13, 2022	Kennedy Krieger Institute, Baltimore, Maryland, United States|University of North Carolina at Chapel Hill, Chapel Hill, North Carolina, United States|Nationwide Children's Hospital, Columbus, Ohio, United States|Children's Hospital of Pennsylvania, Philadelphia, Pennsylvania, United States		https://ClinicalTrials.gov/show/NCT05398250
553	NCT01187784	Cognitive-Behavioral Therapy for Children With High-Functioning Autism Spectrum Disorder and Anxiety		Completed	No Results Available	Autism Spectrum Disorder|Autism|Asperger Syndrome|PDD-NOS	Behavioral: Coping Cat cognitive-behavioral therapy for anxious youth	Anxiety Disorders Interview Schedule - Child/Parent Version|Multidimensional Anxiety Scale for Children|Spence Children's Anxiety Scale (Child and Parent Versions)	Alliant International University|National Foundation for Autism Research|Autism Society of America - San Diego Chapter	All	7 Years to 14 Years   (Child)	Phase 1	22	Other	Interventional	Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Single (Outcomes Assessor)|Primary Purpose: Treatment	McNallyKeehn	May 2009	August 2010	August 2010	August 24, 2010		August 24, 2010	Alliant International University, San Diego, California, United States		https://ClinicalTrials.gov/show/NCT01187784
554	NCT05035511	A Machine Learning Approach for Predicting tDCS Treatment Outcomes of Adolescents With Autism Spectrum Disorders		Recruiting	No Results Available	Transcranial Direct Current Stimulation|Autistic Disorders Spectrum|Electroencephalography|Machine Learning	Device: tDCS	Change in behavioral measures (social communication and restricted repetitive behavior) - Social Responsiveness Scale-2nd edition (SRS-2)|ASD symptomatology - The Autism Diagnostic Interview-Revised (ADI-R)|Change in CANTAB® cognitive tests - Multitasking Test (MTT)|Change in CANTAB® cognitive tests - Stop Signal Task (SST)|Change in CANTAB® cognitive tests - Emotion Recognition Task (ERT)|Change in Neurophysiological measures	The Hong Kong Polytechnic University|Chinese University of Hong Kong	All	16 Years to 22 Years   (Child, Adult)	Not Applicable	90	Other	Interventional	Allocation: N/A|Intervention Model: Single Group Assignment|Masking: None (Open Label)|Primary Purpose: Treatment	HSEAR20201118003-01	January 5, 2022	September 2024	December 2024	September 5, 2021		February 17, 2022	The Hong Kong Polytechnic University, Hung Hom, Kowloon, Hong Kong		https://ClinicalTrials.gov/show/NCT05035511
555	NCT05466617	Gamified App on Increasing Physical Activity and Reducing Anxiety in Autism		Completed	No Results Available	Autism Spectrum Disorder|Physical Activity|Anxiety|Mobile Health	Behavioral: Mobile Health for Physical Activity Behavior Change	Baseline Physical Activity and Changes from Baseline Physical Activity at 4th and 8th weeks|Baseline Anxiety and Changes from Baseline Anxiety at 4th and 8th weeks	Indiana University|American College of Sports Medicine Foundation	All	18 Years and older   (Adult, Older Adult)	Not Applicable	24	Other	Interventional	Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Single (Participant)|Primary Purpose: Treatment	1807483245	July 1, 2019	March 15, 2020	May 30, 2020	July 20, 2022		July 20, 2022	Indiana University School of Public Health, Bloomington, Indiana, United States	"Informed Consent Form", https://ClinicalTrials.gov/ProvidedDocs/17/NCT05466617/ICF_000.pdf	https://ClinicalTrials.gov/show/NCT05466617
556	NCT04146428	Evaluating BOSCC and ELSA as Outcome Measures in the Context of a JASPER Intervention Trial	EBJ	Recruiting	No Results Available	Autism Spectrum Disorder	Behavioral: clinician-mediated JASPER|Behavioral: parent-mediated JASPER	Change in frequency of language utterances and number of conversation turns using the Elicitation of Language Samples for Analysis- Toddlers (ELSA-T)|Change in social communication using the Brief Observation of Social Communication Change (BOSCC)	University of California, Los Angeles|Simons Foundation	All	18 Months to 5 Years   (Child)	Not Applicable	90	Other	Interventional	Allocation: Randomized|Intervention Model: Factorial Assignment|Masking: None (Open Label)|Primary Purpose: Treatment	19-001638	April 27, 2021	April 1, 2023	August 31, 2023	October 31, 2019		September 7, 2022	UCLA, Los Angeles, California, United States|Semel Institute, Los Angeles, California, United States|Boston University, Boston, Massachusetts, United States|Weill Cornell Medical College/New York Presbyterian Hospital, White Plains, New York, United States		https://ClinicalTrials.gov/show/NCT04146428
557	NCT01553240	Neurocircuitry of Autism- fMRI and Transcranial Magnetic Stimulation Studies		Terminated	Has Results	Autism Spectrum Disorder|Asperger Disorder|Pervasive Developmental Disorder	Device: TMS and functional MRI (Magstim)	Repetitive Behavior Scale-revised|Vineland Maladaptive Behavior Scale	New York State Psychiatric Institute	All	18 Years to 55 Years   (Adult)	Not Applicable	8	Other	Interventional	Allocation: N/A|Intervention Model: Single Group Assignment|Masking: None (Open Label)|Primary Purpose: Diagnostic	5438	June 2007	June 2010	June 2010	March 14, 2012	January 13, 2017	January 13, 2017	New York state Psychiatric Institute, New York, New York, United States		https://ClinicalTrials.gov/show/NCT01553240
558	NCT05542602	Study of a Paraprofessional-Delivered After-School Social Intervention for Autistic Children		Not yet recruiting	No Results Available	Autistic Disorder	Behavioral: Social intervention	Social Knowledge Assessment (SKA)|Adapted Skillstreaming Checklist (ASC)|Social Responsiveness Scale, 2nd Edition, School Age Form (SRS-2)|Social Competence Observation Scale (SCOS)	Canisius College	All	7 Years to 12 Years   (Child)	Not Applicable	48	Other	Interventional	Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Single (Outcomes Assessor)|Primary Purpose: Treatment	IRB 2021-22 #40|CDMRP-AR210161	October 2022	June 2025	June 2025	September 15, 2022		September 15, 2022	Canisius College, Buffalo, New York, United States		https://ClinicalTrials.gov/show/NCT05542602
559	NCT02383758	An Interdisciplinary Approach to the Treatment of Encopresis in Children With Autism Spectrum Disorders		Completed	Has Results	Encopresis|Autistic Disorder	Drug: Glycerin Suppository|Drug: Bisacodyl suppository|Drug: Senna	Percent Continent|Percent Independence|Mean Clinical Global Impression for Severity (CGI-S) Score|Mean Clinical Global Impression for Improvement (CGI-I) Score	Emory University|Organization for Autism Research	All	5 Years to 21 Years   (Child, Adult)	Not Applicable	22	Other	Interventional	Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Single (Outcomes Assessor)|Primary Purpose: Treatment	IRB00076608	February 1, 2015	January 1, 2017	January 1, 2017	March 9, 2015	January 11, 2018	July 2, 2018	Marcus Autism Center, Atlanta, Georgia, United States		https://ClinicalTrials.gov/show/NCT02383758
560	NCT04769011	Motor Impairments in Children With Autism Spectrum Disorder: a Multimodal Approach	MOSAICO	Recruiting	No Results Available	Autism Spectrum Disorder|Attention Deficit Hyperactivity Disorder|Intellectual Disability	Diagnostic Test: Clinical evaluation|Diagnostic Test: Neuropsychological evaluation|Diagnostic Test: Neurophysiological evaluation|Diagnostic Test: Genetic evaluation	Movement Assessment Battery for Children 2 (MABC2)|Developmental Coordination Disorder Questionnaire (DCDQ)|kinematic analysis of a reach-to-drop task|Magnetic Resonance (MRI)|Diffusion Tensor Imaging (DTI)|Exome sequencing	IRCCS Eugenio Medea	All	1 Year to 14 Years   (Child)	Not Applicable	80	Other	Interventional	Allocation: N/A|Intervention Model: Single Group Assignment|Masking: None (Open Label)|Primary Purpose: Diagnostic	510	January 2, 2018	December 2022	December 2022	February 24, 2021		March 31, 2022	IRCCS E. Medea, Bosisio Parini, Lecco, Italy		https://ClinicalTrials.gov/show/NCT04769011
561	NCT03333629	Promoting Positive Outcomes for Individuals With ASD: Linking Early Detection, Treatment, and Long-term Outcomes		Enrolling by invitation	No Results Available	Autism Spectrum Disorder	Behavioral: Enhanced early detection	Change in ASD Symptom Severity|Change in Cognitive Functioning|Adaptive Functioning|ASD Symptoms - secondary measure1|Kindergarten Readiness|Social Engagement|Long-term change in Cognitive Functioning|Parent-Child Social Engagement|ASD symptoms - secondary measure2|ASD symptoms - secondary measure3|Long-term change in Cognitive Functioning (alternative)	Drexel University|University of California, Davis|University of Connecticut	All	16 Months to 58 Months   (Child)	Phase 4	3450	Other	Interventional	Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Double (Participant, Outcomes Assessor)|Primary Purpose: Screening	R01MH115715	November 29, 2017	May 31, 2023	May 31, 2023	November 7, 2017		September 24, 2021	University of California, Davis, Sacramento, California, United States|University of Connecticut, Storrs, Connecticut, United States|Drexel University, Philadelphia, Pennsylvania, United States		https://ClinicalTrials.gov/show/NCT03333629
562	NCT00954083	A Pilot Trial of a Developmental, Individual-Difference, Relationship-Bases (DIR)/Floortime for Children With Autistic Spectrum Disorders	DIR	Completed	No Results Available	Autistic Spectrum Disorders	Behavioral: DIR/Floortime|Behavioral: Routine care	The Functional Emotional Assessment Scale (FEAS) Ratings (the child part)|The Childhood Autism Rating Scale (CARS) Clinical rating of the children (6 point scale related to Greenspan's six Functional Development Level -FDL) Satisfaction of the effectiveness of the intervention of their child (Six-point Likert scale)	Mahidol University	All	2 Years to 6 Years   (Child)	Not Applicable	32	Other	Interventional	Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Single (Investigator)|Primary Purpose: Treatment	194/2550 (EC2)	June 2007	October 2008	April 2009	August 6, 2009		August 6, 2009			https://ClinicalTrials.gov/show/NCT00954083
563	NCT01631851	Cognitive-Behavioral Therapy for Irritability in Adolescents With High Functioning Autism Spectrum Disorder		Active, not recruiting	No Results Available	Autism|Autism Spectrum Disorder (ASD|Asperger's Disorder|Pervasive Developmental Disorder (PDD-NOS)	Behavioral: Cognitive-Behavioral Therapy (CBT) for Irritability	ABC Irritability Scale	Yale University	All	9 Years to 16 Years   (Child)	Not Applicable	10	Other	Interventional	Allocation: N/A|Intervention Model: Single Group Assignment|Masking: None (Open Label)|Primary Purpose: Treatment	0102012121-B	May 2011	December 2022	December 2022	June 29, 2012		February 10, 2022	Yale Child Study Center, New Haven, Connecticut, United States		https://ClinicalTrials.gov/show/NCT01631851
564	NCT01352611	Open Label Treatment of Severe Tactile Defensiveness With Intrathecal Baclofen		Withdrawn	No Results Available	Autism Spectrum Disorder	Drug: baclofen, intrathecal	Modified Short Sensory Profile.|Clinical Global Impression of Change in Autism Symptoms	University of Missouri-Columbia	All	10 Years to 65 Years   (Child, Adult, Older Adult)	Not Applicable	0	Other	Interventional	Allocation: N/A|Intervention Model: Single Group Assignment|Masking: None (Open Label)|Primary Purpose: Treatment	1109397	September 2014	April 2015	April 2015	May 12, 2011		October 6, 2016	University Hospital/University of Missouri Health Care, Columbia, Missouri, United States		https://ClinicalTrials.gov/show/NCT01352611
565	NCT02739321	Examining the Efficacy of Mattress Technology in Improving the Sleep Quality of Children With ASD		Completed	Has Results	Autism Spectrum Disorders	Device: Sound to Sleep System	Compare Percentage of Participants Who Drop Out of Study as a Measure of Toleration of Mattress Technology|Parent Reported Quality of Sleep Across Treatment Conditions|Total Time Asleep Recorded by Actigraphy Watch|Total Time to Fall Asleep (Sleep Latency) Recorded by Actigraphy Watch|Total Time Awake During Night Recorded by Actigraphy Watch|Percentage of Time in Bed That the Participant Spent Sleeping (Sleep Efficiency) Recorded by Actigraphy Watch.|Caregiver-Rated Severity of Social Deficits as Measured by the Social Responsiveness Scale 2 (SRS-2)|Caregiver-Rated Severity Problem Behaviors as Measured by the Aberrant Behavior Checklist (ABC)|Caregiver-Rated Communication Problems as Measured by the CCC-2|Caregiver-Rated Problems With Sleep Habits as Measured by the FISH|Caregiver-Rated Sleep Disturbance as Measured by the Children's Sleep Habits Questionnaire (CSHQ)|Caregiver-Rated Sensory Issues Across Domains as Measured by the SSPQ|Caregiver-Rated of Quality of Life as Measured by the CFQL-2 Questionnaire|Caregiver-Rated Measure of Challenging Behavior/Task Compliance as Measured by the Daily Sleep Diary|Caregiver-Rated Measure of Tolerance of Mattress Technology as Measured by the Daily Sleep Diary|Caregiver-Rated Measure of Tolerance of the Actigraph Watch as Measured by the Daily Sleep Diary|Caregiver-Rated Measure of Ease of Mattress Technology Use as Measured by the Daily Sleep Diary|Caregiver-Rated Measure of Sleep Resistance as Measured by the Daily Sleep Diary	The Cleveland Clinic|Kugona LLC	All	30 Months to 13 Years   (Child)	Not Applicable	45	Other	Interventional	Allocation: Randomized|Intervention Model: Crossover Assignment|Masking: Single (Outcomes Assessor)|Primary Purpose: Supportive Care	14-066	May 2014	December 2015	February 2016	April 15, 2016	November 6, 2017	November 6, 2017	Cleveland Clinic Center for Autism, Cleveland, Ohio, United States		https://ClinicalTrials.gov/show/NCT02739321
566	NCT03170453	Confirmatory Efficacy Trial of Cognitive Enhancement Therapy for Adult Autism Spectrum Disorder	PerspectivesII	Active, not recruiting	No Results Available	Autistic Disorder|Autism Spectrum Disorder|Asperger Syndrome|Pervasive Developmental Disorder	Behavioral: Cognitive Enhancement Therapy|Behavioral: Enriched Supportive Therapy	Change in Neurocognition|Change in Social cognition|Change in Functional outcome	University of Pittsburgh	All	16 Years to 45 Years   (Child, Adult)	Not Applicable	86	Other	Interventional	Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Single (Outcomes Assessor)|Primary Purpose: Treatment	MH106450	June 1, 2015	December 31, 2022	March 31, 2023	May 31, 2017		April 8, 2022	University of Pittsburgh, Pittsburgh, Pennsylvania, United States		https://ClinicalTrials.gov/show/NCT03170453
567	NCT02435407	The Sequential Oral Sensory Approach for Limited Food Repertoire in Children With Autism Spectrum Disorder	SOS	Unknown status	No Results Available	Autism Spectrum Disorder|Feeding Disorder|Restricted Diet	Behavioral: SOS|Other: Education	Change in the number of foods eaten after 12 weeks of intervention as determined by the 3 day food diary|Change in the level of parental stress around meal times after 12 weeks of intervention as determined by the Parent Stress Index questionnaire|Description of the sensory profiles of participants as determined by the Short Sensory Profile- short form Questionnaire	Holland Bloorview Kids Rehabilitation Hospital|The Hospital for Sick Children	All	4 Years to 8 Years   (Child)	Not Applicable	20	Other	Interventional	Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Treatment	REB file # 14-511	January 2015	September 2015	December 2015	May 6, 2015		September 29, 2015	Holland Bloorview Kids Rehabilitation Hospital, Toronto, Ontario, Canada		https://ClinicalTrials.gov/show/NCT02435407
568	NCT05194345	An Integrated Nutrition Intervention to Promote Healthy Eating Habits for Children With ASD		Recruiting	No Results Available	Autism Spectrum Disorder	Behavioral: Autism Eats nutrition intervention|Behavioral: We Can! enhanced usual care	Change in fruit and vegetable intake from baseline, as measured by the daily amount of fruit and vegetables consumed by children|Change in food variety from baseline, as measured by the daily food counts consumed by children|Change in diet quality from baseline, as measured by mean Healthy Eating Index (HEI) score from the food records. HEI score ranges from 0 to 100.|Change in mealtime behaviors, as measured by total score of the Brief Autism Mealtime Behavior Inventory (score ranges 5-90).|Change in child's weight-for-length/BMI percentile (calculated with height & weight), as measured by percentile on the CDC weight-for-length/BMI-for-age growth chart.	University of South Florida	All	up to 36 Months   (Child)	Not Applicable	48	Other	Interventional	Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Single (Outcomes Assessor)|Primary Purpose: Prevention	STUDY002968	January 27, 2022	May 2023	July 2023	January 18, 2022		May 23, 2022	University of South Florida, Tampa, Florida, United States		https://ClinicalTrials.gov/show/NCT05194345
569	NCT04593576	Impact of Sports Activity on Pragmatic Skills of Children		Completed	No Results Available	Autistic Disorder of Childhood Onset With Full Syndrome	Other: Physical activity protocol/out door sports|Other: Intensive table teaching speech therapy	Social Interaction tasks ABLLS-R (Assessment of basic language learning Skills-Revised)	Riphah International University	All	5 Years to 7 Years   (Child)	Not Applicable	20	Other	Interventional	Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Treatment	REC/00807 Saman Javaid	October 20, 2020	April 10, 2021	April 10, 2021	October 20, 2020		June 29, 2021	Profiles, Rawalpindi, Pakistan		https://ClinicalTrials.gov/show/NCT04593576
570	NCT02721381	Comparative Efficacy of Self-directed & Therapist-assisted Telehealth Parent Training Intervention for Children With ASD		Terminated	No Results Available	Autism Spectrum Disorder	Behavioral: ImPACT Online	ImPACT Online Fidelity Change Scale|Parent Sense of Competence Change Scale|Mullen Scales of Early Learning Change Score|MacArthur-Bates Child Developmental Inventory Change Score|Parent-child Interaction Change|ImPACT Online electronic tracking system|Intervention Log Change|Vineland Adaptive Behavior Scales Change Score	Michigan State University	All	18 Months to 95 Months   (Child)	Not Applicable	65	Other	Interventional	Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Single (Outcomes Assessor)|Primary Purpose: Treatment	R40MC27704	March 1, 2015	October 10, 2020	October 10, 2020	March 29, 2016		November 4, 2022	Michigan State University Autism Lab, East Lansing, Michigan, United States		https://ClinicalTrials.gov/show/NCT02721381
571	NCT05025553	Oral Administration of Polyethylene Glycol (PEG) for 6 Months in Chronically Constipated Autistic Children		Completed	No Results Available	Autistic Spectrum Disorder|Constipation	Dietary Supplement: Gut mobilization	Change in stool quality|Change from baseline urinary concentrations of total p-cresol|Change in Childhood Autism Rating Scale (CARS)|Change in Repetitive Behavior Scale-Revised (RBS-R)|Change in Conners' Parent Rating Scale - Revised (CPRS-R)|Change in Social Responsiveness Scale (SRS)	University of Messina	All	2 Years to 8 Years   (Child)	Not Applicable	21	Other	Interventional	Allocation: N/A|Intervention Model: Single Group Assignment|Masking: None (Open Label)|Primary Purpose: Treatment	PEG_study_ASD	January 1, 2018	January 1, 2021	February 1, 2021	August 27, 2021		August 27, 2021	Interdipartimental Program "Autismo 0-90" at "G. Martino" University Hospital, Messina, ME, Italy		https://ClinicalTrials.gov/show/NCT05025553
572	NCT02827279	Study of the Visual Perception During Emotional States on Subjects With an Intrusive Disorder of the Development	VisioTED	Terminated	No Results Available	Autism Spectrum Disorder	Other: emotional induction	Ratio corresponding to the relative change in visual orientation	University Hospital, Montpellier	All	8 Years to 12 Years   (Child)	Not Applicable	46	Other	Interventional	Allocation: Non-Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Basic Science	8991	March 4, 2013	April 3, 2017	April 3, 2017	July 11, 2016		December 28, 2021	Montpellier University Hospital, Montpellier, France		https://ClinicalTrials.gov/show/NCT02827279
573	NCT03369769	Wellness Effects of Animal-assisted Activities With Autism Spectrum Disorder Youth in a Specialized Psychiatric Hospital		Completed	No Results Available	Child Behavior|Autism Spectrum Disorder|Psychiatric Hospitalization|Veterinary Therapeutics	Other: Activity	Change in physiological measurements with the wristband device from baseline through 90 minutes.|Observation of Human Animal Interaction for Research (OHAIRE-modified)	University of Colorado, Denver|Human Animal Bond Institute for Research|Purdue University	All	4 Years to 16 Years   (Child)	Not Applicable	75	Other	Interventional	Allocation: Non-Randomized|Intervention Model: Crossover Assignment|Masking: Single (Outcomes Assessor)|Primary Purpose: Health Services Research	15-1227	August 6, 2015	February 27, 2017	March 13, 2019	December 12, 2017		May 20, 2019			https://ClinicalTrials.gov/show/NCT03369769
574	NCT04805957	Validation Digital Bio-markers During Sulforaphane Treatment.		Not yet recruiting	No Results Available	Autism|Autism Spectrum Disorder|Autistic Disorder	Dietary Supplement: Sulforaphane	Aberrant Behavior Checklist (ABC)|Social Responsiveness Scale (SRS)|Ohio Autism Clinical Global Impression Scale - Severity (OACIS-S, an autism specific version of the Clinical Global Impression, CGI)|Digital Biomarkers|EEG|EKG|Electrophysiological recordings.	Rutgers, The State University of New Jersey	Male	13 Years to 30 Years   (Child, Adult)	Not Applicable	10	Other	Interventional	Allocation: N/A|Intervention Model: Single Group Assignment|Masking: None (Open Label)|Primary Purpose: Treatment	Pro2019001854	April 1, 2021	June 30, 2021	June 30, 2022	March 18, 2021		March 18, 2021	Rutgers-RWJMS Department of Neurology, Piscataway, New Jersey, United States		https://ClinicalTrials.gov/show/NCT04805957
575	NCT02939560	TMS for Adults With Autism and Depression	TAD	Completed	Has Results	Autism Spectrum Disorder|Depression|Depressive Disorder|Major Depressive Disorder	Device: NeuroStar® TMS device (Neuronetics, Atlanta, GA)	Change From Baseline in Hamilton Depression Rating Scale|Change From Baseline in Aberrant Behavior Checklist|Change From Baseline in Social Responsiveness Scale-2|Change From Baseline in Ritvo Autism-Aspergers Diagnostic Scale|Change From Baseline in Repetitive Behavior Scale-Revised|Change From Baseline in Functional MRI Scanning During Cognitive Processing Tasks	Medical University of South Carolina	All	18 Years to 65 Years   (Adult, Older Adult)	Not Applicable	13	Other	Interventional	Allocation: N/A|Intervention Model: Single Group Assignment|Masking: None (Open Label)|Primary Purpose: Treatment	Pro00056546	September 2016	June 1, 2018	September 20, 2018	October 20, 2016	October 1, 2019	October 1, 2019	Medical University of South Carolina, Charleston, South Carolina, United States	"Study Protocol and Statistical Analysis Plan", https://ClinicalTrials.gov/ProvidedDocs/60/NCT02939560/Prot_SAP_000.pdf	https://ClinicalTrials.gov/show/NCT02939560
576	NCT04208425	Promoting Resilience in Teens With ASD	PRITA	Unknown status	No Results Available	Autism Spectrum Disorder	Behavioral: Project Personality|Behavioral: Sharing Feelings Intervention	Children's Depression Inventory-2 (CDI-2)|Behavior Rating Inventory of Executive Function, Second Edition (BRIEF-2)|Brief Symptom Inventory 18 (BSI-18)|Multidimensional Anxiety Scale for Children-2 (MASC-2)|Primary Control Scale for Children (PCSC)|Secondary Control Scale for Children (SCSC)|Social Responsiveness Scale-2 (SRS-2)|The Self Perception Profile for Children/ Adolescents (SPPC/A) self-report|Implicit Personality Theory Questionnaire (ITPQ)	Stony Brook University|Society of Clinical Child & Adolescent Psychology|Autism Research Institute	All	11 Years to 16 Years   (Child)	Not Applicable	40	Other	Interventional	Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Double (Participant, Investigator)|Primary Purpose: Treatment	IRB2019-00280|AWD00001042|AWD00001244	January 7, 2019	December 2021	March 2022	December 23, 2019		March 18, 2020	Stony Brook University, Stony Brook, New York, United States		https://ClinicalTrials.gov/show/NCT04208425
577	NCT05207956	App for Strengthening Services In Specialized Therapeutic Support	ASSISTS	Completed	No Results Available	Autism Spectrum Disorder	Behavioral: Behavioral economics strategies|Other: Electronic platform	The average difference in hourly data collection between groups across three weeks|Theory of Planned Behavior Questionnaire|System Usability Scale	University of Pennsylvania	All	18 Years and older   (Adult, Older Adult)	Not Applicable	27	Other	Interventional	Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Treatment	849995	September 9, 2021	June 21, 2022	June 21, 2022	January 26, 2022		July 28, 2022	University of Pennsylvania, Philadelphia, Pennsylvania, United States		https://ClinicalTrials.gov/show/NCT05207956
578	NCT03499262	Group Social ABCs: Early Intervention for Toddlers With Suspected ASD		Completed	No Results Available	Autism Spectrum Disorder|Autism	Behavioral: Group Social ABCs	Vocal Responsivity|Vocal Initiations|Social Orienting|Caregiver Fidelity of Implementation	Holland Bloorview Kids Rehabilitation Hospital	All	12 Months to 36 Months   (Child)	Not Applicable	93	Other	Interventional	Allocation: N/A|Intervention Model: Single Group Assignment|Masking: None (Open Label)|Primary Purpose: Treatment	17-745	March 26, 2018	December 23, 2020	December 23, 2020	April 17, 2018		July 23, 2021	Holland Bloorview Kids Rehabilitation Hospital, Toronto, Ontario, Canada		https://ClinicalTrials.gov/show/NCT03499262
579	NCT04005547	Health Education and Relationships Through Theater: An RCT of Promoting Awareness Through Live Movement and Sound for Youth With Autism Spectrum Disorder (PALMS-ASD)	HEART	Unknown status	No Results Available	Sexual Health|Education, Health	Behavioral: Promoting Awareness through Live Movement and Sound for youth with Autism Spectrum Disorder	unsafe sex self-report survey item|sexual health knowledge self-report survey scale|adult-teen communication youth-report survey scale|sexual health empowerment self-report survey scale|self-protective boundary knowledge self-report survey scale|sexual health efficacy self-report survey, item or scale	Public Health Management Corporation|Temple University	All	14 Years to 19 Years   (Child, Adult)	Not Applicable	250	Other	Interventional	Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Prevention	PublicHMC|90AP2690-01-00	September 15, 2017	February 2021	February 2021	July 2, 2019		July 2, 2019	Public Health Management Corporation, Philadelphia, Pennsylvania, United States		https://ClinicalTrials.gov/show/NCT04005547
580	NCT04845243	Effectiveness of a Short Computer-based Emotion Recognition Training in Different Patient Groups		Not yet recruiting	No Results Available	Autism Spectrum Disorder|Conduct Disorder	Behavioral: Emotionen Verstehen und Ausdrücken (E.V.A.)	Change in performance accuracy in Geneva Emotion Recognition Test (GERT)|Change in performance response times in Geneva Emotion Recognition Test (GERT)|Change in performance reaction times in Social decision-making task|Change in choices in Social decision-making task	Prof. Christina Stadler|University Psychiatric Clinics Basel	All	10 Years to 18 Years   (Child, Adult)	Not Applicable	80	Other	Interventional	Allocation: N/A|Intervention Model: Single Group Assignment|Masking: None (Open Label)|Primary Purpose: Treatment	EmoRecTraining_EVA	April 15, 2021	November 30, 2021	November 30, 2021	April 14, 2021		April 14, 2021			https://ClinicalTrials.gov/show/NCT04845243
581	NCT01730209	Efficacy of RAD001/Everolimus in Autism and NeuroPsychological Deficits in Children With Tuberous Sclerosis Complex	RAPIT	Unknown status	No Results Available	Tuberous Sclerosis Complex|TSC Related Cognitive Disability|TSC Related Autism|TSC Related Learning Problems	Drug: Everolimus|Drug: Placebo	Cognitive ability measured by IQ|Autistic features|Social and communicational skills|Working memory and attention, information processing|Visual-motor integration|Child behavior|Executive functioning|Sleeping problems|Child health|Sensory related difficulties|Epilepsy	Erasmus Medical Center|Utrecht University	All	4 Years to 15 Years   (Child)	Phase 2|Phase 3	60	Other	Interventional	Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)|Primary Purpose: Treatment	NL38619.078.11	November 2012	November 2015	November 2016	November 21, 2012		May 5, 2015	Erasmus Medical Center, Rotterdam, Netherlands		https://ClinicalTrials.gov/show/NCT01730209
582	NCT03814902	A Pilot Study to Characterize the Household Impact of Locating Devices for Children With ASD Who Wander	CHILD	Completed	No Results Available	Autism Spectrum Disorder|Wandering Behavior	Device: Electronic Tracking Device	Rates of participant retention|Rates of questionnaire completion|Adherence to the intervention|Changes from baseline in Caregiver Strain Questionnaire (CGSQ) scores|Changes from baseline in GAD-7 scores|Changes from baseline in BFDS scores|Changes from baseline in the frequency of wandering-related disruptions to the household.|Perceived impact of the intervention	Northwell Health	All	18 Years and older   (Adult, Older Adult)	Not Applicable	31	Other	Interventional	Allocation: N/A|Intervention Model: Single Group Assignment|Masking: None (Open Label)|Primary Purpose: Other	18-0314_A	January 15, 2019	November 11, 2019	November 11, 2019	January 24, 2019		January 5, 2021	Cohen Children's Medical Center of New York, New Hyde Park, New York, United States		https://ClinicalTrials.gov/show/NCT03814902
583	NCT01187940	Evaluating PEGASUS - a Group Intervention for Young People With an Autism Spectrum Disorder		Unknown status	No Results Available	Efficacy of PEGASUS	Behavioral: PEGASUS	Autism Knowledge Questionnaire|Child Behaviour Checklist|Vineland-II, Rosenburg Self-Esteem Scale|Parenting Stress index|Qualitative interview conducted at baseline and termination.	Institute of Child Health	All	9 Years to 14 Years   (Child)	Not Applicable	40	Other	Interventional	Allocation: Randomized|Intervention Model: Single Group Assignment|Masking: None (Open Label)|Primary Purpose: Treatment	09BS22	September 2010	September 2012		August 24, 2010		August 24, 2010	Institute of Child Health, London, United Kingdom		https://ClinicalTrials.gov/show/NCT01187940
584	NCT01854333	The Swedish Versions of ADOS and ADI-R: Psychometric Validation		Completed	No Results Available	Autism Spectrum Disorders	Other: ADOS module 1-4 or ADI-R	Diagnosis of Autism Spectrum Disorders	Karolinska Institutet	All	Child, Adult, Older Adult	Not Applicable	50	Other	Interventional	Allocation: N/A|Intervention Model: Single Group Assignment|Masking: Single (Investigator)|Primary Purpose: Diagnostic	EvaluationADOS&ADI-R	January 2011	October 2014	November 2014	May 15, 2013		June 24, 2015	Karolinska Institute Center for Neurodevelopmental Disorders, Stockholm, Stockholms län, Sweden		https://ClinicalTrials.gov/show/NCT01854333
585	NCT05106166	Joint Attention-Based Occupational Therapy Intervention in Pre-Schoolers With Autism Spectrum Disorder		Completed	No Results Available	Autism Spectrum Disorder|Social Communication|Behavior Problem|Visual Perceptual Weakness	Behavioral: Occupational Therapy	Autistic Behavior Checklist (ABC)|Social Communication Questionnaire (SCQ)|Motor-free Visual Perception Test-4 (MVPT-4)	Hacettepe University	All	4 Years to 6 Years   (Child)	Not Applicable	20	Other	Interventional	Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Single (Investigator)|Primary Purpose: Treatment	2020/126	April 1, 2020	February 2, 2021	June 5, 2021	November 3, 2021		November 3, 2021	Hacettepe University, Ankara, Turkey		https://ClinicalTrials.gov/show/NCT05106166
586	NCT04053036	Effects of Drugs on Responses to Brain and Emotional Processes	MAT	Completed	No Results Available	Autism Spectrum Disorder|Healthy	Drug: MDMA|Drug: Placebo oral tablet	Change in responses to affective touch	University of Chicago	All	21 Years to 40 Years   (Adult)	Early Phase 1	24	Other	Interventional	Allocation: Randomized|Intervention Model: Crossover Assignment|Masking: Triple (Participant, Investigator, Outcomes Assessor)|Primary Purpose: Basic Science	IRB19-0174	August 8, 2019	April 12, 2021	April 12, 2021	August 12, 2019		June 9, 2021	University of Chicago, Chicago, Illinois, United States		https://ClinicalTrials.gov/show/NCT04053036
587	NCT02956226	Cannabinoids for Behavioral Problems in Children With ASD	CBA	Completed	No Results Available	Autistic Disorder	Drug: Cannabinoids - 99% pure cannabinoids mix|Drug: Placebo|Drug: Cannabinoids - whole plant extract	Change from baseline Home Situations Questionnaire-Autism Spectrum Disorder (HSQ-ASD) score, at three months. Within subject difference between the placebo condition and the whole plant extract condition.|Clinical Global Impression-Improvement scores (CGI-I ) at three months. Within subject difference between the placebo condition and the whole plant extract condition.|Clinical Global Impression-Improvement scores (CGI-I ) at three months. Within subject differences between the placebo condition and the pure cannabinoids condition and between the whole plant extract condition and the pure cannabinoids condition.|Change in Social Responsiveness Scale scores-2 (SRS-2, parent and teacher rated) at three months|Change in Autism Parenting Stress Index (APSI) score, at three months|Change from baseline Home Situations Questionnaire-Autism Spectrum Disorder (HSQ-ASD) score, at three months.	Shaare Zedek Medical Center	All	5 Years to 21 Years   (Child, Adult)	Phase 2	150	Other	Interventional	Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)|Primary Purpose: Treatment	CBA	January 2017	October 2018	December 2018	November 6, 2016		December 27, 2018	Shaare Zedek Medical Center, Jerusalem, Israel		https://ClinicalTrials.gov/show/NCT02956226
588	NCT03199937	Executive Function Intervention for High School Students With ASD		Completed	No Results Available	Autism Spectrum Disorder	Behavioral: Flexible Futures|Other: Current standard of care	Change in Behavior Rating Inventory of Executive Function (BRIEF)- Self-Report Form (Gioia, Isquith, Guy & Kenworthy, 2000).|Change in Challenge Task (CT) scores|Change in Wechsler Abbreviated Scale of Intelligence- Second Edition (WASI-II, Wechsler, 2011), block design subtest|Change in Delis-Kaplan Executive Functioning System (DKEFS; Delis, Kaplan, and Kramer, 2001), Sorting subtest|Change in Tower of London-Drexel (TOL-DX; Culbertson & Zillmer, 2000) scores|Change in Adaptive Behavior Assessment System-Second Edition (ABAS-2)|Social Responsiveness Scale-Second Edition (SRS-2; Constantino and Gruber 2012)|Change in Behavior Rating Inventory of Executive Function, Second Edition (BRIEF-2)- Parent Form (Gioia, Isquith, Guy & Kenworthy, 2015).|Flexibility and Planning Interference Scale|The Swanson, Kotkin, Agler, M-Flynn, and Pelham Scale (SKAMP, Swanson, 1992)|Classroom Observations|Cognitive Flexibility Task	Children's National Research Institute|Georgetown University	All	14 Years to 22 Years   (Child, Adult)	Not Applicable	68	Other	Interventional	Allocation: Randomized|Intervention Model: Crossover Assignment|Masking: Single (Outcomes Assessor)|Primary Purpose: Treatment	1K23MH110612-01|OAR Innovative Research Award	July 11, 2015	April 23, 2019	June 30, 2019	June 27, 2017		April 10, 2020	Children's Research Institute, Washington, District of Columbia, United States		https://ClinicalTrials.gov/show/NCT03199937
589	NCT03047018	Open Trial Obesity CHANGE Program ASD		Completed	No Results Available	Autism Spectrum Disorder|Obesity	Behavioral: The Changing Health in Autism through Nutrition, Getting fit and Expanding variety (CHANGE) Program	Willingness to Participate|Attendance Rate|Percent Homework Adherence|Percent Demonstration of Skills|Attrition Rate|Percent Satisfaction|Therapist Fidelity to the Treatment Manual|Difference in Body Mass Index (BMI) Percentile|Change in Food Preference Inventory (FPI) Score|Change in physical activity|Change in Parenting Stress Index- Short Form (PSI-SF) Score	Emory University	All	5 Years to 12 Years   (Child)	Not Applicable	35	Other	Interventional	Allocation: N/A|Intervention Model: Single Group Assignment|Masking: None (Open Label)|Primary Purpose: Treatment	IRB00090911	October 6, 2017	March 20, 2020	March 20, 2020	February 8, 2017		December 4, 2020	Emory University, Atlanta, Georgia, United States		https://ClinicalTrials.gov/show/NCT03047018
590	NCT03225651	Autologous Bone Marrow Stem Cell Therapy Combined With Psychological Therapy and Rehabilitation for Autism	ASPRA	Completed	No Results Available	Stem Cell Transplantation	Biological: Stem cell transplantation|Behavioral: Psychological therapy and Rehabilitation	Assess the change in autism level by using tools|Evaluate the safety of therapy by record number of adverse events	Vinmec Research Institute of Stem Cell and Gene Technology	All	3 Years to 7 Years   (Child)	Phase 2	30	Other	Interventional	Allocation: Non-Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Treatment	VinmecRISCGT69	July 18, 2017	August 30, 2019	August 30, 2019	July 21, 2017		September 6, 2019	Vinmec Research Institute of Stem Cell and Gene Technology, Hanoi, Vietnam		https://ClinicalTrials.gov/show/NCT03225651
591	NCT00227487	Intestinal Inflammation and Carbohydrate Digestion in Autistic Children		Unknown status	No Results Available	Autism|Inflammation	Other: Stool collection|Other: Administration of carbohydrate solution during clinically indicated endoscopy|Other: Questionnaires		Massachusetts General Hospital|Autism Speaks	All	18 Months to 17 Years   (Child)	Not Applicable	115	Other	Interventional	Allocation: N/A|Intervention Model: Single Group Assignment|Masking: None (Open Label)|Primary Purpose: Diagnostic	KRPP1	October 2005	May 2011	December 2017	September 28, 2005		September 30, 2016	Massachusetts General Hospital, Boston, Massachusetts, United States|Newton Wellesley Hospital, Newton, Massachusetts, United States		https://ClinicalTrials.gov/show/NCT00227487
592	NCT05490615	The Virtual Mindfulness Study		Recruiting	No Results Available	Autism	Behavioral: Virtual Mindfulness	Psychological distress: measured using the Depression and Anxiety Stress Scale (DASS-21)|Autistic Participant Self Compassion - measured using Self Compassion Scale-Short Form (SCS-SF)|Autistic Community connectedness (ACC) - measured using Autistic Community Connectedness Measure (ACC)|Autistic Participant Satisfaction-measured using Intervention Satisfaction Scale (ISS)|Autistic Participant reactivity, observing, acting aware, describing, and non-judgment- measured using Five-Facet Mindfulness Questionnaire- Short Form (FFMQ-SF)|Autistic Participant Interoception measured using, Interoception Sensory Questionnaire (ISQ-8)|Autistic participant mental well-being measured using, the Short Warwick-Edinburgh Mental Wellbeing Scale, SWEMWS	Centre for Addiction and Mental Health	All	18 Years and older   (Adult, Older Adult)	Not Applicable	80	Other	Interventional	Allocation: Randomized|Intervention Model: Sequential Assignment|Masking: None (Open Label)|Primary Purpose: Supportive Care		November 17, 2022	August 30, 2023	August 30, 2024	August 5, 2022		November 22, 2022	CAMH, Toronto, Ontario, Canada		https://ClinicalTrials.gov/show/NCT05490615
593	NCT02339935	Improving Hospitalizations for Children With ASD		Completed	No Results Available	Autism Spectrum Disorder|Autistic Disorder	Behavioral: Brief Analogue Functional Analysis|Other: No Brief AFA	Aberrant Behavior Checklist|Decrease in Length of Hospitalization|Clinical Global Impression Scales of Severity|Blinded Observational Ratings|Physician/Nurse/Family Perception of Care	Vanderbilt University	All	6 Years to 18 Years   (Child, Adult)	Not Applicable	36	Other	Interventional	Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Health Services Research	141265	January 2015	November 2015	November 2015	January 16, 2015		April 27, 2016	Vanderbilt University Medical Center - MEND Clinic, Nashville, Tennessee, United States		https://ClinicalTrials.gov/show/NCT02339935
594	NCT02995408	Development of a Resiliency Training Program for Parents of Children With Autism Spectrum Disorder	ASD	Unknown status	No Results Available	Stress	Behavioral: Relaxation Response Resiliency Program for Parents of Children with ASD	Distress Tolerance|Stress Reactivity	Massachusetts General Hospital	All	18 Years and older   (Adult, Older Adult)	Not Applicable	60	Other	Interventional	Allocation: Randomized|Intervention Model: Factorial Assignment|Masking: None (Open Label)|Primary Purpose: Treatment	2016P002037	December 2016	January 2018	January 2018	December 16, 2016		September 20, 2017	Massachusetts General Hospital, Boston, Massachusetts, United States		https://ClinicalTrials.gov/show/NCT02995408
595	NCT00844753	Atomoxetine, Placebo and Parent Management Training in Autism	Strattera	Completed	Has Results	Autism|Pervasive Development Disorder|Asperger's Disorder|Attention Deficit Hyperactivity Disorder	Drug: atomoxetine|Drug: Placebo|Behavioral: Parent Management Training	Percentage of Participants Who Were Attention Deficit Hyperactivity Disorder (ADHD) Respondents|Percentage of Participants Who Were Autism Spectrum Disorder Respondents	University of Rochester|University of Pittsburgh|Ohio State University	All	5 Years to 14 Years   (Child)	Phase 4	128	Other	Interventional	Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Triple (Participant, Care Provider, Investigator)|Primary Purpose: Treatment	1R01MH079082-01A2	October 2008	April 2014	April 2014	February 16, 2009	February 4, 2016	February 4, 2016	University of Rochester Medical Center, Rochester, New York, United States|Ohio State University, Columbus, Ohio, United States|University of Pittsburgh Medical Center, Pittsburgh, Pennsylvania, United States		https://ClinicalTrials.gov/show/NCT00844753
596	NCT05596331	Social Information Processing in Children: an ocUlo-pupillometric Tool for Standard Evaluation	SIRCUS	Not yet recruiting	No Results Available	Autism Spectrum Disorder	Other: eye-tracker	Oculometric measurements 1: Tracking time|Oculometric measurements 2: Fixation time on the screen|Oculometric measurements 3: Fixation time on the eye area during entire stimuli duration|Oculometric measurements 4: Fixation time on the mouth area of face stimuli|Pupillometric measurements|Discriminative power	University Hospital, Tours|UMR 1253, iBrain, Université de Tours, Inserm, Tours, France.|Laboratory of Fundamental and Applied Computer Science of Tours, EA6300|National Research Agency, France|Ministry of Health, France	All	1 Day to 50 Years   (Child, Adult)	Not Applicable	460	Other	Interventional	Allocation: Non-Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Other	DR220031/SIRCUS|2022-A00870-43	November 2022	September 2026	September 2026	October 27, 2022		November 14, 2022			https://ClinicalTrials.gov/show/NCT05596331
597	NCT05193500	Study 3 Learning Verbs and Pronouns		Recruiting	No Results Available	Autism Spectrum Disorder	Behavioral: Addressed Speech|Behavioral: Overheard Speech	Object selection	New York University|Emerson College	All	24 Months to 71 Months   (Child)	Not Applicable	200	Other	Interventional	Allocation: Non-Randomized|Intervention Model: Parallel Assignment|Masking: Single (Outcomes Assessor)|Primary Purpose: Basic Science	280523	August 1, 2022	March 1, 2025	March 1, 2025	January 18, 2022		November 14, 2022	Emerson College, Boston, Massachusetts, United States|New York University, New York, New York, United States	"Informed Consent Form", https://ClinicalTrials.gov/ProvidedDocs/00/NCT05193500/ICF_000.pdf	https://ClinicalTrials.gov/show/NCT05193500
598	NCT05146245	Safety and Pharmacokinetics of Antipsychotics in Children 2: Studying TDM in an RCT	SPACe2:STAR	Recruiting	No Results Available	Autism Spectrum Disorder	Other: Therapeutic Drug Monitoring|Other: Risperidone plasma level	BMI z-score|Effectivity (ABC)|Effectivity (CGI)|Quality of Life (PedsQL)|Metabolic side effects (glucose)|Metabolic side effects (cholesterol)|Metabolic side effects (triglycerides)|Endocrine side effects (prolactin)|Extrapyramidal symptoms (EPS)|Endocrine side effects (ghrelin)|Endocrine side effects (leptin)|Side effects (blood pressure)	Erasmus Medical Center|Stichting de Merel|ZonMw: The Netherlands Organisation for Health Research and Development	All	6 Years to 18 Years   (Child, Adult)	Phase 4	140	Other	Interventional	Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Other	MEC-2021-0278|2020-005450-18	December 1, 2021	May 2024	May 2024	December 6, 2021		December 6, 2021	Erasmus Medical Center, Rotterdam, Netherlands		https://ClinicalTrials.gov/show/NCT05146245
599	NCT02909959	Sulforaphane for the Treatment of Young Men With Autism Spectrum Disorder		Completed	Has Results	Autism Spectrum Disorder|Autistic Disorder|Neurodevelopmental Disorder|Childhood Developmental Disorders, Pervasive	Drug: Sulforaphane|Drug: Placebo	Social Responsiveness Scale-2 (SRS-2) Total Score at Baseline|Social Responsiveness Scale-2 (SRS-2) Total Score at Week 4|Social Responsiveness Scale-2 (SRS-2) Total Score at Week 8|Social Responsiveness Scale-2 (SRS-2) Total Score at Week 12|Social Responsiveness Scale-2 (SRS-2) Total Score at Week 16|Social Responsiveness Scale-2 (SRS-2) Subscale Score (Social Awareness)|Social Responsiveness Scale-2 (SRS-2) Subscale Score (Social Cognition)|Social Responsiveness Scale-2 (SRS-2) Subscale Score (Social Communication)|Social Responsiveness Scale-2 (SRS-2) Subscale Score (Social Motivation)|Social Responsiveness Scale-2 (SRS-2) Subscale Score (Restricted Interests/Repetitive Behaviors)|Aberrant Behavior Checklist (ABC) Subscale Score (Social Withdrawal)|Aberrant Behavior Checklist (ABC) Subscale Scores (Hyperactivity)|Aberrant Behavior Checklist (ABC) Subscale Score (Inappropriate Speech)|Aberrant Behavior Checklist (ABC) Subscale Score (Stereotypy)|Aberrant Behavior Checklist (ABC) Subscale Score (Irritability)|Clinical Global Impression-Severity (CGI-S) Score|Number of Participants With Clinical Global Impression-Improvement (CGI-I) Score of Much Improved or Very Much Improved|Repetitive Behavior Scale-Revised (RBSR) Total Score|Mean Red Blood Cell Value|Mean White Blood Cell Value|Mean Hemoglobin Value|Mean Hematocrit Value|Mean Corpuscular Volume Value|Mean Corpuscular Hemoglobin Value|Mean Corpuscular Hemoglobin Concentration Value|Mean Red Blood Cell Distribution Width Value|Mean Platelets Value|Mean Absolute Neutrophils Value|Mean Absolute Lymphocytes Value|Mean Absolute Monocytes Value|Mean Absolute Eosinophils Value|Mean Absolute Basophils Value|Mean Serum Chemistries (Sodium)|Mean Serum Chemistries (Potassium)|Mean Serum Chemistries (Chloride)|Mean Serum Chemistries (Bicarbonate)|Mean Serum Chemistries (Blood Urea Nitrogen)|Mean Serum Chemistries (Creatinine)|Mean Serum Chemistries (Glucose)|Mean Liver Function Tests Values (Alanine Transaminase)|Mean Liver Function Tests Values (Aspartate Transaminase)|Mean Liver Function Tests Values (Total Bilirubin)|Mean Value of Thyroid Stimulating Hormone (TSH)|Least Squares Mean of Vital Signs (Weight)|Least Squares Mean of Vital Signs (Height)|Least Squares Mean of Vital Signs (Blood Pressure)|Least Squares Mean of Vital Signs (Heart Rate)	University of North Carolina, Chapel Hill|North Carolina Translational and Clinical Sciences Institute	Male	13 Years to 30 Years   (Child, Adult)	Phase 2	48	Other	Interventional	Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)|Primary Purpose: Treatment	16-2059|5KL2TR001109-05	March 1, 2017	May 30, 2019	May 30, 2019	September 21, 2016	May 15, 2020	June 4, 2020	Carolina Institute for Developmental Disabilities, University of North Carolina School of Medicine, Carrboro, North Carolina, United States	"Study Protocol and Statistical Analysis Plan", https://ClinicalTrials.gov/ProvidedDocs/59/NCT02909959/Prot_SAP_000.pdf	https://ClinicalTrials.gov/show/NCT02909959
600	NCT04953793	High School SUCCESS: Vocational Soft Skills Program for Transition-Age ASD Youth	TAY SUCCESS	Completed	No Results Available	Autism Spectrum Disorder	Behavioral: TAY SUCCESS|Other: Usual Care	Behavior Rating Inventory of Executive Function (BRIEF-2/BRIEF-A)|Delis Kaplan Executive Function Scale (DKEFS)|Social Responsiveness Scale 2 (SRS-2)	Rady Children's Hospital, San Diego	All	15 Years to 22 Years   (Child, Adult)	Phase 1	42	Other	Interventional	Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Treatment	R34MH111491	November 6, 2017	January 20, 2020	December 31, 2020	July 8, 2021		July 8, 2021	Rady Children's Hospital San Diego, San Diego, California, United States	"Study Protocol and Statistical Analysis Plan", https://ClinicalTrials.gov/ProvidedDocs/93/NCT04953793/Prot_SAP_000.pdf	https://ClinicalTrials.gov/show/NCT04953793
601	NCT04820647	KF STRIDE to Improve Job Interview Skills		Recruiting	No Results Available	Autism Spectrum Disorder	Behavioral: KF-STRIDE	Mock Job Interview|employment status (yes=1, no=0)|time-to-reach-employment (assessed as weeks since intervention completion).	Kessler Foundation	All	14 Years to 26 Years   (Child, Adult)	Not Applicable	30	Other	Interventional	Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Single (Outcomes Assessor)|Primary Purpose: Treatment	E-1139-21	March 29, 2021	November 30, 2022	April 30, 2023	March 29, 2021		August 29, 2022	Kessler Foundation, East Hanover, New Jersey, United States		https://ClinicalTrials.gov/show/NCT04820647
602	NCT04173663	Advocating for Supports to Improve Service Transitions	ASSIST	Active, not recruiting	No Results Available	Autism Spectrum Disorder|Autism	Behavioral: ASSIST	Change in Parental Knowledge about adult services questionnaire|Change in Parental Empowerment Scale|Change in Advocacy Skills and Comfort Scale|Change in Access to Services interview: Number of services the family applied for|Change in Access to Services interview: Number of services the family is receiving|Change in Access to Services interview: Barriers to services|Social Participation Youth Outcomes|Post-Secondary Youth Outcomes|Change in Advocacy Activities Scale|Post-Secondary Youth Outcomes: Employment stability|Post-Secondary Youth Outcomes: Hours spent in activity	Vanderbilt University Medical Center|University of Illinois at Urbana-Champaign|University of Wisconsin, Madison	All	16 Years and older   (Child, Adult, Older Adult)	Not Applicable	180	Other	Interventional	Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Single (Outcomes Assessor)|Primary Purpose: Treatment	191187	January 3, 2020	May 30, 2024	May 30, 2024	November 22, 2019		September 7, 2022	University of Illinois at Urbana-Champaign, Chicago, Illinois, United States|Vanderbilt University Medical Center, Nashville, Tennessee, United States|Waisman Center at University of Madison-Wisconsin, Madison, Wisconsin, United States		https://ClinicalTrials.gov/show/NCT04173663
603	NCT04714606	Feasibility Controlled Trial of an 8-session Group Intervention for Siblings of Children Who Have ASD		Completed	No Results Available	Autism Spectrum Disorder	Other: Sibling support group|Other: None - control condition	Change in Strengths & Difficulties Questionnaire (SDQ, Goodman et al., 2009) scores|Change in Paediatric Quality of Life Inventory (PedsQL V4.0; Varni, Seid & Kurtin, 2001) scores|Change in Knowledge of Autism Questionnaire (KAS; Ross & Cuskelly, 2006) scores|Change in Goal Based Outcomes (GBOs, Law & Jacob, 2015) scores Goal Based Outcomes (GBOs, Law & Jacob, 2015)|Experience of Service Questionnaire (ESQ, Attride-Stirling, 2002)	University of Surrey	All	7 Years to 11 Years   (Child)	Not Applicable	12	Other	Interventional	Allocation: Non-Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Treatment	260159	December 14, 2020	April 30, 2021	April 30, 2021	January 19, 2021		June 16, 2021	The Howard Partnership Multi-Academy Trust, Leatherhead, United Kingdom		https://ClinicalTrials.gov/show/NCT04714606
604	NCT04316338	Intermittent Theta-Burst Stimulation to Target Irritability in Adults With ASD		Not yet recruiting	No Results Available	Autism Spectrum Disorder	Device: Intermittent theta-burst stimulation (iTBS)	Aberrant Behavior Checklist-irritability subscale (ABC-I)|Irritability Questionnaire|Self-injury questionnaire (SIQ)|THE MODIFIED OVERT AGGRESSION SCALE (MOAS)|Difficulties in Emotion Regulation Scale|The Adult Autism Quotient (AQ)|Repetitive Behavior Scale-Revised (RBS-R)|Montgomery-Åsberg Depression Rating Scale (MADRS)|Functional connectivity between areas involved in negative emotion regulation|EEG recordings|Magnetic resonance spectroscopy (MRS)	Stanford University	All	22 Years to 55 Years   (Adult)	Not Applicable	10	Other	Interventional	Allocation: N/A|Intervention Model: Single Group Assignment|Masking: None (Open Label)|Primary Purpose: Treatment	IRB-41458	May 1, 2022	May 1, 2024	May 1, 2025	March 20, 2020		May 10, 2021			https://ClinicalTrials.gov/show/NCT04316338
605	NCT04166591	Study 1 Replication and Extension of Prior Work		Active, not recruiting	No Results Available	Autism Spectrum Disorder	Behavioral: Overheard Speech|Behavioral: Addressed Speech	Number of children who select the target object by touching, pointing, or grasping on each trial|Number of children who select the target object by touching, pointing, or grasping	New York University|Emerson College	All	18 Months to 71 Months   (Child)	Not Applicable	155	Other	Interventional	Allocation: Non-Randomized|Intervention Model: Parallel Assignment|Masking: Single (Investigator)|Primary Purpose: Basic Science	280521	January 5, 2021	March 1, 2025	March 1, 2025	November 18, 2019		November 14, 2022	Emerson College, Boston, Massachusetts, United States|New York University, New York, New York, United States	"Informed Consent Form", https://ClinicalTrials.gov/ProvidedDocs/91/NCT04166591/ICF_000.pdf	https://ClinicalTrials.gov/show/NCT04166591
606	NCT04114942	PEERS© for Careers		Active, not recruiting	No Results Available	Autism Spectrum Disorder	Behavioral: Never Coach|Behavioral: Internship Only Coach|Behavioral: Constant Coach	Change in Employment-related Social Skills Knowledge as Assessed by Test of Employment Social Skills (TESS)|Change in Employment-related Social Skills Knowledge as Assessed by Adapted Contextual Assessment of Social Skills (CASS)|Change in Social Skills Knowledge as Assessed by Social Responsiveness Scale (SRS-2)|Autism Severity as Assessed by Wechsler Abbreviated Scale of Intelligence (WASI-II)	University of California, Los Angeles	All	18 Years to 35 Years   (Adult)	Not Applicable	106	Other	Interventional	Allocation: Randomized|Intervention Model: Factorial Assignment|Masking: None (Open Label)|Primary Purpose: Treatment	11934	January 1, 2020	December 2022	December 2022	October 3, 2019		October 12, 2022	UCLA CAN Clinic, Los Angeles, California, United States|UCLA PEERS Clinic, Los Angeles, California, United States		https://ClinicalTrials.gov/show/NCT04114942
607	NCT04042337	Improving Access to Pivotal Response Treatment (PRT) Via Telehealth Parent Training		Recruiting	No Results Available	Autism Spectrum Disorder	Behavioral: Pivotal Response Treatment	Change in Parent Fidelity of PRT Implementation from Baseline to Week 12|Change in Child Frequency of Functional Utterances from Baseline to Week 12	Stanford University	All	2 Years to 5 Years   (Child)	Not Applicable	40	Other	Interventional	Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Single (Outcomes Assessor)|Primary Purpose: Treatment	52597	April 13, 2020	August 31, 2023	December 31, 2025	August 1, 2019		October 14, 2022	Department of Psychiatry and Behavioral Sciences, Stanford, California, United States		https://ClinicalTrials.gov/show/NCT04042337
608	NCT03899831	Structured Function-Based Elopement Treatment Program	FBET	Recruiting	No Results Available	Autism Spectrum Disorder	Behavioral: Function-Based Elopement Treatment (FBET)|Behavioral: Parent Education Program (PEP)	Change in Aberrant Behavior Checklist - Hyperactivity (ABC-H) Subscale Score|Change in Clinical Global Impression - Improvement (CGI-I) Score|Change in Home Elopement Safety Checklist (HESC) Score|Direct observation of elopement frequency	Emory University|Autism Speaks	All	4 Years to 12 Years   (Child)	Not Applicable	76	Other	Interventional	Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Single (Outcomes Assessor)|Primary Purpose: Treatment	IRB00108995	May 9, 2019	January 2023	January 2023	April 2, 2019		June 22, 2022	Marcus Autism Center, Atlanta, Georgia, United States		https://ClinicalTrials.gov/show/NCT03899831
609	NCT05104112	Evaluation of a Therapeutic Education Program for Pregnant Women With a First Child Diagnosed With an Autism Spectrum Disorder	AUTMER	Not yet recruiting	No Results Available	Child Psychiatry	Other: The M.E.R. program	Manchester Assessment of Caregiver-infant Interaction (MACI) "caregiver non-directiveness" subscore|Pregnancy-Related Anxiety Questionnaire-Revised2 (PRAQ-R2) subscore|Appraisal of Life Events Scale (ALES)|Edimburgh Postnatal Depression Scale (EPDS)|quality of life score-Bref (WhoQol-Bref)|parental anxiety score (HAM)|mother's intelligence quotient|Social Responsiveness Scale (SRS)|Wechsler Mullen scale	Assistance Publique - Hôpitaux de Paris	Female	18 Years to 70 Years   (Adult, Older Adult)	Not Applicable	160	Other	Interventional	Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Single (Outcomes Assessor)|Primary Purpose: Prevention	APHP191096	February 2023	August 2026	August 2026	November 2, 2021		December 8, 2022	Hôpital Robert Debré, Paris, France		https://ClinicalTrials.gov/show/NCT05104112
610	NCT03934879	Physical Exercise and Contributors to Academic Performance Among Adolescents With ASD (Fit Club Study)	FitClub	Completed	No Results Available	Autism Spectrum Disorders	Behavioral: FitClub|Other: Regular School Activities	Change from baseline in Bruininks-Osteretsky Test of Motor Proficiency, Second Edition|Change from baseline in Adolescent and Young Adult Activity Card Sort|Change from baseline in Depression, Anxiety and Stress Scale|Change from baseline in Repetitive Behavior Scale|Change from baseline in Sensory Profile Adolescent/Adult|Change from baseline in Body Mass Indices|Change from baseline in Exercise Heart Rate|Change from baseline in Delis-Kaplan Executive Function System	The University of Texas Medical Branch, Galveston	All	12 Years to 18 Years   (Child, Adult)	Not Applicable	105	Other	Interventional	Allocation: Non-Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Treatment	16-0185	August 2016	July 2018	December 2020	May 2, 2019		February 1, 2021	Gateway Academy, Houston, Texas, United States		https://ClinicalTrials.gov/show/NCT03934879
611	NCT01931033	An Open-Label Trial of Oxytocin in Adolescents With Autism Spectrum Disorders		Active, not recruiting	No Results Available	Autism Spectrum Disorders|Pervasive Developmental Disorders|ASD|PDD	Drug: Intranasal Oxytocin	Social Responsiveness Scale (SRS-2)|Clinical Global Impression of PDD - Improvement (CGI-I)	Massachusetts General Hospital	All	11 Years to 17 Years   (Child)	Not Applicable	40	Other	Interventional	Allocation: N/A|Intervention Model: Single Group Assignment|Masking: None (Open Label)|Primary Purpose: Treatment	2013-P-001548	October 2013	June 2023	June 2023	August 29, 2013		August 1, 2022	Massachusetts General Hospital, Boston, Massachusetts, United States		https://ClinicalTrials.gov/show/NCT01931033
612	NCT03769571	Generalized Training Program for Caregivers on the ESDM: PEGASE	PEGASE	Unknown status	No Results Available	Autism Spectrum Disorder	Behavioral: Parental coaching program at ESDM (P-ESDM)	effectiveness of a parent's training program (name PEGASE) of young children (aged 2 to 4 years) with Autism Spectrum Disorders.	Assistance Publique Hopitaux De Marseille	All	2 Years to 4 Years   (Child)	Not Applicable	30	Other	Interventional	Allocation: Non-Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Health Services Research	2018-42	November 8, 2018	November 7, 2021	November 7, 2021	December 7, 2018		December 10, 2018	Service de pédopsychiatrie Sainte-Marguerite, Marseille, Marseille Cedex 09, France		https://ClinicalTrials.gov/show/NCT03769571
613	NCT02985749	A Study of Oxytocin for the Treatment of Social Impairment in Individuals With High Functioning Autism Spectrum Disorder		Active, not recruiting	No Results Available	Autism Spectrum Disorder|Pervasive Developmental Disorder|ASD|PDD	Drug: Intranasal Oxytocin	Social Responsiveness Scale (SRS-2 School Age form and SRS-2 Adult Self-Report)|Quality of Life Enjoyment and Satisfaction (PQ-LES-Q and Q-LES-Q)	Massachusetts General Hospital	All	12 Years to 55 Years   (Child, Adult)	Phase 3	60	Other	Interventional	Allocation: N/A|Intervention Model: Single Group Assignment|Masking: None (Open Label)|Primary Purpose: Treatment	2016P002148	October 9, 2017	September 2023	September 2023	December 7, 2016		August 1, 2022	Massachusetts General Hospital, Cambridge, Massachusetts, United States		https://ClinicalTrials.gov/show/NCT02985749
614	NCT03537261	CPI Training for Parents of Children With ASD		Completed	Has Results	Autism Spectrum Disorder	Behavioral: Parent-based Crisis Prevention Institute (CPI) physical management training program (P-CPI)	Change in the Child Adjustment and Parent Efficacy Scale-Developmental Disability Self-Efficacy Scale Total Score|Change in the Parent Stress Index - Short Form Total Score|Change in the Family Quality of Life Scale Total Score	Massachusetts General Hospital|Crisis Prevention Institute	All	5 Years to 12 Years   (Child)	Not Applicable	81	Other	Interventional	Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Treatment	2018P000119	August 8, 2018	June 15, 2020	June 15, 2020	May 25, 2018	June 29, 2021	June 29, 2021	Lurie Center for Autism, Lexington, Massachusetts, United States	"Study Protocol and Statistical Analysis Plan", https://ClinicalTrials.gov/ProvidedDocs/61/NCT03537261/Prot_SAP_000.pdf	https://ClinicalTrials.gov/show/NCT03537261
615	NCT03432832	Emotion Awareness and Skills Enhancement Program	EASE	Active, not recruiting	No Results Available	Autism Spectrum Disorder	Behavioral: EASE|Behavioral: Supportive Therapy	The Clinical Global Impression Scale- Improvement (CGI-I)|Emotion Dysregulation Inventory Reactivity Scale Short Form (EDI-SF)|Brief Psychiatric Rating Scale (BPRS)	University of Pittsburgh|University of Alabama at Birmingham	All	12 Years to 21 Years   (Child, Adult)	Not Applicable	100	Other	Interventional	Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Single (Outcomes Assessor)|Primary Purpose: Treatment	PRO17070496	January 30, 2018	January 15, 2023	July 30, 2023	February 14, 2018		September 10, 2022	University of Alabama, Tuscaloosa, Alabama, United States|Shannondora Porton, Pittsburgh, Pennsylvania, United States	"Study Protocol and Statistical Analysis Plan", https://ClinicalTrials.gov/ProvidedDocs/32/NCT03432832/Prot_SAP_000.pdf	https://ClinicalTrials.gov/show/NCT03432832
616	NCT03370510	Translating Neuroprediction Into Precision Medicine Via Brain Priming		Terminated	Has Results	Autism Spectrum Disorder	Drug: Oxytocin|Behavioral: Pivotal Response Treatment|Drug: Placebo	Social Responsiveness Scale, 2nd Edition (SRS-2)|Vineland Adaptive Behavior Scale, 3rd Edition (Vineland-III)	Yale University	All	5 Years to 9 Years   (Child)	Phase 2	5	Other	Interventional	Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)|Primary Purpose: Treatment	2000021581	December 7, 2018	July 28, 2021	July 28, 2021	December 12, 2017	August 9, 2022	August 9, 2022	Yale School of Medicine, New Haven, Connecticut, United States	"Study Protocol and Statistical Analysis Plan", https://ClinicalTrials.gov/ProvidedDocs/10/NCT03370510/Prot_SAP_000.pdf	https://ClinicalTrials.gov/show/NCT03370510
617	NCT03323918	ImPACT Intervention for Children With ASD		Completed	No Results Available	Autism Spectrum Disorder	Other: ImPACT|Other: TAU	Change from baseline in the score of the Early Social Communication Scales (ESCS)|Change from baseline in the score of a semi-structured social imitation task|Change from baseline in the score of the Brief Observation of Social Communication Change (BOSCC)|Change from baseline in electrophysiological event-related potentials in response to voice and non-voice sounds (N1, N2 and P3 effects), measured with EEG|Change from baseline in haemodynamic response function (oxyhaemoglobin and deoxyhaemoglobin concentration in the cerebral cortex) evoked by social attention cues, measured with NIRS (near infrared spectroscopy)|Change from post-test in the score of the Early Social Communication Scales (ESCS)|Change from post-test in the score of a semi-structured social imitation task|Change from post-test in the score of the Brief Observation of Social Communication Change (BOSCC).|Change from post-test in electrophysiological event-related potentials in response to voice and non-voice sounds (N1, N2 and P3 effects), measured with EEG|Change from post-test in haemodynamic response function (oxyhaemoglobin and deoxyhaemoglobin concentration in the cerebral cortex) evoked by social attention cues, measured with NIRS (near infrared spectroscopy)|Change from baseline in the score of the Autism Diagnostic Observational Scale - 2 (ADOS-2)|Change from baseline in the score of the Mullen Scales of Early Learning (M-SEL)|Change from baseline in the score of the Vineland screener questionnaire (0-6 years).|Change from baseline in the score of the Dutch adaptation of the MacArthur Communicative Development Inventories (NCDI - short form)|Change from baseline in the score of the Nijmeegse Ouderlijke Stress Index|Change from post-test in the score of the Vineland screener questionnaire (0-6 years).|Change from post-test in the score of the Dutch adaptation of the MacArthur Communicative Development Inventories (NCDI - short form)|Change from post-test in the score of the Nijmeegse Ouderlijke Stress Index	University Ghent|European Union	All	18 Months to 48 Months   (Child)	Not Applicable	56	Other	Interventional	Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Double (Investigator, Outcomes Assessor)|Primary Purpose: Treatment	BRAINVIEW/ESR14	November 2016	November 28, 2021	November 28, 2021	October 27, 2017		November 9, 2022	Ghent University, Ghent, Oost-Vlaanderen, Belgium		https://ClinicalTrials.gov/show/NCT03323918
618	NCT03205475	JASPER Implementation in NFLD		Active, not recruiting	No Results Available	Autism Spectrum Disorder	Behavioral: Alternate Coaching and Video Feedback Phase 1|Behavioral: Weekly Coaching in Phase 1|Behavioral: Weekly Coaching plus Intensive Refresher Course Phase 2|Behavioral: Weekly Coaching plus Peer Coaching Phase 2|Behavioral: Video Feedback Only Phase 2	Change in JASPER Strategy Implementation Fidelity|Change in Children's Joint Engagement|Change in Children's Play Skills and Social Communication Skills	Government of Newfoundland and Labrador	All	24 Months to 97 Months   (Child)	Not Applicable	76	Other	Interventional	Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Single (Participant)|Primary Purpose: Treatment	GovernmentNL	May 1, 2018	December 31, 2018	July 30, 2022	July 2, 2017		March 16, 2022	Department of Health and Community Services, Government of Newfoundland and Labrador, St. John's, Newfoundland and Labrador, Canada		https://ClinicalTrials.gov/show/NCT03205475
619	NCT03079765	Training Educators to Conduct Functional Behavior Assessment Via Telehealth		Completed	No Results Available	Autism Spectrum Disorder	Behavioral: Behavioral skills training|Behavioral: Protocol Only	Increased functional behavior assessment procedural fidelity	University of Colorado, Denver	All	Child, Adult, Older Adult	Not Applicable	12	Other	Interventional	Allocation: Non-Randomized|Intervention Model: Sequential Assignment|Masking: None (Open Label)|Primary Purpose: Treatment	16-1691	January 1, 2017	May 31, 2019	May 31, 2019	March 14, 2017		March 3, 2020	University of Colorado, Anschutz Medical Campus, Aurora, Colorado, United States		https://ClinicalTrials.gov/show/NCT03079765
620	NCT03045263	Pivotal Response Treatment (PRT) Telemedicine	PRT	Completed	No Results Available	Autism Spectrum Disorder	Behavioral: Pivotal Response Treatment	Behavioural Intervention Rating Scale (BIRS)|Client Credibility Questionnaire (CCQ)	Yale University	All	3 Years to 6 Years   (Child)	Not Applicable	7	Other	Interventional	Allocation: Randomized|Intervention Model: Crossover Assignment|Masking: Single (Outcomes Assessor)|Primary Purpose: Treatment	1504015664	February 2, 2017	May 3, 2018	May 3, 2018	February 7, 2017		June 26, 2020	Yale Child Study Center, New Haven, Connecticut, United States		https://ClinicalTrials.gov/show/NCT03045263
621	NCT02255786	"ACT" for Parents of Children With Autism Spectrum Disorder		Completed	No Results Available	Stress	Behavioral: Acceptance and Commitment Therapy	Change in Acceptance and Action Questionnaire-II Score	Massachusetts General Hospital|Organization for Autism Research	All	18 Years to 65 Years   (Adult, Older Adult)	Not Applicable	16	Other	Interventional	Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Treatment	2014P001563	October 2014	December 2016	December 2016	October 3, 2014		August 13, 2019	Lurie Center   Massachusetts General Hospital, Lexington, Massachusetts, United States		https://ClinicalTrials.gov/show/NCT02255786
622	NCT03019978	Person-Centered Assessment and Monitoring Systems	PCAMS	Completed	No Results Available	Autism Spectrum Disorder	Other: PCAMS assessments	Social Responsiveness Scale- 2|Adult Behavior Checklist|Additional PROMIS measures|Community Engagement measure|PROMIS measures|Elected Reporter Community Engagement measure	Milton S. Hershey Medical Center|Pennsylvania Bureau of Autism Services	All	18 Years and older   (Adult, Older Adult)	Not Applicable	60	Other	Interventional	Allocation: N/A|Intervention Model: Single Group Assignment|Masking: None (Open Label)|Primary Purpose: Health Services Research	STUDY00004326	July 2016	August 2019	August 2019	January 13, 2017		April 8, 2020	The Penn State College of Medicine, Hershey, Pennsylvania, United States		https://ClinicalTrials.gov/show/NCT03019978
623	NCT03019952	Effectiveness of the Care Coordination, Assessment, and Responsive Engagement Program for Transition-aged Adolescents (t-CARE) With ASD	t-CARE	Completed	No Results Available	Autism Spectrum Disorder	Behavioral: Care Coordination Visit	Holmes and Rahe Stress Scale|SRS-2|Waisman Activities of Daily Living Scale|Intolerance of Uncertainty|PROMIS Multi-Domain 49|Temple University Community Participation (TUCP) measure|PROMIS proxy measures|PROMIS SF measures|Self-Determination Scale|Closure Survey	Milton S. Hershey Medical Center|Pennsylvania Bureau of Autism Services	All	14 Years to 19 Years   (Child, Adult)	Not Applicable	52	Other	Interventional	Allocation: N/A|Intervention Model: Single Group Assignment|Masking: None (Open Label)|Primary Purpose: Health Services Research	STUDY00003849	January 2016	April 9, 2018	April 9, 2018	January 13, 2017		March 13, 2019	The Penn State College of Medicine, Hershey, Pennsylvania, United States		https://ClinicalTrials.gov/show/NCT03019952
624	NCT02856061	Tracking Intervention Effects With Eye Tracking		Completed	No Results Available	Autism Spectrum Disorder	Behavioral: Pivotal Response Treatment	Laboratory Eye Tracking Measuring Longitudinal Change|Home-Based Eye Tracking|Longitudinal Change in Autism Symptom Severity	Yale University|Simons Foundation	All	4 Years to 7 Years   (Child)	Not Applicable	76	Other	Interventional	Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Other	1106008625a|383661	January 2016	March 2018	March 2018	August 4, 2016		March 9, 2020	Yale Child Study Center, New Haven, Connecticut, United States		https://ClinicalTrials.gov/show/NCT02856061
625	NCT02574741	Combination Treatment for Augmenting Language in Children With ASD	PIII	Completed	No Results Available	Autism Spectrum Disorder	Behavioral: Behavioral Therapy|Drug: Aripiprazole|Drug: Placebo	Number of words as assessed in a naturalistic language assessment	University of California, Los Angeles	All	5 Years to 11 Years   (Child)	Phase 2	58	Other	Interventional	Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)|Primary Purpose: Treatment	12-000726	June 2012	December 2019	December 2019	October 14, 2015		April 29, 2020	University of California, Los Angeles, California, United States		https://ClinicalTrials.gov/show/NCT02574741
626	NCT02468505	STEPS: Stepped Transition in Education Program for Students With ASD	STEPS	Completed	No Results Available	Autism Spectrum Disorder	Behavioral: STEPS	Questionnaire to measure feasibility and program acceptability	Virginia Polytechnic Institute and State University|University of Alabama at Birmingham	All	16 Years to 25 Years   (Child, Adult)	Not Applicable	50	Other	Interventional	Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Single (Outcomes Assessor)|Primary Purpose: Supportive Care	R34MH104337	September 2014	July 1, 2018	October 1, 2018	June 11, 2015		July 12, 2019	Virginia Polytechnic Institute and State University, Blacksburg, Virginia, United States		https://ClinicalTrials.gov/show/NCT02468505
627	NCT02440451	Rt-fMRI NF Intervention Study in ASD	NF-ASD	Completed	Has Results	Autism Spectrum Disorder	Device: Neurofeedback using BCI	FEEST - Facial Expression of Emotion: Stimuli and Tests|ATEC - Autism Treatment Evaluation Checklist|VABS - Vineland Adaptive Behaviour Scale	University of Coimbra	All	16 Years to 30 Years   (Child, Adult)	Not Applicable	15	Other	Interventional	Allocation: N/A|Intervention Model: Single Group Assignment|Masking: None (Open Label)|Primary Purpose: Treatment	IBILI-VB-2015-02	February 2016	September 2017	September 2018	May 12, 2015	November 13, 2018	February 20, 2019		"Statistical Analysis Plan", https://ClinicalTrials.gov/ProvidedDocs/51/NCT02440451/SAP_000.pdf|"Study Protocol", https://ClinicalTrials.gov/ProvidedDocs/51/NCT02440451/Prot_001.pdf	https://ClinicalTrials.gov/show/NCT02440451
628	NCT05030610	Adaptation of a Behavioral Activation Treatment to Treat Depression in Autistic Adults		Active, not recruiting	No Results Available	Autism Spectrum Disorder|Depression|Depressive Symptoms	Behavioral: BeatIt-ASD	Change in distress on Patient Health Questionnaire (PHQ-9)|Change in distress on Glasgow Depression Scale (GDS)|Change in distress on Anxiety Depression and Mood Scale (ADAMS)|Change on Adult Behavior Checklist (ABCL)|Change on Adult Self Report (ASR)|Change in frequency of activities on Index of Community Involvement (ICI)|Change in frequency of activities on Index of Participation in Domestic Life (IPDL)|Change in behavioral activation on Behavioral Activation for Depression Scale (BADS)|Change in adaptive behavior on Vineland Adaptive Behavior Scale, 3rd edition (VABS-3)|Change in quality of life on Shalock Quality of Life Questionnaire	Rutgers, The State University of New Jersey|Governor's Council for Medical Research and Treatment of Autism	All	18 Years and older   (Adult, Older Adult)	Not Applicable	20	Other	Interventional	Allocation: N/A|Intervention Model: Single Group Assignment|Masking: None (Open Label)|Primary Purpose: Treatment	Pro2021001254	August 25, 2021	November 2022	November 2022	September 1, 2021		August 10, 2022	Rutgers University - New Brunswick, Piscataway, New Jersey, United States		https://ClinicalTrials.gov/show/NCT05030610
629	NCT02400177	Parents Workgroup About Emotion Regulation		Completed	No Results Available	Autism Spectrum Disorders	Behavioral: emotion regulation training	Mentalization level|Relationship coherence level	Stanford University	All	3 Years to 18 Years   (Child, Adult)	Not Applicable	96	Other	Interventional	Allocation: Non-Randomized|Intervention Model: Single Group Assignment|Masking: None (Open Label)|Primary Purpose: Treatment	IRB32455	March 2015	November 2016	November 2016	March 26, 2015		June 1, 2018	Stanford University, Stanford, California, United States		https://ClinicalTrials.gov/show/NCT02400177
630	NCT01784276	Dental Fear Among Children With Autism Spectrum Disorders		Completed	No Results Available	Dental Fear	Behavioral: Video	Anxiety|Uncooperative behavior	Boston Children's Hospital	All	7 Years to 17 Years   (Child)	Not Applicable	80	Other	Interventional	Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Health Services Research	IRB-CRX10-09-0486-2	September 2010	August 2012	August 2012	February 5, 2013		February 5, 2013	Boston Children'S Hospital, Boston, Massachusetts, United States		https://ClinicalTrials.gov/show/NCT01784276
631	NCT00453180	A Study of Oral N-Acetylcysteine in Children With Autism Spectrum Disorders		Completed	Has Results	Autistic Disorder|Asperger Syndrome|Child Development Disorders, Pervasive	Drug: N-acetylcysteine|Drug: Placebo	Clinical Global Impression - Severity|Clinical Global Impression - Improvement|Aberrant Behavior Checklist|Social Responsiveness Scale|Pervasive Developmental Disorder Behavior Index|Vineland Adaptive Behavior Scales-II (VABS-II)	Indiana University School of Medicine|National Alliance for Autism Research|Indiana University	All	4 Years to 12 Years   (Child)	Phase 2	31	Other	Interventional	Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Triple (Participant, Care Provider, Investigator)|Primary Purpose: Treatment	0611-10	March 2007	August 2009	November 2009	March 28, 2007	June 14, 2017	June 14, 2017	Riley Hospital, Riley Child and Adolescent Psychiatry Clinic, Indianapolis, Indiana, United States		https://ClinicalTrials.gov/show/NCT00453180
632	NCT02574559	CBCT for Parents of Children With Autism		Completed	No Results Available	Stress	Behavioral: Cognitive Based Compassion Training Session: Developing Attention and Stability of Mind|Behavioral: Cognitive Based Compassion Training Session: Cultivating Insight into the Nature of Mental Experience|Behavioral: Cognitive Based Compassion Training Session: Self-compassion|Behavioral: Cognitive Based Compassion Training Session: Cultivating Equanimity|Behavioral: Cognitive Based Compassion Training Session: Developing Appreciation and Gratitude for Others|Behavioral: Cognitive Based Compassion Training Session: Developing Affection and Empathy|Behavioral: Cognitive Based Compassion Training Session: Realizing Wishing and Aspiring Compassion|Behavioral: Cognitive Based Compassion Training Session: Realizing Active Compassion|Behavioral: Meditation Session	Change in Aberrant Behavior Checklist (ABC) Score|Change in Parenting Stress Index/Short Form (PSI/SF) Score|Change in Perceived Stress Scale (PSS) Score|Change in Acceptance and Action Questionnaire (AAQ) Score|Change in Interpersonal Reactivity Index (IRI) Score|Change in Mindful Attention Awareness Scale (MAAS) Score|Change in Behavior Rating Inventory of Executive Function- Adult Version (BRIEF-A) Score|Change in Parenting Sense of Competence Scale Score	Emory University	All	Child, Adult, Older Adult	Not Applicable	29	Other	Interventional	Allocation: N/A|Intervention Model: Single Group Assignment|Masking: None (Open Label)|Primary Purpose: Supportive Care	IRB00074454	June 2014	February 11, 2016	February 11, 2016	October 14, 2015		January 31, 2020	Children's Healthcare of Atlanta, Atlanta, Georgia, United States|Emory University, Atlanta, Georgia, United States		https://ClinicalTrials.gov/show/NCT02574559
633	NCT03206996	Exposure Therapy for Auditory Sensitivity in Autism		Completed	No Results Available	Sensory Disorders|Autism|Autism Spectrum Disorder|Autism With High Cognitive Abilities|Autistic Behavior|Hyperacusis	Behavioral: Exposure therapy|Behavioral: Psycho-education|Behavioral: Caregiver education/home program development	Participant Subjective Unit of Distress (SUD) Level|Parent Stress Index|Spence Child Anxiety Scale|Modified Khalfa Hyperacusis Questionnaire|Autism Symptoms|Sensory Profile	University of Florida	All	5 Years to 17 Years   (Child)	Not Applicable	5	Other	Interventional	Allocation: Non-Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Treatment	IRB201601664	September 30, 2017	May 31, 2019	May 31, 2019	July 2, 2017		June 18, 2019	UF Health Child and Adolescent Psychiatry/Medical Psychology, Gainesville, Florida, United States|University of Florida, Gainesville, Florida, United States		https://ClinicalTrials.gov/show/NCT03206996
634	NCT04432077	Anxiety Intervention for Preschool Children With ASD		Completed	No Results Available	Anxiety Disorder|Autism Spectrum Disorder	Behavioral: DINO Strategies for Anxiety and fear of Uncertainty Reduction (DINOSAUR)	Change in child anxiety diagnostic status on Anxiety Disorders Interview Schedule, Autism Spectrum Disorder Addendum (ADIS-ASA) after 12-week waitlist and 12-week intervention|Improvement in child anxiety symptoms on Clinical Global Impressions Scale-Improvement following 12-week intervention|Change in child anxiety symptoms on Preschool Anxiety Scale - Revised following 12-week waitlist and 12-week intervention|Change in child anxiety symptoms on the Screen for Child Anxiety Related Disorders following 12-week waitlist and 12-week intervention|Change in severity of anxiety and other psychiatric symptoms on Child Behavior Checklist following 12-week waitlist and 12-week intervention|Change in child's tolerance of uncertainty on Response to Uncertainty and Low Environmental Stability Scale following 12-week waitlist and 12-week intervention|Change in child ASD symptoms on Social Responsiveness Scale following 12-week waitlist and 12-week intervention|Change in child repetitive behaviors on Repetitive Behavior Scale-Revised following 12-week waitlist and 12-week intervention|Change in parental anxiety and depression symptoms on Hospital Anxiety and Depression Scale following 12-week waitlist and 12-week intervention|Change in parental tolerance of uncertainty on Intolerance of Uncertainty Scale following 12-week waitlist and 12-week intervention|Change on parental accommodating behaviors on Family Accommodation Scale following 12-week waitlist and 12-week intervention|Change in child attention bias to threat on Behavioral Paradigms following 12-week waitlist and 12-week intervention	Hugo W. Moser Research Institute at Kennedy Krieger, Inc.|Organization for Autism Research	All	48 Months to 83 Months   (Child)	Not Applicable	12	Other	Interventional	Allocation: N/A|Intervention Model: Single Group Assignment|Masking: None (Open Label)|Primary Purpose: Treatment	2019A06	October 12, 2020	July 31, 2022	October 1, 2022	June 16, 2020		October 14, 2022	Kennedy Krieger Institute, Baltimore, Maryland, United States		https://ClinicalTrials.gov/show/NCT04432077
635	NCT05509231	Effects of a Multimodal Exercise Program for Children With ASD		Not yet recruiting	No Results Available	Autism Spectrum Disorder|Asperger Syndrome	Behavioral: High-intensity exercise|Device: Wearable glove and arm sleeve device to measure movement	Bruininks-Oseretsky Test of Motor Proficiency (BOT-2)|Qualitative EEG (qEEG)|Wearable technology: Glove and armband	New York Institute of Technology	All	6 Years to 27 Years   (Child, Adult)	Not Applicable	50	Other	Interventional	Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Treatment	BHS-1599	October 12, 2022	January 31, 2024	January 31, 2024	August 22, 2022		October 12, 2022			https://ClinicalTrials.gov/show/NCT05509231
636	NCT01921244	Shared Decision Making to Improve Care and Outcomes for Children With Autism		Completed	No Results Available	Autistic Disorder|Pervasive Developmental Disorder|Child Development Disorders, Pervasive|Asperger Syndrome|Autism Spectrum Disorder|Autism	Other: Decision Aid	Decisional Conflict|Parent-physician interaction	Children's Hospital Medical Center, Cincinnati	All	4 Years to 15 Years   (Child)	Not Applicable	142	Other	Interventional	Allocation: Randomized|Intervention Model: Crossover Assignment|Masking: Single (Outcomes Assessor)|Primary Purpose: Health Services Research	FP00005038	August 2013	July 2015	July 2015	August 13, 2013		February 5, 2016	Cincinnati Children's Medical Center, Cincinnati, Ohio, United States		https://ClinicalTrials.gov/show/NCT01921244
637	NCT05185128	Neural Basis of Social Cognition Deficits		Recruiting	No Results Available	Autism Spectrum Disorder|Psychosis|Social Communication	Behavioral: PEERS social skills intervention	The Awareness of Social Inference Test (TASIT)|The Social Attribution Task - Multiple Choice (SAT-MC, SAT-MC-II)|The computerized Penn Emotion Identification Task (PennCNB)|Functional MRI	Loma Linda University	All	12 Years to 18 Years   (Child, Adult)	Not Applicable	90	Other	Interventional	Allocation: Non-Randomized|Intervention Model: Single Group Assignment|Masking: None (Open Label)|Primary Purpose: Treatment	5200189	February 1, 2022	April 2025	April 2025	January 11, 2022		April 5, 2022	Loma Linda U, Loma Linda, California, United States		https://ClinicalTrials.gov/show/NCT05185128
638	NCT04639141	Combined Gut-brain Therapy for Children With Autism		Active, not recruiting	No Results Available	Autism Spectrum Disorder|Functional Gastrointestinal Disorders|Neurodevelopmental Disorders|Anxiety	Combination Product: Synbiotic|Behavioral: Gut-directed Hypnotherapy	GI symptom severity|ASD severity/behaviour|Anxiety|Gut microbiome	The University of Queensland	All	5 Years to 10 Years   (Child)	Not Applicable	40	Other	Interventional	Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Treatment	ASD-MGB-RCT2020	December 1, 2021	April 1, 2022	June 30, 2022	November 20, 2020		May 19, 2022	University of Queensland, Child Health Research Centre, Faculty of Medicine, Brisbane, Queensland, Australia		https://ClinicalTrials.gov/show/NCT04639141
639	NCT01012076	Promoting Development in Toddlers With Communication Delays		Completed	No Results Available	Autism Spectrum Disorder	Behavioral: Active Control vs Experimental Treatment	Maternal Synchronization|Early Social Communication Scale	Autism Speaks	All	15 Months to 30 Months   (Child)	Not Applicable	60	Other	Interventional	Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Double (Participant, Outcomes Assessor)|Primary Purpose: Treatment	G07-02-055-03	April 2007	October 2011	October 2011	November 11, 2009		June 14, 2012	University of California, Los Angeles, Los Angeles, California, United States|Hunter College, New York, New York, United States		https://ClinicalTrials.gov/show/NCT01012076
640	NCT05134844	Halliwick Hydrotherapy and Snoezelen		Completed	No Results Available	Autism Spectrum Disorder|Autism|Sensory Disorder	Other: Hydrotherapy- Snoezelen|Other: Snoezelen	Evaluation of Disability and Activity- PEDI|Adaptation and progression in pool- WOTA	University of Thessaly	All	4 Years to 8 Years   (Child)	Not Applicable	53	Other	Interventional	Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Single (Participant)|Primary Purpose: Treatment	36469	February 1, 2021	April 1, 2021	May 1, 2021	November 26, 2021		November 26, 2021	University of Thessaly, Lamía, Central Macedonia, Greece		https://ClinicalTrials.gov/show/NCT05134844
641	NCT04983667	Zinc-AA Supplementation During Pregnancy & Lactation to Assess Effects on ASD Prevalence in Offspring		Not yet recruiting	No Results Available	Autism Spectrum Disorder|Zinc Deficiency|Pregnancy Related	Dietary Supplement: Zn-AA	Autism spectrum disorder|Microbiota modification associated to maternal zinc supplementation or placebo during pregnancy|Immune phenotype	Instituto Tecnologico y de Estudios Superiores de Monterey	Female	18 Years to 35 Years   (Adult)	Not Applicable	3840	Other	Interventional	Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Triple (Participant, Care Provider, Outcomes Assessor)|Primary Purpose: Prevention	Zinc-Autismo	August 1, 2021	September 2025	December 2025	July 30, 2021		July 30, 2021			https://ClinicalTrials.gov/show/NCT04983667
642	NCT00374764	Comparison of Applied Behavioral Analysis (ABA) Versus ABA and Risperidone		Completed	No Results Available	Autistic Disorder	Drug: Risperidone|Behavioral: ABA		Washington University School of Medicine	All	30 Months to 5 Years   (Child)	Not Applicable	60	Other	Interventional	Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Double|Primary Purpose: Treatment	IND #58033	July 2000		June 2002	September 11, 2006		February 16, 2007	Early Emotional Development Program, St. Louis, Missouri, United States		https://ClinicalTrials.gov/show/NCT00374764
643	NCT04788212	Transdiagnostic Group Behavioral Activation for Autistic Adults	GBAT	Completed	No Results Available	Autism Spectrum Disorder|Depression, Anxiety|Anxiety|Anger	Behavioral: Group Behavioral Activation Therapy for Autism Spectrum Disorder	Change in symptoms on the Adult Self Report (ASR)|Change in Clinician Global Impairment rating|Change in symptoms on the Depression Anxiety Stress Scales-21|Change in distress on Patient Health Questionnaire (PHQ-9)|Change in anxiety symptoms on the Generalized Anxiety Disorder Questionnaire (GAD-7)|Change in Adaptive Behavior Assessment System - 3 (ABAS-3)|Change in Behavioral Activation for Depression Scale|Change in Idiographic target goals	Rutgers, The State University of New Jersey	All	18 Years to 40 Years   (Adult)	Not Applicable	6	Other	Interventional	Allocation: N/A|Intervention Model: Single Group Assignment|Masking: None (Open Label)|Primary Purpose: Treatment	Pro2020001634	February 16, 2021	July 8, 2021	July 8, 2021	March 9, 2021		August 5, 2021	Rutgers University, Piscataway, New Jersey, United States		https://ClinicalTrials.gov/show/NCT04788212
644	NCT05595044	Effect of Vitamin D Therapy in Autism Spectrum Disorder		Recruiting	No Results Available	Effect of Drug	Drug: Vitamin D|Other: Habilitation	language ability test|CARS questionnaire for assessment of ASD severity|Inflammatory marker|Serum vitamin D	Mansoura University	All	2 Years to 6 Years   (Child)	Phase 1	80	Other	Interventional	Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Treatment	MansouraA	October 1, 2020	January 1, 2023	March 1, 2023	October 26, 2022		October 26, 2022	Mansoura university hospital, Mansoura, Egypt		https://ClinicalTrials.gov/show/NCT05595044
645	NCT02165410	MRI Study of Cerebral Blood Flow in Development Disorders in Children	IRM-Aut	Recruiting	No Results Available	Autism	Procedure: ASL-MRI|Procedure: Diffusion tensor imaging (diffusion MRI)|Procedure: Resting state MRI|Procedure: Eye-tracking|Procedure: Cognitive profile	CBF|anatomical connectivity|eye-tracking method	Assistance Publique - Hôpitaux de Paris	All	18 Months to 18 Years   (Child, Adult)	Not Applicable	175	Other	Interventional	Allocation: N/A|Intervention Model: Single Group Assignment|Masking: None (Open Label)|Primary Purpose: Diagnostic	P120204|2012-A01695-38	November 13, 2013	September 13, 2023	September 13, 2023	June 17, 2014		October 12, 2022	Hôpital Necker-Enfants Malades Service de Radiologie Pédiatrique, Paris, France		https://ClinicalTrials.gov/show/NCT02165410
646	NCT04308915	Mobile-based Games for Cognitive Training in Children With Neurodevelopmental Disorders		Completed	No Results Available	Autism Spectrum Disorder	Behavioral: Game-based cognitive training	Corsi Task Block Span|Corsi Task Total Score|Autism Treatment Evaluation Checklist Total Score	Indian Institute of Technology Kanpur	All	5 Years to 16 Years   (Child)	Not Applicable	14	Other	Interventional	Allocation: N/A|Intervention Model: Single Group Assignment|Masking: None (Open Label)|Primary Purpose: Supportive Care	IITK/IEC/2017-18II/2	September 6, 2018	October 31, 2018	October 31, 2018	March 16, 2020		March 17, 2020	Indian Institute of Technology Kanpur, Kanpur, Uttar Pradesh, India		https://ClinicalTrials.gov/show/NCT04308915
647	NCT00672360	Folate Rechallenge		Completed	No Results Available	Autism	Dietary Supplement: Folic acid|Dietary Supplement: Placebo	Behavior as measured with the Aberrant Behavior Checklist (ABC) and the Pervasive Developmental Disorder Behavior Inventory (PDDBI).|Level of folate metabolites in plasma and site-specific DNA methylation.	Baylor College of Medicine	All	Child, Adult, Older Adult	Phase 2	13	Other	Interventional	Allocation: Randomized|Intervention Model: Crossover Assignment|Masking: Triple (Participant, Care Provider, Investigator)|Primary Purpose: Treatment	H-20959	May 2007	February 2015	February 2015	May 6, 2008		October 19, 2020	Baylor College of Medicine, Houston, Texas, United States		https://ClinicalTrials.gov/show/NCT00672360
648	NCT05054829	Establishment of Social Skills Training Group in Adults With Autism Spectrum Disorder and Effectiveness Analysis		Recruiting	No Results Available	Social Skill Training Group	Behavioral: PEERS®: program for the education and enrichment of relational skills	Outcome analysis	National Taiwan University Hospital	All	18 Years to 45 Years   (Adult)	Not Applicable	160	Other	Interventional	Allocation: Randomized|Intervention Model: Single Group Assignment|Masking: None (Open Label)|Primary Purpose: Other	201612185RIN	March 8, 2017	December 31, 2018	July 1, 2023	September 23, 2021		September 23, 2021	National Taiwan University Hospital, Taipei, Taiwan		https://ClinicalTrials.gov/show/NCT05054829
649	NCT03826940	From Molecules to Cognition: Inhibitory Mechanisms in ASD and NF1	ASD/NF1inhib	Completed	No Results Available	Autism Spectrum Disorder|Neurofibromatosis 1	Drug: Lovastatin 60 MG|Drug: Placebos	Neurochemical response changes to GABAergic stimulation|Motor evoked potentials changes under motor cortical stimulation|Cortical excitability changes under motor cortical stimulation|Brain oscillations changes under sensory stimulation|Event-related potentials changes under sensory stimulation	University of Coimbra	All	16 Years to 65 Years   (Child, Adult, Older Adult)	Not Applicable	16	Other	Interventional	Allocation: Randomized|Intervention Model: Crossover Assignment|Masking: Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)|Primary Purpose: Basic Science	CRU2C-ICNAS-001|FLAD Life Science 2020	February 19, 2019	March 31, 2020	August 31, 2020	February 1, 2019		April 2, 2021	ICNAS, Coimbra, Portugal		https://ClinicalTrials.gov/show/NCT03826940
650	NCT03424811	Mobile Health (mHealth) Nutrition Intervention for Children With Autism Spectrum Disorder		Completed	No Results Available	Diet Modification	Device: Mobile Health Intervention	Intake of Target Foods|Evaluation of mHealth intervention - Technology Engagement|Evaluation of mHealth intervention - User Evaluation	University of Pennsylvania	All	6 Years to 10 Years   (Child)	Not Applicable	38	Other	Interventional	Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Double (Investigator, Outcomes Assessor)|Primary Purpose: Treatment	827786	December 10, 2018	August 31, 2020	August 31, 2020	February 7, 2018		September 29, 2020	Center for Weight and Eating Disorders, Philadelphia, Pennsylvania, United States		https://ClinicalTrials.gov/show/NCT03424811
651	NCT04509401	Effects of High Dose of Vitamin B6 With Magnesium in Children With Autism Spectrum Disorder		Completed	No Results Available	ASD	Drug: Vitamin B 6 with Magnesium|Drug: placebo of vitamin B6 and magnesium	To measure the urinary homovanillic acid Conc in µgm/mg of creatinine in Vitamin B6 with magnesium treated autistic children pre and post supplementation of Vitamin B6 and Magnesium.	Bangabandhu Sheikh Mujib Medical University, Dhaka, Bangladesh	All	2 Years to 8 Years   (Child)	Not Applicable	66	Other	Interventional	Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)|Primary Purpose: Treatment	BSMMU/2019/12342	January 11, 2020	November 15, 2020	November 15, 2020	August 12, 2020		February 17, 2022	Bangabandhu Sheikh Mujib Medical University, Dhaka, Bangladesh		https://ClinicalTrials.gov/show/NCT04509401
652	NCT03397719	Parent Video Feedback Intervention Study		Completed	No Results Available	Autism Spectrum Disorder|Parent-Child Relations	Behavioral: Treatment Condition|Behavioral: Control Group	Change in Brief Observation of Social Communication Change (BOSCC)|Change in Autism Diagnostic Observation Schedule-2 (ADOS-2)|Change in Beck Depression Inventory|Change in Beck Anxiety Inventory|Change in Parent Stress Index|Change in Behavior Rating Inventory of Executive Function-Preschool Version	Weill Medical College of Cornell University	All	1 Year to 4 Years   (Child)	Not Applicable	20	Other	Interventional	Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Single (Outcomes Assessor)|Primary Purpose: Treatment	1707018416	October 13, 2017	October 25, 2021	October 25, 2021	January 12, 2018		October 29, 2021	Weill Cornell Medicine Center for Autism and the Developing Brain, White Plains, New York, United States		https://ClinicalTrials.gov/show/NCT03397719
653	NCT04047355	Propranolol for Challenging Behaviors in Autism		Recruiting	No Results Available	Autism Spectrum Disorder|Developmental Disability|Aggression|Self-Injurious Behavior|Challenging Behavior	Drug: Propranolol	Change in Aberrant Behavior Checklist (ABC-C)|Change in Clinical Global Impression Scale (CGI)|Change in Modified Overt Aggression Scale (IBR-MOAS)|Change in Questions About Behavior Function (QABF)|Change in Side Effects Survey	Rutgers, The State University of New Jersey|New Jersey Governor's Council for Medical Research and Treatment of Autism|New York State Institute for Basic Research	All	12 Years to 30 Years   (Child, Adult)	Phase 2	24	Other	Interventional	Allocation: Randomized|Intervention Model: Crossover Assignment|Masking: Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)|Primary Purpose: Treatment	Pro20170001942|CAUT17 APL025	January 1, 2021	January 1, 2023	July 1, 2023	August 6, 2019		March 16, 2021	Department of Pediatrics, Division of Pediatric Neurology, Robert Wood Johnson Medical School, New Brunswick, New Jersey, United States		https://ClinicalTrials.gov/show/NCT04047355
654	NCT02830022	Sleep, Autonomic Nervous System and Cardiorespiratory Capacity in Autism Spectrum Disorders Children (APAUTRES)	APAUTRES	Completed	No Results Available	Autonomic Nervous System Diseases|Sleep	Other: physiological explorations	cardiorespiratory evaluation|autonomic nervous system evaluation|sleep evaluation|physical activity|Motor capacities|Behavioural characteristics|biological parameters	University Hospital, Grenoble	All	8 Years to 18 Years   (Child, Adult)	Not Applicable	78	Other	Interventional	Allocation: Non-Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Diagnostic	38RC14.123	December 11, 2013	June 11, 2017	June 18, 2017	July 12, 2016		October 30, 2018	CHU Grenoble, Grenoble, France		https://ClinicalTrials.gov/show/NCT02830022
655	NCT05577234	Contribution of Animal-assisted Intervention in Oral Healthcare for Disabled Patients (YODA)	YODA	Not yet recruiting	No Results Available	Autism	Other: Animal-assisted intervention|Behavioral: Venham scale modified by Veerkamp	Average anxiety|Evaluate the success of the care session (complete achievement of the planned objective)|Validate the use of MEOPA administration|Assess the types of acts for which animal assisted intervention reduces the child's anxiety|Assessing the safety of animal assisted intervention for oral care	Assistance Publique - Hôpitaux de Paris	All	6 Years to 17 Years   (Child)	Not Applicable	50	Other	Interventional	Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Treatment	APHP220662|2022-A00871-42	February 2023	November 2023	January 2024	October 13, 2022		December 9, 2022	Hôpital Bretonneau - Service d'odontologie, Paris, France		https://ClinicalTrials.gov/show/NCT05577234
656	NCT02660099	Internet Delivered CBT for OCD in Adolescents With ASD - A Clinical Case Series		Completed	No Results Available	Obsessive Compulsive Disorder|Autism Spectrum Disorder	Behavioral: Internet-delivered Cognitive Behavior Therapy	Obsessional Compulsive Inventory - Child version, OCI-CV|Children's Yale Brown Obsessive Compulsive Scale|Mini International Neuropsychiatric Interview for Children and Adolescents, MINI-KID|Clinical Global Impression - Severity, CGI-S|Clinical Global Impression - Improvement, CGI-I|Children's Global Assessment Scale, CGAS|Children´s Depression Inventory - Short version|Strength and difficulties, SDQ|Family Accommodation Scale, Parent-Report, FAS-PR|Patient ICBT Adherence Rating, PIAR|Education, Work and Social Adjustment Scale - child and parent version, EWSAS	Karolinska Institutet	All	12 Years to 17 Years   (Child)	Not Applicable	4	Other	Interventional	Allocation: N/A|Intervention Model: Single Group Assignment|Masking: None (Open Label)|Primary Purpose: Treatment	BiP-ASD/OCD	July 2015	April 2016	June 2016	January 21, 2016		September 7, 2016	Karolinska Institutet, Stockholm, Sweden|Karolinska insititute, Stockholm, Sweden		https://ClinicalTrials.gov/show/NCT02660099
657	NCT02618135	Brain-Computer Interface-based Programme for the Treatment of ASD/ADHD	ASDBCI	Completed	No Results Available	Attention Deficit Hyperactivity Disorder|Autism Spectrum Disorders	Other: Intervention Group|Other: Control Group	ADHD Rating Scale (clinicians)|ADHD Rating Scale (parent)|ADHD Rating Scale (clinician and parent)|ADHD Rating Scale|Social Responsiveness Scale|Clinical Global Assessment Scale (C-GAS)|Clinical Global Impression Severity Scale (CGI-S)|Clinical Global Impression Improvement Scale (CGI-I)|Conners' Continuous Performance Test (CPT-II)	Duke-NUS Graduate Medical School|Institute of Mental Health, Singapore|Agency for Science, Technology and Research	All	8 Years to 12 Years   (Child)	Not Applicable	20	Other	Interventional	Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Single (Outcomes Assessor)|Primary Purpose: Treatment	2015/00841	May 2016	March 2018	October 31, 2018	December 1, 2015		July 23, 2020	Institute of Mental Health, Singapore, Singapore		https://ClinicalTrials.gov/show/NCT02618135
658	NCT01655485	Effect of a Social Script iPAD Application for Children With Autism Spectrum Disorder		Completed	No Results Available	Anxiety	Other: Patient teaching	Child behaviors|Parent anxiety	Medical College of Wisconsin|Marquette University	All	4 Years to 16 Years   (Child)	Not Applicable	32	Other	Interventional	Allocation: N/A|Intervention Model: Single Group Assignment|Masking: Single (Outcomes Assessor)|Primary Purpose: Prevention	255769-1	October 2011	July 2013	July 2013	August 2, 2012		August 7, 2013	Children's Hospital of Wisconsin, Milwaukee, Wisconsin, United States		https://ClinicalTrials.gov/show/NCT01655485
659	NCT02028247	Psychotherapy for Anxiety in Children With Autism Spectrum Disorder	TAASD	Completed	Has Results	Autism Spectrum Disorders|Autism|Asperger's Syndrome|Pervasive Developmental Disability - Not Otherwise Specified|Obsessive-compulsive Disorder|Social Phobia|Generalized Anxiety Disorder|Specific Phobia|Separation Anxiety Disorder	Behavioral: Personalized Cognitive-behavioral therapy|Behavioral: Standard Practice Cognitive-behavioral therapy|Behavioral: Treatment as Usual	Change From Baseline in Anxiety Severity on the Pediatric Anxiety Rating Scale After 16 Weeks of Treatment.|Percentage of Participants With Positive Treatment Response as Assessed by the Clinical Global Impressions-Improvement Scale|Change From Baseline in Anxiety/Depression Severity on the Child Behavior Checklist After 16 Weeks of Treatment.|Change From Baseline in Anxiety Related Impairment as Measured by the Childhood Anxiety Impact Scale After 16 Weeks of Treatment.	University of South Florida|Temple University|University of California, Los Angeles	All	7 Years to 13 Years   (Child)	Not Applicable	214	Other	Interventional	Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Single (Outcomes Assessor)|Primary Purpose: Treatment	NICHD CBT for ASD	April 2014	January 2018	October 2018	January 7, 2014	November 11, 2021	November 15, 2021	Rothman Center for Neuropsychiatry, University of South Florida, Saint Petersburg, Florida, United States	"Study Protocol and Statistical Analysis Plan", https://ClinicalTrials.gov/ProvidedDocs/47/NCT02028247/Prot_SAP_000.pdf	https://ClinicalTrials.gov/show/NCT02028247
660	NCT03426826	The Gut-Brain Study		Active, not recruiting	No Results Available	Autism Spectrum Disorder (ASD)|Gastro-Intestinal Disorder	Biological: FMT versus placebo	Primary Outcome Measures, safety and tolerability|Secondary Outcome Measures, symptom improvement	Children's Hospital Los Angeles	All	5 Years to 17 Years   (Child)	Phase 1	10	Other	Interventional	Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)|Primary Purpose: Treatment	APP-18-00409	August 15, 2019	March 2022	June 2022	February 8, 2018		February 1, 2022	Children's Hospital Los Angles, Los Angeles, California, United States		https://ClinicalTrials.gov/show/NCT03426826
661	NCT02096952	Methylphenidate ER Liquid Formulation in Adults With ASD and ADHD		Completed	Has Results	Attention-deficit/Hyperactivity Disorder|Autism Spectrum Disorder	Drug: Methylphenidate extended-release liquid formulation	Change in Adult ADHD Investigator Symptom Report Scale (AISRS) Score	Massachusetts General Hospital	All	18 Years to 40 Years   (Adult)	Phase 4	15	Other	Interventional	Allocation: N/A|Intervention Model: Single Group Assignment|Masking: None (Open Label)|Primary Purpose: Treatment	2014P000501	May 2014	January 2018	January 2018	March 26, 2014	February 23, 2018	February 23, 2018	Massachusetts General Hospital, Boston, Massachusetts, United States	"Study Protocol and Statistical Analysis Plan", https://ClinicalTrials.gov/ProvidedDocs/52/NCT02096952/Prot_SAP_000.pdf|"Informed Consent Form", https://ClinicalTrials.gov/ProvidedDocs/52/NCT02096952/ICF_001.pdf	https://ClinicalTrials.gov/show/NCT02096952
662	NCT04257331	Parent Training to Reduce Behavioral Problems in Children With Autism Spectrum Disorder in China	SREIA	Completed	No Results Available	Child Behavior Problem|Autism Spectrum Disorder|Parent-Child Relations|Parenting|Mental Health Issue|Child Abuse|Family Relations	Behavioral: Stars and Rain Education Institute for Autism (SREIA) Parent Training Programme	Change in frequency of child ehavioral problems|Change in frequency of ASD symptoms|Change in frequency of parenting style: over-reactivity|Change in frequency of parenting style: supportive behaviors|Change in frequency of parental mental health symptoms|Change in family function|Change in parental knowledge	University of Oxford|Beijing Normal University|Beijing Stars and Rain Education Institute for Autism	All	18 Years and older   (Adult, Older Adult)	Not Applicable	111	Other	Interventional	Allocation: Non-Randomized|Intervention Model: Parallel Assignment|Masking: Single (Outcomes Assessor)|Primary Purpose: Prevention	R67619/RE001	September 1, 2020	December 31, 2020	October 12, 2021	February 6, 2020		May 18, 2022	Beijing Stars and Rain Education Institute for Autism, Beijing, Beijing, China		https://ClinicalTrials.gov/show/NCT04257331
663	NCT01302964	Mirtazapine Treatment of Anxiety in Children and Adolescents With Pervasive Developmental Disorders		Completed	Has Results	Autism Spectrum Disorders	Drug: Placebo|Drug: Mirtazapine	Mean 10-Week Change in Pediatric Anxiety Rating Scale 5-Item Total Score, Double-blind Phase|Proportion of Participants Who Responded to Treatment at 10 Weeks According to the Improvement Item of the Clinical Global Impression-Scale (Response Defined as CGI-I=1 or CGI-I=2)	Massachusetts General Hospital|Autism Speaks	All	5 Years to 17 Years   (Child)	Phase 3	30	Other	Interventional	Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)|Primary Purpose: Treatment	2012P001009	August 2010	October 10, 2017	October 10, 2017	February 24, 2011	November 7, 2018	November 7, 2018	Riley Child and Adolescent Psychiatry Clinic Riley Hospital, Indianapolis, Indiana, United States|Lurie Center -MassGeneral Hospital, Lexington, Massachusetts, United States	"Study Protocol and Statistical Analysis Plan", https://ClinicalTrials.gov/ProvidedDocs/64/NCT01302964/Prot_SAP_000.pdf	https://ClinicalTrials.gov/show/NCT01302964
664	NCT02088047	The Effects of ProFoveate on Reducing Self-Stimulating Behaviors		Terminated	Has Results	Autism Spectrum Disorders|Normal Hearing|Normal Intelligence|Exhibit Self- Stimulating or Ritualistic Behaviors	Device: ProFoveate	Numbers of Self-stimulating Behaviors	University of Arkansas	All	10 Years to 17 Years   (Child)	Not Applicable	4	Other	Interventional	Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Supportive Care	202241	August 30, 2014	October 4, 2018	October 4, 2018	March 14, 2014	October 9, 2020	October 9, 2020	University of Arkansas at Little Rock Speech and Hearing Clinic, Little Rock, Arkansas, United States	"Study Protocol", https://ClinicalTrials.gov/ProvidedDocs/47/NCT02088047/Prot_001.pdf	https://ClinicalTrials.gov/show/NCT02088047
665	NCT04243694	Sustainable Mindfulness and Resilience Training (SMART)	SMART	Withdrawn	No Results Available	Caregiver Stress|Autism Spectrum Disorder	Behavioral: Mindfulness training	Acceptance of child's diagnosis: Acceptance of Diagnosis of Autism-modified scale|Acceptance of one's negative experiences (experiential avoidance, negative emotions and thoughts): Acceptance and Action Questionnaire|Acceptance of one's momentary situation as assessed by daily mind states (mind wandering, rejection vs. engagement in current moment): daily diary assessments	University of California, San Francisco	All	20 Years to 60 Years   (Adult)	Not Applicable	0	Other	Interventional	Allocation: Randomized|Intervention Model: Crossover Assignment|Masking: None (Open Label)|Primary Purpose: Other	19-27771	January 1, 2020	July 1, 2020	July 1, 2020	January 28, 2020		January 20, 2021	University of California, San Francisco, San Francisco, California, United States		https://ClinicalTrials.gov/show/NCT04243694
666	NCT03002363	The Effects of Video Modeling of Audiological Testing on Pediatric Patient Compliance		Completed	No Results Available	Autism	Behavioral: Video Modeling Intervention|Behavioral: Placebo Video	Compliance to audiology tests (% of audiology tests completed during an audiology session)|Parent stress	Northwestern University	All	18 Months to 36 Months   (Child)	Phase 1	20	Other	Interventional	Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Triple (Participant, Care Provider, Outcomes Assessor)|Primary Purpose: Treatment	STU00203250	September 2016	September 1, 2017	September 1, 2017	December 23, 2016		August 21, 2018	Northwestern Clinic for Audiology, Speech, Language, and Learning, Evanston, Illinois, United States		https://ClinicalTrials.gov/show/NCT03002363
667	NCT02674022	Screening for Metabolic Problems in Mothers of Children With Autism and Typically Developing Children		Completed	No Results Available	Pregnancy|Autistic Disorder|Folic Acid Deficiency	Dietary Supplement: Prenatal supplement	Homocysteine level	Mayo Clinic|Arizona State University	Female	18 Years and older   (Adult, Older Adult)	Not Applicable	59	Other	Interventional	Allocation: Non-Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Prevention	15-006909	January 20, 2016	April 5, 2018	April 5, 2018	February 4, 2016		October 19, 2020	Mayo Clinic in Arizona, Scottsdale, Arizona, United States		https://ClinicalTrials.gov/show/NCT02674022
668	NCT00631215	Effects of Hyperbaric Oxygen Therapy on Cognitive Function on Autistic Spectrum Disordered Children		Unknown status	No Results Available	Cognition	Procedure: Hyperbaric oxygen therapy	CogState touch screen measuring cognitive changes	Pediatric Partners of Ponte Vedra	All	6 Years to 75 Years   (Child, Adult, Older Adult)	Not Applicable	40	Other	Interventional	Allocation: N/A|Intervention Model: Single Group Assignment|Masking: None (Open Label)|Primary Purpose: Supportive Care	07.11.0005	January 2008	June 2009	October 2009	March 7, 2008		March 7, 2008	Pediatric Partners of Ponte Vedra, Ponte Vedra Beach, Florida, United States		https://ClinicalTrials.gov/show/NCT00631215
669	NCT03957044	the Effect of Vestibular Rehabilitation in Autistic Children		Completed	No Results Available	Autistic Spectrum Disorder|Vestibular Disorder|Sensory Integration Disorder	Other: The education of sensory integration with vestibular education	sensory profile test|postrotary nystagmus test	Istinye University	All	3 Years to 10 Years   (Child)	Not Applicable	22	Other	Interventional	Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Treatment	University	March 1, 2013	June 1, 2013	July 1, 2013	May 21, 2019		July 30, 2020			https://ClinicalTrials.gov/show/NCT03957044
670	NCT05010824	A Brief Parent-based Sleep Intervention for Children With Autism Spectrum Disorder		Enrolling by invitation	No Results Available	ASD|Insomnia	Behavioral: Sleep hygiene practices and behavioural intervention	Child: Change of child's sleep|Child: change of insomnia symptoms (bedtime resistance)|Child: change of insomnia symptoms (sleep onset delay)|Child: change of insomnia symptoms (night waking)|Parent: Change of parental self-reported sleep quality|Parent: Change of parental insomnia symptoms|Child: Change of child's behaviour & other clinical symptoms|Child: Change of child's executive functions reported by parents|Parent: Change of parental mood symptoms|Parent: Change of parental stress|Parent: Change of parental sense of competence and satisfactory in parenting|Parent: Parent's satisfaction to the treatment|Parent: Parent's overall health status	The University of Hong Kong	All	3 Years to 6 Years   (Child)	Not Applicable	60	Other	Interventional	Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Treatment	UW20-204	August 5, 2021	December 31, 2022	December 31, 2022	August 18, 2021		February 15, 2022	Department of Clinical Psychology, The Duchess of Kent Children's Hospital at Sandy Bay, HKWC, Hospital Authority, Hong Kong, Hong Kong|Sleep Research Clinic & Laboratory, Department of Psychology, The University of Hong Kong, Hong Kong, Hong Kong	"Study Protocol", https://ClinicalTrials.gov/ProvidedDocs/24/NCT05010824/Prot_000.pdf	https://ClinicalTrials.gov/show/NCT05010824
671	NCT01033565	Melatonin CR for the Treatment of Impaired Sleep Maintenance in 4-8 Year Old Children With Autism Spectrum Disorders		Terminated	Has Results	Sleep Disorder	Drug: Natrol	Clinical Global Impression-Improvement	University of Nebraska	All	4 Years to 8 Years   (Child)	Phase 4	1	Other	Interventional	Allocation: N/A|Intervention Model: Single Group Assignment|Masking: None (Open Label)|Primary Purpose: Treatment	401-09	December 2009	October 2010	October 2010	December 16, 2009	September 9, 2013	November 29, 2022	University of Nebraska Medical Center Munroe Meyer Institute, Omaha, Nebraska, United States		https://ClinicalTrials.gov/show/NCT01033565
672	NCT03614000	Early Screening of Emotional, Behavioral and Autism Spectrum Disorders in Children With Functional Constipation.		Unknown status	No Results Available	Functional Constipation|Emotional Problems|Behavioural Problems|Developmental Disorder|Autism Spectrum Disorder	Other: Screening Questionnaires	The prevalence of internalizing and externalizing behavioural problems as assessed by the Aseba questionnaires|The prevalence of behavioural and social responsiveness problems as assessed by the Social Responsiveness Scale-2.	Universitair Ziekenhuis Brussel	All	4 Years to 18 Years   (Child, Adult)	Not Applicable	100	Other	Interventional	Allocation: N/A|Intervention Model: Single Group Assignment|Masking: None (Open Label)|Primary Purpose: Screening	B.U.N. 143201733193	January 12, 2018	August 12, 2021	October 12, 2021	August 3, 2018		May 22, 2020	Universitair Kinderziekenhuis Brussel, Jette, Brussels, Belgium		https://ClinicalTrials.gov/show/NCT03614000
673	NCT02147236	Social Skills in Children With Autism Spectrum Disorders	SSD_ASD	Completed	No Results Available	Pervasive Developmental Disorders	Behavioral: Social Skills Training	Clinical Global Impression for Improvement|Social Competence Inventory	Yale University|Organization of Autism Research|Renfield Foundation	All	8 Years to 11 Years   (Child)	Not Applicable	44	Other	Interventional	Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Single|Primary Purpose: Treatment	0402026356	July 2003	January 2005	January 2005	May 26, 2014		May 26, 2014	Yale Child Study Center, New Haven, Connecticut, United States		https://ClinicalTrials.gov/show/NCT02147236
674	NCT05492032	Cumulative and Booster Effects of Multisession Prefrontal tDCS in Adolescents With ASD		Not yet recruiting	No Results Available	Transcranial Direct Current Stimulation|Autistic Spectrum Disorder|Electroencephalography	Device: Active-tDCS|Device: Sham-tDCS	Change in social responsiveness - Social Responsiveness Scale-2nd edition (SRS-2)|Clinical response in tDCS outcome|Change in neuropsychological measures - CANTAB® cognitive tests	The Hong Kong Polytechnic University	All	14 Years to 21 Years   (Child, Adult)	Not Applicable	90	Other	Interventional	Allocation: Randomized|Intervention Model: Crossover Assignment|Masking: Triple (Participant, Care Provider, Outcomes Assessor)|Primary Purpose: Treatment	HSEARS20220216004	January 2023	September 2025	December 31, 2025	August 8, 2022		November 16, 2022	The Hong Kong Polytechnic University, Hung Hom, Kowloon, Hong Kong		https://ClinicalTrials.gov/show/NCT05492032
675	NCT04771338	Examining the Effects of a Job Entry Intervention	IMPRESSIVE	Recruiting	No Results Available	Autism Spectrum Disorder|Autism|ASD	Behavioral: VR-JIT/KF-STRIDE	Mock Job Interview Change	Kessler Foundation	All	16 Years to 18 Years   (Child, Adult)	Not Applicable	60	Other	Interventional	Allocation: Randomized|Intervention Model: Single Group Assignment|Masking: Single (Outcomes Assessor)|Primary Purpose: Treatment	R-1078-19	September 1, 2019	August 31, 2021	August 31, 2022	February 25, 2021		March 29, 2021	Kessler Foundation, East Hanover, New Jersey, United States		https://ClinicalTrials.gov/show/NCT04771338
676	NCT01178385	Cognitive-Behavioral Treatment for Anxiety Disorders in Children With Autism Spectrum Disorders		Completed	Has Results	Autism|Asperger's Syndrome|Generalized Anxiety Disorder|Social Phobia|Separation Anxiety Disorder|Obsessive-compulsive Disorder	Behavioral: Cognitive-behavioral therapy|Behavioral: Treatment as Usual	Pediatric Anxiety Rating Scale (Measures the Severity of Anxiety Symptoms)|Anxiety Disorders Interview Schedule Highest Anxiety Clincian Severity Rating (Measures the Severity of the Child's Anxiety Symptoms)|Clinical Global Impression - Severity Scale (This Scale Measures the Severity of the Child's Anxiety Symptoms).	University of South Florida	All	7 Years to 11 Years   (Child)	Phase 2|Phase 3	45	Other	Interventional	Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Single (Outcomes Assessor)|Primary Purpose: Treatment	ACH-2010	April 2010	December 2012	December 2012	August 10, 2010	April 2, 2013	April 2, 2013	Rothman Center for Neuropsychiatry, University of South Florida, St. Petersburg, Florida, United States		https://ClinicalTrials.gov/show/NCT01178385
677	NCT01565629	Computer- Assisted Cognitive-Behavioral Treatment for Anxiety Disorders in Children With Autism Spectrum Disorders	CCAL	Completed	No Results Available	Autism|Asperger's Syndrome|Generalized Anxiety Disorder|Social Phobia|Separation Anxiety Disorder|Obsessive-compulsive Disorder	Behavioral: Computer assisted cognitive behavioral therapy.	Pediatric Anxiety Rating Scale|Anxiety Disorders Interview Schedule: Parent and Child Versions|Clinical Global Impression - Severity Scale	University of South Florida	All	7 Years to 12 Years   (Child)	Not Applicable	40	Other	Interventional	Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Single (Outcomes Assessor)|Primary Purpose: Treatment	CCAL-2012	February 2012	October 2016	October 2016	March 28, 2012		October 26, 2017	University of South Florida, Saint Petersburg, Florida, United States		https://ClinicalTrials.gov/show/NCT01565629
678	NCT05430022	Group Depression Treatment for Autistic Youth		Recruiting	No Results Available	Autism Spectrum Disorder|Depression|Suicidal Ideation|Self Esteem	Behavioral: Autism-adapted Group Cognitive Behavioral Therapy	Severity of adolescent depressive symptoms, self-report|Severity of adolescent depressive symptoms, parent-report	Vanderbilt University Medical Center	All	11 Years to 17 Years   (Child)	Not Applicable	32	Other	Interventional	Allocation: N/A|Intervention Model: Single Group Assignment|Masking: None (Open Label)|Primary Purpose: Treatment	201725	July 21, 2021	June 30, 2023	December 31, 2023	June 24, 2022		June 24, 2022	Vanderbilt University Medical Center, Nashville, Tennessee, United States		https://ClinicalTrials.gov/show/NCT05430022
679	NCT05093686	RUBIES in Educational Settings	RUBIES	Recruiting	No Results Available	Autism Spectrum Disorder|Disruptive Behavior	Behavioral: RUBIES|Behavioral: Usual Care Training	Aberrant Behavior Checklist|Knowledge of Behavioral Principles|RUBIES fidelity|Student Behavior Observation	Seattle Children's Hospital	All	5 Years and older   (Child, Adult, Older Adult)	Not Applicable	240	Other	Interventional	Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Single (Outcomes Assessor)|Primary Purpose: Treatment	SCH-STUDY00003191	August 1, 2021	June 30, 2024	July 31, 2024	October 26, 2021		November 1, 2021	Seattle Children's Research Institute, Seattle, Washington, United States		https://ClinicalTrials.gov/show/NCT05093686
680	NCT02543203	Essential Oils for Enhancing QOL in ASD		Completed	Has Results	Autism Spectrum Disorder|Quality of Life|Sleep|Anxiety	Biological: Reconnect|Biological: Coconut oil Comparator	Pediatric Quality of Life Inventory|Children's Sleep Habits Questionnaire|Parent-rated Anxiety Scale for Autism Spectrum Disorder PRAS-ASD	Jill Hollway|Young Living Essential Oils|Ohio State University	All	3 Years to 9 Years   (Child)	Phase 2	28	Other	Interventional	Allocation: Randomized|Intervention Model: Crossover Assignment|Masking: Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)|Primary Purpose: Supportive Care	2015H0005	July 2015	March 16, 2018	March 16, 2018	September 7, 2015	April 1, 2021	April 1, 2021	Ohio State University Nisonger Center, Columbus, Ohio, United States	"Study Protocol and Statistical Analysis Plan", https://ClinicalTrials.gov/ProvidedDocs/03/NCT02543203/Prot_SAP_000.pdf	https://ClinicalTrials.gov/show/NCT02543203
681	NCT02153203	Using the Prevent-Teach-Reinforce Model to Reduce Problem Behaviors in Children With Autism Spectrum Disorders		Completed	No Results Available	Child Development Disorders, Pervasive	Behavioral: Prevent-Teach-Reinforce Model|Other: Individual Parent Training Session	Change from baseline in parental report of problem behavior at 8 weeks|Change from baseline in quality of life at 8 weeks|Change from baseline in parental report of stress at 20 weeks|Change from baseline in parental report of stress at 8 weeks|Change from baseline in quality of life at 20 weeks|Social validity of the intervention|Change from baseline in parental report of problem behavior at 20 weeks|Change from baseline in parental report of positive social behavior at 20 weeks|Change from baseline in parental report of positive social behavior at 8 weeks	Université de Montréal	All	up to 12 Years   (Child)	Not Applicable	42	Other	Interventional	Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Treatment	CERFAS-2014-15-058-P	October 2014	June 2016	September 2016	June 2, 2014		October 25, 2016	West Montreal Readaptation Centre, Lachine, Quebec, Canada|Gold Centre, Montreal, Quebec, Canada|CRDITED de Montréal, Montréal, Quebec, Canada		https://ClinicalTrials.gov/show/NCT02153203
682	NCT03624400	Internet-delivered Cognitive Behaviour Therapy for Sleep Problems in ASD		Enrolling by invitation	No Results Available	Autism Spectrum Disorder|Sleep Disturbance|Insomnia	Behavioral: Internet-based CBT-I|Behavioral: Internet-based psychoeducation	Change in sleep impairment by using The Insomnia Severity Index (ISI)|Sleep diaries by using Actigraphy|Quality of sleep by using Athens Insomnia Scale (AIS)|Everyday functioning by using Developmental disabilities modification of the Children's Global Assessment scale (DD-CGAS)|Anxiety problems by using Spence Children's Anxiety Scale|Emotion regulation difficulties by using The brief version of Difficulties in Emotion Regulation Scale (DERS-16)	Stockholm University	All	13 Years to 17 Years   (Child)	Not Applicable	240	Other	Interventional	Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Triple (Participant, Care Provider, Outcomes Assessor)|Primary Purpose: Treatment	Sleep Good Autism	August 15, 2022	June 30, 2025	December 30, 2025	August 10, 2018		September 14, 2022	Nora Choque Olsson, Stockholm, Sverige, Sweden		https://ClinicalTrials.gov/show/NCT03624400
683	NCT02403817	Training Attention and Eye Movement in ASD		Completed	Has Results	Autistic Disorder|Autism Spectrum Disorder	Behavioral: Cognitive Training|Behavioral: Eye Motor Training|Behavioral: Hand Motor Training	Spatial Attention Baseline|Saccadic Eye Movements Baseline|Change in Spatial Attention at 8 Weeks|Change in Saccadic Eye Movements at 8 Weeks	University of California, San Diego	All	9 Years to 25 Years   (Child, Adult)	Not Applicable	30	Other	Interventional	Allocation: Non-Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Treatment	R33MH096967	November 2015	August 31, 2018	August 31, 2018	March 31, 2015	December 4, 2019	December 4, 2019	University of California San Diego, La Jolla, California, United States	"Study Protocol and Statistical Analysis Plan", https://ClinicalTrials.gov/ProvidedDocs/17/NCT02403817/Prot_SAP_000.pdf	https://ClinicalTrials.gov/show/NCT02403817
684	NCT02302209	Dyad Oxytocin Study (DOS)	DOS	Completed	No Results Available	Schizophrenia|Autism Spectrum Disorder	Drug: Oxytocin|Other: Placebo Comparator	Change in Negative Expressed Emotion	University of California, San Francisco	All	18 Years to 75 Years   (Adult, Older Adult)	Phase 1	104	Other	Interventional	Allocation: Randomized|Intervention Model: Crossover Assignment|Masking: Double (Participant, Investigator)|Primary Purpose: Other	10-04286	April 2011	October 2017	October 2017	November 26, 2014		May 21, 2019	University of California, San Francisco, San Francisco, California, United States		https://ClinicalTrials.gov/show/NCT02302209
685	NCT01563003	Cognitive Behavioral Therapy for Anxiety Disorders in Adolescents With Autism		Completed	Has Results	Autism|Asperger's Syndrome|Pervasive Developmental Disorder Not Otherwise Specified|Generalized Anxiety Disorder|Social Phobia|Separation Anxiety Disorder|Obsessive-compulsive Disorder	Other: Cognitive Behavioral Therapy|Other: Treatment as usual	Pediatric Anxiety Rating Scale|Anxiety Disorders Interview Schedule Clinical Severity Rating|Clinical Global Impression - Severity Scale	University of South Florida	All	11 Years to 16 Years   (Child)	Not Applicable	31	Other	Interventional	Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Single (Outcomes Assessor)|Primary Purpose: Treatment	AASD-2012	June 2011	April 2015	April 2015	March 26, 2012	April 17, 2015	April 17, 2015	Rothman Center for Neuropsychiatry, St. Petersburg, Florida, United States		https://ClinicalTrials.gov/show/NCT01563003
686	NCT05066178	Speech Treatment for Minimally Verbal Children With ASD and CAS	TxMVASD+CAS	Not yet recruiting	No Results Available	Developmental Verbal Dyspraxia|Autism Spectrum Disorder	Behavioral: CAS Treatment for Minimally Verbal Children with Autism	Attempts Correct|Phonemes Correct|Lip aperture movement variability|Phoneme distinctiveness	MGH Institute of Health Professions	All	5 Years to 18 Years   (Child, Adult)	Not Applicable	20	Other	Interventional	Allocation: N/A|Intervention Model: Single Group Assignment|Masking: None (Open Label)|Primary Purpose: Treatment	2021P002598	January 1, 2022	November 30, 2023	November 30, 2024	October 4, 2021		October 4, 2021			https://ClinicalTrials.gov/show/NCT05066178
687	NCT05417607	A+ Treatment/Feasibility of Adapted ESDM-informed Caregiver Coaching Delivered Remotely for Children With ASD and ADHD		Completed	No Results Available	Autism Spectrum Disorder|Adhd	Behavioral: P-ESDM informed caregiver coaching	Qualitative assessment of acceptability, appropriateness, and feasibility of intervention as evaluated through analysis of qualitative individual interviews with stakeholders (Caregivers)|Qualitative assessment of acceptability, appropriateness, and feasibility of intervention as evaluated through analysis of qualitative individual interviews with stakeholders (Coaches, Clinicians, and Staff)|Feasibility of Intervention (as measured by Feasibility of Intervention Measure, FIM)|Acceptability of Intervention (as measured by the Acceptability of Intervention Measure, AIM)|Appropriateness of Intervention (as measured by the Intervention Appropriateness Measure, IAM)|Changes from baseline (pre-intervention) to week 9 (post-intervention) in Fidelity of Intervention Delivery using an adapted version of the Parent Early Start Denver Model (P-ESDM) Caregiver Fidelity Rating System|Changes in from baseline (pre-intervention) to 9-weeks (post-intervention) in caregiver sense of competence measured by the Parent Sense of Competence Scale.|Change from baseline (pre-intervention) to 9 weeks (post-intervention) in child behaviors as measured by Joint Engagement Rating Inventory (JERI)	Duke University	All	36 Months to 131 Months   (Child)	Not Applicable	35	Other	Interventional	Allocation: N/A|Intervention Model: Single Group Assignment|Masking: None (Open Label)|Primary Purpose: Treatment	Pro00085179_1	December 16, 2020	April 5, 2022	April 5, 2022	June 14, 2022		June 22, 2022	Duke University, Durham, North Carolina, United States	"Informed Consent Form", https://ClinicalTrials.gov/ProvidedDocs/07/NCT05417607/ICF_000.pdf	https://ClinicalTrials.gov/show/NCT05417607
688	NCT05277103	Exploring Predictors of Response to a Peer-Mediated Intervention for Preschoolers With ASD		Recruiting	No Results Available	Autism Spectrum Disorder|Nonverbal Communication	Behavioral: Exploring predictors of response to a peer-mediated communication intervention for minimally verbal preschoolers with ASD	Social Attention|Peer interest|Rates of focal child communication|Rates of reciprocal child-peer exchanges	University of Kansas Medical Center	All	3 Years to 6 Years   (Child)	Not Applicable	40	Other	Interventional	Allocation: N/A|Intervention Model: Single Group Assignment|Masking: None (Open Label)|Primary Purpose: Treatment	STUDY00147284	September 21, 2021	May 31, 2023	May 31, 2023	March 14, 2022		June 1, 2022	University of Kansas, Kansas City, Kansas, United States		https://ClinicalTrials.gov/show/NCT05277103
689	NCT03553875	Memantine for the Treatment of Social Deficits in Youth With Disorders of Impaired Social Interactions		Recruiting	No Results Available	Autism|Autism Spectrum Disorder|Nonverbal Learning Disability	Drug: Memantine Hydrochloride|Drug: Placebo	Clinical Global Impression-Improvement Scale (CGI-I)	Massachusetts General Hospital	All	8 Years to 18 Years   (Child, Adult)	Phase 3	100	Other	Interventional	Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)|Primary Purpose: Treatment	2018P001082	November 13, 2018	June 2023	June 2023	June 12, 2018		August 1, 2022	Massachusetts General Hospital, Boston, Massachusetts, United States		https://ClinicalTrials.gov/show/NCT03553875
690	NCT02850666	Social Skills in Children With ASD and Process Drama		Completed	No Results Available	Autistic Disorder	Behavioral: Interdisciplinary process drama	Social Skills Improvement Scale|Theory of Mind Battery and Inventory|Structured Play Assessment|Retention Rate|Recruitment|Brain activity during Theory of Mind tasks|Parental perceptions of social skills|Changes in social skills during program|Modifications needed to program	University of Utah	All	3 Years to 4 Years   (Child)	Not Applicable	11	Other	Interventional	Allocation: N/A|Intervention Model: Single Group Assignment|Masking: None (Open Label)|Primary Purpose: Treatment	IRB_00091961	July 2016	September 12, 2017	October 1, 2017	August 1, 2016		May 15, 2018	University of Utah, Salt Lake City, Utah, United States		https://ClinicalTrials.gov/show/NCT02850666
691	NCT04047615	The Effects of Exercise on Behavior and Fitness in Children With ASD		Unknown status	No Results Available	Autism Spectrum Disorder|Behavior	Other: Exercise	Behavior|Fitness Level	Institute of Technology, Carlow	All	4 Years to 13 Years   (Child)	Not Applicable	50	Other	Interventional	Allocation: N/A|Intervention Model: Single Group Assignment|Masking: None (Open Label)|Primary Purpose: Treatment	ASD Intervention	September 1, 2019	February 2021	February 2021	August 7, 2019		August 9, 2019	Institute of Technology, Carlow, Carlow, Ireland		https://ClinicalTrials.gov/show/NCT04047615
692	NCT03820869	The Effect Of Occupational Therapy On Sensory-Based Feeding Problems		Unknown status	No Results Available	Feeding Disorder|Autism Spectrum Disorder|Sensory Integration Disorder (Disorder)	Other: Family Training|Other: Occupational Therapy	Dunn Sensory Profile|BAMBİ|STEP	Hacettepe University	All	3 Years to 10 Years   (Child)	Not Applicable	18	Other	Interventional	Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Treatment	2018/454	March 2019	May 2019	July 2019	January 29, 2019		January 29, 2019			https://ClinicalTrials.gov/show/NCT03820869
693	NCT00324909	Effects of Hyperbaric Oxygen Therapy in Autistic Children: A Pilot Study		Completed	No Results Available	Autism|Oxidative Stress|Inflammation	Drug: Hyperbaric Oxygen Therapy	Scores on autism rating scales before and after HBOT|Measure of inflammation before and after HBOT|Measures of oxidative stress before and after HBOT	International Hyperbarics Association	All	2 Years to 18 Years   (Child, Adult)	Not Applicable	18	Other	Interventional	Allocation: Non-Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Treatment	HBA-1				May 11, 2006		April 10, 2007	Blue Ridge Medical Center, Arrington, Virginia, United States		https://ClinicalTrials.gov/show/NCT00324909
694	NCT04204226	Autism and Disruptive Behavior Trial		Completed	No Results Available	ASD|Child Behavior Problem	Behavioral: Social Worker|Behavioral: Autism Behavioral Health Navigation (ABHN)|Behavioral: Social work + ABHN|Behavioral: Social work + ABHN + CAP	Number of children referred to the study each month meeting eligibility requirements|Number of families successfully contacted by the navigator or social worker|Retention Rate|Number of subjects consented|Changes (or Improvement) with interpersonal relationships|Changes in ABC-irritability subscale|Changes in levels of challenging behavior	Children's Hospital of Philadelphia|Eagles Autism Challenge, Inc|University of Pennsylvania	All	5 Years to 12 Years   (Child)	Not Applicable	42	Other	Interventional	Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Single (Participant)|Primary Purpose: Treatment	19-016364	December 17, 2019	August 27, 2021	August 27, 2021	December 18, 2019		March 11, 2022	The Children's Hospital of Philadelphia, Philadelphia, Pennsylvania, United States		https://ClinicalTrials.gov/show/NCT04204226
695	NCT02383732	A Study of the Elopement Prevention and Safety Training Program		Completed	No Results Available	Elopement|Autism Spectrum Disorder	Behavioral: Universal Safety Measures Module (All participants)|Behavioral: Proximity Training Module (Bolting Prevention Participants)|Behavioral: Check-In Training Module (Wandering Prevention Participants)	Feasibility of intervention, assessed by change in severity on Clinical Global Impression for Severity (CGI-S)|Change in elopement behavior	Emory University	All	4 Years to 12 Years   (Child)	Not Applicable	24	Other	Interventional	Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Prevention	IRB00076337	February 2015	January 31, 2017	January 31, 2017	March 9, 2015		March 30, 2017	Marcus Autism Center, Atlanta, Georgia, United States		https://ClinicalTrials.gov/show/NCT02383732
696	NCT03771001	5Minutes4Myself: A Wellness Program for Caregivers		Active, not recruiting	No Results Available	Autism|Stress|Autism Spectrum Disorder	Other: Motivational Interviewing coaching and habit-building app	SF-36 Questionnaire|Perceived Stress Scale|Ryff's Psychological Well-Being Scale|Center for Epidemiological Depression Scale-Revised|Five facets of Mindfulness Questionnaire|Modified System Usability Scale|Participant Feedback	University of Wisconsin, Madison	All	Child, Adult, Older Adult	Not Applicable	70	Other	Interventional	Allocation: N/A|Intervention Model: Single Group Assignment|Masking: None (Open Label)|Primary Purpose: Other	2015-1004	November 2015	August 2025	December 2025	December 10, 2018		June 30, 2022	Community Sites, Madison, Wisconsin, United States		https://ClinicalTrials.gov/show/NCT03771001
697	NCT05501405	Brain and Oculometric Markers of Emotional Facial Expression Recognition Deficits	FERmarkers	Recruiting	No Results Available	Autism|Psychotic Disorders	Other: Electroencephalogram and eye-tracking recordings	Fast Periodic Visual Stimulation Task (FPVS-EEG)|Eye-tracking task	Hôpital le Vinatier	All	10 Years to 50 Years   (Child, Adult)	Not Applicable	210	Other	Interventional	Allocation: Non-Randomized|Intervention Model: Parallel Assignment|Masking: Single (Participant)|Primary Purpose: Basic Science	2021-A01367-34	March 30, 2022	March 25, 2026	September 30, 2026	August 15, 2022		August 15, 2022	centre de réhabilitation - Hôpital le Vinatier, Lyon, Rhône, France		https://ClinicalTrials.gov/show/NCT05501405
698	NCT05512221	Transdiagnostic Group Therapy (GBAT) for Autistic Adults With Personalized Therapeutics	(GBAT+)	Recruiting	No Results Available	GBAT+Individual|GBAT+Engagement Booster|GBAT+Both	Other: GBAT+I, GBAT+E - Phase I|Other: Watchful Waiting and Groups - Phase 2|Other: GBAT+IE	Change in Clinical Global Impression Severity (CGIS) Scale: Independent Evaluator|Change in distress on Patient Health Questionnaire (PHQ-9)|Change in anxiety symptoms on the Generalized Anxiety Disorder Questionnaire (GAD-7)|Anxiety Disorders Interview Schedule for DSM-5|Behavior Rating Inventory of Executive Function - Adult Form|Mirror Tracing Persistence Task|Distress Tolerance Test	Rutgers, The State University of New Jersey|New Jersey Governor's Council for Medical Research and Treatment of Autism	All	18 Years to 40 Years   (Adult)	Not Applicable	30	Other	Interventional	Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Treatment	Pro2022001343	September 23, 2022	June 2024	June 2024	August 23, 2022		October 26, 2022	Rutgers University, Piscataway, New Jersey, United States		https://ClinicalTrials.gov/show/NCT05512221
699	NCT03546504	Program to Improve Dental Care: Children With ASD		Terminated	No Results Available	Autism	Behavioral: Procedure alteration and occupational therapy	Child's behavior in typical oral hygiene activities|Decayed, Missing, Filled Surfaces (DMFS) Index|Simplified Oral Hygiene Index|Modified Gingival index from the Community Periodontal Index|Assessment of saliva for bacteria content|Number of dental procedures completed|Dental Subscale of the Childrens Fear Survey|Frankl Behavioral Scale|Child's behavior during dental visits|Parent report of burden of oral hygiene activities|Wong-Baker Faces Scale	University of Utah	All	5 Years to 12 Years   (Child)	Not Applicable	3	Other	Interventional	Allocation: N/A|Intervention Model: Single Group Assignment|Masking: None (Open Label)|Primary Purpose: Treatment	IRB_0085018	December 1, 2018	December 31, 2019	February 28, 2020	June 6, 2018		November 4, 2020	University of Utah, Salt Lake City, Utah, United States		https://ClinicalTrials.gov/show/NCT03546504
700	NCT05302167	Molehill Mountain Feasibility Study.		Recruiting	No Results Available	Anxiety|Autism	Behavioral: Molehill Mountain app|Device: Molehill Mountain app	Change in 7-item Generalised Anxiety Disorder Scale (GAD-7)|App acceptability/ feasibility survey|Change in Medication/ service use|Change in Goal Attainment Scaling	King's College London|South London and Maudsley NHS Foundation Trust	All	16 Years and older   (Child, Adult, Older Adult)	Not Applicable	200	Other	Interventional	Allocation: N/A|Intervention Model: Single Group Assignment|Masking: None (Open Label)|Primary Purpose: Treatment	1286908	September 6, 2022	March 31, 2023	March 31, 2023	March 31, 2022		October 24, 2022	King's College London, London, United Kingdom|South London and Maudsley NHS Foundation Trust (SLaM), London, United Kingdom		https://ClinicalTrials.gov/show/NCT05302167
701	NCT02430051	Sensory Adapted Dental Environments to Enhance Oral Care for Children	SADE-2	Active, not recruiting	No Results Available	Autism	Behavioral: Sensory Adapted Dental Environment	Electrodermal Activity (EDA)|Children's Dental Behavior Rating Scale (CDBRS)|Anxiety and Cooperation Scale|Duration|Number of hands used to restrain child|Faces Pain Scale - Revised|Dental Sensory Sensitivity Scale|Frankl Scale	University of Southern California|Children's Hospital Los Angeles	All	6 Years to 12 Years   (Child)	Not Applicable	220	Other	Interventional	Allocation: Randomized|Intervention Model: Crossover Assignment|Masking: None (Open Label)|Primary Purpose: Treatment	DE024978-01	May 2015	April 30, 2022	April 30, 2022	April 29, 2015		May 11, 2021	Children's Hospital Los Angeles, Los Angeles, California, United States		https://ClinicalTrials.gov/show/NCT02430051
702	NCT02428205	Combined Effects of Early Behavioral Intervention and Propranolol on ASD		Completed	No Results Available	Autism	Drug: Propranolol|Drug: Placebo	Change in General Social Outcome Measure (GSOM)|Change in Social Responsiveness Scale (SRS)|Change in Preschool Anxiety Scale (PAS)|Change in Clinical Global Impression of Change (CGIC) scale|Change in Clinical Global Impression of Severity (CGIS) scale|Change in Aberrant Behavior Checklist (ABC)|Change in Vineland Adaptive Behavior Scales-II (VABS)|Change in Autism Impact Measure (AIM)|Change in Preschool Language Scale (PLS):	University of Missouri-Columbia|Autism Science Foundation	All	3 Years to 10 Years   (Child)	Not Applicable	10	Other	Interventional	Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)|Primary Purpose: Treatment	2001935	April 2015	November 1, 2022	November 1, 2022	April 28, 2015		November 4, 2022	Thompson Center for Autism & Neurodevelopmental Disorders, Columbia, Missouri, United States	"Study Protocol and Statistical Analysis Plan", https://ClinicalTrials.gov/ProvidedDocs/05/NCT02428205/Prot_SAP_000.pdf	https://ClinicalTrials.gov/show/NCT02428205
703	NCT04896671	Physical Exercise Training to Enhance Executive and Social Functions		Completed	No Results Available	Broad Autism Phenotype	Behavioral: Physical exercise (running on a treadmill)	Demographics|Change from baseline autistic traits at 6 weeks|Change from baseline executive functions at 6 weeks|Change from baseline psychological resilience at 6 weeks|Change from baseline schizotypal personality traits at 6 weeks|Change from baseline aggression at 6 weeks|Change from baseline empathy at 6 weeks	The University of Hong Kong|The Hong Kong Polytechnic University|Griffith University	All	7 Years to 20 Years   (Child, Adult)	Not Applicable	30	Other	Interventional	Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Single (Participant)|Primary Purpose: Treatment	HSEARS20190311003	April 1, 2019	September 30, 2020	September 30, 2020	May 21, 2021		May 25, 2021	The Hong Kong Polytechnic University, Hong Kong, Hong Kong	"Study Protocol", https://ClinicalTrials.gov/ProvidedDocs/71/NCT04896671/Prot_003.pdf|"Statistical Analysis Plan", https://ClinicalTrials.gov/ProvidedDocs/71/NCT04896671/SAP_004.pdf|"Informed Consent Form", https://ClinicalTrials.gov/ProvidedDocs/71/NCT04896671/ICF_005.pdf	https://ClinicalTrials.gov/show/NCT04896671
704	NCT03473080	An eHealth Intervention for Obsessive Compulsive Disorder in Youth With Autism Spectrum Disorder		Completed	No Results Available	Obsessive-Compulsive Disorder	Behavioral: Internet CBT	Children's Yale-Brown Obsessive Compulsive Scale|Obsessive-compulsive inventory - child version|Autism spectrum quotient (AQ-10)|Education, work and social adjustment scale - child and parent version|Family accommodation scale for obsessive-compulsive disorder|Mood and Feeling Questionnaire - child and parent version|Children's Obsessional Compulsive Inventory Revised - parent rated (ChOCI-R-P)|Mini International Neuropsychiatric Interview for Children and Adolescents|Children's global assessment scale|Children's Assessment Scale for Developmental Disabilities|Clinical global impression - severity|Clinical global impression - improvement|internet intervention Patient Adherence Scale|Client Satisfaction Questionnaire (CSQ-8)|Parent strategies|Patient EX/RP Adherence Scale|Drop-out rate from treatment|Completed treatment modules	Karolinska Institutet	All	7 Years to 17 Years   (Child)	Not Applicable	22	Other	Interventional	Allocation: N/A|Intervention Model: Single Group Assignment|Masking: None (Open Label)|Primary Purpose: Treatment	BIP ASD/OCD pilot	March 9, 2018	February 15, 2021	February 15, 2021	March 22, 2018		July 6, 2021	BUP OCD and Related Disorders, Stockholm, Sweden		https://ClinicalTrials.gov/show/NCT03473080
705	NCT05307094	Optimizing Intervention Options for Toddlers With Early Social Communication Delays	SibWatch	Recruiting	No Results Available	Autism Sibling	Behavioral: Improving Parents as Communication Teachers	Parent implementation|Child social communication	University of Texas at Austin	All	11 Months to 18 Months   (Child)	Not Applicable	44	Other	Interventional	Allocation: Randomized|Intervention Model: Sequential Assignment|Masking: Single (Outcomes Assessor)|Primary Purpose: Treatment	1R21DC018908-01A1	January 15, 2022	April 2024	August 2024	April 1, 2022		November 2, 2022	The University of Texas at Austin, Austin, Texas, United States		https://ClinicalTrials.gov/show/NCT05307094
706	NCT04557488	Effectiveness of Music Therapy in Social Skill Intervention for Children With ASD/ID		Active, not recruiting	No Results Available	Autism Spectrum Disorder|Intellectual Disability	Other: Music therapy|Behavioral: Behavioral-based social skill training	Changes of Childhood Autism Rating Scale-2|Changes of Social Responsiveness Scale second edition|In-session social behavior|Changes of EEG recording	Education University of Hong Kong	All	6 Years to 13 Years   (Child)	Not Applicable	80	Other	Interventional	Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Single (Outcomes Assessor)|Primary Purpose: Treatment	FHB/H/41/165	October 1, 2020	October 31, 2022	February 28, 2023	September 21, 2020		March 23, 2022	The Education University of Hong Kong, Hong Kong, Hong Kong		https://ClinicalTrials.gov/show/NCT04557488
707	NCT02791321	Fragility Assessment in Adults With ADHD and Mental Retardation	EFAAR	Active, not recruiting	No Results Available	Autism Spectrum Disorder|Mental Retardation	Other: ADS severity|Other: Adaptative and intellectual functioning|Other: Psychiatric and somatic comorbidities	Frailty index	University Hospital, Montpellier	All	20 Years to 95 Years   (Adult, Older Adult)	Not Applicable	63	Other	Interventional	Allocation: N/A|Intervention Model: Single Group Assignment|Masking: None (Open Label)|Primary Purpose: Diagnostic	9691	September 23, 2016	May 2023	May 2023	June 6, 2016		December 28, 2021	CHU Montpellier, Montpellier, France		https://ClinicalTrials.gov/show/NCT02791321
708	NCT04532424	Transcranial Magnetic Stimulation for Restricted and Repetitive Behavior in ASD	TMS for ASD	Suspended	No Results Available	Autism Spectrum Disorder|Autism|Asperger Syndrome	Device: Transcranial magnetic stimulation	Repetitive Behavior Scale-Revised (RBS-R)|Set-shifting performance (Dimensional Change Card Sort Test score)	Stanford University	All	12 Years to 45 Years   (Child, Adult)	Not Applicable	67	Other	Interventional	Allocation: Non-Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Treatment	57738	January 4, 2021	December 1, 2023	December 1, 2024	August 31, 2020		February 16, 2022	Robin Libove, Stanford, California, United States		https://ClinicalTrials.gov/show/NCT04532424
709	NCT02054949	Treatment Resistant Epilepsy and N-Acetyl Cysteine	TRE-NAC	Withdrawn	No Results Available	Autistic Disorder|Seizures|Irritability	Drug: N-Acetyl Cysteine (NAC)	Recruitment rate|seizure frequency	Nationwide Children's Hospital	All	6 Years to 21 Years   (Child, Adult)	Not Applicable	0	Other	Interventional	Allocation: N/A|Intervention Model: Single Group Assignment|Masking: None (Open Label)|Primary Purpose: Treatment	IRB12-00325	April 2013	January 2015	January 2015	February 4, 2014		October 9, 2015	Nationwide Children's Hospital, Columbus, Ohio, United States		https://ClinicalTrials.gov/show/NCT02054949
710	NCT04119492	DCD & ASD Imaging Intervention Study		Unknown status	No Results Available	Motor Skills Disorders|Autism Spectrum Disorder	Behavioral: CO-OP Treatment Group	Canadian Occupational Performance Measure (COPM)|Diffusion Tensor Imaging on MRI|Performance Quality Rating Scale (PQRS)|Bruninks-Oseretsky Test of Motor Proficiency 2nd ed. (BOT-2) short form|Resting-state connectivity on MRI|Voxel-based morphometry	University of British Columbia|Waterloo Foundation	All	8 Years to 12 Years   (Child)	Not Applicable	30	Other	Interventional	Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Single (Outcomes Assessor)|Primary Purpose: Treatment	H18-02759	February 20, 2019	June 30, 2021	June 30, 2021	October 8, 2019		October 12, 2020	University of British Columbia, Vancouver, British Columbia, Canada		https://ClinicalTrials.gov/show/NCT04119492
711	NCT05568303	the Role of Problem Solving in Cognitive Behavioral Therapy for Mothers With Autistic Children		Active, not recruiting	No Results Available	Applying CBT Sessions Improve Problem Solving Ability	Behavioral: CBT techniques	Decreasing mean scores of psychological distress (DAS)scores among study group post intervention|minimizing mean scores of problem solving skills inventory (PSI) among study group post intervention	Jouf University	Female	20 Years to 50 Years   (Adult)	Not Applicable	60	Other	Interventional	Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Other	62	June 5, 2022	October 1, 2022	December 25, 2022	October 5, 2022		October 5, 2022	Governmental Clinic, Behera Governate, Beera, Egypt|Enas Mahrous Abdelaziz, Jouf, Saudi Arabia		https://ClinicalTrials.gov/show/NCT05568303
712	NCT00280670	CBT for Comorbid Anxiety Disorders in Children With Autism, Asperger Syndrome, or PDD-NOS	BIACA	Completed	No Results Available	Autistic Disorder|Asperger Syndrome|Anxiety Disorders	Behavioral: Cognitive-behavioral therapy	Score on anxiety diagnostic interview after treatment or waitlist|Score on anxiety rating scale after treatment or waitlist|Score on daily living skills rating scale after treatment or waitlist|Score on children's social functioning and service use after treatment or waitlist	University of California, Los Angeles	All	7 Years to 11 Years   (Child)	Phase 2	20	Other	Interventional	Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Treatment	R03MH075806-01	January 2005	August 2008	August 2009	January 23, 2006		April 2, 2012	University of California, Los Angeles, Los Angeles, California, United States		https://ClinicalTrials.gov/show/NCT00280670
713	NCT01602016	A Folinic Acid Intervention for Autism Spectrum Disorders		Terminated	Has Results	Autism Spectrum Disorder|Autistic Disorder|Autism|Asperger's Syndrome|Pervasive Development Disorders	Drug: Folinic Acid and placebo|Drug: Folinic Acid	Language Improvement|Improved Stereotyped Behavior and Improved Social Skills	University of Arkansas|Arkansas Children's Hospital Research Institute	All	3 Years to 14 Years   (Child)	Phase 2	99	Other	Interventional	Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)|Primary Purpose: Treatment	136002	May 2012	November 2015	November 2015	May 18, 2012	November 6, 2016	October 17, 2017	Arkansas Children's Hospital Research Institute, Little Rock, Arkansas, United States		https://ClinicalTrials.gov/show/NCT01602016
714	NCT02565524	the Phenotypic and Genetic Profile of Patients With Early Onset Schizophrenia Associated With Autism Spectrum Disorder.	GenAuDiss	Recruiting	No Results Available	Schizophrenia|Dissociative Disorders	Other: genetic and phenotypic profile	characterization of the genetic abnormalities associated to Early Onset Schizophrenia phenotypes by performing standard karyotype|characterization of the genetic abnormalities associated to Early Onset Schizophrenia phenotypes by performing search CGG|characterization of the genetic abnormalities associated to Early Onset Schizophrenia phenotypes by performing whole exome sequencing|Intensity of positive symptoms of schizophrenia|Co-morbid psychiatric diagnosis|Evaluation of executive and attentional by the verbal fluency test|Clinical evaluation of autistic symptoms|Neurocognitive profile|Personality dimensional test	Fondation Lenval	All	7 Years to 18 Years   (Child, Adult)	Not Applicable	120	Other	Interventional	Allocation: N/A|Intervention Model: Single Group Assignment|Masking: None (Open Label)|Primary Purpose: Diagnostic	14-HPNCL08	May 18, 2014	May 18, 2023	May 18, 2023	October 1, 2015		May 16, 2022	Fondation Lenval, Nice, France		https://ClinicalTrials.gov/show/NCT02565524
715	NCT03253081	Heterogeneity in ASD: Biological Mechanisms, Trajectories, and Treatment Response		Active, not recruiting	No Results Available	Children With Autism	Behavioral: PARENT focused intervention|Behavioral: CHILD focused intervention	Change in Joint Engagement on the Caregiver-child interaction (CCX) over the course of the study|Early Social- Communication Scales|The Structured Play Assessment-R|Parenting Stress Index (PSI)|The Broader Autism Phenotype Questionnaire (BAPQ)|Caregiver Expectancies /Belief in the Intervention|BOSCC|Caregiver-child interaction (CCX)	University of California, Los Angeles	All	12 Months to 36 Months   (Child)	Not Applicable	120	Other	Interventional	Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Single (Outcomes Assessor)|Primary Purpose: Treatment	2P50HD055784-11	June 15, 2018	September 30, 2023	September 30, 2023	August 17, 2017		November 2, 2022	UCLA Semel Institute, Los Angeles, California, United States		https://ClinicalTrials.gov/show/NCT03253081
716	NCT04460976	Psychoeducation for Adults With Autism and Their Significant Others/Family Members	Prisma	Completed	No Results Available	Treatment Satisfaction|Knowledge Acquisition Disability Nos|Anxiety|Depression|Quality of Life|Relation, Family|Acceptance of Diagnosis|Stigma of Mental Illness|Participation	Behavioral: Psychoeducation for Adults With Autism and Their Significant Others/Family members (Prisma)|Behavioral: Treatment as usual/standard care	Study 1: Evaluation of session 1|Study 1: Evaluation after session 2|Study 1: Evaluation after session 3|Study 1: Evaluation after session 4|Study 1: Number of individuals that completed the intervention|Study 1: Adverse events during the intervention|Study 1: Adverse events after the intervention|Study 1: Overall treatment satisfaction measured by The Evaluation Questionnaire|Study 1: Open answer questions regarding Treatment satisfaction measured by The Evaluation Questionnaire|Study 1: Well-beining before and after the intervention measures by The Evaluation Questionnaire|Study 1: Credibility measured with the Credibility Scale (TCS: Borkovec & Nau, 1972)|Study 2: Knowledge about autism measured by Autism specific quiz|Study 3: Participation measured by Patient Participation in Rehabilitation Questionnaire.|Study 3: Patient Stigma|Study 3: Affiliate Stigma|All studies: Quality of life: Satisfaction with life scale (SWLS)|All studies: Acceptance of diagnosis measured with "What I think about my diagnosis"|All studies: Well-being with Hospital Anxiety and Depression Scale (HADS)|Study 1 and 2: The burden of care on significant others measured with Assessment Scale (BAS)|Study 1 and 2: Relation to significant others (QAFM)	Karolinska Institutet|Region Stockholm	All	18 Years and older   (Adult, Older Adult)	Not Applicable	718	Other	Interventional	Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Double (Participant, Care Provider)|Primary Purpose: Treatment	Prisma	September 1, 2017	September 15, 2020	September 15, 2020	July 8, 2020		December 14, 2020	Karolinska Institutet, Stockholm, Sweden		https://ClinicalTrials.gov/show/NCT04460976
717	NCT03957993	OT Intervention Via Telehealth for Children With ASD and ADHD		Completed	No Results Available	Autism Spectrum Disorder|Attention Deficit Hyperactivity Disorder	Other: Occupational Therapy via Telehealth|Other: Standard of Care Occupational Therapy	Change in Goal Attainment Scale|Change in Canadian Occupational Performance Measure	Children's Hospital Medical Center, Cincinnati	All	4 Years to 18 Years   (Child, Adult)	Not Applicable	44	Other	Interventional	Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Single (Outcomes Assessor)|Primary Purpose: Treatment	2017-5623	August 6, 2018	December 30, 2019	December 30, 2019	May 21, 2019		July 16, 2020	Cincinnati Children's Hospital Medical Center, Cincinnati, Ohio, United States		https://ClinicalTrials.gov/show/NCT03957993
718	NCT05480826	Familial and Functional Study of Genetic Variants Identified in People With Schizophrenia, Bipolar Disorder, Autism Spectrum Disorder or Resistant Depression	GENI	Not yet recruiting	No Results Available	Psychiatric Disorder	Genetic: study of the transmission of genetic variants	Measure of the probability of having a psychiatric disorder given the presence of the genetic variant studied.	Fondation FondaMental	All	18 Years and older   (Adult, Older Adult)	Not Applicable	50	Other	Interventional	Allocation: Non-Randomized|Intervention Model: Parallel Assignment|Masking: Single (Outcomes Assessor)|Primary Purpose: Other	FF21-GENI|2021-A02551-40	September 15, 2022	September 15, 2027	September 15, 2028	July 29, 2022		July 29, 2022			https://ClinicalTrials.gov/show/NCT05480826
719	NCT02498262	Using Virtual Reality and Robotics Technologies for Vocational Evaluation, Training and Placement	VR4VR	Unknown status	No Results Available	Autism Spectrum Disorder|Traumatic Brain Injury	Other: Virtual Reality System	Improvement in composite score of performing the vocational tasks of shelving, cleaning, environmental awareness, loading back of a truck, money management and social skills.	University of South Florida|Florida Department Of Education	All	18 Years to 60 Years   (Adult)	Not Applicable	100	Other	Interventional	Allocation: N/A|Intervention Model: Single Group Assignment|Masking: None (Open Label)|Primary Purpose: Other	Ame2_Pro00013008	June 2015	December 2019	December 2020	July 15, 2015		July 12, 2019	Rehabilitation Robotics & Prosthetics Testbed (RRT) Laboratory on the campus of the University of South Florida, Tampa, Florida, United States		https://ClinicalTrials.gov/show/NCT02498262
720	NCT03860389	The Effects of Exercise in Anxiety in Children With ASD		Unknown status	No Results Available	Autism Spectrum Disorder|Anxiety|Behavior	Other: Exercise	Anxiety|Behaviour|Fitness level	Institute of Technology, Carlow|University of Reading	All	4 Years to 18 Years   (Child, Adult)	Not Applicable	50	Other	Interventional	Allocation: N/A|Intervention Model: Single Group Assignment|Masking: None (Open Label)|Primary Purpose: Treatment	ASD1	January 7, 2019	June 24, 2019	December 16, 2019	March 1, 2019		March 1, 2019	Sharon Kinsella, Carlow, Co. Carlow, Ireland		https://ClinicalTrials.gov/show/NCT03860389
721	NCT04539990	A Behavioral Intervention for Ameliorating Sleep Problems in Children With ASD		Not yet recruiting	No Results Available	Autism|Autism Spectrum Disorder|Sleep	Behavioral: Behavioral treatment for sleep difficulties	Child Sleep Habits Questionnaire|Night time sleep as measured by Fitbit sensor	Soroka University Medical Center	All	18 Months to 5 Years   (Child)	Not Applicable	100	Other	Interventional	Allocation: N/A|Intervention Model: Single Group Assignment|Masking: None (Open Label)|Primary Purpose: Treatment	sor 0266-20 ctil	October 2020	September 2022	September 2023	September 7, 2020		September 7, 2020			https://ClinicalTrials.gov/show/NCT04539990
722	NCT04182633	MTT for Children With ASD Who Have Gastrointestinal Disorders		Recruiting	No Results Available	Autism Spectrum Disorder|Gastro-Intestinal Disorder|Constipation|Diarrhea	Combination Product: vancomycin, Miralax, intestinal microbiota|Combination Product: placebo vancomycin, Miralax, placebo intestinal microbiota	Childhood Autism Rating Scale (CARS)|Gastrointestinal Symptom Severity Scale (GSRS)|Daily Stool Record|Social Responsiveness Scale 2|Aberrant Behavior Checklist	Arizona State University|University of Minnesota|Finch Therapeutics	All	5 Years to 17 Years   (Child)	Phase 2	70	Other	Interventional	Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)|Primary Purpose: Treatment	NEIRB#: 120190306	November 15, 2019	February 28, 2023	December 30, 2024	December 2, 2019		December 30, 2021	Arizona State University, Tempe, Arizona, United States		https://ClinicalTrials.gov/show/NCT04182633
723	NCT01300923	Acamprosate in Youth With Fragile X Syndrome		Completed	Has Results	Fragile X Syndrome|Autism Spectrum Disorders	Drug: Acamprosate	Clinical Global Impression- Severity Scale (CGI-S)|The Aberrant Behavior Checklist (ABC)|Social Responsiveness Scale|Children's Yale-Brown Obsessive Compulsive Scale Modified for PDD|ADHD Rating Scale 4th Edition|Vineland Adaptive Behavior Scales-II (VABS-II) Communication Domain|Peabody Picture Vocabulary|Brain-derived Neurotrophic Factor (BDNF)	Indiana University	All	5 Years to 17 Years   (Child)	Phase 2	14	Other	Interventional	Allocation: Non-Randomized|Intervention Model: Single Group Assignment|Masking: None (Open Label)|Primary Purpose: Treatment	1003-26	August 2010	September 2011	September 2011	February 23, 2011	April 28, 2017	July 30, 2019	Riley Child and Adolescent Psychiatry Clinic - Riley Hospital for Children, Indianapolis, Indiana, United States		https://ClinicalTrials.gov/show/NCT01300923
724	NCT02803801	Build Your Parenting Toolkit: Guiding Children to Become Flexible Thinkers		Completed	No Results Available	Autism Spectrum Disorder (ASD)|Developmental Disorder	Behavioral: Build Your Parenting Toolkit Program	Relationship Development Assessment|Being a Parent Scale|Cooking Club Feedback Questionnaires|Exit Questionnaire	Rehabilitation Centre for Children, Canada	All	18 Years and older   (Adult, Older Adult)	Not Applicable	7	Other	Interventional	Allocation: N/A|Intervention Model: Single Group Assignment|Masking: None (Open Label)|Primary Purpose: Treatment	BYPT2016	September 2016	December 2016	April 2017	June 17, 2016		April 12, 2017	Rehabilitation Centre for Children, Winnipeg, Manitoba, Canada		https://ClinicalTrials.gov/show/NCT02803801
725	NCT01932515	Diagnostic Instruments for Autism in Deaf Children Study	DIADS	Unknown status	No Results Available	Hearing Loss|ASD	Behavioral: A revised screening instrument for use in Deaf children	A validated Autism Spectrum Disorder screening instrument to identify those in need of further assessment from deaf children suspected of ASD, with both English and BSL versions (for deaf parents).|A modified version of the Autism Diagnostic Interview Revised (ADIR) validated for use in the assessment of deaf young people; accessible in English and BSL (for hearing and deaf parents to fully participate in assessment).	Leeds and York Partnership NHS Foundation Trust|University of Manchester|Newcastle University	All	2 Years to 18 Years   (Child, Adult)	Not Applicable	325	Other	Interventional	Allocation: N/A|Intervention Model: Single Group Assignment|Masking: None (Open Label)|Primary Purpose: Diagnostic	BH120870	November 2013	April 2017	April 2017	August 30, 2013		June 26, 2014	Leeds and York Partnership NHS Foundation Trust, York, North Yorkshire, United Kingdom		https://ClinicalTrials.gov/show/NCT01932515
726	NCT05127863	Efficacy of a Pragmatic Intervention to Improve Adaptation to Context and Interlocutor		Terminated	No Results Available	Autism Spectrum Disorder|Developmental Language Disorder	Behavioral: social communication intervention (pragmatic)	social communication abilities (according parents)|social communication abilities (evaluated by clinician)	Université Catholique de Louvain	All	8 Years to 14 Years   (Child)	Not Applicable	5	Other	Interventional	Allocation: N/A|Intervention Model: Single Group Assignment|Masking: None (Open Label)|Primary Purpose: Treatment	PRAGMA-INTERV	December 1, 2021	June 1, 2022	June 1, 2022	November 19, 2021		June 21, 2022	UCLouvain - faculty of psychology, Louvain-la-Neuve, Belgium		https://ClinicalTrials.gov/show/NCT05127863
727	NCT03620097	Evaluate the Efficacy and Safety of DHA in the Adjuvant Treatment of Children With ASD.		Completed	No Results Available	ASD	Dietary Supplement: EuPoly-3 DHA Infant|Other: Placebo	Plasma and erythrocytic level of DHA	Maimónides Biomedical Research Institute of Córdoba	All	2 Years to 5 Years   (Child)	Not Applicable	60	Other	Interventional	Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Double (Participant, Investigator)|Primary Purpose: Treatment	ICI14/00355	January 21, 2015	December 2, 2015	December 2, 2015	August 8, 2018		August 8, 2018			https://ClinicalTrials.gov/show/NCT03620097
728	NCT03625297	Shelter Cat Adoption in Families of Children With Autism (Feline Friends)		Completed	No Results Available	Social Skills|Anxiety	Other: shelter cat	Change in Social Skills of child with autism over time from baseline to 6, to 12 and to 18 weeks|Change in Anxiety of child with autism over time from baseline to 6, to 12 and to 18 weeks|change in parent Human-animal Bonding over time from 2-3 days, to 6, to 12 and 18 weeks|change in child Human-animal Bonding over time from 2-3 days, to 6, to 12 and 18 weeks	University of Missouri-Columbia|Winn Feline Foundation|Human Animal Bond Research Institute (HABRI)	All	6 Years to 17 Years   (Child)	Not Applicable	11	Other	Interventional	Allocation: Randomized|Intervention Model: Crossover Assignment|Masking: None (Open Label)|Primary Purpose: Other	2008460	June 23, 2017	October 1, 2019	October 1, 2019	August 10, 2018		November 2, 2020	University of Missouri, Columbia, Missouri, United States		https://ClinicalTrials.gov/show/NCT03625297
729	NCT01993251	Does Melatonin Restore Sleep Architecture in Autistic Children	SOMELIA	Completed	No Results Available	Sleep Disorders	Drug: melatonin|Drug: Melatonin|Drug: placebo	To determine the most effective dose of melatonin to improve sleep quality in autistic children.|To assess in autistic children the melatonin effects on sleep characteristics|To assess the effectiveness of treatment on sleep disorders.|To assess the effectiveness of melatonin on daytime autistic behavior|To assess the melatonin safety in autistic children.|Establish whether there is a correlation between sleep quality and melatonin secretion.|To assess in autistic children the melatonin effects on sleep characteristics.	Hospices Civils de Lyon	All	3 Years to 12 Years   (Child)	Phase 2	26	Other	Interventional	Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)|Primary Purpose: Treatment	2012-732|2013-001230-17	June 2014	June 12, 2018	June 12, 2018	November 25, 2013		January 28, 2019	Hôpital Femme Mere Enfant, Bron, France|CHU de Caen, Caen, France|Centre Hospitalier du Chinonais, Chinon, France|CHRU de Strasbourg, Strasbourg, France|CHU de Tours, Tours, France		https://ClinicalTrials.gov/show/NCT01993251
730	NCT02369445	Investigation of Teacher-Mediated Toilet Training Using a Manualized Moisture Alarm Intervention		Completed	No Results Available	Autistic Disorder|Enuresis	Behavioral: Moisture Pager Intervention for Toilet Training|Behavioral: Standard of Care	Teacher Satisfaction with Toilet Training Experience (teacher satisfaction survey)|Number of Toileting Accidents/Day and Number of Successful Toilet Use for Urination/Day at End of Treatment (Toileting Data Logs)|Number of Toileting Accidents/Day and Number of Successful Toilet Use (3-Month Follow-Up) (Toileting Data Logs)	University of Rochester|Nationwide Children's Hospital|Vanderbilt University	All	3 Years to 10 Years   (Child)	Not Applicable	60	Other	Interventional	Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Treatment	1 R40 MC27705-01-00	September 2014	June 1, 2018	June 1, 2018	February 24, 2015		November 21, 2018	University of Rochester Medical Center, Rochester, New York, United States|Nationwide Children's Hospital, Columbus, Ohio, United States|Whitney Loring, Nashville, Tennessee, United States		https://ClinicalTrials.gov/show/NCT02369445
731	NCT02574273	Pilot Trial of a Social Skills Group Treatment (Secret Agent Society Program)		Completed	No Results Available	Anxiety|Attention Deficit Hyperactivity Disorder (ADHD)|Autistic Spectrum Disorder (ASD)	Behavioral: Secret Agent Society (SAS) Program|Other: Waitlist Group / Treatment As Usual	Anxiety Disorders Interview Schedule for DSM-IV-Child Version (ADIS)	Weill Medical College of Cornell University	All	8 Years to 12 Years   (Child)	Not Applicable	106	Other	Interventional	Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Treatment	1503015990	October 2015	December 2018	December 2018	October 12, 2015		July 30, 2019	Weill Cornell Medical College, New York, New York, United States		https://ClinicalTrials.gov/show/NCT02574273
732	NCT02328638	Development of a Manual-based, Interdisciplinary Intervention for Youth With ASD and Obesity		Completed	No Results Available	Autism|Obesity	Behavioral: Parent Education Program|Behavioral: Manual-based Behavioral Treatment	Change in body mass index percentile/ratio|Change in intake of healthy food|Change in physical activity	Emory University	All	3 Years to 10 Years   (Child)	Not Applicable	10	Other	Interventional	Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Treatment	IRB00073170	December 2014	August 2015	August 2015	December 31, 2014		January 20, 2016	Pediatric Feeding Disorders Program at the Marcus Autism Center, Atlanta, Georgia, United States		https://ClinicalTrials.gov/show/NCT02328638
733	NCT05497167	Development and Evaluation of "Period Kits" for Adolescents With Intellectual and Developmental Disabilities		Recruiting	No Results Available	Autistic Spectrum Disorder|Patient Empowerment|Menstrual Discomfort	Other: Period Kit	Number of participants who report feeling more comfortable and/or prepared for menstruation after period kit exploration	Tufts Medical Center|Tufts University	Female	5 Years to 17 Years   (Child)	Not Applicable	50	Other	Interventional	Allocation: N/A|Intervention Model: Single Group Assignment|Masking: None (Open Label)|Primary Purpose: Other	STUDY00002861	September 23, 2022	August 1, 2023	September 1, 2023	August 11, 2022		September 28, 2022	Tufts Medical Center, Boston, Massachusetts, United States		https://ClinicalTrials.gov/show/NCT05497167
734	NCT05244265	Mindfulness Based Stress Reduction for Intellectually Able Autistic Adults		Terminated	No Results Available	Treatment Satisfaction|Participation Rate, Patient|Quality of Life|Mental Illness|Acceptance Processes|Stress, Psychological	Behavioral: Mindfulness-based stress reduction (MBSR)|Behavioral: Treatment as usual (TAU)	Study 1 (feasibility study): Treatment completion.|Study 1 (feasibility study): Credibility as measured by the Treatment Credibility Scale (TCS: Borkovec & Nau, 1972).|Study 2 (RCT): Perceived stress as measured by the Perceived stress scale (Cohen et al., 1983).|Study 1 (feasibility study): Perceived stress as measured by the Perceived stress scale (Cohen et al., 1983).|Study 1 (feasibility study): Symptoms of anxiety and depression as measured by Hospital anxiety and depression scale (HADS: the Swedish Lisspers et al., 1997; Zigmond & Snaith, 1983).|Study 1 (feasibility study): Satisfaction with life as measured by Satisfaction with life scale (SWLS: Diener et al., 1985).|Study 1 (feasibility study): Mindfulness, assessed by Mindful attention awareness scale (MAAS: Brown & Ryan, 2003).|Study 1 (feasibility study): Acceptance of the Autism diagnosis, assessed by a modified version of the Acceptance and action questionnaire (Bond et al., 2011) for ASD.|Study 2 (RCT): Symptoms of anxiety and depression as measured by Hospital anxiety and depression scale (HADS: the Swedish Lisspers et al., 1997; Zigmond & Snaith, 1983).|Study 2 (RCT): Life satisfaction as measured by Satisfaction With Life Scale (SWLS: Diener et al., 1985).|Study 2 (RCT): Five Facets Mindfulness Questionnaire|Study 2 (RCT): Acceptance of the autism diagnosis, assessed by a modified version of the Acceptance and Action Questionnaire (AAQ: Bond et al., 2011) for ASD.	Karolinska Institutet|Region Stockholm	All	18 Years and older   (Adult, Older Adult)	Not Applicable	140	Other	Interventional	Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)|Primary Purpose: Treatment	MBSRautisticAdults	January 1, 2016	September 1, 2021	September 1, 2021	February 17, 2022		March 8, 2022			https://ClinicalTrials.gov/show/NCT05244265
735	NCT04295512	Adaptation and Implementation of an ASD Executive Functioning Intervention in Children's Mental Health Services		Unknown status	No Results Available	Autism Spectrum Disorder|Mental Health Disorder|Executive Dysfunction	Behavioral: Unstuck and on Target (UOT)	Acceptability of Intervention Measure|Intervention Appropriateness Measure|Feasibility of Intervention Measure|Provider Fidelity- Change since baseline in provider fidelity|Eyberg Child Behavior Inventory- Change since baseline in child behaviors	San Diego State University|Rady Children's Hospital, San Diego	All	5 Years to 13 Years   (Child)	Not Applicable	52	Other	Interventional	Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Single (Outcomes Assessor)|Primary Purpose: Health Services Research	HS-2018-0147	April 1, 2021	April 1, 2022	August 31, 2022	March 4, 2020		March 4, 2020	Child and Adolescent Services Research Center, San Diego, California, United States		https://ClinicalTrials.gov/show/NCT04295512
736	NCT03003286	Community Based Intervention for Children With ADHD and ASD		Completed	No Results Available	Autism Spectrum Disorder|Attention Deficit-Hyperactivity Disorder|Executive Function	Behavioral: Unstuck and on Target (UOT)|Behavioral: Parents and Teachers Supporting Students (PATSS)	Change in Classroom Observation total raw score at termination of intervention|Change in Wechsler Abbreviated Scale of Intelligence--II Block Design- T-score at termination of intervention (post testing) and 1 year later (long-term follow-up)|Change in Delis-Kaplan Executive Function System - Category Fluency and Switching Accuracy scaled scores at termination of intervention (post testing) and 1 year later (long-term follow-up)|Change in Executive Function Challenge Task - Flexibility and Planning raw scores at termination of intervention (post testing) and 1 year later (long-term follow-up)|Change in Flexibility Interference Questions Questionnaire total raw score at termination of intervention (post testing) and 1 year later (long-term follow-up)|Change in Behavior Rating Inventory of Executive Function (BRIEF) - Parent Form - Shift, Plan/Organize, Emotional Control and Global Executive at termination of intervention (post testing) and 1 year later (long-term follow-up)Composite T-scores|Change in The Child Behavior Checklist (CBCL) - Parent Report Externalizing Behaviors T-scores at termination of intervention (post testing) and 1 year later (long-term follow-up)|Parent Feedback Form - Acceptability total raw score|Child Feedback-Acceptability raw score	Lauren Kenworthy|Georgetown University|University of Colorado, Denver|Children's National Research Institute	All	8 Years to 11 Years   (Child)	Not Applicable	148	Other	Interventional	Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Double (Investigator, Outcomes Assessor)|Primary Purpose: Treatment	AD-1304-7379	September 13, 2014	August 5, 2017	August 5, 2017	December 28, 2016		April 4, 2018	Children's Research Institude, Children's National Heath System, Washington, District of Columbia, United States		https://ClinicalTrials.gov/show/NCT03003286
737	NCT02124720	Using Mobile Technology to Reduce Stereotypy		Completed	No Results Available	Child Development Disorders, Pervasive	Behavioral: iSTIM	Frequency and duration of stereotypy|Social validity score	Université de Montréal	All	up to 12 Years   (Child)	Not Applicable	39	Other	Interventional	Allocation: N/A|Intervention Model: Single Group Assignment|Masking: None (Open Label)|Primary Purpose: Treatment	CERFAS-2014-15-030-P	December 2014	February 2019	February 2019	April 28, 2014		September 26, 2019	Monarch House, Mississauga, Ontario, Canada|CRDITED de Montréal, Montreal, Quebec, Canada|Gold Centre, Montreal, Quebec, Canada		https://ClinicalTrials.gov/show/NCT02124720
738	NCT02316145	Internet-based Coaching for Young Adults With Neuropsychiatric Disorders		Completed	No Results Available	Attention Deficit Hyperactivity Disorder|Autism Spectrum Disorder|Tourette's Disorder	Behavioral: Habilitation (Internet-based support and coaching)	quality of life (QoL)	Vardalinstitutet The Swedish Institute for Health Sciences		Child, Adult, Older Adult	Not Applicable	12	Other	Interventional	Allocation: N/A|Intervention Model: Single Group Assignment|Masking: None (Open Label)|Primary Purpose: Treatment	16611	September 2008	June 2010	December 2010	December 12, 2014		December 12, 2014			https://ClinicalTrials.gov/show/NCT02316145
739	NCT02088905	Efficacy of Parent-Child Interaction Therapy With Autism Spectrum Disorder	PCIT	Completed	Has Results	Noncompliance	Behavioral: Parent Child Interaction Therapy	Eyberg Child Behavior Inventory|Parental Stress Index-4 Short Form|Social Responsiveness Scale 2 Score|Dyadic Parent-Child Interaction Coding System Scores|Parental Stress Index Score	University of Pittsburgh|Autism Speaks	All	30 Months to 83 Months   (Child)	Not Applicable	25	Other	Interventional	Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Treatment	0031588|PRO023120445	April 2014	July 2016	July 2016	March 17, 2014	March 1, 2019	March 22, 2019	Merck Child Outpatient Clinic, Pittsburgh, Pennsylvania, United States		https://ClinicalTrials.gov/show/NCT02088905
740	NCT03776656	Evaluation of a Treatment With Allopurinol in Adenylosuccinate Lyase Deficiency	ADSL	Completed	No Results Available	Adenylosuccinate Lyase Deficiency	Drug: Allopurinol	Measurement of adaptive functional improvement : composite total score for Vineland II adaptive behaviour Scale|Evolution of the Scores of different subdomains Vineland II scale from baseline|Evolution of the Psycho-Educative Profile (PEP III/R) from baseline|Evolution of the Score ADI-R (Autism Diagnostic Interview-Revised) from baseline|Evolution of the Score ADOS-2 (Autism Diagnostic Observation Schedule 2) from baseline|Evolution of the Score on Conners hyperactivity Scale|Evolution of the Score on ABC scale (Aberrant Behaviour Checklist)|Evolution of SAICAr levels in the urine|Evolution of S-Ado levels in the urine|Evolution of SAICAr levels in the blood|Evolution of S-Ado levels in the blood|Evolution of the number of seizures from Baseline for epileptic patients|Evolution of antiepileptic treatments from Baseline for epileptic patients|Evolution of electroencephalogram tracing from Baseline for epileptic patients	Assistance Publique - Hôpitaux de Paris|URC-CIC Paris Descartes Necker Cochin	All	18 Months and older   (Child, Adult, Older Adult)	Phase 2	8	Other	Interventional	Allocation: N/A|Intervention Model: Single Group Assignment|Masking: None (Open Label)|Primary Purpose: Treatment	P160902J|2017-002155-28	October 14, 2019	June 17, 2022	June 17, 2022	December 17, 2018		October 12, 2022	LA PITIE-SALPETRIERE Hospital, AP-HP, Paris, France|Department of Pediatry. Reference centre of Hereditary diseases of the metabolism of child and adult. Necker - Enfants malades Hospital, Paris, France		https://ClinicalTrials.gov/show/NCT03776656
741	NCT04096430	Evaluation of Effectiveness of Child-oriented Goal-setting in Paediatric Rehabilitation (the ENGAGE Approach)		Recruiting	No Results Available	Autism Spectrum Disorder|Neurodevelopmental Disorders|Cerebral Palsy	Behavioral: ENGAGE approach (child-oriented goal-setting)	Goal performance and satisfaction will be measured using the Canadian Occupational Performance Measure (COPM).|Child engagement in therapy will be measured using the Pediatric Rehabilitation Intervention Measure of Engagement (PRIME-SP).|Perceived confidence will be measured using the Belief in Goal Self-Competence Scale [BiGSS].|Goal related performance will be measured using the Goal Attainment Scaling (GAS).|Participation for young children will be measured using the Participation and Environment Measure for Children & Youth (PEM-CY).|Quality of life for children will be measured using the KIDSCREEN-27.|Caregiver quality of life will be measured with the Caregiver Quality of Life (CarerQol-7D).|Functional abilities will be measured with the Pediatric Evaluation of Disability Inventory (PEDI-CAT).	University of Alberta|Alberta Health services	All	5 Years to 12 Years   (Child)	Not Applicable	96	Other	Interventional	Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Single (Outcomes Assessor)|Primary Purpose: Treatment	Pro00090963	March 1, 2022	May 31, 2024	May 31, 2024	September 19, 2019		May 16, 2022	Renfrew Educational Services, Calgary, Alberta, Canada|Society for Treatment of Autism, Calgary, Alberta, Canada|Children's Rehabilitation Services, Alberta Health Services, Camrose, Alberta, Canada|Centre for Autism Services Alberta, Edmonton, Alberta, Canada|Children's Rehabilitation Services, Alberta Health Services, Grande Prairie, Alberta, Canada|Children's Rehabilitation Services, Alberta Health Services, Red Deer, Alberta, Canada		https://ClinicalTrials.gov/show/NCT04096430
742	NCT04878198	Treatment of Sleep Disturbance in Children With ASD		Not yet recruiting	No Results Available	Physical Exercise|Sleep Disturbance|Autism Spectrum Disorder|Melatonin Deficiency	Behavioral: Jogging program|Drug: Melatonin supplement intervention	Sleep onset latency|Sleep efficiency|Wake after sleep onset|Sleep duration|Parental-assessed sleep quality|24-h melatonin level|First morning void melatonin level	Education University of Hong Kong|Chinese University of Hong Kong|Castle Peak Hospital|University of Leicester|United Christian Hospital	All	8 Years to 12 Years   (Child)	Not Applicable	75	Other	Interventional	Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Treatment	RG 21/2019-2020R	January 1, 2023	June 30, 2023	December 30, 2023	May 7, 2021		August 2, 2022			https://ClinicalTrials.gov/show/NCT04878198
743	NCT00445471	A Prospective Study Comparing the Mifne Approach of Treating Childhood Autism With Routine Standard Treatment		Terminated	No Results Available	Child Development Disorders, Pervasive	Behavioral: Mifne Approach to PDD|Behavioral: Treatment as usual	ADOS scores at 3 and 6 months after commencement of treatment|CGI-I score after 3 and 6 months	Rabin Medical Center	All	2 Years to 5 Years   (Child)	Not Applicable	45	Other	Interventional	Allocation: Non-Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Treatment	4222	April 2007	December 2012	December 2012	March 9, 2007		December 25, 2014	Schneider Children's Medical Center of Israel, Departemnt of Psychological Medicine, Petach Tikva, Israel		https://ClinicalTrials.gov/show/NCT00445471
744	NCT02919215	Teacher Help for Children and Youth With Mental Health Disorders	TeacherHelp	Unknown status	No Results Available	Attention Deficit Hyperactivity Disorder|Autism Spectrum Disorder|Learning Disabilities	Behavioral: Teacher Help Intervention	Teacher Demographic Questionnaire (author made)|Change in Teacher Attitudes at 3 and 5 months (Kos, 2008)|Willingness to Pay Questionnaire|Change in Strengths and Difficulties Questionnaire at 3 and 5 months (SDQ; Goodman, 2001)|Change in Pediatric Quality of Life Inventory at 3 and 5 months (PedsQL-4; Varni et al., 1999)|Client Satisfaction Questionnaire (Attkisson & Swick, 1990)|Collaborating Psychologist Support Log (author-made)|Youth Satisfaction Measure (author-made)|Parent Demographic Questionnaire (author-made)|Change in Treatment Utilization at 3 and 5 months|Change in The Beach Center Family Quality of Life Scale at 3 and 5 months (Hoffman et al., 2006)	IWK Health Centre	All	6 Years and older   (Child, Adult, Older Adult)	Not Applicable	550	Other	Interventional	Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Treatment	348363	January 2017	June 2017	September 2018	September 29, 2016		September 29, 2016	Dalhousie University, Halifax, Nova Scotia, Canada		https://ClinicalTrials.gov/show/NCT02919215
745	NCT04302818	SKOLKONTAKT - Social Skills Training in a School Setting	SKOLKONTAKT	Completed	No Results Available	Autism Spectrum Disorder|Attention Deficit Hyperactivity Disorder|Anxiety|Depression	Behavioral: SKOLKONTAKT|Behavioral: Social activity group	Social Skills Group Questionnaire (SSGQ)|Social Responsiveness Scale-2 (SRS-ll)|KIDSCREEN-27 (short version)|Worlds Health Organisation Disability Assessment Schedule 2.0 (WHODAS 2.0)|Conners 3-F|Negative Effects Questionnaire (NEQ)|Goal Attainment Scaling (GAS)	Karolinska Institutet|Marcus och Amalia Wallenbergs minnesfond	All	15 Years to 20 Years   (Child, Adult)	Not Applicable	33	Other	Interventional	Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Single (Outcomes Assessor)|Primary Purpose: Treatment	SKOLKONTAKT	September 2, 2019	March 31, 2021	March 31, 2021	March 10, 2020		March 29, 2022	CAP Research Center, Center of Neurodevelopmental disorders at Karolinska Institutet (KIND), Stockholm, Sweden		https://ClinicalTrials.gov/show/NCT04302818
746	NCT04026386	A Center Based Early Intervention Program For Preschoolers With Developmental Disorders		Recruiting	No Results Available	Development Disorder, Child|Developmental Disability|Development Delay|Autism Spectrum Disorder	Behavioral: Center Based or In Home Early Intervention Program	Change From Baseline in Parent Rated Social Responsiveness Scale, 2nd Edition (SRS-2) T-Score After Treatment.|Change From Baseline in Parent Rated Repetitive Behavior Scale Revised (RBS-R) Scores During Treatment.|Change From Baseline in Parent Rated Stanford Social Dimension Scale (SSDS) Scores During Treatment.|Change From Baseline in Parent Rated Vineland Adaptive Behavior Scale- 3 (VABS-3) Scores During Treatment.|Change From Baseline in Parent Rated Short Sensory Profile Questionnaire (SSPQ) Scores During Treatment.|Change From Baseline in Parent Rated General Self Efficacy Scale (GSES) Scores During Treatment.	Stanford University|John & Marcia Goldman Foundation	All	2 Years to 5 Years   (Child)	Not Applicable	75	Other	Interventional	Allocation: N/A|Intervention Model: Single Group Assignment|Masking: None (Open Label)|Primary Purpose: Treatment	IRB-52348	October 19, 2019	December 2024	December 2024	July 19, 2019		December 5, 2022	Stanford University School of Medicine, Stanford, California, United States		https://ClinicalTrials.gov/show/NCT04026386
747	NCT03282162	The Effects of Oxytocin on Affective Touch		Completed	No Results Available	Healthy	Drug: intranasal oxytocin|Drug: intranasal placebo	brain function: neural activity during affective touch as assessed via BOLD fMRI|Brain function: functional connectivity during affective touch as assessed via BOLD fMRI|Perceived affective quality of the touch|Associations with trait autism as assessed via the Autism-Spectrum Quotient (AQ) - brain function: activity|Associations with trait autism as assessed via the Autism-Spectrum Quotient (AQ) - brain function: functional connectivity|Associations with trait autism as assessed via the Autism-Spectrum Quotient (AQ) - behaviour: pleasantness experience|Associations with Sensory Responsivity as assessed via the Sensory Responsivity Scale - brain function: activity|Associations with Sensory Responsivity as assessed via the Sensory Responsivity Scale - brain function: functional connectivity|Associations with Sensory Responsivity as assessed via the Sensory Responsivity Scale - behaviour: pleasantness experience	University of Electronic Science and Technology of China	Male	18 Years to 30 Years   (Adult)	Not Applicable	50	Other	Interventional	Allocation: Randomized|Intervention Model: Crossover Assignment|Masking: Triple (Participant, Investigator, Outcomes Assessor)|Primary Purpose: Basic Science	UESTC-neuSCAN-40	August 28, 2017	January 31, 2018	July 12, 2018	September 13, 2017		October 29, 2018	University of Electronic Science and Technology of China(UESTC), Chengdu, Sichuan, China		https://ClinicalTrials.gov/show/NCT03282162
748	NCT03518346	Use of Virtual Reality Game Playing During Venipuncture		Completed	No Results Available	Autism|Development Delay|Typical Development	Behavioral: Virtual Reality|Behavioral: Standard of Care	Attempting vs. Refusing Venipuncture|Blood volume|Pain Scale|Satisfaction Survey|Fear Scale|Time to Achieve Optimal Blood Volume	University of California, Davis	All	8 Years to 19 Years   (Child, Adult)	Not Applicable	12	Other	Interventional	Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Health Services Research	1170355	April 9, 2018	January 15, 2019	January 15, 2019	May 8, 2018		May 15, 2019	University of California Davis MIND Institute, Sacramento, California, United States		https://ClinicalTrials.gov/show/NCT03518346
749	NCT02504502	Enhancing Genomic Laboratory Reports to Enhance Communication and Empower Patients		Completed	Has Results	Intellectual Disability|Autism|Multiple Congenital Anomalies	Other: enhanced genomic report	Satisfaction With Genomic Test Report	Geisinger Clinic|Patient-Centered Outcomes Research Institute	All	up to 21 Years   (Child, Adult)	Not Applicable	52	Other	Interventional	Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Single (Participant)|Primary Purpose: Health Services Research	2013-0594	August 2015	January 1, 2017	January 1, 2017	July 22, 2015	June 15, 2017	February 12, 2018			https://ClinicalTrials.gov/show/NCT02504502
750	NCT04167839	Effects of Sensory Diets on Children's Sensory Processing Skills, Psychosocial Skills, and Classroom Engagement		Completed	No Results Available	Sensory Processing Disorder|Special Education|Autism	Other: Sensory diet	Change in frequency of a target behaviors related to psycho-social behaviors|Change in duration of a target behavior related to off-task behaviors.|Change in duration of a target behavior related to sensory seeking behaviors.	Pingale, Vidya, OTR|Tina S. Fletcher, EdD, MFA, OTR|Catherine Candler, PhD, OTR|Noralyn Pickens, PhD, OT|Karen Dunlap, EdD	Male	4 Years to 11 Years   (Child)	Not Applicable	5	Other	Interventional	Allocation: N/A|Intervention Model: Single Group Assignment|Masking: Single (Outcomes Assessor)|Primary Purpose: Treatment	TWU protocol# 19711	September 6, 2017	February 15, 2018	February 15, 2018	November 19, 2019		November 19, 2019	Vidya Pingale, Cliffside Park, New Jersey, United States		https://ClinicalTrials.gov/show/NCT04167839
751	NCT03293511	Oxytocin Modulates Eye Gaze Behavior During Social Processing		Unknown status	No Results Available	Healthy	Drug: intranasal oxytocin|Drug: intranasal placebo	Global eye gaze characteristic: differences between oxytocin and placebo treatment|Feature-specific eye gaze characteristics: differences between oxytocin and placebo treatment|Global eye gaze characteristic - associations with autism traits|Feature-specific eye gaze characteristics - associations with trait autism	University of Electronic Science and Technology of China	Male	18 Years to 30 Years   (Adult)	Not Applicable	40	Other	Interventional	Allocation: Randomized|Intervention Model: Crossover Assignment|Masking: Triple (Participant, Investigator, Outcomes Assessor)|Primary Purpose: Basic Science	UESCT_neuSCAN_42	June 9, 2017	July 2019	July 2019	September 26, 2017		October 29, 2018	school of life science and technology, University of Electronic Science and Technology of China, Chengdu, Sichuan, China|University of Electronic Science and Technology of China, Chengdu, Sichuan, China		https://ClinicalTrials.gov/show/NCT03293511
752	NCT04639570	KneuroKnits: Participation and Anxiety in People With Neurological Conditions Participating in a Knitting Group		Completed	No Results Available	Autism Spectrum Disorder|Neurodevelopmental Disorders|Acquired Brain Injury|Physical Disability	Other: KneuroKnits	Self-reported Experience of Activity Settings (SEAS)|Symptom Checklist-90 (SCL-90; anxiety subscale; change during program participation)|State-Trait Anxiety Inventory (STAI; change between beginning and end of sessions; change between weeks 1 and 4)	Holland Bloorview Kids Rehabilitation Hospital	All	15 Years to 24 Years   (Child, Adult)	Not Applicable	14	Other	Interventional	Allocation: N/A|Intervention Model: Single Group Assignment|Masking: None (Open Label)|Primary Purpose: Treatment	17-717	November 3, 2018	February 9, 2019	February 9, 2019	November 20, 2020		November 20, 2020	Holland Bloorview Kids Rehabilitation Hospital, Toronto, Ontario, Canada		https://ClinicalTrials.gov/show/NCT04639570
753	NCT03610919	Effects of Oxytocin Dose Frequency on Behavioral and Neural Responses		Unknown status	No Results Available	Healthy	Drug: Nasal Sprays	Between group differences in the changes between acute and chronic administration effects of oxytocin on amygdala reactivity towards fearful faces as assessed by fMRI.|Between group differences in the changes between acute and chronic administration effects of oxytocin on amygdala resting state connectivity as assessed by fMRI.|Association between trait autism with acute and chronic treatment effects on amygdala activity in response to fearful faces|Association between trait autism with acute and chronic treatment effects on amygdala resting state connectivity|Interaction of acute and chronic treatment effects on amygdala activity with oxytocin receptor genotype.|Interaction of acute and chronic treatment effects on amygdala connectivity with oxytocin receptor genotype.|Treatment effects on arousal will be assessed by subjects rating their arousal on a 9-point Likert scale in response to the face pictures presented again after their fMRI scans on day 1 and day 5|Treatment effects on valence will be assessed by subjects rating their valence on a 9 point Likert scale in response to the face pictures presented again after their fMRI scans on day 1 and day 5|Treatment effects on intensity will be assessed by subjects rating their intensity on a 9 point Likert scale in response to the face pictures presented again after their fMRI scans on day 1 and day 5	University of Electronic Science and Technology of China	Male	17 Years to 30 Years   (Child, Adult)	Phase 1	150	Other	Interventional	Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Triple (Participant, Investigator, Outcomes Assessor)|Primary Purpose: Basic Science	UESTC-neuSCAN-57	March 1, 2018	September 1, 2018	December 1, 2018	August 1, 2018		October 29, 2018	school of life science and technology, University of Electronic Science and Technology of China, Chengdu, Sichuan, China		https://ClinicalTrials.gov/show/NCT03610919
754	NCT05198232	The Effects of Virtual Zumba® in Individuals With Developmental Disabilities		Completed	No Results Available	Developmental Disability|Autism Spectrum Disorder|Down Syndrome|Cerebral Palsy	Behavioral: Zumba High Tempo|Behavioral: Zumba Low Tempo	Change in Cardiorespiratory functioning using the 6-minute Walk Test (6MWT)|Change in Functional Mobility using the Timed-Up and Go (TUG).|Change in Static Balance using the Biodex Balance SD - modified Clinical Test of Sensory Interaction on Balance.|Change in Attention/Inhibition using the NIH Toolbox Flanker Test.|Change in Physical activity levels|Change in Body mass index|Change in Weight|Change in Body fat percentage|Change in Body Fat Mass|Change in Fat free mass|Change in Height	Auburn University	All	18 Years to 75 Years   (Adult, Older Adult)	Not Applicable	57	Other	Interventional	Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Single (Participant)|Primary Purpose: Other	Virtual Adaptive Zumba	January 26, 2021	March 30, 2022	March 30, 2022	January 20, 2022		May 5, 2022	Auburn University School of Kinesiology, Auburn, Alabama, United States		https://ClinicalTrials.gov/show/NCT05198232
755	NCT02342366	Characterization of the Prosocial and Prosexual Effects of GHB		Completed	No Results Available	Depressive Disorder, Major|Bipolar Disorder|Autistic Disorder	Drug: GHB 35 mg/kg p.o.|Drug: GHB 20 mg/kg p.o.	Sexual Arousal|Social Cognition and Behavior|Composite measure of Neuroendocrine Parameters|electroencephalography (EEG) activity|fMRI activity	University of Zurich|University of Regensburg|University of Salerno|University of Vienna|University of Freiburg	Male	18 Years to 40 Years   (Adult)	Not Applicable	19	Other	Interventional	Allocation: Randomized|Intervention Model: Crossover Assignment|Masking: Double (Participant, Investigator)|Primary Purpose: Other	PUK-GHB01	February 2012	November 2014	December 2014	January 19, 2015		July 29, 2019	Hospital for Psychiatry, University of Zurich, Zurich, Switzerland	"Study Protocol and Statistical Analysis Plan", https://ClinicalTrials.gov/ProvidedDocs/66/NCT02342366/Prot_SAP_000.pdf	https://ClinicalTrials.gov/show/NCT02342366
756	NCT03847402	The Early Integrated Intervention for Child Brain-developmental Disorders in China		Completed	No Results Available	Brain Developmental Diseases|Autism Spectrum Disorder|Global Developmental Delay|Attention Deficit-Hyperactivity Disorder	Behavioral: The early integrated intervention for GDD|Behavioral: The early integrated intervention for ASD|Behavioral: The early integrated intervention for ADHD|Behavioral: community intervention for ASD|Behavioral: Community intervention for GDD|Behavioral: community intervention for ADHD	Change from baseline development quotient (DQ) in the Griffiths Development Scales-Chinese version at 1 year, 2 years for GDD and ASD|Change from baseline score of the Conners Early Childhood (Conners EC) at 1 year, 2 years for ADHD|Change from baseline score of the Communication and Symbolic Behavior Scales Developmental Profile-Infant Toddler Checklist（CSBS-DP-ITC）at 1 year, 2 years for ASD|Change from baseline intelligence quotient (IQ) in the Wechsler Intelligence Scale at 1 year, 2 years for ADHD	Children's Hospital of Fudan University|National Key Research and Development Program of China	All	3 Months to 3 Years   (Child)	Not Applicable	900	Other	Interventional	Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Single (Outcomes Assessor)|Primary Purpose: Treatment	MBDZXGY2018	June 15, 2018	June 30, 2021	July 30, 2021	February 20, 2019		January 11, 2022	Children's hospital of Fudan University, Shanghai, Shanghai, China		https://ClinicalTrials.gov/show/NCT03847402
757	NCT02160886	Effects of a Task Oriented Intervention With Two Goal-setting Approaches		Completed	No Results Available	Movement Disorder|Learning Disability|Autism Spectrum Disorder|Children	Behavioral: child-goal|Behavioral: parent-goal	Goal Attainment Scaling (GAS)|Performance scale of the Canadian Occupational Performance Measure|Beck Youth scales, subscale self-concept	Region Gävleborg	All	5 Years to 12 Years   (Child)	Not Applicable	34	Other	Interventional	Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Single (Outcomes Assessor)|Primary Purpose: Treatment	RFR-296311	October 2011	January 2014	February 2014	June 11, 2014		June 11, 2014	Gävleborg County Council, Gävle, Sweden		https://ClinicalTrials.gov/show/NCT02160886
758	NCT01731119	Study of Lurasidone in Treating Antipsychotic Naive or Quasi-Naive Children and Adolescents		Completed	Has Results	Schizophrenia|Schizoaffective Disorder|Schizophreniform Disorder|Psychosis NOS|Autistic Disorder|Asperger Syndrome|Child Development Disorders, Pervasive|Bipolar I Disorder|Bipolar II Disorder|Mood Disorder NOS|Severe Major Depression With Psychotic Features|Single Episode Major Depression Without Psychotic Symptoms|Severe Mood Disorder With Psychotic Features	Drug: Latuda©	Change in Weight|Proportion of Participants Completing Treatment|Changes in Efficacy Measures|Number of Participants Experiencing Side Effects|Overall Clinical Improvement	University of North Carolina, Chapel Hill|Foundation of Hope, North Carolina	All	6 Years to 19 Years   (Child, Adult)	Phase 2	9	Other	Interventional	Allocation: N/A|Intervention Model: Single Group Assignment|Masking: None (Open Label)|Primary Purpose: Treatment	12-2302	December 2012	August 2014	August 2014	November 21, 2012	May 17, 2017	June 14, 2017	University of North Carolina, Chapel Hill, North Carolina, United States		https://ClinicalTrials.gov/show/NCT01731119
759	NCT02741063	Oxytocin Effect on Attentional Bias Towards Emotional Expression Faces in Individuals With High and Low Autistic Traits: A Functional Magnetic Resonance Imaging (fMRI) Study		Unknown status	No Results Available	Healthy	Behavioral: screen low autistic subjects|Behavioral: screen high autistic subjects|Drug: oxytocin|Drug: placebo	attentional bias toward emotional expression faces|brain activity during RSVP task	University of Electronic Science and Technology of China	Male	18 Years to 30 Years   (Adult)	Early Phase 1	120	Other	Interventional	Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Double (Participant, Investigator)|Primary Purpose: Prevention	UESTC-neuSCAN-19	May 2016	June 2019	September 2019	April 18, 2016		October 29, 2018	China, Sichuan, Chengdu, Sichuan, China		https://ClinicalTrials.gov/show/NCT02741063
760	NCT02660775	Social Cognitive Assessment in Autism and Schizophrenia	(ClaCoS)	Completed	No Results Available	Schizophrenia	Behavioral: schizophrenia|Behavioral: Autism|Behavioral: Healthy controls	Change from Baseline in social cognition measures|Change from Baseline in symptoms measure|Change from Baseline in Neurocognitive functioning measures	Hôpital le Vinatier	All	18 Years to 45 Years   (Adult)	Not Applicable	440	Other	Interventional	Allocation: Non-Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Screening	2015-A00580-49	December 4, 2015	March 31, 2021	June 30, 2021	January 21, 2016		January 27, 2022	Professeur FRANCK Nicolas, Bron, Rhone-alpes, France		https://ClinicalTrials.gov/show/NCT02660775
761	NCT02097355	Using an Online Patient Monitoring System to Improve Care for Children With Chronic Conditions	TriVoxHealth	Completed	No Results Available	Attention Deficit Hyperactivity Disorder|Asthma|Autism Spectrum Disorder|Depression|Epilepsy	Other: TriVox for clinical care	Change in caregiver-rated disease-specific symptoms|Number of patients with "red flag" alerts|Change in caregiver-rated global functioning|Experience of care	Boston Children's Hospital	All	Child, Adult, Older Adult	Not Applicable	946	Other	Interventional	Allocation: Randomized|Intervention Model: Crossover Assignment|Masking: None (Open Label)|Primary Purpose: Health Services Research	BCH PPQI 52012	December 2014	December 2019	December 2019	March 27, 2014		July 14, 2020	Boston Children's Hospital, Boston, Massachusetts, United States		https://ClinicalTrials.gov/show/NCT02097355
762	NCT01874327	Biomarkers of Developmental Trajectories and Treatment in Autism Spectrum Disorder (ASD)	BabyJ	Completed	No Results Available	Children at Risk for ASD	Behavioral: Baby JASPER|Behavioral: Standard Baby Classroom	Assessing change in Parent Child Interaction (PCX) throughout the diverse time points.|Autism Diagnostic Observation Schedule Toddler module (ADOS-T)|Imitation Task|Vineland Adaptive Behavior Scales (VABS)|EEG/Event Related Potential (ERP)|Mullen Scales of Early Learning (MSEL)|Early Social Communication Scales (ESCS)|Structured Play Assessment (SPA)	University of California, Los Angeles	All	12 Months to 21 Months   (Child)	Not Applicable	110	Other	Interventional	Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Single (Care Provider)|Primary Purpose: Treatment	12-000607	January 2013	August 2018	September 2018	June 11, 2013		October 10, 2018	UCLA Semel Institue, Los Angeles, California, United States		https://ClinicalTrials.gov/show/NCT01874327
763	NCT04075552	Healthy Eating ASD		Withdrawn	No Results Available	Food Selectivity	Behavioral: Pre Meal Presentation|Behavioral: Pre Meal Presentation + Modeling|Behavioral: Pre Meal Presentation + Token Economy	Increased consumption of healthy foods	Penn State University	All	6 Years to 14 Years   (Child)	Not Applicable	0	Other	Interventional	Allocation: N/A|Intervention Model: Single Group Assignment|Masking: None (Open Label)|Primary Purpose: Treatment	STUDY00005814	September 23, 2016	September 26, 2022	September 26, 2022	August 30, 2019		September 28, 2022	Hogan Learning Academy, Fleetwood, Pennsylvania, United States		https://ClinicalTrials.gov/show/NCT04075552
764	NCT05238766	Behavioral Interventions to Increase Parent Adherence With Behavior Plans		Recruiting	No Results Available	Family Accommodation|Nonadherence|Behavior Problem	Behavioral: DEAL	Accommodation to Adherence Change Score|Experiential Avoidance|Cognitive Fusion|Parenting Stress	Hugo W. Moser Research Institute at Kennedy Krieger, Inc.|Organization for Autism Research	All	Child, Adult, Older Adult	Not Applicable	50	Other	Interventional	Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Treatment	IRB00292589	June 21, 2022	January 31, 2024	January 31, 2024	February 14, 2022		June 27, 2022	Kennedy Krieger Institute, Baltimore, Maryland, United States|Kennedy Krieger Institute, Columbia, Maryland, United States		https://ClinicalTrials.gov/show/NCT05238766
765	NCT02902952	Physical Exercise to Reduce Anxiety in Underserved Children With ASD	PETRA	Active, not recruiting	No Results Available	Physical Exercise Condition|Control Condition	Behavioral: Physical Exercise|Behavioral: Control Intervention	Anxiety rating|Salivary Cortisol	University of California, Irvine|Massachusetts General Hospital|University of Missouri-Columbia	All	6 Years to 12 Years   (Child)	Not Applicable	220	Other	Interventional	Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Treatment	HS 2016-2859	October 2016	March 2024	March 2024	September 16, 2016		May 17, 2022	2500 Red Hill Avenue, Santa Ana, California, United States|Thompson Center for Autism, Columbia, Missouri, United States		https://ClinicalTrials.gov/show/NCT02902952
766	NCT02908321	CBT for Anxiety Disorder in Children With Co-morbid ASD		Completed	No Results Available	Randomized Treatment Study	Behavioral: CBT	Anxiety Disorders Interview Schedule for DSM-IV: Parent & Child interview schedule (ADIS/CP).|Spence Children's Anxiety Scale (SCAS),|Children's Anxiety Life Inference Scale (CALIS)|Children's Automatic Thoughts Scale (CATS).	University of Aarhus	All	7 Years to 14 Years   (Child)	Not Applicable	49	Other	Interventional	Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Treatment	2016-2018	August 2016	September 2019	December 2019	September 20, 2016		November 10, 2020	Centre for Child and Adolescent Psychiatry, Risskov, Region Of Midtjylland, Denmark		https://ClinicalTrials.gov/show/NCT02908321
767	NCT03826498	Allogenic Cord Blood Transfusion in Patients With Cerebral Palsy		Active, not recruiting	No Results Available	Cerebral Palsy	Biological: CP CB-MNC injection|Other: Standard therapy	Number of participants with non-serious and serious adverse events|Changes in Standardized Gross Motor Function 66 (GMFM-66) Score for all child.|Changes in Cognitive Neurodevelopmental Outcome for child before 3yrs|Changes in The Infant Toddler Quality of Life Questionnaire for child above 3yrs.|Changes in Ashworth scale score for all child.|Number of Participants with Chimerism (longevity) of infused cell	State-Financed Health Facility "Samara Regional Medical Center Dinasty"	All	1 Year to 10 Years   (Child)	Phase 2	40	Other	Interventional	Allocation: Non-Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Treatment	12102017	January 12, 2018	December 26, 2021	January 26, 2022	February 1, 2019		March 17, 2021	Medical Centre Dinasty, Samara, Russian Federation		https://ClinicalTrials.gov/show/NCT03826498
768	NCT04327648	Effect and Mechanism of Social Interaction Treatment on ASD Children		Not yet recruiting	No Results Available	ASD	Device: Social interaction treatment|Device: Neuronal cognition treatment|Other: Routine treatment	Childhood Autism Rating Scale, (CARS)|Social responsiveness scale, (SRS)|Autism Diagnostic Observation Schedule, ADOS|Clinical Global Impression, CGI	Xinhua Hospital, Shanghai Jiao Tong University School of Medicine	All	3 Years to 6 Years   (Child)	Not Applicable	90	Other	Interventional	Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)|Primary Purpose: Treatment	XH-20-004	June 1, 2020	December 30, 2023	December 30, 2023	March 31, 2020		March 31, 2020			https://ClinicalTrials.gov/show/NCT04327648
769	NCT05135728	Development and Pilot Testing of a Novel Preschool Executive Function Curriculum		Enrolling by invitation	No Results Available	Executive Dysfunction	Behavioral: Unstuck and On Target: Preschool|Behavioral: Treatment as Usual	Feasibility of Intervention|Feasibility - Child Attendance|Acceptability of Intervention|Intervention Appropriateness|Fidelity Observations|Interventionist Knowledge	Children's National Research Institute|AppleTree Institute|The Maddux School	All	3 Years to 6 Years   (Child)	Not Applicable	55	Other	Interventional	Allocation: Non-Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Treatment	Pro00014103	November 15, 2021	June 30, 2026	June 30, 2026	November 26, 2021		November 7, 2022	Children's National Hospital, Silver Spring, Maryland, United States		https://ClinicalTrials.gov/show/NCT05135728
770	NCT03354923	Parent-Child Reciprocity and the Effectiveness of PEERS	ISR-PEERS	Unknown status	No Results Available	Social Skills|Parent-Child Relational Problem	Behavioral: PEERS intervention	Change from baseline Parent-Adolescent reciprocity paradigm at 4 and 8 months|Change from baseline Contextual Assessment of Social Skills at 4 and 8 months|Change from baseline Social Responsiveness Scale at 4 and 8 months|Change from baseline The Social Skills Improvement System at 4 and 8 months|Change from baseline Friendship Qualities Scale|Change from baseline Quality of Play Questionnaire at 4 and 8 months|Change from baseline Test of Adolescent Social Skills Knowledge at 4 and 8 months|Change from baseline Vineland Adaptive Behaviors Scales II at 4 and 8 months|Change from baseline Loneliness and Social Dissatisfaction Questionnaire at 4 and 8 months|Change from baseline Beck Depression Inventory II at 4 and 8 months|Change from baseline Autism Spectrum Quotient at 4 and 8 months|Change from baseline Empathy Quotient at 4 and 8 months|Change from baseline Parenting Stress Index Short Form at 4 and 8 months	Bar-Ilan University, Israel	All	12 Years to 17 Years   (Child)	Not Applicable	80	Other	Interventional	Allocation: Randomized|Intervention Model: Crossover Assignment|Masking: Single (Outcomes Assessor)|Primary Purpose: Treatment	BIU121216	January 2016	August 2018	August 2019	November 28, 2017		February 26, 2019	Bar Ilan University, Ramat Gan, Israel		https://ClinicalTrials.gov/show/NCT03354923
771	NCT04237870	Effect of rTMS on the Abnormal Executive Function of ASD Children		Unknown status	No Results Available	Executive Dysfunction|ASD	Device: Active cTBS|Device: Sham	Change in scores on Behaviour Rating Inventory of Executive Functioning (BRIEF)|Change in scores, reaction time and brain blood flow on the Working Memory Task by fNIRS|Change in size and connections of different parts of the brain to assess brain structure and blood flow by functional magnetic resonance imaging (fMRI)	Xinhua Hospital, Shanghai Jiao Tong University School of Medicine	All	6 Years to 16 Years   (Child)	Not Applicable	40	Other	Interventional	Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)|Primary Purpose: Treatment	XH-19-013	January 1, 2019	August 31, 2021	September 30, 2021	January 23, 2020		January 23, 2020	Fei Li, Shanghai, Shanghai, China		https://ClinicalTrials.gov/show/NCT04237870
772	NCT01712464	Modulation of Reinforcement Learning		Completed	No Results Available	Impact of Oxytocin on Social Learning	Drug: Oxytocin vs. Placebo	Bold Signal in nucleus accumbens|Bold signal in ventral tegmental areal	RWTH Aachen University	Male	18 Years to 26 Years   (Adult)	Not Applicable	60	Other	Interventional	Allocation: Randomized|Intervention Model: Crossover Assignment|Masking: Double (Participant, Investigator)|Primary Purpose: Diagnostic	12-033	October 18, 2013	August 7, 2016	August 7, 2016	October 23, 2012		May 1, 2018	Universtiy Hospital Aachen, Aachen, Northrhine-Westfalia, Germany		https://ClinicalTrials.gov/show/NCT01712464
773	NCT05281965	A Clinical Study Evaluating the Efficacy and Safety of Retinoic Acid in Patients With 15q11-q13 Duplication Syndrome		Recruiting	No Results Available	Autism|Treatment Adherence|Retinoic Acid|Dup15Q Syndrome	Drug: Retinoic acid	ADORS-2	Second Affiliated Hospital, School of Medicine, Zhejiang University	All	6 Years to 18 Years   (Child, Adult)	Early Phase 1	20	Other	Interventional	Allocation: Randomized|Intervention Model: Crossover Assignment|Masking: Single (Participant)|Primary Purpose: Treatment	2021-0438	April 1, 2022	June 1, 2023	June 1, 2024	March 16, 2022		March 16, 2022	Zhejiang University, Hangzhou, Zhejiang, China|Miao pu, Hangzhou, China		https://ClinicalTrials.gov/show/NCT05281965
774	NCT01804582	The Family VOICE Study		Completed	Has Results	Autism|Aggression|Bipolar Disorder|Psychotic Disorders	Other: Family Navigator consultation	Family Empowerment Scale|Duke-UNC (University of North Carolina) Functional Social Support Questionnaire|Youth Services Survey for Families|Child Behavior Checklist - Brief Problem Monitor|Psychosocial Service Utilization|Medication Regimen	University of Maryland, Baltimore	All	2 Years to 15 Years   (Child)	Not Applicable	350	Other	Interventional	Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Treatment	HP-00054913|1300476	May 2013	March 31, 2016	March 31, 2016	March 5, 2013	November 20, 2019	November 20, 2019	University of Maryland, School of Medicine, Department of Psychiatry, Division of Child and Adolescent Psychiatry, Baltimore, Maryland, United States		https://ClinicalTrials.gov/show/NCT01804582
775	NCT03880383	BRIGHT Coaching Program for Families		Active, not recruiting	No Results Available	Mental Health Wellness 1|Parent-Child Relations|Child Developmental Delay|Parenting|Parent-child Problem|Child Development Disorder|Autism Spectrum Disorder	Behavioral: Coaching|Behavioral: Online parent education|Behavioral: Online peer support	Family Empowerment Scale (FES) - change is being assessed.|Parent Sense of Competency (PSOC) Scale - change is being assessed.|36-Item Short Form Survey (SF-36) - change is being assessed.|Parenting Stress Index - 36 (PSI-36) - change is being assessed.|Measure of Process of Care - 20 (MPOC - 20) - change is being assessed.|Resource Utilization Questionnaire - Preschoolers (RUQ-P) - change is being assessed.	McGill University Health Centre/Research Institute of the McGill University Health Centre|Canadian Institutes of Health Research (CIHR)|University of Alberta	All	18 Months to 54 Months   (Child)	Not Applicable	350	Other	Interventional	Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Health Services Research	2017-3159	August 23, 2018	September 2022	March 2023	March 19, 2019		August 24, 2022	Child Health BC, BC Children's Hospital, UBC, Vancouver, British Columbia, Canada|Specialized Services for Children and Youth (SSCY) Centre, Winnipeg, Manitoba, Canada|Izaak Walton Killam (IWK) Health Centre, Halifax, Nova Scotia, Canada|Research Institute of McGill University Health Centre, Montreal Children's Hospital, Montréal, Quebec, Canada	"Study Protocol", https://ClinicalTrials.gov/ProvidedDocs/83/NCT03880383/Prot_000.pdf	https://ClinicalTrials.gov/show/NCT03880383
776	NCT01379443	Rehabilitation of Children With Multiple Disabilities		Completed	No Results Available	Cerebral Palsy|Autism|Down's Syndrome|Brain Injury	Other: CTN model of care for children and their families	Parental reports in the Quality of Life of Children and Youth|Integration of teams amongst service providers. Integration was measured at two levels using the Integration of Human Services Measure.	Children's Treatment Network|McMaster University	All	1 Minute to 19 Years   (Child, Adult)	Phase 1	445	Other	Interventional	Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Double (Investigator, Outcomes Assessor)|Primary Purpose: Health Services Research	2008H00766	April 2007	December 2009	December 2009	June 23, 2011		June 23, 2011	McMaster University, Hamilton, Ontario, Canada		https://ClinicalTrials.gov/show/NCT01379443
777	NCT03852550	READYorNot[TM] Brain-Based Disabilities Trial		Active, not recruiting	No Results Available	Autism Spectrum Disorder|Cerebral Palsy|Epilepsy|Fetal Alcohol Spectrum Disorders|Spina Bifida	Other: e-health application	Transition Readiness Assessment Questionnaire (TRAQ) Change|Canadian Occupational Performance Measure (COPM) Change|TRANSITION-Q Change|Pediatric Quality of Life Instrument (PedsQL[TM]) Change|Measure of Process of Care (MPOC) Change|Health Utilities Index® (Hui2/3) Proxy-Assessed Change|Resource Use Questionnaire (RUQ) Change|System Usability Scale (SUS)	McMaster University|Canadian Institutes of Health Research (CIHR)|McGill University Health Centre/Research Institute of the McGill University Health Centre|The Montreal Children's Hospital Foundation|McMaster Children's Hospital Foundation|Hamilton Health Sciences Corporation|New Brunswick Health Research Foundation|The Hospital for Sick Children|Harvard Medical School (HMS and HSDM)|Oregon Health and Science University	All	15 Years to 17 Years   (Child)	Not Applicable	46	Other	Interventional	Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Health Services Research	1666	June 22, 2020	July 31, 2022	December 2022	February 25, 2019		March 17, 2022	Alberta Health Services and The Governors of the University of Alberta, Edmonton, Alberta, Canada|Horizon Health Network, Saint John, New Brunswick, Canada|Izaak Walton Killam Health Centre (IWK), Halifax, Nova Scotia, Canada|McMaster Children's Hospital, Hamilton Health Sciences, Hamilton, Ontario, Canada|Lawson Health Research Institute, London, Ontario, Canada|Children's Hospital of Eastern Ontario Research Institute Inc., Ottawa, Ontario, Canada|Holland Bloorview Kids Rehabilitation Hospital, Toronto, Ontario, Canada		https://ClinicalTrials.gov/show/NCT03852550
778	NCT05584059	iACT Programme for Parents of Children With Special Healthcare Needs - Phase I		Not yet recruiting	No Results Available	Neurodevelopmental Disorders|Attention Deficit Hyperactivity Disorder|Autism Spectrum Disorder|Development Delay|Chronic Disease	Behavioral: Focused Acceptance and Commitment Therapy	Parental depressive symptoms|Parental anxiety symptoms|Parental Stress|Parental Psychological Flexibility	Chinese University of Hong Kong|Hong Kong Association of Youth Department|Hong Kong Christian Service|Hong Kong Federation of Youth Groups|Hong Kong School Nurse Association|Hong Kong Young Women's Christian Association|Yang Memorial Methodist Social Service	All	21 Years and older   (Adult, Older Adult)	Not Applicable	150	Other	Interventional	Allocation: N/A|Intervention Model: Single Group Assignment|Masking: None (Open Label)|Primary Purpose: Treatment	ITB/FBL/6033/21/P	October 17, 2022	June 9, 2023	May 31, 2024	October 18, 2022		October 18, 2022			https://ClinicalTrials.gov/show/NCT05584059
779	NCT03217110	Cerebellar Stimulation and Cognitive Control		Recruiting	No Results Available	Schizophrenia|Autism Spectrum Disorder|Bipolar Disorder|Depression|Parkinson Disease	Device: Repetitive Transcranial Magnetic Stimulation (rTMS)|Device: Sham Repetitive Transcranial Magnetic Stimulation (rTMS)	Change in disease-specific symptom rating scale, one scale identified for each group (MADRS for bipolar group; PANSS for schizophrenia group; UPDRS in Parkinson's patient group).|Change in brain rhythms|Change in cognitive function|Changes in functional MRI|Change in NIH Toolbox emotion battery|Change in motor function|Schizophrenia group: Change in Calgary depression scale.|Bipolar group: Change in Young Mania Rating Scale.|Bipolar group: Change in Columbia Suicide Severity Rating Scale.|Change in PHQ9 score.|Change in CGI.|Change in cognitive function.|Changes in structural MRI.|Changes in MRI-based timing task.|Changes in DTI.|Changes in T1 rho MRI signal.	Krystal Parker, PhD|University of Iowa	All	18 Years to 90 Years   (Adult, Older Adult)	Not Applicable	200	Other	Interventional	Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Single (Participant)|Primary Purpose: Basic Science	201610712	November 30, 2017	August 1, 2023	August 1, 2023	July 13, 2017		April 15, 2022	University of Iowa, Iowa City, Iowa, United States		https://ClinicalTrials.gov/show/NCT03217110
780	NCT00391261	An Open-label Trial of Metformin for Weight Control of Pediatric Patients on Antipsychotic Medications.		Completed	No Results Available	Schizophrenia|Schizoaffective Disorder|Schizophreniform Disorder|Bipolar Disorder|Autism Spectrum Disorders	Drug: Metformin	BMI|MOSES	Cambridge Health Alliance|American Psychiatric Association	All	10 Years to 18 Years   (Child, Adult)	Phase 4	11	Other	Interventional	Allocation: Non-Randomized|Intervention Model: Single Group Assignment|Masking: None (Open Label)|Primary Purpose: Treatment	CHA-IRB-0143/12/05	July 2006	October 2007	October 2007	October 23, 2006		March 25, 2010	Cambridge Health Alliance, Medford, Massachusetts, United States		https://ClinicalTrials.gov/show/NCT00391261
781	NCT00318162	Trial of Low-Dose Naltrexone for Children With Pervasive Developmental Disorder (PDD)		Unknown status	No Results Available	Pervasive Developmental Disorder	Drug: low dose naltrexone	play observation|Autism Behavior Checklist (ABC) questionnaire	Hadassah Medical Organization|Jerusalem Institute for Child Development	All	3 Years to 6 Years   (Child)	Phase 1|Phase 2	50	Other	Interventional	Allocation: Randomized|Intervention Model: Crossover Assignment|Masking: Double|Primary Purpose: Treatment	PDDLDN-HMO-CTIL				April 26, 2006		May 3, 2006	Jerusalem Institute for Child Development, Jerusalem, Israel		https://ClinicalTrials.gov/show/NCT00318162
782	NCT02766101	Manville Moves: an Exercise Intervention for Behavioral Regulation Among Children With Behavioral Health Challenges	MM	Completed	No Results Available	Autistic Disorder|Attention Deficit and Disruptive Behavior Disorders|Anxiety Disorders|Mood Disorders|Conduct Disorder|Oppositional Defiant Disorder	Behavioral: Aerobic Exergaming PE Curriculum|Behavioral: Standard PE	Change in Minutes and Number of Disciplinary Time Out of Class Events (classroom functioning)|Change in Conners Abbreviated Teacher Rating Scale score (behavioral dysregulation: impulsivity/emotional lability)	Harvard School of Public Health (HSPH)|Judge Baker Children's Center	All	7 Years to 18 Years   (Child, Adult)	Not Applicable	103	Other	Interventional	Allocation: Randomized|Intervention Model: Crossover Assignment|Masking: None (Open Label)|Primary Purpose: Treatment	IRB14-2312	October 2014	April 2015	April 2015	May 9, 2016		May 9, 2016	Judge Baker Children's Center, Manville School, Boston, Massachusetts, United States		https://ClinicalTrials.gov/show/NCT02766101
783	NCT04158960	Motor Skill Proficiency After Equine-assisted Activities and Brain-building Tasks		Completed	No Results Available	Motor Delay|Motor Skills Disorders|Autism Spectrum Disorder|Attention Deficit Hyper Activity|Intellectual Disability|Sensory Disorders	Behavioral: Equine-assisted activities|Behavioral: GaitWay program	Fine motor precision|Fine motor integration|Manual dexterity|Bilateral coordination|Balance|Running speed and agility|Upper-limb coordination|Strength|Overall Motor Skill Scores|Caregiver reports	Texas Woman's University	All	5 Years to 18 Years   (Child, Adult)	Not Applicable	25	Other	Interventional	Allocation: Non-Randomized|Intervention Model: Crossover Assignment|Masking: Single (Care Provider)|Primary Purpose: Treatment	17959	February 1, 2015	May 31, 2018	May 31, 2018	November 12, 2019		November 12, 2019			https://ClinicalTrials.gov/show/NCT04158960
784	NCT01919970	Exposure-Focused Family-Based CBT for Youth With ASD and Comorbid Anxiety		Completed	Has Results	Autism|Asperger's Syndrome|Pervasive Developmental Disorder Not Otherwise Specified|Generalized Anxiety Disorder|Social Phobia|Separation Anxiety Disorder|Obsessive-compulsive Disorder|Specific Phobia	Other: Cognitive Behavioral Therapy|Other: Treatment as usual	Pediatric Anxiety Rating Scale|Clinical Global Impression - Severity Scale	University of South Florida	All	6 Years to 12 Years   (Child)	Not Applicable	32	Other	Interventional	Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Single (Outcomes Assessor)|Primary Purpose: Treatment	ASD-FET 2013	August 2013	August 2016	August 2017	August 9, 2013	June 14, 2019	June 14, 2019	Rothman Center for Neuropsychiatry, Saint Petersburg, Florida, United States		https://ClinicalTrials.gov/show/NCT01919970
785	NCT00147394	Risperidone Pharmacokinetics in Children With Pervasive Developmental Disorder (PDD)		Completed	No Results Available	Child Development Disorders, Pervasive	Drug: Risperidone	Quantify the variability of clearance and volume of distribution among AE rating, weight gain and ABC responder status.|Exploratory analysis will be performed to examine the relationship of other factors to risperidone and metabolite concentrations for PK/PD assessment.	Children's Hospital Medical Center, Cincinnati	All	5 Years to 16 Years   (Child)	Phase 1	100	Other	Interventional	Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Treatment	PPRU 10544	December 2001		June 2004	September 7, 2005		October 29, 2012	Children's Hospital of Michigan/Wayne State University, Detroit, Michigan, United States|Duke University Medical Center, Durham, North Carolina, United States|Cincinnati Children's Hospital, Cincinnati, Ohio, United States|Rainbow Babies and Children's Hospital, Cleveland, Ohio, United States|The Ohio State University Medical Center, Columbus, Ohio, United States		https://ClinicalTrials.gov/show/NCT00147394
786	NCT04255472	Effectiveness of the WHO Caregivers Skills Training Program		Unknown status	No Results Available	Autism Spectrum Disorder|Development Delay|Developmental Disorder|Language Delay|Behavioral Problem|Emotional Problem|Maternal Distress	Behavioral: WHO Caregiver skills training (CST) program|Behavioral: Treatment as usual	Play-based caregiver-child interaction|Adaptive functioning behaviors|Child emotional and behavioral problems|Parental health related quality of life|Health services utilization|Communication and Symbolic Behavior	Human Development Research Foundation, Pakistan|World Health Organization|University of Liverpool|WHO Collaborating Center for mental health research, Institute of Psychiatry, Rawalpindi, Pakistan	All	2 Years to 9 Years   (Child)	Not Applicable	160	Other	Interventional	Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Double (Investigator, Outcomes Assessor)|Primary Purpose: Treatment	WHO CST-RCT	February 11, 2020	December 31, 2020	January 31, 2021	February 5, 2020		February 25, 2020	Human Development Research Foundation, Islamabad, Pakistan		https://ClinicalTrials.gov/show/NCT04255472
787	NCT05284435	Internet-Based, Parent-Led Cognitive-Behavioral Therapy for Anxiety in Youth With ASD		Recruiting	No Results Available	Cognitive Behavioral Therapy|Autism Spectrum Disorder|Anxiety Disorder|Obsessive-Compulsive Disorder|Social Anxiety Disorder|Generalized Anxiety Disorder|Specific Phobia	Behavioral: Cognitive Behavioral Therapy-Email (iCBT-E)|Behavioral: Cognitive Behavioral Therapy-Email and Videoconferencing (iCBT-EV)	5-item Pediatric Anxiety Rating Scale - Autism Spectrum Disorder|Clinical Global Impression-Improvement|Revised Child Anxiety and Depression Scale- Parent-Report- Anxiety Subscale|Revised Child Anxiety and Depression Scale- Self-Report- Anxiety Subscale|Social Responsiveness Scale, Second Edition|Sheehan Disability Scale	Baylor College of Medicine	All	7 Years to 15 Years   (Child)	Not Applicable	256	Other	Interventional	Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Single (Outcomes Assessor)|Primary Purpose: Treatment	H-51359	March 28, 2022	May 2023	September 2023	March 17, 2022		September 15, 2022	Baylor College of Medicine, Houston, Texas, United States		https://ClinicalTrials.gov/show/NCT05284435
788	NCT04111874	Parent-Led Cognitive-Behavioral Teletherapy for Anxiety in Youth With ASD		Active, not recruiting	No Results Available	Cognitive Behavioral Therapy|Autism Spectrum Disorder|Anxiety Disorders|Obsessive-Compulsive Disorder|Social Anxiety Disorder|Generalized Anxiety Disorder|Specific Phobia	Behavioral: Cognitive Behavioral Teletherapy LTA|Behavioral: Cognitive Behavioral Teletherapy STA	6-item Pediatric Anxiety Rating Scale|Clinical Global Impression-Improvement|Clinical Global Impression-Severity	Baylor College of Medicine	All	7 Years to 13 Years   (Child)	Not Applicable	190	Other	Interventional	Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Single (Outcomes Assessor)|Primary Purpose: Treatment	H45203	July 30, 2019	December 31, 2022	December 31, 2022	October 1, 2019		September 13, 2022	Baylor College of Medicine, Houston, Texas, United States		https://ClinicalTrials.gov/show/NCT04111874
789	NCT03720795	Stepped-Care Cognitive-Behavioral Treatment for Youth With ASD and Anxiety		Active, not recruiting	No Results Available	Cognitive Behavioral Therapy|Autism Spectrum Disorder|Anxiety Disorders|Obsessive-Compulsive Disorder|Social Anxiety Disorder|Generalized Anxiety Disorder|Specific Phobia	Behavioral: Stepped Care CBT	6-item Pediatric Anxiety Rating Scale|Clinical Global Impression-Improvement|Clinical Global Impression-Severity	Baylor College of Medicine	All	4 Years to 14 Years   (Child)	Not Applicable	200	Other	Interventional	Allocation: N/A|Intervention Model: Single Group Assignment|Masking: None (Open Label)|Primary Purpose: Treatment	BCM SC-CBT001	February 1, 2019	December 30, 2021	December 31, 2022	October 25, 2018		February 1, 2022	Baylor College of Medicine, Houston, Texas, United States		https://ClinicalTrials.gov/show/NCT03720795
790	NCT04689282	Intranasal Inhalations of M2 Macrophage Soluble Factors in Children With Developmental Speech Disorders		Completed	No Results Available	Language Delay|Language; Developmental Disorder, Expressive|Language; Developmental Disorder, Receptive|Autism Spectrum Disorder|Attention Deficit-Hyperactivity Disorder|Speech Disorders in Children	Biological: Bioactive Factors, Produced by M2 Type Macrophages (M2-BFs).	Change in the severity of speech disorders according to Speech Assessment Scale (SAS)|The number of patients with adverse events	Russian Academy of Medical Sciences	All	3 Years to 18 Years   (Child, Adult)	Phase 1|Phase 2	14	Other	Interventional	Allocation: N/A|Intervention Model: Single Group Assignment|Masking: None (Open Label)|Primary Purpose: Treatment	IFCI-23/06/2017	February 1, 2020	September 1, 2021	September 1, 2021	December 30, 2020		May 2, 2022	Institute of Fundamental and Clinical Immunology, Novosibirsk, Russian Federation		https://ClinicalTrials.gov/show/NCT04689282
791	NCT05056415	Effect and Cost-effectiveness of the Everyday Life Rehabilitation Intervention	ELR	Recruiting	No Results Available	Psychiatric or Mood Diseases or Conditions|Neuropsychiatric Syndrome|Psychosis|Autism|Severe Mental Disorder	Other: Everyday Life Rehabilitation (ELR)|Other: Treatment as usual (TAU)	Change from baseline 'Recovering quality of life score' at 6 months|Change from baseline 'Total Recovery score' at 6 months	Umeå University|Swedish Council for Working Life and Social Research	All	18 Years and older   (Adult, Older Adult)	Not Applicable	140	Other	Interventional	Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Triple (Participant, Investigator, Outcomes Assessor)|Primary Purpose: Health Services Research	330210302 - FORTE 2021-2024, M	September 15, 2021	March 15, 2024	March 15, 2024	September 24, 2021		November 14, 2022	Umeå university, Umeå, Sweden	"Statistical Analysis Plan", https://ClinicalTrials.gov/ProvidedDocs/15/NCT05056415/SAP_000.pdf	https://ClinicalTrials.gov/show/NCT05056415
792	NCT04293120	Training Balance Among People With Neurodevelopmental Disabilities	TAPAS	Terminated	No Results Available	Posture|Balance|Cerebral Palsy|Autism|Down Syndrome	Other: Training with weighted ball	Muscle activation timing|Muscle amplitude response	University of Hartford|Universita di Verona	All	8 Years to 25 Years   (Child, Adult)	Not Applicable	3	Other	Interventional	Allocation: N/A|Intervention Model: Single Group Assignment|Masking: None (Open Label)|Primary Purpose: Treatment	PRO19020012	February 10, 2020	August 31, 2020	August 31, 2020	March 3, 2020		June 1, 2021	University of Hartford, West Hartford, Connecticut, United States		https://ClinicalTrials.gov/show/NCT04293120
793	NCT00870974	A PET Brain Imaging Study of mGluR5 in Subjects With Neuropsychiatric Conditions	FPEB	Completed	No Results Available	Parkinson Disease|Huntington Disease|Autistic Spectrum Disorders|Fragile X Syndrome|Alzheimer Disease|Mild Cognitive Impairment	Drug: [18F]FPEB	Does FPEB reliably represent the known distribution of MGLUR5 in the brain?	Institute for Neurodegenerative Disorders	All	18 Years to 85 Years   (Adult, Older Adult)	Phase 1	48	Other	Interventional	Allocation: N/A|Intervention Model: Single Group Assignment|Masking: None (Open Label)	FPEB	March 2009	October 2016	November 2016	March 27, 2009		January 6, 2017	Institute for Neurodegenerative Disorders, New Haven, Connecticut, United States		https://ClinicalTrials.gov/show/NCT00870974
794	NCT02714868	Evaluation of Project TEAM (Teens Making Environmental and Activity Modifications)	ProjectTEAM	Completed	Has Results	Transition-age Youth|Developmental Disabilities|Cerebral Palsy|Autism|Intellectual Disability	Behavioral: Project TEAM|Behavioral: Matched Comparison	Goal Attainment Scaling (GAS)|Project TEAM Knowledge Test|AIR Self-Determination Scale (American Institutes on Research- AIR)|Generalized Self Efficacy Scale (GSES)|Participation and Environment Measure for Children and Youth (PEM-CY)|Readiness for Advocacy	Boston University Charles River Campus|Wayne State University	All	14 Years to 21 Years   (Child, Adult)	Not Applicable	82	Other	Interventional	Allocation: Non-Randomized|Intervention Model: Parallel Assignment|Masking: Single (Outcomes Assessor)|Primary Purpose: Treatment	H133G120091|90IF0032-01-00	October 2012	September 2016	July 31, 2017	March 22, 2016	November 25, 2019	November 25, 2019			https://ClinicalTrials.gov/show/NCT02714868
795	NCT01313325	Hippotherapy to Improve the Balance of Children With Movement Disorders	HPOT	Completed	No Results Available	Neuromuscular Diseases|Cerebral Palsy|Down Syndrome|Autism|Developmental Coordination Disorder	Other: Hippotherapy	Pediatric Balance Scale|Activities Scale for Kids	Central Michigan University	All	5 Years to 17 Years   (Child)	Not Applicable	16	Other	Interventional	Allocation: N/A|Intervention Model: Single Group Assignment|Masking: Single (Outcomes Assessor)|Primary Purpose: Treatment	09/14/2006	September 2006	December 2007	December 2007	March 11, 2011		March 11, 2011	CHUM Therapeutic Riding Center, Dansville, Michigan, United States		https://ClinicalTrials.gov/show/NCT01313325
796	NCT01243905	Group Psychoeducational Program for Mothers of Children With High Functional Pervasive Developmental Disorders		Unknown status	No Results Available	Pervasive Developmental Disorder	Other: Family psychoeducational therapy plus TAU|Other: Treatment as usual	Change from baseline in the total score of the General Health Questionaire 28(GHQ28) at 21 weeks|Change from baseline in the total score of the General Health Questionaire 28(GHQ28) at 7 weeks|Change from baseline in the total score of the Abnormal Behavior Checklist at 7 weeks	Nagoya City University	Female	Child, Adult, Older Adult	Phase 2|Phase 3	74	Other	Interventional	Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Treatment	NCUPsychiatry003	September 2010	December 2011	March 2012	November 19, 2010		January 19, 2011	Nagoya City University Hospital, Nagoya, Aichi, Japan|Nagoya City University Hospital, Nagoya, Aichi, Japan		https://ClinicalTrials.gov/show/NCT01243905
797	NCT00709202	Efficacy and Tolerability Study of Betahistine to Ameliorate Antipsychotic Associated Weight Gain		Completed	Has Results	Schizophrenia|Schizoaffective Disorder|Schizophreniform Disorder|Bipolar I Disorder|Bipolar II|Bipolar NOS(Not Otherwise Specified)|Psychotic Disorder Not Otherwise Specified|Autism Spectrum Disorder	Drug: Betahistine|Drug: Placebo Oral Tablet	Change in Weight|Change in Body Mass Index (BMI)|Change in Waist Circumference|Change in Hip Circumference|Change in Glucose|Change in Cholesterol|Change in LDL|Change in HDL|Change in Triglycerides|Change in Appetite Hunger|Change in Appetite Fullness	Nathan Kline Institute for Psychiatric Research|Stanley Medical Research Institute	All	18 Years to 59 Years   (Adult)	Phase 2	48	Other	Interventional	Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)|Primary Purpose: Treatment	07TGF-1112	July 2008	May 2016	December 2016	July 3, 2008	January 25, 2019	January 25, 2019	Nathan Kline Insitute for Psychiatric Research, Orangeburg, New York, United States		https://ClinicalTrials.gov/show/NCT00709202
798	NCT05467527	PACT Programme for Parents of Children With SHCN		Recruiting	No Results Available	Urologic Diseases|Gastrointestinal Diseases|Vascular Diseases|Cleft Lip and Palate|Neurodevelopmental Disorders|Attention Deficit Hyperactivity Disorder|Autism Spectrum Disorder|Developmental Delay	Behavioral: Prosocial-orientated Acceptance and Commitment Training plus positive parenting advice|Behavioral: Positive parenting advice	Parental mental well-being|Child mental well-being|Parental psychological flexibility|Parental prosociality|Parenting competence|Family functioning	Chinese University of Hong Kong|Hong Kong Children's Hospital|Hong Kong Young Women's Christian Association	All	21 Years and older   (Adult, Older Adult)	Not Applicable	196	Other	Interventional	Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Triple (Participant, Investigator, Outcomes Assessor)|Primary Purpose: Treatment	2191269	June 27, 2022	December 12, 2023	September 29, 2024	July 20, 2022		July 20, 2022	Department of Surgery, Hong Kong Children's Hospital, Ngau Tau Kok, Kowloon, Hong Kong|Hong Kong Young Women's Christian Association, Kowloon, Hong Kong		https://ClinicalTrials.gov/show/NCT05467527
799	NCT03342495	Evaluating Innovations in Transition From Pediatric to Adult Care - The Transition Navigator Trial	TNT	Active, not recruiting	No Results Available	Diabetes|Endocrine System Diseases|Gastro-Intestinal Disorder|Neuro-Degenerative Disease|Epilepsy|Autoimmune Diseases|Renal Disease|Cardiac Disease|Metabolic Disease|Genetic Diseases, Inborn|Respiratory Disease|Hematologic Diseases|Autism Spectrum Disorder|Fetal Alcohol Spectrum Disorders|Traumatic Brain Injury|Stroke	Other: Patient Navigator|Other: Usual Care	Health services utilization|cost analysis|Variation in TRAQ (Transition Readiness Questionnaire) scores|Variation in SF-12 Scores	University of Calgary|Alberta Health services|University of Alberta	All	16 Years to 21 Years   (Child, Adult)	Not Applicable	337	Other	Interventional	Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Health Services Research	REB16-2561	February 6, 2018	August 31, 2021	December 31, 2022	November 17, 2017		September 24, 2021	Alberta Children's Hospital, Calgary, Alberta, Canada|Glenrose Rehabilitation Hospital, Edmonton, Alberta, Canada|Stollery Childrens Hospital, Edmonton, Alberta, Canada		https://ClinicalTrials.gov/show/NCT03342495
800	NCT03522337	Oral Health Promotion Among Preschool Children With Special Needs		Completed	No Results Available	Intellectual Disability|Cerebral Palsy|Developmental Disorders|Developmental Delay|Autistic Spectrum Disorders|Down Syndrome|Epilepsy|Developmental Disability|Learning Disorders	Other: Visual pedagogy (social stories)|Other: Conventional leaflets	Change in carious tooth surfaces over course of the trial|Change in the prevalence of dental caries|Change in oral hygiene status|Change in gingival status|Change in children's tooth-brushing performance|Change in children's eating habits|Change in children's dental-visit experience|The amount of toothpaste|Toothbrush wear	The University of Hong Kong	All	2 Years to 6 Years   (Child)	Not Applicable	306	Other	Interventional	Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Double (Participant, Outcomes Assessor)|Primary Purpose: Prevention	SCCC2016to2018|HKUCTR-2015	April 12, 2016	September 28, 2018	September 30, 2018	May 11, 2018		April 18, 2019	Dental Faculty, The University of Hong Kong, Hong Kong, Hong Kong, China	"Statistical Analysis Plan", https://ClinicalTrials.gov/ProvidedDocs/37/NCT03522337/SAP_000.pdf|"Study Protocol", https://ClinicalTrials.gov/ProvidedDocs/37/NCT03522337/Prot_001.pdf	https://ClinicalTrials.gov/show/NCT03522337
801	NCT05274126	Implementation of a Social and Mental Health Support to Promote Recovery in Five Mental Health Facilities in Paris Area	PASSVERS-2	Not yet recruiting	No Results Available	Severe Mental Disorder	Behavioral: Patient group/Passvers	Patient self rating of recovery support by caregivers T0|Patient self rating of recovery support by caregivers T12|Patient self rating of recovery support by caregivers and structure T0|Patient self rating of recovery support by caregivers and structure T12|Patient functioning T0|Patient functioning T12|Patient functioning T24|Patient self rating of quality of life T0|Patient self rating of quality of life T12|Patient self rating of quality of life T24|Psychotic symptoms T0|Psychotic symptoms T12|Depression T0|Depression T12|Clinical outcome T0: Clinically significant events|Clinical outcome T12: Clinically significant events|Patient self rating of recovery T0|Patient self rating of recovery T12|Patient self rating of recovery T24|Professional's Recovery knowledge on patients T0|Professional's Recovery knowledge on patients T12|Professional's Recovery opinions on patients T0|Professional's Recovery opinions on patients T12|Stigmatization T0|Stigmatization T12|Perceived needs T0|Perceived needs T12|Goal achievement T12|Metacognitive strategies T0|Sleep T0|Sleep T12|Medication adherence T0|Medication adherence T12|Illness severity T0|Illness severity T12|Cognitive disability T0|Cognitive disability T12|Entourage assessment of structure recovery orientation T0|Entourage assessment of structure recovery orientation T12	Versailles Hospital|Agence régionale de santé Ile de France|UNION NATIONALE DE FAMILLES ET AMIS DE PERSONNES MALADES ET/OU HANDICAPÉES PSYCHIQUES	All	18 Years to 65 Years   (Adult, Older Adult)	Not Applicable	300	Other	Interventional	Allocation: N/A|Intervention Model: Single Group Assignment|Masking: None (Open Label)|Primary Purpose: Supportive Care	P20/03_ PASSVERS-2	May 1, 2022	May 1, 2025	May 1, 2026	March 10, 2022		March 25, 2022	Centre Hospitalier d'Argenteuil, secteurs 95G05, 95G06, 95G13,, Argenteuil, France|Hôpital Sainte Anne - GHU Paris Psychiatrie & Neurosciences, secteur G75015, Paris, France|Centre Hospitalier de Plaisir, secteur 78G16, CMP de Rambouillet, Rambouillet, France|Etablissement de Santé Mentale de Rueil-Malmaison, Groupe MGEN, secteur 92G13, CMP de Rueil-Malmaison, Rueil-Malmaison, France|Centre Hospitalier de Versailles, secteur 78G17, Centre Bleuler, Versailles, Versailles, France		https://ClinicalTrials.gov/show/NCT05274126
802	NCT04014413	Safety and Efficacy of Fecal Microbiota Transplantation		Recruiting	No Results Available	Crohn Disease|Ulcerative Colitis|Celiac Disease|Irritable Bowel Syndrome|Functional Dysphonia|Constipation|Clostridium Difficile Infection|Diabetes Mellitus|Obesity|Multidrug -Resistant Infection|Hepatic Encephalopathy|Multiple Sclerosis|Pseudo-Obstruction|Carbapenem-Resistant Enterobacteriaceae Infection|Vancomycin Resistant Enterococci Infection|Multiple Organ Dysfunction Syndrome|Dysbiotic Bowel Syndrome|MRSA Enteritis|Pseudomembranous Enterocolitis|Alopecia|Autism|Graft-versus-host Disease|Idiopathic Thrombocytopenic Purpura|Atopy or Allergy|Liver Disease|Alcohol Dependence|Psoriatic Arthropathy	Procedure: Fecal Microbiota Transplantation	The efficacy of FMT in treating dysbiosis-associated disorder will be assessed by number of patients who have improvement in clinical symptoms (depends on each disease as stated in outcome)|Number of Participants With Treatment-Related Adverse Events as Assessed by CTCAE v4.0	Chinese University of Hong Kong	All	Child, Adult, Older Adult	Not Applicable	450	Other	Interventional	Allocation: Non-Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Treatment	FMT-Pilot	July 15, 2019	October 31, 2023	October 31, 2024	July 10, 2019		February 14, 2022	The Chinese University of Hong Kong, Hong Kong, Shatin, Hong Kong		https://ClinicalTrials.gov/show/NCT04014413
803	NCT03944447	Outcomes Mandate National Integration With Cannabis as Medicine	OMNI-Can	Recruiting	No Results Available	Chronic Pain|Chronic Pain Syndrome|Chronic Pain Due to Injury|Chronic Pain Due to Trauma|Fibromyalgia|Seizures|Hepatitis C|Cancer|Crohn Disease|HIV/AIDS|Multiple Sclerosis|Traumatic Brain Injury|Sickle Cell Disease|Post Traumatic Stress Disorder|Tourette Syndrome|Ulcerative Colitis|Glaucoma|Epilepsy|Inflammatory Bowel Diseases|Parkinson Disease|Amyotrophic Lateral Sclerosis|Chronic Traumatic Encephalopathy|Anxiety|Depression|Insomnia|Autism|Opioid-use Disorder|Bipolar Disorder|Covid19|SARS-CoV Infection|COVID-19|Corona Virus Infection|Coronavirus	Drug: Cannabis, Medical|Device: RYAH-Medtech Inhaler	Prevention of COVID-19|Treatment of COVID-19|Treatment of Symptoms|Cannabis Impact on Quality of Life|Cannabis Route and Dosing|Monitoring Adverse Events	OMNI Medical Services, LLC|OMNI Medical Services Inc	All	7 Years and older   (Child, Adult, Older Adult)	Phase 2	200000	Other	Interventional	Allocation: Non-Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Treatment	Pro00033337	December 1, 2018	December 31, 2025	December 31, 2025	May 9, 2019		June 2, 2022	OMNI Medical Services, Boca Raton, Florida, United States|OMNI Medical Services, Bradenton, Florida, United States|OMNI Medical Services, Fort Lauderdale, Florida, United States|OMNI Medical Services, Fort Myers, Florida, United States|OMNI Medical Services, Gainesville, Florida, United States|OMNI Medical Services, Merritt Island, Florida, United States|OMNI Medical Services, Miami, Florida, United States|OMNI Medical Services, Ocoee, Florida, United States|OMNI Medical Services, Pensacola, Florida, United States|OMNI Medical Services, Pompano Beach, Florida, United States|OMNI Medical Services, Tampa, Florida, United States|OMNI Medical Services, Wesley Chapel, Florida, United States|OMNI Medical Services, Beechwood, Ohio, United States|OMNI Medical Services, Bowling Green, Ohio, United States|OMNI Medical Services, Sandusky, Ohio, United States|OMNI Medical Services, Toledo, Ohio, United States|OMNI Medical Services, Toledo, Ohio, United States		https://ClinicalTrials.gov/show/NCT03944447
804	NCT02396576	Using Telehealth to Deliver Mental Health Services in Primary Care Settings for Children in Underserved Areas		Completed	No Results Available	Developmental, Behavioral and Mental Health|Adhd|Depression|Anxiety|Developmental Delay|Autism|Behavioral Problems	Behavioral: Telehealth Intervention	Access to specialty services- Referral time|Access to specialty services- Travel|Access to specialty services- Missed school/work|Access to specialty services- Out of pocket cost|Access to specialty services- Visits|Quality of care measures|Child Behavior measures|Provider coordination- Communication|Provider coordination- Comfort level	University of California, Los Angeles|Patient-Centered Outcomes Research Institute	All	18 Years and older   (Adult, Older Adult)	Not Applicable	359	Other	Interventional	Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Health Services Research	IH-12-11-4168	April 7, 2015	June 15, 2017	June 15, 2017	March 24, 2015		August 10, 2017	Northeast Valley Health Corporation- Canoga Park, Canoga Park, California, United States|Northeast Valley Health Corporation- Pacoima, Pacoima, California, United States|Northeast Valley Health Corporation- San Fernando, San Fernando, California, United States|Northeast Valley Health Corporation- Santa Clarita, Santa Clarita, California, United States|Northeast Valley Health Corporation- Valencia, Valencia, California, United States|Northeast Valley Health Corporation- Van Nuys, Van Nuys, California, United States		https://ClinicalTrials.gov/show/NCT02396576
805	NCT01166152	Development of a New Diagnosis and Intervention Method for Developmental Disorders	DIDD	Unknown status	No Results Available	Developmental Disabilities	Behavioral: social skills training	thermogram of head|view direction	Tokyo University of Agriculture and Technology|Ashiya University|Saitama Medical University	All	up to 50 Years   (Child, Adult)	Not Applicable	20	Other	Interventional	Allocation: Non-Randomized|Intervention Model: Single Group Assignment|Masking: Single (Participant)|Primary Purpose: Diagnostic	TokyoUAT_21_11	August 2010	November 2011	March 2013	July 20, 2010		July 21, 2011	Ashiya University Graduate School of Clinical Education, Ashiya, Hyogo, Japan		https://ClinicalTrials.gov/show/NCT01166152
806	NCT02922400	Social Cognition Assessment in Young Adults		Completed	No Results Available	Cognitive Function 1, Social	Behavioral: Social Cognition Assessment and Training	Brain Activation Change: Social Cognitive Network|Change in Neuropsychological Scores: Recognizing Emotion|Change in Neuropsychological Scores: Theory of Mind|Change in Neuropsychological Scores: Social Behavior|Change in Neuropsychological Scores: Social Functioning	The University of Texas at Dallas|University of Texas Southwestern Medical Center|Yale University	All	17 Years to 40 Years   (Child, Adult)	Not Applicable	153	Other	Interventional	Allocation: N/A|Intervention Model: Single Group Assignment|Masking: None (Open Label)|Primary Purpose: Supportive Care	STU 042011-021	November 2006	September 2016	January 2018	October 4, 2016		May 8, 2018	Center for BrainHealth University of Texas at Dallas, Dallas, Texas, United States		https://ClinicalTrials.gov/show/NCT02922400
807	NCT02680379	Combined Treatment of Minocycline and Lovastatin to Treat Individuals With Fragile X Syndrome	LovaMiX	Completed	No Results Available	Fragile X Syndrome	Drug: Minocycline, then Minocycline/Lovastatin|Drug: Lovastatin, then Minocycline/Lovastatin	Change from baseline Aberrant Behavior Checklist-Community (ABC-C) total score at 8,12 and 20 weeks|Clinical Global Impression Scale improvement (CGI-I)|Change from baseline Social Responsiveness Scale (SRS) at 8 and 20 weeks|Anxiety, depression and mood scale (ADAMS), change from baseline to 8 and 20 weeks|Behavior Rating Inventory of Executive Function (BRIEF)|Change from baseline Vineland II; adaptive behaviour scale at 20 weeks	Université de Sherbrooke|FRAXA Research Foundation	All	8 Years to 45 Years   (Child, Adult)	Phase 2	22	Other	Interventional	Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Treatment	2016-1177	March 2016	October 2017	November 2017	February 11, 2016		October 15, 2018	Centre de Recherche du CHUS, Sherbrooke, Quebec, Canada		https://ClinicalTrials.gov/show/NCT02680379
808	NCT01474746	Trial of Sertraline to Treat Children With Fragile X Syndrome		Completed	Has Results	Fragile X Syndrome	Drug: Sertraline|Drug: Placebo	Change in Mullen Scales of Early Learning - Expressive Language Raw Score|Clinical Global Impression - Improvement|Change in Mullen Scales of Early Learning - Expressive Language Standard T Score|Autism Diagnostic Observation Schedule|Visual Analog Scale|Eye Tracking|Preschool Language Scale-fifth Edition (PLS-5): AC+EC Total Raw Score|Sensory Processing Measure - Preschool (SPM-P) Social Participation: Raw Score|Sensory Profile - Sensation Seeking Subscale Raw Score|Vineland Adaptive Behavior Scales, Second Edition (Vineland-II) - Adaptive Behavior Composite Standard Score|Mullen Scales of Early Learning - Visual Reception Raw Score|Mullen Scales of Early Learning - Fine Motor Raw Score|The Autism Diagnostic Observation Schedule (ADOS-2)|The Visual Analog Scale|Sensory Processing Measure-Preschool (SPM-P) Social Participation: Raw Score|Vineland Adaptive Behavior Scales, Second Edition (Vineland-II) Adaptive Behavior Composite Standard Score|Mullen Scales of Early Learning - Visual Reception Age-equivalent Score|Mullen Scales of Early Learning - Fine Motor Age-equivalent Score|Mullen Scales of Early Learning - Cognitive T Score Sum|Mullen Scales of Early Learning - Summary Age-equivalent Score	Randi J. Hagerman, MD|University of California, Davis	All	24 Months to 68 Months   (Child)	Phase 2	57	Other	Interventional	Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Triple (Participant, Care Provider, Investigator)|Primary Purpose: Treatment	271070|R40MC22641	January 2012	August 2015	September 2015	November 18, 2011	September 25, 2017	September 25, 2017	UC Davis M.I.N.D. Institute, Sacramento, California, United States		https://ClinicalTrials.gov/show/NCT01474746
809	NCT01777542	Treatment of Rett Syndrome With Recombinant Human IGF-1		Completed	Has Results	Rett Syndrome	Drug: Recombinant Human Insulin Growth Factor 1 (rhIGF-1)|Drug: Placebo	Rett Syndrome Behavior Questionnaire (RSBQ) - Fear/Anxiety Subscale|Anxiety, Depression, and Mood Scale (ADAMS) - Social Avoidance Subscale|Clinical Global Impression - Severity (CGI-S)|Clinical Global Impression - Improvement (CGI-I)|Parental Global Impression - Severity (PGI-S)|Parental Global Impression - Improvement (PGI-I)|Parent Targeted Visual Analog Scale (PTSVAS) - Scale 1|Parent Targeted Visual Analog Scale (PTSVAS) - Scale 2|Parent Targeted Visual Analog Scale (PTSVAS) - Scale 3|Kerr Clinical Severity Scale|Rett Syndrome Behavior Questionnaire (RSBQ)|Anxiety, Depression, and Mood Scale (ADAMS)|Mullen Scales of Early Learning (MSEL)|Vineland Adaptive Behavior Scales, Second Edition (VABS-II)|Communication and Symbolic Behavior Scales - Developmental Profile (CSBS-DP)|Aberrant Behavior Checklist - Community Edition (ABC-C)|Quantitative Measures of Respiration: Apnea Index	Boston Children's Hospital|International Rett Syndrome Foundation	Female	2 Years to 10 Years   (Child)	Phase 2	30	Other	Interventional	Allocation: Randomized|Intervention Model: Crossover Assignment|Masking: Triple (Participant, Care Provider, Investigator)|Primary Purpose: Treatment	IRB-P00005610	January 2013	July 2016	November 2016	January 29, 2013	March 26, 2018	March 26, 2018	Boston Children's Hospital, Boston, Massachusetts, United States		https://ClinicalTrials.gov/show/NCT01777542
810	NCT04003207	Growth Hormone Treatment in Children With Phelan McDermid Syndrome		Completed	No Results Available	Phelan McDermid Syndrome	Drug: Recombinant human Growth hormone	ABC - Social Withdrawal subscale|Repetitive Behavior Scale-Revised (RBS-R)|The Sensory Profile|The Sensory Assessment for Neurodevelopmental Disorders (SAND)|Visual evoked potentials (VEP)|Change in Auditory event related potentials (AERP)	Swathi Sethuram|Icahn School of Medicine at Mount Sinai	All	2 Years to 12 Years   (Child)	Phase 2	6	Other	Interventional	Allocation: N/A|Intervention Model: Single Group Assignment|Masking: None (Open Label)|Primary Purpose: Treatment	GCO 18-2549	September 13, 2019	June 5, 2020	June 5, 2020	July 1, 2019		June 12, 2020	Seaver Autism Center, New York, New York, United States		https://ClinicalTrials.gov/show/NCT04003207
811	NCT01013545	Developmental and Augmented Intervention for Facilitating Expressive Language	CCNIA	Completed	No Results Available	Joint Engagement + Enhanced Milieu Training|Joint Engagement + Enhanced Milieu Training+Augmentative Communication (AAC)	Behavioral: JAE Intervention	Number of words used spontaneously during language sample	Autism Speaks|Hugo W. Moser Research Institute at Kennedy Krieger, Inc.|Vanderbilt University|University of California, Los Angeles	All	5 Years to 8 Years   (Child)	Not Applicable	96	Other	Interventional	Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Double (Participant, Outcomes Assessor)|Primary Purpose: Treatment	G09-04-013-01|5666	July 2009	July 2012	December 2012	November 13, 2009		July 11, 2013	University of California, Los Angeles, Los Angeles, California, United States|Kennedy Krieger Institute, Baltimore, Maryland, United States|Vanderbilt University, Nashville, Tennessee, United States		https://ClinicalTrials.gov/show/NCT01013545
812	NCT03858816	Efficacy of Multiple Strain Probiotics Reduces the Neurobehavioral Disorder in Premature Very Low Birth Weight Infants		Withdrawn	No Results Available	Very Low Birth Weight Infants	Other: Mixture probiotics|Other: Placebo	Incidence rate of death or ADHD and ASD|Incidence rate of NEC ≧ stage 2, sepsis, severe (grade 3-4) IVH, BPD, liver function and adverse effects or intolerance and neurodevelopment impairment.	China Medical University Hospital	All	Child, Adult, Older Adult	Not Applicable	0	Other	Interventional	Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Double (Participant, Investigator)|Primary Purpose: Treatment	CMUH106-REC2-102	June 14, 2018	June 30, 2020	June 30, 2021	March 1, 2019		March 21, 2022	Department of Pediatrics, Children Hospital, China Medical University, Taichung, Taiwan		https://ClinicalTrials.gov/show/NCT03858816
813	NCT00399698	Study to Determine Whether There Are Any Cognitive or Motor Effects From Taking the Medicine Risperidone.		Completed	No Results Available	Oppositional Defiant Disorder|Conduct Disorder|Attention Deficit/Hyperactivity Disorder (ADHD)|Intermittent Explosive Disorder|Impulse-Control Disorders|Adjustment Disorder|Bipolar Disorder|Pervasive Developmental Disorder	Drug: Risperdal	Short Term Recognition Memory task (accuracy)|Titrated Delayed Matching-to-Sample task (accuracy)|Continuous Performance task (omission errors)|Seat Activity|Graduated Holes task (errors and error times)	Ohio State University	All	4 Years to 14 Years   (Child)	Phase 3	30	Other	Interventional	Allocation: Randomized|Intervention Model: Crossover Assignment|Masking: Double|Primary Purpose: Diagnostic	1998H0298	May 1999		June 2005	November 15, 2006		June 23, 2016	Ohio State University Nisonger Center, Columbus, Ohio, United States		https://ClinicalTrials.gov/show/NCT00399698
814	NCT04922684	Can Mimic Emotional Expression Training Help Improve Emotion Processing		Recruiting	No Results Available	Healthy	Behavioral: Mimic facial expressions	Intensity score of subjects' mimic facial emotions|Valence score of subjects' mimic facial emotions|Arousal score of subjects' mimic facial emotions|Task-dependent functional MRI data	University of Electronic Science and Technology of China	Male	17 Years to 30 Years   (Child, Adult)	Not Applicable	90	Other	Interventional	Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Basic Science	UESTC-neuSCAN-66	March 30, 2020	December 30, 2021	March 30, 2022	June 11, 2021		June 11, 2021	University of Electronic Science and Technology of China, Chengdu, Sichuan, China		https://ClinicalTrials.gov/show/NCT04922684
815	NCT02694003	Better Nights, Better Days for Children With Neurodevelopment Disorders	BNBD-NDD	Active, not recruiting	No Results Available	Nonorganic Insomnia|Neurodevelopmental Disorders|Primary Insomnia	Behavioral: BNBD-NDD Intervention	Disorder of Initiating and Maintaining Sleep (DIMS) Score|Sleep Diary|Actigraphy|Child Behavior Checklist (CBCL) to assess Child Psychosocial Health|Pediatric Quality of Life (Peds-QL)|Single Item Fatigue Impact Scale (SIFIS) to assess Caregiver Fatigue|Parenting Scale (PS) to assess Parenting Practices|Depression Anxiety Stress Scale (DASS-21) to assess Caregiver Psychological Health	IWK Health Centre	All	4 Years to 12 Years   (Child)	Not Applicable	218	Other	Interventional	Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Treatment	1024081	June 10, 2019	May 2022	May 2022	February 29, 2016		April 25, 2022	Dalhousie University, Halifax, Nova Scotia, Canada		https://ClinicalTrials.gov/show/NCT02694003
816	NCT02567357	Parents Resources for Decreasing the Incidence of Change Triggered Temper Outbursts	PREDICTORS	Completed	No Results Available	Child Behavior	Behavioral: Visual Scheduling|Behavioral: signalling change	Change in frequency of temper outbursts between baseline and intervention|Change in percentage of changes to routines/plans experienced by children that are followed by temper outbursts between baseline and intervention|Change in cost of services with which the child engages - Cost of Services Receipt Inventory|Process information on how the intervention strategies are being implemented by caregivers	Queen's University, Belfast|University of Warwick|University of Birmingham	All	7 Years to 16 Years   (Child)	Phase 1	80	Other	Interventional	Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Triple (Participant, Care Provider, Investigator)|Primary Purpose: Treatment	R2149PSY	January 2015	May 2017	June 2017	October 5, 2015		February 17, 2020	Queen's University Belfast, Belfast, Northern Ireland, United Kingdom		https://ClinicalTrials.gov/show/NCT02567357
817	NCT02792894	Family Networks (FaNs) for Children With Developmental Disorders and Delays	FaNs	Completed	No Results Available	Neurodevelopmental Disorders|Developmental Disabilities	Behavioral: Family networks program	Developmental Disorders- Children Disability Assessment Schedule (DD-CDAS)|Caregiver-Child Interaction|Strengths and Difficulties Questionnaire (SDQ)|Family Empowerment Scale (FES)|Inventory of Stigmatizing Experiences (Family version)|Pediatric Quality of Life (PedsQL) family impact module|Client Services Receipt Inventory (CSRI)|Clinical Global Impression (CGI)	Human Development Research Foundation, Pakistan|Grand Challenges Canada|Autism Speaks|World Health Organization|Institute of Psychiatry, Benazir Bhutto Hospital, Rawalpindi, Pakistan|University of Liverpool	All	2 Years to 12 Years   (Child)	Not Applicable	540	Other	Interventional	Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Single (Outcomes Assessor)|Primary Purpose: Treatment	746-05	April 2016	December 2017	April 2018	June 8, 2016		January 27, 2021	Human Development Research Foundation, Gujar Khan, Punjab, Pakistan		https://ClinicalTrials.gov/show/NCT02792894
818	NCT05620368	Mindfulness for Mothers of Children With Disabilities		Active, not recruiting	No Results Available	Parental Burnout|Caregiver Burnout	Behavioral: Mindfulness and Compassionate Living Course (MCLC)|Behavioral: Usual care intervention	Families in Early Intervention Quality of Life (FEIQoL)|Parental Burnout Measure (PBM-12)|Self-Compassion Scale (SCS)|Perceived Stress Scale (PSS-10)|Ego Resilience Scale (ER89)	University School of Physical Education in Wroclaw|University of Silesia in Katowice|Jan Dlugosz University in Czestochowa	Female	Child, Adult, Older Adult	Not Applicable	24	Other	Interventional	Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Single (Outcomes Assessor)|Primary Purpose: Treatment	01/2021	October 1, 2021	January 30, 2023	February 28, 2023	November 17, 2022		December 20, 2022	Wroclaw University of Health and Sport Sciences, Wroclaw, Lower Silesia, Poland|Jan Dlugosz University in Czestochowa, Częstochowa, Upper Silesia, Poland|University of Silesia in Katowice, Katowice, Upper Silesi, Poland		https://ClinicalTrials.gov/show/NCT05620368
819	NCT01741051	A Randomized Air Filter Intervention Study of Air Pollution and Fetal Growth in a Highly Polluted Community		Completed	No Results Available	Fetal Growth Restriction	Device: HEPA Filter	Gestational-age adjusted birthweight|Birthweight|Gestational age|Head circumference|Small for gestational age|Birth length|Child body mass index|Child wheeze|Child behavioural development|Child neurocognitive development|Child social development|Blood pressure|C-reactive protein|Stratified Analyses	Simon Fraser University|Canadian Institutes of Health Research (CIHR)	Female	18 Years and older   (Adult, Older Adult)	Not Applicable	540	Other	Interventional	Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Single (Outcomes Assessor)|Primary Purpose: Prevention	275997	January 2014	December 2019	December 2019	December 4, 2012		January 23, 2020	Mongolia National University of Medical Sciences, Ulaanbaatar, Mongolia		https://ClinicalTrials.gov/show/NCT01741051
820	NCT01329770	Safety and Efficacy Study of Antioxidants for the Treatment of the Fragile X Syndrome	SXF-TRA152	Completed	No Results Available	Fragile X Syndrome	Dietary Supplement: Ascorbic Acid (Vitamin C) and Alpha-tocopherol (Vitamin E)|Dietary Supplement: Placebo	Changes in the baseline Conner's Parent and Teacher Scales at 12 and 24 weeks|Change in the baseline measure of the Inventory of behaviour development (DBC-P24) at 12 and 24 weeks|Wechsler Intelligence Scale for children|Composite measure of blood and urine.	Yolanda de Diego Otero|The Mediterranean Institute for the Advance of Biotechnology and Health Research	Male	6 Years to 18 Years   (Child, Adult)	Phase 2	30	Other	Interventional	Allocation: Randomized|Intervention Model: Crossover Assignment|Masking: Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)|Primary Purpose: Treatment	2009-017837-23	December 2010	April 2015	April 2015	April 6, 2011		April 14, 2015	Psychiatric Service. Hospital Carlos Haya, Malaga, Spain		https://ClinicalTrials.gov/show/NCT01329770
821	NCT03218462	Effect of Sensory Adapted Dental Environment on Dental Anxiety of Children With Intellectual and Developmental Disabilities		Completed	No Results Available	Developmental Disability|Intellectual Disability|Dental Anxiety	Behavioral: Sensory Adapted Dental Environment (SADE)	Behavior during initial dental exam|Behavior during recall exam|Physiologic outcomes (oxygen saturation) during initial exam|Physiologic outcomes (oxygen saturation) during recall exam|Physiologic outcomes (hearts rate) during initial exam|Patient cooperation during initial exam|Patient cooperation during recall exam	Virginia Commonwealth University	All	6 Years to 21 Years   (Child, Adult)	Not Applicable	22	Other	Interventional	Allocation: Randomized|Intervention Model: Crossover Assignment|Masking: None (Open Label)|Primary Purpose: Supportive Care	HM20009272	July 10, 2017	March 30, 2018	March 30, 2018	July 14, 2017		April 18, 2018	Virginia Commonwealth University, Richmond, Virginia, United States		https://ClinicalTrials.gov/show/NCT03218462
822	NCT04665453	Dexmedetomidine and Melatonin for Sleep Induction for EEG in Children	MeloDex	Completed	No Results Available	Electroencephalography|Child|Dexmedetomidine|Melatonin|Sleep|Epilepsy	Diagnostic Test: Electroencephalography|Diagnostic Test: Monitoring of vital functions|Drug: Melatonin 0,1mg/kg oral syrup|Drug: Dexmedetomidine 3 mcg/kg sublingually|Drug: Dexmedetomidine 3 mcg/kg intranasally	Comparison of the three medical interventions on sleep initiation|Comparison of the three medical interventions on the depth of sleep and the most prominent sleep stage on EEG|Comparison of the three medical interventions on respiratory rate|Comparison of the three medical interventions on heart rate|Comparison of the three medical interventions on oxygene saturation|Comparison of the three medical interventions on blood pressure	University Medical Centre Ljubljana	All	1 Year to 20 Years   (Child, Adult)	Not Applicable	150	Other	Interventional	Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Diagnostic	0120-597/2019/16	September 1, 2020	September 1, 2022	October 1, 2022	December 11, 2020		November 2, 2022	University Medical Centre Ljubljana, Ljubljana, Slovenia		https://ClinicalTrials.gov/show/NCT04665453
